Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.8356788639862648,2.10953551648107,0.0,0.0356896020517774,0.02,10/23,11.11%,RYK;MAP2;MDGA2;TOX;GRID2;CHD5;OPHN1;PROX1;MDGA1;AGTPBP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.7372594426531159,1.959343682481144,0.0,0.44612002564721753,0.36,15/38,15.64%,IL15;EPHA3;ERBB4;ABL1;FER;IGF1R;ABL2;EGFR;ABI1;MAPK3;RELN;AATK;TTBK1;FYN;FLT1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.9320516177630015,1.9053069823739563,0.0,0.6186197688974749,0.53,2/10,1.18%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.7679594320414018,1.8995208401429617,0.0,0.4951932284684114,0.56,5/14,11.70%,LRFN4;LRRC4C;GPC4;LRFN5;PTPRS
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.7952403642351401,1.8818590632363035,0.0,0.5067923491352391,0.63,2/15,1.18%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.8461109963016046,-1.8407422408095406,0.0,0.007403344459481436,0.01,16/44,10.78%,CD44;B2M;HLA-F;HLA-B;TRIM5;HLA-C;TRIM25;RPL13A;IFNGR2;HLA-A;IRF1;OAS3;OAS1;MT2A;GAPDH;CAMK2A
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.9450408345112614,1.7989244927580326,0.0,1.0,0.91,2/7,1.18%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.7540942487583355,1.779749203315961,0.0,1.0,0.94,11/24,20.15%,RAB31;SPTBN1;RAB10;NSF;GGA1;SEC16A;KIF13A;BLZF1;ARFRP1;ANK3;GOLPH3
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.8692103628220085,-1.7772054020182115,0.0,0.014806688918962871,0.04,13/31,8.11%,CD44;B2M;HLA-F;HLA-B;TRIM5;HLA-C;TRIM25;IFNGR2;HLA-A;IRF1;OAS3;OAS1;MT2A
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.7810910547084667,1.7710761699884918,0.030303030303030304,1.0,0.97,3/12,4.91%,EHD1;NR1H2;PPARG
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.7857690933616126,1.7693266057512933,0.0,1.0,0.97,3/11,8.10%,GRAMD1B;OSBPL7;RORA
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7756602330163234,1.7646178011006903,0.05263157894736842,0.871150740991112,0.98,7/17,10.46%,IL1RAPL2;LRFN4;GPC4;IL1RAPL1;WNT7A;LRFN5;MDGA1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7756602330163234,1.7646178011006903,0.05263157894736842,0.871150740991112,0.98,7/17,10.46%,IL1RAPL2;LRFN4;GPC4;IL1RAPL1;WNT7A;LRFN5;MDGA1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.685420322908493,1.7600297290628086,0.0,0.8416797817210838,0.98,15/41,12.75%,IL1RAPL2;LRFN4;SYNDIG1;NLGN1;PDLIM5;SLIT1;GPC4;IL1RAPL1;WNT7A;NRXN1;GRID2;LRFN5;MDGA1;LHFPL4;ROBO2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6792536019089749,1.757988155534034,0.0,0.7975253381570259,0.99,7/23,13.75%,CRB2;NLGN1;IL1RAPL1;GRID2;NECTIN3;ALCAM;TENM3
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.8141559397984345,1.7570055182869007,0.03125,0.7494816430873255,0.99,2/12,3.53%,TOP1MT;ABL1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.9818012913205543,1.7534014362414956,0.0,0.7149816944372739,0.99,2/6,1.18%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.8498557423731946,1.7384819428040164,0.06060606060606061,0.7673264441132142,1.0,3/6,5.38%,PCDH15;MYO7A;NRXN1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.8480387428357306,-1.7371569368033564,0.0,0.08637235202728341,0.25,1/28,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5380604226110494,1.7326988352070067,0.0,0.7631276674012404,1.0,23/108,8.05%,PLD1;ASXL3;ERC2;NOVA2;CSRNP3;ADGRB3;RGS7BP;ASTN1;PCLO;NCS1;MAP2;PLD2;NRXN1;ANK2;LSAMP;UNC5D;CDC42BPA;GUCY1A2;SLC8A2;MAPK10;KCTD16;CACNA2D1;CNTN1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.716177220318934,1.7309115579358552,0.043478260869565216,0.7346109755657515,1.0,4/17,9.87%,ACACB;CPT1A;ACACA;CERT1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6726224772825055,1.7304465286170319,0.07692307692307693,0.7015824403336243,1.0,13/34,14.56%,NEDD4L;ADGRB3;HECW2;CAMSAP2;SEMA4D;CSMD3;VLDLR;DCC;BMP7;NEDD4;SDC2;COBL;RAP2A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7760754944194067,-1.729786274619834,0.0,0.07773511682455507,0.29,59/102,16.16%,RPS14;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RBM8A;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;RPS12;RPS28;RPL27A;RPS3A;PNRC2;RPS21;RPL41;RPL7A;RPL15;RPS13;RPL36;RPL18;RPL4;RPL9;NCBP1;RPLP0;CASC3;RPS4X;RPS20;UPF3B;UBA52;RPL18A;RPS7;MAGOHB
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.8369406715006303,-1.7287247147771885,0.0,0.06218809345964406,0.29,4/31,3.72%,CD44;IFI6;VEGFA;BEX3
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8001753266686951,-1.7272553019937735,0.0,0.05429119270286386,0.31,48/83,11.27%,RPS14;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;RPS12;RPS28;RPL27A;RPS3A;RPS21;RPL41;RPL7A;RPL15;RPS13;RPL36;ZFAND2B;RPL18;RPL4;RPL9
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.8369488665554405,-1.725313075611878,0.0,0.05393865249050759,0.36,5/35,3.72%,CD44;IFI6;VEGFA;NOL3;BEX3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7904158593874557,-1.720287745935212,0.0,0.052748829273805226,0.37,50/84,12.94%,RPS14;TMA7;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;RPS12;RPS28;RPL27A;RPS3A;RPS21;RPL41;RPL7A;RPL15;RPS13;RPL36;RPL18;RPL4;RPL9;RPLP0;RPS4X;RPL22L1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.7117892600852184,1.7179700261325186,0.041666666666666664,0.762865243856742,1.0,7/20,16.62%,KAT2B;SALL1;CHD7;SMOC1;KAT2A;BMPR1B;GREM1
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.8565222667338799,-1.7095881394280137,0.01282051282051282,0.05264600504520132,0.4,9/20,10.65%,DUOX1;FMO6P;IL20RA;FMO3;CP;CFTR;CLCA4;TMC4;VWA2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7794857916977861,1.706210079514601,0.0,0.8327573812081392,1.0,8/17,15.46%,SOX11;SHANK2;LIMD1;MAPK14;MOB3B;NF2;IQCJ-SCHIP1;WWC2
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7901430577759038,-1.7050143753608231,0.0,0.05182341121637004,0.43,47/86,11.27%,RPS14;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;RPS12;RPS28;RPL27A;RPS3A;RPS21;RPL41;RPL7A;RPL15;RPS13;RPL36;RPL18;RPL4;RPL9
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.9080074724968966,1.7037447645372121,0.0,0.807882810081143,1.0,3/7,4.04%,SOX11;GPNMB;FGL1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.8157905218258896,1.703368621632169,0.0,0.7781884969115812,1.0,4/8,16.73%,NEDD4L;HECW2;NEDD4;PRKCE
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.8522536723837422,1.7026666200071023,0.041666666666666664,0.7494816430873253,1.0,5/14,5.38%,NLGN4X;NLGN1;ASTN1;NCAM2;NRXN1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8291912766242746,-1.6990804459300868,0.0,0.049355629729876234,0.47,17/33,8.10%,IFI6;MX1;HLA-F;HLA-B;IFIT1;HLA-C;ISG15;PSMB8;IFIT3;IFI35;IFIT5;IFITM3;HLA-A;IRF1;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8291912766242746,-1.6990804459300868,0.0,0.049355629729876234,0.47,17/33,8.10%,IFI6;MX1;HLA-F;HLA-B;IFIT1;HLA-C;ISG15;PSMB8;IFIT3;IFI35;IFIT5;IFITM3;HLA-A;IRF1;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7352092495337202,-1.6988655710763483,0.0,0.04555904282757806,0.47,56/154,12.93%,RPS14;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;DXO;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RBM8A;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;POLR2G;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;RPS12;RPS28;RPL27A;RPS3A;PNRC2;DDX5;RPS21;RPL41;RPL7A;RPL15;RPS13;RPL36;RPL18;RPL4;RPL9;NCBP1;RPLP0;CASC3;RPS4X
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.855658584965442,1.6975613237626321,0.0,0.7523368112514676,1.0,4/10,5.38%,NLGN4X;NLGN1;WNT7A;NRXN1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5087557709048779,1.6944723975324776,0.0,0.7487953045863297,1.0,33/79,24.64%,PHLDB2;EPHA3;FAM107A;ABL1;RICTOR;MAPK1;RHOBTB1;TRAF3IP1;MAPK3;RAC3;MLST8;P2RX7;CLASP1;IQCJ-SCHIP1;ARHGAP44;GPM6B;CCDC88A;DIAPH1;MTOR;EPHA5;CRK;CYLD;BICD1;CDK10;ARHGAP35;TJP1;PTK2;TAOK2;BAIAP2;MAPT;DMTN;ARHGAP18;RHOQ
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.7282757440140054,1.6919137786329645,0.0,0.7395678647396096,1.0,9/25,15.53%,WNT7A;IGF1R;ARC;WASL;CHRNA7;ITGA3;DOCK10;CTNND2;FYN
prerank,MSigDB_Hallmark_2020__Apical Junction,0.5067301385027967,1.6894204829306991,0.0,0.7367353566402621,1.0,29/129,11.07%,MAPK11;CERCAM;SHROOM2;LAMA3;NEGR1;ARHGEF6;IRS1;THBS3;ADAM23;TNFRSF11B;VCAN;TRAF1;PPP2R2C;CADM2;ITGA2;MYH9;TUBG1;MAP4K2;HADH;NECTIN3;EGFR;CNTN1;MAPK14;WASL;PTPRC;MSN;ADAMTS5;PARD6G;NF2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.8892615598703201,-1.6836990373185394,0.0,0.058697945357317094,0.61,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.771295772083333,-1.6801318769741223,0.0,0.06120098086504653,0.63,60/94,17.79%,RPS14;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;RPS12;RPS28;RPL27A;RPS3A;RPS21;RPL41;RPL7A;RPL15;RPS13;RPL36;ZFAND2B;RPL18;RPL4;RPL9;RPLP0;RPS4X;RPS20;SPCS2;UBA52;RPL18A;CHMP4B;RPS7;SEC61G;RPL35;SRP14;RPS6
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.8655599121980512,1.6790162866788332,0.0,0.7882479349711526,1.0,3/9,5.71%,ACACB;CPT1A;ACACA
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7725029936719935,1.6779296665531196,0.03571428571428571,0.7738695378227067,1.0,7/11,16.16%,SOX11;TCOF1;WNT7A;PTPRC;SOX8;KLHL12;CDH2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.7727567613699053,-1.6773004473735489,0.0,0.06339113693430978,0.67,1/42,0.01%,CD44
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6745470780243898,1.6771876437294955,0.05555555555555555,0.7535111142867196,1.0,7/29,6.52%,SHROOM2;PBX3;MYO7A;PBX1;CHD7;SMOC1;MEIS1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.9071842809357856,-1.673099751810895,0.0,0.06575911843421746,0.68,1/13,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Basophils,-0.743005828223906,-1.6725234196279366,0.0,0.0629284279055922,0.68,2/39,0.97%,CD44;F13A1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7319030178883026,-1.670127686446761,0.0,0.06117500421782028,0.69,50/136,9.78%,RPS14;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;MRPS18C;RPS12;RPS28;RPL27A;RPS3A;MRPS7;COPS5;RPS21;RPL41;RPL7A;RPL15;RPS13;MRPL51;RPL36;MRPL27;RPL18
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.8269646934074703,1.652242247105714,0.0,0.9329485036347437,1.0,4/8,16.73%,NEDD4L;HECW2;NEDD4;PRKCE
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.859463844332871,1.6518574106273547,0.08,0.9079218461353675,1.0,4/7,11.11%,GRID2;OPHN1;PROX1;AGTPBP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.7554465837310216,-1.6512472810613625,0.0,0.08846996629080314,0.81,4/49,3.72%,CD44;IFI6;VEGFA;BEX3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.6051037522113099,1.6510754995660368,0.05,0.886466733315471,1.0,18/40,20.15%,ARFGEF2;RAB31;SPTBN1;RAB10;NSF;GGA1;OSBPL5;STXBP6;KIF13A;BLZF1;EXOC2;ARFRP1;EXOC6;ARL3;EXOC4;EXOC6B;ANK3;GOLPH3
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5911042070988762,1.650813563541395,0.0,0.8626686667372481,1.0,31/99,10.36%,ASXL3;FAM149A;LMO3;CSRNP3;CNTN3;RGS7BP;ERBB4;SORBS2;UNC5C;PCLO;PCP4;TOX3;MAP2;PBX1;ESRRG;NRXN1;FGF12;ANK2;NOL4;MEIS1;NOVA1;GUCY1A2;PDZRN4;MAPK10;MAGI1;FGF14;NFIB;CNTN1;LONRF2;PROX1;ADGRA1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9125334046179755,-1.6466281338516753,0.0,0.08989775415084598,0.82,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8342551637403623,1.6462113667304399,0.058823529411764705,0.8803435172771759,1.0,1/8,0.20%,TOP1MT
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6138687158037535,1.6456050073691748,0.0,0.859926492679988,1.0,13/43,16.27%,BCAR1;ATP2C1;RICTOR;MYH9;GAB1;FER;CDC42BPA;AUTS2;NRP1;RAP2A;MCU;SIPA1L1;RALA
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.8255710401812257,1.6379566140649597,0.0,0.8870744509974673,1.0,5/11,8.71%,AKR1C2;AKR1C3;STARD3;FDX1;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6575603716766476,1.6370786826063526,0.0,0.8743952502685465,1.0,2/12,4.09%,EHD1;PLIN5
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6118405636427894,1.6347177022062138,0.045454545454545456,0.865472849755602,1.0,7/23,9.84%,ZDHHC2;FAM107A;ABL1;YTHDF1;ARC;RELN;CHRNA7
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.7066211335302333,1.632759404738824,0.043478260869565216,0.860032361637953,1.0,2/11,11.43%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.782348964609286,1.6326583836740958,0.037037037037037035,0.8395554006465731,1.0,3/15,5.71%,ACACB;CPT1A;ACACA
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.626613036666268,1.6321124633606257,0.0,0.8241808101724409,1.0,10/37,9.65%,LGR5;ADRA1A;ADGRB3;CALCRL;CALCB;ADGRL3;GNG2;ADCY6;GNAQ;RXFP1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.8055711992721022,-1.6307554794171717,0.0,0.12417427752493862,0.91,2/37,1.12%,CD44;ITGA4
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.8427920151504305,1.629076171331324,0.02857142857142857,0.814516029048342,1.0,2/8,4.78%,IRS1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.8427920151504305,1.629076171331324,0.02857142857142857,0.814516029048342,1.0,2/8,4.78%,IRS1;SIRT1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.9656707054748375,1.6273977429542674,0.0,0.8092229334783442,1.0,1/6,1.74%,FKBP7
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.7509570060602888,1.622095382258267,0.058823529411764705,0.8333901755707595,1.0,2/12,1.16%,RANGAP1;BARD1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6828371401123896,-1.6181293847457074,0.0,0.15064196552336137,0.94,65/186,16.05%,RPS14;TMA7;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;MRPS18C;RPS12;RPS28;RPL27A;RPS3A;MRPS7;COPS5;RPS21;RPL41;RPL7A;RPL15;RPS13;NARS1;MRPL51;RPL36;MRPL27;RPL18;RPL4;RPL9;RPLP0;RPS4X;RPL22L1;MRPL36;RPS20;AIMP1;SARS1;ZC3H15;UBA52;RPL18A;RPS7
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7635743895770256,1.6179888655386456,0.0,0.8502304155459887,1.0,3/10,11.43%,NEDD4L;SLC12A1;SLC8A1
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8226643200180296,1.612442127013255,0.041666666666666664,0.8740310706557731,1.0,1/10,0.11%,VAPB
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.7161944549289517,1.610109794611093,0.05555555555555555,0.8736814582275108,1.0,1/25,0.01%,CPA1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.9058878885867255,1.6097165771248008,0.0,0.8582999395393134,1.0,3/6,8.99%,ABL1;MAP2K6;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8472139004749337,-1.6076406413372606,0.0,0.17860568508498964,0.96,1/20,0.01%,CD44
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7364332717974028,-1.6076217430365805,0.0,0.17146145768159005,0.96,22/52,17.29%,NDUFA1;COA6;NDUFS5;NDUFA12;UQCRQ;NDUFB2;NDUFB11;COX4I1;NDUFC1;UQCR10;NDUFB9;COX7C;NDUFA6;NDUFAF1;COX7B;COX5B;UQCRB;COX6C;NDUFS7;CYC1;UQCC3;NDUFB7
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7478402540192579,1.6065423363364613,0.0,0.8634138342526149,1.0,6/16,12.24%,CRB2;PARD3;LRRC7;ERBIN;DLG2;PARD3B
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8232113335731156,-1.6050773591073053,0.0,0.17312436274479664,0.97,2/18,4.39%,CD44;PLET1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8914818274440732,1.6044904200181145,0.0,0.8696815292428399,1.0,2/8,5.38%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.8929211158460765,-1.5997623116789637,0.0,0.18261583000054207,0.99,3/11,6.41%,CD44;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8974459595568536,1.5992403213268336,0.03225806451612903,0.8991796961378362,1.0,3/6,3.39%,ZSWIM6;ERBB4;SALL1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6489554030332014,1.598637305405713,0.05263157894736842,0.8867243855227968,1.0,8/24,11.70%,SEMA3B;MAP2;DIP2B;SEMA4D;SEMA6C;SEMA3A;SEMA6A;PTPRS
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8433670084008829,1.5982348913874178,0.041666666666666664,0.874713907429723,1.0,1/10,0.01%,CPA1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7441438505246523,1.597859257411745,0.029411764705882353,0.8609333828279637,1.0,3/9,5.38%,NLGN1;PCLO;NRXN1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7737683763308034,-1.592105694959287,0.011764705882352941,0.20702923970621295,1.0,10/33,9.89%,CD44;MX1;IFIT1;PLSCR1;IFIT3;NAAA;IFITM3;IGSF6;OAS1;FN1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7545475898560641,1.5903028477921457,0.0625,0.9027007967234044,1.0,1/10,0.11%,PKP2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7310201122124992,1.588286880281985,0.0,0.9022210416987456,1.0,2/12,5.39%,VTI1A;TMED5
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.8107921675640324,-1.5876225623860345,0.0,0.2159734280248722,1.0,2/24,4.32%,CD44;FLOT1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5078983685818353,1.5875169614369744,0.0,0.8919426379440035,1.0,43/114,16.18%,DPYSL5;ERC2;NOVA2;CSRNP3;LRRC4C;EPHA3;ADGRB3;STIM2;ASTN1;ZNF536;PCLO;CADM2;ROBO1;NRXN1;ADGRL3;ANK2;NOL4;LSAMP;NOVA1;SLC8A2;LRRTM3;NPAS3;SOX5;NXPH1;CTNNA2;CLVS2;PROX1;ADGRA1;FUT9;SLC35F1;GRIK3;KIF1B;ROBO2;KCNQ2;EFR3B;BCL2;TTBK1;ADCYAP1R1;ATRNL1;CTNND2;GPM6B;CAMKV;PURG
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7768373362439652,1.5872899656569923,0.02631578947368421,0.8657606691269873,1.0,7/10,18.16%,RAP2B;RAPGEF6;MAP4K4;RAPGEF2;RAP2A;RAP1A;RAP1B
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7768373362439652,1.5872899656569923,0.02631578947368421,0.8657606691269873,1.0,7/10,18.16%,RAP2B;RAPGEF6;MAP4K4;RAPGEF2;RAP2A;RAP1A;RAP1B
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9291724806625326,-1.5872576248642578,0.0,0.2095146482033246,1.0,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.7572570053999518,1.5867084388272232,0.03333333333333333,0.8576834524823966,1.0,4/11,15.50%,PLIN5;PPARG;OSBPL8;ABHD5
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.7000095489101513,1.5847815965660466,0.10714285714285714,0.8585022243548642,1.0,6/13,21.20%,RIPOR2;OXSR1;WNK1;LRCH1;PTK2B;SH2B3
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7273215513133905,-1.5845690672815063,0.0,0.20944300293436185,1.0,22/51,18.72%,NDUFA1;NDUFS5;NDUFA12;UQCRQ;NDUFB2;NDUFB11;COX4I1;NDUFC1;UQCR10;NDUFB9;COX7C;NDUFA6;NDUFAF1;COX7B;COX5B;UQCRB;COX6C;NDUFS7;CYC1;UQCC3;NDUFB7;NDUFA3
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8188674324748983,-1.5835232399325079,0.0,0.20636822680804498,1.0,3/26,2.25%,CD44;HES5;DDRGK1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7500002706024695,1.5826502536475804,0.0625,0.8601194094478354,1.0,5/12,13.06%,TRPS1;SOX5;KAT2A;ZBTB16;BMPR1B
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.852139320341812,-1.5811676278425881,0.0,0.20684495732248132,1.0,4/13,9.46%,CD44;TGFB1;CEMIP;HAS2
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.865083134225793,1.5809657261463872,0.0,0.8589838312007334,1.0,4/8,8.31%,AKNA;CEP120;WNT7A;PCM1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.8156668241517836,1.577971169030845,0.0,0.8656060199125116,1.0,5/9,11.03%,ABL1;IGF1R;EGFR;MAPK3;AATK
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7038086310903726,-1.5767422351604359,0.0,0.21905189783053894,1.0,62/141,19.02%,RPS14;RPLP1;RPL12;RPL31;RPS24;RPS2;DHX37;RPL30;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;DDX27;RPL19;RPL38;RPL13A;RPS16;RPL23A;RPL14;NOB1;RPS28;RPL27A;LAS1L;UTP15;IMP3;RPL41;RPL7A;RPL15;RPL36;RPL18;NOL6;RPL4;RPL9;NOP58;RPLP0;EMG1;NOP14;NOP56;UBA52;RPL18A;UTP3;RPS7;WDR12;RPL35;RPS6;DKC1;NIFK;RPL5;PELP1;RPL6
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.9080655370585053,1.5742753171905033,0.058823529411764705,0.8754449444465399,1.0,3/6,4.78%,LMO3;PLIN5;SIRT1
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8943228707316636,1.5726959477817466,0.029411764705882353,0.8733607690496542,1.0,3/6,9.84%,CHRM3;ATP2B4;CHRNA7
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7711041907040499,1.5724278262945994,0.0,0.8626686667372481,1.0,4/12,4.70%,SYNDIG1;RAB27A;NLGN1;SYNJ1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.8187613703425058,1.5700450515668443,0.10256410256410256,0.8711278923342287,1.0,3/8,13.26%,FNBP1L;SNX33;PACSIN2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.8614627117113007,1.5696193699879286,0.04,0.8620030273339014,1.0,4/7,12.67%,ERC2;FCHSD2;ERC1;KIF1B
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7352678344270303,1.5689218376961453,0.03333333333333333,0.856305999913536,1.0,2/9,11.43%,NEDD4L;SLC8A1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.7638900254540867,-1.5677143759765966,0.0,0.2529828563868513,1.0,9/37,6.81%,CD44;ITGA4;A2M;JUN;IFNGR2;HAX1;TGFB1;IL3RA;IRF1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.873379201453105,1.5669606473015838,0.0,0.8594442007603693,1.0,3/8,5.38%,NLGN4X;NLGN1;NRXN1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7259709397368344,1.5657343838033542,0.0,0.8570263106033481,1.0,5/14,14.23%,NLGN1;TSHZ3;NRXN1;RELN;CACNG2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.741850139929259,-1.5651060244698556,0.0,0.2572662199669799,1.0,5/37,3.57%,B2M;FTH1;FTL;CP;NUBP1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6883135484638616,1.5650101285947833,0.0,0.8516196489591885,1.0,10/20,18.58%,POT1;STN1;TNKS;GNL3L;CTC1;ERCC4;HNRNPC;TERF1;TERF2;XRN1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6965386455011117,-1.5632973742000782,0.011363636363636364,0.25851678490945984,1.0,4/61,2.99%,CD44;CD63;ITGA4;ECM2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.5974522250100921,1.5624891256154791,0.06666666666666667,0.8565504492426578,1.0,7/32,11.88%,DYNC2LI1;IFT140;PCM1;TRAF3IP1;IFT172;SSX2IP;KIF3C
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.75337943579511,1.5621836560321771,0.0,0.8476280487297134,1.0,7/16,14.56%,PARD3;FERMT1;OPHN1;MSN;CLASP1;CYTH1;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9094254115525822,-1.5621668642701303,0.0125,0.2563895081230939,1.0,1/11,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8952760926100425,1.5608452242437847,0.0,0.8461598056073301,1.0,1/5,1.49%,LMO3
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.8705158759704733,-1.559326561030294,0.014705882352941176,0.25856180524738914,1.0,2/11,3.72%,CRYM;PIPOX
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.8705158759704733,-1.559326561030294,0.014705882352941176,0.25856180524738914,1.0,2/11,3.72%,CRYM;PIPOX
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.8549871250604745,1.5589918808573051,0.0,0.8494125288323023,1.0,3/10,5.13%,NLGN4X;NLGN1;IL1RAPL1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.7896943250682961,1.5588271891813126,0.0,0.8395868729587882,1.0,1/10,0.08%,DPYD
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.6116657981112348,1.5588087687979555,0.06896551724137931,0.8293480086544127,1.0,4/24,7.87%,RPA1;ESR1;ATR;TNKS
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.7371645507940201,-1.5575638679222912,0.0,0.2594781948359713,1.0,7/53,8.00%,CD44;VEGFA;PFN2;CAMK1;HAX1;TGFB1;HDAC6
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7976392506222224,-1.5572376274885524,0.0,0.2541814931088626,1.0,3/30,2.25%,CD44;HES5;DDRGK1
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9373198337389197,-1.5551301787754792,0.0,0.2568788356638675,1.0,1/9,0.01%,CD44
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.5442348002532461,1.5546794168165134,0.0,0.8475205499283526,1.0,8/56,7.42%,ABHD3;NUDT19;ACADS;ACADVL;ACAA2;MMAA;HADH;PLA2G15
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.7161763747094699,-1.5544740720385244,0.0,0.25440583688036206,1.0,5/57,3.53%,CD44;POLR2I;SFRP1;FGF1;POLR2G
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.9123446746286848,1.5539292242618832,0.024390243902439025,0.8421046579359858,1.0,2/5,5.38%,NLGN1;NRXN1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7416101948252294,-1.5538678612826458,0.0,0.25122015532507,1.0,9/30,9.34%,NDUFA1;NDUFS5;NDUFA12;NDUFB2;NDUFB11;NDUFC1;NDUFB9;NDUFA6;NDUFAF1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6645983108054349,1.5530941762123769,0.07142857142857142,0.8370261375319793,1.0,5/22,5.84%,ACACB;CPT1A;PPARG;ACACA;RPS6KB1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8108833528065424,1.5503149000221936,0.0,0.8436855926891099,1.0,2/8,4.81%,GRAMD1B;OSBPL7
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7524579119568149,1.5452388450979013,0.06060606060606061,0.8680367579489767,1.0,3/10,12.40%,SYNJ1;INPP1;OCRL
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6990356961777392,1.5449706106979346,0.10714285714285714,0.8606060858394504,1.0,6/21,9.14%,HOMER1;NCS1;IL1RAPL1;NTNG2;ZNF804A;CTNNA2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.855106722691974,1.5446041924366536,0.0,0.853943905272584,1.0,3/9,5.13%,NLGN4X;NLGN1;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.919597063609658,-1.5439620466464068,0.0,0.2914664525243669,1.0,2/9,3.27%,PPIF;COX7A2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6779759969282763,-1.5439117480024234,0.0,0.28542255660809274,1.0,65/175,19.02%,RPS14;RPLP1;RPL12;RPL31;RPS24;RPS2;DHX37;RPL30;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;DDX27;RPL19;RPL38;RPL13A;RPS16;RPL23A;RPL14;NOB1;RPS28;RPL27A;LAS1L;UTP15;IMP3;RPL41;RPL7A;RPL15;RPL36;RPL18;NOL6;RPL4;RPL9;NOP58;RPLP0;EMG1;HNRNPA2B1;NOP14;NOP56;SARS1;UBA52;RPL18A;UTP3;RPS7;SRRT;WDR12;RPL35;RPS6;ADAR;DKC1;RPL5;PELP1;RPL6
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.8807251378436107,1.5432595881745355,0.041666666666666664,0.8511970089348909,1.0,2/6,7.44%,CPT1A;CPT1C
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6789115935126585,-1.5409523225003752,0.0,0.29443717860729296,1.0,63/154,19.02%,RPS14;RPLP1;RPL12;RPL31;RPS24;RPS2;DHX37;RPL30;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;DDX27;RPL19;RPL38;RPL13A;RPS16;RPL23A;RPL14;NOB1;RPS28;RPL27A;LAS1L;UTP15;IMP3;RPL41;RPL7A;RPL15;RPL36;RPL18;NOL6;RPL4;RPL9;NOP58;RPLP0;EMG1;NOP14;NOP56;UBA52;RIOK2;RSL1D1;RPL18A;UTP3;RPS7;WDR12;RPL35;RPS6;DKC1;RPL5;PELP1;RPL6
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.5233585794725919,1.540296696874726,0.0,0.8602762868194915,1.0,20/47,24.64%,EPHA3;FAM107A;ABL1;RICTOR;RHOBTB1;RAC3;MLST8;ARHGAP44;GPM6B;CCDC88A;MTOR;EPHA5;CRK;CDK10;ARHGAP35;TAOK2;BAIAP2;DMTN;ARHGAP18;RHOQ
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6966393425146684,1.5394763094395623,0.0,0.8563564840141153,1.0,6/19,7.55%,PKP2;NEDD4L;FGF12;ANK2;GPD1L;CACNA2D1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.8781661476062939,1.5385521097857544,0.0,0.8540560146906516,1.0,4/10,6.74%,PKP2;NEDD4L;ANK2;GPD1L
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6786760462901869,1.538397434092561,0.043478260869565216,0.8461093422594248,1.0,8/19,18.14%,PHLDB2;FAM107A;SLIT1;ROBO2;IKBKB;CORO1C;ARHGAP6;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8584965569228837,-1.5382902938904763,0.013157894736842105,0.30172405888947806,1.0,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.922119498517014,1.538135739054295,0.0,0.8387056482167689,1.0,1/6,0.11%,PKP2
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.7887846063879611,-1.5375566042330562,0.0,0.3005757850549463,1.0,3/16,3.65%,COA6;SURF1;COX18
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.611037849837298,1.5353614581208572,0.05,0.8472562820416739,1.0,8/37,11.09%,IL15;NOVA2;PLCL1;NR1H2;MAP2K6;NOVA1;ADAMTS5;IP6K1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.7398023764634182,1.5339105045846133,0.043478260869565216,0.8486398673445833,1.0,5/21,9.66%,IL15;RAB27A;MERTK;RAB31;PTPRC
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5334083440087541,1.5323216313666934,0.07142857142857142,0.8498131264063526,1.0,19/56,13.14%,EMILIN3;SOX11;SPSB4;DPYSL5;NLGN4X;TOX3;CNTNAP2;MYCN;GAL3ST3;UNC5D;GRID2;BMP7;TMEM200C;SEMA6A;DNMT3B;MEX3A;TRIM71;IGLON5;KCNQ2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.8008591342412879,1.5307651436440437,0.058823529411764705,0.850421931718615,1.0,3/8,7.85%,LEPR;SIRT1;BBS4
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.7438666584662583,1.5302194131929427,0.11428571428571428,0.8431668484732412,1.0,3/10,13.34%,SOX11;PTPRC;LTBP3
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.69207398752484,-1.5296028626283993,0.0,0.33750540918224187,1.0,6/53,3.99%,SLC28A2;RIMS1;LIN7B;PPFIA4;DVL1;NAAA
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7685666332547499,1.529367837679734,0.037037037037037035,0.8395890542081496,1.0,4/12,4.98%,CPA1;TSPAN8;GIPC2;AKR1C3
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6792775050085665,-1.5287803634710078,0.0,0.3361403128622244,1.0,66/170,18.62%,RPS14;RPLP1;RPL12;RPL31;RPS24;RPS2;DHX37;RPL30;RBIS;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;RPS9;RPL23;RPS15;DDX27;RPL19;RPL38;RPL13A;RPS16;RPL23A;RPL14;NOB1;RPS28;RPL27A;LAS1L;UTP15;IMP3;RPL41;RPL7A;RPL15;RPL36;RPL18;RPF2;NOL6;GLUL;RPL4;RPL9;NOP58;RPLP0;EMG1;MRPL36;SURF6;NOP14;NOP56;UBA52;RIOK2;RPL18A;UTP3;RPS7;WDR12;RPL35;RPS6;DKC1;RPL5;PELP1
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.838705079707222,1.528570664340431,0.025,0.8369561579201132,1.0,2/5,9.87%,GLTP;CERT1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.5898055615978918,1.5275872658161513,0.0,0.8347208868226385,1.0,16/29,20.27%,HOMER1;GRIK2;PLCB1;GRID2;GNAQ;GRIA3;GRIK3;GRIN2B;GRIK4;CPEB4;GRM8;GRIK1;GRM5;PTK2B;GRIN1;GRM7
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.788158934609981,-1.5252899686696684,0.013333333333333334,0.3485159325737015,1.0,2/18,1.74%,DUOX1;VEGFA
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.7591296385106499,-1.5251477761378665,0.013157894736842105,0.342884527651168,1.0,5/21,10.26%,HES5;HES1;ATP6AP2;BHLHE41;HES4
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6325709837082707,1.524710943592266,0.0,0.8448826947257304,1.0,5/23,7.78%,ZNF358;MBNL1;SALL1;WNT7A;MYH3
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.6979173014143769,1.5245966371627797,0.038461538461538464,0.8371760938431213,1.0,5/13,15.12%,INTS6L;INTS7;INTS6;INTS11;INTS8
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.698795846791701,1.5241393347597056,0.06896551724137931,0.8314667194987199,1.0,7/13,17.05%,RIPOR2;DAPK2;THBS4;MCU;JAM3;SLIT2;MOSPD2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.5080876721553409,1.5238022060313183,0.0,0.8265311577972374,1.0,18/51,13.20%,MAPK11;MAP3K5;ARHGEF6;TAB3;MAP3K11;BTRC;MAP4K2;MAPK1;MAPK10;MAPK14;FBXW11;MAPK3;MAP3K7;TAB1;TAB2;UBE2N;MAP3K8;MAPK8
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8509769158445024,1.522079935220358,0.02857142857142857,0.831270314455982,1.0,1/6,2.83%,RFWD3
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8197644094794877,1.5218641829290476,0.09090909090909091,0.8247899776919935,1.0,5/7,16.26%,SALL1;PKD2;BMP7;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.8573056877281872,-1.5215502309004385,0.02531645569620253,0.35643738415830617,1.0,3/11,5.16%,ROMO1;RPL30;RARRES2
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.8281283774076399,1.5212649796350115,0.02702702702702703,0.8206986217270086,1.0,2/5,3.98%,PRR5L;RICTOR
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7448830541516649,1.5211955859564352,0.06666666666666667,0.8144302882626321,1.0,3/12,8.83%,SHANK2;LIMD1;MAPK14
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.7288181809192636,1.5177614978820329,0.1,0.8299425762844129,1.0,3/13,11.08%,ATF7IP;SIRT6;TRIM28
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.7923434540884605,-1.5167814285279841,0.0,0.3780993777520875,1.0,3/27,7.22%,CD44;LFNG;RASGRP1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7098308658095148,1.5164627878964232,0.04,0.8309676371524456,1.0,5/11,21.90%,EPHA3;NRCAM;SEMA5A;MEGF8;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4982664306956332,1.5155660647597233,0.0,0.829939781046157,1.0,25/61,24.64%,EPHA3;FAM107A;ABL1;RICTOR;ABL2;RHOBTB1;RAC3;PIK3CA;MLST8;ARHGAP44;GPM6B;CCDC88A;EPS8;MTOR;EPHA5;PTK2B;CRK;CDK10;ARHGAP35;TWF1;TAOK2;BAIAP2;DMTN;ARHGAP18;RHOQ
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.7500622626433735,1.5145359210338831,0.03333333333333333,0.8286194563325711,1.0,3/12,13.61%,ZFYVE27;RAB10;ATL2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.9278659477758477,-1.513457281112488,0.0,0.3934163222415661,1.0,2/6,2.36%,COA6;NDUFA12
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6241722016109026,1.5127706285851472,0.04,0.8322445995694644,1.0,5/17,9.70%,RANGAP1;BARD1;TAF3;BBS4;PML
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.6984016064622158,-1.5125138876532005,0.011363636363636364,0.392249612482525,1.0,7/54,6.19%,B2M;HLA-F;HLA-B;PSMB9;HLA-C;PSMB8;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.6245504653812455,1.5119013658742535,0.14285714285714285,0.8310796648723722,1.0,8/17,18.60%,NAV3;CAMSAP2;CLASP1;KATNB1;HDGFL3;ATXN7;CLASP2;TTBK2
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.7681641633050491,1.511355835686681,0.037037037037037035,0.8263050237750497,1.0,5/12,13.57%,ANK2;CACNA2D1;STIM1;BCL2;ORAI1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6021743977735569,1.5112715533368557,0.07692307692307693,0.8199611093240287,1.0,12/33,17.12%,EPHA3;ERBB4;ABL1;FER;ABL2;EGFR;ABI1;RELN;TTBK1;FYN;FLT1;PKDCC
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.8126957629923056,1.5110572555457507,0.07692307692307693,0.8144664601566034,1.0,4/8,18.16%,FERMT1;FBLIM1;JAM3;RAP1B
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.606817377633249,1.5100226021679128,0.0,0.8156991278858711,1.0,5/32,11.87%,USP51;RFWD3;ABL1;SMG1;UBE2N
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7528481686840474,1.5088070591009894,0.06060606060606061,0.8098347912724448,1.0,3/9,12.40%,SYNJ1;INPP1;OCRL
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.7528481686840474,1.5088070591009894,0.06060606060606061,0.8098347912724448,1.0,3/9,12.40%,SYNJ1;INPP1;OCRL
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.8542022121412435,-1.5084642446337184,0.0,0.4114502793667733,1.0,4/11,6.56%,PPIF;NOL3;CLU;PRELID1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.6145021786453267,-1.5083479263752353,0.0,0.40508633100795916,1.0,46/298,10.78%,CD44;DUOX1;B2M;IFI6;MX1;HLA-F;HLA-B;IFIT1;F13A1;TXNDC17;OPRM1;TRIM5;PSMB9;VEGFA;IL20RA;HLA-C;RPS27A;ISG15;PSMB8;NDN;IFIT3;IFI35;TRIM25;ALOX5;IL12RB2;SNRPA1;IFIT5;IFITM3;IFNGR2;TGFB1;HLA-A;GSTO1;IL3RA;IRF1;OAS3;RSAD2;OAS1;MT2A;CEACAM1;FN1;IL5;STAT5A;OSMR;PIK3CB;PSMA3;CAMK2A
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.8798588345540727,1.507764361419715,0.06060606060606061,0.8099237110782388,1.0,2/6,7.42%,STARD3;FDX1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5885084393078626,1.5066137890924693,0.1111111111111111,0.810153966575347,1.0,3/28,3.88%,DUSP4;DUSP7;PTPN13
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7731793284922325,-1.506424502163596,0.012658227848101266,0.40997537023161135,1.0,7/24,10.60%,EPN1;VEGFA;FGF1;ALOX5;CEACAM1;PIK3CB;GLUL
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.9383940285027146,-1.5058332621344221,0.015873015873015872,0.4006031946408288,1.0,4/5,6.19%,HLA-F;HLA-B;HLA-C;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.9383940285027146,-1.5058332621344221,0.015873015873015872,0.4006031946408288,1.0,4/5,6.19%,HLA-F;HLA-B;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.8570912742438965,1.504660584335607,0.10344827586206896,0.8137795769425117,1.0,1/5,6.94%,FOXP1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.672815231032068,-1.5036159578282247,0.03529411764705882,0.3996667032049286,1.0,12/50,10.18%,NDUFA1;NDUFS5;NDUFA12;NDUFB2;NDUFB11;NDUFC1;NDUFB9;NDUFA6;NDUFAF1;TMEM126B;ECSIT;FOXRED1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.672815231032068,-1.5036159578282247,0.03529411764705882,0.3996667032049286,1.0,12/50,10.18%,NDUFA1;NDUFS5;NDUFA12;NDUFB2;NDUFB11;NDUFC1;NDUFB9;NDUFA6;NDUFAF1;TMEM126B;ECSIT;FOXRED1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7464689467087449,1.503226733197245,0.1111111111111111,0.8156619681518419,1.0,5/15,14.86%,WNT7A;ARC;WASL;DOCK10;CTNND2
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.795461460556828,-1.5022045202108396,0.012658227848101266,0.4012388353267438,1.0,1/18,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7730179746719131,-1.501304837558894,0.013157894736842105,0.40011209384749663,1.0,2/21,4.41%,CD44;IL12RB2
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7806946177556185,1.499919244462651,0.04,0.8297832477038246,1.0,3/9,12.94%,HSPA1A;DNAJA4;BAG5
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.8287886785184155,1.4994542673711786,0.06666666666666667,0.8265324506177131,1.0,2/7,3.78%,PHLDB2;FERMT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.6878345308873689,-1.499297968897752,0.011235955056179775,0.4056597272945269,1.0,7/56,6.19%,B2M;HLA-F;HLA-B;PSMB9;HLA-C;PSMB8;HLA-A
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.7939976656819437,1.4984624082328728,0.03333333333333333,0.8264888228990451,1.0,1/9,0.08%,DPYD
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.8327664340384645,1.4978980451746295,0.0,0.8239939038595477,1.0,1/6,8.83%,JADE3
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6899017102864574,1.4976439824863261,0.10344827586206896,0.8203200956446413,1.0,2/12,10.43%,SLC25A18;GPD2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9734357875120738,-1.4965967417161608,0.0,0.414909174272677,1.0,1/6,0.29%,APIP
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.8177210237346386,1.4955944247681885,0.05555555555555555,0.8270327332599846,1.0,2/6,5.87%,LAMA3;LAMC1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.666246533550585,1.494170036229513,0.045454545454545456,0.8287178864485476,1.0,6/15,11.23%,PDE4B;PDE4D;SPTBN1;PTPRC;MAP3K7;PNP
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.8043986453774847,1.4937965179636234,0.14634146341463414,0.8235045214169379,1.0,3/6,11.06%,AKR1C3;H6PD;DGKQ
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6938905148752602,-1.4932872463633433,0.011904761904761904,0.42791330975802694,1.0,7/48,5.96%,CD44;VEGFA;SFRP1;ENPP2;HAX1;TGFB1;AGT
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6721345842311974,-1.4930180980566234,0.03333333333333333,0.4230333587621997,1.0,25/60,19.76%,IFI6;MX1;IFIT1;TRIM5;ISG15;PLSCR1;IFIT3;AGBL5;IFIT5;IFITM3;IRF1;OAS3;RSAD2;OAS1;NLRP1;RNASE1;NLRC5;DDIT4;IFIT2;SKP2;STAT1;SHFL;EIF2AK2;TRIM52;CGAS
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5614808138784968,1.4927060526993552,0.047619047619047616,0.8237475061803622,1.0,5/30,7.60%,RIPOR2;SPRY4;LZTR1;ABL2;KANK1
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.7649927980328044,1.4925775183179095,0.06666666666666667,0.8190372908816653,1.0,1/8,1.15%,MOXD1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.9210965247031604,-1.4922300412657938,0.014285714285714285,0.42137368881881837,1.0,1/7,0.24%,B2M
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7647707994399745,1.4915932883989218,0.05128205128205128,0.8196970558196266,1.0,3/10,6.33%,IRS1;IGF1R;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.7349964133032388,1.4885841084733435,0.13793103448275862,0.8325434147689801,1.0,5/9,20.46%,ZKSCAN3;SIRT1;TERF2;CDK6;AKT3
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.7907169892872856,1.486661362660021,0.058823529411764705,0.8383232596233571,1.0,2/9,5.16%,SALL1;WNT7A
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.7661993558627855,1.4856463051964643,0.125,0.8371869417464806,1.0,2/8,2.73%,SMPD4;SGMS1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7140375891707532,-1.4854994484710649,0.011627906976744186,0.4562060910166939,1.0,4/31,5.93%,CD44;A2M;FLOT1;CTSL
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7140375891707532,-1.4854994484710649,0.011627906976744186,0.4562060910166939,1.0,4/31,5.93%,CD44;A2M;FLOT1;CTSL
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.8159388295672149,1.4854099237165026,0.0,0.8329249380252839,1.0,3/7,11.13%,TRERF1;UBR5;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.8246441503171774,1.4853972187766518,0.0,0.8271002881090231,1.0,2/10,10.27%,PC;VAPA
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.47530752756856254,1.4845853194391105,0.0,0.8258177363647382,1.0,5/153,2.31%,CPA1;ATG4A;MMP16;CTSV;ADAM10
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.8729796389377609,1.4844439876852593,0.05,0.8209839147841622,1.0,2/5,9.72%,SLC15A2;XIAP
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.774486485008775,-1.484119869372834,0.030303030303030304,0.45811895515271117,1.0,3/13,6.19%,ROMO1;RARRES2;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.9321450080469125,-1.4836845924021314,0.017857142857142856,0.45550050911230516,1.0,5/6,6.19%,B2M;HLA-F;HLA-B;HLA-C;HLA-A
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.6979947462310933,-1.4830183012551093,0.0,0.45448843194764604,1.0,10/63,10.88%,CD44;F13A1;ITGA4;TAF7;IL3RA;MAFF;PROCR;FPR3;RNASE1;MGST1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.888588705590456,-1.4827878101018082,0.0125,0.45093960932046534,1.0,2/10,4.32%,CD44;FLOT1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.803720843832074,1.4826231198722704,0.0,0.8245275871277068,1.0,4/7,13.19%,ADRA1A;PDE4D;ZDHHC21;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.7864284071915278,1.4823147091860174,0.12121212121212122,0.8213464200079112,1.0,3/8,16.00%,SPRED2;NNMT;SPRED1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5276376833592318,1.4799682544340909,0.05263157894736842,0.8294215287641107,1.0,12/52,12.03%,YJEFN3;TP63;FBXW7;KAT2B;TSPAN15;BMP2K;EGFR;POFUT1;BEND6;TSPAN5;TSPAN14;ZMIZ1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8916797333525837,1.4791924848704936,0.05263157894736842,0.8288850194642665,1.0,4/5,9.23%,PLA2R1;SIRT1;MAPK14;MAPKAPK5
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9293726383142908,-1.4790886209742629,0.0,0.46261648691184615,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9293726383142908,-1.4790886209742629,0.0,0.46261648691184615,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6492555280110984,-1.4775232113408465,0.011627906976744186,0.4674160934047909,1.0,23/72,19.92%,NDUFA1;NDUFS5;SURF1;NDUFA12;NDUFB2;COX18;NDUFB11;NDUFC1;NDUFB9;NDUFA6;NDUFAF1;TMEM126B;TTC19;ECSIT;FOXRED1;NDUFS7;UQCC3;COA3;DMAC1;NDUFB7;AIFM1;NDUFA3;SDHAF4
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6747368994717643,1.4771067329816043,0.11764705882352941,0.8345418613107283,1.0,3/13,5.35%,DSE;VCAN;CSGALNACT1
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.8357821886710852,1.476433222147222,0.12,0.8323240637439346,1.0,2/6,5.76%,ACADS;MMAA
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.610006268928921,1.476330882390103,0.09523809523809523,0.8272004475553407,1.0,5/26,9.88%,KCNJ6;KCNMB3;ANK2;GNG2;KCNN2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9018571279796337,-1.475833908300945,0.0136986301369863,0.4721889210132671,1.0,2/9,4.06%,CD44;ENPP2
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5869042482789948,1.475272551298277,0.0,0.8270423795723973,1.0,6/26,6.39%,DAPK2;STYXL1;DEPTOR;SGMS1;TRAF1;CRADD
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.8194863503052209,-1.4750552694671728,0.02564102564102564,0.4725652885100318,1.0,5/15,6.32%,RPS14;RPS27;RPS15;RPS28;MRPS7
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6505973880742696,1.4747524096073752,0.08,0.8249164837876732,1.0,4/18,11.13%,NEDD4L;ANK2;NETO1;NEDD4
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8263557997359587,1.4747017516722107,0.08,0.819709569705339,1.0,2/9,0.40%,PHLDB2;CRB2
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7955801623565812,1.473524920296698,0.08,0.821547185691876,1.0,2/9,5.60%,LIMD1;PUM2
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.85593958053817,1.4729752225604977,0.09090909090909091,0.8191559298954132,1.0,2/6,9.58%,PATL1;DCP1B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8311485346487675,1.4722034299322773,0.07317073170731707,0.8184890698393381,1.0,3/5,8.07%,FOXO1;ATP2B4;LMNA
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.8052545087971881,1.4707041541025738,0.1111111111111111,0.8163996469344081,1.0,4/6,13.97%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.8052545087971881,1.4707041541025738,0.1111111111111111,0.8163996469344081,1.0,4/6,13.97%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7591160668574322,1.4706870108640169,0.043478260869565216,0.8114396789473988,1.0,2/7,15.45%,RAP1GDS1;MCU
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.6357100901973699,1.4706822187955542,0.10526315789473684,0.8065409451330684,1.0,8/33,11.09%,IL15;NOVA2;PLCL1;NR1H2;MAP2K6;NOVA1;ADAMTS5;IP6K1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6590873838571765,1.4687572797816475,0.16666666666666666,0.8124310945590187,1.0,4/14,4.94%,PDGFC;BCAR1;ABL1;FER
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.9347506736276687,-1.4687488836166305,0.0,0.5103019573856846,1.0,2/6,3.84%,VEGFA;HES1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.8581452285510168,1.4682184683016029,0.10526315789473684,0.8110679685791121,1.0,1/5,5.38%,NRXN1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7618973845980868,1.4678500787695612,0.1,0.8086398622458778,1.0,4/8,18.42%,IL1RAPL1;STXBP6;SNCA;PRKN
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8254133542319515,1.4673827353755255,0.09523809523809523,0.8060260126030934,1.0,4/6,16.26%,ALCAM;NRP1;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.599962692833127,1.4672010281577084,0.07692307692307693,0.8021612053972843,1.0,16/32,16.43%,SEMA3B;SOX11;ERBB4;TCOF1;SEMA4D;SEMA6C;ANXA6;RADIL;SEMA3A;SOX8;SEMA6A;PHACTR4;SOX10;KLHL12;CDH2;CORO1C
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.710481592781239,1.467097049507355,0.07142857142857142,0.7934073071510515,1.0,2/14,3.08%,PHLDB2;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.710481592781239,1.467097049507355,0.07142857142857142,0.7934073071510515,1.0,2/14,3.08%,PHLDB2;FAM107A
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.5013407705129882,1.4668267374287371,0.2,0.7906296548646687,1.0,36/115,15.94%,DUSP4;EYA4;PPM1E;UBLCP1;DUSP7;PPP2R2C;PTPN13;PPM1A;PTPRK;BTRC;PDP1;EYA2;PPP4R2;SSH1;FBXW11;PTPRC;PPP2R5E;PPP3CA;TAB1;PTPRR;PTPRU;MTMR3;PTPRS;PPM1L;PPM1F;PTPN4;PPM1D;MTM1;CDC14B;PTPRG;PTPRN2;DUSP26;PPP2R2B;DUSP16;SSH2;EYA3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.8396224772170792,1.4667530754152094,0.12,0.7864235118777616,1.0,3/5,15.86%,SEC16A;LRRK2;GBF1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.8659125386823986,1.4663908402199684,0.030303030303030304,0.7834075148051487,1.0,1/6,3.11%,NR1H2
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.703365588826961,1.4662826428846383,0.10714285714285714,0.7794980425008146,1.0,3/11,9.92%,GRIK2;SLC8A2;SLC4A10
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5822773275945278,1.4655896076990376,0.0,0.7788127528195332,1.0,10/24,17.96%,ABHD3;SLC44A1;STARD7;SLC44A5;PCYT1B;GPAT4;PCTP;ACHE;LPCAT1;CEPT1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6660538514231689,1.4653423159921697,0.047619047619047616,0.7761978594803702,1.0,8/17,15.47%,DUSP4;PPM1E;DUSP7;PPM1A;PDP1;PPM1F;PPM1D;DUSP16
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.8783428336284823,1.4652374711138232,0.058823529411764705,0.7721932080293656,1.0,2/5,5.48%,PDE4B;PDE4D
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6426515640580486,1.4647565568143992,0.0,0.770855077084435,1.0,7/18,19.10%,PDE7B;PDE4D;KSR1;DGKQ;RAPGEF2;ADCY2;EPHA5
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5230661907308956,1.4644078878504472,0.14285714285714285,0.7680282059513108,1.0,33/101,16.61%,ASXL3;SYNDIG1;CSRNP3;LRRC4C;ADGRB3;RGS7BP;NLGN1;ASTN1;ZNF536;MAP2;LRRC3B;ADGRL3;ANK2;RUNX1T1;NOVA1;GUCY1A2;MAPK10;CACNA2D1;NPAS3;CLVS2;ADGRA1;TMEM200C;SLC35F1;FBXL7;NFASC;MEGF10;ADCYAP1R1;PCDH17;GPM6B;TMEM178A;PURG;SLIT2;CDH4
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6838504812951769,1.4642863072018415,0.07692307692307693,0.7644353869637686,1.0,5/14,10.75%,HDAC9;SIRT1;SMARCAD1;HDAC4;SIRT6
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.881898661873924,1.4635938766623122,0.03571428571428571,0.762964381640219,1.0,3/6,5.62%,PDE4B;PDE4D;ANK2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.6923078914961132,-1.4616925502291003,0.023809523809523808,0.5553379326312191,1.0,4/29,17.31%,DALRD3;WDR6;TRMT10C;TRMT5
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.8349280141076156,-1.4612227290364148,0.0,0.55275435784105,1.0,2/11,0.88%,PPIF;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6819490764663727,1.4603819604792951,0.07142857142857142,0.7757065992911176,1.0,8/14,21.90%,RIPOR2;ABL2;KANK1;ITGA3;KCTD13;CCDC125;ARHGAP35;TNFAIP1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6326174013796442,1.4601756544012392,0.0,0.7724249586920394,1.0,3/13,10.60%,SPRY4;CREB3L1;GPC1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.626750970910163,1.459521489476865,0.03333333333333333,0.7712269470696925,1.0,7/25,9.92%,ZDHHC2;MCTP1;GRIK2;SLC8A2;ARC;NETO1;SLC4A10
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.7322602818026733,1.4588887296101536,0.125,0.7705268703841617,1.0,4/8,8.71%,IRS1;AKR1C2;AKR1C3;AKR1C1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.7788417215289162,1.4586944897413994,0.07692307692307693,0.7669406105775193,1.0,1/11,0.39%,SOX11
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.8696757840998973,1.4585934323478111,0.06060606060606061,0.7632010331233582,1.0,1/5,1.49%,LMO3
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.6208593905439659,-1.4584787200707017,0.0,0.5652921522337376,1.0,17/118,9.40%,CD44;GADD45B;ETV4;COCH;PLSCR1;SLC2A3;CDKN1C;IFITM3;CTSZ;GSTO1;IL3RA;SCN9A;MAFF;CKAP4;XBP1;GPX4;PTRH2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7124481181629044,-1.4576086574612928,0.012195121951219513,0.5666082378932666,1.0,6/40,6.41%,CD44;AGRN;PRELP;TGFB1;FUCA1;CEMIP
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.7010084816562634,-1.4569862011161994,0.036585365853658534,0.5651496882889536,1.0,8/33,8.63%,ROMO1;RPL30;ISG15;RARRES2;HLA-A;OAS3;OAS1;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.9004666420166749,-1.4569228898697026,0.028985507246376812,0.5591170254566145,1.0,3/8,6.19%,HLA-F;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.907216074420939,-1.4568383432106247,0.046875,0.5533796594878322,1.0,1/6,5.85%,SELENOS
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6831354362688054,-1.4554166199402272,0.011363636363636364,0.5579063819302694,1.0,33/67,19.22%,B2M;MX1;EPSTI1;HERC6;TRIM5;PSMB9;HLA-C;ISG15;PLSCR1;PSMB8;IFIT3;IFI35;TRIM25;IFITM3;PARP14;IRF1;RSAD2;USP18;PROCR;OAS1;PARP9;OGFR;PSMA3;LPAR6;PSME1;UBE2L6;TAP1;IFIT2;WARS1;IL7;ADAR;SP110;EIF2AK2
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.625292079438529,1.4543196085622732,0.043478260869565216,0.781163321914037,1.0,3/12,7.55%,PKP2;FGF12;CACNA2D1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.7229228040341484,1.454121710528772,0.125,0.777957389405233,1.0,4/11,15.38%,RIPOR2;OXSR1;WNK1;LRCH1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.6294376838987608,1.4539301913609342,0.07692307692307693,0.7745965482348725,1.0,7/23,11.23%,NAV3;PDE4B;PDE4D;SPTBN1;PTPRC;MAP3K7;PNP
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.597945245756052,1.4533555561256948,0.058823529411764705,0.7738069244857737,1.0,6/24,8.25%,NLGN4X;NLGN1;PLD2;SYNJ1;WNT7A;OPHN1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.8370532269756461,1.4532265836773501,0.041666666666666664,0.7703161489971327,1.0,2/6,7.95%,PKD2;BMP7
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.7792776220628462,-1.4527280856755447,0.05128205128205128,0.5734805751194005,1.0,2/16,0.24%,SLC28A2;B2M
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6642997803516546,1.4527215701846,0.0967741935483871,0.7689993942093911,1.0,2/9,11.43%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6331741063307547,1.452205820286502,0.15,0.7690831861831202,1.0,14/37,18.67%,SMAD9;CRIM1;PPARG;SMAD7;UBE2D1;SPART;CHRD;BMPR1B;SMAD1;VWC2;GREM1;LEMD3;BMPR1A;SMAD5
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6082184867644042,1.4516891089280006,0.05555555555555555,0.7684302462385268,1.0,5/17,13.29%,STYXL1;PPP4R4;PPP1R8;MFHAS1;ARPP19
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.7893251975090042,1.4512883883634378,0.08108108108108109,0.7668688851125502,1.0,1/6,4.09%,PLIN5
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7338705629686717,-1.4509052470365944,0.024691358024691357,0.579823637347897,1.0,16/37,17.89%,RPS14;RPS24;RPS27;RPS25;RPS15;RPS16;NOB1;RPS28;MRPS7;EMG1;SURF6;NOP14;RIOK2;RPS7;RPS6;RPS27L
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.7855620019465881,-1.4497494521985799,0.02564102564102564,0.5844745625906397,1.0,5/17,16.49%,EMD;DCTN1;NEMP1;CHMP4B;TMEM43
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7097369112382254,1.4488678480513113,0.11764705882352941,0.775520485400612,1.0,3/9,9.13%,HDAC9;SMARCAD1;HDAC4
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8434019343116452,1.4487839154200775,0.18181818181818182,0.7721273296684025,1.0,2/5,5.35%,DSE;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.8809006721556651,1.4477852010506964,0.0625,0.7727339595756046,1.0,2/5,3.69%,ABL1;MAP2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.9059512483448835,-1.4476001563957237,0.05970149253731343,0.5945811019021028,1.0,1/6,5.16%,RARRES2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.7771982549494043,1.4475832033643181,0.037037037037037035,0.770016615122142,1.0,3/11,10.40%,RNF139;BAG2;LRRK2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.8536752634427018,-1.447550960986345,0.028169014084507043,0.5886040460981529,1.0,3/9,4.52%,TAF7;TAF7L;TAF11
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.802451020301133,1.4473256105711862,0.11428571428571428,0.7675941161286025,1.0,2/7,6.72%,RFX3;FOXO1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7883485870374631,-1.446420978462889,0.057971014492753624,0.5917387464399804,1.0,2/13,2.19%,LIPI;HSD17B14
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.7899620083406398,-1.446153330696319,0.07792207792207792,0.5886032751573573,1.0,4/12,9.68%,VEGFA;TTN;KDM6B;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.9109410647153879,1.4453934677145188,0.02564102564102564,0.7736298315402693,1.0,4/5,8.84%,NLGN1;BTRC;RORA;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.8081004783218961,-1.444485673172106,0.041666666666666664,0.5962653627666348,1.0,4/16,10.10%,B2M;HES5;HES1;MED1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.8719251728132009,1.4438141842910661,0.075,0.7786340408028862,1.0,1/6,4.11%,LIG4
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6639368586154455,-1.4437964352987118,0.022222222222222223,0.5966655831700879,1.0,7/69,8.00%,CD44;VEGFA;PFN2;CAMK1;HAX1;TGFB1;HDAC6
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6499072494037877,1.4427535108985152,0.041666666666666664,0.7800727305602776,1.0,4/13,9.16%,FBXW7;PLIN5;SIRT1;FTO
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.6912651525361845,1.4427348319953333,0.10714285714285714,0.7762488446261586,1.0,1/13,0.08%,DPYD
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.7484320754455744,1.4424395295190358,0.03571428571428571,0.775247794812511,1.0,1/8,0.98%,RACGAP1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.7880419848967121,-1.4416148699743385,0.02666666666666667,0.6084533000375771,1.0,5/14,13.93%,DDRGK1;PRELID1;APH1A;GRN;PSME1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8694814249131931,1.440844193251393,0.0,0.7796272292863996,1.0,3/6,12.88%,SLC2A9;PNP;PRPS1
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.8609277518387322,1.4408418671426826,0.075,0.775860914169074,1.0,3/5,13.20%,MAPK14;MAPK3;MAPK8
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.8168050117939033,1.440369933101335,0.05714285714285714,0.7741898291231714,1.0,1/7,0.08%,DPYD
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.660511782006167,-1.4400819954072146,0.0,0.6140463273529116,1.0,9/65,6.63%,CD44;HES5;VEGFA;HES1;ENPP2;HAX1;TGFB1;AGT;PARP14
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.851192221379082,-1.4400642149655472,0.0,0.6084267797614215,1.0,4/11,8.89%,ESRRB;HES5;HES1;JAG1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7170700142550623,1.4398533095765533,0.13793103448275862,0.7728762626140887,1.0,2/9,2.99%,ACADS;ACADVL
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.618858511673187,1.4391533542494443,0.09523809523809523,0.7730197853929024,1.0,12/22,24.76%,CRIM1;SEMA4D;PPARG;LIMD1;CHRD;GREM1;TRPM4;CDK6;SUFU;NOTCH1;TMEM64;NOCT
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.6660275151905836,-1.4389024473881764,0.024390243902439025,0.6119393006079941,1.0,15/40,21.84%,CRNKL1;NOL3;SNRPD2;SNRPD1;CELF4;PRPF6;SRSF10;SRSF5;NCBP1;LUC7L3;SNRNP200;SF3A3;SRPK1;USP39;SNRPG
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7561851577620643,1.4377367393424938,0.1111111111111111,0.7762911308845136,1.0,5/11,21.42%,TTLL1;CEP41;TTLL11;TTLL9;TTLL5
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8881862299825742,-1.4368756325623828,0.0,0.623347634913885,1.0,3/8,2.26%,MX1;IFIT1;ISG15
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.8136357348506584,1.4351030927191968,0.037037037037037035,0.7851712451391029,1.0,3/8,11.21%,GPNMB;FGL1;WNK1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7159044758827191,1.4344726021542917,0.06060606060606061,0.7769543367597401,1.0,2/10,1.21%,RIPOR2;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.7159044758827191,1.4344726021542917,0.06060606060606061,0.7769543367597401,1.0,2/10,1.21%,RIPOR2;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.7159044758827191,1.4344726021542917,0.06060606060606061,0.7769543367597401,1.0,2/10,1.21%,RIPOR2;DAPK2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6170076613260247,-1.4332093170380997,0.0,0.6481039958127346,1.0,90/302,17.47%,RPS14;RPS8;DENND3;PAPPA;RPS23;RPLP1;RPL12;RPL31;TNC;RPS24;RPS2;SCG2;SCG3;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;CP;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;USP6;RPLP2;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;MRPS18C;RPS12;ICMT;RPS28;RPL27A;RPS3A;DUSP12;MRPS7;COPS5;CKAP4;RPS21;RPL41;RPL7A;RPL15;RPS13;MRPL51;UBL5;RPL36;CHGB;MRPL27;RPL18;FN1;PAPPA2;APH1A;GPC3;PIGH;RPL4;CST3;RPL9;SERPIND1;RPLP0;RPS4X;MRPL36;MSRB2;RPS20;SPG7;SPCS2;UBE2L6;SARS1;PARP4;UBA52;RPL18A;NUCB1;RPS7;C3;APOE;RPL35;WARS1;RSL24D1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5669866475700246,1.4325883791732468,0.05555555555555555,0.7833537191086883,1.0,5/17,19.37%,IRS1;ARPP19;OSBPL8;AKT2;PIK3R1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.5395627909626557,1.4325517102739629,0.0,0.7799082623480573,1.0,24/71,16.24%,LGR5;ASXL3;HID1;B4GALNT3;LRRN1;AHCYL2;PRIMA1;TSPAN8;TOX3;SH3BGRL2;PBX1;GPC4;APCDD1;BMP7;NEBL;CDS1;AMOT;SEMA6A;COBL;FRZB;NEO1;NDRG2;ZNF704;PPP1R9A
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.6090115927560907,1.4302863311674225,0.14285714285714285,0.7877906654731783,1.0,8/34,16.00%,DUSP4;LMO3;SPRED2;PTPRC;PTPRR;SEMA6A;DUSP26;SPRED1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5376010058149416,1.4296964260412082,0.09090909090909091,0.786800907333248,1.0,8/45,7.76%,PKP2;TLN2;PKP4;CDH20;CDH9;SMAD7;CDH10;CDH18
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7836521322741531,1.4291409605227061,0.0625,0.7861445979223333,1.0,4/7,13.69%,PUM2;ANKRD17;ZCCHC3;USP15
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.7626597928094667,1.4289724322460327,0.05555555555555555,0.784202296667109,1.0,4/10,13.62%,BBS4;FBXW11;CTNNA2;SPEF2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7853735566198281,-1.428893154318997,0.057971014492753624,0.6795996015861014,1.0,3/15,2.92%,FTH1;SFRP1;EMD
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.7716408058444605,1.4284981862690738,0.10526315789473684,0.7829205495142161,1.0,1/7,0.39%,SOX11
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5896915227785735,1.4281723319280752,0.05263157894736842,0.7806900395003146,1.0,7/23,12.75%,SEMA3B;SEMA4D;SEMA6C;ROBO1;SEMA3A;SEMA6A;ROBO2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7231184024107261,1.4275664199461917,0.058823529411764705,0.7803117234311601,1.0,4/10,14.56%,OPHN1;RAB10;MSN;RAP2A
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.605116552219723,-1.4274468050089266,0.0,0.6851829257545754,1.0,86/303,17.99%,RPS14;RPS8;RPS23;SRSF7;RPLP1;RPL12;RPL31;RPS24;RPS2;POLR2I;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RBM8A;RBM3;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;POLR2G;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;MRPS18C;RPS12;RPS28;RPL27A;RPS3A;MRPS7;COPS5;RBMS2;NUP155;RPS21;RPL41;RPL7A;RPL15;RPS13;MRPL51;PTMA;DHX38;RPL36;MRPL27;RPL18;CDC40;RPL4;RPL9;SRSF5;NCBP1;RPLP0;CASC3;RPS4X;PRPF4;HNRNPA2B1;MRPL36;RPS20;SEC13;PPP5C;UPF3B;SARS1;RPL18A;RPS7;MAGOHB;THOC5;CHTOP;RPL35;WARS1;RSL24D1;RPS6;ADAR;DKC1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.6339106920904657,1.4271026629724044,0.03571428571428571,0.7786678065430013,1.0,4/15,25.83%,SNF8;PRKN;STAM;SMPD3
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6925144506330688,1.4270597721070657,0.030303030303030304,0.7756961295501354,1.0,2/7,6.86%,GRID2;ARC
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.7025009205773823,1.4259137670316664,0.17647058823529413,0.776052315980499,1.0,4/12,13.69%,PUM2;ANKRD17;ZCCHC3;USP15
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5578479926317491,1.4252029572353342,0.041666666666666664,0.7770315113378203,1.0,8/34,6.51%,SOX11;SYNDIG1;NLGN1;LIG4;IL1RAPL1;WNT7A;NRXN1;GRID2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.846948218996463,-1.4247282484740453,0.03896103896103896,0.7039907549652347,1.0,1/11,1.28%,LHFPL5
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.8180094140461911,-1.4243687259353293,0.014084507042253521,0.7006498517734457,1.0,3/9,10.10%,ETV4;SFRP4;MED1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6047776568025864,1.4242183386805083,0.043478260869565216,0.777768380084695,1.0,12/21,19.45%,ABHD17C;ABL1;ABHD17B;PDLIM5;IL1RAPL1;CTNNA2;MDGA1;NEDD4;ARHGAP22;CDKL5;SLITRK4;YWHAZ
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.8165377646626492,-1.4237589966772184,0.02666666666666667,0.7002109630293467,1.0,2/11,10.62%,FLG;KRT10
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5175572011921649,1.4217373765444465,0.14285714285714285,0.786800553058858,1.0,11/51,7.76%,PKP2;TLN2;NLGN4X;PKP4;CADM2;SDK2;CDH20;CDH9;CDH10;NECTIN3;CDH18
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.7147961561258893,1.420585910150362,0.08823529411764706,0.7896517579507979,1.0,3/6,21.72%,SENP1;SENP6;SENP7
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.9498524886373069,-1.4202960042631527,0.0,0.7244794958667763,1.0,1/5,2.41%,PDCD1LG2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.6767839325444809,1.4188635568450128,0.10714285714285714,0.7945551491268547,1.0,1/10,2.04%,PRKX
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7110042334113886,1.418794639584858,0.13333333333333333,0.7912982154484209,1.0,2/8,4.91%,NR1H2;PPARG
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.45182569414899276,1.4182605444693237,0.0,0.7905856933136247,1.0,18/92,10.36%,BAIAP3;ASXL3;FAM149A;CSRNP3;RGS7BP;SORBS2;LEPR;ASTN1;TOX3;NRXN1;NOL4;UNC5D;MAPK10;CNTN1;UNC5B;PROX1;GRIA3;ADGRA1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8905379895020769,1.4182605233587586,0.06896551724137931,0.7872214988739922,1.0,3/5,8.25%,TOX;CHD5;OPHN1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6823721716220769,1.417712178171777,0.09375,0.7863054485941381,1.0,8/15,18.58%,POT1;STN1;GNL3L;CTC1;HNRNPC;TERF1;TERF2;XRN1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.6853617409513116,1.4175461210048885,0.04,0.7841924163908474,1.0,6/13,20.37%,MBNL1;MYH3;BMPR1B;NIPBL;FBXW4;MEGF8
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8484759116308831,-1.4168725093613177,0.041666666666666664,0.7517641707276937,1.0,3/7,6.20%,PDXDC1;ENPP2;FUCA1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.826599392079186,1.4162680531134155,0.15,0.7855461359169575,1.0,3/5,15.50%,PPARG;OSBPL8;ABHD5
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7972867381880392,1.4160420064939605,0.07692307692307693,0.7832299697136923,1.0,1/10,0.08%,DPYD
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.8978604410650277,-1.4157699212972352,0.02857142857142857,0.756493049942316,1.0,2/8,7.76%,ROMO1;TIMM8B
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.8258335630055007,1.4156797853732184,0.1282051282051282,0.7813792249211015,1.0,2/6,9.40%,ABCC11;ABCC5
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.7063467789107606,1.4156282253742694,0.07142857142857142,0.7782850771083657,1.0,3/12,8.03%,PLOD1;EGLN3;P3H2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.8455647245450788,1.415614361591102,0.09523809523809523,0.7750690230707279,1.0,3/5,5.43%,SIRT1;PPARG;CTBP1
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.763705436427421,1.4155413952961178,0.06060606060606061,0.7726137925653292,1.0,4/6,23.41%,CPEB2;UNK;CPEB4;CPEB3
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.9222191018780774,1.4150337088308198,0.08571428571428572,0.768783162564307,1.0,2/5,5.38%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.9222191018780774,1.4150337088308198,0.08571428571428572,0.768783162564307,1.0,2/5,5.38%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7199867138291598,-1.4145192920145313,0.0375,0.7600554238617622,1.0,1/29,0.07%,EPN1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.831741616196312,-1.412657407649692,0.02857142857142857,0.7710867998567588,1.0,1/8,3.27%,GTF3C6
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8358201233216342,-1.4123823110321463,0.016666666666666666,0.7669362938364497,1.0,1/7,0.88%,IFIT1
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.7475485732906718,1.412050796911163,0.023809523809523808,0.7787151992394927,1.0,3/9,15.88%,GLTP;CERT1;ABCA2
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.781188890759033,1.4119068545952294,0.029411764705882353,0.7761404753891592,1.0,5/8,14.38%,PPARG;ZDHHC17;ZDHHC3;UNC119B;VMP1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.9150658090021513,-1.4110009582423682,0.0,0.765259038961731,1.0,2/5,3.84%,HES5;HES1
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.9150658090021513,-1.4110009582423682,0.0,0.765259038961731,1.0,2/5,3.84%,HES5;HES1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.7903335911366495,1.4109604244550435,0.058823529411764705,0.7777598963259312,1.0,2/6,12.38%,PARD3;MYRF
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.4690577322625781,1.4102037732317727,0.0,0.7785063194547347,1.0,39/131,16.16%,RIT2;LRRC4C;EPHA3;STYXL1;NCS1;CAMSAP2;PDLIM5;CSMD3;TOX;TANC2;IL1RAPL1;NTNG2;MAGI2;ARC;DCC;ZNF804A;ABL2;KANK1;ADCY6;CTNNA2;SEMA3A;ROR2;RELN;LRRC7;SRCIN1;LRRK2;FUT9;PTPRS;PRKD1;KIF13B;BAG5;RAPGEF2;TENM3;LPAR1;RAP1A;ARHGAP44;SIPA1L1;CCDC88A;CDH2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.604972600851669,-1.4100177960408764,0.0,0.7699478237860692,1.0,59/249,11.57%,RPS14;RPS8;RPS23;RPLP1;RPL12;RPL31;RPS24;RPS2;POLR2I;RPL30;RPS27A;RPL3;RPL37;RPL35A;RPL13;RPL34;RPS27;RPL10A;RPL10;RPL32;RPS25;RPL11;RPL29;RPLP2;POLR2G;POLE3;RPS9;RPL23;RPS15;RPL19;RPL38;RPS18;RPL13A;RPS16;RPL23A;RPL14;RPS11;MRPS18C;RPS12;RPS28;RPL27A;RPS3A;MRPS7;COPS5;RPS21;RPL41;RPL7A;RPL15;RPS13;MRPL51;PTMA;RFC2;RPL36;MRPL27;RPL18;GCNT1;RPL4;RPL9;RPA3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.904269294744196,-1.409422307501893,0.0,0.7692196259703826,1.0,2/5,5.96%,TGFB1;AGT
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.7887833219174186,-1.4093768789023815,0.06666666666666667,0.7634473262118905,1.0,4/16,6.19%,B2M;HLA-F;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7173241848808631,1.408999121247679,0.13157894736842105,0.779675046423129,1.0,4/10,12.66%,SOX11;FZD3;SEMA3A;NRP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.6613752980934562,1.4085444543214158,0.041666666666666664,0.7784883316074951,1.0,2/18,1.16%,RANGAP1;BARD1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.7921510321047996,1.4084207600752234,0.02857142857142857,0.7759655938162237,1.0,4/10,13.85%,SOX11;PKD2;RELN;DLL1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.7854006969053635,1.4083085491096612,0.14705882352941177,0.7735333314265667,1.0,4/6,13.69%,PUM2;ANKRD17;ZCCHC3;USP15
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.8071669228902979,1.408277376182423,0.08,0.7705581797320759,1.0,3/7,11.60%,ADAM10;SLC29A4;ANTXR2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.7115083155311233,1.4070611454066948,0.11538461538461539,0.7729248130625125,1.0,2/14,4.06%,SOX11;DSCAML1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.8423340836158693,-1.4060135978611443,0.02702702702702703,0.7895308639692138,1.0,1/7,1.74%,VEGFA
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.7381039773480569,1.4056868489066745,0.11538461538461539,0.7754820758320773,1.0,1/9,0.97%,ABHD3
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.4969140676244792,1.405416669786788,0.09090909090909091,0.7732978561296594,1.0,13/41,13.26%,SYTL4;FNBP1L;DYSF;MYH9;ANK2;SPTBN1;BIN1;ANXA6;SNX33;NSF;P2RX7;MYOF;PACSIN2
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8551225883912051,1.4054046266575326,0.1388888888888889,0.7703005776175289,1.0,1/5,0.45%,CHRM3
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.8693632687006037,-1.405363070940565,0.046153846153846156,0.7884265715569349,1.0,1/7,3.15%,SLC2A3
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.7067203024752743,1.405094441537187,0.08695652173913043,0.7689800164090493,1.0,4/13,18.58%,ERI1;TENT2;MTPAP;XRN1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7594132525927498,1.4049579892187394,0.1724137931034483,0.7665714717621188,1.0,4/8,21.20%,OXSR1;WNK1;PTK2B;SH2B3
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.5846454549519091,1.404037058093982,0.0,0.768146894735094,1.0,3/27,0.98%,PHLDB2;CRB2;RACGAP1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.7236906909067067,1.4038497519051596,0.17857142857142858,0.766100465416779,1.0,2/11,6.32%,ZDHHC2;SPTBN1
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.761533748485377,1.4034231056427664,0.15384615384615385,0.7647481078433138,1.0,3/7,19.73%,B4GALT3;FA2H;UGT8
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5264821815424938,1.4031952485000487,0.0625,0.7632032135731414,1.0,13/35,19.79%,RIPOR2;ARAP1;NLGN1;FNBP1L;CAPZB;WASL;NRP1;DOCK11;ARHGAP44;RALA;GPM6A;PIK3R1;TENM1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.7271602202734481,1.4025466428170783,0.2727272727272727,0.7631514340618741,1.0,3/8,17.83%,FGD4;DNM3;SRGAP2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.6764467067586799,-1.4025015751260506,0.04938271604938271,0.8101961646967422,1.0,4/35,3.57%,FTH1;FTL;CP;NUBP1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.8243835710209515,-1.402372304311022,0.04477611940298507,0.8050408424050285,1.0,5/8,12.47%,OPRM1;RETREG1;SCN9A;NIPSNAP1;P2RX4
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.6334064501539306,-1.4018212862107742,0.010752688172043012,0.8043039691683503,1.0,15/85,16.58%,CD44;TNC;PLCD4;SFRP4;PAMR1;FN1;OSMR;SLC6A6;P2RX4;COL6A1;LMOD1;ACTA2;COL4A1;RUNX2;ADAMTS2
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6707951429176937,-1.4012467024819162,0.0625,0.8031767884530441,1.0,2/32,0.29%,B2M;APIP
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.5956487739770444,1.400872679346802,0.1,0.7645193967608271,1.0,4/13,7.85%,SHROOM2;RAB27A;RAB27B;BBS4
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.5956487739770444,1.400872679346802,0.1,0.7645193967608271,1.0,4/13,7.85%,SHROOM2;RAB27A;RAB27B;BBS4
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.609608617145804,-1.4006855825428335,0.011627906976744186,0.8020669489795118,1.0,25/111,13.00%,RPS14;CRNKL1;RPL3;RPS27;RPL10;NOL3;RPL11;RPS15;RPL38;RPL23A;RPS28;MRPS7;PRPF18;SNRPD2;SNRPD1;SNRPB;CELF4;RPF2;PRPF6;SRSF10;SRSF5;NCBP1;RPLP0;LUC7L3;SNRNP200
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.9098387988525036,-1.4005561094442887,0.056338028169014086,0.7966789835519832,1.0,2/5,9.03%,SLC3A1;SLC7A6
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.7297219099918794,-1.4004235702772765,0.04819277108433735,0.7922139431073884,1.0,3/20,3.01%,B2M;FTL;CP
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.9273627374217888,-1.4002686981602703,0.031746031746031744,0.7872037394435072,1.0,2/5,6.19%,HLA-B;HLA-A
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.5815831381236968,1.4001156814882174,0.09090909090909091,0.7649959663672958,1.0,4/19,7.50%,IL15;FER;NMI;PKD2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6977845443350297,-1.3999414844809435,0.046511627906976744,0.7845887661872825,1.0,1/32,0.07%,EPN1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.8764750011546201,-1.3984874366847324,0.029411764705882353,0.792486894696046,1.0,1/6,3.27%,GTF3C6
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.7556452753334008,-1.3978587296627596,0.06329113924050633,0.7919945480955544,1.0,3/17,7.76%,ROMO1;COX18;TIMM8B
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.7689592525487389,-1.3966674743685272,0.05555555555555555,0.7963728999954591,1.0,7/16,12.47%,MT1E;MT1M;HVCN1;MT2A;SLC30A4;KHK;P2RX4
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.7851669771129259,-1.3966216889703316,0.06153846153846154,0.7909776138448861,1.0,3/11,6.90%,NOP10;PUS3;GAR1
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.7570228125679991,1.395787228579943,0.08333333333333333,0.7797979035662517,1.0,2/8,9.48%,HSPA1A;DNAJA4
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.7414502284401066,1.3951583864713266,0.11428571428571428,0.7803465396765478,1.0,1/7,1.24%,SHANK2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.4892768894371473,1.3951286670644891,0.0,0.7778621199956577,1.0,36/119,12.67%,GABRG1;LRRC4C;ADGRB3;RGS7BP;SEPTIN4;BTBD17;ASTN1;FAM107A;KCND3;CADM2;LRRC3B;CDH20;NRXN1;CDC42EP4;MAGI2;LSAMP;HEPACAM;MAPK10;GRIA1;LRRTM3;ZEB2;EGFR;SLC1A2;NPAS3;RFTN2;DPP6;CTNNA2;CLVS2;CA10;GRIA3;ADGRA1;DLG2;GRIN2B;P2RX7;NFASC;KIF1B
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.6847586302182884,-1.3943275843656933,0.011904761904761904,0.8048873487171471,1.0,7/32,7.29%,ISG15;PDCD1LG2;BTN3A1;IL12RB2;HLA-A;RASGRP1;ZFPM1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.801321179110638,-1.3934838460206787,0.047619047619047616,0.8064357357649421,1.0,1/9,5.47%,ARHGEF18
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6439009632050513,1.3934428683998048,0.06666666666666667,0.7835967038721127,1.0,8/16,17.57%,SCD5;ACACA;FASN;ACSL4;ACSL3;SLC25A1;HSD17B4;FAR1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.8195346807729864,-1.3934391448646553,0.07246376811594203,0.8010838753071508,1.0,1/7,1.86%,RANGRF
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6708892609599522,-1.392708609939333,0.023529411764705882,0.8022722855105656,1.0,22/54,18.56%,RPS24;DHX37;RBIS;RPL35A;RPS25;RPL11;RPS15;RPL38;RPS16;RPL14;RPS28;RPF2;GLUL;EMG1;MRPL36;SURF6;NOP14;RIOK2;RPS7;WDR12;RPS6;RPL5
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.4875636665637311,1.392324562447413,0.1,0.7857595352828135,1.0,10/47,9.30%,TAF1A;SERTAD2;KAT2B;PADI2;ARID1A;H1-10;ARID1B;KAT2A;TAF1B;BAZ1B
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6933145025759682,1.3917907596943362,0.05555555555555555,0.7853666261722331,1.0,6/14,12.90%,TAFA1;TOX;SLC16A2;PROX1;LRRK2;TRIM71
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.7186844287234387,1.3916092234026598,0.16666666666666666,0.7829649788304475,1.0,1/8,0.42%,GINS1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.822647140902116,1.391384297561414,0.16,0.7818738362538843,1.0,1/7,0.39%,SOX11
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.7030329599001389,1.391261720478313,0.08108108108108109,0.779566560340358,1.0,1/9,1.16%,BARD1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.5657573078955691,1.3911365360948678,0.1,0.7771475036706278,1.0,4/23,2.67%,RIPOR2;ARAP1;NLGN1;FNBP1L
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.7783569187063607,1.3910119326853714,0.12903225806451613,0.7721700329630983,1.0,3/5,19.73%,B4GALT3;FA2H;UGT8
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.7783569187063607,1.3910119326853714,0.12903225806451613,0.7721700329630983,1.0,3/5,19.73%,B4GALT3;FA2H;UGT8
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.46146835198299396,1.3908848515474863,0.0,0.7701206478325704,1.0,25/113,13.58%,SYNDIG1;PCDH15;LRRC4C;ADGRB3;ASTN1;ZNF536;VCAN;MAP2;CDO1;LRRC3B;ADGRL3;ANK2;SLC8A2;LRRTM3;NXPH1;CLVS2;CA10;ADGRA1;VSTM2B;SLC35F1;NFASC;MEGF10;SOX10;TTBK1;ADCYAP1R1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.7849406819206963,1.3907280934375594,0.13793103448275862,0.7679592384758344,1.0,2/6,10.46%,MDGA2;MDGA1
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6204335115839975,-1.3907176163868684,0.01098901098901099,0.8151444651366098,1.0,46/108,21.48%,B2M;MX1;HLA-B;IFIT1;EPSTI1;HERC6;PSMB9;ISG15;PLSCR1;PSMB8;IFIT3;IFI35;TRIM25;IFITM3;SSPN;HLA-A;PARP14;IRF1;OAS3;RSAD2;USP18;APOL6;MT2A;OGFR;PSMA3;NLRC5;BTG1;PSME1;RNF213;PFKP;UBE2L6;TNFAIP6;TAP1;IFIT2;WARS1;IL7;STAT1;ADAR;SP110;EIF2AK2;P2RY14;CASP3;IFIH1;HLA-DMA;IFI44;TAPBP
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.7406976180956517,1.3907131347964916,0.15384615384615385,0.7653717132587882,1.0,6/10,20.46%,ZKSCAN3;SIRT1;MARCHF5;TERF2;CDK6;AKT3
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.6853422539782128,-1.390494571741395,0.09411764705882353,0.8113345757991425,1.0,6/24,10.62%,FLG;SPINK5;OVOL2;JAG1;MED1;KRT10
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.6072114939016944,1.3902341576117876,0.13793103448275862,0.7641847537917549,1.0,7/15,17.12%,TRPS1;SOX5;ZBTB16;CHADL;BMPR1B;GREM1;PKDCC
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.6743472981596265,-1.3901951466265292,0.08433734939759036,0.8084962725233692,1.0,3/23,7.22%,GADD45B;VEGFA;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.8058696767510318,-1.3891803001326972,0.13432835820895522,0.81269453186376,1.0,4/7,18.54%,A2M;C4BPA;CD55;CD46
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.7774719351738595,1.3889270115290084,0.12903225806451613,0.7672012174393483,1.0,3/7,10.09%,ILRUN;TRAF3IP1;PCBP2
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6160902383087018,1.3858504401789238,0.13636363636363635,0.77762152162815,1.0,6/15,7.16%,NLGN4X;NLGN1;PCLO;IL1RAPL1;WNT7A;LRRTM3
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.8343979067588161,-1.3845228299735122,0.04285714285714286,0.8495715488911043,1.0,4/9,9.38%,HLA-F;HLA-B;HLA-A;CEACAM1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7469024088591092,1.3843802321970349,0.13333333333333333,0.7829950498920433,1.0,3/10,7.90%,SOX11;DSCAML1;TGFBR2
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.8165566564391902,1.384127687185783,0.13333333333333333,0.7812676949146897,1.0,3/5,15.68%,ATPSCKMT;SCN11A;MGLL
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.8827393299365909,-1.3840917505076216,0.014925373134328358,0.8478830310014212,1.0,2/6,11.00%,VEGFA;MESD
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.7325549418652869,1.3838461665707327,0.1,0.779181813652905,1.0,2/8,7.78%,MBNL1;MYH3
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6507164219566474,-1.383530955551175,0.024691358024691357,0.8468134202882021,1.0,18/47,20.15%,RPL3;RPL35A;RPL10A;RPL10;RPL11;RPL23A;RPL14;LAS1L;RPL7A;RPF2;RPLP0;SURF6;RSL1D1;WDR12;RSL24D1;RPL5;RPL6;MALSU1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6935556051569649,1.3833150219606198,0.13513513513513514,0.7781563923220295,1.0,2/10,3.28%,DSE;VCAN
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.7130852848799182,1.3821283549874965,0.05555555555555555,0.7806333919572618,1.0,3/9,11.75%,POGLUT2;GALNT16;GALNT13
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6255703420805939,-1.382086694271453,0.033707865168539325,0.8550862850701058,1.0,28/67,21.34%,IFI6;MX1;IFIT1;TRIM5;ISG15;PLSCR1;IFIT3;AGBL5;IFIT5;IFITM3;IRF1;OAS3;RSAD2;OAS1;NLRP1;RNASE1;ZDHHC1;NLRC5;DDIT4;IFIT2;SKP2;STAT1;SHFL;EIF2AK2;TRIM52;CGAS;IFIH1;AKAP1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.780770321552388,1.3818618178645994,0.1,0.7794877982370219,1.0,2/8,5.75%,FYCO1;IGF1R
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5767932468904649,1.3815325557997622,0.15789473684210525,0.7786545430579762,1.0,8/17,20.33%,CAMSAP2;PDE4DIP;MAPK1;MAPK3;MYO5A;MAP2K2;STX18;EHD3
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.6548956379720248,-1.381431640871271,0.075,0.8557972022533009,1.0,6/31,9.89%,S100A6;FTH1;SFRP1;EMD;AGT;FN1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4551532732348456,1.3811120170191005,0.0,0.7777662596793804,1.0,36/116,19.39%,DAPK2;PRKX;ERBB4;ATR;PEAK1;ABL1;MAP3K11;GRK5;FER;MAP3K9;IGF1R;OXSR1;CDK12;EGFR;MAPK3;MAPKAPK5;PIKFYVE;LRRK2;SMG1;AATK;LMTK2;PRKD1;STK17B;MAP2K2;STK24;FLT1;CDKL5;PINK1;UHMK1;MKNK2;ACVR1B;VRK1;MTOR;PDPK1;EIF2AK3;PTK2B
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.516980985146466,1.3795071732380524,0.13333333333333333,0.7828725928035647,1.0,10/43,13.35%,VAPB;SGMS1;ACER3;SPTLC2;CERT1;VAPA;PPM1L;PRKD1;ST3GAL4;CERS6
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7260835231980762,-1.3792895211252232,0.09876543209876543,0.8687240248638874,1.0,6/24,8.10%,ISG15;POLR3D;FLOT1;IRF1;OAS3;OAS1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.6011642591305194,1.3791297392665072,0.11538461538461539,0.7814334827620587,1.0,5/17,13.11%,LAMA3;PRKX;TRAF3IP1;SOX8;SOX10
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.7000354777981888,1.377303201520857,0.16129032258064516,0.7861926647264432,1.0,1/10,0.39%,SOX11
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.7128147548449408,1.3769829554241735,0.11764705882352941,0.7848119538432796,1.0,4/7,21.54%,NT5C1A;PNP;AMPD2;HPRT1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.8379586246747275,-1.3761145587717543,0.15942028985507245,0.8933852859830441,1.0,3/7,8.11%,MT1E;MT1M;MT2A
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.7952276374073105,1.3758412598853735,0.20588235294117646,0.7872601014464812,1.0,1/5,3.92%,BOK
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8228839972585275,1.375009957232752,0.11428571428571428,0.7883833093237629,1.0,1/5,2.50%,CEP120
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5229062380967266,1.374967285615207,0.08333333333333333,0.7858826657780087,1.0,9/52,11.24%,PLD1;FER;TBC1D14;ATG5;DYNC2LI1;IFT140;CAPZB;RABGAP1;TBC1D1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.8152530249264208,1.3736789215231835,0.09375,0.7885983923559954,1.0,2/5,13.33%,CDO1;MPST
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.8437639522009553,1.373644277394634,0.10714285714285714,0.7861724385960009,1.0,1/5,0.39%,SOX11
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6071080413648756,1.3734004165579674,0.09523809523809523,0.7844081450952326,1.0,6/25,11.26%,DSE;VCAN;CHST3;CSGALNACT1;UGDH;HEXB
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9119751877389556,-1.3730747973950468,0.0410958904109589,0.9155629560443113,1.0,2/5,4.32%,CD44;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.6020418001565815,1.373067494244058,0.11764705882352941,0.7836500489860763,1.0,6/15,12.05%,EPHA3;MCTP1;NR1H2;PICALM;SNX33;PRKD1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.672762997777289,1.3730231685707501,0.10810810810810811,0.7813806828296821,1.0,4/12,14.21%,KAT2B;NAA50;NAA11;NAA16
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7953274429082076,1.3729025001563089,0.11538461538461539,0.7795329855315746,1.0,3/5,19.79%,PKD2;TRPM4;ABCC8
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.8127185444615952,-1.3726870407369016,0.06451612903225806,0.9138115238632182,1.0,1/7,1.99%,SCG2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5952663847911399,1.3726652131515427,0.09090909090909091,0.7778131615992072,1.0,5/25,4.91%,YJEFN3;RXRA;NR1H2;SIRT1;PPARG
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.7899682502017842,-1.3723736108365001,0.0821917808219178,0.91084865519761,1.0,5/10,14.19%,SFRP1;SFRP4;GPC3;WNT5B;RNF213
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6753812854145805,-1.372211267063551,0.058823529411764705,0.9007246237000736,1.0,5/30,12.10%,POLR2I;POLR2G;GTF2F1;CDK7;NCBP1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6753812854145805,-1.372211267063551,0.058823529411764705,0.9007246237000736,1.0,5/30,12.10%,POLR2I;POLR2G;GTF2F1;CDK7;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.6436735410961231,1.3718604305409983,0.11538461538461539,0.7794539787910026,1.0,9/20,18.58%,POT1;STN1;GNL3L;CTC1;ERCC4;HNRNPC;TERF1;TERF2;XRN1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7145586657122616,-1.371804258522451,0.07142857142857142,0.8994365089547351,1.0,5/25,6.19%,B2M;HLA-F;HLA-B;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.8418273029126531,1.3714399507684853,0.0625,0.7787240912200721,1.0,2/5,9.88%,CHD7;PROX1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.763476585146964,-1.3714166979303473,0.1095890410958904,0.897470432100637,1.0,2/11,6.25%,DDRGK1;ATAD5
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.792737018280585,1.3711159258748868,0.1935483870967742,0.775104947124499,1.0,3/8,4.21%,ABHD17C;ABHD17B;ABHD10
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.792737018280585,1.3711159258748868,0.1935483870967742,0.775104947124499,1.0,3/8,4.21%,ABHD17C;ABHD17B;ABHD10
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6960115588887674,1.3698139720251261,0.15625,0.7784438121644868,1.0,2/9,10.40%,RNF139;LRRK2
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.8184653276463766,-1.3694846544874426,0.029850746268656716,0.9107953025400546,1.0,1/8,0.75%,PPIF
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.4215947524768271,1.3694097387849076,0.0,0.7778401007685944,1.0,34/105,16.35%,PKP2;ZDHHC2;TSPAN17;ZFYVE27;EHD1;TSPAN15;ANK2;C2CD5;SPTBN1;EFR3A;NECTIN3;RAB10;DPP6;PACS1;DPP10;SEC16A;TSPAN5;KCNIP4;TSPAN14;RAPGEF6;ZDHHC3;FLOT2;MYO5A;PACS2;RAPGEF2;EFR3B;MAP7;SPTBN4;RAP2A;RAP1A;PPIL2;RAB40C;CCDC88A;IKBKB
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7731120238144468,1.3686862262742705,0.16666666666666666,0.7788830771585517,1.0,2/8,6.17%,BOK;FZD3
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7281926192363259,1.3685130420700662,0.11428571428571428,0.777095907965995,1.0,7/10,23.66%,IRS1;PPARG;PRKCE;AKT2;PPM1K;GPLD1;PPARD
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.7709489853549025,-1.3683117994385865,0.056338028169014086,0.9163695253180354,1.0,2/11,3.84%,HES5;HES1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.9098141279407135,-1.3682815212756043,0.04411764705882353,0.9111109807190035,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.6331964328463542,1.368210532712432,0.14285714285714285,0.7754325997842804,1.0,3/12,10.00%,FOXP1;MAPK14;GLO1
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.7523126130374493,-1.3664837718213063,0.0821917808219178,0.9231157978776576,1.0,2/14,4.14%,TRIM5;TRIM25
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.6486068488424629,1.3664623462203762,0.13043478260869565,0.7790546309509838,1.0,3/12,4.09%,FBXW7;NR1H2;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8759122988980015,-1.366364991548756,0.047619047619047616,0.9182390567471974,1.0,4/6,9.38%,HLA-F;HLA-B;HLA-A;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.8451321340994513,-1.3662361278333193,0.041666666666666664,0.9138670561399644,1.0,2/7,5.88%,VEGFA;TGFB1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8492043506028919,1.3659477430432392,0.10714285714285714,0.778905985844747,1.0,2/5,9.36%,AK3;CMPK1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.7736186979537021,-1.365946704690414,0.02857142857142857,0.9108330255359615,1.0,2/13,4.72%,EMD;CAMK1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6083666455342773,-1.3652671422605498,0.021739130434782608,0.9116689891532853,1.0,16/108,9.15%,CD44;GADD45B;TRIP10;TNC;VEGFA;EIF1;SLC2A3;HES1;TUBB2A;JUN;IFNGR2;TRIB1;IRF1;MAFF;JAG1;KDM6B
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.7054093430000499,1.3650321481211007,0.15625,0.7800408648441599,1.0,4/9,11.52%,RIT2;SLC8A2;LRRK2;CDH13
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7514490735966204,-1.3646402935338582,0.08450704225352113,0.9121007987625028,1.0,3/15,5.00%,SLC28A2;SLC3A1;PBLD
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5649575545883733,1.3646092931874714,0.13636363636363635,0.7799456647763816,1.0,8/24,9.19%,SEMA3B;UNC5C;SEMA4D;SEMA6C;SLIT1;ROBO1;SLIT3;SEMA3A
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6850265210453811,-1.3643891249069968,0.08433734939759036,0.9093919941346548,1.0,6/33,5.51%,RPS14;RPS8;DHX37;RPS16;NOB1;RPS28
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.8099591693989723,-1.363277674738282,0.04918032786885246,0.9146377488362855,1.0,1/9,3.27%,COX7A2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.7525166313708445,-1.363039810793058,0.04411764705882353,0.9120317776276287,1.0,3/15,5.88%,DUOX1;RARRES2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5016305549729856,1.3630173769109604,0.10526315789473684,0.7830099183067747,1.0,20/54,18.67%,SMAD9;SPRY4;CRIM1;CREB3L1;PPARG;SMAD7;UBE2D1;ATP2B4;SPART;GPC1;NEDD4;CHRD;BMPR1B;SMAD1;VWC2;SLIT2;GREM1;LEMD3;BMPR1A;SMAD5
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.6725683092222656,1.3628778096573555,0.12,0.7810829625511284,1.0,2/15,3.11%,YJEFN3;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6954551697911859,-1.361900137863959,0.06172839506172839,0.9180147129756979,1.0,9/33,8.10%,MX1;IFIT1;ISG15;PLSCR1;IFIT5;IFITM3;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6988003446522393,1.3617713136340035,0.06060606060606061,0.7831334129231835,1.0,2/10,4.09%,IRS1;PLIN5
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.8145141557499829,-1.3617656627296357,0.0625,0.9143981366592846,1.0,3/6,17.32%,ZFAND2B;CDH3;MYORG
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.735658431709455,-1.3615148506486432,0.041666666666666664,0.9112036360729749,1.0,2/15,3.72%,CRYM;PIPOX
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.8401248892418558,-1.3611690235384646,0.043478260869565216,0.9090549836014391,1.0,1/7,3.27%,GTF3C6
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.6781100403772391,-1.3610142653331887,0.08433734939759036,0.9052993642995265,1.0,9/36,25.10%,DVL1;RPL23;GABARAPL2;DVL2;MAP1LC3B2;CAV1;DVL3;VIPAS39;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.8278061328540018,-1.3606573961655168,0.05970149253731343,0.9032912077023472,1.0,3/9,10.50%,VEGFA;CEACAM1;SH3GL2
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.8700551345720611,-1.3605870785374556,0.03508771929824561,0.8986584827687856,1.0,2/5,11.61%,PDHX;PDHB
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7241496412305113,-1.3601834041407046,0.045454545454545456,0.8979022938607732,1.0,2/14,3.65%,SURF1;COX18
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.726520520776559,-1.3601195138900493,0.0641025641025641,0.8936368494516597,1.0,3/17,7.22%,CDC37;FLOT1;YBX3
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.759822030865943,1.3599806410190238,0.07894736842105263,0.7892343690649976,1.0,3/7,15.53%,IGF1R;ITGA3;FYN
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.8247975774029513,-1.3598179383693874,0.06557377049180328,0.89173690791622,1.0,1/8,1.66%,TUBB4B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8427308394655348,1.3594491129405735,0.05128205128205128,0.7891124281877655,1.0,4/5,12.58%,CHRM3;DOCK5;DOCK4;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.7982562514293338,1.3592421865504547,0.13157894736842105,0.7875178091883788,1.0,2/5,18.48%,FOXP1;MTOR
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6527950962485297,1.3588306201613536,0.16216216216216217,0.787184225742633,1.0,2/11,3.28%,DSE;VCAN
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6483105119892288,-1.3585579706775999,0.056179775280898875,0.8982320056495426,1.0,10/45,8.10%,MX1;IFIT1;TRIM5;ISG15;PLSCR1;IFIT5;IFITM3;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.8860169244521732,-1.3583903289550434,0.07272727272727272,0.894839025972104,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5905406211671511,1.3581861486262823,0.08333333333333333,0.7870153887101674,1.0,7/24,6.51%,SYNDIG1;NLGN1;SEMA4D;IL1RAPL1;WNT7A;NRXN1;GRID2
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.7279815776100637,-1.358117295728386,0.1095890410958904,0.8919629440939553,1.0,2/14,1.74%,GADD45B;VEGFA
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5273889878941938,1.3576331146600413,0.15,0.7869557252416918,1.0,8/36,15.88%,SMPD4;LARGE1;CTSA;ESYT2;GLTP;HEXB;ARSA;ABCA2
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.7682621687459488,1.3569760485494566,0.175,0.7871120694198642,1.0,3/8,13.79%,GABRG1;GABRG3;GABRA1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.627111820979928,-1.3566812336918064,0.07058823529411765,0.9000635928078156,1.0,4/32,4.89%,PFN2;PLSCR1;DNAJC9;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6363595850679443,1.3560126955199223,0.125,0.7892561995908124,1.0,5/15,11.66%,SEMA3B;SEMA4D;SEMA6C;SEMA3A;SEMA6A
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.44307599159402533,1.3553768856401993,0.0,0.7896190483978079,1.0,23/78,19.39%,EPHA3;ERBB4;BCAR1;RYK;FER;MERTK;IGF1R;TNK2;EGFR;ABI1;ROR2;PTPRU;LMTK2;MTSS1;FRS2;PTPRG;FYN;FLT1;CLNK;ACVR1B;EPHA7;EPHA5;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7100698942652475,-1.3553245911738447,0.05063291139240506,0.9074441623303422,1.0,6/19,7.29%,ISG15;BTN3A1;IL12RB2;HLA-A;RASGRP1;ZFPM1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6021065391723318,-1.3549350879856774,0.02127659574468085,0.9059645884831377,1.0,14/128,6.20%,CD44;GADD45B;GLIPR1;TNC;VEGFA;SCG2;SFRP1;PFN2;ECM2;PPIB;COL5A3;JUN;TGFB1;FUCA1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.761891299328571,1.354455682322825,0.15151515151515152,0.7914222682529621,1.0,2/8,7.85%,OR3A2;BBS4
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7489209101963098,1.3542396992233086,0.2222222222222222,0.7898588346623213,1.0,1/5,0.11%,PKP2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.6475206632834511,1.354206937423543,0.10344827586206896,0.7876673929016527,1.0,4/9,25.30%,NRCAM;SEMA5A;ARHGAP35;CNTN4
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7940669163158224,-1.354148269518531,0.05970149253731343,0.9075168488744226,1.0,4/8,15.68%,B2M;RPS27A;PGK1;UBA52
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.7088400569634623,1.3539791309170983,0.05,0.7838513634064187,1.0,4/15,13.45%,KANSL3;JADE3;KAT8;MCRS1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.7088400569634623,1.3539791309170983,0.05,0.7838513634064187,1.0,4/15,13.45%,KANSL3;JADE3;KAT8;MCRS1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5811729027672408,1.3538790065125643,0.0,0.7818549546829642,1.0,7/24,18.28%,FYCO1;LIG4;SYNJ1;C2CD5;P2RX7;STX18;AKT2
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8044372838175711,-1.3524673168268084,0.08823529411764706,0.9168067988796774,1.0,3/6,17.55%,BUD23;EMG1;NSUN5
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.7105642166866615,1.351468218608772,0.1724137931034483,0.7892650524332772,1.0,4/6,26.68%,B4GALT3;FA2H;UGT8;UGCG
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.6081014548561607,1.350967925905996,0.1111111111111111,0.7891483855436997,1.0,6/15,14.66%,FNBP1L;MYO7A;WASL;MYO5A;MYO1E;SUN2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.6439727919814249,1.3508506956652555,0.16,0.7874670674933106,1.0,3/11,4.89%,BARD1;ZC3H3;PAPOLA
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.778563345889842,-1.3504465584894951,0.1232876712328767,0.9303019391204916,1.0,3/8,9.78%,PARP2;PARP14;PARP9
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6365889191686395,1.3502283996313915,0.13636363636363635,0.7875644254516128,1.0,4/16,12.42%,KCND3;ATP7B;ATP2B4;KCNIP2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8681306657755289,-1.350098384112571,0.05,0.9236151704424558,1.0,2/5,2.23%,B2M;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8681306657755289,-1.350098384112571,0.05,0.9236151704424558,1.0,2/5,2.23%,B2M;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.8018208487445904,-1.3499995555642295,0.08333333333333333,0.9194648526120912,1.0,2/9,5.88%,DDRGK1;TGFB1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.4934257649622299,1.3499888593840312,0.043478260869565216,0.7865718545219487,1.0,8/44,9.61%,VAPB;EXTL1;PREB;ACADVL;EDEM1;LMNA;DNAJB11;EXTL3
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.7682327168999148,1.3499114799447396,0.09090909090909091,0.7846540045296568,1.0,4/7,14.38%,PPARG;ZDHHC17;UNC119B;VMP1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6396560767419526,1.3493020509898999,0.13333333333333333,0.78481022315303,1.0,1/8,4.28%,LARGE1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.8744809877361996,-1.3491682566091918,0.06153846153846154,0.9224567196513869,1.0,1/6,2.73%,PHF1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5778138803285952,-1.3485578728816576,0.02247191011235955,0.9228495501737266,1.0,25/119,17.69%,CD44;ITGA4;ADAMTS16;TNC;HRNR;ECM2;COL5A3;AGRN;COL9A3;SPINK5;MMP24;MARCOL;FN1;COL15A1;COL6A1;COL9A2;ADAMTS7;MMP19;ADAMTS3;COL4A1;THSD4;ADAMTS2;MMP25;VWF;COL10A1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6968064051796032,1.3483280076891875,0.0625,0.7866111714466674,1.0,7/10,28.38%,ACVR1;ACVR1C;ACVR1B;GDF6;ACVR2A;TGFBR1;SMAD2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6399602787306726,-1.3481140820824047,0.02531645569620253,0.9218103362772595,1.0,6/47,5.88%,B2M;VEGFA;SFRP1;FGF1;CDKN1C;TGFB1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.776327749512767,1.3474286218051734,0.13157894736842105,0.7880428223156827,1.0,4/6,21.75%,ARFIP1;LRRK2;PRKN;USP7
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.7157210380930636,1.3468158683960623,0.10344827586206896,0.7882902504760059,1.0,3/9,5.51%,SHROOM2;SHROOM3;INSC
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6667005883849874,-1.346807720122991,0.07407407407407407,0.9285588702361713,1.0,17/39,19.48%,RPS14;DHX37;RPL3;RPS27;RPL10;RPL11;RPS15;RPL23A;RPS28;MRPS7;RPF2;RPLP0;RSL24D1;RPS27L;RPL5;RPL6;EIF2A
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.7771943423752,1.3467506454331457,0.17857142857142858,0.7863948886380208,1.0,2/5,17.73%,FOXP1;BCL10
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.48592314305888856,1.3467091549048933,0.047619047619047616,0.7844086468046632,1.0,12/45,14.85%,RIT2;RIPOR2;ABL1;ROBO1;ABL2;KANK1;OPHN1;GPR174;NRP1;STARD13;ITGA3;LPAR1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7564222450367402,-1.3463743346861194,0.10810810810810811,0.9279478434816353,1.0,5/16,5.54%,SYCE2;STAG3;RNF212B;ZCWPW1;IHO1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7754027511396523,-1.3452721747106784,0.07894736842105263,0.9323031677824971,1.0,2/11,8.10%,MX1;OAS1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.9220619226295077,-1.3451146057018275,0.015384615384615385,0.9289908157066704,1.0,1/5,0.17%,ART4
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.7893524877950648,-1.3449544560685511,0.08450704225352113,0.9261877120572047,1.0,1/11,0.75%,PPIF
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7134403300782242,1.3449370091044879,0.0,0.7883560113278592,1.0,4/8,11.43%,SLC8A2;CACNA2D1;ATP2B4;SLC8A1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7134403300782242,1.3449370091044879,0.0,0.7883560113278592,1.0,4/8,11.43%,SLC8A2;CACNA2D1;ATP2B4;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.8007799227677158,-1.3444785156193797,0.06944444444444445,0.9258921632380034,1.0,2/8,10.10%,ETV4;MED1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.6784231628645008,-1.3444543327918643,0.08433734939759036,0.9215349306843729,1.0,7/32,11.01%,ISG15;POLR3D;FLOT1;IRF1;OAS3;OAS1;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.6233667287879916,1.342710136255277,0.125,0.7953538717131975,1.0,2/9,9.66%,NAV3;PTPRC
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.4800137666539767,1.3422319549786845,0.1,0.7948225178066256,1.0,28/87,13.58%,LGR5;DPYSL5;ERC2;NOVA2;CSRNP3;LRRC4C;ASTN1;ZNF536;PCLO;CADM2;IGDCC4;ADGRL3;ANK2;NOL4;GAL3ST3;UNC5D;SLC8A2;CLVS2;TMEM200C;SLC35F1;GRIK3;GALNT13;LHFPL4;MEGF10;KCNQ2;EFR3B;STOX2;ADCYAP1R1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5261044012846522,1.3416252566937363,0.09090909090909091,0.7948455333357223,1.0,15/68,8.25%,PKP2;TLN2;SHANK2;NLGN1;RYK;PKP4;SDK2;CDH20;CDH9;NRXN1;ADGRL3;CDH10;NRCAM;CDH18;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7568644458945474,1.341581759044753,0.15625,0.7928190170073408,1.0,3/7,20.37%,NSF;SNCA;RAB29
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8285858854313344,-1.3410826603240384,0.08196721311475409,0.9478447740660965,1.0,2/7,8.63%,APIP;NLRP1
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6703537519452235,-1.3409589741979109,0.09876543209876543,0.9440342342798949,1.0,4/25,9.78%,ART4;PARP2;PARP14;PARP9
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.7933105108358127,-1.340918549891998,0.041666666666666664,0.9397955669651868,1.0,2/9,10.28%,PPIB;STAT5A
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7855110850383427,1.339893056534793,0.13513513513513514,0.7967354737368855,1.0,2/7,4.78%,LIG4;SIRT1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.4259829537731812,1.3396523227035575,0.0,0.7960073638679155,1.0,30/105,13.58%,LDB2;ASXL3;SYNDIG1;CSRNP3;RGS7BP;ASTN1;VCAN;MAP2;CDO1;PBX1;ADGRL3;ANK2;PRDX6;MPDZ;RUNX1T1;SLC16A2;GUCY1A2;MAPK10;CACNA2D1;WASF3;PRKG1;EDIL3;LRFN5;PRICKLE2;TMEM200C;FBXL7;NFASC;MEGF10;STOX2;ADCYAP1R1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5190117449627268,1.3395342502418348,0.15789473684210525,0.7942423523272629,1.0,8/26,13.02%,MAPK11;HDAC9;ABL1;CDON;MAPK14;CTNNA2;PTBP1;MEGF10
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8307913240763867,-1.339381094137822,0.08955223880597014,0.9504399379881384,1.0,2/7,4.29%,EPN1;ALOX5
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.7776376857766245,1.3385575263175755,0.17073170731707318,0.7965899405324,1.0,3/5,12.74%,LARGE1;PPP3CA;CFLAR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.752607753821567,-1.3381935447298925,0.10256410256410256,0.9565900341066801,1.0,5/17,10.50%,HLA-F;HLA-B;HLA-A;RASGRP1;CD160
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.744487913660635,1.338149914150848,0.21052631578947367,0.7955724965657949,1.0,4/7,16.62%,PLCB1;WASL;SLIT2;GREM1
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7883303971617115,-1.3379091670738426,0.08571428571428572,0.9546083870182777,1.0,5/10,12.47%,MT1E;MT1M;HVCN1;MT2A;P2RX4
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.6154445105440549,-1.337856121529848,0.05952380952380952,0.9504701329994909,1.0,16/58,16.59%,SRSF7;RBM8A;FLOT1;SIDT2;NUP155;DHX38;CDC40;SRSF5;NCBP1;CASC3;HNRNPA2B1;UPF3B;MAGOHB;RTRAF;THOC5;CHTOP
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6423236153941104,-1.3371728534733511,0.08433734939759036,0.952028191765957,1.0,16/41,24.26%,ROMO1;ATP5F1E;TIMM8B;DMAC2L;ATP5MC3;ATP5PF;SPG7;MICOS13;UQCC3;AFG3L2;HSPA9;ATP5ME;ATP5MC1;ATP5PD;ATP5PB;GHITM
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.8567397672945356,-1.3371167580164756,0.07575757575757576,0.9479756656708764,1.0,2/5,2.79%,A2M;F8
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.6246393984420959,-1.3358860522138911,0.09090909090909091,0.9557233366244585,1.0,5/65,7.69%,CD44;SCG2;TACR1;TGFB1;FPR3
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.5134316668202878,1.33537942797867,0.09090909090909091,0.8041958677204222,1.0,3/31,3.08%,PHLDB2;EPHA3;FAM107A
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.8318236728346227,-1.3352961173668598,0.06451612903225806,0.9565121041650014,1.0,3/7,8.89%,VEGFA;TTN;JAG1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7408647652018896,-1.3350687977260494,0.1111111111111111,0.9544487646443497,1.0,5/11,14.23%,COX4I1;COX7C;COX7B;COX5B;COX6C
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.8839896589414793,-1.334260685526119,0.07575757575757576,0.9571125597524984,1.0,1/6,0.55%,DENND3
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.9036527569738295,-1.334193712862751,0.08064516129032258,0.9533334204888204,1.0,2/5,8.91%,PAH;BCAT2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.7927729994964697,-1.3340544655909308,0.1095890410958904,0.9504339245585413,1.0,1/7,2.25%,DDRGK1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.8596810391290111,-1.3336699037664064,0.11666666666666667,0.9497144878885684,1.0,1/5,5.29%,PUS3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5174941490830054,1.3335918695449465,0.05,0.8088499234234551,1.0,7/32,12.42%,KCNJ6;KCNMB3;ANK2;GNG2;KCNN2;WNK1;KCNIP2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7386335711178138,1.3335559172992313,0.11538461538461539,0.8068783455651154,1.0,5/11,16.16%,SOX11;TCOF1;SOX8;KLHL12;CDH2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5757053256160597,1.332766263921656,0.15384615384615385,0.8080867000084134,1.0,10/19,20.79%,HS6ST3;UGDH;EXT2;EXTL3;GPC1;HS2ST1;EXT1;NDST3;HS6ST2;B3GAT3
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.8819734568594235,-1.3321884779804043,0.031746031746031744,0.9584483634851736,1.0,2/5,10.39%,B2M;BDNF
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.7782302524427201,1.332032448455744,0.17857142857142858,0.8089967287976463,1.0,2/7,6.74%,PKP2;GPD1L
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.45530100741063123,1.3318891904662704,0.0625,0.8073802638071925,1.0,10/49,8.27%,RIT2;HIP1;NEDD4L;EPHA3;MCTP1;ABL1;PICALM;ABL2;OPHN1;SNX33
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6209844424449422,1.3314414528427345,0.0625,0.8066430382434242,1.0,14/25,18.08%,ABHD17C;HOMER1;ABHD17B;PDLIM5;TANC2;IL1RAPL1;ARC;SRCIN1;LRRK2;ARHGAP22;ARHGAP44;SIPA1L1;CDKL5;PPFIA2
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5683217330748417,-1.3314348980362134,0.0449438202247191,0.9617011149663316,1.0,24/120,17.69%,CD44;ITGA4;ADAMTS16;TNC;ECM2;COL5A3;AGRN;COL9A3;SPINK5;MMP24;MARCOL;FN1;COL15A1;COL6A1;COL9A2;ADAMTS7;MMP19;ADAMTS3;COL4A1;THSD4;ADAMTS2;MMP25;VWF;COL10A1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.765041230597109,-1.3314316980423975,0.13157894736842105,0.957388553912671,1.0,5/10,18.07%,EMC3;EMC7;EMC6;MMGT1;EMC10
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.6677770833421116,-1.330365725215191,0.10144927536231885,0.9623025771529529,1.0,5/25,8.58%,CD63;VEGFA;FLOT1;LRPAP1;SFRP4
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.7631180553147627,1.3302510791930073,0.25806451612903225,0.8096716746557284,1.0,1/6,1.65%,SPRED2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.7210985878623282,1.3301842845112595,0.21875,0.8080183623555373,1.0,3/5,22.05%,SPTBN1;ANK3;PEX16
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.81991060796618,-1.3296820341762932,0.07575757575757576,0.964705138700161,1.0,4/9,10.56%,B2M;HLA-F;HLA-A;ERAP1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.7371655747495068,1.3295126601996425,0.125,0.8081008550594653,1.0,3/9,16.71%,AK3;NT5C1A;AMPD2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.8248833306418384,-1.3290212205047174,0.1,0.9669226478341306,1.0,1/5,3.33%,NOL3
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5551966060000545,-1.32846800271502,0.031578947368421054,0.9679139069096477,1.0,52/174,23.05%,PDHX;NDUFA1;SURF1;ATP5F1E;UQCRQ;COX7A2;NDUFB2;NQO2;COX4I1;SLC25A6;NDUFC1;VDAC2;UQCR10;ISCA1;TIMM8B;COX7C;GPX4;NDUFA6;COX7B;COX5B;ATP5MC3;ATP5PF;PDHB;ATP6V1F;ACO2;UQCRB;COX6C;NDUFS7;VDAC1;SUPV3L1;PMPCA;CYC1;SLC25A5;ISCU;HADHA;NDUFB7;LDHA;BAX;AIFM1;NDUFA3;MRPS22;AFG3L2;FH;COX11;MRPS30;VDAC3;HSPA9;MRPS11;ATP5ME;ATP6V1D;ATP5MC1;ATP5PD
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.649484331647613,1.3283026510291644,0.09523809523809523,0.8109098589512425,1.0,4/18,10.58%,PKP2;SMAD7;PROX1;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.6813560355439843,1.3277188395556596,0.10714285714285714,0.8108410391282155,1.0,1/9,2.35%,IRS1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.6297491041299024,-1.327599872974404,0.0625,0.9715915478798399,1.0,7/37,7.52%,HLA-B;HLA-C;FTL;PDCD1LG2;NAAA;HLA-A;IGSF6
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6408211584321848,1.3275655341017847,0.12121212121212122,0.8045780579258782,1.0,3/10,12.47%,NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6408211584321848,1.3275655341017847,0.12121212121212122,0.8045780579258782,1.0,3/10,12.47%,NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6408211584321848,1.3275655341017847,0.12121212121212122,0.8045780579258782,1.0,3/10,12.47%,NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.8086143288854238,-1.3274213299552549,0.08823529411764706,0.9691592148748231,1.0,2/8,3.84%,HES5;HES1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6904694145386182,1.3262147952352419,0.15625,0.8092003555152333,1.0,5/10,26.88%,WASHC1;JMY;ARPC2;ACTR3;IQGAP2
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.624396067979791,1.3257084469569036,0.17857142857142858,0.8083365277373541,1.0,7/15,17.66%,ROBO1;TGFBR2;ZFPM2;NRP1;ROBO2;ACVR1;BMPR1A
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.6065556091300718,1.3256778285744004,0.13636363636363635,0.8063502063566708,1.0,5/20,9.88%,PKP2;SOX11;SMAD7;TGFBR2;PROX1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.541161622614734,1.3251670164937825,0.047619047619047616,0.8060604347914555,1.0,5/25,8.69%,LAMA3;PEAK1;PTPRK;LAMC1;THSD1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.734141841192048,1.3251568162500669,0.13333333333333333,0.8019444262600426,1.0,2/7,6.33%,IL15;PLCB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.734141841192048,1.3251568162500669,0.13333333333333333,0.8019444262600426,1.0,2/7,6.33%,IL15;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.70107562824237,1.3249910755721404,0.20512820512820512,0.8005530918567307,1.0,3/5,24.55%,PLAUR;ANK3;DMTN
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.6999470402618373,-1.3244019114423031,0.10526315789473684,0.9874971839200951,1.0,2/17,3.53%,POLR2I;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.6999470402618373,-1.3244019114423031,0.10526315789473684,0.9874971839200951,1.0,2/17,3.53%,POLR2I;POLR2G
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6474137633599653,-1.323817724112226,0.06818181818181818,0.9878039988933095,1.0,9/37,11.01%,CDC37;PLSCR1;POLR3D;IFI35;IRF1;USP18;PARP9;ERAP1;CACTIN
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7184229132012074,1.3236095518270372,0.14285714285714285,0.8031087464300611,1.0,2/7,4.09%,IRS1;PLIN5
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.8233359436916384,-1.323378907868472,0.125,0.987853988177158,1.0,4/6,10.62%,FLG;F13A1;FN1;KRT10
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.6748695880494997,1.3232825659989758,0.16666666666666666,0.802276365293452,1.0,2/8,4.78%,DIP2B;SIRT1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.7732749080788182,1.3231952441561872,0.2,0.8006182951227532,1.0,1/5,5.28%,ROBO1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7050212206301361,1.3228294761966573,0.22580645161290322,0.7997966232994962,1.0,2/11,11.08%,ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7989869922761303,1.3223791170362762,0.20689655172413793,0.7992085436324755,1.0,2/6,14.03%,CNOT2;CNOT6L
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.7946317424498016,1.3219180001865343,0.13953488372093023,0.7990810387592827,1.0,3/6,20.26%,METTL4;MTG1;MTG2
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.8401545784211784,-1.3217371028489464,0.09523809523809523,0.9983441641834903,1.0,1/5,3.99%,NAAA
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.8785091626459607,-1.3217264048986355,0.0967741935483871,0.9857381340227687,1.0,1/5,2.91%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.8785091626459607,-1.3217264048986355,0.0967741935483871,0.9857381340227687,1.0,1/5,2.91%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.8785091626459607,-1.3217264048986355,0.0967741935483871,0.9857381340227687,1.0,1/5,2.91%,PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5941977540038915,-1.3215907147423502,0.06976744186046512,0.9826539977941955,1.0,8/51,7.29%,B2M;IFIT1;ITGA4;DVL1;CAMK1;CTSZ;LRPAP1;ZFPM1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.7176892711705042,1.3210051559242604,0.125,0.8008710189317005,1.0,3/7,21.54%,NT5C1A;PNP;HPRT1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.864332278605288,-1.3209300413155065,0.03773584905660377,0.98402528637802,1.0,2/5,9.16%,LAGE3;OSGEP
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.8595516060057491,-1.3199995095025288,0.1323529411764706,0.9884390271465151,1.0,1/5,3.94%,PAH
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.7551360302499899,1.3197441839137343,0.17857142857142858,0.8041085850033113,1.0,3/6,6.94%,ADAM10;DYSF;FOXP1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6624879487249251,1.3197223122046042,0.14285714285714285,0.8021079137972619,1.0,4/11,18.81%,SLC9A9;SLC8A1;TRPM4;SLC9A5
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6793467407406739,1.3193691329317998,0.16666666666666666,0.8018837618359377,1.0,1/8,0.15%,MYRFL
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6943484424067436,1.319220717951379,0.16666666666666666,0.8002150900545989,1.0,4/12,17.13%,PLA2G15;SERAC1;CDS2;LPCAT1
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.6243829028890096,1.3191748511515633,0.07142857142857142,0.7985548459085193,1.0,4/10,11.41%,BCO1;AKR1C3;AKR1C1;BCO2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.37707275513772376,1.3182506053442213,0.0,0.8002741497856988,1.0,37/145,16.55%,GABRG1;ITPR2;MPPED1;RGS7BP;ASTN1;FAM107A;DSCAML1;SEMA4D;NRXN1;TSPAN15;HEPACAM;VLDLR;HDAC11;LRRTM3;SLC1A2;FASN;ENPP6;CA10;SRCIN1;ADGRA1;DLG2;VSTM2B;SOX8;ST18;KIF13B;MYRF;KIF1B;ANLN;SOX10;TTBK1;ADCYAP1R1;PEX5L;NDRG2;GPM6B;TMEM178A;FA2H;PHYHIP
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.8036001544117798,1.3178179197520157,0.047619047619047616,0.7999671856882066,1.0,1/5,7.42%,PLA2G15
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.7637203297542606,-1.317646071840228,0.041666666666666664,1.0,1.0,3/11,4.52%,TAF7;TAF7L;TAF11
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7379395541255727,1.3175623588729348,0.20512820512820512,0.79921452213692,1.0,3/6,20.26%,TSHZ3;MTG1;MTG2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.6954769353028643,1.3173855440693352,0.19230769230769232,0.7981533378854369,1.0,3/8,17.43%,PIKFYVE;MAP2K2;PINK1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5340903589763762,1.3166577041421168,0.06666666666666667,0.7991889816058234,1.0,3/31,3.08%,PHLDB2;EPHA3;FAM107A
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.669459319529211,-1.3158358212400725,0.13924050632911392,1.0,1.0,10/24,18.44%,ZNHIT3;RPL10A;LAS1L;RPL7A;RPF2;DDX18;RSL1D1;WDR12;RPL35;NIFK
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.8755807410436582,-1.3157754364198497,0.057971014492753624,1.0,1.0,1/5,4.29%,ALOX5
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7483934490259364,-1.315744916332589,0.1,1.0,1.0,3/12,7.07%,B2M;HLA-A;RSAD2
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6608913456878998,-1.3157007249669783,0.16049382716049382,1.0,1.0,12/25,24.04%,ATP5F1E;DMAC2L;ATP5MC3;ATP5PF;SPG7;MICOS13;UQCC3;AFG3L2;ATP5ME;ATP5MC1;ATP5PD;ATP5PB
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.7676731875803428,1.3155695965469616,0.16216216216216217,0.8015955644912889,1.0,1/5,5.05%,INAVA
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5185150952446993,1.3155132715365045,0.2,0.7998721730313983,1.0,12/26,13.11%,SEMA3B;ERBB4;SEMA4D;SEMA6C;ANXA6;RADIL;SEMA3A;SOX8;SEMA6A;PHACTR4;NRP1;SOX10
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6734850313929316,1.3152222798050057,0.14285714285714285,0.7994382518999,1.0,5/9,18.16%,RAP2B;RAPGEF2;RAP2A;RAP1A;RAP1B
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5963035243729127,-1.314828155810279,0.08045977011494253,1.0,1.0,7/55,8.11%,FTH1;MT1E;FTL;CP;NUBP1;MT1M;MT2A
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5809800402893323,-1.3147879104939348,0.021052631578947368,1.0,1.0,8/98,8.51%,CD44;GADD45B;IFITM3;JUN;VDAC2;CLU;IRF1;GPX4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.81069727548525,-1.3147427605216675,0.09523809523809523,1.0,1.0,1/7,0.45%,HLA-F
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.8599092271616264,-1.3145928745342275,0.1,0.9989163205028023,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5787213025759428,1.3145284629747045,0.2,0.7998436370937224,1.0,8/20,10.40%,ABL1;PDE4B;MAPK1;GNG2;ATP2B4;ADCY6;MAPK3;LRRK2
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.533725464116073,1.3141093235832007,0.14285714285714285,0.7988405385357812,1.0,5/22,7.55%,PKP2;KCND3;ANK2;BIN1;CACNA2D1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.8102147328292088,-1.3136480819421308,0.07575757575757576,1.0,1.0,2/8,5.41%,VEGFA;EIF2B2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.632262769080453,1.313489737706905,0.1111111111111111,0.799596158007696,1.0,1/10,2.35%,IRS1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.8385852516176561,1.3131338166112643,0.17647058823529413,0.7969514316354108,1.0,1/5,0.35%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.8385852516176561,1.3131338166112643,0.17647058823529413,0.7969514316354108,1.0,1/5,0.35%,PHLDB2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.5805936162973268,1.3129008235773494,0.1724137931034483,0.7957040301348713,1.0,4/19,8.71%,VCAN;CHST3;CSGALNACT1;UGDH
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.7256802844670627,-1.312674826947893,0.05263157894736842,1.0,1.0,3/16,5.13%,TRIM5;TRIM25;IFITM3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.7136939448955444,-1.3126565961295718,0.08,1.0,1.0,2/13,4.32%,VEGFA;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.8241658548351674,-1.312435159748174,0.056338028169014086,1.0,1.0,2/8,1.99%,VEGFA;SCG2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5453590228615611,1.3119566911479623,0.08695652173913043,0.7975019592299846,1.0,7/26,12.66%,SEMA3B;SEMA4D;SEMA6C;PLXNA3;SEMA3A;SEMA6A;NRP1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.5992174089485371,1.3117924066476956,0.16129032258064516,0.7960860263491125,1.0,5/13,14.09%,FNBP1L;MYO7A;WASL;MYO5A;MYO1E
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.7232764880368644,-1.311523248303116,0.13157894736842105,1.0,1.0,1/13,0.19%,DUOX1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.5506331912007724,1.3110488191759246,0.14285714285714285,0.797053376572806,1.0,11/52,13.35%,VAPB;SMPD4;SGMS1;ACER3;LARGE1;SPTLC2;CERT1;VAPA;PPM1L;PRKD1;CERS6
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.6995225285313722,1.310941118688644,0.16129032258064516,0.7955591607121444,1.0,3/9,7.90%,CHD7;WNT7A;TGFBR2
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.8160157240493346,-1.3106520081636222,0.125,1.0,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.8240480896738529,1.3105077181508193,0.18181818181818182,0.7956201286313702,1.0,1/5,2.93%,RYK
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6801711047858353,1.3104460713001966,0.15384615384615385,0.7939649571831104,1.0,4/9,13.77%,FAM107A;AKR1C3;BCL2L11;NR3C1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5942394111401167,-1.3099594948347237,0.03409090909090909,1.0,1.0,21/67,25.18%,POLR2I;RPS27A;COPS6;UVSSA;POLR2G;COPS5;RFC2;RPA3;CDK7;UBA52;RFC1;RFC4;LIG1;UBC;HMGN1;RFC3;XPA;POLD2;COPS7A;RBX1;XRCC1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7016241177333636,-1.309610406101041,0.09333333333333334,1.0,1.0,6/15,18.54%,C4BPA;CLU;CPB2;CD55;C3;CD46
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7016241177333636,-1.309610406101041,0.09333333333333334,1.0,1.0,6/15,18.54%,C4BPA;CLU;CPB2;CD55;C3;CD46
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.5323779277204669,1.3093614123732789,0.09523809523809523,0.7964686731267158,1.0,10/34,10.00%,IL15;RXRA;MYH9;SIRT1;PPARG;FOXP1;TGFBR2;MAPK14;PML;GLO1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.47561250689083917,1.3092379316523408,0.08333333333333333,0.7950755366175866,1.0,21/66,16.42%,RIPOR2;ARAP1;NLGN1;CEP120;FNBP1L;DEF8;CDC42EP4;BBS4;WASL;AUTS2;PIK3CA;P2RX7;NRP1;ANLN;WASHC1;CDC42EP1;NCKAP1;DOCK11;CCDC88A;RALA;EPS8
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6874283637768844,1.3088098249716162,0.21428571428571427,0.7950944877143584,1.0,5/11,18.28%,IRS1;SIRT1;NNMT;ARPP19;AKT2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7347926464691874,-1.308732574389876,0.06153846153846154,1.0,1.0,8/15,24.04%,ATP5F1E;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5MC1;ATP5PD;ATP5PB
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6960904043584537,1.3084006197174562,0.24242424242424243,0.7952832990537732,1.0,2/7,9.84%,WNT7A;CHRNA7
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5115702044381885,1.308065072790836,0.05555555555555555,0.7943267725063047,1.0,10/26,14.56%,CRB2;PARD3;OPHN1;MSN;LRRC7;ERBIN;DLG2;PARD3B;LIN7A;RAP2A
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5885811187341865,1.308063311053924,0.15384615384615385,0.792444481576195,1.0,7/23,14.21%,KAT2B;SIRT1;FOXO1;NAA50;DSCC1;NAA11;NAA16
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6872356051518684,-1.3079738398447456,0.125,1.0,1.0,4/15,22.43%,SELENOS;DERL2;SYVN1;TMEM129
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.4553196313755383,1.307902906533929,0.07692307692307693,0.7910773258568912,1.0,24/90,17.02%,FMNL3;PCLO;PLD2;FGD4;ZRANB1;LIMD1;SH3KBP1;SH3D19;ARC;BIN1;RHOBTB1;WASF3;CAPZB;RAC3;MAST3;SYNE3;BRWD3;PALLD;SEMA6A;PACSIN2;FMNL2;DIAPH1;MICAL1;LARP4
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5597098641945062,1.3069646314522987,0.11538461538461539,0.7922418266776625,1.0,3/17,9.65%,LGR5;ADCY6;RXFP1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.8581417056179989,-1.3066676088897078,0.12121212121212122,1.0,1.0,1/5,2.73%,PHF1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.5697297129683174,1.3061884400693007,0.13043478260869565,0.7933168719603321,1.0,4/22,6.74%,PHLDB2;ARAP1;ARHGAP28;TMEFF2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.7526593551433967,-1.3049451793428435,0.13432835820895522,1.0,1.0,4/11,17.10%,HTR2B;PIK3CB;S100A1;APOE
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6969560923707139,1.3043895542998862,0.21428571428571427,0.798785236532093,1.0,2/12,11.08%,ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.7252549520146637,-1.3039150280884348,0.11842105263157894,1.0,1.0,6/15,12.06%,ISG15;OAS3;USP18;OAS1;CACTIN;NLRC5
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4567375473079651,1.3035864428477955,0.14285714285714285,0.7997145490196866,1.0,20/59,20.88%,TRAPPC12;TBC1D14;ATG5;DYNC2LI1;IFT140;TBC1D12;MSN;PIKFYVE;RABGAP1;TBC1D1;MTMR3;ATG3;CDKL5;RNF4;STX18;TBC1D5;NPM1;SENP6;CYLD;NPRL2
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.6010954549411013,1.303539680218154,0.1,0.7961942574278219,1.0,3/17,13.53%,TP63;MAPK8;BCL2
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.6010954549411013,1.303539680218154,0.1,0.7961942574278219,1.0,3/17,13.53%,TP63;MAPK8;BCL2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.7541091864288662,1.3023223666456851,0.15625,0.7996130841088919,1.0,5/7,19.39%,ADAM10;OXSR1;WNK1;ADAM17;PTK2B
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.4825586943642211,1.3021820461434288,0.09090909090909091,0.7983374788426588,1.0,15/76,8.91%,BARD1;ZDHHC2;BANP;NEDD4L;ASB5;SF3B3;HECW2;CTSA;FMN2;HACE1;FOXO1;SNF8;EGFR;TIPARP;NSF
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.6119561566613757,-1.302123932029903,0.10256410256410256,1.0,1.0,9/43,10.22%,B2M;SCG2;SFRP1;CDKN1C;ALOX5;TGFB1;CEACAM1;MED1;CNMD
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5984027121324361,1.3018273762330506,0.05263157894736842,0.7978526199422228,1.0,8/17,21.75%,USP51;KAT2A;USP15;ATXN7;USP49;USP22;USP3;USP7
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.6737915605071708,-1.3017651043681504,0.12987012987012986,1.0,1.0,2/21,5.22%,FANCB;ZCWPW1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6481434465254601,-1.3010227092226818,0.1282051282051282,1.0,1.0,4/24,15.66%,POLR2I;POLR2G;GTF2F1;CTDP1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6952791300389743,-1.3009431646273135,0.11688311688311688,1.0,1.0,6/16,18.54%,C4BPA;CLU;CPB2;CD55;C3;CD46
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.5254300821962099,1.300893329944514,0.20689655172413793,0.7998015092596352,1.0,4/16,13.02%,XKR6;MYH9;RHOBTB1;MEGF10
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.8635040430094086,-1.3008069687944872,0.08955223880597014,1.0,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.7573685201545591,-1.3004366106432468,0.1643835616438356,1.0,1.0,2/8,11.56%,ITM2A;ITM2B
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8221197081480002,1.3003294366029963,0.15625,0.800590140034744,1.0,1/5,2.93%,RYK
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5695265765238636,1.2998975974705356,0.15,0.8002265140505997,1.0,7/22,10.75%,ABHD17C;HDAC10;ABHD17B;ABHD10;SIRT1;HDAC4;SIRT6
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.6832761476846014,1.299775527287053,0.14285714285714285,0.7990459872211585,1.0,5/13,15.12%,INTS7;INTS6;MTREX;INTS11;INTS8
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.5692846227288185,1.2996320137187447,0.1111111111111111,0.7978708632605019,1.0,10/31,12.85%,LRRC4C;NLGN4X;NLGN1;NRG3;GRIK2;GRID2;ARC;RELN;GRIK3;GRIK4
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.5435820775154935,1.2995069301004196,0.05555555555555555,0.796293689614143,1.0,4/26,6.74%,PKP2;STIM2;ANK2;GPD1L
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.534043646701223,1.2994728079752313,0.13333333333333333,0.7944798087721974,1.0,8/21,13.77%,CD247;CD96;PPARG;RORA;GPR174;PTPRC;KLRD1;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.6584608581159439,-1.2994507659024312,0.10256410256410256,1.0,1.0,8/27,13.57%,A2M;ISG15;OAS3;USP18;OAS1;CACTIN;NLRC5;GRN
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5735460515899604,-1.2991183203323835,0.053763440860215055,1.0,1.0,21/116,17.10%,CD44;CRYM;VEGFA;HES1;CLU;AGT;CRYAB;DBI;PAMR1;FNDC4;GLUL;RDH10;ITM2B;COL6A1;GSTM5;LMOD1;PCDHB4;CADM3;COL4A1;ZBED4;APOE
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7372616524235927,-1.2987407809532843,0.0625,1.0,1.0,8/14,24.04%,ATP5F1E;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5MC1;ATP5PD;ATP5PB
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6970926637028159,-1.2986214902696223,0.075,1.0,1.0,5/18,17.07%,SURF1;UQCR10;UQCRB;NDUFS7;MTFR1L
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.7734435584122935,-1.2984516748364254,0.14705882352941177,1.0,1.0,2/7,5.11%,B2M;ARG2
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.8761099611215716,-1.298408731785123,0.14925373134328357,1.0,1.0,2/6,7.91%,ZFPM1;OLFM1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6751436034813183,1.2984019209295017,0.24242424242424243,0.7966486967080267,1.0,5/12,12.56%,NUTF2;NUP98;BANF1;RBM15B;AAAS
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.8230675286597935,-1.2983490903678216,0.10344827586206896,1.0,1.0,4/5,12.89%,HTR2B;HTR2C;HTR4;HTR1F
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.8367761077274378,-1.2982598837007067,0.12903225806451613,1.0,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5819619498098065,-1.298009915996966,0.07777777777777778,1.0,1.0,7/90,5.15%,CD44;HES5;EVC;DDRGK1;RPL13;PPIB;PRELP
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5746197446015235,-1.297665949124001,0.07142857142857142,1.0,1.0,18/74,17.38%,F13A1;CD63;VEGFA;A2M;SCG3;F8;TUBA4A;RARRES2;CLU;TGFB1;TTN;FN1;CALM1;BRPF3;CHID1;PCYOX1L;VWF;CYB5R1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5575624748225578,-1.2973483458632153,0.07865168539325842,1.0,1.0,10/87,7.29%,B2M;IFIT1;RPL11;DVL1;FLOT1;CAMK1;PRMT8;CTSZ;LRPAP1;ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.5872135583230457,1.2972264897907,0.125,0.7986458908117127,1.0,4/19,6.74%,PHLDB2;ARAP1;ARHGAP28;TMEFF2
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5424538215323347,1.2969582456345383,0.13333333333333333,0.797969439540023,1.0,5/40,4.16%,POU6F2;EYA4;CRYGS;PCDH15;MYO7A
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.67841865466187,-1.2969559947316442,0.13580246913580246,1.0,1.0,4/17,22.43%,SELENOS;DERL2;SYVN1;TMEM129
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4501847073665266,1.2969278192036544,0.1111111111111111,0.7962084358413455,1.0,30/97,16.91%,SEMA3B;CSRNP3;PCDH7;PBX1;CHST3;INSC;ADGRL3;ANK2;MPDZ;RUNX1T1;MAGI1;CACNA2D1;EDIL3;ADCY6;PRICKLE2;FBXL7;FARP1;TUSC3;NFASC;PTPRG;TENM3;FIGN;NAV2;NCKAP1;EPB41L1;FRZB;AMOTL2;TEAD1;SLIT2;GFRA1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.6021436132855832,1.2968750217201044,0.14285714285714285,0.7948170835314752,1.0,6/27,6.91%,RPA1;HDAC10;LIG4;RAD51B;RECQL5;RAD54B
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.6572313495880755,-1.2966535358476987,0.13253012048192772,1.0,1.0,7/21,24.42%,TAF11;JUN;SAP30;CTDP1;SAP30BP;SNW1;LRRC19
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.8347047545222962,-1.2966081844435953,0.11428571428571428,1.0,1.0,1/7,1.44%,LIPI
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.7293311698420413,-1.2964730228326902,0.14285714285714285,1.0,1.0,4/13,15.34%,ATP6AP2;ATP6V0A4;GRN;ATP6V0E2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.6778742327125247,-1.2953182416505484,0.10126582278481013,1.0,1.0,5/18,15.34%,DMAC2L;HVCN1;ATP6V1F;ATP6V0A4;ATP6V0E2
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7392234273503593,-1.2947977301368505,0.10144927536231885,1.0,1.0,3/11,5.41%,VEGFA;COL9A3;EIF2B2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5810316548582026,1.293695187424016,0.16666666666666666,0.8060235968996919,1.0,4/21,2.93%,COL7A1;LAMA3;PLOD1;ATP2C1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6297910613578279,-1.2934998164076994,0.21333333333333335,1.0,1.0,2/19,5.63%,M6PR;CLU
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.8038749122914179,-1.2933807373696933,0.15151515151515152,1.0,1.0,2/5,17.10%,PROCR;APOE
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.8404580634232214,-1.293148226525549,0.06451612903225806,1.0,1.0,1/5,2.25%,DDRGK1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.48339607008657826,1.293099268414247,0.125,0.806737047275771,1.0,16/73,13.14%,KCNJ6;KCNH5;KCNF1;KCND2;KCNQ3;KCND3;SLC9A9;PKD2;SLC24A3;SLC12A8;SLC12A1;KCNC4;KCNN2;KCNC2;KCNIP2;KCNQ2
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7707818778859812,-1.2924849136679037,0.11688311688311688,1.0,1.0,2/10,5.13%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7630108989100974,1.2922117161190154,0.3409090909090909,0.8062424499219044,1.0,4/5,19.37%,MAP4K4;IQSEC1;MAPRE2;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7630108989100974,1.2922117161190154,0.3409090909090909,0.8062424499219044,1.0,4/5,19.37%,MAP4K4;IQSEC1;MAPRE2;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.7388659748003101,-1.2916766641979636,0.12987012987012986,1.0,1.0,4/10,15.81%,BUD23;UTP15;DIMT1;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.590266962717257,-1.2907916950967953,0.08791208791208792,1.0,1.0,6/75,7.50%,CD44;OPRM1;HTR2B;TGFB1;RASGRP1;HTR2C
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.5775410213446875,1.2902447067591463,0.16666666666666666,0.8112429366156797,1.0,10/41,10.75%,HDAC9;MIER3;HDAC10;SIRT1;TBL1XR1;HDAC11;TRERF1;SMARCAD1;HDAC4;SIRT6
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5399155415661866,-1.2900743319127175,0.021052631578947368,1.0,1.0,22/217,8.51%,CD44;APIP;IFI6;PPIF;VEGFA;RPS27A;DDRGK1;SFRP1;RPL10;NOL3;HMGN5;IFIT3;HTR2B;HAX1;RPS3A;COPS5;PRELID1;ANGPTL4;CRYAB;XBP1;PTMA;GPX4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.6285652251360034,-1.2900095942728205,0.1917808219178082,1.0,1.0,2/26,4.71%,B2M;GORASP1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7916587920456096,-1.289794770584099,0.08450704225352113,1.0,1.0,5/9,17.10%,PFDN6;CLU;CRYAB;VBP1;APOE
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7631568919030027,1.289628190117785,0.30303030303030304,0.8112643097502913,1.0,1/5,1.65%,SPRED2
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.7615076873107358,1.2895206388451907,0.3333333333333333,0.8100590053282026,1.0,3/6,16.40%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6407244736927793,-1.2891556914829398,0.13157894736842105,1.0,1.0,5/27,8.58%,B2M;CD63;VEGFA;CLU;SFRP4
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6770428013466047,-1.2891214014410737,0.12658227848101267,1.0,1.0,7/24,12.06%,ISG15;CDC37;OAS3;USP18;OAS1;CACTIN;NLRC5
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.6979788378923847,-1.2888022770437682,0.1411764705882353,1.0,1.0,1/15,0.48%,ESRRB
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.5802334515859562,-1.2887743618141403,0.07142857142857142,1.0,1.0,14/54,16.59%,SRSF7;RBM8A;DHX38;CDC40;SRSF5;CSTF2;NCBP1;CSTF1;CASC3;SUPV3L1;UPF3B;MAGOHB;THOC5;CHTOP
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7159503101167736,1.2886854077025345,0.17647058823529413,0.8076934279316893,1.0,3/8,10.70%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7159503101167736,1.2886854077025345,0.17647058823529413,0.8076934279316893,1.0,3/8,10.70%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7159503101167736,1.2886854077025345,0.17647058823529413,0.8076934279316893,1.0,3/8,10.70%,HSPB1;RAB27B;DLG2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7178149932458521,1.2886283474889935,0.15151515151515152,0.8061535935981149,1.0,1/5,3.73%,CNTNAP2
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.6806106793609793,-1.2885591589123577,0.14814814814814814,1.0,1.0,5/17,20.18%,PSMB9;PSMB8;PSMA3;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.753052143337156,1.2877651504589354,0.2,0.8063351010603976,1.0,2/5,17.66%,RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.753052143337156,1.2877651504589354,0.2,0.8063351010603976,1.0,2/5,17.66%,RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.6245200173514964,1.2876541358241558,0.21428571428571427,0.8050810558906949,1.0,3/9,18.28%,ERBB4;LATS1;AKT2
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.8353134843046438,1.2875521977710365,0.15151515151515152,0.8035214544729143,1.0,1/5,1.76%,AKNA
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.6247582896767763,1.2869058465935357,0.09090909090909091,0.8035979418506184,1.0,2/10,1.29%,SOX11;GPNMB
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.784469955925456,-1.2868756414255575,0.14285714285714285,1.0,1.0,3/10,6.19%,B2M;HLA-F;HLA-A
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.6554738045696475,-1.286065041592835,0.15853658536585366,1.0,1.0,4/25,8.09%,ZBTB32;SP140;ALOX5;HVCN1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.8172311040308962,1.2860628977574757,0.17647058823529413,0.8014358370028718,1.0,2/5,11.43%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.8172311040308962,1.2860628977574757,0.17647058823529413,0.8014358370028718,1.0,2/5,11.43%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.8172311040308962,1.2860628977574757,0.17647058823529413,0.8014358370028718,1.0,2/5,11.43%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7825550818069476,-1.2852806635889535,0.12,1.0,1.0,2/9,5.13%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.8103101317887835,1.2849756583908445,0.17647058823529413,0.8034006323939978,1.0,2/5,2.39%,BAIAP3;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.601738314494429,-1.2848555978951564,0.12643678160919541,1.0,1.0,9/56,9.72%,ISG15;POLR3D;FLOT1;POLR3H;POLR1C;IRF1;OAS3;OAS1;GAPDH
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.7434000757911795,1.284139320738467,0.21428571428571427,0.8052418493037046,1.0,3/5,19.25%,FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7733649876631781,-1.2840869946769353,0.16176470588235295,1.0,1.0,3/7,8.93%,ALOX5;GPX4;ALOX12
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7898011185374014,-1.2835577830132479,0.11267605633802817,1.0,1.0,5/10,16.44%,UQCRQ;UQCR10;UQCRB;CYC1;UQCC3
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.543506371942137,1.28303354508223,0.14285714285714285,0.8074580996392471,1.0,7/26,16.35%,FMNL3;NLGN1;RHOBTB1;RAC3;NCKAP1;FMNL2;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.691645439871651,1.2826961065206395,0.22580645161290322,0.8054563608351987,1.0,4/9,18.86%,SPRY4;KANK1;CORO1C;ACTN4
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.691645439871651,1.2826961065206395,0.22580645161290322,0.8054563608351987,1.0,4/9,18.86%,SPRY4;KANK1;CORO1C;ACTN4
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5039909193805513,1.2826761296934015,0.09523809523809523,0.803853115722709,1.0,20/52,17.66%,SOX11;CRB2;SMAD9;ELAPOR2;CRIM1;PPARG;SMAD7;UBE2D1;TWSG1;XIAP;SPART;CHRD;BMPR1B;SMAD1;ITGA3;VWC2;GREM1;LEMD3;RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7234826678164252,1.2826463185625105,0.2,0.8021807576063329,1.0,4/9,18.40%,DGKB;DGKQ;DGKG;DGKE
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.6498810686482837,1.2826271857729752,0.28,0.8005533878493168,1.0,2/10,5.45%,PKP2;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.5453214816915345,1.2819398372773676,0.1111111111111111,0.8019952630554597,1.0,5/26,9.88%,KCNJ6;KCNMB3;ANK2;GNG2;KCNN2
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3918645625389521,1.2815424462726364,0.0,0.8012051572659583,1.0,51/163,16.85%,SHROOM2;RACGAP1;SORBS2;BCAR1;ABL1;RICTOR;FGD4;PDLIM5;MYH9;MAP3K11;CDC42EP4;SPTBN1;CDC42BPA;KIF15;BIN1;BCL2L11;CNTRL;PKD2;CAPZB;PPP4R2;OPHN1;PCM1;ABI1;WASL;PALLD;RABGAP1;FARP1;KIF3C;LATS1;DOCK4;RAPGEF6;KIF1B;ANLN;CLASP1;CDC42EP1;PCNT;RASA2;ARHGEF12;MYO1E;CLIP2;ARHGEF11;SUN2;SOS1;SHROOM1;SASS6;SSH2;ARHGEF7;CCDC88A;KATNB1;SMC4;ARFGEF1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4984551913442945,1.2813592490326065,0.058823529411764705,0.8002677962179665,1.0,16/34,21.13%,NLGN1;HOMER1;TSHZ3;NRXN1;OPHN1;RELN;LRRK2;GRIK3;CACNG2;CDH2;GRM8;GRIK1;GRM5;PTK2B;GRM7;TPRG1L
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7636024569532981,1.2811986237464943,0.2222222222222222,0.7990714059382161,1.0,3/7,11.93%,SOX11;BMP7;PHACTR4
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.779827101418423,-1.2805134040351631,0.125,1.0,1.0,1/7,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.8524316804405331,-1.2803451725174995,0.10606060606060606,1.0,1.0,1/5,2.91%,PLSCR1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.8032035270248068,1.2802010255540888,0.08333333333333333,0.8012165704312884,1.0,3/5,16.26%,ROBO1;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.7573464030569153,-1.2801187022209497,0.12,1.0,1.0,3/8,16.46%,SIDT2;HNRNPA2B1;RTRAF
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.6247234731168793,-1.2800677634990099,0.13095238095238096,1.0,1.0,10/36,21.05%,SURF1;UQCR10;UQCRB;NDUFS7;COQ10A;NR4A3;MTFR1L;SDHAF4;ETFRF1;MTLN
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7435443796893051,-1.2796274600561437,0.125,1.0,1.0,5/11,18.86%,CDC37;IFNGR2;PARP9;STAT1;HSP90AB1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.676091574344873,-1.2794789458350342,0.14285714285714285,1.0,1.0,4/16,10.62%,FLG;JAG1;MED1;KRT10
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.6000876928180675,-1.2794198393564453,0.15555555555555556,1.0,1.0,7/49,10.50%,EPN1;IFI6;HAP1;AGT;RHBDF1;CEACAM1;SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6944060926426754,-1.2788810442838578,0.16,1.0,1.0,5/14,19.72%,DUOX1;GRN;HRAS;PTN;MYLK
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.6981545014306171,-1.278806240656576,0.1282051282051282,1.0,1.0,2/16,7.73%,ESRRB;BACH1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.6653444523605829,-1.2787747869696746,0.1125,1.0,1.0,9/19,23.89%,NUBP1;ISCA1;CIAO2B;ISCU;NDOR1;MMS19;HSPA9;GLRX5;CIAO1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.6232550221069808,-1.278263292180347,0.13157894736842105,1.0,1.0,6/26,14.83%,NOL3;CELF4;SRSF10;SRSF5;LUC7L3;SF3A3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.7557869720782704,-1.2778833128632219,0.14084507042253522,1.0,1.0,1/9,1.73%,FANCB
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7833098494271327,-1.2778606752294008,0.14084507042253522,1.0,1.0,2/9,5.80%,ART4;PRMT8
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6877345576655702,-1.2773007061600363,0.20512820512820512,1.0,1.0,4/17,10.50%,B2M;HLA-F;HLA-A;CD160
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.5183477944023107,1.2772310287808306,0.11764705882352941,0.8100118067348892,1.0,4/38,4.16%,POU6F2;EYA4;CRYGS;MYO7A
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7882946345612176,-1.2764087803363409,0.11428571428571428,1.0,1.0,2/6,10.10%,ZFPM1;MED1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7542538952280622,-1.2761183467613135,0.12162162162162163,1.0,1.0,1/8,10.28%,STAT5A
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7532079342914558,1.2759917635804996,0.17647058823529413,0.813506399906152,1.0,3/6,16.83%,SNX33;SNX18;SPIRE1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.765391892316069,1.2758969306890091,0.24242424242424243,0.812068836664555,1.0,3/6,16.62%,PADI2;SLIT2;GREM1
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.6521083220110597,-1.2754136155313454,0.1686746987951807,1.0,1.0,2/21,4.29%,DUOX1;ALOX5
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.7372002027888797,-1.2750023429167558,0.13636363636363635,1.0,1.0,1/8,1.43%,OPRM1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.6769153046323497,-1.27486274031926,0.16666666666666666,1.0,1.0,1/14,0.24%,B2M
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.7689118472564922,-1.2741610346768222,0.14285714285714285,1.0,1.0,2/8,6.01%,VDAC2;BLOC1S2
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.5692269381414622,1.274051827940439,0.16666666666666666,0.8160278802463686,1.0,3/13,9.84%,ZDHHC2;RELN;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.64824138130168,1.2740328923716424,0.2,0.814368455965245,1.0,2/9,4.09%,NR1H2;PLIN5
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.6762763706438976,-1.2738367901259362,0.189873417721519,1.0,1.0,3/15,11.97%,GSS;PLSCR1;GAMT
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.7455023332615033,-1.2738016096367937,0.13432835820895522,1.0,1.0,4/9,9.80%,TAF7;SELENOS;TGFB1;AP2A1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.7564021052959795,-1.2736745622031074,0.24242424242424243,1.0,1.0,2/10,6.42%,COPS6;COPS5
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.8320567545585684,-1.2730317855123257,0.1044776119402985,1.0,1.0,1/5,9.15%,KDM6B
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4554348738242358,1.2724272630566857,0.11764705882352941,0.8171215839053725,1.0,7/50,7.90%,PHLDB2;CRB2;SPRED2;EPHA3;SMAD7;GCNT2;TGFBR2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5666669087922301,1.2723983048068546,0.125,0.8154298207916967,1.0,5/15,21.84%,CBLB;RGPD3;NUP35;IPO5;NUP54
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.7280190966294768,-1.2722446936281224,0.0821917808219178,1.0,1.0,6/13,18.57%,FTL;IGSF6;TYMP;CHIT1;MYO1F;PILRA
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.6809076814438548,1.2721097542286277,0.22580645161290322,0.8151092171081558,1.0,4/7,18.96%,SLC8A2;ATP2B4;LETM1;ATP2B1
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.8146758111282062,-1.2716006286589128,0.1746031746031746,1.0,1.0,2/6,17.99%,PUS3;DKC1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4618895098251095,1.271567642488777,0.0,0.8150106959267229,1.0,12/57,13.06%,SOX11;TP63;CRIM1;SEMA4D;PPARG;LIMD1;SMOC1;BMP7;PRKD1;CHRD;ACVR1;BMPR1B
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.799627144042856,-1.2711834537798798,0.07894736842105263,1.0,1.0,2/8,16.38%,ACMSD;PGP
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.5262671978477909,1.2710451657275952,0.2,0.8156102164363492,1.0,4/28,6.70%,THAP4;NOX4;GLS;SRR
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.7734157755607001,-1.2710418175034728,0.16666666666666666,1.0,1.0,2/8,6.28%,SLC2A3;GSTO1
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.737201378519897,1.270851758949489,0.21951219512195122,0.8145950135657736,1.0,3/7,11.05%,DAPK2;MAP3K7;PIK3CA
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.6552472826085434,1.2706679060214876,0.2,0.8134377025018322,1.0,3/8,11.73%,ICE2;SNAPC1;ELL
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.49218984417801864,1.2705553250160306,0.14285714285714285,0.812212139945204,1.0,8/51,6.03%,IL15;RAB27A;NEDD4L;RXRA;SGK1;BOK;MERTK;C2CD5
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.6202385833130066,-1.2705543825254537,0.16091954022988506,1.0,1.0,2/25,5.01%,DUOX1;CFTR
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.7350265733740504,1.2704793323997814,0.2571428571428571,0.8091581467217638,1.0,4/5,26.52%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.7350265733740504,1.2704793323997814,0.2571428571428571,0.8091581467217638,1.0,4/5,26.52%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.8123420888272409,1.2700196497032894,0.23333333333333334,0.8089280432528368,1.0,3/6,9.72%,SPSB4;MARCHF7;XIAP
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.6963345681125516,1.2697702532998136,0.16666666666666666,0.80840930245882,1.0,4/6,24.29%,FYCO1;KIF13A;KIFAP3;MAPT
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.49692255209876207,1.2697103990471665,0.2857142857142857,0.8069173386969671,1.0,14/122,6.56%,CPA1;TCF7L1;LDB2;CALCRL;PCDH7;ACER3;GRIK2;SYNPO2;CREB3L1;HS3ST1;CDH9;RAB27B;LSAMP;CDC42BPA
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5088406787113489,1.2694828048654085,0.10714285714285714,0.8059721546177651,1.0,7/29,9.88%,SOX11;PCP4;TCF4;BRINP3;NRCAM;BEND6;PROX1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5225644563691311,1.2694301532163885,0.16,0.8045270978647644,1.0,11/31,17.61%,TP63;KAT2B;ROBO1;BMP2K;TSPAN5;TSPAN14;ZMIZ1;ROBO2;DLL1;RBPJ;MAML1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6794881029468655,1.26942126855605,0.21428571428571427,0.8029083310682558,1.0,3/8,3.15%,SPRED2;ATR;PLA2R1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.7906280952008148,-1.269375751134278,0.17391304347826086,1.0,1.0,4/7,16.10%,B2M;HLA-A;ERAP1;TAP1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.8354688666942682,-1.2689603454022114,0.136986301369863,1.0,1.0,2/5,9.60%,HSD17B14;EPHX2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6051803458915588,1.268569879609472,0.2,0.8045926952516161,1.0,3/15,7.65%,THAP4;PPA2;DDO
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.73984859538923,1.26847161287593,0.23684210526315788,0.8032306129107939,1.0,2/5,16.62%,SMAD7;GREM1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.7496410237035341,1.2679770518198856,0.22580645161290322,0.803908286216286,1.0,1/5,10.34%,ATP6V1A
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.7121345094333315,-1.2678978792634785,0.1780821917808219,1.0,1.0,4/14,13.24%,EIF2B2;SELENOS;KHK;ZBED3
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.6506651712383197,1.2670039700056124,0.2608695652173913,0.80579427866004,1.0,5/11,12.17%,SYTL4;DYSF;MYH9;ANXA6;MYOF
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.624224411765102,1.266992336039133,0.17857142857142858,0.8041891107742631,1.0,4/12,30.66%,SNF8;STAM;SMPD3;ATP13A2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.7006533349054768,-1.2666186056634214,0.11764705882352941,1.0,1.0,3/14,8.58%,CD63;VEGFA;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.8046182040893625,-1.2665888677578347,0.2413793103448276,1.0,1.0,1/5,3.39%,FGF1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.6575555813457488,1.2660555719605546,0.10344827586206896,0.805925138976369,1.0,3/10,14.56%,OPHN1;MSN;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.6535727052273923,-1.2657542043388048,0.1518987341772152,1.0,1.0,3/19,8.39%,DUOX1;ENPP4;XBP1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.6372001916473122,-1.265227094383507,0.14102564102564102,1.0,1.0,4/24,11.08%,RPL13;PPIB;SFRP4;LRRC17
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.6203691737443308,1.2651049468940374,0.1724137931034483,0.8081499670950587,1.0,4/11,13.97%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.7544734376697708,-1.2649575034511942,0.20833333333333334,1.0,1.0,3/10,8.11%,MT1E;MT1M;MT2A
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5397108701028932,1.264386668610335,0.14285714285714285,0.8091645518650007,1.0,3/22,1.90%,CHRM3;KCNJ6;NEDD4L
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7814031210951808,-1.2638821595812146,0.09230769230769231,1.0,1.0,2/9,2.26%,RPS27A;ISG15
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.5341746866171572,1.2630188619899698,0.13636363636363635,0.813278570075137,1.0,8/21,18.48%,PRR5L;RICTOR;RPS6KB1;SMG1;MLST8;CCDC88A;PINK1;MTOR
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.8291736230666746,1.2627578971985876,0.23529411764705882,0.812519194640317,1.0,2/5,11.06%,H6PD;DGKQ
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.7206942172212882,-1.2615890959091796,0.1323529411764706,1.0,1.0,1/10,3.77%,RPS15
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5212414002208166,1.2615663042209089,0.13333333333333333,0.8153458201021706,1.0,7/29,14.57%,SOX11;TP63;BMP7;PRKD1;ACVR1;BMPR1B;ZHX3
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.7088738608625214,1.2613778784663627,0.25,0.8143399572285712,1.0,3/8,6.51%,NLGN1;WNT7A;GRID2
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.6834721463950071,1.2612044344332578,0.25806451612903225,0.8134779981389929,1.0,3/5,13.71%,FGGY;RPE;RPIA
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.729392476483229,-1.2604384767572532,0.13333333333333333,1.0,1.0,2/11,7.28%,OPRM1;HHIP
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.8380761322626178,-1.2600261937783612,0.14084507042253522,1.0,1.0,1/6,0.75%,PPIF
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.7082720519181503,1.2595491042487732,0.2682926829268293,0.8162602344263933,1.0,1/6,3.18%,PARD3
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.7082720519181503,1.2595491042487732,0.2682926829268293,0.8162602344263933,1.0,1/6,3.18%,PARD3
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.7992808734966248,-1.2593328726636261,0.23684210526315788,1.0,1.0,1/6,2.91%,PLSCR1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6329082066758578,1.2592873713227468,0.16129032258064516,0.8155039283643951,1.0,2/10,5.35%,DSE;CSGALNACT1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.6789478442916285,1.2592198348584385,0.21739130434782608,0.8141950849399646,1.0,2/9,3.84%,CRB2;ITGA2
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.48602371990919696,1.2581717847901288,0.1111111111111111,0.816806785598591,1.0,9/20,18.60%,NAV3;CAMSAP2;PIK3CA;CLASP1;KATNB1;HDGFL3;ATXN7;CLASP2;TTBK2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.6362813752662555,-1.2578445526581774,0.16455696202531644,1.0,1.0,5/21,17.31%,TGFB1;ANKLE2;CALM1;PTPA;PPP2R5A
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.4002445692938864,1.2576249137288171,0.0,0.8177829648433917,1.0,18/88,16.24%,BAIAP3;HID1;SHANK2;SORBS2;TOX3;DSCAML1;SH3BGRL2;ZSWIM5;NEBL;SRCIN1;COBL;ARFGEF3;NEO1;FAAH;NDRG2;ZNF704;USP54;PPP1R9A
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5517344120526574,1.2565505098791343,0.15384615384615385,0.8193421407205919,1.0,9/18,24.88%,PEAK1;PTPRK;THSD1;ARHGEF7;TRIP6;ACTN1;CTTN;TAOK2;BCR
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.8527610039344788,-1.2561772960398783,0.140625,1.0,1.0,1/5,4.29%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.5610184192101069,1.2548873871649826,0.13636363636363635,0.8229278125606743,1.0,4/22,8.81%,SOX11;TNKS;RSF1;ILRUN
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7930404320788325,-1.254807646449559,0.25757575757575757,1.0,1.0,1/6,3.77%,RPS15
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.7660122515730458,-1.2545791610351107,0.17567567567567569,1.0,1.0,3/9,12.39%,SYCE2;STAG3;REC8
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.7660122515730458,-1.2545791610351107,0.17567567567567569,1.0,1.0,3/9,12.39%,SYCE2;STAG3;REC8
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.796930939243929,-1.25411981624065,0.15492957746478872,1.0,1.0,1/6,0.91%,HES5
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.5918789424957038,1.2539532939168072,0.24,0.8240928535423899,1.0,1/13,0.42%,GINS1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.4928759327621195,1.2538323890161671,0.25,0.8228169119187181,1.0,15/66,13.14%,KCNJ6;KCNH5;KCNF1;KCND2;KCNQ3;KCNMB3;KCND3;SLC9A9;PKD2;SLC24A3;KCNC4;KCNN2;KCNC2;KCNIP2;KCNQ2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.644228389058101,1.2535771110835956,0.037037037037037035,0.8220253831503432,1.0,4/16,11.86%,NLGN4X;NLGN1;NRXN1;LHFPL4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5758818500307676,-1.2530609006521805,0.1827956989247312,1.0,1.0,18/51,29.57%,PSMB9;RPS27A;PSMB8;PSMA3;PSME1;UBA52;PSMA7;PSMB6;UBC;GMNN;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.6153258124604427,1.2529214994495332,0.3,0.8222624503365917,1.0,1/8,0.35%,PHLDB2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.7404218847673958,-1.2527123532134243,0.19753086419753085,1.0,1.0,4/11,23.04%,DVL1;DVL2;CAV1;DVL3
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.8757644273002605,-1.250532032407932,0.0967741935483871,1.0,1.0,2/5,1.99%,VEGFA;SCG2
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.8167736390750338,-1.2495292278649528,0.25806451612903225,1.0,1.0,3/5,8.97%,DUOX1;ALOX12;NOXA1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.7106440885424392,-1.2489757339217324,0.19696969696969696,1.0,1.0,1/9,1.82%,NPM2
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6698916507883941,1.248732943350936,0.125,0.834508878568233,1.0,4/11,16.35%,FMNL3;NCKAP1;FMNL2;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.7966468947374801,1.2487013200317698,0.23684210526315788,0.8329844143000719,1.0,3/5,7.64%,PADI2;ROBO1;SLIT3
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6191279815395364,-1.2483915407844095,0.125,1.0,1.0,4/33,3.99%,RIMS1;LIN7B;DVL1;NAAA
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.7120589942396361,1.2482013325997565,0.21212121212121213,0.8317848508607208,1.0,4/6,28.27%,HDAC4;FBP1;PFKFB1;GIT1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.7120589942396361,1.2482013325997565,0.21212121212121213,0.8317848508607208,1.0,4/6,28.27%,HDAC4;FBP1;PFKFB1;GIT1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.696196295336331,1.247935610340513,0.1282051282051282,0.8313239278682988,1.0,4/7,12.66%,UNC5C;FZD3;SEMA3A;NRP1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6207332699833387,-1.2479343952366293,0.1518987341772152,1.0,1.0,4/32,3.99%,RIMS1;LIN7B;DVL1;NAAA
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.44484923234453605,1.2478402650539753,0.16666666666666666,0.8300536234769441,1.0,21/71,15.26%,SPOCK3;MCTP1;NAV3;SRGAP1;PTPRK;ROBO1;SMAD7;MAGI2;TP53INP1;TMEFF2;ZMYND8;KANK1;MITF;PTPRU;NF2;RAP2B;CHRD;FOXO3;RAP2A;ARID2;STK24
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.821213794736053,-1.247607065015633,0.12162162162162163,1.0,1.0,2/5,14.75%,PLSCR1;PPP5C
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7231464502813227,1.2471063049573172,0.08,0.8306771744092802,1.0,1/7,3.92%,BOK
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.44737127074648325,1.2469649353805758,0.09090909090909091,0.8294802227807434,1.0,14/44,15.55%,CALCRL;CD247;CALCB;MYH9;GNG2;VIPR2;ADCY6;MAPK14;RXFP1;PRKACB;ADCYAP1R1;ADAM17;FYN;ADCY2
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.6665506129311108,1.2466756197014432,0.16666666666666666,0.8292623542652158,1.0,3/8,13.02%,XKR6;RHOBTB1;MEGF10
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5407649078027099,1.2465387843607834,0.10526315789473684,0.8281731904684061,1.0,7/19,17.03%,NLGN4X;NLGN1;SYNJ1;OPHN1;STX1A;AMPH;SNCA
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.6427965788348409,1.246411792320523,0.17857142857142858,0.8270546336632807,1.0,3/11,12.72%,PATL1;LIMD1;LSM14A
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.737069011645725,1.2458255180092963,0.36363636363636365,0.826364383955874,1.0,3/6,22.33%,IWS1;SETD2;NSUN2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.737069011645725,1.2458255180092963,0.36363636363636365,0.826364383955874,1.0,3/6,22.33%,IWS1;SETD2;NSUN2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.5813852823136174,1.245556558298026,0.15,0.8255883877611717,1.0,2/12,4.09%,NR1H2;PLIN5
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.7126792768022203,-1.2454843399500826,0.140625,1.0,1.0,1/9,1.66%,TUBB4B
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5709710461278823,1.245363578782566,0.21875,0.8244829762631742,1.0,4/22,8.83%,MAPK11;HSPA1A;ABCB10;MAPK14
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.7519332188120941,1.2450983187457438,0.21212121212121213,0.8235806867524469,1.0,1/6,2.67%,FNBP1L
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.7232255458585575,-1.2446028296183416,0.2465753424657534,1.0,1.0,2/11,5.63%,HES5;CLU
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.5380171344793316,1.2445912201196003,0.22727272727272727,0.8237411768555413,1.0,8/20,18.60%,NAV3;CAMSAP2;CLASP1;KATNB1;HDGFL3;ATXN7;CLASP2;TTBK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7551141920005331,1.2443518945475076,0.3076923076923077,0.8231079702830292,1.0,2/6,8.99%,MAPK1;MAPK3
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4628852130389193,1.244236997877867,0.125,0.8218174076894953,1.0,16/75,10.40%,PLD1;RIT2;RNF139;HIP1;SEPTIN4;STXBP5;ABL1;MAPK1;PICALM;ABL2;OPHN1;RAB10;NSF;MAPK3;PTPRC;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.5465782224639286,1.2440829567656995,0.28,0.8208279232037476,1.0,3/19,3.96%,SOX11;CRB2;ELAPOR2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5932974962605673,1.2438854418320688,0.18181818181818182,0.820104990057187,1.0,6/21,7.55%,PKP2;KCND3;FGF12;ANK2;DMD;CACNA2D1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.6726846837553556,-1.2432232949127264,0.22535211267605634,1.0,1.0,4/13,22.04%,TAF11;JUN;CTDP1;SNW1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.599815196184937,-1.2430231094987354,0.18823529411764706,1.0,1.0,6/33,22.41%,POLR2I;POLR2G;PTMA;PPP5C;MMS19;PAX8
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.622967680733524,1.2426778404125474,0.14285714285714285,0.8225666002301196,1.0,2/11,4.91%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.7965420655116237,1.242664983109481,0.25806451612903225,0.8211555319784637,1.0,2/5,11.21%,FUT9;WNK1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5439582318772394,-1.2420287891095807,0.11702127659574468,1.0,1.0,9/108,10.10%,CD44;VEGFA;SFRP1;EMD;TGFB1;OVOL2;HAS2;MEF2C;MED1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.5913037276351094,1.2416736026069906,0.2222222222222222,0.8228218143365823,1.0,5/11,15.12%,ERI1;INTS6L;INTS7;INTS6;INTS8
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.6254897737761124,-1.2416639254845427,0.20512820512820512,1.0,1.0,5/22,18.87%,RPL13A;IFITM3;GAPDH;STAT1;SHFL
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5668264779653367,1.2415505477273352,0.1875,0.8219047843624131,1.0,5/19,13.36%,AHCY;NOX4;CDO1;MPST;MSRA
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5690753305952558,1.2412773861926667,0.19230769230769232,0.8213492997737056,1.0,2/14,3.66%,STYXL1;PPP4R4
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.6694349260481278,1.2412129365771054,0.23684210526315788,0.8201457549821926,1.0,2/7,3.41%,SGCZ;NOX4
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.6972156966326084,-1.2411194749609546,0.17567567567567569,1.0,1.0,7/14,23.88%,EMC3;EMC7;EMC6;MMGT1;EMC10;BAG6;CAMLG
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7584945280577118,1.2408728268452567,0.2777777777777778,0.8196279336654552,1.0,2/5,21.03%,MGLL;LYPLA2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4984976848251366,1.2406886739913354,0.16666666666666666,0.8186909712040662,1.0,6/29,7.72%,RAB27A;SYTL4;STXBP5;RAB27B;SNF8;RAB9A
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.7215042008167215,1.2406651593172673,0.2,0.8173048180009387,1.0,1/7,0.23%,YJEFN3
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.691562658558531,1.2406203037280064,0.23529411764705882,0.8159559470897318,1.0,2/7,19.45%,RIPOR1;YWHAZ
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.6450407081950028,-1.2406093724478557,0.1917808219178082,1.0,1.0,8/22,24.84%,RPS27A;COPS6;COPS5;UBA52;UBC;XPA;COPS7A;RBX1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6336605385033575,-1.2404316471350683,0.12162162162162163,1.0,1.0,4/22,7.68%,OPRM1;SFRP1;RSAD2;RHBDF1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.5513488164747558,1.2404043076047067,0.14285714285714285,0.8151273190634287,1.0,3/18,11.69%,HSPA1A;AFAP1L2;HMGB1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.4737695783752097,1.2401195709913626,0.1875,0.8147196634144033,1.0,13/58,11.87%,SEM1;RMI1;RPA1;RFWD3;RAD51B;RECQL5;RAD54B;SAMHD1;NSMCE2;SMC6;ERCC4;HELQ;UBE2N
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.7035026617420432,1.240104560288907,0.23529411764705882,0.8133185302105136,1.0,3/5,27.63%,SNX33;MAPKAPK2;RAB34
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.5074586499131062,-1.2399040426179784,0.052083333333333336,1.0,1.0,22/275,9.38%,CD44;B2M;HLA-B;GLIPR1;CD63;FTH1;TUBB4B;HRNR;HLA-C;FTL;PGRMC1;SLC2A3;ALOX5;CTSZ;ENPP4;FUCA1;ATP6AP2;CKAP4;GGH;HVCN1;AGA;CEACAM1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.7154494367464522,1.2395515958002878,0.30952380952380953,0.8138126313458255,1.0,2/5,16.06%,DMD;DMPK
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.695426802581355,-1.2389353633394338,0.21739130434782608,1.0,1.0,4/11,18.76%,IFI35;FLOT1;NINJ1;NR1D1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5572022355710663,1.2387456297507184,0.2222222222222222,0.814784660461635,1.0,3/25,6.15%,TCF7L1;TLE1;PYGO2
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.6235313621054257,1.2384017058223753,0.16666666666666666,0.8129900153098187,1.0,2/9,14.79%,VTA1;CHMP1A
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.6235313621054257,1.2384017058223753,0.16666666666666666,0.8129900153098187,1.0,2/9,14.79%,VTA1;CHMP1A
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5074743544480623,-1.2383742728913254,0.052083333333333336,1.0,1.0,22/274,9.38%,CD44;B2M;HLA-B;GLIPR1;CD63;FTH1;TUBB4B;HRNR;HLA-C;FTL;PGRMC1;SLC2A3;ALOX5;CTSZ;ENPP4;FUCA1;ATP6AP2;CKAP4;GGH;HVCN1;AGA;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7080389070326361,1.2383498766422099,0.25,0.8116680709048164,1.0,2/7,9.56%,NRXN1;RELN
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.6368007150840862,-1.2383232482059559,0.19480519480519481,1.0,1.0,2/18,4.14%,TRIM5;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.6234173856459247,-1.2383177262173384,0.1282051282051282,1.0,1.0,5/35,6.14%,EMD;ECT2;CAMK1;TGFB1;ZIC1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7258823914086545,1.2379546683018907,0.30303030303030304,0.8117479327879799,1.0,2/6,3.53%,RIT2;ABL1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.5104074151351166,-1.2377437274010992,0.07446808510638298,1.0,1.0,20/174,9.89%,CD44;ITGA4;ADAMTS16;TNC;A2M;ECM2;PPIB;COL5A3;AGRN;FLOT1;COL9A3;TGFB1;CTSL;SPINK5;P4HA3;MMP24;OPTC;MARCOL;HAS2;FN1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.7337498030917251,-1.2375562847651838,0.16417910447761194,1.0,1.0,2/8,5.11%,B2M;ARG2
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.7534520638521562,-1.2375046755234334,0.14666666666666667,1.0,1.0,1/8,2.32%,SFRP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.49697506586271284,1.2373537885235733,0.1875,0.8121127742190414,1.0,4/20,5.62%,PKP2;PDE4B;PDE4D;ANK2
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.46697232107319525,1.2373319053890448,0.125,0.8107677771070886,1.0,7/33,15.54%,DHCR7;OSBPL7;AKR1C3;CYP7B1;HMGCR;OSBPL6;HSD17B4
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.7020112472911433,1.2365340452641105,0.16666666666666666,0.8119542385372509,1.0,2/7,8.61%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.682795555337011,-1.2364708026025988,0.1643835616438356,1.0,1.0,6/15,22.91%,HTR2B;CDH3;PIK3CB;S100A1;APOE;PARK7
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.6250128772828624,1.2364650165963285,0.23684210526315788,0.8106458020806542,1.0,1/7,9.39%,USP30
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7332678200577957,-1.2359526567523993,0.16417910447761194,1.0,1.0,3/10,15.28%,ZW10;BUB3;MIS12
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.668710951067371,-1.2359489174849265,0.2236842105263158,1.0,1.0,6/15,22.48%,C2ORF49;FAM98B;CSTF2;RTRAF;TRPT1;CPSF1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5710356071668448,1.235574056914743,0.20588235294117646,0.8128039352638476,1.0,4/10,19.41%,PDE4D;ADCY6;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.5062307047098318,-1.2352291909954467,0.0625,1.0,1.0,22/277,9.38%,CD44;B2M;HLA-B;GLIPR1;CD63;FTH1;TUBB4B;HRNR;HLA-C;FTL;PGRMC1;SLC2A3;ALOX5;CTSZ;ENPP4;FUCA1;ATP6AP2;CKAP4;GGH;HVCN1;AGA;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7791070286148346,-1.2352267336451705,0.25,1.0,1.0,2/7,12.07%,CD63;EMP2
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.6821442890593561,-1.234424280413544,0.14473684210526316,1.0,1.0,2/15,4.46%,OPRM1;GALR1
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.43088999183092264,1.2343268059908261,0.125,0.8151429708058244,1.0,41/120,16.90%,MMP16;IRS1;RXRA;ATP2C1;INPP4B;PDLIM5;BCKDHB;PPARG;GRK5;SMAD7;IGF1R;LAMC1;APBB2;MAGI2;CDON;VLDLR;CDC42BPA;ATXN1;TGFBR2;ATP2B4;NFIB;PLCB4;MAPK14;ZMIZ1;SCAF8;SDC2;NRP1;RASA2;NR3C1;COL5A2;PRDM2;LPAR1;NIPBL;FYN;MGLL;SPOP;SIPA1L1;AMPH;PRKCA;PRKCE;MGMT
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.6325052739929596,1.2338488688924656,0.20689655172413793,0.8151843814866873,1.0,2/9,4.76%,LARGE1;CHST3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.5215030166575214,1.2335225855676164,0.25,0.814599513497586,1.0,5/21,5.62%,ADRA1A;PDE4B;SMAD7;PDE4D;ANK2
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.7587546317586598,-1.2332138312385195,0.24324324324324326,1.0,1.0,1/7,1.74%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.7828240344300902,-1.232278904586803,0.16417910447761194,1.0,1.0,2/6,11.56%,ITM2A;ITM2B
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.6879367886385485,-1.231955484524279,0.1780821917808219,1.0,1.0,3/14,8.97%,DUOX1;ALOX12;NOXA1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6181819356789278,1.2318944760986457,0.2222222222222222,0.8191419959537106,1.0,8/16,18.42%,HSPA1A;DCUN1D2;DCUN1D5;ZMIZ1;WASHC1;DCUN1D1;PINK1;PRKN
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.44586502569113856,1.2317166708667653,0.09090909090909091,0.818271479209851,1.0,11/61,10.27%,VAPB;COL7A1;SEC24D;PREB;CNIH2;GRIA1;BET1;NSF;SEC16A;TGFA;VAPA
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5990498719960664,-1.2316556674558932,0.13414634146341464,1.0,1.0,7/36,10.62%,FLG;HRNR;COL5A3;JAG1;ALOX12;MED1;KRT10
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6947576935275251,-1.2313050974301596,0.2571428571428571,1.0,1.0,6/14,18.87%,PLSCR1;IFITM3;IRF1;OAS1;STAT1;SHFL
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4778660789569,1.231290354018074,0.09523809523809523,0.8179957133437916,1.0,12/30,20.15%,RAB31;SPTBN1;NECTIN3;RAB10;NSF;GGA1;KIF13A;BLZF1;ARFRP1;RILPL2;ANK3;GOLPH3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6723554280041342,1.2312506704699822,0.36666666666666664,0.8166328107108788,1.0,2/8,7.55%,ANK2;CACNA2D1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.518954394940377,1.231217668955802,0.16666666666666666,0.8153677519185631,1.0,3/17,11.87%,BARD1;SMARCAD1;UBE2N
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6073934237710276,1.2311314838462473,0.2222222222222222,0.814323949592855,1.0,6/15,19.40%,FBXW7;CBLB;TGFA;ADAM17;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.7799497487397585,1.2310920871097921,0.25806451612903225,0.813190984704883,1.0,1/5,0.30%,IL15
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.78871973725629,-1.2309672849217719,0.2,1.0,1.0,2/6,5.88%,HLA-F;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.7306076126541718,-1.2304344040047166,0.17142857142857143,1.0,1.0,2/12,3.39%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6362923035744797,-1.2300430684783545,0.2236842105263158,1.0,1.0,4/15,16.72%,PSMB9;BEX3;USP50;DELE1
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.7148434218095858,1.229590964107892,0.2978723404255319,0.8157049963754419,1.0,3/5,23.53%,BCL11B;JAM3;GPLD1
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.669668621927233,1.2295716184008951,0.22727272727272727,0.8143886395649103,1.0,5/9,12.03%,SERTAD2;PADI2;ARID1A;ARID1B;ZMIZ1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.5773096125233742,-1.2295538761008067,0.16455696202531644,1.0,1.0,18/52,18.85%,SLC28A2;TREH;CDH19;DEGS2;ASPN;TMC4;CEACAM1;EPHX2;RBP2;KHK;GSTM3;VIL1;NR5A2;CD55;FAHD1;CA1;PDZK1;CBR1
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6906193957355122,-1.2291818557401395,0.2028985507246377,1.0,1.0,2/9,11.01%,ITGA4;GCNT1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7293176730195184,-1.2290814249955828,0.21739130434782608,1.0,1.0,1/11,0.19%,DUOX1
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.7340951751295821,-1.2289020135548094,0.12280701754385964,1.0,1.0,2/8,5.96%,VEGFA;AGT
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.7340951751295821,-1.2289020135548094,0.12280701754385964,1.0,1.0,2/8,5.96%,VEGFA;AGT
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.5555391257004854,1.2287257086178245,0.14814814814814814,0.8155381737814342,1.0,5/16,4.98%,ASXL3;FBXW7;ACADVL;PRMT3;AKR1C3
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6290650702760197,1.2287154697392153,0.2222222222222222,0.8141344936200203,1.0,3/8,11.59%,SEMA4D;NTNG2;MOV10
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.7343080025260992,1.2287037526904179,0.23529411764705882,0.8127662982719205,1.0,2/5,15.93%,DEF8;PRKCA
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.711576823669802,1.2286682246195129,0.2972972972972973,0.8101356328756629,1.0,2/6,12.66%,BCAR1;NRP1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.711576823669802,1.2286682246195129,0.2972972972972973,0.8101356328756629,1.0,2/6,12.66%,BCAR1;NRP1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.7566757984774486,-1.2285373340266534,0.2463768115942029,1.0,1.0,2/6,13.60%,CHCHD10;DCTN1
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.4245159414793176,1.2282733755146757,0.0,0.8096659036413056,1.0,10/42,13.23%,KCNJ6;SLC9A9;SLC8A2;CACNA2D1;ATP2B4;SLC12A8;SLC12A1;SLC39A8;SLC8A1;SLC39A10
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4219770863258358,1.2282397985019315,0.16666666666666666,0.808375576848535,1.0,28/100,12.83%,CRB2;LRFN4;LRRC4C;NLGN1;ATP2C1;IGSF11;DSCAML1;SDK2;GPC4;IL1RAPL1;ROBO1;CDH20;CDH9;ADGRL3;UNC5D;GRID2;CDH10;NECTIN3;CDH18;TGFBR2;LRFN5;PALLD;CLDN12;CDH13;PTPRS;ALCAM;ROBO2;ACVR1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.6798702903769283,-1.2281902972780234,0.20270270270270271,1.0,1.0,2/9,1.99%,VEGFA;SCG2
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.519565893540232,1.2279335900899007,0.17857142857142858,0.8080016464516113,1.0,4/26,8.84%,RNF139;SIRT1;BTRC;FBXW11
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.6462477226502956,1.2279329954621734,0.20588235294117646,0.8066274939916596,1.0,2/8,16.02%,ATP6V1A;CPEB4
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.7307750783629148,-1.2274218207597407,0.2028985507246377,1.0,1.0,1/7,0.43%,MX1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.40720590430840803,1.2269510011707323,0.0,0.8082270916258623,1.0,29/125,10.70%,ASXL3;TLN2;ZDHHC2;ERC2;CSRNP3;PRKX;ADGRB3;RGS7BP;ASTN1;ZNF536;GDAP1;MAP2;CADM2;CALCB;NRXN1;ANK2;MAGI2;LSAMP;GCNT2;NOVA1;MAPK10;LRRTM3;NKAIN2;KCTD16;CLVS2;LRFN5;CA10;ADGRA1;DLG2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6241539747667874,1.226518029015719,0.14285714285714285,0.8081275230690174,1.0,4/12,13.23%,FOXP1;LPXN;CBFB;SLC39A10
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.6654846866751996,1.2262448033218893,0.3103448275862069,0.8076357662275313,1.0,2/12,5.74%,RPA1;RECQL5
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.6823427425239146,-1.2261143341466931,0.2125,1.0,1.0,5/11,12.01%,MX1;IFIT1;OAS1;NLRP1;ZDHHC1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5072043498105825,1.2260104856093599,0.13333333333333333,0.8069045247669167,1.0,8/28,9.23%,ATR;NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPK3;MAPKAPK5
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.7716380794515735,-1.225782313167238,0.25757575757575757,1.0,1.0,3/6,22.57%,CAMK2A;CAV1;ACTN2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.7053441411215926,-1.2257626751961035,0.1282051282051282,1.0,1.0,1/10,1.74%,VEGFA
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.6987179389971602,1.2255947155534708,0.20833333333333334,0.8068979674674193,1.0,5/8,12.03%,SERTAD2;PADI2;ARID1A;ARID1B;ZMIZ1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7466871890064077,-1.2254302936203825,0.16176470588235295,1.0,1.0,6/9,18.54%,HLA-A;JAG1;EMP2;BTN3A3;CD55;CD46
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.686407586868529,-1.225145937180539,0.21739130434782608,1.0,1.0,10/16,22.20%,ARG2;OAS3;IGSF6;TBXAS1;CEACAM1;MYO1F;PILRA;MYLK;ADPGK;PSTPIP1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.6403742157930127,1.225080335705419,0.25,0.80770255956573,1.0,1/8,5.48%,PDE4D
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.6889548829673007,1.2248391139732997,0.2972972972972973,0.807334787925879,1.0,1/5,11.70%,PTPRS
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.748027319579839,1.2244460719110621,0.3684210526315789,0.8072377188909149,1.0,2/5,12.50%,RPS6KB1;ACSL3
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6585486212672953,-1.2242761949054284,0.1927710843373494,1.0,1.0,8/24,16.02%,RPS14;RPS8;DHX37;RPS16;RPS21;KRI1;NOP14;UTP3
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6147938430618975,-1.223162594744206,0.189873417721519,1.0,1.0,6/24,8.93%,F13A1;VEGFA;PDE6B;TGFB1;TBXAS1;ALOX12
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.3912013780892916,1.2231442396461498,0.0,0.8094724565864186,1.0,34/108,16.35%,PKP2;ZDHHC2;TSPAN17;ZFYVE27;EHD1;TSPAN15;ANK2;C2CD5;SPTBN1;EFR3A;RAB10;DPP6;PACS1;DPP10;SEC16A;TSPAN5;KCNIP4;TSPAN14;RAPGEF6;ZDHHC3;FLOT2;MYO5A;PACS2;RAPGEF2;EFR3B;MAP7;LIN7A;SPTBN4;RAP2A;RAP1A;ARL3;PPIL2;RAB40C;IKBKB
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.6047870257254603,-1.2231305308301303,0.16666666666666666,1.0,1.0,6/32,12.82%,ITGA4;RPL23;TRIM41;CACNB1;XBP1;DDX11
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.6706789177095475,-1.2227811305729392,0.1917808219178082,1.0,1.0,3/15,10.50%,ITGA4;SCG2;CD160
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6151722667979596,1.2227130762246452,0.34615384615384615,0.8093124558915175,1.0,4/10,14.10%,NFATC1;PPP3CA;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.7385115253854271,1.221651413013895,0.28888888888888886,0.8114766863842777,1.0,2/5,17.13%,SERAC1;LPCAT1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5361606594801718,1.2216341944307465,0.18181818181818182,0.8101837079103902,1.0,4/25,5.13%,IL15;RAB27A;DYSF;MERTK
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.5582824197015093,-1.2216338384987182,0.1728395061728395,1.0,1.0,12/60,10.56%,B2M;HLA-F;HLA-B;ITGA4;HLA-C;PLSCR1;HLA-A;SPINK5;IRF1;RSAD2;CD160;ERAP1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5863567973951487,1.2216135028768234,0.28,0.8089841077393736,1.0,1/10,0.11%,PKP2
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6133626373522888,-1.2215425884674278,0.21951219512195122,1.0,1.0,7/25,19.61%,PPIF;NOL3;CLU;PRELID1;PDCD5;BAX;DNM1L
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.7670605365927379,-1.2213489635379209,0.2602739726027397,1.0,1.0,1/6,10.78%,CAMK2A
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.6647044931854948,1.221264944873212,0.22857142857142856,0.8088556239093438,1.0,3/6,21.75%,UHRF2;UHRF1;USP7
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5884034165313224,1.221230405373595,0.21212121212121213,0.8075438314999186,1.0,2/12,3.39%,SOX11;SALL1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6718828057412416,-1.2206937884182967,0.2,1.0,1.0,3/16,11.90%,FANCB;POLQ;MAGEF1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5927470089363688,-1.219736975481819,0.1875,1.0,1.0,6/41,11.90%,FANCB;POLR2I;POLR2G;H1-4;POLQ;MAGEF1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.710395494439879,1.2195877150056345,0.2727272727272727,0.8112589261090692,1.0,3/7,18.84%,NR1H2;PRKN;ITGAV
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.6790009282357494,1.218888993084067,0.25,0.8122776453751223,1.0,1/5,1.34%,HIP1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3903096086180556,1.2188474246640817,0.0,0.8111433812856933,1.0,47/130,20.59%,PRKX;ATR;SGK1;RICTOR;RPS6KB1;MAPK1;TNKS;TGFBR2;MAPK14;MAST3;MAPKAPK5;PIKFYVE;LRRK2;SMG1;DGKQ;WNK1;CSNK1E;LATS1;LMTK2;PRKD1;MAPK8;CSNK1G3;SRPK2;TTBK1;PNCK;MAP2K2;CSNK1G1;CAMKV;PRKCA;RPS6KA3;DMPK;NLK;IKBKB;PRKCE;PINK1;UHMK1;MKNK2;VRK1;AKT2;RPS6KA2;MTOR;TTBK2;PDPK1;EIF2AK3;SGK3;AKT3;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.7442726410697288,1.2187071360212538,0.20588235294117646,0.8103656347259013,1.0,4/8,11.69%,MAPK11;PLCB1;MAPK14;HMGB1
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.6333214721357068,-1.218656063901797,0.21518987341772153,1.0,1.0,9/20,23.89%,NUBP1;ISCA1;CIAO2B;ISCU;NDOR1;MMS19;HSPA9;GLRX5;CIAO1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.6507336483135329,-1.2183248388527017,0.16,1.0,1.0,3/16,6.88%,VEGFA;SFRP1;S100A10
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.7827096134386726,-1.2181488764550494,0.17142857142857143,1.0,1.0,1/6,2.19%,HSD17B14
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7629621145540582,1.2178573887510824,0.3142857142857143,0.8118797466745613,1.0,3/5,19.47%,SMAD7;MALT1;RC3H2
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.4547101798812652,1.2178506862519778,0.17647058823529413,0.8105759126094568,1.0,7/31,11.70%,ZFYVE27;ABL1;MAP2;DIP2B;NRCAM;SEMA3A;PTPRS
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6328297959938494,1.217444583147695,0.23076923076923078,0.8102709816640414,1.0,8/9,30.88%,MAP3K7;TNFRSF10B;MALT1;TRAF2;TRAF6;IRAK1;TIRAP;CARD14
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6144639089962991,1.2172165809526014,0.2413793103448276,0.8095873722383549,1.0,3/11,8.85%,LAMA3;RAB10;TRAF3IP1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.6910735077085177,1.2167487000872967,0.3,0.8096349511206726,1.0,3/7,14.56%,OPHN1;MSN;RAP2A
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.7700730578885331,-1.2166454001455218,0.15625,1.0,1.0,1/7,2.59%,GSS
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.7700730578885331,-1.2166454001455218,0.15625,1.0,1.0,1/7,2.59%,GSS
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.5719288775815976,1.2164115765429055,0.2692307692307692,0.8093039369016832,1.0,1/15,0.39%,SOX11
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.7381680522042066,-1.21637008478716,0.2537313432835821,1.0,1.0,1/8,1.74%,VEGFA
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.5356510678179487,1.2160021029630013,0.25,0.808915874517199,1.0,4/21,6.52%,PBX3;PBX1;SMOC1;MEIS1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5667728289074203,1.2153812147447811,0.17857142857142858,0.8096316797160528,1.0,3/13,11.13%,NEDD4L;HECW2;NEDD4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.7782233797733302,-1.2151997369095204,0.25333333333333335,1.0,1.0,4/5,16.71%,FLOT1;TGFB1;MEF2C;USP19
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5646826882130419,1.2150665914995311,0.2857142857142857,0.8093022828900206,1.0,3/14,7.69%,ZDHHC2;NEDD4L;SNF8
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.5950051135995555,-1.2150469687164704,0.21518987341772153,1.0,1.0,6/27,8.27%,VEGFA;HES1;HTR2B;ZFPM1;OLFM1;TTN
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6104579500089878,-1.215007577566503,0.225,1.0,1.0,9/28,22.23%,RBM47;FPR3;RNASE1;STEAP4;TYMP;C3;NRN1;CEBPD;CLDN18
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.496062875785178,1.2148435096802206,0.25,0.8085401255749507,1.0,8/28,11.92%,RIPOR2;NEDD4L;PICALM;SNX33;ILRUN;ANKRD13A;MFHAS1;LATS1
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.6579481593313253,-1.2147959778655424,0.1794871794871795,1.0,1.0,5/18,17.21%,DUOX1;TMC4;VWA2;STEAP4;RAB3D
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.7208502413257072,1.214570319782622,0.3157894736842105,0.8079536852838054,1.0,2/5,15.42%,ANXA6;PPP1R12B
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6355850083767078,-1.2144726462226074,0.23376623376623376,1.0,1.0,7/16,13.14%,GSTK1;GSTM4;GSTO1;AKR1A1;MGST1;GSTM3;GSTM5
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6355850083767078,-1.2144726462226074,0.23376623376623376,1.0,1.0,7/16,13.14%,GSTK1;GSTM4;GSTO1;AKR1A1;MGST1;GSTM3;GSTM5
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6187041040074017,-1.2143824235247331,0.2,1.0,1.0,4/19,12.62%,BUD23;NOP10;GAR1;DIMT1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.7347366203716912,1.2140079547178915,0.22580645161290322,0.8085511056108245,1.0,3/8,14.53%,FCHSD2;WASF3;NCKAP1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.45070789648430126,1.2138662250626677,0.16666666666666666,0.8075635922328794,1.0,33/99,18.24%,PHLDB2;CRB2;GPNMB;LRRC4C;NEDD4L;ADGRB3;HECW2;SEMA4D;PDLIM5;TANC2;ZRANB1;SH3D19;ARC;CAPZB;SRCIN1;LRRK2;NEDD4;KIF13B;SDC2;CLASP1;DLL1;RAP2A;INF2;FMNL2;ARHGAP44;MARCHF5;SIPA1L1;CDH2;LARP4;PID1;PPFIA2;CLASP2;NF1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.7605823351018616,-1.2138120635410627,0.2191780821917808,1.0,1.0,4/6,23.07%,ZNHIT3;NOP58;PRPF31;FBL
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.6585374167923467,-1.213746585562166,0.20512820512820512,1.0,1.0,3/14,7.07%,IFI35;FLOT1;RSAD2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6049276598488172,1.2136991231419851,0.2962962962962963,0.8069240863252507,1.0,2/10,4.70%,RAB27A;SYNJ1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6720781565078283,-1.2135060897221386,0.2465753424657534,1.0,1.0,6/14,22.48%,C2ORF49;FAM98B;CSTF2;RTRAF;TRPT1;CPSF1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.7533310612898527,1.2133138319124348,0.3611111111111111,0.8068604245210512,1.0,2/5,11.78%,PLCB1;LHFPL2
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.6101991935295437,-1.2132356576421874,0.2077922077922078,1.0,1.0,6/21,24.35%,ABRAXAS1;DONSON;FZR1;BRCA1;TAOK3;BRCC3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.501852861452083,-1.2131821642352314,0.05263157894736842,1.0,1.0,30/277,11.23%,CD44;APIP;IFI6;PPIF;VEGFA;RPS27A;DDRGK1;SFRP1;RPL10;NOL3;BEX3;HMGN5;IFIT3;HTR2B;RETREG1;HAX1;RPS3A;COPS5;PRELID1;ANGPTL4;CRYAB;XBP1;PTMA;ALOX12;PTRH2;MEF2C;MED1;BDNF;ANKLE2;PRDX5
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.631544719142259,1.2131679977895315,0.23333333333333334,0.8059376668787005,1.0,2/9,4.91%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.6864564954002816,1.2126228342589156,0.2857142857142857,0.8061903617320968,1.0,3/6,11.85%,ERC2;PCLO;ERC1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.5788552138073312,-1.212368715723298,0.13580246913580246,1.0,1.0,4/39,3.84%,B2M;HES5;OPRM1;HES1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.750810087471192,-1.212136549363306,0.21428571428571427,1.0,1.0,1/7,0.91%,HES5
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.7822155705671825,-1.2120471637600259,0.25316455696202533,1.0,1.0,1/7,0.33%,IFI6
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.6884849369984574,-1.2117262729094007,0.1891891891891892,1.0,1.0,5/12,17.10%,PFDN6;CLU;CRYAB;VBP1;APOE
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.433667948763743,1.2112600261286885,0.18518518518518517,0.8090975543546144,1.0,12/41,13.97%,RAD51B;LSM11;STOX1;ANKRD17;PLCB1;EGFR;NSMCE2;MECP2;UBE2E2;ANAPC4;CDC16;ADAM17
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.7560789464230334,1.2105004532679258,0.25806451612903225,0.8095724427080497,1.0,4/6,12.17%,DYSF;ANK2;BIN1;MYOF
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6555698505372232,1.2099712696888076,0.24242424242424243,0.8101881193045832,1.0,5/8,26.52%,AGPS;FAR1;DHRS7B;CHPT1;GNPAT
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7599485191491762,-1.2096448001942144,0.2318840579710145,1.0,1.0,3/7,17.10%,PRELID1;DBI;APOE
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6880240853563591,-1.2094206942794012,0.17647058823529413,1.0,1.0,6/13,22.00%,PRPF8;PRPF6;SRSF10;USP4;PRPF31;DDX20
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7402279693172387,-1.2092030810743861,0.1875,1.0,1.0,2/8,7.67%,NAAA;DEGS2
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.731296838425221,1.2091619685051873,0.3684210526315789,0.8111144033184602,1.0,3/5,17.03%,ATP2B4;NOSIP;SNCA
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5491711008756212,-1.2088785082085616,0.16666666666666666,1.0,1.0,21/60,26.69%,TNC;TGFB1;CRYAB;PAMR1;FN1;KRT10;COL15A1;COL6A1;LMOD1;ACTA2;TNFAIP6;COL4A1;ADAMTS2;THBS2;CALD1;THY1;COL14A1;SRPX;COL4A2;PDGFRB;C1S
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6325527327466167,1.2086990422375021,0.17857142857142858,0.8114987099276955,1.0,6/8,22.83%,RAP2B;RAPGEF6;RAPGEF2;AFDN;TJP1;RAB1A
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.46352528432916074,1.2086088338268073,0.16,0.8105221926282622,1.0,10/26,17.03%,FER;INAVA;SRR;FOXP1;ERBIN;TAB2;ADAM17;NOS1;RPS6KA3;SNCA
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7156465092160322,-1.2084323585935823,0.2676056338028169,1.0,1.0,3/10,17.10%,CLU;LRPAP1;APOE
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.4387514666524305,1.20837031607435,0.2727272727272727,0.8101992148822273,1.0,23/82,17.77%,SYNDIG1;PRIMA1;RGS7BP;ASTN1;ZNF536;FAM107A;NRXN1;ADGRL3;ANK2;CNTN1;GRIK3;INTS6;NFASC;MEGF10;SOX10;ADCYAP1R1;PCDH17;FRZB;NDRG2;GPM6B;PHYHIP;RAPGEF4;FREM1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.6769857542746945,1.2082943014992038,0.2222222222222222,0.8090301958778306,1.0,2/8,5.48%,ADRA1A;PDE4D
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.48477771438035655,1.208097003889321,0.2631578947368421,0.808400496395552,1.0,12/31,20.45%,SMPD4;SGMS1;ACER3;PLA2G15;SPTLC2;CERS6;ABCA2;FA2H;PLPP2;ACER2;SGPL1;NSMAF
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.6523580393694464,1.2079214244449177,0.37037037037037035,0.8077727833469714,1.0,4/8,9.13%,HDAC9;HDAC10;SIRT1;HDAC4
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.7086025813357832,1.2075811850499492,0.3055555555555556,0.8075685780802577,1.0,1/5,0.92%,SLC25A18
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.6755135939900245,1.207361357751508,0.30434782608695654,0.8067477419770093,1.0,4/8,14.31%,PBX1;TOX;PTPRC;NFIL3
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.5161664384323723,-1.207325958032816,0.1702127659574468,1.0,1.0,19/119,16.58%,CD44;VEGFA;COL5A3;RARRES2;CKAP4;HHIP;ASPN;WIF1;PAMR1;FN1;P4HTM;COL15A1;COL6A1;GSTM5;LMOD1;ACTA2;COL4A1;CD55;ADAMTS2
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5216439376098504,1.2072732999263978,0.28,0.805677358719873,1.0,10/26,12.83%,SOX11;SALL1;ROBO1;SMAD7;SLIT3;TGFBR2;PROX1;ZFPM2;ROBO2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7775917368235303,-1.2072642162459506,0.26153846153846155,1.0,1.0,3/6,17.10%,PRELID1;DBI;APOE
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.8001099099823492,1.2070439606566603,0.2564102564102564,0.8051137892322983,1.0,4/5,17.24%,SLCO1A2;SLC16A2;SLCO5A1;SLCO3A1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6364621667963553,1.206986727302739,0.2894736842105263,0.8040213870678585,1.0,2/8,11.05%,FBXW7;PIK3CA
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5387016848582887,1.2068676546657708,0.16666666666666666,0.8029602811617856,1.0,2/17,5.45%,SOX11;SMAD7
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.6218542364134642,1.2066163259105283,0.3157894736842105,0.8024314270986208,1.0,3/10,17.85%,DSCAML1;PALLD;DSCAM
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6296687681493419,1.2064412746227355,0.2727272727272727,0.8017096510743112,1.0,4/6,19.39%,BCOR;GREM1;TRPM4;PTK2B
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6325091429100288,1.206158643605214,0.2702702702702703,0.801517415907763,1.0,1/8,3.18%,PARD3
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.5639340950875128,1.2061236082564073,0.16129032258064516,0.8003559516021261,1.0,6/13,9.66%,CD247;CD96;BCL11B;RORA;GPR174;PTPRC
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.6785322911952372,-1.2059482358962688,0.2191780821917808,1.0,1.0,1/11,5.92%,ARFIP2
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.7663090136622807,-1.2059287088627288,0.27692307692307694,1.0,1.0,2/5,14.02%,GALE;GALM
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.6738200203964818,-1.2057269661613907,0.20588235294117646,1.0,1.0,1/10,1.12%,ITGA4
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.6746526152364678,1.2053102401644877,0.22580645161290322,0.8013560646742113,1.0,3/9,4.21%,ABHD17C;ABHD17B;ABHD10
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.7770245196429034,-1.2048389638135435,0.20967741935483872,1.0,1.0,4/7,21.00%,OAS3;OAS1;APOD;GSTP1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7679754624276156,-1.204408892743576,0.18461538461538463,1.0,1.0,2/7,14.87%,TRMT10C;SUPV3L1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.563905126607178,1.204187484825657,0.14285714285714285,0.8037895050329867,1.0,10/18,22.83%,PDE4D;MSN;RAP2B;RAPGEF6;RAPGEF2;RAP1A;RAP1B;AFDN;TJP1;RAB1A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.624061058854191,-1.2040327731550615,0.189873417721519,1.0,1.0,6/19,27.99%,RPS27A;UBA52;UBC;XPA;RBX1;DDB2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.7422076187290474,-1.2040153981092494,0.21739130434782608,1.0,1.0,1/6,5.88%,TGFB1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.4896380898177069,1.2035274080564031,0.21052631578947367,0.8040089562684414,1.0,8/32,15.72%,ZDHHC2;NEDD4L;SNF8;SSH1;CHRNA7;PLAUR;MAPK8;SPOP
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5646997576634314,1.203372105563654,0.14285714285714285,0.8032088140773083,1.0,6/19,13.97%,LSM11;ANKRD17;PLCB1;EGFR;UBE2E2;ADAM17
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7414445217007338,1.2030941388579488,0.2926829268292683,0.8026860960689813,1.0,1/5,7.85%,BBS4
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.5162059354173323,-1.202662846115225,0.07216494845360824,1.0,1.0,69/176,29.66%,SRSF7;RPS2;H2AZ1;RPL34;POLE3;APEX1;SNRPA1;RPL14;COPS5;SNRPD2;SNRPD1;RPL18;CAD;BUB3;PGK1;DDX18;CSTF2;NCBP1;HDGF;IFRD1;RPLP0;HNRNPA2B1;VDAC1;NOP56;VBP1;RACK1;CYC1;RSL1D1;PRPF31;CCT7;PPM1G;RFC4;RPS6;EIF3J;SRPK1;LDHA;PSMA7;HSP90AB1;RPL6;VDAC3;SET;SNRPG;ILF2;HSPD1;POLD2;FBL;CDK4;SRSF2;ERH;LSM7;PSMC4;CBX3;SERBP1;NOLC1;MRPS18B;HNRNPR;COX5A;HNRNPA3;PSMB3;IMPDH2;SF3A1;RANBP1;TFDP1;HDDC2;EIF1AX;ABCE1;PSMD7;PSMA4;NCBP2
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.7948912305080476,1.202563517779917,0.29411764705882354,0.8030709532450713,1.0,3/6,7.64%,PADI2;ROBO1;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.6445414421000705,1.2021792780587122,0.3103448275862069,0.8028789893214748,1.0,2/10,4.09%,IRS1;PLIN5
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6696186932131286,-1.2021345368027005,0.24324324324324326,1.0,1.0,1/12,0.19%,DUOX1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.6801039654517768,1.201378761680413,0.3,0.8040013419271572,1.0,1/6,9.46%,MECP2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.4226061915131305,1.2012371426044295,0.125,0.8032619928866348,1.0,18/81,14.53%,RIPOR2;ZDHHC2;PRKX;ADAM10;ABL1;PKP4;PLXNA1;SEMA4D;ADAM22;PLXNA3;ABL2;LPXN;PPP3CA;CDH13;CHRD;DLL1;CYTH1;DUSP26
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7288383964657721,-1.2012310317124348,0.2638888888888889,1.0,1.0,5/8,22.95%,COPS5;XBP1;RACK1;BAX;FICD
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.7117096995855945,-1.201062030392034,0.25757575757575757,1.0,1.0,1/6,5.85%,SELENOS
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.7729473951908485,-1.2010061774662437,0.18840579710144928,1.0,1.0,1/5,10.95%,CAD
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.7372791376205037,-1.20093975853468,0.28378378378378377,1.0,1.0,1/8,1.81%,DXO
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5535477086227233,1.2004699371709289,0.18421052631578946,0.8040256144187499,1.0,2/13,2.05%,CHRM3;ADRA1A
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5701099212568337,1.1999964270314813,0.20833333333333334,0.8042420248614267,1.0,6/16,26.42%,ESR1;NIPBL;RUVBL2;TASOR;MACROH2A1;LRWD1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5465909920674311,-1.1996618590574597,0.1724137931034483,1.0,1.0,15/71,20.18%,ESRRB;HES5;PSMB9;PSMB8;HES1;LDB1;JAG1;PSMA3;LMO2;PSME1;ZFP36L2;PSMA7;EIF2AK2;PTN;PSMB6
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.45473936568802376,1.199594848365544,0.125,0.8040225364667567,1.0,11/62,12.02%,DUSP4;LMO3;SPRED2;DUSP7;SPRY4;FOXO1;BMP7;PTPRC;PTPRR;SEMA6A;P2RX7
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.7981456045496689,-1.1994273754762284,0.18461538461538463,1.0,1.0,1/5,6.85%,OAS3
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7708760221891459,-1.199277242114124,0.21739130434782608,1.0,1.0,3/7,9.80%,ACMSD;TGFB1;AP2A1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.7769012804847648,-1.198778984497204,0.24285714285714285,1.0,1.0,1/5,0.19%,DUOX1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7559968453540696,-1.1984702075813498,0.234375,1.0,1.0,3/8,15.28%,ZW10;BUB3;MIS12
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.569172844760148,1.1983080977992928,0.2727272727272727,0.8068729133578016,1.0,5/16,19.52%,LARGE1;TMTC1;CRPPA;TMTC2;TMTC3
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.6059823708796074,1.1980630601210194,0.29411764705882354,0.8063788962063445,1.0,2/11,6.35%,DYNC2LI1;IFT140
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5777663554990627,1.1976650770448698,0.17391304347826086,0.8060759285867297,1.0,2/18,3.04%,SPRY4;LZTR1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.46820087088452644,1.1975779089531975,0.3076923076923077,0.8051790523499478,1.0,6/26,15.76%,ST6GAL2;GAL3ST3;FUT9;ST3GAL4;MAN2C1;FUT8
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.6143883461296444,1.1973970680006054,0.21875,0.8046628432339465,1.0,1/9,2.05%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4344583336072168,1.1973652592038209,0.21428571428571427,0.803743855270277,1.0,10/45,11.13%,BARD1;NEDD4L;ASB5;HECW2;HACE1;FOXO1;SNF8;TIPARP;NSF;NEDD4
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6376733787173006,1.1971190424830656,0.3333333333333333,0.802102306353425,1.0,4/7,10.40%,ABL1;MAPK1;MAPK3;LRRK2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6376733787173006,1.1971190424830656,0.3333333333333333,0.802102306353425,1.0,4/7,10.40%,ABL1;MAPK1;MAPK3;LRRK2
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.7733329030496965,-1.1968423438314535,0.14492753623188406,1.0,1.0,3/7,9.72%,ROMO1;RPL30;GAPDH
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6318294944950384,1.1967231515127572,0.2903225806451613,0.8017280003766568,1.0,1/8,2.55%,EHD1
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7583740256426521,-1.1965383654054416,0.2191780821917808,1.0,1.0,3/6,19.08%,NUP155;LDB1;NUP107
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5225610665162367,-1.1964112962553748,0.17204301075268819,1.0,1.0,11/95,8.63%,B2M;IFI6;MX1;IFIT1;TRIM5;ISG15;TRIM25;IFITM3;RARRES2;OAS1;NLRP1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.361834778432893,1.196350038201724,0.0,0.8014619944239982,1.0,23/94,13.36%,PRR5L;HSPA1A;PLA2R1;NOX4;ABL1;FER;AKR1C3;PTPRK;CAT;MAPK1;PRDX6;ADNP2;FOXO1;KEAP1;PKD2;EGFR;MAPK3;CPEB2;LRRK2;PRKD1;ERCC6L2;MAPK8;MSRA
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5868257782002981,1.196210753350652,0.32432432432432434,0.8008489863702435,1.0,2/9,6.46%,SLC15A2;VLDLR
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6267996696424565,1.1957753269744196,0.2903225806451613,0.800611806505815,1.0,6/10,17.72%,SMAD7;MAGI2;ACVR1;IGSF1;LEMD3;ACVR1B
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.4614047727250867,1.1955896009188234,0.21428571428571427,0.7999218803667808,1.0,11/29,14.56%,NEDD4L;ADGRB3;HECW2;SEMA4D;IL1RAPL1;NEDD4;FBXW8;SDC2;CAPRIN1;RAPGEF2;RAP2A
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.7585111707421677,-1.1954940785598254,0.31746031746031744,1.0,1.0,2/6,11.25%,ZW10;NABP2
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.6518563367677195,1.1954634066562386,0.36,0.7991807456459945,1.0,3/11,10.51%,RAD54B;NSMCE2;SMC6
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5240634388408075,-1.195446497404111,0.14130434782608695,1.0,1.0,25/92,25.18%,POLR2I;RPS27A;COPS6;UVSSA;POLR2G;COPS5;RFC2;RPA3;FAN1;CDK7;FANCC;PNKP;UBA52;RFC1;RFC4;LIG1;MMS19;UBC;HMGN1;RFC3;XPA;POLD2;COPS7A;RBX1;XRCC1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5532485241225927,1.1954306398782193,0.15625,0.7981226879105005,1.0,4/16,12.02%,ADAM10;NUP98;NUP93;P2RX7
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5349931077615481,-1.1953023037241703,0.1590909090909091,1.0,1.0,30/90,26.69%,GADD45B;TNC;VEGFA;SFRP1;COL9A3;CRYAB;HAS2;PAMR1;FN1;COL15A1;COL6A1;LMOD1;ATF4;COL4A1;RUNX2;ADAMTS2;COL10A1;STAT1;NRP2;SCRG1;AEBP1;THBS2;CALD1;THY1;COL14A1;COL4A2;PDGFRB;RHOJ;PDZRN3;C1S
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.6248056242003673,1.195292951525249,0.3157894736842105,0.7973864363175385,1.0,3/9,13.77%,FAM107A;BCL2L11;NR3C1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6634470686500875,1.1952726786520667,0.26666666666666666,0.7950203044590294,1.0,6/7,16.26%,SLIT1;SLIT3;SEMA3A;ALCAM;NRP1;SLIT2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6634470686500875,1.1952726786520667,0.26666666666666666,0.7950203044590294,1.0,6/7,16.26%,SLIT1;SLIT3;SEMA3A;ALCAM;NRP1;SLIT2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5647318374543536,-1.1951410244332403,0.22093023255813954,1.0,1.0,5/35,15.66%,POLR2I;POLR2G;IFITM3;GTF2F1;CTDP1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5419367485220118,-1.1946940601176887,0.1839080459770115,1.0,1.0,15/54,22.66%,DXO;RPS27A;IHO1;PNRC2;RFC2;RNASE1;RPA3;FAN1;UBA52;RFC1;RFC4;UBC;RFC3;XPA;POLD2
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7567948885419522,-1.194656335566103,0.29411764705882354,1.0,1.0,1/6,2.32%,SFRP1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5203232191058498,-1.1945501716203903,0.1595744680851064,1.0,1.0,9/118,9.89%,CD44;APIP;OPRM1;HTR2B;TGFB1;RASGRP1;HTR2C;CEACAM1;FN1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.674998015587349,-1.1943974832328594,0.3333333333333333,1.0,1.0,4/8,17.99%,NOP10;GAR1;RPUSD3;DKC1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.7177356566491255,-1.1941742800863384,0.26666666666666666,1.0,1.0,3/8,17.10%,HTR2B;HTR2C;APOE
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.7114604783480785,1.193178947292217,0.3235294117647059,0.7979213026768309,1.0,3/6,13.28%,CDC42EP4;WASHC1;CDC42EP1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.7114604783480785,1.193178947292217,0.3235294117647059,0.7979213026768309,1.0,3/6,13.28%,CDC42EP4;WASHC1;CDC42EP1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.39740910748141145,1.1927913287619123,0.0,0.7974543725808518,1.0,17/74,14.22%,PRR5L;HSPA1A;NOX4;ABL1;CAT;PRDX6;ADNP2;STOX1;FOXO1;KEAP1;PKD2;CPEB2;LRRK2;PIK3CA;PRKD1;MSRA;FOXO3
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.7087765679713423,-1.19245870765043,0.27631578947368424,1.0,1.0,1/9,1.81%,DXO
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.7397274537176401,-1.1917218871692643,0.19117647058823528,1.0,1.0,2/9,7.28%,OPRM1;HHIP
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5760087994160209,1.1917091380286853,0.25,0.799962953364102,1.0,3/12,2.34%,IL15;GPNMB;LEPR
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.6510068738338813,1.1916434440820536,0.2413793103448276,0.7989162096995442,1.0,7/9,31.77%,KDM3B;JMJD1C;KDM4C;KDM3A;KDM4B;KDM7A;KDM1A
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.516626743864282,1.1916080923554222,0.2222222222222222,0.7978463023383737,1.0,10/25,15.01%,PKP2;FGF12;GPD1L;NKAIN2;ATP2B4;NEDD4;WNK1;P2RX7;SPTBN4;NOS1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5942088983507694,1.1915597298475906,0.26666666666666666,0.7967795371427279,1.0,2/10,7.86%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.6659548946014178,1.1913914211735748,0.23333333333333334,0.7959775542647509,1.0,4/7,30.66%,ARL8B;PIP4K2A;PIP4K2B;ATP13A2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6751323514847625,1.1907524678824548,0.34210526315789475,0.7964842741935828,1.0,7/8,29.31%,FUT9;ZDHHC21;NFAT5;ETS1;TRAF6;IRAK1;RHOA
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5789236241116231,1.1905853777267335,0.22727272727272727,0.7956850679657594,1.0,6/15,20.21%,EGFR;NRP1;SNCA;BCL10;DSCAM;PSEN1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6400050307112112,1.1903034750998338,0.25925925925925924,0.7954613128839584,1.0,3/9,8.61%,KAT2B;SIRT1;KAT2A
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.48577912970175513,1.1898739209421545,0.125,0.7958104923979781,1.0,12/73,8.61%,PKP2;CRB2;HDAC9;FBXW7;ERBB4;KAT2B;SALL1;PDLIM5;FGF12;PKD2;TGFBR2;KAT2A
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.6618658865228222,-1.1898374773946347,0.21794871794871795,1.0,1.0,2/13,3.29%,SCG2;PPIB
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.67794980670379,-1.1897810682282617,0.2625,1.0,1.0,3/12,11.53%,NAAA;GDE1;RDH10
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.6253699658500823,-1.1896232816392927,0.2465753424657534,1.0,1.0,1/16,2.78%,TUFT1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.6617316710843585,-1.1890615739208386,0.24324324324324326,1.0,1.0,9/18,19.02%,RPL3;RPL10;RPL11;RPL23A;RPF2;RPLP0;RSL24D1;RPL5;RPL6
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.5607113723831096,1.188956340605129,0.25,0.7971457040516715,1.0,9/40,10.75%,HDAC9;MIER3;HDAC10;SIRT1;TBL1XR1;HDAC11;TRERF1;HDAC4;SIRT6
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.5985470870572869,-1.188780592954666,0.225,1.0,1.0,10/29,23.04%,DVL1;TGFB1;SEMA4C;FUZ;LMO4;DVL2;STIL;PLXNB2;MTHFD1;DVL3
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.6600785360049235,1.1887370737213139,0.2,0.7965317434666307,1.0,3/8,10.70%,NSMCE2;SMC6;ERCC4
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.6957570055115713,1.1886212864361931,0.2972972972972973,0.7958418663621306,1.0,3/5,15.16%,DCX;AGTPBP1;ARL3
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.6109774694514959,1.1881690460254217,0.2727272727272727,0.7960074359069975,1.0,2/9,8.61%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.692643370324145,-1.1878325114298887,0.22535211267605634,1.0,1.0,2/8,13.57%,CLU;GRN
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6537256080994582,-1.187570132408222,0.23076923076923078,1.0,1.0,2/16,5.41%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.7308310538138681,-1.1875380703900014,0.18840579710144928,1.0,1.0,1/6,0.43%,MX1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.6022508970724825,1.1874105057840716,0.3333333333333333,0.7970763873575322,1.0,4/10,19.39%,VEZF1;KLRG1;KLRC2;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6529226779553695,1.1872707205104225,0.24324324324324326,0.796285564853204,1.0,1/7,4.09%,PLIN5
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6230162157695986,1.1867240440557087,0.3870967741935484,0.7966300279046445,1.0,2/9,3.95%,ATR;PDS5A
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.6720890221171564,-1.1864390202327295,0.2,1.0,1.0,2/14,4.32%,CDC37;FLOT1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.558768557276546,1.186404244415098,0.34782608695652173,0.7965620907507293,1.0,5/13,15.68%,SMPD4;PRDX6;ENPP6;PNPLA6;MGLL
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.688551616217554,-1.1860629856136689,0.2597402597402597,1.0,1.0,3/12,10.50%,HLA-F;RASGRP1;CD160
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.5425005724369806,-1.1859576038576811,0.19753086419753085,1.0,1.0,2/46,0.29%,B2M;APIP
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7271252780201743,1.1857729436227902,0.41379310344827586,0.797161924389592,1.0,3/6,13.29%,SIRT1;NNMT;ARPP19
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.7535100883913416,-1.1854844892622662,0.26153846153846155,1.0,1.0,2/5,17.88%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.7535100883913416,-1.1854844892622662,0.26153846153846155,1.0,1.0,2/5,17.88%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6879220833675742,1.185100421361056,0.32558139534883723,0.7975036435492358,1.0,4/6,28.50%,FAR1;HDHD5;CPNE3;CPNE1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.7361798826039312,-1.1850841670941252,0.3181818181818182,1.0,1.0,1/5,5.96%,AGT
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.5906506957860079,1.184726413641218,0.24324324324324326,0.797741972978,1.0,3/8,16.26%,SLIT1;SEMA3A;SLIT2
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.5532500408164858,1.1846640319649369,0.14285714285714285,0.7967780354911851,1.0,2/17,1.29%,IL15;GPNMB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.7096180666713088,-1.1844452479893428,0.2,1.0,1.0,2/7,9.68%,TGFB1;MEF2C
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5824378977015487,-1.1841132851842469,0.23376623376623376,1.0,1.0,7/28,24.35%,ABRAXAS1;NABP2;DONSON;FZR1;BRCA1;TAOK3;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5338036177046857,-1.1838867713901016,0.06521739130434782,1.0,1.0,10/127,7.50%,CD44;OPRM1;TRIM5;VEGFA;FGF1;HTR2B;TGFB1;SEMA4C;RASGRP1;HTR2C
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.7049761945558923,-1.1826021355848135,0.23943661971830985,1.0,1.0,2/11,3.65%,ISG15;COX18
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.5931641036553131,1.1824138449205257,0.3333333333333333,0.801637477845395,1.0,3/8,18.62%,NOX4;MPST;BLMH
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6037575137251445,1.182201316028419,0.2222222222222222,0.8010021329063556,1.0,3/11,15.17%,NUDT19;PLA2G15;FAAH
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6122344410686291,1.1821309970552443,0.25,0.800012213752645,1.0,2/11,7.55%,ANK2;CACNA2D1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.692438942955689,1.1818231249688833,0.20689655172413793,0.798700802673667,1.0,4/7,14.10%,NFATC1;PPP3CA;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.692438942955689,1.1818231249688833,0.20689655172413793,0.798700802673667,1.0,4/7,14.10%,NFATC1;PPP3CA;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5870686235548384,-1.181693900971841,0.2,1.0,1.0,9/32,22.59%,ANKRD53;RAB11A;ZW10;MIS12;CENPC;CHMP4B;EML3;KIF22;RMDN1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.7694262572032496,-1.1815051850950193,0.22666666666666666,1.0,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.5688555614156454,1.1813354314924587,0.1875,0.7987069322808992,1.0,4/11,13.16%,KEAP1;PKD2;LATS1;MDFI
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.6031919499721572,-1.1808467455344065,0.2289156626506024,1.0,1.0,5/21,18.41%,PIGO;PIGC;PIGH;PIGL;PIGG
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4791120786701989,1.1804241636720552,0.16,0.8000798803224339,1.0,5/27,9.64%,DEPTOR;SIRT1;SESN1;MAPKAPK5;TNFAIP8L1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.4727197746813874,1.1801704666207553,0.13636363636363635,0.7997554522098362,1.0,12/44,11.44%,ATR;NAF1;MAPK1;POT1;STN1;TNKS;GNL3L;MAP3K4;MAPK3;CTC1;MAPKAPK5;HNRNPC
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.5637507881764182,1.1801527063798412,0.25,0.7986747367216354,1.0,3/19,4.30%,STYXL1;PPP4R4;SEMA4D
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.7802276134825438,-1.1798676393320162,0.2,1.0,1.0,1/5,5.30%,DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.7802276134825438,-1.1798676393320162,0.2,1.0,1.0,1/5,5.30%,DOLPP1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.6859542673278497,1.1797734724067719,0.2222222222222222,0.7984792323448503,1.0,2/6,9.36%,AK3;CMPK1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.455065129272691,1.178978313016704,0.23076923076923078,0.7995175590809315,1.0,23/70,20.88%,EPHA3;ERBB4;RYK;MERTK;IGF1R;EGFR;ROR2;RELN;PTPRC;TAB2;LMTK2;EEF1A2;RAPGEF2;RAP1A;ZNF16;FLT1;EPHA7;EPHA5;PTK2B;MMD;CACUL1;TRAF4;RASSF2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.4520787269703498,1.1786080988363248,0.2,0.7994973530049572,1.0,28/110,13.79%,RIT2;GABRG1;NEGR1;CSRNP3;LRRC4C;ADGRB3;RGS7BP;ASTN1;ZNF536;DPF1;CADM2;LRRC3B;NRXN1;LSAMP;SLC8A2;LRRTM3;ATXN1;NXPH1;CLVS2;CA10;ADGRA1;VSTM2B;KCNC2;NFASC;GABRB1;TTBK1;ADCYAP1R1;GABRA1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.536911000445259,1.1784151034465962,0.32142857142857145,0.7987242585764867,1.0,4/16,13.02%,XKR6;RHOBTB1;HMGB1;MEGF10
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7704408646866728,-1.1783901173906768,0.21212121212121213,1.0,1.0,2/6,10.42%,RIMS1;SLC22A4
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.41466847600712314,1.1782500513592198,0.17647058823529413,0.7981037132983142,1.0,33/92,15.91%,SHROOM2;SHANK2;BCAR1;TOX3;SHROOM3;CDC42EP4;MPDZ;SLC16A2;SLC29A4;MAGI1;EGFR;UNC13B;ADCY6;SLC4A10;MMP15;PRICKLE2;PTPRU;FARP1;PARD3B;CMTM4;SDC2;CHRD;COBL;RNF128;FLRT3;NCKAP1;EPB41L1;FRZB;CHMP1A;NEO1;AMOTL2;TEAD1;TMEM178A
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.45210384888813027,1.1779106627905453,0.23529411764705882,0.7978853530229056,1.0,6/60,8.55%,MYRFL;MMP16;ADAM10;KLKB1;PHEX;ADAM19
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.7083107098199601,-1.1778932979663124,0.25,1.0,1.0,2/8,14.88%,SELENOS;SYT11
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.7543637775607875,-1.1778315057755864,0.208955223880597,1.0,1.0,2/7,8.00%,CLU;HDAC6
prerank,MSigDB_Hallmark_2020__Apical Surface,0.42329224040891344,1.177807462259418,0.2727272727272727,0.7970177937193147,1.0,9/31,12.32%,SHROOM2;ADAM10;HSPB1;ADIPOR2;AFAP1L2;MDGA1;PLAUR;AKAP7;FLOT2
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.4879184543213283,1.1777671492501967,0.2222222222222222,0.7959030835183086,1.0,5/20,9.14%,MAPK11;ABL1;CDON;MAPK14;CTNNA2
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7045148310747035,-1.1776643663934319,0.23880597014925373,1.0,1.0,3/10,8.93%,FLG;HRNR;ALOX12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7045148310747035,-1.1776643663934319,0.23880597014925373,1.0,1.0,3/10,8.93%,FLG;HRNR;ALOX12
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.7144729180258717,-1.1774030470711758,0.3055555555555556,1.0,1.0,2/6,14.02%,GALE;GALM
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6457540092903554,-1.177050313676666,0.25,1.0,1.0,3/15,8.11%,MT1E;MT1M;MT2A
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.506195993056071,-1.1769171438692958,0.16091954022988506,1.0,1.0,10/82,9.68%,B2M;PPIF;MT1E;ECT2;JUN;HPCA;MT1M;HVCN1;MT2A;MEF2C
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.7584176886297198,-1.176815929078225,0.19117647058823528,1.0,1.0,1/7,5.28%,JUN
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6404748564542315,1.1764560410747942,0.3170731707317073,0.7979317732470009,1.0,3/6,24.32%,USP15;USP7;ATXN3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7856480201161354,1.1763021874293726,0.358974358974359,0.7972668843281988,1.0,3/5,18.42%,HSPA1A;ADAM17;PRKN
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.6686305434052614,-1.1759259777221829,0.2692307692307692,1.0,1.0,2/17,3.39%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5618780843616286,-1.1755635463995453,0.2,1.0,1.0,5/32,8.11%,RPL13A;CLU;HDAC6;ANKRD27;CRYAB
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.7423893994659079,1.1749513000749487,0.3235294117647059,0.8001081886162047,1.0,1/5,0.47%,BCO1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.45080069705667036,1.174740986679076,0.2857142857142857,0.7994669410930831,1.0,11/51,11.43%,VAPB;STIM2;ATP2C1;CALCB;ANK2;SLC8A2;ATP2B4;SLC24A3;CHRNA7;STIM1;SLC8A1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.4223716898299029,1.1747295222908705,0.25,0.7983565703415649,1.0,17/93,10.36%,USP51;EYA4;HDAC9;MIER3;PADI2;HDAC10;SIRT1;TBL1XR1;HDAC11;EYA2;TRERF1;KAT2A;HDAC4;BAZ1B;NAA50;KAT8;PHF20L1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5428405815299535,-1.1746826218706439,0.2345679012345679,1.0,1.0,6/40,11.97%,LIPI;ACMSD;ALOX5;XBP1;ACSM3;GAMT
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4013486789732068,1.1743218501625272,0.14285714285714285,0.7984867832138991,1.0,32/92,18.24%,PHLDB2;MCTP1;NAV3;SRGAP1;PTPRK;ROBO1;SMAD7;MAGI2;TP53INP1;TMEFF2;ZMYND8;KANK1;MITF;PTPRR;PTPRU;NF2;RAP2B;CLASP1;CHRD;PTPRG;FOXO3;ACVR1C;RAP2A;ARID2;STK24;SLIT2;CORO1C;MACIR;BMPR1A;SRGAP2;CLASP2;NF1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6208576371901247,1.1741406699796473,0.21739130434782608,0.797949309031602,1.0,2/8,7.55%,NEDD4L;CACNA2D1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6311255712823052,1.1738188031505665,0.3055555555555556,0.7976848193024854,1.0,2/8,9.56%,NRXN1;RELN
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6977225710310484,1.1736269112680737,0.35555555555555557,0.7972485276013755,1.0,3/5,11.23%,TGFBR2;CBFB;PNP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.7794709908165619,-1.1734777127027294,0.2222222222222222,1.0,1.0,1/5,2.41%,PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.714332859869921,1.1734248254103645,0.3170731707317073,0.7965426907583588,1.0,2/5,12.83%,TGFBR2;ACVR1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.7545001653916169,-1.1733651655133408,0.3333333333333333,1.0,1.0,1/6,2.65%,HAP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.6866257177597923,1.1725023974468147,0.3,0.7979280657071969,1.0,2/5,12.11%,NFATC1;NFATC3
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.5804681481218752,1.17220019293415,0.21428571428571427,0.7977141520500095,1.0,2/9,12.46%,TRAPPC8;PACS2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.6665594120727528,-1.172199156112953,0.2465753424657534,1.0,1.0,4/14,17.10%,A2M;F8;CPB2;APOE
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.6700545682942683,-1.17190890718809,0.2647058823529412,1.0,1.0,1/8,5.85%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6547489232596468,-1.171905462290966,0.3,1.0,1.0,6/12,31.06%,DDRGK1;RACK1;WFS1;UFL1;PPP1R15B;BFAR
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.5101209711191266,-1.1716982708545762,0.21348314606741572,1.0,1.0,35/73,33.24%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL51;MRPL27;MRPL19;MRPL36;CHCHD1;MRPS25;MRPS22;MRPL16;MRPL48;MRPS16;MRPS30;MRPS11;MRPL32;PTCD3;MRPS14;MRPS18B;MRPL21;MRPS33;MRPL52;MRPS34;MRPL47;MRPL57;MRPL43;MRPL44;AURKAIP1;MRPL34;MRPL9;MRPL35;MRPS23;MRPS15
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6950706619892802,1.171656010315137,0.25,0.7981136283007363,1.0,4/6,29.05%,PICALM;RAB22A;RAB5A;ALS2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5564768886510439,-1.171422105745562,0.2289156626506024,1.0,1.0,2/25,12.13%,TAF7;SMARCA5
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.7973494683286493,-1.1713958686205266,0.25757575757575757,1.0,1.0,2/5,17.10%,SELENOS;APOE
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.7085190586397936,-1.171316634031449,0.2777777777777778,1.0,1.0,3/7,24.89%,WARS2;DARS2;GARS1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.5173422685361203,1.171261112282645,0.16666666666666666,0.7980713962236616,1.0,4/15,15.37%,RACGAP1;KAT2A;TRIP12;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.5618855447951274,1.171091493020476,0.15384615384615385,0.797540381192664,1.0,8/25,17.72%,MAPK11;HSPA1A;ABCB10;MAPK14;FOXO3;ZNF16;MTURN;ACVR1B
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.6339937674165586,-1.1709945672862294,0.23076923076923078,1.0,1.0,2/17,3.29%,PPIF;PPIB
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.5567083793209204,1.1709701240503467,0.25,0.7967667040820537,1.0,2/15,5.31%,AGMO;TEX2
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.7343282331509957,1.170743472141391,0.25806451612903225,0.7962876785650663,1.0,4/5,22.27%,ABCC5;ABCC4;LRRC8A;SLC19A1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.6983969547823988,-1.1707064317310114,0.3194444444444444,1.0,1.0,2/11,11.56%,ITM2A;ITM2B
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.47422750070697395,1.1705499646920638,0.15789473684210525,0.7957369254190969,1.0,11/37,20.66%,DOCK5;SPRY4;ABL1;KANK1;RAC3;NRP1;ARHGEF7;CORO1C;ACTN4;WASHC2C;CRK
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.685760440312356,-1.1705290217345974,0.3188405797101449,1.0,1.0,5/9,26.81%,CEACAM1;CD160;PHPT1;THY1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4673176313634687,1.170524106263171,0.26666666666666666,0.7947014386025202,1.0,9/49,8.70%,SOX11;BAIAP3;RAB27A;SYTL4;STXBP5;RAB27B;RAB9A;UNC13B;FRMD4A
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.6155934067925924,-1.1702139889457226,0.2948717948717949,1.0,1.0,2/14,2.41%,ISG15;PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.5991162719407656,-1.1699870180492125,0.2875,1.0,1.0,3/20,6.88%,VEGFA;SFRP1;S100A10
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.6974290304256737,1.169444700712553,0.4166666666666667,0.7965093704167763,1.0,3/5,28.25%,SETD2;SETD3;SETMAR
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.571331261333951,-1.1693454357253037,0.21518987341772153,1.0,1.0,6/42,9.51%,S100A6;ITGA4;A2M;PAH;AGT;ARX
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6822074601767162,1.1693155168730114,0.34375,0.7958150870553597,1.0,1/5,8.89%,MAP3K4
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.61367840849773,1.169149227042581,0.3448275862068966,0.7951226877736215,1.0,1/8,4.97%,SLC44A1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.7745089548421968,-1.1689137775321785,0.30434782608695654,1.0,1.0,1/5,11.97%,GAMT
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.43398894328531745,1.1689040985987662,0.21739130434782608,0.7947465042261651,1.0,11/29,16.90%,USP51;FMN2;POT1;PPP4R2;UBR5;PML;SIRT6;SETD2;TRIP12;SPIRE1;MGMT
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.6997264470682277,-1.1686332856055515,0.2835820895522388,1.0,1.0,3/8,26.88%,TTC19;UQCC3;BCS1L
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.6997264470682277,-1.1686332856055515,0.2835820895522388,1.0,1.0,3/8,26.88%,TTC19;UQCC3;BCS1L
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.5131517312118494,1.168134901377811,0.3333333333333333,0.7959650557731653,1.0,5/23,9.56%,NLGN1;CNIH2;ARC;GSG1L;RELN
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.42742871052653203,1.167724969047534,0.14285714285714285,0.7959745841385598,1.0,5/30,7.84%,BANP;SF3B3;CTSA;FMN2;EGFR
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.6925687384935019,-1.1675844456636886,0.3220338983050847,1.0,1.0,4/8,26.81%,RFFL;GSTP1;CARD8;PTPN2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6789340031418576,1.1673838018388991,0.3142857142857143,0.7959118406283692,1.0,3/7,21.58%,FOXP1;CDK6;CTNNBIP1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.36353362279425827,1.167323063749168,0.0,0.7949353815494947,1.0,27/154,10.81%,SOX11;CRB2;MAPK11;TP63;RIPOR2;LMO3;PCP4;ABL1;TCF4;BRINP3;PPARG;ZNF268;CDON;PLCB1;GCNT2;WDFY2;NRCAM;TGFBR2;BMP7;SOX5;MAPK14;CTNNA2;RIN2;BEND6;CDS1;GPC1;ZBTB16
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.666789728447861,-1.1672966132747604,0.2638888888888889,1.0,1.0,2/11,4.14%,TRIM5;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.6897079763507125,1.1668868396329195,0.30952380952380953,0.7948261711315755,1.0,1/5,3.11%,NR1H2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5951377793052738,-1.1667984859384668,0.26582278481012656,1.0,1.0,6/22,20.30%,B2M;ARG2;NEK6;RSL1D1;CGAS;CDKN2A
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5801249642503954,1.1667629796271395,0.2692307692307692,0.7940696607044317,1.0,8/12,28.45%,ACER3;IP6K1;IP6K2;CYP27A1;CYP2R1;PPIP5K2;ITPKB;IPMK
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.7255170490159892,-1.1665607383621468,0.3,1.0,1.0,3/9,12.53%,CTSL;MED1;LMO2
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.7255170490159892,-1.1665607383621468,0.3,1.0,1.0,3/9,12.53%,CTSL;MED1;LMO2
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5435982039679478,1.1663570303503863,0.23076923076923078,0.7940816692755198,1.0,3/10,12.42%,KCND3;KCNN2;KCNIP2
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6577470467212494,-1.165814684460245,0.323943661971831,1.0,1.0,2/13,10.73%,SRSF7;SRSF10
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.5549613148817856,1.1654412668210072,0.2692307692307692,0.7952896778923882,1.0,5/14,18.84%,NR1H2;PPARG;OSBPL8;ABHD5;ITGAV
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.7059033230516936,1.1652535954449337,0.3888888888888889,0.7947744713939987,1.0,2/7,9.78%,WASL;MSN
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6772994399521979,1.1650261520302323,0.2571428571428571,0.7942606424530916,1.0,2/7,12.66%,BCAR1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.5828513607226801,-1.164759557891946,0.19736842105263158,1.0,1.0,4/24,6.56%,PPIF;NOL3;CLU;PRELID1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5746282459315241,-1.1644780154930636,0.2840909090909091,1.0,1.0,17/42,29.57%,PSMB9;PSMB8;PSMA3;PSME1;PSMA7;OAZ2;PSMB6;AZIN1;NQO1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.6562317362824563,-1.1643786318195462,0.2702702702702703,1.0,1.0,3/13,9.38%,IFI6;RHBDF1;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7273949969302229,-1.1641206809916234,0.3,1.0,1.0,1/7,7.22%,YBX3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7273949969302229,-1.1641206809916234,0.3,1.0,1.0,1/7,7.22%,YBX3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6327971448664307,-1.1635823651756223,0.273972602739726,1.0,1.0,5/12,26.31%,TRMT10C;RPUSD3;COA3;RMND1;RCC1L
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5880214272871842,1.1635085059267716,0.34375,0.7973219107241539,1.0,1/8,0.46%,SPOCK3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5213248451315433,1.1633151222267522,0.25,0.7967584692719132,1.0,4/18,4.91%,RXRA;NR1H2;SIRT1;PPARG
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.6161098296757563,-1.163027416447301,0.2714285714285714,1.0,1.0,3/15,9.72%,TRPC5;NLRP1;GAPDH
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6619905492624371,-1.1623709090740664,0.27941176470588236,1.0,1.0,4/10,16.10%,TRIM5;TRIB1;CACTIN;CD55
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.7215773769453441,-1.1621096687299108,0.2835820895522388,1.0,1.0,3/7,23.92%,DDX11;HNRNPA2B1;DHX36
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.570632005151928,1.161684697123956,0.36666666666666664,0.8003785322983156,1.0,2/9,12.42%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.5269064278907789,1.1614285497227923,0.3076923076923077,0.7999074438586199,1.0,4/11,18.18%,ILRUN;TRAF3IP1;PCBP2;ZMPSTE24
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.6656304262420395,-1.1613420114841881,0.25,1.0,1.0,2/11,6.28%,PPIF;GSTO1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.5508094927276151,-1.161195642661862,0.2361111111111111,1.0,1.0,3/45,4.32%,B2M;RPL11;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.721601137761107,1.1610643975564319,0.3333333333333333,0.7997693824989268,1.0,4/7,18.28%,IRS1;PRKCE;SNCA;AKT2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6391985782109244,-1.1606216564226255,0.31666666666666665,1.0,1.0,1/12,0.24%,B2M
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.4263505364392978,1.160404833637194,0.16666666666666666,0.8003653595404564,1.0,18/67,13.75%,RIT2;EPHA3;STYXL1;TOX;MAGI2;VLDLR;ZNF804A;ABL2;BMP7;ROR2;RELN;LRRC7;FUT9;PRKD1;COBL;CAPRIN1;RAPGEF2;TENM3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.6738965581243008,-1.1596982641112858,0.25675675675675674,1.0,1.0,4/13,16.59%,PPIF;CAMK2A;SPG7;SLC25A5
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7882667083005773,-1.1594036510407186,0.28125,1.0,1.0,2/5,13.91%,DDRGK1;SVBP
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5870465276091437,-1.1593725622279711,0.3108108108108108,1.0,1.0,2/20,1.33%,HLA-F;SP140
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.7601773596048348,-1.1590866346432451,0.28125,1.0,1.0,3/6,21.22%,ARG2;AZIN2;AZIN1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6860062050510887,1.1589449478615066,0.32432432432432434,0.8035596626200848,1.0,1/5,11.59%,MOV10
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6405183076795018,1.1586933441819405,0.25925925925925924,0.8033465054432487,1.0,3/9,19.40%,CBLB;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.4778291948903303,1.1585893952419855,0.21739130434782608,0.802780315636248,1.0,9/25,13.20%,MAPK11;MAP3K5;BTRC;MAPK1;FBXW11;MAPK3;MAP3K7;MAP3K8;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.7880177008565067,-1.158247668879603,0.32786885245901637,1.0,1.0,2/5,9.38%,HLA-F;CEACAM1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.7265134880481774,-1.1580091748878056,0.3157894736842105,1.0,1.0,2/8,7.22%,BTN3A1;RASGRP1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.6616777339609459,-1.1575434599240464,0.32,1.0,1.0,2/10,13.24%,TLE6;ZBED3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.5638114369436928,1.157256558146131,0.24242424242424243,0.8051583639662526,1.0,3/11,13.16%,KEAP1;PKD2;MDFI
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.504931236615738,1.1566492245279523,0.23333333333333334,0.8054846945282568,1.0,12/23,27.04%,FER;CAPZB;AUTS2;PIK3CA;NCKAP1;SLIT2;PIK3R1;ARPC2;TWF1;DMTN;ACTR3;WASF2
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.6613868639898896,-1.1564701520418965,0.3055555555555556,1.0,1.0,2/13,9.46%,OLFM1;HAS2
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5210634009555809,1.1564410323551952,0.25,0.8049648862770294,1.0,1/14,1.54%,SEC24D
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.44050290354109095,1.1562280427857383,0.23076923076923078,0.8045402407335629,1.0,22/80,16.26%,EMILIN3;EYA4;BCAR1;SALL1;IGDCC4;CHST3;MPDZ;MAGI1;CACNA2D1;PRTG;PTPRU;TUSC3;MEX3A;PTPRG;TENM3;FIGN;NCKAP1;EPB41L1;AMOTL2;TEAD1;CDH2;SLIT2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5601086671635699,-1.1560383691595175,0.2926829268292683,1.0,1.0,10/37,23.62%,CDC37;CDKN1C;CDKN2C;CCNI2;CDK7;CNPPD1;HSP90AB1;CCNK;HERC5;BCCIP
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.5908522172728367,-1.155869453658577,0.25333333333333335,1.0,1.0,7/22,17.88%,SCG2;ALOX5;MEF2C;CNMD;AIMP1;APOE;STAT1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.42385881815230764,1.1556708809609464,0.23809523809523808,0.8051939549516157,1.0,7/35,12.84%,DHCR7;RXRA;STARD3;FDX1;OSBPL5;CYP7B1;HMGCR
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.764825965929232,-1.155484892202858,0.203125,1.0,1.0,1/5,4.70%,POLR3H
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.598842805475339,1.1553186416005976,0.3939393939393939,0.8050741621417651,1.0,2/9,11.55%,AGMO;GPAT4
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.5422425755677889,-1.155244932852997,0.25,1.0,1.0,4/28,12.07%,VEGFA;SFRP1;S100A10;EMP2
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.6816280091419955,-1.1551722134670928,0.3,1.0,1.0,3/8,27.49%,TRMT10C;TRMT5;HSD17B10
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.45860093371927807,1.1550782346443138,0.22727272727272727,0.8047678263704126,1.0,2/26,1.02%,GSTT2;GSTM2
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.5064867343917582,-1.1547329739612937,0.2,1.0,1.0,36/74,33.24%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL51;MRPL27;MRPL19;MRPL36;CHCHD1;MRPS25;MRPS22;MRPL16;MRPL48;MRPS16;MRPS30;MRPS11;MTRF1L;MRPL32;PTCD3;MRPS14;MRPS18B;MRPL21;MRPS33;MRPL52;MRPS34;MRPL47;MRPL57;MRPL43;MRPL44;AURKAIP1;MRPL34;MRPL9;MRPL35;MRPS23;MRPS15
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6063477953749524,1.1545199305788318,0.2916666666666667,0.8052087406701335,1.0,7/12,23.21%,SOX5;ZBTB16;BMPR1B;PKDCC;GDF6;TAPT1;SOX6
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5318280471457556,-1.1544300781529624,0.1978021978021978,1.0,1.0,12/63,20.76%,ELOB;PSMB9;VEGFA;RPS27A;PSMB8;BACH1;PSMA3;PSME1;UBA52;PSMA7;PSMB6;UBC
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.583756592644799,1.154371240203428,0.20833333333333334,0.8046001799375248,1.0,5/15,15.12%,INTS6L;INTS7;EXOSC7;INTS6;INTS8
prerank,PanglaoDB_Augmented_2021__Podocytes,0.4166281402902776,1.1541724182302469,0.14285714285714285,0.8040862689123068,1.0,40/141,15.69%,CRB2;LAMA3;DOCK5;SRGAP1;BCAR1;ILDR2;CHST3;MERTK;LAMC1;APBB2;MPDZ;MAGI2;SH3D19;CDC42BPA;MAGI1;QKI;KANK1;EGFR;UNC13B;NFIB;ADCY6;NEBL;PRICKLE2;PALLD;CDH13;TOB1;PARD3B;STARD13;SNX7;PTPRG;MYO1E;KITLG;ITGA3;NAV2;NCKAP1;ETF1;EPB41L1;NTN4;AMOTL2;TEAD1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.6475703270395619,-1.1532112496711697,0.3181818181818182,1.0,1.0,3/11,23.91%,DCTD;TYMP;ERH
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.5201305745647166,-1.1526780265954988,0.24719101123595505,1.0,1.0,19/94,22.79%,RPS14;IFIT1;VEGFA;TUBB2A;IMP3;XBP1;FKBP14;H2AX;DCTN1;NOP14;DDIT4;NOP56;ATF4;DKC1;WFS1;HSPA9;POP4;TSPYL2;EIF4EBP1
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.6779132131558075,1.1525111171094156,0.2972972972972973,0.8078025422734982,1.0,3/6,22.59%,COL5A2;NIPBL;INTU
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6203642874933495,1.1523844085372767,0.3888888888888889,0.8071233670773222,1.0,3/8,8.31%,NINL;BBS4;PCM1
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.613048205044181,1.152317655833425,0.2916666666666667,0.8063300806412279,1.0,5/11,17.45%,ITGA2;OPHN1;PTPRC;NRP1;ANKS1A
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.793315805953861,-1.1518208250827293,0.2711864406779661,1.0,1.0,1/5,12.10%,NCBP1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6565592212117539,-1.1514280930318395,0.3013698630136986,1.0,1.0,3/14,11.01%,FLOT1;IRF1;CACTIN
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.5926110693972648,1.151121908969419,0.30303030303030304,0.8085939930485703,1.0,4/12,18.78%,PRR5L;MOV10;ZC3HAV1;CNOT7
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.5018251888074954,-1.1508971999815383,0.2111111111111111,1.0,1.0,39/80,33.24%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL51;MRPL27;MRPL19;MRPL36;CHCHD1;MRPS25;MRPS22;MRPL16;MRPL48;MRPS16;APEH;MRPS30;MRPS11;MTRF1L;MRPL32;PTCD3;MRPS14;MRPS18B;GSPT2;MRPL21;MRPS33;MRPL52;ABCE1;MRPS34;MRPL47;MRPL57;MRPL43;MRPL44;AURKAIP1;MRPL34;MRPL9;MRPL35;MRPS23;MRPS15
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6295947258207458,-1.1506615044439557,0.2987012987012987,1.0,1.0,3/16,8.11%,MT1E;MT1M;MT2A
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.702838901874682,1.1504961539140024,0.3611111111111111,0.8091415283824274,1.0,1/5,4.97%,SLC44A1
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.7498035318878835,-1.1500370047490154,0.3076923076923077,1.0,1.0,2/5,18.73%,SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.4775859386268266,1.1499941825148163,0.29411764705882354,0.8093875404510786,1.0,10/24,19.08%,DCX;NAV1;NCKAP5;TTLL3;AAAS;CLASP1;PSRC1;SPAG16;TOGARAM1;ZNF207
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5432981928278224,1.1498826942991263,0.32,0.8086645942933414,1.0,6/12,28.14%,UBA1;SENP6;DESI2;NAE1;UBA6;UBA2
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.34201267669652663,1.149843903118558,0.0,0.8077593094054213,1.0,82/297,19.45%,DGKB;DAPK2;STK36;MAP3K5;FAM20B;ADAM10;PEAK1;RYK;SGK1;ABL1;MAP3K11;GRK5;FER;MAP3K9;MERTK;FGGY;LIMD1;CTBP1;MAP4K2;TNK2;MAPK1;GRK6;PRKG2;CDC42BPA;OXSR1;CDK12;BMP2K;MAPK10;SIK3;TGFBR2;PRKG1;MAPK3;MAP3K1;POMK;LRRK2;AATK;PIK3CA;DGKQ;WNK1;CDK14;TBCK;CSNK1E;PRKACB;LATS1;LMTK2;PRKD1;MAP4K4;ACVR1;CDK18;BMPR1B;MAPK8;STK17B;SRPK2;TTBK1;ACVR1C;STK24;FYN;LMTK3;PRKCA;DMPK;NLK;IKBKB;PRKCE;PXK;CDKL5;DGKG;PINK1;MKNK2;MAML1;BMPR1A;BRAF;ACVR1B;EPHA7;VRK1;DGKE;MTOR;PDPK1;CSK;PPP4R1;EIF2AK3;PTK2B;YWHAZ
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.6885713793840821,-1.1497843354623323,0.3157894736842105,1.0,1.0,3/11,10.50%,HLA-F;RASGRP1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.6885713793840821,-1.1497843354623323,0.3157894736842105,1.0,1.0,3/11,10.50%,HLA-F;RASGRP1;CD160
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.500491997147332,1.149249011367925,0.29411764705882354,0.8081671227497842,1.0,10/27,18.60%,NAV3;MAP2;CAMSAP2;CLASP1;KATNB1;HDGFL3;ATXN7;SNCA;CLASP2;TTBK2
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.7486197465254618,-1.1489693365932445,0.2857142857142857,1.0,1.0,1/5,10.50%,SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5623100402814734,1.1486634728193026,0.3103448275862069,0.8084590549721159,1.0,2/10,4.09%,IRS1;PLIN5
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.733256921442754,-1.14859849365345,0.25,1.0,1.0,1/6,0.43%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.733256921442754,-1.14859849365345,0.25,1.0,1.0,1/6,0.43%,MX1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.5794027561111563,-1.1484492211943376,0.2808988764044944,1.0,1.0,4/24,8.89%,VEGFA;TGFB1;SPINT2;JAG1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.45989063598010876,1.1483580243475524,0.25,0.8082685647188842,1.0,9/31,16.49%,ITPR2;ANK2;SLC8A2;ATP2B4;STIM1;SLC8A1;NOS1;DMPK;TMEM65
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6694015936108856,-1.1482805851743794,0.35294117647058826,1.0,1.0,2/13,5.63%,IFI6;CLU
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6419479736869351,-1.1478376399900365,0.2647058823529412,1.0,1.0,2/10,11.01%,ITGA4;GCNT1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7118587211173076,1.1476110638177581,0.3684210526315789,0.8092468367670991,1.0,2/5,16.08%,LIMD1;ACHE
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.6669191337553051,1.1470929978518627,0.46153846153846156,0.8096048957745504,1.0,3/8,8.93%,RIPOR2;PADI2;WASL
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.42455697695481387,1.146880042328102,0.14285714285714285,0.8089795456115433,1.0,31/113,13.79%,RIT2;GABRG1;KCND2;ADGRB3;SATB2;KCNQ3;ASTN1;PCP4;KCND3;MAP2;CADM2;LRRC3B;CDH20;NRXN1;SLC8A2;GRIA1;LRRTM3;NXPH1;CTNNA2;CLVS2;SEZ6L;CA10;GRIA3;ADGRA1;VSTM2B;GRIN2B;KCNC2;KCNQ2;TTBK1;ADCYAP1R1;GABRA1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.5279020911482736,1.146721417702516,0.24,0.808469892002827,1.0,4/21,7.41%,EPHA3;BRINP3;ADNP2;ABL2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6053145721857757,-1.1465994682444771,0.2777777777777778,1.0,1.0,4/25,16.24%,GABARAPL2;CALM1;ATG14;MAP1LC3B2
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.7301413175840279,-1.146591326209986,0.36231884057971014,1.0,1.0,2/6,8.39%,TAF7;XBP1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.7341120494253703,-1.1460863558171168,0.30303030303030304,1.0,1.0,1/5,8.00%,HDAC6
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.7367937910852771,-1.145903745252625,0.29508196721311475,1.0,1.0,1/6,9.89%,FN1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.6934966504067145,1.1458414810838156,0.3939393939393939,0.8101721988113888,1.0,2/6,9.60%,SRR;SERINC5
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.6210410856903156,1.1455981648372715,0.3055555555555556,0.8100265037108765,1.0,1/5,3.84%,ITGA2
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.7368176660197097,1.1453975922021222,0.25806451612903225,0.8095856608101913,1.0,3/5,23.21%,EGFR;FRS2;SOX6
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.49817574830762335,1.1444141191485195,0.2857142857142857,0.8110757209285927,1.0,3/19,0.95%,COL7A1;DUSP4;LAMA3
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7826314871132484,-1.1442388432923467,0.2631578947368421,1.0,1.0,2/5,17.10%,LRPAP1;APOE
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.6661509255254295,-1.1441004655925842,0.3157894736842105,1.0,1.0,3/12,14.47%,CAD;TK2;TYMP
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.4933677222369484,-1.1440064522631723,0.21978021978021978,1.0,1.0,38/88,33.24%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL51;MTIF3;MRPL27;MRPL19;MRPL36;CHCHD1;MRPS25;MRPS22;MRPL16;MRPL48;MRPS16;MRPS30;MRPS11;MTRF1L;MRPL32;PTCD3;MRPS14;QRSL1;MRPS18B;MRPL21;MRPS33;MRPL52;MRPS34;MRPL47;MRPL57;MRPL43;MRPL44;AURKAIP1;MRPL34;MRPL9;MRPL35;MRPS23;MRPS15
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.7482544735993006,-1.143992990441751,0.3283582089552239,1.0,1.0,1/6,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6650021503620014,-1.1436524351902717,0.32432432432432434,1.0,1.0,2/11,8.86%,KIF20B;OBSL1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7224564824253394,-1.1435304245373854,0.35294117647058826,1.0,1.0,3/6,22.18%,PGP;COQ3;GOT1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.7297145273199956,-1.1435250527686693,0.31746031746031744,1.0,1.0,2/5,20.68%,IL5;GSN
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.5445678835603074,-1.1434429271796371,0.2823529411764706,1.0,1.0,9/44,11.15%,LIPI;GSTM4;ALOX5;XBP1;GPX4;ALOX12;EPHX2;ACSM3;HACD4
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7095597571376925,-1.1433297695321252,0.3787878787878788,1.0,1.0,2/7,12.37%,HDAC6;TOMM7
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7262722806686271,1.1432519582066303,0.35,0.812834087898422,1.0,3/5,20.58%,HS6ST3;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6777093430583642,-1.1430511359582642,0.296875,1.0,1.0,1/8,0.45%,HLA-F
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.6859329891399153,1.1430115865186046,0.35294117647058826,0.8123007776632332,1.0,1/5,0.48%,SLC16A10
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.5969850913402872,-1.1427044325021372,0.34615384615384615,1.0,1.0,5/15,18.29%,TGFB1;TMBIM1;PPP2R5A;SAPCD2;LZTFL1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.619433108533656,1.1424727677385969,0.3333333333333333,0.8132389233052979,1.0,2/7,4.09%,ACADVL;PLIN5
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6584472265584708,-1.1421243238519887,0.3561643835616438,1.0,1.0,2/11,11.40%,ZW10;BUB3
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6584472265584708,-1.1421243238519887,0.3561643835616438,1.0,1.0,2/11,11.40%,ZW10;BUB3
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6584472265584708,-1.1421243238519887,0.3561643835616438,1.0,1.0,2/11,11.40%,ZW10;BUB3
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.6584472265584708,-1.1421243238519887,0.3561643835616438,1.0,1.0,2/11,11.40%,ZW10;BUB3
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.6144160334727085,-1.1418722132554142,0.3076923076923077,1.0,1.0,3/19,3.94%,SLC3A1;FMO3;PAH
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7424889806169077,-1.141781191737493,0.3194444444444444,1.0,1.0,3/7,12.00%,PPIF;DNAJC30;ANTKMT
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.6506888721990076,-1.1416562270341486,0.2625,1.0,1.0,4/11,14.44%,HES5;HES1;OCIAD2;CRLF3
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.6445638735105647,-1.141648668610569,0.3157894736842105,1.0,1.0,2/14,2.32%,EVC;SFRP1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.5566628649028882,-1.1411380218802634,0.34782608695652173,1.0,1.0,9/25,21.55%,PMM1;FUCA1;AKR1A1;OAS1;KHK;GALM;APOD;FUCA2;ADPGK
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6352189021959807,-1.14107202326107,0.3670886075949367,1.0,1.0,2/12,12.07%,CD63;EMP2
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.649836034716722,1.1409265447133101,0.3333333333333333,0.8164787061794594,1.0,3/8,14.51%,MYO1E;ITGA3;TBC1D8B
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.7018046409520193,-1.1402955482481154,0.3333333333333333,1.0,1.0,1/7,4.29%,ALOX5
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.711059745500394,-1.1402197590309422,0.29850746268656714,1.0,1.0,2/6,9.68%,TGFB1;MEF2C
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.6235692949409696,1.1399041852922827,0.20689655172413793,0.8183341497004889,1.0,3/9,2.39%,BAIAP3;ADRA1A;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5441737750431941,-1.139836344840937,0.25274725274725274,1.0,1.0,8/48,11.48%,EPN1;ALOX5;SPINK5;NAXE;CNMD;PIK3CB;CD160;PGK1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.5581286901937063,-1.1398245443741244,0.3037974683544304,1.0,1.0,10/32,22.00%,SNRPD2;SNRPD1;PRPF8;SNRPB;PRPF6;SRSF10;USP4;PRPF31;SNRPG;DDX20
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.594552317910091,1.1391563708775596,0.3548387096774194,0.8194188430675761,1.0,3/10,8.31%,NINL;BBS4;PCM1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.618411599087003,-1.1385875967795056,0.35443037974683544,1.0,1.0,2/18,5.41%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5830861358371447,1.1385809527751347,0.3448275862068966,0.8199607311240006,1.0,6/12,26.52%,AGMO;AGPS;FAR1;DHRS7B;PLA2G7;GNPAT
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.6593655318783442,-1.1382603825885007,0.36764705882352944,1.0,1.0,3/8,16.10%,NOXA1;DVL2;CD55
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.5953442557651578,-1.1380533372517954,0.32926829268292684,1.0,1.0,3/24,10.95%,ART4;GLUL;CAD
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6034661339568796,-1.1380310746102638,0.33766233766233766,1.0,1.0,4/17,8.11%,MT1E;JUN;MT1M;MT2A
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5298389320025434,1.13750703615935,0.3,0.8218272532917784,1.0,5/22,13.18%,SYNJ1;MTMR10;MTMR3;OCRL;MTM1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.44405656528467236,1.137501923962875,0.0,0.820815954609683,1.0,59/146,21.03%,SEMA3B;LAMA3;EPHA3;UNC5C;RYK;DSCAML1;PLXNA1;SEMA4D;SEMA6C;GAB1;SLIT1;ROBO1;NRXN1;SH3KBP1;MAPK1;SPTBN1;UNC5D;VLDLR;DCC;PLXNA3;SLIT3;NFIB;OPHN1;MAPK3;UNC5B;SEMA3A;RELN;PALLD;GPC1;PIK3CA;KLF7;SEMA6A;SPTB;ALCAM;FRS2;NRP1;ROBO2;SPTBN4;SOS1;NTN4;FYN;PRKCA;SLIT2;GFRA1;NRXN3;NCAM1;DSCAM;EPHA7;PLXNA2;EPHA5;KIF5A;SEMA5A;PIK3R1;GAB2;RANBP9;ENAH;DAB1;PLXNC1;LYPLA2
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.7549016781613376,-1.1370804472234688,0.2923076923076923,1.0,1.0,1/5,2.65%,HAP1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.5440649331871091,-1.1367812786591052,0.29333333333333333,1.0,1.0,14/33,33.24%,TFAM;MRPS7;MRPL51;MRPL16;MRPS16;MRPS11;PTCD3;MRPS14;QRSL1;MRPS18B;MRPS34;MRPL47;MRPL57;MRPS15
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.6110461171485427,-1.1365979711530152,0.3235294117647059,1.0,1.0,2/15,5.96%,SFRP1;AGT
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6753995736611388,1.1364395991418603,0.3783783783783784,0.822474949796237,1.0,1/5,2.59%,DEPTOR
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6705669978117519,-1.1363935593673564,0.375,1.0,1.0,3/10,17.88%,IRF1;OAS1;STAT1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4028857224416131,1.1363060729963266,0.0,0.821980345373182,1.0,44/182,12.75%,SEMA3B;LAMA3;EPHA3;UNC5C;RYK;PARD3;DSCAML1;SEMA4D;SEMA6C;GAB1;SLIT1;WNT7A;ROBO1;NRXN1;SH3KBP1;MAPK1;NTNG2;SPTBN1;UNC5D;VLDLR;DCC;NRCAM;SLIT3;OPHN1;RAB10;MAPK3;UNC5B;SLITRK5;CTNNA2;SEMA3A;RELN;USP9X;PALLD;GPC1;AUTS2;PIK3CA;ZDHHC17;KLF7;SEMA6A;SPTB;LMTK2;FRS2;NRP1;ROBO2
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.6400655312201147,1.1362666793320082,0.391304347826087,0.82103974243926,1.0,2/6,3.96%,CD247;CD96
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.7355147330383571,-1.1361560692642032,0.3076923076923077,1.0,1.0,2/7,8.93%,ALOX5;ALOX12
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.6404613637113147,-1.1360427954547294,0.37333333333333335,1.0,1.0,1/12,4.29%,ALOX5
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5047626696678542,1.1359236511529727,0.3333333333333333,0.8211065202963681,1.0,3/13,13.13%,PLIN5;CDS1;CDS2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.5385902347102859,-1.1351401028333348,0.27380952380952384,1.0,1.0,8/41,13.77%,PFN2;ENPP2;RAB11A;HDAC6;CEACAM1;GLUL;EMP2;VIL1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.4100532473048374,1.1351249916102588,0.2,0.8223107372742336,1.0,19/63,15.55%,CALCRL;CD247;CALCB;MYH9;FER;GNG2;NMI;VIPR2;ILRUN;ADCY6;MAPK14;TRAF3IP1;RXFP1;PCBP2;PRKACB;ADCYAP1R1;ADAM17;FYN;ADCY2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.48575295433436955,-1.1349098448473824,0.19318181818181818,1.0,1.0,27/113,22.57%,F13A1;CD63;VEGFA;A2M;RIMS1;SCG3;F8;TUBA4A;RARRES2;CLU;TGFB1;TTN;FN1;CALM1;SYT11;BRPF3;CHID1;PCYOX1L;VWF;CYB5R1;STEAP2;APLP2;CPLX1;SYT4;VCL;VEGFB;ACTN2
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6894448380025644,-1.1346942452069753,0.21212121212121213,1.0,1.0,1/9,2.41%,PDCD1LG2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.574579861891354,1.134445061199301,0.2903225806451613,0.8228213247068331,1.0,2/8,10.34%,FOXO1;ATP6V1A
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.6079372492188571,-1.1343766651319178,0.32051282051282054,1.0,1.0,3/19,6.14%,ECT2;TGFB1;ZIC1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5597421438207236,-1.1341390245071774,0.3068181818181818,1.0,1.0,17/45,29.57%,PSMB9;PSMB8;PSMA3;PSME1;PSMA7;OAZ2;PSMB6;AZIN1;NQO1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.5494572856846719,1.133916220067628,0.43478260869565216,0.8233528892294083,1.0,2/10,2.95%,RXRA;SGK1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6463942518230132,-1.1338950251849162,0.2777777777777778,1.0,1.0,6/10,28.89%,JAG1;BTN3A3;CD55;CD46;IL18;GNL1
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.6415690044937757,-1.1335710683576443,0.3026315789473684,1.0,1.0,8/13,29.20%,PSMB8;PSMA3;CST3;SVBP;CAV1;A2ML1;NRDC;CSTB
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.6740239040094318,-1.1333488426443405,0.40540540540540543,1.0,1.0,4/8,18.33%,XBP1;BHLHE41;BDNF;HDAC3
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.6699001439040135,-1.133179746444968,0.32432432432432434,1.0,1.0,1/10,2.65%,HAP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.681216000741467,-1.1331470136517023,0.391304347826087,1.0,1.0,1/7,3.94%,ENTPD7
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.562981911196396,1.1328524935761948,0.3225806451612903,0.8249720404533826,1.0,3/10,10.60%,SPRY4;CREB3L1;GPC1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.66632307807217,1.13277060530261,0.36363636363636365,0.8241235160351659,1.0,3/9,12.11%,PPARG;NFIB;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.5810405165779827,1.1324148509633893,0.3125,0.823942123392866,1.0,2/9,4.53%,NLGN1;DEF8
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.6180863192280326,-1.13199825197367,0.3076923076923077,1.0,1.0,1/12,3.62%,STX10
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.6644635332287724,1.1317339186412105,0.3611111111111111,0.8250010181484996,1.0,2/5,13.19%,ROBO2;RAPGEF2
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6222955607281805,-1.1313684200043899,0.29411764705882354,1.0,1.0,3/13,22.21%,RBP2;CBR1;UBIAD1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7576638757063141,-1.1312114455785152,0.3,1.0,1.0,2/5,12.06%,TAF7;NLRC5
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7393467736912356,-1.1308975153252268,0.36619718309859156,1.0,1.0,1/5,16.38%,PGP
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6486725991507805,-1.130880708642912,0.39436619718309857,1.0,1.0,1/11,1.45%,PARP2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.4585427206384784,1.130726942215929,0.3333333333333333,0.8268533392330312,1.0,10/29,15.74%,NLGN1;PDLIM5;TANC2;ARC;RELN;SRCIN1;LRRK2;CAPRIN1;ARHGAP44;SIPA1L1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.6192614326430463,-1.130670266001194,0.2647058823529412,1.0,1.0,3/13,13.14%,VEGFA;AGT;WNT5B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.521577672759675,-1.1303346992709644,0.36046511627906974,1.0,1.0,8/51,8.39%,PPIF;NOL3;RTKN2;CREB3;CLU;SELENOS;YBX3;XBP1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.5794585145198695,-1.130330095968617,0.3373493975903614,1.0,1.0,7/14,22.56%,IFIT1;FLOT1;SLC3A2;CGAS;IFIH1;CAV1;RFTN1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5371119267844736,-1.129738888381545,0.2911392405063291,1.0,1.0,9/47,16.59%,PPIF;COX18;SLC25A6;TIMM8B;KIFBP;TIMM44;TOMM7;SPG7;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.5087535384038604,1.1294532492938945,0.28,0.8292532041089963,1.0,3/18,3.76%,SOX11;HOMER1;GRIK2
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.48131671249024766,-1.1293575219555911,0.1956521739130435,1.0,1.0,35/115,30.73%,POLR2I;SURF1;POLR2G;MRPL40;POLR1C;EIF1B;NME3;GPX4;DAD1;RFC2;RPA3;GTF2F1;TK2;SF3A3;UPF3B;RFC4;EDF1;LIG1;RFC3;GUK1;RBX1;ELOA;RNMT;IMPDH2;DDB2;SNAPC4;NPR2;CMPK2;MPG;NT5C;SUPT5H;NCBP2;DGUOK;MPC2;POLR1D
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.6046509758672394,-1.1289459900134544,0.35135135135135137,1.0,1.0,4/16,8.11%,MT1E;JUN;MT1M;MT2A
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.688644580980513,1.1287427331494646,0.3333333333333333,0.8301913179374204,1.0,3/7,20.03%,PDE4D;SPTBN4;RNLS
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.639284117108208,-1.1284998300186542,0.3291139240506329,1.0,1.0,3/16,9.17%,SCN9A;CACNA1G;CACNA1C
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6878937116327839,-1.128133081559467,0.3508771929824561,1.0,1.0,4/9,24.04%,ATP5MC3;ATP5MC1;ATP5PD;ATP5PB
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5574259291143876,1.1280455313068625,0.32,0.8311050848168534,1.0,6/13,23.85%,ATP2B4;PTBP1;LMCD1;CHP1;CAMTA1;AKAP6
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5593966762671192,1.1276147784603687,0.2916666666666667,0.8311804670196618,1.0,6/13,17.67%,CEP120;PCM1;FBXW11;SYNE3;SUN2;TMEM201
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.5555126207416149,-1.1275627725746435,0.3023255813953488,1.0,1.0,6/38,10.65%,FMO6P;MROH9;IL20RA;CFTR;CFAP52;VWA2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6875323981185871,1.1275160490108518,0.3888888888888889,0.8303766093142912,1.0,1/5,5.01%,CHD7
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.507827851793396,-1.1269182701501304,0.2872340425531915,1.0,1.0,2/60,3.15%,SLC28A2;SLC2A3
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6052898780475866,-1.126909026469845,0.3291139240506329,1.0,1.0,6/21,15.99%,CENPH;CENPX;SMARCA5;ITGB3BP;MIS12;CENPC
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4801251375484735,-1.1268177398693766,0.19791666666666666,1.0,1.0,23/221,12.74%,CD44;VEGFA;DDRGK1;PFN2;SPDYA;FGF1;ENPP2;FLOT1;CAMK1;RARRES2;HAX1;TGFB1;AGT;CEMIP;RASGRP1;HDAC6;IL5;TOM1L1;BDNF;EFNA1;CALM1;ATG14;WNK3
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.7589234645125702,-1.1267665130716265,0.3548387096774194,1.0,1.0,1/5,5.00%,PBLD
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5647400007757322,-1.1266015731424306,0.32926829268292684,1.0,1.0,4/30,9.68%,EVC;SGCA;EMD;MEF2C
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.7131989770187088,-1.1265232021498248,0.30303030303030304,1.0,1.0,4/8,23.33%,SFRP1;XBP1;ZFP36L2;ID2
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5775886541579947,-1.126202388070481,0.35064935064935066,1.0,1.0,5/24,10.49%,B2M;FLOT1;CLU;LRPAP1;PIK3CB
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5874783899842349,1.1259639255517617,0.2972972972972973,0.833393911626037,1.0,2/10,3.11%,HDAC9;NR1H2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.57306639514426,-1.1259014012788766,0.31645569620253167,1.0,1.0,8/27,24.60%,HES5;HES1;BHLHE41;TYMP;NSUN5;PTN;PRUNE1;HES6
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.7143602592454077,-1.125451604993701,0.423728813559322,1.0,1.0,4/5,25.13%,TMSB15B;TMSB10;GSN;TMSB4X
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.509295838189605,1.1254307129740229,0.25,0.8337073501407215,1.0,5/19,15.54%,OSBPL7;AKR1C1;CYP7B1;OSBPL6;HSD17B4
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6036138375758331,-1.1253748199085616,0.3466666666666667,1.0,1.0,3/18,10.73%,SRSF7;RPS13;SRSF10
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.570928401313718,-1.12536427163943,0.3058823529411765,1.0,1.0,5/24,18.41%,PIGO;PIGC;PIGH;PIGL;PIGG
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.6155412383293843,-1.125074400158846,0.3684210526315789,1.0,1.0,2/16,5.96%,HTR2B;AGT
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.7146053965312221,-1.1249589059117144,0.31666666666666665,1.0,1.0,3/6,15.99%,CENPH;MIS12;CENPC
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5319979381523591,-1.1249212956499193,0.2976190476190476,1.0,1.0,12/36,22.66%,RPS27A;ISG15;TRIM25;RFC2;RPA3;UBE2L6;UBA52;RFC1;RFC4;UBC;RFC3;POLD2
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.5313022890935262,1.1246698988649553,0.2,0.8344798241701474,1.0,1/7,8.27%,SNX33
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.5759636204290731,-1.1245986859497858,0.32051282051282054,1.0,1.0,8/26,20.49%,TGFB1;SEMA4C;FUZ;LMO4;DVL2;STIL;PLXNB2;MTHFD1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.5759636204290731,-1.1245986859497858,0.32051282051282054,1.0,1.0,8/26,20.49%,TGFB1;SEMA4C;FUZ;LMO4;DVL2;STIL;PLXNB2;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.5581675491610328,1.1235969215744475,0.3333333333333333,0.8361688872866181,1.0,1/10,0.46%,SPOCK3
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.487790510905904,-1.1235039855266233,0.31521739130434784,1.0,1.0,40/87,33.31%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL51;MRPL27;MRPL19;MRPL36;ZNF598;CHCHD1;RACK1;MRPS25;MRPS22;MRPL16;MRPL48;MRPS16;MRPS30;MRPS11;GTPBP1;MRPL32;PTCD3;MRPS14;MRPS18B;MRPL21;MRPS33;MRPL52;MRPS34;MRPL47;MRPL57;MRPL43;MRPL44;AURKAIP1;MRPL34;MRPL9;MRPL35;MRPS23;EEF1B2;MRPS15;NEMF
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4879907050214988,1.123478668830688,0.2692307692307692,0.8355604201289747,1.0,4/12,13.62%,CABYR;RFX3;ODAD4;SPEF2
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.6232199247051449,1.1232774067241662,0.3793103448275862,0.8349970709864498,1.0,3/6,28.82%,HACL1;SLC25A17;PHYH
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7395115961456196,-1.1231745454931124,0.29508196721311475,1.0,1.0,2/6,12.16%,ESRRB;CDK2AP2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.6070932920100492,-1.1230885423034536,0.38095238095238093,1.0,1.0,6/16,24.33%,MEF2C;MYL6B;MYORG;SELENON;CAV1;MYL6
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5963750905881123,1.1226912303171817,0.2916666666666667,0.8354809466882811,1.0,3/7,11.21%,NEDD4L;NEDD4;WNK1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5825208680379542,-1.1225320037310564,0.3291139240506329,1.0,1.0,4/20,18.94%,PUS3;TRMT10C;DKC1;PCIF1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.6112435914067278,-1.1222670477628909,0.37681159420289856,1.0,1.0,1/12,1.74%,VEGFA
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6474169745916039,1.1220431422794217,0.4,0.8359854041579444,1.0,4/11,22.46%,NFIB;SPTBN4;MYCBP2;SZT2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.4007085324185621,1.1219623877028901,0.2222222222222222,0.8353149186673917,1.0,16/86,11.33%,BAIAP3;LRRC4C;MCTP1;NLGN4X;NLGN1;HOMER1;NRG3;GRIK2;GRID2;SLC8A2;ARC;OPHN1;RELN;CHRNA7;LRRK2;GRIK3
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.63122761594155,1.1215795911838833,0.4,0.8352104986241071,1.0,2/6,9.46%,HSPA1A;MECP2
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.6301617039513905,-1.1212748148365392,0.28,1.0,1.0,4/15,13.46%,PBLD;TGFB1;OVOL2;VEPH1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.5003865293881072,-1.1207967697536216,0.24096385542168675,1.0,1.0,13/63,16.59%,SRSF7;RBM8A;DHX38;CDC40;SRSF5;CSTF2;NCBP1;CSTF1;CASC3;UPF3B;MAGOHB;THOC5;CHTOP
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.6075061989535747,1.1206536178021191,0.2857142857142857,0.8367108466440085,1.0,4/10,9.66%,CD247;CD96;GPR174;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6172673921121081,-1.1202929080034503,0.3384615384615385,1.0,1.0,6/19,16.26%,IFIT1;HDAC6;PARP9;CAMK2A;TMBIM1;PHPT1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.5429730026030106,-1.1200949752266445,0.345679012345679,1.0,1.0,3/28,6.11%,MX1;RIMS1;NAPA
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.6370549004958004,-1.1200577524107942,0.352112676056338,1.0,1.0,2/11,8.89%,TGFB1;JAG1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5344993314408333,-1.1200366650124234,0.2125,1.0,1.0,9/33,23.94%,IL12RB2;SNRPA1;GSTO1;RPLP0;HNRNPDL;HNRNPA2B1;CA1;HSPA9;AIP
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5768985495549526,1.119959838731478,0.375,0.8376444889324625,1.0,1/10,6.92%,NETO1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.6410845091630054,1.1199492394817094,0.375,0.8366724224029102,1.0,2/7,6.98%,LEPR;SGIP1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.5736283748859944,1.119828820446035,0.28,0.8361779948026903,1.0,1/8,0.90%,WDR81
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3392080974394188,1.1197339759441565,0.0,0.8353826743860715,1.0,59/210,19.04%,STK36;ARHGEF6;EHD1;FNBP1L;FGD4;SEPTIN6;IFT140;RFX3;RABL2B;CDC14A;BBS4;OPHN1;PCM1;TRAF3IP1;TTLL3;CEP41;IFT172;DNM3;TCTN2;CDH13;SSX2IP;P2RX7;RAP2B;RAPGEF6;MTSS1;UNC119B;MAP4K4;OCRL;NRP1;RAPGEF2;EXOC2;PCNT;CDC14B;RAB3IP;CEP20;EXOC6;RAP2A;CEP89;TMEM138;RAP1A;ARL3;SPAG16;CEP290;ARHGEF7;GBF1;CCDC88A;RILPL2;EXOC4;TTC39C;MACIR;GALNT11;ABLIM2;ATAT1;SRGAP2;RAP1B;ABCC4;TTBK2;KIAA0586;WDR19
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.6761089507800319,-1.1196352708907398,0.38961038961038963,1.0,1.0,2/9,17.88%,IL12RB2;STAT1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5102869115940729,-1.1194650921694753,0.27906976744186046,1.0,1.0,16/64,24.61%,ISG15;POLR3D;TRIM25;POLR3H;POLR1C;IRF1;GAPDH;NLRC5;POLR3E;UBE2L6;CGAS;IFIH1;HERC5;TRIM32;DHX36;TRIM56
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.688659292313963,-1.1193650373586836,0.3387096774193548,1.0,1.0,3/7,27.49%,TRMT10C;TRNT1;HSD17B10
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5021111876157628,1.118607148379911,0.3103448275862069,0.8372401331566719,1.0,9/22,12.83%,SOX11;ROBO1;SMAD7;SLIT3;TGFBR2;PROX1;ZFPM2;ROBO2;ACVR1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.5902705403003966,1.1185184934589074,0.2972972972972973,0.8364239245632779,1.0,4/6,29.34%,HMGCR;MVK;PHYH;PDSS2
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.6333001752049016,1.1184738188331,0.32142857142857145,0.8355666832170344,1.0,4/9,8.33%,BAG2;MYH9;KLKB1;PLGRKT
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.7038619467932586,1.1183779350468004,0.34615384615384615,0.8347759266912123,1.0,2/6,20.03%,NOS1;RNLS
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6618826671996224,-1.1183364120953736,0.35384615384615387,1.0,1.0,6/11,29.05%,IFITM3;ADAR;EIF2AK2;KLHL20;IFNAR1;AXL
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.7245887477517521,-1.118248928787882,0.3793103448275862,1.0,1.0,1/5,9.19%,DBI
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.44077654324753307,1.1180123100039563,0.21052631578947367,0.8348020979923558,1.0,8/38,11.21%,NEDD4L;FBXW7;SLC4A7;PPARG;ABHD8;ZBTB20;SLC4A10;WNK1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5184213188355765,-1.1177103864457512,0.24096385542168675,1.0,1.0,4/44,4.04%,ITGA4;VEGFA;SCG2;HTR2B
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.4296097939036676,1.1176952061203282,0.23076923076923078,0.8347210948064265,1.0,9/44,7.84%,ZSWIM6;ARAP1;ERBB4;ABL1;ZSWIM5;YTHDF1;ABL2;NRG2;EGFR
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6206538096311043,1.1171549238006702,0.42424242424242425,0.8353249784780514,1.0,4/7,31.15%,KDM4C;RIOX2;KDM4B;KDM7A
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.49441761419869745,-1.1169316940376524,0.21875,1.0,1.0,8/123,8.39%,CD44;PPIF;HES1;RETREG1;OVOL2;RASGRP1;OLFM1;XBP1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.6486409997837663,1.1169021198758426,0.3870967741935484,0.8351580590307839,1.0,3/7,16.40%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5077018794999972,-1.116760234622451,0.26595744680851063,1.0,1.0,2/61,3.15%,SLC28A2;SLC2A3
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5314434893367184,-1.1166925080712828,0.275,1.0,1.0,9/35,23.94%,IL12RB2;SNRPA1;GSTO1;RPLP0;HNRNPDL;HNRNPA2B1;CA1;HSPA9;AIP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.5578550534773796,-1.1164520344262876,0.3625,1.0,1.0,3/24,5.16%,VEGFA;CREB3;RARRES2
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.7204858830920496,-1.1164394220450993,0.40298507462686567,1.0,1.0,2/5,6.85%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.47887323844770746,1.1164061797192948,0.3333333333333333,0.8353330662046992,1.0,8/31,11.55%,PLD1;DGKB;PLD2;GPD1L;ABHD8;AGPAT5;DGKQ;GPAT4
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.49271600386208836,-1.1163689307063196,0.24390243902439024,1.0,1.0,14/65,16.59%,SRSF7;RBM8A;TGFB1;NUP155;DHX38;CDC40;SRSF5;NCBP1;CASC3;STRADB;UPF3B;MAGOHB;THOC5;CHTOP
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5328525790586787,-1.116340308136734,0.29545454545454547,1.0,1.0,16/39,25.29%,APEX1;ADPRS;RFC2;POLQ;RPA3;PNKP;RFC1;RFC4;PARG;LIG1;RFC3;XPA;POLD2;MBD4;XRCC1;NTHL1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.38737005468255037,1.115942834082276,0.3333333333333333,0.8356142549685565,1.0,24/86,14.53%,FLRT2;NOVA2;RNF150;TACC2;CHST3;ANK2;APBB2;MPDZ;RUNX1T1;SLC16A2;GUCY1A2;NAV1;MAGI1;ZNF462;CACNA2D1;SLIT3;FBXL7;FARP1;ZNF532;NFASC;PTPRG;TENM3;FIGN;NCKAP1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.6142754993848368,1.1157124977068653,0.34615384615384615,0.8352346427666258,1.0,6/8,23.21%,SOX5;ZBTB16;BMPR1B;PKDCC;GDF6;SOX6
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.5432196486658974,-1.1156381670262587,0.26373626373626374,1.0,1.0,7/32,16.94%,CDKN1C;TGFB1;ZW10;TOM1L1;NABP2;BTG1;ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.6074083371557575,-1.115560282800489,0.373134328358209,1.0,1.0,3/15,9.89%,S100A6;AGT;FN1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6130760040225266,-1.1155037191933188,0.39436619718309857,1.0,1.0,3/12,20.10%,SCG2;CAST;WFS1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6219031186164342,1.1152179159634739,0.35294117647058826,0.8355578168081497,1.0,3/10,11.69%,ESR1;ATF7IP;HMGB1
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.45514726344891143,1.1150962447884578,0.2,0.8350092251471206,1.0,8/22,16.26%,SLIT1;SLIT3;SEMA3A;USP9X;AUTS2;ALCAM;NRP1;SLIT2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6164576379202186,-1.1148819317153158,0.3472222222222222,1.0,1.0,8/15,29.66%,CACTIN;SNRNP200;CWC15;WBP11;PSIP1;RBM22;WBP4;NCBP2
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.6155844508732614,1.1146695225987941,0.3902439024390244,0.8349711833171775,1.0,4/9,15.10%,FLRT2;NTNG2;LAMB4;NTN4
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.3534927845901301,1.1146694618647304,0.1111111111111111,0.8339795310804587,1.0,12/76,9.32%,HDAC9;IRS1;KAT2B;PPARG;FER;RPS6KB1;RAB31;C2CD5;FOXO1;RAB10;ADCY6;CPEB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.7081834608365284,1.1146257455185993,0.3333333333333333,0.8331807454080419,1.0,1/5,0.11%,VAPB
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4128046100428674,1.1145559628059074,0.2222222222222222,0.8322781369467807,1.0,21/52,23.84%,EVI5L;CEP120;TBC1D14;ATG5;DYNC2LI1;IFT140;BBS4;RABGAP1;TBC1D1;ATG3;CCDC88A;CDKL5;TBC1D5;TBC1D7;CYLD;CEP97;CDK10;ARHGAP35;TAPT1;TBC1D13;YAP1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.5315429131578049,-1.1144993268796097,0.29411764705882354,1.0,1.0,4/29,15.13%,HAP1;BLOC1S2;DCTN1;KIF1A
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.7116778604541046,-1.1143349350615188,0.4090909090909091,1.0,1.0,1/5,9.57%,ZFAND2B
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.6680138396569304,1.1141865143522915,0.39473684210526316,0.8322223891458248,1.0,3/5,18.08%,PRKCA;VRK1;DCAF1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7016672259849389,-1.1141802272216301,0.3194444444444444,1.0,1.0,3/8,23.37%,ZFPM1;PRKCQ;RARA
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6814935707551278,-1.1141571863080708,0.38095238095238093,1.0,1.0,1/7,5.96%,AGT
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.5130102172939881,-1.114095398304466,0.27380952380952384,1.0,1.0,11/52,18.14%,VEGFA;SCG2;HTR2B;ALOX5;CNMD;STAT5A;AIMP1;APOE;STAT1;EMC10;NRP2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5737943332613944,-1.1139224914909909,0.35,1.0,1.0,4/31,10.10%,RPS14;VEGFA;ZFPM1;MED1
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.6967248944112752,1.1138828134774337,0.4117647058823529,0.8318503759550505,1.0,2/6,2.55%,ZDHHC2;EHD1
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.6758172455695198,1.1132586628177852,0.3793103448275862,0.8325537215348806,1.0,1/7,4.62%,SUV39H2
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.6390969889114406,1.1124981111203744,0.36363636363636365,0.8337814932167007,1.0,2/6,4.78%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5934960987410846,1.112261036612638,0.3333333333333333,0.8334089581596147,1.0,5/18,18.40%,DGKB;PLA2G15;DGKQ;DGKG;DGKE
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.6084421499389406,1.1121839357041468,0.34210526315789475,0.8326384158679668,1.0,2/7,12.50%,RPS6KB1;ACSL3
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.4405717775183851,1.1121253706955418,0.35714285714285715,0.8317438692031437,1.0,11/42,12.42%,KCNJ6;NEDD4L;KCNMB3;GNG2;BIN1;DPP6;DPP10;KCNN2;KCNIP4;NEDD4;KCNIP2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.5636084285631517,-1.1116487999268998,0.2597402597402597,1.0,1.0,3/21,11.85%,GLRX;NME3;DCTD
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.45515122476388153,1.1114069367921615,0.3125,0.8325269905845657,1.0,2/23,3.92%,TP63;BOK
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.7261648859305456,-1.1109987646346653,0.3382352941176471,1.0,1.0,2/6,9.68%,DDX5;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.7021341230346676,-1.1109379192233302,0.37681159420289856,1.0,1.0,1/8,5.88%,TGFB1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.5435265653666066,-1.1108357425710902,0.25,1.0,1.0,6/34,15.34%,FTH1;CP;ATP6V1F;ATP6V0A4;DNM2;ATP6V0E2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6379821565685742,-1.1106459087218756,0.36486486486486486,1.0,1.0,6/14,18.44%,ZNHIT3;RPF2;DDX18;WDR12;RPL35;NIFK
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5686818390593272,-1.1097257399504956,0.35,1.0,1.0,2/25,4.70%,GTF3C6;POLR3H
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.6393633087020135,-1.1096173318223124,0.37142857142857144,1.0,1.0,5/10,30.52%,ENTPD7;ENTPD5;ADPRM;ENTPD3;ENTPD1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.7202201544364504,1.109304536209621,0.45454545454545453,0.8366764035514569,1.0,3/5,22.03%,ZNF16;MTURN;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.39145527519467216,1.1090842242365584,0.38461538461538464,0.8363444508913294,1.0,13/60,11.13%,BARD1;NEDD4L;ASB5;HECW2;SH3D19;HACE1;FOXO1;SNF8;TIPARP;SNX33;NSF;MSN;NEDD4
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.6467596881380977,-1.1090086319967127,0.41333333333333333,1.0,1.0,4/12,19.20%,DDRGK1;RETREG1;UFC1;ULK1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3879072168276969,1.108966658176914,0.058823529411764705,0.8357002080439878,1.0,11/48,11.69%,SH3RF1;MAP3K5;TRAF1;MAP3K11;WNT7A;MAP4K2;PLCB1;SH3RF3;SEMA3A;MFHAS1;HMGB1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6164142575746351,-1.1085759540575246,0.32894736842105265,1.0,1.0,5/17,15.99%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6164142575746351,-1.1085759540575246,0.32894736842105265,1.0,1.0,5/17,15.99%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.3882022705698228,1.1085236102040228,0.2727272727272727,0.8359747265644426,1.0,12/62,9.32%,HDAC9;IRS1;KAT2B;SIRT1;PPARG;FER;RPS6KB1;RAB31;C2CD5;FOXO1;RAB10;CPEB2
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.49640522436993234,-1.1084499982014124,0.36363636363636365,1.0,1.0,7/58,12.10%,MIF4GD;EIF1;POLR2G;EIF2B2;EIF1B;EIF5B;NCBP1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.65925722140769,1.1082089015064251,0.34375,0.8358738011461495,1.0,2/6,9.84%,NLGN1;CHRNA7
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.6939392192271566,-1.1081875633312581,0.4,1.0,1.0,3/6,22.47%,LMOD1;TMOD3;PGM5
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.4794678754330682,1.107518159845131,0.2727272727272727,0.8366050364409942,1.0,5/24,15.46%,MAP2;DIP2B;DCC;PTPRS;WWC2
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.7017641330967558,-1.107162501397813,0.3333333333333333,1.0,1.0,3/7,28.49%,BCAT2;HMGCL;HMGCLL1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.699547890519229,1.1071153866009797,0.43243243243243246,0.836752899326858,1.0,1/5,1.90%,NEDD4L
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.36816741977774514,1.1069755817169735,0.1,0.8361741764433289,1.0,11/82,7.95%,ONECUT1;PRIMA1;BCAR1;PCLO;TOX3;SHROOM3;FAM222A;SLC7A2;MAGI1;JPH1;BMP7
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.691069289117827,1.106770549391377,0.42857142857142855,0.8357211518779444,1.0,2/6,7.50%,SALL1;PKD2
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.39597416151140064,1.106428271178852,0.3333333333333333,0.8356418076694007,1.0,32/120,15.78%,DUSP4;PPM1E;UBLCP1;DUSP7;PTPN13;PPM1A;PTPRK;BTRC;PDP1;PPP4R2;SSH1;FBXW11;PTPRC;PPP2R5E;PPP3CA;ALPL;TAB1;PTPRR;PTPRU;MTMR3;PTPRS;PPM1L;PPM1F;PTPN4;PPM1D;MTM1;CDC14B;PTPRG;PTPRN2;DUSP26;DUSP16;SSH2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.6973108537350722,1.1063875899201558,0.43243243243243246,0.8347975747591873,1.0,2/5,8.61%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.66723701890789,-1.1062540225946214,0.36507936507936506,1.0,1.0,2/6,19.67%,SLC25A5;SLC25A42
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6920587945414526,-1.1060023095888287,0.3611111111111111,1.0,1.0,1/6,2.10%,ACMSD
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.5698774120429024,1.1056859202867328,0.3235294117647059,0.8357521684173453,1.0,1/9,2.83%,RFWD3
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.6379147749027049,-1.1053254132460208,0.35714285714285715,1.0,1.0,5/11,33.06%,COQ10A;COQ3;UBIAD1;COQ6;COQ8B
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.6379147749027049,-1.1053254132460208,0.35714285714285715,1.0,1.0,5/11,33.06%,COQ10A;COQ3;UBIAD1;COQ6;COQ8B
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.6121828074400976,-1.1047576627832953,0.4264705882352941,1.0,1.0,3/11,21.05%,KDM6B;MEF2C;MTLN
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.4829452696396427,1.1044303733393752,0.2962962962962963,0.8380042340723988,1.0,3/11,18.72%,CEP120;CEP290;KIAA0586
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5062398243117967,-1.1043145895050999,0.2727272727272727,1.0,1.0,7/60,13.85%,DXO;POLR2I;DDX24;POLR2G;GTF2F1;NCBP1;HNRNPA2B1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5229238847398362,-1.1041534790203513,0.32941176470588235,1.0,1.0,7/37,15.68%,B2M;RPS27A;APH1A;CST3;ITM2B;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.7538055108593424,-1.104134606659933,0.38461538461538464,1.0,1.0,2/5,7.50%,HTR2B;HTR2C
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5792098450419955,-1.1041073294310573,0.3291139240506329,1.0,1.0,5/20,18.33%,ECT2;TGFB1;ZIC1;PDCD5;HDAC3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.6621304073329903,1.1040559217568204,0.42857142857142855,0.8379844380136441,1.0,4/5,33.79%,BICD1;APC;MARK4;CEP250
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.5984859590021456,1.1040137181674088,0.35714285714285715,0.8371002335916026,1.0,2/8,10.99%,ABCC5;SLC39A8
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.6824789017902251,-1.1039072260103306,0.4090909090909091,1.0,1.0,1/7,6.16%,CTSZ
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.6933238523619841,-1.1034782190570127,0.46875,1.0,1.0,1/5,4.06%,ENPP2
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.7006100327870876,-1.1032972392947125,0.3972602739726027,1.0,1.0,2/6,13.42%,AGBL5;AGBL3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.6540773119281647,-1.1032032169529804,0.38028169014084506,1.0,1.0,3/10,25.98%,CAMK1;BRCA1;SPHK2
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.7298775065668905,-1.1031021126579466,0.36065573770491804,1.0,1.0,1/6,9.15%,KDM6B
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.49800978798700796,-1.1029636843574213,0.3411764705882353,1.0,1.0,5/48,9.75%,LIPI;ALOX5;DOLPP1;XBP1;ACSM3
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.6354758304897772,-1.102936491040462,0.3815789473684211,1.0,1.0,4/13,14.44%,HES5;HES1;OCIAD2;CRLF3
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.7252870362136297,-1.102921381487262,0.359375,1.0,1.0,4/5,23.06%,FN1;CDH3;HSP90AB1;LAPTM4B
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.6814740236480081,-1.1026827928007472,0.352112676056338,1.0,1.0,2/6,17.90%,APOBEC2;ADAR
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.5010442908404164,-1.102627981071283,0.34065934065934067,1.0,1.0,21/62,29.57%,PSMB9;RPS27A;PSMB8;PSMA3;BUB3;PSME1;CDC26;UBA52;FZR1;SKP2;PSMA7;PSMB6;UBC;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.549061814248801,-1.102512462182374,0.3170731707317073,1.0,1.0,8/40,15.48%,EVC;SFRP1;ZIC1;HHIP;GPC3;FUZ;ULK3;RACK1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5613681045543756,-1.1024530208243808,0.3142857142857143,1.0,1.0,7/25,17.10%,NOSTRIN;HTR2B;PIK3CB;CALM1;DNM2;S100A1;APOE
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.5129187639328566,1.1023074379302007,0.3870967741935484,0.8406175911838285,1.0,7/16,12.99%,GRIK2;UNC13C;GRID2;UNC13B;GRIK3;GRIK4;NAPB
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5517091905307467,-1.1022707787291295,0.345679012345679,1.0,1.0,5/31,13.28%,FANCB;ZCWPW1;PARP9;DDX11;PNKP
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6839205423464821,1.1022270829419991,0.3684210526315789,0.8399377403474402,1.0,2/5,27.87%,ARL8B;VPS41
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.6943993634344007,-1.1022111796784237,0.4492753623188406,1.0,1.0,2/6,22.87%,DDX11;CTCF
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.724054592653974,-1.1020186869175599,0.373134328358209,1.0,1.0,2/5,12.34%,KCNK12;CHCHD10
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.46751523083211866,1.1019572369834836,0.23333333333333334,0.8398132565563069,1.0,4/25,8.71%,VCAN;CHST3;CSGALNACT1;UGDH
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4797802392988318,1.1018154439617853,0.30434782608695654,0.8392383288444074,1.0,10/26,15.36%,FAM20B;CSGALNACT1;GAL3ST3;UGDH;EXT2;EXTL3;CHST8;BMPR1B;EXT1;NDST3
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.5075955909683186,-1.1017695523291249,0.3253012048192771,1.0,1.0,9/47,8.10%,MX1;IFIT1;ISG15;PLSCR1;IFIT5;IFITM3;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.40611624273794417,1.1016840298538444,0.2222222222222222,0.838685183995409,1.0,14/85,8.61%,PKP2;FLRT2;SGCZ;HDAC9;ERBB4;KAT2B;SALL1;PDLIM5;CHD7;FGF12;PKD2;TGFBR2;BMP7;KAT2A
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7378648348122677,-1.101651595975692,0.36764705882352944,1.0,1.0,3/5,12.07%,FLOT1;S100A10;EMP2
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.6637047452116336,1.1014510671983828,0.4634146341463415,0.8381128655939158,1.0,2/5,21.90%,EPS8;ARHGAP35
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.40262747495765533,1.1014136061243736,0.25,0.8371947611733871,1.0,13/44,17.96%,ABHD3;NR1H2;SLC44A1;STARD7;PLA2G15;SLC44A5;PCYT1B;GPAT4;PLAAT1;PCTP;ACHE;LPCAT1;CEPT1
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.579869361374986,-1.1012542368407099,0.3188405797101449,1.0,1.0,3/17,8.89%,VEGFA;LRPAP1;JAG1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5658088083913746,-1.1011159743575256,0.3013698630136986,1.0,1.0,9/24,13.56%,OPRM1;TACR1;HTR2B;CHRM2;AGT;HTR2C;FPR3;GRM1;LPAR6
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.42410849707325143,1.1010207566938963,0.24,0.8374004284845896,1.0,6/29,13.18%,EVI5L;KAT2B;STYXL1;KAT2A;LRRK2;MTM1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.5498964796616134,-1.1006467864637388,0.33766233766233766,1.0,1.0,3/19,10.10%,ETV4;CTSL;MED1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.46609862754835646,-1.1006020566994863,0.3404255319148936,1.0,1.0,18/85,22.55%,ITGA4;DHX37;DHX16;DHX38;PRPF8;NOL6;HDGF;DDX11;SNRNP200;NOP14;NEMP1;USP19;NUP107;MCM3AP;HEATR1;DARS2;NUP188;NUP85
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5891245920494286,-1.1005662931190154,0.4166666666666667,1.0,1.0,2/13,10.56%,XPNPEP1;ERAP1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.4798553045775008,1.1003629387706757,0.3333333333333333,0.8380334125616841,1.0,5/31,7.41%,EPHA3;RXRA;BRINP3;ADNP2;ABL2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.6717638173994063,-1.1000407739024016,0.3939393939393939,1.0,1.0,1/7,4.84%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.6329819305608572,1.0994127090309704,0.3333333333333333,0.8397637207975515,1.0,2/6,10.51%,RAD18;SMC6
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.6235212053598505,-1.0993605052732394,0.4155844155844156,1.0,1.0,2/13,8.59%,ROMO1;TIMM44
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.6752798324886178,-1.099230063109351,0.4142857142857143,1.0,1.0,3/8,23.64%,CEACAM1;GSTP1;CARD8
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.601433993339859,1.0992014991218135,0.3939393939393939,0.8393357038338561,1.0,2/8,7.04%,NEDD4L;BIN1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.416874728938783,1.099088382802413,0.2,0.8388071544797149,1.0,31/105,18.24%,PLD1;RIT2;MAPK11;CDC42EP4;HACE1;KSR1;MAPK14;MAPKAPK5;TRIM28;CDH13;PHACTR4;PRKD1;RAP2B;RAPGEF6;RRAS2;RAPGEF2;CDC42EP1;ARHGEF11;NCKAP1;RAP2A;SOS1;RAP1A;NRAS;RALA;EPS8;ARHGAP5;ARHGAP6;RIPOR1;RALB;RAP1B;NF1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5875182891517111,-1.0984087252072259,0.38461538461538464,1.0,1.0,2/15,4.32%,IFIT1;FLOT1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.7084042790033335,-1.0983529593299917,0.40298507462686567,1.0,1.0,1/7,2.91%,PLSCR1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.6708547052200424,-1.0983369392807887,0.4057971014492754,1.0,1.0,3/6,22.31%,FLOT1;EMP2;CAV1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.4468917209775087,1.098092176140468,0.2857142857142857,0.8402873464895182,1.0,12/58,11.43%,VAPB;NEDD4L;STIM2;ATP2C1;CALCB;ANK2;SLC8A2;ATP2B4;SLC24A3;CHRNA7;STIM1;SLC8A1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.57222687054099,1.0980398659880617,0.3888888888888889,0.8395766203440257,1.0,3/6,29.42%,HEXB;NEU1;NEU3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.4788607292291386,1.0979184142390053,0.2916666666666667,0.838968666825994,1.0,8/32,11.55%,PLD1;DGKB;PLD2;GPD1L;ABHD8;AGPAT5;DGKQ;GPAT4
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.44093992627721734,1.0978030621492414,0.25925925925925924,0.8384833460522336,1.0,8/30,9.23%,ATR;NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPK3;MAPKAPK5
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.5482620253666024,1.0975595433364527,0.4,0.8380596825687731,1.0,5/12,16.40%,POT1;STN1;CTC1;TERF1;TERF2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.6970077570748553,-1.097475174287721,0.39705882352941174,1.0,1.0,1/7,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6659724127081101,-1.0972085723488476,0.3968253968253968,1.0,1.0,2/10,12.64%,PDE6B;CALM1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.734222904196789,-1.0972056807208779,0.3870967741935484,1.0,1.0,1/5,3.29%,PPIB
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.48584421904069824,-1.097155559845473,0.313953488372093,1.0,1.0,20/94,16.85%,TRIP10;EPSTI1;ECM2;COL5A3;RARRES2;AGT;APOL6;CRYAB;MT2A;ASPN;BCAT2;COL15A1;METRN;COL6A1;STEAP4;LMOD1;METRNL;ACTA2;ADAMTS2;C3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6651937490910489,-1.097033120382953,0.29850746268656714,1.0,1.0,4/7,26.28%,CLU;APOE;ABCA1;ABCA5
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.743967518940224,-1.0963077732251618,0.4090909090909091,1.0,1.0,2/5,12.39%,FANCB;REC8
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6098548266032437,1.0959827233531612,0.4,0.8415688818277025,1.0,1/6,3.78%,PDIA2
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.4723156353685643,-1.095865577039324,0.25,1.0,1.0,25/124,14.98%,VEGFA;MT1E;CP;SLC2A3;PPFIA4;CDKN1C;JUN;XPNPEP1;GLRX;MAFF;PDK1;ANGPTL4;MT2A;GAPDH;GPC3;PRDX5;EFNA1;PHKG1;PGK1;SLC6A6;SAP30;BTG1;PNRC1;DDIT4;PFKP
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5983505436102935,-1.0958640027713598,0.39473684210526316,1.0,1.0,4/19,16.04%,TMEM50A;TMEM50B;LEPROTL1;CHMP4B
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.497107457632711,1.0955325474504962,0.2727272727272727,0.8416864953407324,1.0,2/20,4.04%,PKP2;FGL1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.7440502638778527,-1.095236145591616,0.3484848484848485,1.0,1.0,1/5,4.84%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.6248716931255371,-1.0950209937961066,0.4166666666666667,1.0,1.0,7/14,26.81%,ZFPM1;CEACAM1;LRRC17;TCTA;FSTL3;RARA;PTPN2
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.7201729597199111,-1.0943902716070826,0.4057971014492754,1.0,1.0,1/5,7.87%,TRIM41
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.568987824106767,1.0939809530329148,0.25,0.8450629843206932,1.0,3/5,8.83%,RIPOR2;EHD1;MAPK14
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.677713235212488,-1.0931991692983445,0.3230769230769231,1.0,1.0,3/7,18.47%,JAG1;KDM6B;EDF1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.6251711883251437,1.0928216677953897,0.3488372093023256,0.8473266162799516,1.0,1/7,1.16%,BARD1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.5697764345329885,-1.0926585887743228,0.3170731707317073,1.0,1.0,11/23,29.81%,ROMO1;PEX1;TIMM44;AIFM1;TOMM20;PEX14;HSPD1;TOMM40;TIMM23;TIMM17B;PEX6
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.6113684782333303,-1.0926364321807727,0.38571428571428573,1.0,1.0,2/18,8.27%,NCAPD3;TTN
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.46509677757153134,1.092337828747429,0.2222222222222222,0.8476782309598199,1.0,11/48,7.23%,SHANK2;NLGN4X;NLGN1;RYK;SDK2;WNT7A;NRXN1;ADGRL3;GRID2;LRRTM3;NRCAM
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5534124275909472,1.092310269819087,0.47058823529411764,0.8467658841857659,1.0,6/18,20.53%,RAP1GDS1;ANXA6;SMDT1;MCU;LETM1;MICU3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.5937991762415279,-1.092253472105573,0.3815789473684211,1.0,1.0,2/13,13.72%,DCAKD;PPCS
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.654440014534487,1.0920562155833646,0.3076923076923077,0.8464163647094369,1.0,1/6,3.19%,PADI2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5574707556880455,1.0918618544200513,0.4444444444444444,0.8458875804682198,1.0,2/10,9.54%,EDEM1;SEC16A
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6315349363528073,1.0914810615534098,0.4,0.8458795379908944,1.0,2/7,9.66%,CBFB;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.43993398978325815,1.091205867459655,0.3333333333333333,0.845532182837411,1.0,5/24,8.10%,ESR1;SIRT1;PPM1A;TLE1;RORA
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5579193095455657,-1.0909395159786668,0.3780487804878049,1.0,1.0,9/30,18.07%,EMC3;EMD;EMC7;EMC6;MMGT1;TRAM1L1;SEC61G;CCDC47;EMC10
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.7101037732819353,-1.0909069748862137,0.4153846153846154,1.0,1.0,1/5,5.88%,TGFB1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.5970863299538933,-1.0908530415353623,0.41025641025641024,1.0,1.0,7/16,18.86%,CDC37;IFNGR2;PARP14;PARP9;NLRC5;STAT1;HSP90AB1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.5407770401339702,1.0905464287039703,0.3125,0.8450389592951536,1.0,9/14,30.27%,KCTD13;TNFAIP1;FHDC1;ITGB5;FAM171A1;SORBS1;PHACTR1;RHOA;ZYX
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.5407770401339702,1.0905464287039703,0.3125,0.8450389592951536,1.0,9/14,30.27%,KCTD13;TNFAIP1;FHDC1;ITGB5;FAM171A1;SORBS1;PHACTR1;RHOA;ZYX
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.72727722244793,-1.090083796745722,0.4915254237288136,1.0,1.0,2/5,19.26%,MYORG;SELENON
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.72727722244793,-1.090083796745722,0.4915254237288136,1.0,1.0,2/5,19.26%,MYORG;SELENON
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.6819868144203476,-1.0897719427373567,0.36363636363636365,1.0,1.0,2/5,11.15%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5599455294563911,-1.0897686134451203,0.38271604938271603,1.0,1.0,9/21,33.07%,PHKG1;CALM1;NR1D1;PYGL;GBE1;PER2;PHKB;PHKG2;UGP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6485309996168254,1.0897158740584791,0.38461538461538464,0.8463647880104893,1.0,2/5,7.96%,DMD;ATP2B4
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6229052527919401,-1.0892442240860543,0.41333333333333333,1.0,1.0,3/14,16.22%,DDX5;CELF4;SCNM1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6330977384337151,-1.0891714594911888,0.3888888888888889,1.0,1.0,4/11,10.78%,RIMS1;FLOT1;MEF2C;CAMK2A
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.5396472882276644,-1.088730534294879,0.30120481927710846,1.0,1.0,10/32,26.56%,SLC7A6;SLC6A6;SLC16A4;SLC6A9;SLC3A2;SLC17A5;SLC7A8;SLC16A1;SLC36A4;SLC16A3
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.38401768246060725,1.0886507462694481,0.42105263157894735,0.8485421476686786,1.0,11/45,9.32%,KCND2;HP1BP3;ACAA2;SUV39H2;SIRT1;FMN2;EGLN3;BMP7;LMNA;RORA;CPEB2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.6204132374234387,1.0885298142389788,0.38235294117647056,0.8470332220288505,1.0,1/7,8.81%,ADCY6
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.6204132374234387,1.0885298142389788,0.38235294117647056,0.8470332220288505,1.0,1/7,8.81%,ADCY6
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6253815698787583,-1.0884803770971252,0.410958904109589,1.0,1.0,1/12,2.73%,PHF1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.7121752252557054,-1.0881751720188666,0.43548387096774194,1.0,1.0,3/6,24.28%,ABHD12B;ALDH4A1;CHAC2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.49710654912340624,-1.0877676685330249,0.3625,1.0,1.0,3/29,12.07%,ECM2;PIK3CB;EMP2
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.6040531806269129,-1.0876879755106938,0.36363636363636365,1.0,1.0,2/16,13.46%,LIPI;ABHD12B
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.6067683937757078,1.0870309557969382,0.36666666666666664,0.8501532564220561,1.0,3/8,18.48%,SMG1;MLST8;MTOR
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.6368422501843536,1.086941346139331,0.38235294117647056,0.8495470572657569,1.0,5/6,34.81%,CDK9;LARP6;EIF3E;EIF4G1;EIF3D
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6457304881205755,-1.0868787679686787,0.410958904109589,1.0,1.0,2/9,11.23%,TGFB1;CST3
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.5516581479588285,1.0868433587482602,0.35,0.8488433923211776,1.0,1/7,2.12%,ADGRB3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6842815388827841,-1.086840811143778,0.3787878787878788,1.0,1.0,6/11,29.03%,ZW10;BUB3;MIS12;CTCF;BOD1;CHAMP1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.6127228664212223,1.0867200453101167,0.39473684210526316,0.8482399832781674,1.0,3/6,17.01%,SIRT1;KLF7;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.4173644202542108,1.0867167961142936,0.4,0.8473224195408722,1.0,16/62,11.87%,SPSB4;FBXW7;SEPTIN4;FAM107A;INAVA;SMAD7;HSPBP1;DCUN1D2;UBE2D1;DCUN1D5;MARCHF7;NDFIP2;XIAP;LRRK2;RCHY1;UBE2N
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.47890580731011934,-1.0867108491526558,0.3118279569892473,1.0,1.0,16/89,11.79%,GDAP1L1;VEGFA;SCG2;SCG3;ENPP2;HPCA;INA;SCG5;SST;ARX;CHGB;CELF4;CACNA1B;SH3GL2;KCNC1;CCK
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.7132206077360895,-1.0865289849599238,0.46153846153846156,1.0,1.0,3/5,15.88%,TRMT10C;SUPV3L1;TRNT1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5887070206353127,1.0861892573073035,0.4,0.8479431887036805,1.0,3/13,8.61%,SGK1;ARC;KAT2A
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.6033773449802419,-1.0859152775757779,0.410958904109589,1.0,1.0,4/19,12.06%,PLSCR1;POLR3D;IFI35;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.6443302080028497,-1.0857288011705784,0.373134328358209,1.0,1.0,2/10,17.99%,CCT7;DKC1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.6443302080028497,-1.0857288011705784,0.373134328358209,1.0,1.0,2/10,17.99%,CCT7;DKC1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.46912290220299224,1.0853171930395624,0.2857142857142857,0.8493298957955782,1.0,1/24,0.11%,VAPB
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.6589241293172393,-1.0851026971278883,0.42028985507246375,1.0,1.0,1/7,15.55%,BEX4
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.6614389503496934,-1.08487546948845,0.40540540540540543,1.0,1.0,1/8,11.38%,CEP72
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6494424366092107,-1.08427761091774,0.3880597014925373,1.0,1.0,2/9,17.99%,CCT7;DKC1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4914413852826557,-1.0840624206133835,0.3229166666666667,1.0,1.0,2/110,0.75%,CD44;PPIF
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.4743939822122155,-1.0835301988580988,0.4,1.0,1.0,17/68,24.36%,B2M;RPL11;HES1;FLOT1;PARP9;NCBP1;DDX11;APOE;TRIB3;EDF1;TXN;GMNN;CAV1;RARA;STMN1;DTX3L;HIP1R
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.650081956537513,-1.083501494392883,0.4492753623188406,1.0,1.0,2/6,17.85%,APOE;PRKCQ
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.5991116858601311,-1.0834312555391434,0.37037037037037035,1.0,1.0,2/12,4.32%,IFIT1;FLOT1
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.6598782274569239,-1.083410035858034,0.410958904109589,1.0,1.0,2/8,13.74%,RAB11A;STX1B
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.5389167706471417,-1.083242862865348,0.36904761904761907,1.0,1.0,16/35,29.81%,ROMO1;PEX1;TIMM44;ZFAND2B;SEC61G;RTN2;AIFM1;TOMM20;PEX14;HSPD1;TOMM40;SEC62;TIMM23;TIMM17B;SRP54;PEX6
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.6655873916120498,-1.0831210893589045,0.4375,1.0,1.0,2/8,1.74%,CDHR1;VEGFA
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.44943083951520174,1.0831122216870563,0.32,0.8532094622664451,1.0,2/20,1.16%,RANGAP1;BARD1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.49279611022226266,-1.0830379795835343,0.3448275862068966,1.0,1.0,16/62,22.91%,IFIT1;DVL1;CAMK1;JUN;CTSZ;LRPAP1;ZFPM1;GTF2F1;DDX11;RACK1;IFIT2;BAX;MITD1;PEX14;CAV1;PARK7
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.5802417108536169,-1.0829598079425595,0.36363636363636365,1.0,1.0,7/17,28.09%,FGF1;LPCAT3;SREBF1;APOE;ERLIN2;MBTPS2;MBTPS1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.5336184660243237,1.0827385361159543,0.3548387096774194,0.8532916626966759,1.0,6/13,13.11%,SOX11;SEMA3A;SOX8;PHACTR4;NRP1;SOX10
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.6658156948017377,-1.0823967815111495,0.3787878787878788,1.0,1.0,2/8,11.33%,ZFPM1;EFNA1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6419130129581676,-1.0822621577199476,0.3582089552238806,1.0,1.0,1/9,14.07%,LPCAT3
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.47333499373751403,-1.0822378665248717,0.39361702127659576,1.0,1.0,19/138,15.18%,CD44;VEGFA;PPFIA4;NOL3;AGRN;HAX1;GLRX;GMPPA;AKR1A1;ANGPTL4;GPC3;DSC2;MPI;PGK1;SAP30;GALE;DDIT4;PFKP;TPST1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.37312733110003776,1.0821931225178332,0.2727272727272727,0.8538050952386749,1.0,20/100,15.69%,SEMA3B;SHROOM2;BCAR1;SALL1;NCS1;CHST3;MPDZ;EGFR;GPC1;PTPRU;FARP1;KAZN;CMTM4;ALCAM;TNFRSF21;NAV2;EPB41L1;FMNL2;AMOTL2;TEAD1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.513619603183589,-1.0820186087614918,0.39285714285714285,1.0,1.0,7/42,11.01%,PDCD1LG2;SELENOS;TGFB1;TRIM41;XBP1;MEF2C;CACTIN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.4978227988983288,-1.0819372985776299,0.3409090909090909,1.0,1.0,11/55,23.62%,CDC37;SPDYA;CDKN1C;CDKN2C;CCNI2;CDK7;CNPPD1;CCNK;CDKN2A;HERC5;BCCIP
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.4021313541691781,1.0818036077795423,0.2,0.8538081087996012,1.0,14/58,12.13%,BAIAP3;ZDHHC2;SHANK2;ADRA1A;NLGN1;GRIK2;TSHZ3;NRXN1;SLC8A2;ARC;RELN;CHRNA7;GRIN2B;ZDHHC3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.5627137894860904,-1.0816745828305347,0.3875,1.0,1.0,7/20,27.00%,UTP15;DDX11;ATF4;NCL;HEATR1;UBTF;MARS1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.6146232202124492,1.0815287295652265,0.43243243243243246,0.8535763157383429,1.0,1/5,10.54%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.6839202344386597,-1.081008467361933,0.41935483870967744,1.0,1.0,2/5,21.32%,P2RX4;P2RY12
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.6471324530349121,1.0809757220702993,0.5128205128205128,0.8540291137198323,1.0,2/5,8.84%,MAP2;FBXW11
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.5959571053041388,-1.0808237735041277,0.3835616438356164,1.0,1.0,3/16,9.17%,HES5;VEGFA;CACNA1C
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.5834022543969408,-1.0807822060847945,0.40540540540540543,1.0,1.0,2/16,3.84%,VEGFA;HES1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.6491318449179633,-1.0807045122455352,0.3918918918918919,1.0,1.0,1/11,2.41%,PDCD1LG2
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.46353980482795887,1.0803801122322267,0.28,0.8549885410565843,1.0,1/12,1.05%,ALG1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6400795234483633,-1.080222258241048,0.4246575342465753,1.0,1.0,1/9,1.80%,RIMS1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.5475634094508548,1.0802189632689279,0.32432432432432434,0.8543856701018121,1.0,4/6,12.74%,RIPOR2;EHD1;MAPK14;CFLAR
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5030206195971908,-1.0800260170703253,0.38095238095238093,1.0,1.0,13/38,22.66%,RPS27A;ISG15;TRIM25;RFC2;RPA3;UBE2L6;UBA52;RFC1;RFC4;BRCA1;UBC;RFC3;POLD2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.3983263743275853,1.0796164530579822,0.3333333333333333,0.8552452072462227,1.0,6/31,10.70%,RPA1;ATR;POT1;STN1;CTC1;ERCC4
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6609183053536578,1.0796090968722583,0.4666666666666667,0.8534013667086774,1.0,4/6,23.85%,PTBP1;LMCD1;CAMTA1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6609183053536578,1.0796090968722583,0.4666666666666667,0.8534013667086774,1.0,4/6,23.85%,PTBP1;LMCD1;CAMTA1;AKAP6
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.6341961598432386,1.0796010758769103,0.39285714285714285,0.8524727471583958,1.0,3/9,11.06%,DGKB;PLA2G15;DGKQ
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.6085784594109341,1.079464745384934,0.43333333333333335,0.851875887234789,1.0,4/8,17.91%,SPRED2;DLL1;SPRED1;ZEB1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.5000548070572157,-1.0793250141574033,0.3695652173913043,1.0,1.0,25/69,31.77%,SEL1L2;TRIM25;SELENOS;DERL2;TMUB1;USP19;DNAJC10;SYVN1;WFS1;FAM8A1;FBXO6;RNF175;TMEM129;BAG6;ERLIN2;MAN1A1;TRIM13;STUB1;OS9;EDEM2;DNAJC18;FBXO2;ANKZF1;UBE2G2;FBXO27
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5345396823925289,1.0790950004770452,0.3076923076923077,0.851958464613846,1.0,3/16,14.85%,RYBP;RNF2;BCOR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.4717457291499202,-1.0789146055399041,0.3977272727272727,1.0,1.0,14/99,16.17%,VEGFA;SPDYA;ECT2;CAMK1;CLU;AGT;TOM1L1;EFNA1;EMP2;CALM1;MTCP1;STRADB;TELO2;MAP2K1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5396255082857229,1.0788988529979524,0.3870967741935484,0.8514408749792796,1.0,2/11,4.76%,LARGE1;CHST3
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.7006069496838143,-1.0788713229509643,0.3472222222222222,1.0,1.0,1/7,5.59%,DNAH17
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.49839546979090266,-1.0786962065244536,0.3068181818181818,1.0,1.0,13/61,24.42%,VEGFA;PFN2;FLOT1;CLU;TGFB1;VIL1;RACK1;WARS1;BAX;MTLN;RHOC;PARK7;SLF1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.5146212876764577,-1.0784792835125692,0.38202247191011235,1.0,1.0,19/51,29.57%,PSMB9;PSMB8;PSMA3;PSME1;PSMA7;OAZ2;PSMB6;AZIN1;CAV1;NQO1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PANK2;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.3954034819596591,1.078470240802559,0.3181818181818182,0.8518910808274472,1.0,2/53,1.02%,GSTT2;GSTM2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.524592352760725,-1.0782856745347273,0.3614457831325301,1.0,1.0,7/38,19.43%,DXO;LSM5;DDX5;SUPV3L1;ZFP36L2;NUDT12;RNH1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.7202206802289663,-1.0781307071507098,0.4189189189189189,1.0,1.0,1/5,10.78%,CAMK2A
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.48411323893878405,-1.0779528981084836,0.40860215053763443,1.0,1.0,23/80,24.54%,SRSF7;DXO;LSM5;PRPF18;DDX5;PRPF8;SNRPB;SRRM4;SRSF5;NCBP1;HNRNPA2B1;SF3A3;ZFP36L2;NUDT12;RNH1;LSM3;USP39;KIN;SNRPG;ALKBH5;SRSF2;SLBP;SON
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.5287336692204173,1.077925902048622,0.4074074074074074,0.8521085615414083,1.0,4/10,15.01%,ADGRB3;PTGFRN;ADAMTS5;NOS1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.40227317821690367,1.0779069704847204,0.35714285714285715,0.8513031131572072,1.0,15/60,15.55%,LGR5;ADGRB3;CALCRL;CALCB;GRK5;ADGRL3;VIPR2;ADCY6;GNAQ;RXFP1;PRKACB;ADCYAP1R1;HTR1E;LPAR1;ADCY2
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.5842955706459895,-1.0771553923209778,0.375,1.0,1.0,5/19,15.99%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.7040798005918327,-1.0764117395436932,0.453125,1.0,1.0,2/6,21.32%,P2RX4;P2RY12
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.598671681891973,1.0752508455058325,0.29411764705882354,0.8571093037024318,1.0,2/5,10.66%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.6499093486260805,1.0747818427736442,0.4411764705882353,0.8576092022700836,1.0,1/6,10.40%,LRRK2
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.7162299826655706,-1.0746031745475435,0.45161290322580644,1.0,1.0,1/5,4.60%,LETM2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6041531812524086,1.0745299735810268,0.5151515151515151,0.8573196217006701,1.0,1/6,2.21%,FBXW7
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.6389003934614269,-1.074405339639662,0.46153846153846156,1.0,1.0,2/12,16.91%,AGT;NR4A3
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6214800760272956,1.0743742312120625,0.46153846153846156,0.8568193698178596,1.0,1/5,4.11%,LIG4
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.3893307071944586,1.0741581331661705,0.3333333333333333,0.8565312612845654,1.0,6/48,4.56%,LAMA3;ADAM10;BCAR1;ABL1;ITGA2;MYH9
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5163737812014305,-1.07381731099019,0.3780487804878049,1.0,1.0,11/41,24.84%,ROMO1;SLC25A6;TIMM8B;TIMM44;TOMM7;PMPCA;AIFM1;TOMM20;HSPD1;AIP;TOMM40
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.37587163067497037,1.0736583961606616,0.2,0.8567804574191461,1.0,9/50,11.43%,NEDD4L;SGK1;SLC8A2;PKD2;SCNN1D;SLC24A3;SLC12A1;SCN11A;SLC8A1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5827228847342332,-1.0735931340086544,0.3698630136986301,1.0,1.0,3/16,7.52%,HLA-F;ALOX5;IGSF6
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3598070719277,1.0735355728015454,0.25,0.8562632475094084,1.0,14/72,13.99%,HSPA1A;RPA1;BAG2;ATR;SIRT1;MAPK1;NUP98;NUP93;MAPK3;HSPH1;MLST8;AAAS;BAG5;NUP210
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.5962532391794791,-1.0725411172239703,0.4342105263157895,1.0,1.0,2/13,4.89%,DDRGK1;GABARAPL2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.5778445739651621,1.0723782662299206,0.3902439024390244,0.857965792518023,1.0,1/7,7.49%,TGFBRAP1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7440412281643689,-1.0721555522847386,0.4444444444444444,1.0,1.0,1/5,10.02%,SMC1A
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5803233217771211,-1.0718742880746712,0.3625,1.0,1.0,7/14,32.79%,PHKG1;CALM1;PYGL;AOAH;MGAM;PHKB;PHKG2
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.7293338756034748,-1.0718038536493186,0.4126984126984127,1.0,1.0,1/5,2.25%,DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.7293338756034748,-1.0718038536493186,0.4126984126984127,1.0,1.0,1/5,2.25%,DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.7293338756034748,-1.0718038536493186,0.4126984126984127,1.0,1.0,1/5,2.25%,DDRGK1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.567260828129735,-1.0717683050452151,0.417910447761194,1.0,1.0,6/17,26.31%,TRMT10C;RPUSD3;COA3;MALSU1;RMND1;RCC1L
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.5215788522904139,1.070881359634013,0.4642857142857143,0.8605817693887632,1.0,4/13,20.21%,BARD1;SMG7;IKBKB;PSEN1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5111058455534757,-1.0707981169869685,0.35802469135802467,1.0,1.0,13/38,24.08%,FTL;GLRX;SELENOS;GPX4;NDUFA6;MGST1;PTPA;PFKP;ATOX1;TXN;GLRX2;NQO1;JUNB
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.5323918532652651,-1.0707846387154547,0.41025641025641024,1.0,1.0,10/35,24.84%,ROMO1;SLC25A6;TIMM8B;TIMM44;TOMM7;AIFM1;TOMM20;HSPD1;AIP;TOMM40
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.676143691804838,-1.0703687260642998,0.43283582089552236,1.0,1.0,2/6,8.00%,HAP1;HDAC6
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5320891097708957,-1.0700792581337295,0.4044943820224719,1.0,1.0,5/28,19.20%,DDRGK1;RETREG1;MTIF3;UFC1;ULK1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5241172319966927,1.0698881956115174,0.35,0.8625432487315657,1.0,5/19,5.16%,SYNDIG1;NLGN1;PCLO;PLD2;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.6643644000184186,-1.0696556489712887,0.36363636363636365,1.0,1.0,2/5,23.92%,YBX3;DHX36
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.5178985272410925,-1.0695263645705169,0.4044943820224719,1.0,1.0,10/38,18.63%,BUD23;DXO;TGFB1;UTP15;DDX5;DIMT1;SUPV3L1;RIOK2;MAP2K1;HRAS
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.7238960578874489,1.0691312623430118,0.47368421052631576,0.8635282240027808,1.0,2/5,4.13%,HSPA1A;ACAA2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.5923567231301806,1.0690356631746107,0.45161290322580644,0.8629303941131728,1.0,2/7,12.42%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6335090014742707,-1.0686958230137666,0.42857142857142855,1.0,1.0,5/12,23.37%,SFRP1;PELP1;SRA1;LOC400499;RARA
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.6349015155579076,1.0684746539906407,0.45714285714285713,0.863722613407647,1.0,2/5,13.23%,FOXP1;SLC39A10
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5287101013858717,-1.0682143935594948,0.4024390243902439,1.0,1.0,7/28,21.89%,ISG15;TRIM25;CACTIN;NLRC5;UBE2L6;IFIH1;HERC5
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5432348555508897,1.0681187718257088,0.37037037037037035,0.863771987463997,1.0,3/12,4.13%,HSPA1A;BOK;ACAA2
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.7011048928215866,-1.0680428262752852,0.4,1.0,1.0,2/5,17.71%,RAB3D;IL7
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.6262469735159439,-1.067978177592561,0.36619718309859156,1.0,1.0,6/10,31.19%,ENTPD7;SMPDL3A;ENTPD5;ENTPD3;ENTPD1;ENPP1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.5539591644474307,-1.0679687650021414,0.42105263157894735,1.0,1.0,6/17,30.02%,GAPDH;PGK1;LDHA;PGAM1;ENO4;PFKFB2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5417241943697034,1.0677846588542597,0.4444444444444444,0.8638971917926778,1.0,1/10,3.78%,PDIA2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.5345878450012751,-1.0674103120548353,0.4,1.0,1.0,7/28,20.54%,SLC22A4;GLUL;SLC6A6;SLC1A6;SLC12A4;SLC7A8;SLC29A2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5265747446332296,-1.067237240925784,0.43209876543209874,1.0,1.0,5/23,18.38%,RANGRF;SELENOS;DERL2;SEC13;SYVN1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.6044876222961,-1.0669646451792574,0.4647887323943662,1.0,1.0,3/11,18.86%,CLU;P2RX4;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6044876222961,-1.0669646451792574,0.4647887323943662,1.0,1.0,3/11,18.86%,CLU;P2RX4;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6045831419164163,-1.066858025992148,0.4155844155844156,1.0,1.0,4/15,15.81%,BUD23;UTP15;DIMT1;RIOK2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.616831305105575,1.0666812618726422,0.32142857142857145,0.8653495859865603,1.0,2/6,12.42%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.33894881435,1.0663060264179374,0.3333333333333333,0.8653023580260553,1.0,22/82,15.60%,HIP1;ERBB4;ESR1;IRS1;RICTOR;AKR1C2;GAB1;AKR1C3;IGF1R;GCNT2;NRG2;STRN;EGFR;TGFA;MFHAS1;PIK3CA;THEM4;FRS2;KITLG;OSBPL8;FYN;TCF7L2
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.5928610751962107,-1.066022901393682,0.39436619718309857,1.0,1.0,3/18,8.89%,VEGFA;HES1;JAG1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.6783155664950662,-1.0659612517399932,0.4117647058823529,1.0,1.0,3/5,27.49%,TRMT10C;TRNT1;HSD17B10
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.674848885824726,1.06593127896209,0.475,0.8652173833570341,1.0,2/5,14.04%,MEGF10;THBS4
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.6234141517675447,1.0657319072408389,0.4166666666666667,0.8648490378553326,1.0,2/5,11.85%,MAP3K7;ERC1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.5940743487384325,1.0656377740193133,0.42105263157894735,0.8642737546602115,1.0,3/5,29.42%,HEXB;NEU1;NEU3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5528047522822735,-1.0655357941941452,0.4090909090909091,1.0,1.0,5/20,16.09%,VEGFA;CREB3;XBP1;ATF4;RUNX2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.3096978862941245,1.0655093240717022,0.3333333333333333,0.863699687708632,1.0,38/152,15.16%,PKP2;ZDHHC2;TSPAN17;NLGN1;ZFYVE27;EHD1;ARL5A;NRXN1;TSPAN15;ANK2;C2CD5;MAGI2;SPTBN1;EFR3A;RAB10;DPP6;PACS1;SYNE3;DPP10;SEC16A;TSPAN5;LRRC7;KCNIP4;DLG2;TSPAN14;RAPGEF6;ZDHHC3;FLOT2;MYO5A;PACS2;RAPGEF2;EFR3B;MAP7;LIN7A;SPTBN4;RAP2A;RAP1A;ARL3
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.6924588295917677,-1.0652952577268047,0.463768115942029,1.0,1.0,1/6,1.50%,ZNHIT3
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6484725513701964,1.0652141183456412,0.5,0.8635602338061534,1.0,4/7,22.31%,CTSA;EEF1A2;SNCA;GFAP
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.581894400247527,1.0650354398376933,0.4594594594594595,0.8630446015147373,1.0,3/6,31.47%,LYST;UBXN6;CHMP2B
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.3392679930260807,1.0649404675855543,0.4,0.862304410374293,1.0,45/139,19.35%,POGLUT2;PRKX;ATR;SGK1;RICTOR;RPS6KB1;MAPK1;TNKS;TGFBR2;GALNT16;MAPK14;MAST3;MAPKAPK5;LRRK2;SMG1;DGKQ;WNK1;CSNK1E;GALNT13;LATS1;LMTK2;PRKD1;NAA11;MAPK8;CSNK1G3;SRPK2;TTBK1;PNCK;CSNK1G1;CAMKV;PRKCA;RPS6KA3;DMPK;IKBKB;PRKCE;PINK1;UHMK1;MKNK2;VRK1;AKT2;RPS6KA2;MTOR;TTBK2;PDPK1;EIF2AK3
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5397273767832298,1.064530871417956,0.4,0.8623922735785011,1.0,2/12,5.45%,PKP2;SMAD7
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.4784768099204327,1.0644523807019033,0.3333333333333333,0.8616918535340282,1.0,3/20,3.76%,RPA1;ABL1;PMS1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.6033652468397557,-1.064407395884358,0.3333333333333333,1.0,1.0,7/12,23.89%,ISCA1;CIAO2B;CISD3;MAGEF1;MMS19;GLRX5;CIAO1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.445381642228,1.064393018162973,0.34782608695652173,0.8608991822657733,1.0,4/21,4.91%,RXRA;NR1H2;SIRT1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.47259822583162014,-1.0638896794542354,0.3263157894736842,1.0,1.0,12/67,16.17%,VEGFA;SPDYA;FGF1;HTR2B;CAMK1;TGFB1;CEMIP;RASGRP1;CALM1;MTCP1;TELO2;MAP2K1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.6654720707525694,-1.0638058155670524,0.47058823529411764,1.0,1.0,1/7,5.63%,CLU
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.646812306196198,-1.063557905006594,0.4166666666666667,1.0,1.0,2/5,21.04%,PDZK1;ATP8B1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.6768155091200058,-1.0632531611086664,0.4189189189189189,1.0,1.0,1/6,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.44173113384136636,1.0630494710324496,0.32142857142857145,0.8635535505896486,1.0,6/23,14.29%,SOX11;SMAD7;TWSG1;XIAP;LATS1;ITGA3
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5893310941559011,-1.0630489997107642,0.47297297297297297,1.0,1.0,1/14,3.53%,POLR2G
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.4927943611788626,-1.0626918534790202,0.38202247191011235,1.0,1.0,10/69,15.68%,ELOB;PSMB9;VEGFA;RPS27A;PSMB8;BACH1;PSMA3;PSME1;ATF4;UBA52
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5563708953269628,-1.0626245509046959,0.4,1.0,1.0,11/23,26.03%,ALOX5;TBXAS1;GPX4;ALOX12;EPHX2;FAAH2;CBR1;PTGES2;CYP1B1;CYP2E1;EPHX1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.470304880924431,1.0625754597256982,0.3333333333333333,0.8636584412655482,1.0,7/24,17.37%,KAT2B;KAT2A;NAA50;KAT8;PHF20L1;MRGBP;ATAT1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5599700395985509,-1.0624193989876134,0.32,1.0,1.0,6/24,15.99%,RNF8;CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.39989496384986467,1.0622454357688464,0.375,0.8633333421980478,1.0,26/99,13.79%,RIT2;GABRG1;CSRNP3;ASTN1;GLS;NRXN1;NOL4;MAGI2;LSAMP;SLC8A2;GRIA1;LRRTM3;KCTD16;SLC1A2;NXPH1;CTNNA2;CLVS2;CA10;ADGRA1;FUT9;DLG2;GRIN2B;KCNC2;TTBK1;ADCYAP1R1;GABRA1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.5062146739711403,-1.061967393900835,0.3707865168539326,1.0,1.0,5/46,4.72%,TRIM5;DVL1;STX10;TRIM25;CAMK1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.570062091320519,-1.061903811210501,0.4342105263157895,1.0,1.0,5/20,14.25%,PRELID1;APH1A;EFNA1;PSME1;USP50
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.6577024015780911,-1.0618496822006525,0.3968253968253968,1.0,1.0,1/9,1.74%,VEGFA
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7100213253342299,-1.0617849189828987,0.3880597014925373,1.0,1.0,3/5,14.45%,RPS21;KRI1;NOP14
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.6166730908027228,-1.0615129110583195,0.5072463768115942,1.0,1.0,2/9,13.72%,PDHB;PPCS
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.6329810104350051,-1.0613526992517006,0.4626865671641791,1.0,1.0,3/8,22.31%,ENPP4;APOE;CAV1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5251734040849928,-1.061257712588851,0.4050632911392405,1.0,1.0,6/28,15.68%,NPM2;RPS27A;ZW10;BUB3;CDC26;UBA52
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.4049530751535434,1.0611944731503902,0.3684210526315789,0.8649501986795299,1.0,4/30,7.60%,IRS1;SIRT1;RPS6KB1;KANK1
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.563200799489577,-1.0611623428647574,0.4230769230769231,1.0,1.0,8/20,26.81%,CEACAM1;CD160;PHPT1;CD226;THY1;NECTIN2;TESPA1;PTPN2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.6750924148664589,-1.0611386325752925,0.4657534246575342,1.0,1.0,4/7,27.16%,OCIAD2;LPCAT3;LRRC19;UBAP2L
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.41211436832247567,1.0610369225434633,0.3333333333333333,0.8644566097807734,1.0,6/24,18.48%,RNF139;INAVA;GLRA1;PRKN;RNF185;MTOR
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.5506279652748812,-1.0607501410895444,0.4225352112676056,1.0,1.0,10/24,25.81%,HES5;TRIB1;OGN;APOD;NR4A3;STAT1;ID2;IL18;NDRG4;PDGFRB
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.5197564261214652,1.0605921243235417,0.32142857142857145,0.8647836455406146,1.0,5/10,17.19%,ACER3;SPTLC2;QDPR;ABCA2;ACER2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.3641243001070597,1.060501244272773,0.16666666666666666,0.864030751653927,1.0,18/66,18.37%,RXRA;SLCO1A2;PRELID3B;ABCC11;ATP8A1;NCOA2;GLTP;AKR1C1;CERT1;OSBPL5;ABCA10;OSBPL8;PITPNA;PCTP;ABCA2;PRELID3A;SLCO3A1;ABCC4
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.6141961273536244,-1.0604987331421027,0.43478260869565216,1.0,1.0,5/10,33.30%,APOE;ABCA1;ABCA5;SOAT1;ABCG1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6078234212675117,-1.0603505832981346,0.47540983606557374,1.0,1.0,2/12,6.42%,DDRGK1;COPS5
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.6797371881469982,-1.0601324403702088,0.4782608695652174,1.0,1.0,1/7,3.84%,HES1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.5379450729378219,-1.06002095285743,0.4050632911392405,1.0,1.0,5/25,18.33%,ECT2;TGFB1;ZIC1;APOD;HDAC3
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.6618383389458813,-1.059767341158985,0.4925373134328358,1.0,1.0,2/6,13.57%,ATP6AP2;GRN
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.3829452075064341,1.0596207306085177,0.2727272727272727,0.8653799080835921,1.0,18/64,20.35%,PREB;CAMSAP2;PDE4DIP;MAPK1;STOX1;ZEB2;MAPK3;MSN;MYO5A;MTM1;RHOT1;DIAPH1;PINK1;STX18;PRKN;GOLPH3;EHD3;PRMT6
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.5701764037447353,1.059599916247793,0.39285714285714285,0.8645165466829348,1.0,1/7,2.29%,ESR1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.6273204552405494,-1.0593220694645418,0.43661971830985913,1.0,1.0,1/10,1.60%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.39462903571149444,1.0590818876941441,0.2,0.8648978093899029,1.0,9/35,17.20%,ZFYVE27;PLXNA1;SEMA4D;ROBO1;PLXNA3;ROBO2;TIAM2;SLIT2;CDKL5
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.3982136501250441,1.0590634671184878,0.21428571428571427,0.8639996808235583,1.0,12/51,11.66%,RIPOR2;ADAM10;PLXNA1;SEMA4D;ADAM22;GCNT2;PLXNA3;LPXN;PTPRC;NF2;CDH13;SEMA6A
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5147063401782906,-1.0588005847882322,0.4024390243902439,1.0,1.0,11/34,26.57%,PDHX;GAPDH;PGK1;PDHB;VDAC1;NR4A3;LDHA;SLC16A1;PGAM1;SLC16A3;ENO4
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4777495906098793,1.0587986822223352,0.4,0.8636032181128481,1.0,5/20,14.88%,LARGE1;TMTC1;DPY19L3;CRPPA;TMTC2
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6175513603906082,-1.0587320639382476,0.39705882352941174,1.0,1.0,3/9,19.72%,ZFPM1;TTN;MYLK
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.40154313473923176,1.057908208064143,0.3333333333333333,0.8651492393743034,1.0,8/41,12.74%,SYTL4;DYSF;MYH9;WNT7A;ANXA6;PPP3CA;MYOF;CFLAR
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5935329102160269,-1.0577497592093277,0.3582089552238806,1.0,1.0,3/15,17.99%,NOP10;CCT7;DKC1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4537297558451939,1.0577336369481016,0.3225806451612903,0.8647339345992505,1.0,5/16,12.48%,SMAD7;PDE4D;DMD;GPD1L;PPM1F
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5574991444921659,1.057104763752619,0.4090909090909091,0.8652790851115774,1.0,5/8,16.26%,SALL1;PKD2;BMP7;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.5047552346062292,-1.0570606355467789,0.3372093023255814,1.0,1.0,10/38,26.74%,HLA-B;SELENOS;XBP1;SYT11;MAPK13;IFIH1;HSPD1;SPHK2;SCIMP;C1QTNF4
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5502521262293391,-1.0567928765827792,0.4523809523809524,1.0,1.0,8/21,25.81%,TTN;OBSL1;OBSCN;LMOD1;TMOD3;PGM5;ACTN2;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6397095037962204,-1.0567364013294624,0.45714285714285713,1.0,1.0,2/8,10.50%,ITGA4;CD160
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5235442093693548,1.0565302895965054,0.36666666666666664,0.8659521522624957,1.0,3/11,11.43%,GSTM2;PIK3CA;SLC8A1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4158004060385669,1.0564226599710045,0.3125,0.8653347321006027,1.0,12/49,14.07%,ABHD3;SMPD4;SYNJ1;PRDX6;PLCB1;PLA2G15;ENPP6;SERINC5;PIGQ;PNPLA6;PIGX;PLAAT1
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.6156446234752442,1.056417262694459,0.5172413793103449,0.864461031140732,1.0,2/6,15.50%,PLIN5;ABHD5
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6723407028016781,-1.0562228291512301,0.4492753623188406,1.0,1.0,1/7,7.29%,ZFPM1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.6640744157216985,-1.056119298108244,0.47761194029850745,1.0,1.0,2/6,19.80%,SHMT1;PAICS
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.7121818675285342,-1.0556900663909008,0.543859649122807,1.0,1.0,1/5,1.23%,NOP10
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5845261799179272,-1.055664233361308,0.42857142857142855,1.0,1.0,3/18,17.99%,NOP10;CCT7;DKC1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6407663869341964,-1.0555134574910652,0.5068493150684932,1.0,1.0,4/10,31.73%,DONSON;GMNN;ZRANB3;ZNF830
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5632532924833081,1.0554962284873155,0.3793103448275862,0.8660885045798732,1.0,1/9,3.09%,FYCO1
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.6662028831308208,-1.0553779754027115,0.484375,1.0,1.0,2/5,29.47%,CAV1;SOD2
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5720520709999779,-1.0553642754105308,0.3950617283950617,1.0,1.0,6/13,32.79%,PHKG1;CALM1;PYGL;MGAM;PHKB;PHKG2
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.6703082948973296,1.0551450094434442,0.43243243243243246,0.8660052563705719,1.0,1/5,0.28%,PLD1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5802629440514877,-1.0551002749018699,0.43373493975903615,1.0,1.0,6/15,22.65%,TGFB1;SARS1;ATF4;C3;BRCA1;CYP1B1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.5609227027629056,-1.0549965967560035,0.3918918918918919,1.0,1.0,9/15,17.23%,OPRM1;HTR2B;CHRM2;AGT;HTR2C;HTR4;HTR1F;CHRM5;TSHR
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.40374154470223483,1.0549936048488116,0.3684210526315789,0.8654820197458517,1.0,7/42,12.84%,DHCR7;RXRA;ACAA2;STARD3;FDX1;OSBPL5;HMGCR
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.504460072508987,1.0549745050171553,0.35714285714285715,0.8646117556609235,1.0,3/13,11.23%,NT5C1A;SAMHD1;PNP
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6829671877914969,-1.054967328317859,0.5230769230769231,1.0,1.0,2/5,28.49%,HMGCL;HMGCLL1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.5001428156103306,1.054872761773012,0.4583333333333333,0.8640361144935176,1.0,6/15,23.45%,OSBPL7;CYP7B1;OSBPL6;HSD17B4;ACOT8;CYP27A1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.6707892570798066,-1.054798891302438,0.4492753623188406,1.0,1.0,1/6,10.40%,CDH3
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.658806344591066,-1.0545919433686868,0.5076923076923077,1.0,1.0,3/5,22.56%,FLOT1;CAV1;RFTN1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5843744923982479,-1.0545029220367519,0.42028985507246375,1.0,1.0,7/17,25.81%,VEGFA;TGFB1;HAS2;RASA1;CAV1;CUL7;PDGFRB
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.5017326605047474,1.0541141469361264,0.4090909090909091,0.8649426251349557,1.0,5/16,11.53%,SHANK2;TSHZ3;SLC8A2;ARC;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.690906103255615,-1.0538960381256597,0.4375,1.0,1.0,3/7,23.04%,DVL1;DVL2;DVL3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3887764763714332,1.0537855991113383,0.3888888888888889,0.8648792407143109,1.0,14/43,15.55%,CALCRL;CD247;CALCB;MYH9;GNG2;VIPR2;ADCY6;MAPK14;RXFP1;PRKACB;ADCYAP1R1;ADAM17;FYN;ADCY2
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.6201460562789352,1.053657575624468,0.42105263157894735,0.8643050918152575,1.0,1/5,8.59%,ADIPOR2
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.626026583493482,1.053530357849776,0.4594594594594595,0.8636592055246766,1.0,2/8,3.39%,TG;SALL1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.5450158122124856,1.0535173938249305,0.4166666666666667,0.862832547562996,1.0,4/9,7.16%,NLGN4X;NLGN1;WNT7A;LRRTM3
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.6224216892600154,-1.0534954862045198,0.47540983606557374,1.0,1.0,2/10,14.56%,HACD4;ELOVL2
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.6224216892600154,-1.0534954862045198,0.47540983606557374,1.0,1.0,2/10,14.56%,HACD4;ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.6804048664853278,-1.0532339485008835,0.5,1.0,1.0,2/5,18.32%,PRELID1;BAX
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.4460285167251008,1.0531511427577336,0.2,0.8629170958879797,1.0,7/21,16.55%,SHROOM2;FAM107A;PAWR;SHROOM1;EPS8;ADD2;MICAL1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.7242120346345838,-1.0530839628985829,0.53125,1.0,1.0,4/5,26.44%,BBOF1;CCDC39;E2F4;CCDC40
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.6883627852168714,-1.0530494465050155,0.4838709677419355,1.0,1.0,3/5,21.89%,ISG15;UBE2L6;HERC5
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.6344948634812796,1.0529319370382766,0.42105263157894735,0.8624926589529077,1.0,2/5,18.76%,TBC1D23;FAM91A1
prerank,PanglaoDB_Augmented_2021__NK Cells,0.43665185796485634,1.0528249211120493,0.34615384615384615,0.8618693980733649,1.0,8/28,11.81%,PCDH15;CD247;ITGA2;CD96;PTPRC;KLRD1;ZBTB16;KLRG1
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.6491144097125311,1.0527788951978683,0.4,0.8611023243010906,1.0,2/5,4.91%,RXRA;PPARG
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.4192922947043616,1.0525345566753466,0.25,0.8610795865588731,1.0,19/45,19.02%,TAB3;LEPR;CTSA;ZKSCAN3;TBC1D14;FOXK1;EIF4G3;LRRK2;SMG1;PIK3CA;DAPL1;TAB2;WASHC1;BCL2;SNCA;EIF4E;PINK1;MTOR;MTMR8
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.3412496313860902,1.052299582049508,0.25,0.8608035204810793,1.0,19/129,10.73%,GABRG1;SYNDIG1;ADGRB3;RGS7BP;ASTN1;FAM107A;CADM2;LRRC3B;SLIT1;CDH20;NRXN1;SLC16A2;SRR;LRRTM3;SLC1A2;CA10;GRIA3;ADGRA1;VSTM2B
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.5968658702296596,-1.0521624964893614,0.4444444444444444,1.0,1.0,2/12,9.68%,SFRP1;MEF2C
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.6019301858453112,-1.0521273674786122,0.4657534246575342,1.0,1.0,2/10,13.72%,DCAKD;PPCS
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.6019301858453112,-1.0521273674786122,0.4657534246575342,1.0,1.0,2/10,13.72%,DCAKD;PPCS
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.6019301858453112,-1.0521273674786122,0.4657534246575342,1.0,1.0,2/10,13.72%,DCAKD;PPCS
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3488769679212906,1.0517335747660814,0.4166666666666667,0.8612512073649788,1.0,11/72,8.25%,DHCR7;RXRA;ACACB;NFYC;PPARG;TBL1XR1;ACACA;NCOA2;BBS4;RORA;FASN
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6269371618368724,-1.051709421397517,0.4647887323943662,1.0,1.0,3/11,5.54%,RNF212B;ZCWPW1;IHO1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.5719563386773885,-1.0515957134342844,0.38666666666666666,1.0,1.0,3/15,15.48%,ZCWPW1;BRME1;BTBD18
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.45280074809067566,1.0514149874080505,0.42857142857142855,0.8610658341176295,1.0,5/29,8.84%,BAG2;BTRC;SH3D19;SNX33;FBXW11
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.6083644239052247,-1.0513826263615944,0.4925373134328358,1.0,1.0,4/9,18.54%,JAG1;BTN3A3;CD55;CD46
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.4794960716785298,1.0512882674263806,0.4375,0.8597228583139267,1.0,4/12,12.33%,RAB27A;RAB27B;BBS4;MYO5A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.4794960716785298,1.0512882674263806,0.4375,0.8597228583139267,1.0,4/12,12.33%,RAB27A;RAB27B;BBS4;MYO5A
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.38832651042939914,1.051175577519772,0.38461538461538464,0.8590534031706077,1.0,13/46,11.87%,EYA4;SIRT1;TOX;POT1;EYA2;EGFR;MECP2;PML;USP9X;SIRT6;TRIM28;HMGB1;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.4568369641864596,1.0509328858243854,0.3684210526315789,0.8587810493708936,1.0,3/21,7.60%,IRS1;RPS6KB1;KANK1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.43290384128775605,1.0509221786602838,0.23076923076923078,0.8579341850724597,1.0,2/21,2.56%,EPHA3;PEAK1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5364400418383456,-1.0508036880055198,0.5061728395061729,1.0,1.0,9/21,23.37%,SFRP1;TRIM25;GSTM3;PELP1;BRCA1;SRA1;LOC400499;CAV1;RARA
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.49948351497599197,-1.0506421488027013,0.35802469135802467,1.0,1.0,19/53,26.50%,HLA-C;CTSZ;RBM47;OAS3;OAS1;TMBIM1;GRN;TYMP;ABCC3;CEBPD;MAPK13;NFIC;IFIH1;TAPBP;TNFRSF1A;JUNB;DTX3L;ANXA5;SAT1
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.6766645683891787,-1.05063951641243,0.5079365079365079,1.0,1.0,2/6,8.27%,HTR2B;TTN
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.6902866774377665,-1.0501159317129098,0.4444444444444444,1.0,1.0,2/5,16.65%,XBP1;USF1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.7099210050827549,-1.049797223008436,0.43333333333333335,1.0,1.0,1/5,8.63%,NLRP1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.4808871500851119,1.049699032076368,0.3,0.8604461452412672,1.0,4/19,13.45%,KANSL3;JADE3;KAT8;MCRS1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.6850920469820511,-1.04932024835264,0.532258064516129,1.0,1.0,2/6,25.63%,SAPCD2;NUMA1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.4637172772974058,-1.049065727309682,0.40476190476190477,1.0,1.0,8/65,8.58%,ROMO1;CD63;VEGFA;TGFB1;AGT;PRELID1;CHCHD2;SFRP4
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6007855836151637,-1.048965052615533,0.4246575342465753,1.0,1.0,1/11,10.28%,STAT5A
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.516429794591299,1.0489155865819129,0.4642857142857143,0.8608683177639821,1.0,1/7,10.93%,EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.516429794591299,1.0489155865819129,0.4642857142857143,0.8608683177639821,1.0,1/7,10.93%,EIF4E2
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.4969655229746361,1.048870470316874,0.4,0.8601301485457445,1.0,3/10,23.97%,HEXB;ABCA2;NEU1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6329076104031527,1.0486954256734433,0.4358974358974359,0.8596437864946403,1.0,3/5,18.28%,ERBB4;LATS1;AKT2
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4939569294565215,-1.0485699927161107,0.4117647058823529,1.0,1.0,12/35,22.66%,RPS27A;ISG15;TRIM25;RFC2;RPA3;UBE2L6;UBA52;RFC1;RFC4;UBC;RFC3;POLD2
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5466251168890837,1.0485053270254052,0.42424242424242425,0.859372750105611,1.0,2/8,4.91%,RXRA;PPARG
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.6383275709705489,-1.0484191214208967,0.45714285714285713,1.0,1.0,2/7,15.86%,VEGFA;COL4A1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.4621298682780212,-1.0484003348313935,0.36363636363636365,1.0,1.0,11/51,18.41%,SELENOK;PIGO;PIGC;GLUL;PIGH;ZDHHC1;ZDHHC8;ZDHHC22;ZDHHC15;PIGL;PIGG
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.4395346868108013,1.0483371133368018,0.391304347826087,0.8590487213862821,1.0,7/23,15.92%,SCD5;ACACA;FASN;ACSL4;ACSL3;SLC25A1;ACSBG2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6381520770173466,-1.0483365728198715,0.4857142857142857,1.0,1.0,2/7,6.85%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5723053107705242,-1.0483051995478292,0.4691358024691358,1.0,1.0,3/13,19.93%,PHKG1;CALM1;PYGL
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.6962223319553063,-1.048189276290866,0.4444444444444444,1.0,1.0,1/5,6.22%,SPINK5
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6254849141053327,-1.0481747403443682,0.375,1.0,1.0,3/9,14.45%,RPS21;KRI1;NOP14
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.46880247845049544,1.0477915170177547,0.32142857142857145,0.8596345157536254,1.0,6/11,24.29%,MAP2;RAPGEF2;B4GALT5;B4GALT6;ARHGAP35;MAPT
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6730190732924572,1.0477765658919262,0.5641025641025641,0.8588300246232103,1.0,3/5,11.69%,TWSG1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5681773874099671,-1.0472500191031993,0.4714285714285714,1.0,1.0,6/16,23.37%,ARG2;SELENOS;CACTIN;SYT11;GSTP1;RARA
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.5681773874099671,-1.0472500191031993,0.4714285714285714,1.0,1.0,6/16,23.37%,ARG2;SELENOS;CACTIN;SYT11;GSTP1;RARA
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.40466047111523645,1.0467977509307869,0.2777777777777778,0.8601265260185337,1.0,5/37,4.29%,LGR5;CHRM3;HID1;TSPAN8;SH3BGRL2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.4656116650577448,1.0467405924081359,0.35714285714285715,0.8594297896472334,1.0,5/13,19.81%,GNL3L;HDAC4;ZMIZ1;PIAS1;RASD2
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.5886982404015435,-1.0460657911519207,0.4666666666666667,1.0,1.0,6/17,23.78%,RBM47;ANGPTL4;ABCC3;CEBPD;MAPK13;IL18
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.4719451146857854,-1.0460248302998567,0.3793103448275862,1.0,1.0,10/65,20.79%,POLR2I;POLR2G;TAF11;NABP2;GTF2F1;CDK7;NCBP1;SRRT;CCNK;PHAX
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5535723290234742,1.0459157460744986,0.391304347826087,0.8606876021173163,1.0,7/11,27.53%,BMP7;RBPJ;BMPR1A;TGFBR3;NOTCH1;NRG1;TGFBR1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.5772164895556049,-1.0458603361390135,0.47435897435897434,1.0,1.0,4/15,19.61%,MX1;DNM2;MTFR1L;DNM1L
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.564601726862065,-1.0458109250160643,0.4268292682926829,1.0,1.0,3/16,13.24%,HAP1;TLE6;ZBED3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5129048054897332,1.0457648936513204,0.4074074074074074,0.8602045536276806,1.0,4/15,11.06%,SPRED2;PARD3;SMAD7;DGKQ
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.6580503771821058,-1.0456519400773703,0.453125,1.0,1.0,3/7,13.56%,HTR2C;GRM1;LPAR6
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6257954491728663,-1.0456314086691656,0.4605263157894737,1.0,1.0,2/7,19.36%,APEX1;TERF2IP
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.6041839523096714,1.045584741698399,0.5277777777777778,0.8596693022521477,1.0,2/5,21.54%,AMPD2;HPRT1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.4694799053641936,-1.0455063543235785,0.38636363636363635,1.0,1.0,10/66,20.79%,POLR2I;POLR2G;TAF11;NABP2;GTF2F1;CDK7;NCBP1;SRRT;CCNK;PHAX
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.5101811127805493,-1.0454610925814898,0.3974358974358974,1.0,1.0,9/28,23.63%,VEGFA;HES1;TGFB1;HAS2;COL4A1;RASA1;CAV1;CYP1B1;CUL7
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.4020420507080746,1.0454563482542978,0.3333333333333333,0.8591351128833121,1.0,6/33,10.10%,FNBP1L;ARFGEF2;EPS15;SNX33;WASL;WASHC5
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.6527325005683051,-1.0453630863381258,0.46875,1.0,1.0,1/5,12.70%,ATG14
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6540649641416616,-1.0453290431908644,0.4583333333333333,1.0,1.0,2/7,19.57%,RPS27L;KAT5
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.6621481915983549,-1.0452402772256004,0.4594594594594595,1.0,1.0,6/7,29.03%,MIS12;CENPC;RMDN1;NUF2;BOD1;CHAMP1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.43996181727686723,-1.0444711956501067,0.3979591836734694,1.0,1.0,29/221,11.01%,DUOX1;IFIT1;F13A1;OPRM1;VEGFA;IL20RA;RPS27A;SFRP1;NDN;ALOX5;IL12RB2;RPL13A;IFNGR2;HAX1;TGFB1;IL3RA;IRF1;YBX3;OAS1;MT2A;XBP1;HAS2;GAPDH;FN1;IL5;STAT5A;OSMR;PIK3CB;CACTIN
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5965181766188182,-1.0443556347064284,0.4722222222222222,1.0,1.0,4/11,26.80%,CLU;TRIM32;TPT1;CDKN2D
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.5978182911933435,-1.0443477237281493,0.4444444444444444,1.0,1.0,3/10,15.29%,PARP14;PARP9;PARP4
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.6173852743983894,-1.0442871926591515,0.4264705882352941,1.0,1.0,3/8,15.18%,PRELP;OMD;OGN
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.6640426809432475,-1.0435839130981654,0.4838709677419355,1.0,1.0,2/5,26.94%,YME1L1;BNIP3
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.6181728725292852,1.0434563905438015,0.47058823529411764,0.8628111623875184,1.0,4/5,38.18%,CBLL1;GRB2;CBL;CTNNB1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5862824860102905,-1.043292561178313,0.4393939393939394,1.0,1.0,1/9,0.88%,IFIT1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.43543103543392286,1.0427909881506476,0.3333333333333333,0.8634940203349093,1.0,9/40,11.87%,EYA4;SPRED2;ATR;PLA2R1;SIRT1;EYA2;EGFR;TRIM28;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.5094232393334719,-1.0423234338137854,0.40476190476190477,1.0,1.0,15/46,29.57%,PSMB9;PSMB8;PSMA3;PSME1;PSMA7;PSMB6;RBX1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.5419673218631538,1.0422617439066464,0.42424242424242425,0.8641578767818842,1.0,1/7,2.77%,BCAR1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5254138651775573,1.0421083322107914,0.34375,0.8636566298883425,1.0,3/10,11.43%,GSTM2;PIK3CA;SLC8A1
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.5638955459296503,1.0418319017710644,0.4,0.8633853779672823,1.0,1/8,4.62%,SUV39H2
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.6775741266503073,-1.0415102451674283,0.53125,1.0,1.0,4/6,25.38%,PRELID1;ISCU;PARK7;IFNAR1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.5327733180807332,-1.0414844838956396,0.3950617283950617,1.0,1.0,3/22,9.94%,ITGA4;CACNB1;CACNA1B
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.4824241074951458,1.0411717102411964,0.43333333333333335,0.8642409601384301,1.0,6/14,20.31%,SCD5;ACACA;FASN;SLC25A1;MLYCD;ACSS1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.5365923663257924,-1.0409121727900947,0.38961038961038963,1.0,1.0,3/26,3.01%,TRPC5;FTH1;CP
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.42503677016146746,-1.0407007354829154,0.36082474226804123,1.0,1.0,64/265,23.15%,SRSF7;CRNKL1;POLR2I;RBM8A;POLR2G;LSM5;SNRNP27;SNRPA1;PNN;RBM4B;PDCD7;SNRNP25;DHX16;PRPF18;DDX5;SNRPD2;SNRPD1;UBL5;DHX38;PRPF8;SNRPB;CDC40;SRRM4;PRPF6;SRSF10;RNPC3;CACTIN;SRSF5;CSTF2;GTF2F1;CDK7;NCBP1;CSTF1;CASC3;PPWD1;SNRNP200;PRPF4;PRPF38A;HNRNPA2B1;DNAJC8;BUD31;SF3A3;UPF3B;MAGOHB;SRRT;PRPF31;THOC5;CHTOP;SMNDC1;SRRM2;LSM3;CWC15;WBP11;SYF2;RBM19;USP39;KIN;CWF19L1;SNRPG;SNW1;CPSF1;ALKBH5;SF3B5;PPIL1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.3646462160523016,1.040691829305832,0.25,0.8645850049754962,1.0,21/81,16.27%,PLD1;RIT2;MAPK11;PLD2;TNK2;KSR1;MAPK14;MAPKAPK5;RIN2;TRIM28;PRKD1;RAPGEF6;RRAS2;TIAM2;RAPGEF2;SOS1;ARL3;RGL1;CCDC88A;NRAS;RALA
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.601337467372094,-1.0405689938865845,0.43283582089552236,1.0,1.0,5/10,35.11%,RNF8;DTX3L;PAF1;RNF20;RNF40
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.6488333707787434,-1.0405611659715228,0.4307692307692308,1.0,1.0,5/6,31.42%,HAS2;MARS1;SYAP1;CORO1B;HYAL1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6160828736166611,1.0404443463106106,0.46511627906976744,0.8634988673412337,1.0,4/5,24.93%,FOXO1;KCNC2;MTR;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6160828736166611,1.0404443463106106,0.46511627906976744,0.8634988673412337,1.0,4/5,24.93%,FOXO1;KCNC2;MTR;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.5413293792514238,-1.040375260605427,0.4155844155844156,1.0,1.0,2/19,8.32%,ITGA4;CACNB1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.6257516090853974,-1.0402112333913114,0.4857142857142857,1.0,1.0,1/8,10.88%,MGST1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.7021530053935293,-1.039987807018084,0.5344827586206896,1.0,1.0,2/6,9.38%,HLA-F;CEACAM1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.42854914768758245,-1.0396309671340582,0.39361702127659576,1.0,1.0,52/225,21.06%,SRSF7;CRNKL1;POLR2I;RBM8A;POLR2G;LSM5;SNRNP27;SNRPA1;PNN;RBM4B;PDCD7;SNRNP25;DHX16;DDX5;SNRPD2;SNRPD1;UBL5;DHX38;PRPF8;SNRPB;CDC40;PRPF6;SRSF10;RNPC3;CACTIN;SRSF5;CSTF2;GTF2F1;NCBP1;CSTF1;CASC3;PPWD1;SNRNP200;PRPF4;PRPF38A;HNRNPA2B1;DNAJC8;BUD31;SF3A3;UPF3B;MAGOHB;SRRT;PRPF31;SMNDC1;SRRM2;LSM3;CWC15;WBP11;SYF2;RBM19;USP39;CWF19L1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.6005426524898657,-1.0393813619890508,0.4657534246575342,1.0,1.0,4/11,18.33%,XBP1;BHLHE41;BDNF;HDAC3
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.5991875443228514,1.039118110668942,0.43333333333333335,0.8657533181410777,1.0,5/7,27.53%,RBPJ;BMPR1A;NOTCH1;NRG1;TGFBR1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.47392563070028326,1.0390730036400506,0.41379310344827586,0.8650087798564988,1.0,4/12,6.23%,SLC26A3;TSPAN8;CREB3L1;CDON
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.4817827048623782,1.0389920283449545,0.42857142857142855,0.8643881657716754,1.0,2/13,2.45%,SOX11;TCOF1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.49593331573773947,-1.0389639017826644,0.42168674698795183,1.0,1.0,6/40,11.01%,PDCD1LG2;SELENOS;TRIM41;XBP1;MEF2C;CACTIN
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5265119389159763,-1.03871325917169,0.4318181818181818,1.0,1.0,14/30,25.29%,APEX1;ADPRS;RFC2;RPA3;PNKP;RFC1;RFC4;PARG;LIG1;RFC3;POLD2;MBD4;XRCC1;NTHL1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3584205726595529,1.0387086722402892,0.375,0.8641707560470528,1.0,10/65,8.59%,ZNF516;PDGFC;LEPR;ACACB;ESRRG;ACACA;IGF1R;HADH;FASN;ADIPOR2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.5526796589085702,1.0386905757385267,0.4,0.8633426484589695,1.0,2/7,6.96%,PLXNA1;PLXNA3
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.44876583834705897,1.0384584925816414,0.34782608695652173,0.8630394677975263,1.0,4/16,11.69%,IL15;PTPRC;PNP;HMGB1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6251744009760934,-1.0384509882019692,0.46153846153846156,1.0,1.0,2/8,19.57%,RPS27L;KAT5
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7053294041514837,-1.038425491576752,0.45161290322580644,1.0,1.0,2/5,18.86%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.4523999356977454,1.0383619299809352,0.3333333333333333,0.8624580542697828,1.0,2/22,4.13%,DHCR7;ACAA2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5087600606512558,1.0381091468998767,0.37037037037037035,0.8620344612652479,1.0,8/17,15.36%,HS6ST3;CSGALNACT1;UGDH;EXT2;EXTL3;HS2ST1;EXT1;NDST3
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.5766202337292193,-1.038103993920843,0.4520547945205479,1.0,1.0,2/10,11.25%,ZW10;NABP2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6549627085793038,-1.0380712610458922,0.5,1.0,1.0,3/7,31.73%,DONSON;ZRANB3;ZNF830
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.4597521310878167,1.0379581925881813,0.3333333333333333,0.8615247310101081,1.0,3/10,15.37%,CTBP1;NNMT;NIPBL
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.5314873548740546,-1.0374656896336314,0.5,1.0,1.0,3/23,4.17%,ITGA4;DVL1;AGRN
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4163469450648912,1.0373202038501022,0.3333333333333333,0.8620759085671296,1.0,12/34,14.86%,MAP2;WNT7A;ARC;WASL;CTNNA2;CHRNA7;KLF7;FARP1;BTBD3;SDC2;DOCK10;CTNND2
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.6769264306351265,-1.0372669949705435,0.4827586206896552,1.0,1.0,1/5,3.33%,NOL3
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.42329860119011636,-1.0369436360168427,0.3854166666666667,1.0,1.0,61/244,23.15%,SRSF7;CRNKL1;POLR2I;RBM8A;POLR2G;LSM5;SNRNP27;SNRPA1;PNN;RBM4B;PDCD7;SNRNP25;DHX16;DDX5;SNRPD2;SNRPD1;UBL5;DHX38;PRPF8;SNRPB;CELF4;CDC40;PRPF6;SRSF10;RNPC3;CACTIN;SRSF5;CSTF2;GTF2F1;NCBP1;CSTF1;CASC3;PPWD1;SNRNP200;PRPF4;PRPF38A;HNRNPA2B1;DNAJC8;BUD31;SF3A3;UPF3B;MAGOHB;SCNM1;SRRT;PRPF31;SRPK1;SMNDC1;SRRM2;LSM3;CWC15;WBP11;SYF2;RBM19;USP39;CWF19L1;SNRPG;DDX20;SNW1;CPSF1;SF3B5;PPIL1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.531184196475479,-1.0369099723796427,0.4675324675324675,1.0,1.0,3/26,11.90%,FANCB;POLQ;MAGEF1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.48156857219665716,-1.036648196945498,0.4367816091954023,1.0,1.0,9/35,19.43%,DXO;LSM5;SIDT2;NCBP1;RNASEH2C;SUPV3L1;ZFP36L2;NUDT12;RNH1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.6888818797666473,-1.036638239717199,0.47058823529411764,1.0,1.0,1/5,2.32%,SFRP1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6078290021500473,1.0365449308165195,0.5172413793103449,0.862869036376338,1.0,2/7,17.54%,PIKFYVE;ARL8B
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.5718736167410088,-1.036334130558814,0.4166666666666667,1.0,1.0,8/15,36.65%,UTP15;ATF4;HEATR1;UBTF;DHX33;FLNA;POLR2L;SIRT7
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5972887242190122,-1.0360817775772027,0.5205479452054794,1.0,1.0,1/12,3.53%,POLR2G
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5346596658956615,-1.0360187766384756,0.475,1.0,1.0,8/20,21.66%,RPS27A;RFC2;RPA3;UBA52;RFC1;RFC4;UBC;RFC3
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.49729239381723245,1.0359851582644386,0.4482758620689655,0.8632444173631562,1.0,7/13,23.98%,PKD2;BMP7;ROBO2;NIPBL;NF1;GDF6;GDNF
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.6241141103052716,1.0357280004375116,0.45454545454545453,0.863064667869584,1.0,2/5,19.71%,BBS4;UBR3
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.47099717241698014,1.0356223025819191,0.5555555555555556,0.8623660197030831,1.0,4/14,9.40%,SLC15A2;ABCC11;SLC29A4;ABCC5
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5425030664968039,-1.0356022586268685,0.4268292682926829,1.0,1.0,7/20,18.86%,RPL11;RPL23;GABARAPL2;EFNA1;RPS7;RPL5;HSP90AB1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.4831020008706559,1.0354389570370792,0.38235294117647056,0.8619108061399692,1.0,3/10,7.85%,CRB2;MYO7A;BBS4
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.5891394225292823,-1.0353877200848645,0.42857142857142855,1.0,1.0,1/11,5.88%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.6630177371816884,-1.035333748550842,0.4727272727272727,1.0,1.0,2/5,21.22%,HDAC6;TMEM39A
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.470729812322132,-1.0351540237785675,0.4050632911392405,1.0,1.0,10/36,18.36%,F13A1;NAAA;GPR34;PARP14;IGSF6;CPM;CHIT1;NR4A3;NRP2;MYO1F
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.6348775769191105,1.0345949664177583,0.5517241379310345,0.8631666726627112,1.0,1/6,23.27%,TASOR
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.46131046865989794,1.0343681769962356,0.2857142857142857,0.862953177657169,1.0,1/16,0.11%,PKP2
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.5458035443579692,-1.0343492481968748,0.4189189189189189,1.0,1.0,6/17,24.12%,BUD23;DIMT1;EMG1;NSUN5;FBL;MTERF4
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.4570254745557159,-1.0343020289485667,0.4482758620689655,1.0,1.0,9/52,24.12%,BUD23;DIMT1;WDR6;TRMT10C;TRMT5;NSUN5;PCIF1;FBL;MTERF4
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5680629232806224,-1.0341990498096632,0.475,1.0,1.0,1/14,0.75%,PPIF
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.4803030111368714,-1.0340042438600114,0.42696629213483145,1.0,1.0,7/56,10.02%,GOLGA8B;RAB11A;GOLGA8A;ABRAXAS1;TUBGCP2;TUBGCP4;SMC1A
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5203501284174875,-1.033780190854134,0.43373493975903615,1.0,1.0,6/23,27.99%,RPS27A;UBA52;UBC;XPA;RBX1;DDB2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.5007486252693282,-1.0337746293914767,0.43209876543209874,1.0,1.0,4/51,3.39%,IGFBPL1;PFN2;SEZ6L2;FGF1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5979575687218428,-1.0336546444403802,0.4722222222222222,1.0,1.0,4/15,16.49%,EMD;NUP155;NEMP1;TMEM43
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.593657813893133,-1.033628103758682,0.49295774647887325,1.0,1.0,2/12,5.88%,HES1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.6662176165066276,-1.0335792415887675,0.47761194029850745,1.0,1.0,1/5,15.55%,BEX4
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.5406984418482796,1.0333475818917428,0.4666666666666667,0.8646021613963678,1.0,4/10,17.75%,NDFIP2;PPM1F;TERF1;SNX3
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.6609682043046947,-1.0331040222561954,0.43859649122807015,1.0,1.0,5/6,33.71%,RSAD2;RARA;IL18;DENND1B;CD81
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.6770141739728583,-1.0329049375018784,0.43478260869565216,1.0,1.0,1/5,8.27%,TTN
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.5668131251150798,1.0327857456471128,0.375,0.8648527601446637,1.0,6/8,31.27%,LATS1;WWC2;WWC1;DUSP6;PTEN;DUSP9
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3935482392352117,1.0326451074182,0.38461538461538464,0.8644489677295264,1.0,17/53,17.19%,ESR1;RXRA;PPARG;FER;SRR;FOXO1;FOXP1;ERBIN;ALPL;TAB2;ADAM17;FOXO3;NOS1;ABCA2;RPS6KA3;SNCA;ACER2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.49643348811139265,1.0321036595921014,0.39285714285714285,0.8651462108158218,1.0,4/17,11.43%,SGCZ;DMD;PIK3CA;SLC8A1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.5542307450676653,1.032103649905391,0.40540540540540543,0.8643135388131117,1.0,4/7,18.48%,MAP4K4;IQSEC1;MAPRE2;MTOR
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.6018035648862237,-1.0315279694550064,0.44871794871794873,1.0,1.0,3/9,27.72%,PPAT;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5728288667800594,1.0313993589301769,0.48,0.8654556912930771,1.0,1/9,0.30%,IL15
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5697912230184407,-1.0310865146809831,0.4594594594594595,1.0,1.0,5/11,26.81%,CEACAM1;CD160;PHPT1;THY1;PTPN2
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5670964934196976,1.03086754118066,0.52,0.8658071183627152,1.0,5/6,19.20%,ATP2C1;ACSL3;CNST;PKDCC;CSK
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.38661270938917,1.0305240683087833,0.4375,0.8660551177353335,1.0,11/40,12.69%,RAB27A;SYTL4;SEPTIN4;STXBP5;IL1RAPL1;RAB27B;RAB9A;RAB10;NSF;STXBP6;CLASP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5108025739326969,-1.0304407244954727,0.4074074074074074,1.0,1.0,13/33,25.29%,RPS27A;RFC2;RPA3;FAN1;UBA52;RFC1;RFC4;UBC;RFC3;XPA;POLD2;RBX1;NTHL1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.5514048019602354,-1.030215429780939,0.43037974683544306,1.0,1.0,4/20,21.07%,PEX1;DNM1L;PEX11B;PEX14
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.4564431260671773,1.030121864291639,0.3157894736842105,0.866199986901911,1.0,6/17,22.96%,PDE4D;RAPGEF2;PEX5L;RASD2;CDC34;PRKAR1B
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.5744902926370791,-1.0301173145969913,0.4819277108433735,1.0,1.0,4/12,18.41%,PIGC;PIGH;PIGL;PIGG
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5099827094639998,-1.0300679322993633,0.375,1.0,1.0,3/23,9.38%,TRIM25;TMCO4;TMC4
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.40889730271691443,1.0298613048768528,0.42857142857142855,0.8660027241155661,1.0,11/33,13.20%,MAP3K5;ARHGEF6;TAB3;MAP3K11;MAP4K2;MAPK10;MAP3K7;TAB1;TAB2;UBE2N;MAPK8
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.41897379799302314,-1.0298161298757795,0.3838383838383838,1.0,1.0,40/461,10.33%,CD44;APIP;IFI6;GADD45B;PPIF;BEX2;VEGFA;RPS27A;DDRGK1;SFRP1;TFPT;VAV3;ECT2;RPL10;NOL3;STK17A;HMGN5;IFIT3;HTR2B;APEX1;RASGRF2;JUN;ARHGEF18;HAX1;CLU;RPS3A;AGT;COPS5;PRELID1;BCL2L14;ANGPTL4;OLFM1;CRYAB;XBP1;PTMA;SFRP4;MEF2C;OBSCN;MED1;APH1A
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.41829375887001474,1.02981364370949,0.2857142857142857,0.8652593951978761,1.0,23/106,13.26%,RIT2;HIP1;WFDC1;BCAR1;NRG3;SGK1;FAM107A;ABL1;CAMSAP2;SEMA4D;MLLT3;PICALM;METTL4;ABL2;DCUN1D5;OPHN1;LAMTOR2;NEDD4;CDH13;LATS1;BAG5;RAPGEF2;PACSIN2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.37608773613188834,1.0294671975948773,0.4,0.8653534294810502,1.0,22/94,11.75%,LRFN4;SHANK2;LRRC4C;NLGN4X;NLGN1;RYK;SDK2;GPC4;NRXN1;UNC13C;ADGRL3;APBB2;SLC8A2;NRCAM;UNC13B;LRFN5;CHRNA7;DNM3;LRRK2;NEDD4;PTPRS;FARP1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.48197587613255105,1.0292710632981865,0.4375,0.8650552780028472,1.0,5/13,22.02%,NUP98;NUP93;NUP35;NUP54;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5388139130872823,-1.0291695049182317,0.4864864864864865,1.0,1.0,4/16,17.91%,HAP1;CLU;APOE;RTN2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5562577362556976,-1.0290558651571637,0.4375,1.0,1.0,7/15,23.60%,PARP9;NAXE;QPRT;NUDT12;NMNAT3;NAMPT;NMNAT1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.5368514186116348,-1.0290158124464066,0.4666666666666667,1.0,1.0,3/19,16.91%,AGT;P2RX4;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6156613883928305,-1.028909805428984,0.5584415584415584,1.0,1.0,1/10,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.5994568034285487,1.028567212542501,0.4838709677419355,0.8660517841400297,1.0,3/7,36.79%,TASOR;INPP5K;TOP2B
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.609150444907377,1.0282815529371172,0.36666666666666664,0.8659406591247267,1.0,1/7,2.19%,PLOD1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.606555691772679,1.0279958160775255,0.46153846153846156,0.8657787606303314,1.0,3/6,15.10%,NTNG2;LAMB4;NTN4
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.5699308377617022,-1.0277177869864933,0.47297297297297297,1.0,1.0,4/15,19.61%,PPIF;PDCD5;BAX;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.6748305992958484,-1.0274441985589122,0.4782608695652174,1.0,1.0,2/6,13.77%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.6008938868540962,-1.0273799743560004,0.5,1.0,1.0,3/11,25.53%,AGT;AEBP1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.6567289706620592,-1.0273413566605882,0.5303030303030303,1.0,1.0,1/5,16.94%,ZFP36L2
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.536188950227783,1.027176412214499,0.375,0.8671113115053625,1.0,4/11,9.66%,CD247;CD96;GPR174;PTPRC
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.421284724236653,1.0269863099410195,0.4090909090909091,0.8667111296746989,1.0,3/23,3.74%,ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.5289483691219223,-1.026742237731719,0.5063291139240507,1.0,1.0,3/25,8.39%,VEGFA;RRAGA;XBP1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.48473433820438677,1.0267398836516686,0.5,0.8667014804055326,1.0,4/15,10.30%,MAP3K5;MAP3K11;MAP3K4;MAP3K7
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.3977912157515073,1.0265801596202355,0.1111111111111111,0.8662685856647261,1.0,12/85,9.13%,RANGAP1;HDAC9;PLOD1;KAT2B;HDAC10;SIRT1;SENP1;NUP98;ATPSCKMT;NUP93;NSMCE2;HDAC4
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.6823497182438525,-1.0264740061713051,0.4925373134328358,1.0,1.0,2/5,15.48%,ZNF598;RACK1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.3972561530156088,1.0260161112825998,0.3,0.8665807497245079,1.0,15/82,12.05%,VAPB;SMPD4;SGMS1;ACER3;CTSA;TEX2;PLA2G15;ESYT2;GLTP;SPTLC2;CERT1;VAPA;HEXB;PPM1L;PRKD1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.6328429131149499,1.025905277403205,0.45161290322580644,0.8659629058443811,1.0,4/6,26.42%,NIPBL;RUVBL2;MACROH2A1;LRWD1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.5808480835549704,1.0257335631601188,0.45714285714285713,0.86549817350351,1.0,2/7,10.79%,BBS4;SOX8
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.47264593572115843,-1.0256862596395129,0.4823529411764706,1.0,1.0,9/69,9.02%,PARP2;SCG3;IL12RB2;CFTR;PCSK1N;ZPBP;CCT6B;ZC2HC1C;SCG5
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5048452644693604,-1.0256687451992408,0.4880952380952381,1.0,1.0,10/37,13.93%,PSMB9;SERPINE3;PSMB8;AGT;PRELID1;GAPDH;APH1A;PSMA3;SERPIND1;PSME1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.5763328537649856,1.025622955642714,0.4,0.8649668535072309,1.0,4/6,18.48%,MAP4K4;IQSEC1;MAPRE2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.669866965608291,-1.025471061481306,0.5573770491803278,1.0,1.0,2/5,14.15%,NOXA1;DVL2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.4755989279871632,1.025093909177492,0.3548387096774194,0.8656497812105329,1.0,4/17,12.47%,NSMCE2;TGFA;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.5616735399798681,-1.0250938603383482,0.49382716049382713,1.0,1.0,3/12,8.86%,VEGFA;TTN;OBSL1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5500016628227482,1.0249344961661202,0.4,0.8652539984222657,1.0,3/5,18.42%,LRRK2;D2HGDH;PRKN
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.47729649752105174,1.024672011305136,0.45454545454545453,0.8649598747967994,1.0,5/23,12.48%,ARFIP1;STXBP5;NDFIP2;DISP1;PPM1F
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.449965869690243,-1.024650338794319,0.4659090909090909,1.0,1.0,22/82,24.08%,SRSF7;RBM8A;NUP155;DHX38;CDC40;SRSF5;NCBP1;CASC3;HNRNPA2B1;SEC13;UPF3B;MAGOHB;THOC5;CHTOP;NUP107;MCM3AP;CPSF1;NUP188;NUP85;ALKBH5;SRSF2;SLBP
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.4313843749944499,1.02442747420883,0.5217391304347826,0.8647503201472092,1.0,5/22,11.05%,ABL1;MAP2;CAMSAP2;CHRNA7;PIK3CA
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5286843321783845,-1.0242170549551728,0.4567901234567901,1.0,1.0,5/24,15.99%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.6880375850871046,-1.0240838356599324,0.5,1.0,1.0,1/5,13.23%,GALE
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.6968044095932264,-1.0240293117578871,0.5614035087719298,1.0,1.0,2/5,16.59%,VDAC1;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5391430509055586,-1.023859940607959,0.44155844155844154,1.0,1.0,4/16,12.74%,TGFB1;CEMIP;CALM1;WNK3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5037967434604135,-1.0235054119008484,0.44594594594594594,1.0,1.0,8/24,19.36%,NOP10;ZBTB48;GAR1;TELO2;RFC1;DKC1;HSP90AB1;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.3867755810111126,1.0229643780159252,0.4166666666666667,0.8676635802672469,1.0,6/44,10.30%,FYCO1;GPSM1;SIRT1;SESN1;SPTLC2;MAP3K7
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.4525161405462933,1.0229258279184996,0.45454545454545453,0.8669655069842713,1.0,2/19,1.90%,KCNJ6;NEDD4L
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.5362251467682014,-1.0226810428263702,0.42857142857142855,1.0,1.0,2/20,3.39%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.6346436664720865,1.0226343240829898,0.47058823529411764,0.8667546594067574,1.0,1/5,5.45%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.48022539997928687,-1.0221569819042367,0.45121951219512196,1.0,1.0,10/46,25.95%,ECT2;TGFB1;ZIC1;PARP9;CCT7;DKC1;HDAC3;PARK7;DTX3L;RBM22
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.48679485051243965,-1.022109779147031,0.47058823529411764,1.0,1.0,13/38,21.77%,FANCB;RPS27A;FANCI;RNF8;CENPX;RPA3;FAN1;FANCC;UBA52;UBC;MSH6;ATRIP;XPA
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.359860611079074,1.0214638172799464,0.4444444444444444,0.8690049820412141,1.0,10/45,13.18%,SNX31;EHD1;ANKRD50;SNF8;EPS15;SNX27;LMTK2;VPS50;RAB11FIP4;WASHC1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.5970744366560277,-1.021317493970035,0.47761194029850745,1.0,1.0,3/12,12.64%,NAAA;DEGS2;CALM1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.38798708454323133,1.021220443201433,0.25,0.8687257211703493,1.0,38/134,19.44%,PLD1;ABHD3;DGKB;INPP4B;PTPN13;PLD2;SYNJ1;SLC44A1;STARD7;GPD1L;ETNK1;ABHD8;PIKFYVE;SLC44A5;CDS1;AGPAT5;PIK3CA;DGKQ;PCYT1B;MTMR3;GPAT4;OCRL;CDS2;MTM1;FIG4;PIP5K1B;ABHD5;PCTP;ACHE;PITPNM2;LPCAT1;DGKG;FAR1;CEPT1;DGKE;MTMR8;PIK3R1;LCLAT1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.5790479092561258,-1.0210738603711422,0.44,1.0,1.0,5/15,9.60%,GSTM4;ALOX5;GPX4;ALOX12;EPHX2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.4254307355260798,1.0210640324202944,0.5,0.8683133143383746,1.0,6/26,11.71%,ACACB;ACOT9;ACACA;GLYAT;GPAT4;THEM4
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.5437409155275172,-1.02102154725864,0.4383561643835616,1.0,1.0,2/18,3.03%,VEGFA;TACR1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3059101084644187,1.0210095552043104,0.2,0.8676178983354211,1.0,69/321,15.60%,TP63;HDAC9;DPF1;NR1H2;NPAS1;SALL1;HDAC10;SP3;ATF7IP;SUV39H2;TSHZ3;ZKSCAN3;SIRT1;CREB3L1;MBD2;PPARG;PTPRK;BTRC;LIMD1;CTBP1;ZHX2;TLE1;KCTD1;RUNX1T1;FOXK1;PSPC1;PLCB1;RFX3;FOXO1;MTERF3;FOXP1;PHC2;YAF2;SMARCA2;ATXN1;BMP7;EED;TRERF1;PRDM11;RSF1;FBXW11;ATOH8;HDAC4;MECP2;PML;PROX1;KAT8;ZNF282;ZFPM2;SOX8;ZBTB16;RBM15B;TRIM28;ZNF93;PPM1F;NKRF;PRDM16;NR3C1;NAB1;NFIL3;NACC1;ZHX3;CHMP1A;GLIS2;BCOR;ZMYND11;NIPBL;MTA3;TCF7L2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.5385165711768908,-1.020906485630237,0.4605263157894737,1.0,1.0,4/19,13.60%,DVL1;AGRN;CACNB1;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.45870079180610274,1.020889982536118,0.36666666666666664,0.8672740072423272,1.0,8/13,27.54%,PPARG;ZBTB20;EEF1A2;MTOR;SIRT4;PPARD;CREB1;SORBS1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.3606620376290594,1.0208800088903216,0.375,0.8664808894027227,1.0,17/79,19.44%,INPP4B;PTPN13;SYNJ1;PLCB1;MTMR10;PIKFYVE;CDS1;PIK3CA;MTMR3;OCRL;MTM1;FIG4;PIP5K1B;PITPNM2;MTMR8;PIK3R1;LCLAT1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.36815567819080086,1.0207930950919184,0.375,0.8658224214174898,1.0,35/136,13.79%,RIT2;CHRM3;GABRG1;GABRR1;KCND2;NLGN4X;NLGN1;KCNQ3;HOMER1;GRIK2;CHRNB3;PDE7B;DOC2A;NRXN1;UNC13C;MAPK1;NOVA1;GRIA1;SLC1A2;UNC13B;KCNC4;CHRNA7;GLRA1;GRIA3;DLG2;GRIN2B;PRKACB;APBA1;GABRG3;KCNIP2;GRIK4;GABRB1;KCNQ2;DLGAP1;GABRA1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.6101498956307481,-1.0205994114539125,0.4805194805194805,1.0,1.0,2/8,20.10%,SELENOS;WFS1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5050294162625208,-1.020521128048543,0.4457831325301205,1.0,1.0,12/31,25.29%,RPS27A;RFC2;RPA3;UBA52;RFC1;RFC4;UBC;RFC3;XPA;POLD2;RBX1;NTHL1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4161463024673232,1.020409902058811,0.44,0.8658636725180516,1.0,5/26,15.79%,DOCK5;ABL1;RAC3;NRP1;ARHGEF7
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.6546018379215913,-1.020390275947934,0.4931506849315068,1.0,1.0,1/8,3.84%,HES1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.5900433907463403,1.020283398411189,0.4782608695652174,0.8653897734007329,1.0,3/6,29.32%,PTAR1;RABGGTB;PGGT1B
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.6025326019151898,-1.0196950948488597,0.5714285714285714,1.0,1.0,3/8,18.66%,CNMD;COL15A1;POF1B
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5073709210723354,1.0192823125067623,0.52,0.8671909305985597,1.0,6/11,17.29%,SLC26A3;ATG16L1;DLL1;RAP1A;KLF15;FBP1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.5415165407821589,-1.0189509042416016,0.49382716049382713,1.0,1.0,3/24,8.00%,SFRP1;DDX5;HDAC6
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.4472218332532471,-1.0186792216181877,0.45454545454545453,1.0,1.0,22/84,24.08%,SRSF7;RBM8A;NUP155;DHX38;CDC40;SRSF5;NCBP1;CASC3;HNRNPA2B1;SEC13;UPF3B;MAGOHB;THOC5;CHTOP;NUP107;MCM3AP;CPSF1;NUP188;NUP85;ALKBH5;SRSF2;SLBP
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.5493848735332684,1.0186287807233763,0.38235294117647056,0.8672043090937686,1.0,3/8,17.03%,PDE4B;ATP2B4;SNCA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.5493848735332684,1.0186287807233763,0.38235294117647056,0.8672043090937686,1.0,3/8,17.03%,PDE4B;ATP2B4;SNCA
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.5365356597381303,-1.0184684530684274,0.47297297297297297,1.0,1.0,1/16,1.80%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.6531447805301965,-1.0183560562377159,0.5194805194805194,1.0,1.0,2/6,18.76%,APOE;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.47139716821666156,-1.0180067411912517,0.43023255813953487,1.0,1.0,7/57,10.39%,PPIF;SCG2;NOL3;RTKN2;CLU;PRELID1;BDNF
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.48209952044872706,1.0178664941826967,0.47619047619047616,0.8685187156078873,1.0,3/23,12.17%,SGCZ;ADCY6;MYOF
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.4247552529842021,-1.017596181364006,0.4105263157894737,1.0,1.0,28/179,20.43%,ELOB;POLR2I;TAF7;GTF3C6;TFAM;POLR2G;NFE2L3;TAF11;POLR3H;POLR1C;DDX5;XBP1;PTMA;GTF2F1;CDK7;NCBP1;SMARCA5;GLIS3;PPP5C;ATF4;CTDP1;TAF9B;CEBPD;DRAP1;CCNK;NFIC;RTF1;MMS19
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.5618526620545926,-1.0172146707770247,0.5205479452054794,1.0,1.0,1/11,3.78%,CDKN1C
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.40234951444533046,1.016709313760641,0.3181818181818182,0.8702772192625721,1.0,11/30,20.79%,PRR5L;EHD1;PCM1;NEDD4;PCNT;CEP290;STX18;RIPOR1;TENM1;RAB29;B3GAT3
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.4554251083704016,1.0166190212988215,0.4,0.8698183892646841,1.0,4/23,10.11%,RXRA;STARD3;FDX1;OSBPL5
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.47397027380757034,1.0165956381773755,0.4074074074074074,0.8690467622644873,1.0,2/16,3.27%,NLGN1;PCLO
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.5524969754805664,-1.016559314372986,0.5142857142857142,1.0,1.0,5/14,23.60%,PRPSAP1;PPAT;NMNAT3;MTHFD1;NMNAT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.5851481008121335,1.0163028679712989,0.45161290322580644,0.8689197660350945,1.0,1/6,0.30%,IL15
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.58880668740393,1.0159372976736052,0.5128205128205128,0.8691060710171057,1.0,2/6,3.53%,FAM107A;ABL1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.41550287188741375,1.015581461902669,0.4666666666666667,0.8692261842887224,1.0,7/22,19.37%,IRS1;C2CD5;ARPP19;OSBPL8;BRAF;AKT2;PIK3R1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5294145524915304,-1.015571351825187,0.4868421052631579,1.0,1.0,8/20,21.66%,RPS27A;RFC2;RPA3;UBA52;RFC1;RFC4;UBC;RFC3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5270458917089835,-1.0151874476481073,0.5616438356164384,1.0,1.0,4/18,18.29%,TGFB1;TMBIM1;PPP2R5A;LZTFL1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.6659443772275768,-1.015140293921457,0.515625,1.0,1.0,1/5,5.35%,PDE6B
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.43378777251200895,1.0143181205617038,0.42105263157894735,0.8715499501971373,1.0,6/21,11.27%,YLPM1;PML;ERCC4;SIRT6;SMG1;HNRNPD
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.6278934869448244,-1.0140364421864245,0.4918032786885246,1.0,1.0,5/6,34.99%,ADPRS;CCS;SOD2;MT3;SOD1
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.45841696729896053,-1.013467162896334,0.5287356321839081,1.0,1.0,25/74,26.69%,RARRES2;CRYAB;ASPN;RNASE1;PAMR1;GSTM3;COL15A1;COL6A1;LMOD1;ACTA2;COL4A1;MYLIP;MYLK;RASD1;THBS2;SAT2;CYP1B1;CALD1;COL14A1;MATN2;TPM4;COL4A2;PDGFRB;EPHX1;C1S
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.5118494553319155,-1.0132367972507779,0.4605263157894737,1.0,1.0,6/25,18.01%,PRPF8;PRPF6;SRSF10;PRPF4;SF3A3;SMNDC1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.5913073300930575,-1.013146185187028,0.45714285714285713,1.0,1.0,1/10,6.01%,BLOC1S2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.5913073300930575,-1.013146185187028,0.45714285714285713,1.0,1.0,1/10,6.01%,BLOC1S2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.666502437768091,-1.0131443746952766,0.543859649122807,1.0,1.0,1/5,5.97%,PNRC2
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.48689345457631317,1.0130491363742689,0.5416666666666666,0.8739844583480608,1.0,5/12,24.86%,NSF;KIF16B;SNCA;RAB29;LAMTOR1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.47324407473477215,1.0127978907520707,0.4583333333333333,0.8736893381764459,1.0,3/24,3.76%,SOX11;HOMER1;GRIK2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.5383636828914669,1.0127774333356914,0.5,0.8728863148876808,1.0,5/10,22.74%,TGFBR2;ACVR1;BMPR1A;MDM4;NOTCH1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5365220074333716,1.0125565686792377,0.40540540540540543,0.8725435858829399,1.0,5/9,22.03%,LIG4;HMGB1;DCAF1;TCF3;HMGB2
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.5111740219956693,-1.0124132121514584,0.4567901234567901,1.0,1.0,2/22,6.96%,PDE6B;RBM4B
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5426612125417046,-1.0121462867497417,0.4857142857142857,1.0,1.0,7/23,25.81%,HES5;JUN;NR4A3;STAT1;ID2;IL18;PDGFRB
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.5060232403669256,1.0119836353281635,0.34615384615384615,0.8731346542327726,1.0,1/14,1.26%,HSPA1A
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.44309514299253855,1.0117709247680908,0.36363636363636365,0.8728741077429665,1.0,5/21,16.14%,SMPD4;SGMS1;SPTLC2;CERS6;FA2H
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.40914350138442973,1.0117251499033972,0.5,0.8721074552652273,1.0,15/54,18.94%,SH3RF1;UBE3D;OBI1;UHRF2;RAD18;SH3RF3;MARCHF7;TRIM71;RNF11;MARCHF5;RNF4;UBE2D2;PRKN;RNF185;TRAF2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3291876398101112,1.0116934771822605,0.3125,0.8713422056282525,1.0,13/65,11.13%,PDGFC;PTPN13;SEMA4D;GAB1;SIRT1;IGF1R;MAPK1;EGFR;MAPK3;UNC5B;ROR2;PIK3CA;NEDD4
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.5682472164650978,1.0113547958670688,0.42857142857142855,0.8713939309003895,1.0,2/6,4.78%,IL15;SIRT1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.5134284568414966,1.0109999924398803,0.5185185185185185,0.8714618583190852,1.0,3/9,7.87%,ATR;POT1;TNKS
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.6382157899235598,-1.0102440920301772,0.5846153846153846,1.0,1.0,4/7,30.33%,WIZ;DBF4B;DBF4;CDC7
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.4592670713067092,1.0101683019484968,0.47058823529411764,0.8727670749924616,1.0,3/20,7.60%,IRS1;RPS6KB1;KANK1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.5299702043396254,-1.0099126125051787,0.45569620253164556,1.0,1.0,3/11,18.86%,RANGRF;RIC3;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.4737894563431728,1.0096213825914324,0.4090909090909091,0.8732402996096238,1.0,4/17,3.54%,BCO1;SLC26A3;TSPAN8;TOX3
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.5906451793558982,1.0094435934196055,0.5666666666666667,0.872786292798999,1.0,2/6,23.37%,FYN;NECAB2
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.44944775713791796,1.008740215502456,0.5416666666666666,0.873518435659449,1.0,2/25,0.46%,CRB2;SPOCK3
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.5770501565685656,-1.0086411687211514,0.4935064935064935,1.0,1.0,3/13,17.71%,VAV3;MEF2C;IL7
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.591396423128865,1.0084502177415033,0.5,0.8736165680419622,1.0,1/5,7.85%,BBS4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.522151074886263,-1.0083334123570493,0.4794520547945205,1.0,1.0,2/14,9.68%,ITGA4;MEF2C
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.41743218786259145,1.008257766143765,0.42105263157894735,0.873276911239676,1.0,2/19,4.11%,ATR;LIG4
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.5855019505909346,-1.008246783138075,0.5061728395061729,1.0,1.0,4/13,16.04%,TMEM50A;TMEM50B;LEPROTL1;CHMP4B
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.5552915541740329,1.008230918667892,0.4634146341463415,0.8725330432649372,1.0,1/7,4.80%,TOX
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.6306723736295231,-1.0082091970306353,0.5068493150684932,1.0,1.0,1/7,12.98%,ATP6V0A4
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.6507591838757998,-1.008028480919124,0.5483870967741935,1.0,1.0,2/6,15.54%,HTR2B;ACTA2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.4283855365100524,1.007935186834387,0.5416666666666666,0.8724214826120111,1.0,2/21,4.06%,SOX11;DSCAML1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.4457934694034057,-1.0066843431413521,0.48314606741573035,1.0,1.0,8/56,11.20%,TREH;A2M;FGF1;ENPP2;CFTR;AGT;SST;HTR4
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.54487000697452,1.0066553842381618,0.5161290322580645,0.8747508531875405,1.0,3/8,17.32%,GALNT16;GALNT13;GALNT11
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5140275261887836,-1.0065300181131043,0.5061728395061729,1.0,1.0,12/36,24.08%,HLA-F;HLA-C;IFI35;IRF1;TYMP;CD55;TAP1;MMP25;MAPK13;IFIH1;KIAA0040;JUNB
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5332041084137372,-1.0065160980268317,0.5384615384615384,1.0,1.0,5/23,11.33%,CFTR;OVOL2;JAG1;TMC4;EFNA1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.5730816435182103,-1.0063997688638553,0.4605263157894737,1.0,1.0,1/15,1.81%,DXO
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5679768110774062,-1.0062185908202679,0.5072463768115942,1.0,1.0,2/15,13.74%,STX19;STX1B
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.664828078576627,-1.005923248733122,0.5230769230769231,1.0,1.0,1/6,3.84%,HES1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.44283351815691974,-1.0057945292335753,0.5,1.0,1.0,9/78,10.45%,SLC28A2;TACR1;IFNGR2;SELENOS;IRF1;RASGRP1;HAS2;GPC3;OSMR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.48085218548238173,1.0056147300996388,0.4827586206896552,0.8767368757425318,1.0,4/10,12.66%,PLXNA1;PLXNA3;SEMA3A;NRP1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.34028830865602644,1.0052962880907743,0.42857142857142855,0.8768154312395078,1.0,22/91,13.75%,RIT2;EPHA3;STYXL1;PLXNA1;TOX;IL1RAPL1;ROBO1;MAGI2;PLXNA3;ZNF804A;ABL2;ROR2;RELN;LRRC7;FUT9;FBXW8;PRKD1;ROBO2;CAPRIN1;TIAM2;RAPGEF2;TENM3
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.43713865591640144,1.0050570042097684,0.39285714285714285,0.876555325550813,1.0,8/25,13.79%,GABRG1;INSYN1;GRID2;GLRA1;LRRK2;GRIN2B;GABRG3;GABRA1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5965612179568337,-1.0049790530552545,0.5342465753424658,1.0,1.0,5/10,27.23%,ATF4;RACK1;NR4A3;PARK7;NONO
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5521066304978962,-1.0048848240382726,0.47560975609756095,1.0,1.0,5/14,22.65%,TGFB1;ATF4;C3;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.6133400293192353,-1.0048810376866362,0.5588235294117647,1.0,1.0,2/6,14.24%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6312067899297535,-1.0048069125364378,0.5166666666666667,1.0,1.0,1/8,4.29%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.4582143741462905,1.0047395834088737,0.47619047619047616,0.8766661139370033,1.0,1/9,0.87%,ASXL3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.6696308353876714,-1.0045770087634334,0.45614035087719296,1.0,1.0,2/5,25.98%,BRCA1;SPHK2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.480286906320129,-1.0044489069091207,0.48314606741573035,1.0,1.0,7/31,19.05%,EIF2B2;SELENOS;XBP1;KHK;ZBED3;RACK1;PDK3
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5188065721453399,-1.0044025837623525,0.5333333333333333,1.0,1.0,4/22,17.10%,RHBDF1;EFNA1;PSME1;APOE
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.5954437204240687,-1.004313812132795,0.5147058823529411,1.0,1.0,2/9,18.35%,BTBD18;MAEL
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.4858738934346694,1.004184570993084,0.5142857142857142,0.8771146112905258,1.0,3/13,11.55%,AGMO;PLA2G15;GPAT4
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.5217836915185532,-1.0041750393039472,0.5569620253164557,1.0,1.0,3/25,9.68%,SFRP1;HTR2B;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.4450621832815777,1.003917220272682,0.5714285714285714,0.8769031682505631,1.0,5/27,9.13%,BANP;SF3B3;FMN2;EGFR;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3555857286517351,1.0038234596099789,0.38461538461538464,0.8762744957411197,1.0,7/43,8.59%,HSPA1A;BAG2;ABL1;PRMT3;SMAD7;GNL3L;MARCHF7
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.36067833104913294,1.0037976932942887,0.6,0.8755667165229438,1.0,48/144,16.82%,RIPOR2;DPYSL5;ERC2;CSRNP3;ADGRB3;NLGN1;ASTN1;ZNF536;ISOC1;MAP2;CADM2;CNTNAP2;TMEM170B;ADGRL3;ANK2;NOL4;GRID2;NOVA1;WRAP73;AATF;GNL3L;EDIL3;SLITRK5;CLVS2;ABCC5;RELN;DNM3;FUT9;TMEM200C;SLC35F1;TBCK;GALNT13;KIF1B;MEGF10;KCNQ2;MAPK8;ADCYAP1R1;SMAD1;ATRNL1;FLRT3;FSD1;GPM6B;CAMKV;NBEA;ACHE;PURG;CDH4;FAXC
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.4465716676207484,1.0037233940526302,0.3684210526315789,0.8749564075335113,1.0,7/21,16.55%,SHROOM2;FAM107A;PAWR;SHROOM1;EPS8;ADD2;MICAL1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5317851794338775,-1.0029193850670877,0.5375,1.0,1.0,5/21,9.78%,HES5;VEGFA;HES1;PARP14;PARP9
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.48545393075016163,-1.0028943087887814,0.4880952380952381,1.0,1.0,16/50,29.57%,PSMB9;PSMB8;PSMA3;NABP2;PSME1;PSMA7;PSMB6;RBX1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.40326708669757877,1.002612241571634,0.47368421052631576,0.8766378644010638,1.0,4/22,10.60%,ZDHHC2;GPC4;SPTBN1;GPC1
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.5351317750235537,1.0025656542454564,0.4166666666666667,0.875995680853828,1.0,2/6,13.34%,SOX5;LTBP3
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.4834431211065974,-1.0024480820509856,0.5111111111111111,1.0,1.0,21/62,24.33%,SGCA;EMD;SSPN;CRYAB;TTN;MYL6B;MYL12B;GAMT;CALM1;LMOD1;TMOD3;ACTA2;SNTB1;CHRNE;MYLK;UTS2;VCL;ACTN2;CALD1;TPM4;MYL6
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.5803499391038275,-1.0024077208610416,0.4810126582278481,1.0,1.0,1/11,5.88%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6447502014683587,-1.0018318880874335,0.5757575757575758,1.0,1.0,2/5,11.23%,TGFB1;CST3
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.3514077738561179,1.0017995034675995,0.625,0.8769216647507062,1.0,33/134,11.13%,TAFA1;ASXL3;ZDHHC2;CSRNP3;LRRC4C;ADGRB3;RGS7BP;ASTN1;ZNF536;PCLO;STXBP5;MAP2;CADM2;TOX;NRXN1;ADGRL3;ANK2;LSAMP;GCNT2;NOVA1;GUCY1A2;MAPK10;TAFA5;KCTD16;CACNA2D1;CNTN1;CLVS2;CA10;PLEKHA5;ADGRA1;TSHZ1;PIK3CA;AHDC1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5813997099132343,1.0016053369443816,0.4411764705882353,0.8767117195154165,1.0,5/8,24.33%,DCUN1D2;DCUN1D5;DCUN1D1;DCUN1D4;NAE1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.5118428526812573,-1.0012083926475683,0.4819277108433735,1.0,1.0,3/25,8.00%,SFRP1;EMD;HDAC6
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.5101174577640476,-1.001154092525355,0.5285714285714286,1.0,1.0,5/18,23.78%,OAS3;OAS1;IL7;EIF2AK2;IL18
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.600150983339427,-1.0009556659458239,0.5652173913043478,1.0,1.0,1/8,8.58%,SFRP4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.668749246911964,-1.0007777940163587,0.5735294117647058,1.0,1.0,2/6,23.37%,PRKCQ;RARA
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5319167884902014,-1.0007406127907021,0.5405405405405406,1.0,1.0,1/19,0.94%,RPS23
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.4831907923533986,1.00058255636245,0.35,0.8784334744720793,1.0,5/17,22.77%,LIMD1;MOV10;CELF1;CNOT7;TNRC6C
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4720360577048839,-1.000516617689178,0.43023255813953487,1.0,1.0,24/68,29.89%,PSMB9;PSMB8;DVL1;AP2A1;PSMA3;DAAM1;PSME1;DVL2;SAPCD2;PSMA7;PSMB6;AP2A2;DVL3;PSMC4;CELSR2;PSMB1;PSMD2;PSMB3;PSMC3;FZD6;PSMC5;PSMD7;PSMA4;AP2S1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.3996779686114875,1.0005134230417474,0.6190476190476191,0.8778398231207286,1.0,17/64,15.98%,GALNT7;POGLUT2;PLOD1;LARGE1;TMTC1;TRAK1;GALNT16;C1GALT1;POFUT1;GALNT8;POMK;GALNT13;ST3GAL4;CRPPA;TET2;TMTC2;B4GALT5
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.6483897231595088,-1.0004871538140978,0.5211267605633803,1.0,1.0,1/6,6.22%,SPINK5
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.49859412180954477,-1.0003768997142481,0.47368421052631576,1.0,1.0,7/21,19.36%,NOP10;GAR1;TELO2;RFC1;DKC1;HSP90AB1;TERF2IP
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.5839527098419703,1.0002529275503445,0.46153846153846156,0.8777092847447828,1.0,3/6,12.66%,FZD3;SEMA3A;NRP1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.31975870348866076,1.0000472635555415,0.5,0.8774197928153071,1.0,23/95,14.86%,KCNJ6;DPYSL5;ERC2;NOVA2;CSRNP3;ASTN1;HS6ST3;NRXN1;NOL4;SLC8A2;CHD5;NXPH1;CLVS2;LONRF2;SRCIN1;ADGRA1;GRIK3;LHFPL4;KCNQ2;TTBK1;ADCYAP1R1;ATRNL1;CTNND2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.6202385601043192,-1.000019358693909,0.5423728813559322,1.0,1.0,1/6,17.90%,ADAR
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.2925876082361161,1.0,1.0,0.8745380086767535,1.0,64/324,14.81%,RIT2;MAPK11;TP63;RACGAP1;BARD1;DAPK2;BANP;RMI1;ARAP1;RPA1;ARHGEF6;ATR;NLGN1;STYXL1;TAF3;SGMS1;SRGAP1;ZFAND6;SGK1;BOP1;TRAF1;PTPN13;RICTOR;FGD4;ARHGAP28;SLC15A2;HSPB1;MAPK1;TP53INP1;MAP2K6;ARAP2;FAM13A;EGFR;OPHN1;PRDM11;MAPK14;MAPK3;RAC3;ARHGAP20;MAPKAPK5;PML;XIAP;LRRK2;MOB3B;NF2;MLST8;TBCK;AKAP7;MAP4K4;OCRL;STARD13;TTI1;TIAM2;RHOT1;RAD1;ARHGAP22;ARHGEF12;TRAF5;ARHGEF11;MBD3;JMY;SOS1;PIP5K1B;PEX5L
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.2406668519645542,1.0,1.0,0.8745380086767535,1.0,271/1410,16.35%,MYRFL;ONECUT1;EBF1;ZNF761;SOX11;TCF7L1;ZNF358;TRPS1;POU6F2;ZNF280D;TP63;ZNF516;HDAC9;CREM;ZNF280B;SMAD9;CSRNP3;MAP3K5;RYBP;ZNF189;ERBB4;SATB2;ESR1;ZNF98;PBX3;RXRA;TCF12;ZNF536;ZBTB34;DPF1;ZBTB1;SIM2;NR1H2;ZNF79;NPAS1;SALL1;NFYC;GPBP1L1;ABL1;TOX3;ETV3;HDAC10;DMTF1;SP3;ATF7IP;ZXDB;NDP;HP1BP3;LCOR;MED24;ARID1A;PBX1;TCF4;MYCN;PKNOX1;ZNF354B;SUV39H2;TSHZ3;ZKSCAN3;SIRT1;BBX;TOX;CREB3L1;ZBTB41;VEZF1;MBD2;PPARG;PPM1A;CHD7;ESRRG;WNT7A;PTPRK;BTRC;KLF12;LIMD1;MLLT3;CTBP1;SMAD7;ZNF2;ZNF283;ZHX2;ZNF268;TLE1;BCL11B;TBL1XR1;KCTD1;IKZF2;APBB2;RUNX1T1;TP53INP1;FOXK1;ZNF696;PSPC1;PLCB1;RFX3;MEIS1;MED12L;PLAGL2;ZNF678;ZNF221;FOXO1;MTERF3;NCOA2;FOXP1;PHC2;YAF2;ZNF697;PHF14;PICALM;ZEB2;ZBTB40;METTL4;CHD5;BAZ2B;TRAK1;TGFBRAP1;SMARCA2;ATXN1;SNF8;AATF;KDM3B;ARID1B;EGFR;NPAS3;BMP7;ATP2B4;ZNF676;SOX5;NFIB;EED;ZBTB5;RORA;CAMTA2;TRERF1;SUPT20H;ZNF239;PRDM11;ZBTB20;ZBTB10;NFATC1;KAT2A;RSF1;AFAP1L2;MAPK14;FBXW11;ZKSCAN7;ATOH8;HDAC4;BAZ1B;RFX7;MECP2;ZNF595;CBFB;BRWD3;POFUT1;PML;ZNF444;PROX1;ZNF415;KAT8;ZNF433;MITF;ZNF701;TGFA;PHF20L1;NFIA;ZNF282;ZNF175;ZFPM2;SOX8;ZBTB16;SPIN1;TSHZ1;RBM15B;SLC39A8;DGKQ;TRIM28;ST18;ZNF699;HNRNPD;ZNF250;CAND2;CDK14;KLF7;ZNF93;HMGB1;ZNF557;ERC1;ARID3A;ZMIZ1;NFATC3;ZNF717;ZNF608;MYRF;PPM1F;PRRX1;IRF2;SLTM;NKRF;PRDM16;ACVR1;CDK18;ZNF730;ZNF266;KDM5A;SOX10;CNOT2;JMJD1C;LCORL;MAGED1;SUB1;ELP3;ZSCAN23;NR3C1;NAB1;RAI1;SMAD1;NFAT5;NAA16;FOXO3;ZNF710;NFIL3;ARHGEF11;ZNF34;MXD4;HOMEZ;PRDM2;NACC1;ZHX3;JMY;ZNF527;CHMP1A;GLIS2;BCOR;MAP3K2;MRGBP;KLF6;PSRC1;ZNF16;NOS1;MAP2K2;ZNF519;ZNF561;ZMYND11;ZSCAN12;CHD2;NIPBL;SP1;CEP290;WWC2;ZNF32;MTA3;TCF7L2;ETS2;TEAD1;FOXN2;ZNF630;ABCA2;ZNF704;SSBP2;KLF15;RPS6KA3;IGSF1;ZNF496;HDGFL3;PURG;ZBTB37;NLK;VHL;TRIP4;IKBKB
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2591351937462199,1.0,1.0,0.8745380086767535,1.0,50/262,16.00%,MAPK11;FLRT2;SPRED2;PDGFC;EPHA3;ERBB4;IRS1;ZFYVE27;BCAR1;HNRNPH1;RYK;GAB1;FER;MERTK;IGF1R;TNK2;MAPK1;PLCB1;FOXO1;EGFR;ABI1;MAPK14;WASL;MAPK3;ROR2;ATP6V1A;PTBP1;PIK3CA;GRIN2B;SH2B2;LMTK2;PRKD1;MTSS1;SDC2;FRS2;NRP1;TRIM71;RAPGEF2;PTPRG;VEGFD;GTF2F2;FLRT3;NCKAP1;SOS1;FYN;FLT1;SIPA1L1;ARHGEF7;CLNK;SPRED1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4004121650625646,1.0,1.0,0.8745380086767535,1.0,106/354,19.45%,DAPK2;STK36;MAP3K5;EPHA3;PRKX;ERBB4;FAM20B;ADAM10;ATR;PEAK1;RYK;SGK1;ABL1;RICTOR;MAP3K11;GRK5;FER;MAP3K9;MERTK;CTBP1;SMAD7;IGF1R;MAP4K2;RPS6KB1;MAPK1;GRK6;PRKG2;MAP2K6;CDC42BPA;OXSR1;CDK12;BMP2K;MAPK10;ABL2;SIK3;EGFR;TNKS;TGFBR2;PRKG1;ABI1;MAPK14;MAPK3;MAST3;MAPKAPK5;MAP3K1;BAZ1B;RELN;MAP3K7;LRRK2;SMG1;AATK;DGKQ;WNK1;CDK14;TBCK;CSNK1E;PRKACB;ERC1;LATS1;LMTK2;PRKD1;MAP4K4;ACVR1;CDK18;BMPR1B;MAPK8;STK17B;CSNK1G3;SRPK2;TTBK1;USP15;ACVR1C;PNCK;STK24;CSNK1G1;FYN;LMTK3;FLT1;CAMKV;PRKCA;RPS6KA3;DMPK;NLK;IKBKB;PRKCE;PXK;PKDCC;CDKL5;PINK1;UHMK1;MKNK2;MAML1;BMPR1A;BRAF;ACVR1B;VRK1;AKT2;RPS6KA2;MTOR;TTBK2;PDPK1;CSK;PPP4R1;EIF2AK3;PTK2B;YWHAZ
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.44185988420491057,0.9999827363256933,0.4782608695652174,0.8738564196869476,1.0,7/15,21.16%,MAPK1;MAPK3;MSN;MAP2K2;SNX3;DNAJC13;RAB21
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.5547146500806142,0.9998134397967926,0.5428571428571428,0.8735718876657547,1.0,1/7,3.11%,NR1H2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5332148778142112,-0.9997921199856308,0.48,1.0,1.0,3/16,11.11%,CDKN1C;CDKN2C;ANKLE2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5833753161153404,-0.9995562792118431,0.5555555555555556,1.0,1.0,3/11,28.14%,CHMP4B;SEC61G;SEC62
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.6537094401571492,-0.9993945916389473,0.5588235294117647,1.0,1.0,2/5,23.64%,GSTP1;CARD8
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.4439458007925232,0.999305196145185,0.4642857142857143,0.8738890147784503,1.0,4/23,11.70%,MAP2;DIP2B;DCC;PTPRS
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.6123354431720073,0.998676255962903,0.5333333333333333,0.8745216970428662,1.0,2/5,8.55%,PPARG;ADAM19
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.40151149540969483,0.998593979913873,0.375,0.8739214944890981,1.0,17/61,11.49%,PLD1;MACC1;PLA2R1;PDZD2;LPP;FGD4;ESRRG;TSC22D2;BAZ2B;ATP10B;NEBL;PLEKHA5;RSPH3;TRHDE;WNK1;SLC8A1;GSTO2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.43222494367272324,0.9985758328654477,0.39285714285714285,0.8731645743357265,1.0,4/16,5.79%,GSTM2;PDE4D;ANK2;DMD
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.5656678889477824,-0.9983305971395074,0.5526315789473685,1.0,1.0,4/15,19.35%,LHFPL5;TTN;PKD2L2;PKD1L1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5475507654417807,0.9982475472043196,0.4583333333333333,0.8732129533807887,1.0,3/12,13.32%,IWS1;CPSF6;SETD2
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.6215776367378397,0.9981455884844437,0.5952380952380952,0.8726942454046488,1.0,2/5,12.75%,ROBO1;ROBO2
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.45464644519982556,-0.9979918372641794,0.5172413793103449,1.0,1.0,13/67,21.78%,NCAPD3;ANKRD53;RAB11A;ZW10;TTN;SMC1A;REC8;MIS12;CHMP4B;KIF18B;EML3;KIF22;SET
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.38603824460814185,0.9978788091777574,0.375,0.8717539052708818,1.0,8/37,10.89%,HDAC9;EHD1;NR1H2;GRAMD1B;SIRT1;RORA;AKR1C1;CYP7B1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.38603824460814185,0.9978788091777574,0.375,0.8717539052708818,1.0,8/37,10.89%,HDAC9;EHD1;NR1H2;GRAMD1B;SIRT1;RORA;AKR1C1;CYP7B1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5014114057699673,-0.9977260160483139,0.5411764705882353,1.0,1.0,5/27,9.78%,HES5;VEGFA;HES1;PARP14;PARP9
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.3856263419036334,0.9970862759133823,0.45,0.8727301543981729,1.0,7/35,11.05%,PLCL1;IRS1;IGF1R;RPS6KB1;PLCB1;PLCB4;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.5592288907232073,-0.9969403808904652,0.5616438356164384,1.0,1.0,1/15,1.74%,VEGFA
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6011341467453858,-0.9968072265914618,0.5915492957746479,1.0,1.0,3/11,19.61%,SLIRP;SUPV3L1;DNM1L
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.46427588274597414,-0.9966639069271741,0.4819277108433735,1.0,1.0,11/56,22.67%,RPS27A;ISG15;CTSL;CTSZ;HDAC6;ADAMTS7;UBA52;CHMP4B;NR1D1;UBC;BAG6
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.5916017571212588,-0.9966482045947131,0.5671641791044776,1.0,1.0,1/9,7.29%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.4293507646040409,0.9964397061233413,0.4444444444444444,0.8735948238373059,1.0,1/20,0.11%,PKP2
prerank,PanglaoDB_Augmented_2021__Platelets,-0.47106541305243066,-0.9964260094087439,0.49411764705882355,1.0,1.0,7/52,8.93%,F13A1;VEGFA;SLC2A3;OST4;HLA-A;TBXAS1;ALOX12
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.6710144472979558,-0.9963785139485332,0.59375,1.0,1.0,4/6,32.76%,CCDC39;CFAP100;CCDC40;DNAH7
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.4368140185682721,-0.9961771210809384,0.4888888888888889,1.0,1.0,22/112,22.57%,GADD45B;SGCA;PPFIA4;AGRN;GABARAPL2;SSPN;CLU;TGFB1;CRYAB;MEF2C;MYL6B;COL15A1;IFRD1;APOD;PLXNB2;CRAT;AEBP1;MYLK;GSN;PTP4A3;LDB3;ACTN2
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.4425679552911128,0.9960993466837844,0.5,0.8737366548001041,1.0,4/25,10.06%,RACGAP1;XPR1;SLC4A10;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6761598825695578,-0.9959012936378373,0.5285714285714286,1.0,1.0,4/5,32.15%,CD226;HSPD1;NECTIN2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.4793986659152356,-0.995876890205911,0.4691358024691358,1.0,1.0,5/43,12.07%,SFRP1;ECM2;S100A10;FN1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6348367536746883,-0.995769932020911,0.5538461538461539,1.0,1.0,3/7,20.53%,CACNA1G;SCAMP5;SYT4
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.5603491499067645,0.9948417300477789,0.5384615384615384,0.8760716275378791,1.0,4/6,19.86%,D2HGDH;SNCA;FBP1;ANK3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.633474076197266,-0.9946404513290757,0.5238095238095238,1.0,1.0,1/5,10.60%,GLUL
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.524739234277461,-0.9943621315457459,0.5,1.0,1.0,4/23,7.01%,ECT2;FGF1;HTR2B;KIF20B
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.43941931340067003,-0.994332708550941,0.5,1.0,1.0,10/109,4.89%,SCG3;DDRGK1;ISG15;EMD;ARL1;FSIP2;RPL11;DVL1;RAB11A;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.5237547082207057,0.9941942696568457,0.4634146341463415,0.8768841304116308,1.0,3/9,18.48%,ICE2;ELL;MTOR
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.5283594562207357,-0.994177466983999,0.5194805194805194,1.0,1.0,5/23,16.09%,HES5;TGFB1;MEF2C;WNT5B;RUNX2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.5560920500593014,-0.9933011164183309,0.5217391304347826,1.0,1.0,4/10,18.57%,IGSF6;TBXAS1;MYO1F;PILRA
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.5366791897220617,-0.9928046412372403,0.547945205479452,1.0,1.0,1/12,3.78%,CDKN1C
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.4720707608598391,-0.99272440669635,0.5287356321839081,1.0,1.0,5/26,14.87%,ENTPD7;SIDT2;NCBP1;RNASEH2C;SUPV3L1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.6351349696154902,-0.9923375744537707,0.5138888888888888,1.0,1.0,3/6,30.58%,ATF4;SESN2;MT3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5995877541718612,-0.9922364072627433,0.5324675324675324,1.0,1.0,1/9,2.32%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5029154043849818,0.9917736659114028,0.4594594594594595,0.8823088955964163,1.0,8/12,23.68%,KAT2B;PBX1;RBPJ;MAML1;WWC1;MAML2;NOTCH1;CREBBP
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.6355323721743297,-0.9917130909546816,0.5441176470588235,1.0,1.0,2/7,28.14%,SEC61G;SEC62
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5097709343434318,-0.9915362021697265,0.4942528735632184,1.0,1.0,6/20,27.12%,SLC6A6;SLC6A9;SLC3A2;SLC7A8;SLC36A4;SLC7A10
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.47269675921819765,-0.9912648250353898,0.4634146341463415,1.0,1.0,6/42,11.33%,IL20RA;HES1;OVOL2;TMC4;VWA2;EFNA1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.543234083388301,-0.990862628762599,0.47368421052631576,1.0,1.0,7/16,18.76%,TRIM25;PLET1;IGSF6;TYMP;MYO1F;PILRA;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.5342081371731138,0.99055824533894,0.3939393939393939,0.88444271704582,1.0,5/10,21.37%,NEDD4L;BIN1;NOS1;PTK2B;CAB39
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.4789987426072355,-0.9901699064861992,0.5411764705882353,1.0,1.0,3/36,10.56%,PDXDC1;ENPP2;ERAP1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.670195637188091,-0.9901625433595318,0.5081967213114754,1.0,1.0,3/5,28.32%,PDGFRB;AAMP;PLAT
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.5155987143072346,-0.9900375156029501,0.4936708860759494,1.0,1.0,2/21,6.96%,PDE6B;RBM4B
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5092292989490713,0.9897522858101782,0.45454545454545453,0.8857921923060781,1.0,6/11,21.21%,IWS1;NUP93;NXF1;THOC2;PCID2;POLDIP3
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.398281926191096,0.9895543299887793,0.2857142857142857,0.8855950467166128,1.0,10/45,16.26%,LRRC4C;PLXNA1;ROBO1;PLXNA3;KIF13B;ROBO2;TIAM2;SIPA1L1;CDH2;SLIT2
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5535818556854808,0.9890953348161577,0.5,0.885896964816237,1.0,2/9,8.41%,NUP98;NUP93
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.6124871798452219,-0.9888497526761929,0.5714285714285714,1.0,1.0,3/8,20.49%,PRPSAP1;PPAT;MTHFD1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.5470520824125379,0.9887590983488114,0.5666666666666667,0.8859647853141269,1.0,2/7,4.78%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.37422459298563954,0.9883430059250727,0.3076923076923077,0.8859702563393932,1.0,14/35,19.39%,BCAR1;GAB1;REPS2;EGFR;ERBIN;TGFA;PIK3CA;ADAM17;SOS1;KIF16B;BRAF;PDPK1;PIK3R1;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.5441222248082963,-0.9882280789177325,0.5277777777777778,1.0,1.0,9/22,32.03%,HDAC6;CST3;EFNA1;BAG6;PLAT;CSTB;TIMP3;TIMP1;CAMK2N1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.38059339305271267,0.9881478997157515,0.42857142857142855,0.8856337442944328,1.0,6/31,7.14%,NLGN4X;NLGN1;IL1RAPL1;NRXN1;SPTBN1;PICALM
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5711290696113699,-0.9881067414729083,0.6231884057971014,1.0,1.0,2/14,16.91%,AGT;NR4A3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.37802233035954647,0.9879409983673765,0.5263157894736842,0.8851735722110763,1.0,5/29,4.78%,AEN;ZNF385B;BOK;FHIT;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5539897878337661,-0.9879064826759512,0.5263157894736842,1.0,1.0,2/13,16.91%,JUN;NR4A3
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6001148211013898,-0.9873542309213598,0.5352112676056338,1.0,1.0,4/9,25.98%,RACK1;ORMDL1;TNFRSF1A;SPHK2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4673322700211686,-0.9870465202465164,0.5,1.0,1.0,8/33,12.98%,TUFT1;OVOL2;RHBDF1;TOM1L1;CDH3;TEAD3;EMP2;ATP6V0A4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.5136793017775194,0.9869363213938063,0.4857142857142857,0.8868710937683851,1.0,1/7,4.11%,LIG4
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6185663420696146,-0.9869068491997769,0.4722222222222222,1.0,1.0,2/8,21.20%,EFNA1;ATRAID
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.48640624635839935,-0.9868867372750172,0.5211267605633803,1.0,1.0,3/17,9.34%,PFDN6;CLU;NDUFAF1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.4777678517021808,0.9862306465548085,0.5151515151515151,0.8874338928947605,1.0,1/10,0.87%,ASXL3
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5764569501042075,-0.9861896598029288,0.5492957746478874,1.0,1.0,1/10,3.29%,PPIB
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.4797208582331089,0.9860698860250402,0.41935483870967744,0.8869578662685427,1.0,6/9,30.46%,HDAC4;PIAS1;RASD2;PIAS4;UBA2;MUL1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.4599168620551851,-0.9859367086083604,0.5434782608695652,1.0,1.0,14/53,22.91%,RPS27A;DDRGK1;RETREG1;CFTR;HDAC6;ATG14;DYNC1LI2;PJVK;UBA52;UFC1;ULK1;UBC;LGALS8;PARK7
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.45228342831285884,0.9858637263630041,0.37037037037037035,0.886668387487566,1.0,5/19,13.18%,TBC1D14;TBC1D12;PIKFYVE;MTMR3;MTM1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.5529560323508159,0.9858143979440864,0.41379310344827586,0.8861010686191509,1.0,5/7,33.05%,KDM5A;RIOX2;KDM5B;KDM1A;KDM1B
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.4476354871636017,0.9857804823886428,0.5652173913043478,0.8854420318560012,1.0,3/16,6.44%,SOX11;LIG4;RFX3
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.6081091774360193,-0.9855045587660534,0.49230769230769234,1.0,1.0,1/7,2.19%,HSD17B14
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.650643679864223,0.9854617029928975,0.5128205128205128,0.8852472356675081,1.0,3/5,21.64%,ATP8A1;ATP8A2;ATP11B
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.6107774139264386,-0.9849312128524175,0.53125,1.0,1.0,5/8,33.30%,WIZ;DBF4B;DBF4;CDC7;SSBP1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.44566121487494076,0.9847789286304146,0.5,0.8862557964992365,1.0,23/60,19.81%,FBXW7;SEPTIN4;FAM107A;INAVA;SMAD7;HSPBP1;DCUN1D2;UBE2D1;DCUN1D5;NDFIP2;HDAC4;XIAP;LRRK2;RCHY1;DCUN1D1;PIAS1;TANK;PINK1;BCL10;MYCBP2;MALT1;TBC1D7;RASD2
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.4716889961244993,-0.9843155641400331,0.5764705882352941,1.0,1.0,7/37,16.64%,ITGA4;LAT2;AKAP17A;RASGRP1;MEF2C;SLC25A5;BLNK
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.6434070895184008,-0.9842655701244897,0.5483870967741935,1.0,1.0,1/6,3.90%,LFNG
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.430682841017194,-0.9842590867668864,0.550561797752809,1.0,1.0,23/88,18.01%,SRSF7;RBM8A;NOL3;SNRPA1;PDCD7;SNRNP25;DHX16;PRPF18;SNRPD2;SNRPD1;PRPF8;SNRPB;PRPF6;SRSF10;RNPC3;NCBP1;LUC7L3;PRPF4;SF3A3;MAGOHB;SCNM1;SRPK1;SMNDC1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.41859737501218147,0.9839784032063617,0.4,0.8878019660651985,1.0,6/77,2.98%,TOP1MT;BARD1;RMI1;RPA1;ATR;RBMS1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.6207667727997168,-0.9838810785998724,0.5571428571428572,1.0,1.0,2/5,17.35%,APOE;SNX17
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.6207667727997168,-0.9838810785998724,0.5571428571428572,1.0,1.0,2/5,17.35%,APOE;SNX17
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.6207667727997168,-0.9838810785998724,0.5571428571428572,1.0,1.0,2/5,17.35%,APOE;SNX17
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.5769252367671529,-0.9837039181256059,0.5657894736842105,1.0,1.0,4/8,31.55%,DERL2;ERLEC1;OS9;UBE2G2
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.4346565310748514,-0.983319389706803,0.5402298850574713,1.0,1.0,22/86,24.08%,SRSF7;RBM8A;NUP155;DHX38;CDC40;SRSF5;NCBP1;CASC3;HNRNPA2B1;SEC13;UPF3B;MAGOHB;THOC5;CHTOP;NUP107;MCM3AP;CPSF1;NUP188;NUP85;ALKBH5;SRSF2;SLBP
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.45611299568978736,-0.9831836782189678,0.5176470588235295,1.0,1.0,17/62,25.13%,TRIM5;ALOX5;PDE6B;IRF1;USP18;NLRP1;ERAP1;P2RX4;CALM1;GRN;CD55;P2RY12;HERC5;CAV1;PARK7;LRRC19;TMSB4X
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4687028079376786,-0.982819127576156,0.47058823529411764,1.0,1.0,5/38,8.97%,ROMO1;STK17A;ALOX5;AGT;NOXA1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.45969512108143384,-0.9828150475167401,0.4659090909090909,1.0,1.0,19/66,26.69%,ITGA4;TNC;COL5A3;PAMR1;SNED1;COL15A1;COL6A1;LMOD1;ACTA2;COL4A1;ADAMTS2;AEBP1;THBS2;THY1;COL14A1;COL4A2;PDGFRB;RHOJ;C1S
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.47172445283343223,-0.9827927611566404,0.5555555555555556,1.0,1.0,7/43,16.87%,DENND3;CTSL;CTSZ;AP2A1;CLTA;ADAMTS7;MYLIP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.6370766063964933,-0.9827681183548752,0.6451612903225806,1.0,1.0,1/5,3.55%,DVL1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.5940270185515492,0.9826611367172268,0.6129032258064516,0.8898227659095649,1.0,3/8,19.45%,GBF1;VRK1;YWHAZ
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.43522776869743124,0.9825454027658536,0.3793103448275862,0.8894864138947505,1.0,4/17,10.56%,GLTP;CERT1;ABCB9;DISP1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.5628642598949801,-0.9824517696424186,0.5217391304347826,1.0,1.0,3/12,15.31%,NPM2;ATAD5;BRPF3
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.49517426328531505,-0.9820750797291355,0.56,1.0,1.0,5/24,12.51%,HES1;LFNG;JAG1;APH1A;SAP30
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.6348175464344048,-0.9818561181283212,0.5733333333333334,1.0,1.0,1/6,4.84%,RAB11A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.41824071402574686,0.9814427899372526,0.5294117647058824,0.8913946903500561,1.0,2/23,6.75%,USP51;POT1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5705438131479879,-0.9814074976364106,0.5616438356164384,1.0,1.0,3/12,15.77%,CD63;PIK3CB;ADAMTS3
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.4297012816260738,-0.9813088970174173,0.5113636363636364,1.0,1.0,23/87,24.22%,SRSF7;RBM8A;NUP155;DHX38;CDC40;SRSF5;NCBP1;CASC3;HNRNPA2B1;SEC13;UPF3B;MAGOHB;THOC5;CHTOP;NUP107;MCM3AP;CPSF1;NUP188;NUP85;ALKBH5;SRSF2;SLBP;ENY2
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.6336145270360044,-0.981217987518638,0.5538461538461539,1.0,1.0,2/5,29.18%,C3;PANK2
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.6170399500351423,-0.9811973322756861,0.5588235294117647,1.0,1.0,1/5,18.54%,CD46
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.5267468495278442,0.9808792419478171,0.52,0.8916257724295164,1.0,1/9,0.54%,BAIAP3
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.5861491855748663,-0.9803313719887602,0.5797101449275363,1.0,1.0,1/11,4.29%,ALOX5
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.5099022903429136,0.9800869871926694,0.5862068965517241,0.8926543330035486,1.0,5/11,20.21%,PICALM;CHRNA7;FLOT2;ABCA2;RANBP9
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.44412855198594753,-0.9799101322964474,0.5543478260869565,1.0,1.0,8/48,14.88%,ARG2;CLU;SELENOS;OAS3;RASGRP1;OAS1;CACTIN;SYT11
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.34075676436152297,0.9798890246204017,0.5,0.8923473653899516,1.0,15/85,11.43%,VAPB;TRPC4;STIM2;ATP2C1;CALCB;ANK2;SLC8A2;ANXA6;SMDT1;ATP2B4;SLC24A3;PML;CHRNA7;STIM1;SLC8A1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.5968614976185322,-0.979483467329984,0.5714285714285714,1.0,1.0,6/9,39.81%,XBP1;MBTPS2;MBTPS1;ATF6B;CALR;DDIT3
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.3649795990480395,0.9793209765953871,0.5384615384615384,0.8928833831769135,1.0,17/82,10.15%,LDB2;ASXL3;CSRNP3;CNTN3;RGS7BP;SORBS2;TOX3;GLS;NOL4;RUNX1T1;MAPK10;MAGI1;CACNA2D1;FGF14;EDIL3;PROX1;GRIA3
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.4400717387114498,-0.9791248641937494,0.5060240963855421,1.0,1.0,4/40,16.38%,ENPP2;GPX4;GDE1;PGP
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4470172322997012,0.9788267666056167,0.36363636363636365,0.8932654386604167,1.0,4/28,7.17%,SEPTIN4;STYXL1;BOK;BCL2L11
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.5755849504385351,0.9787843164744879,0.5555555555555556,0.8925305836161934,1.0,2/7,14.51%,MYO1E;TBC1D8B
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.45204769202663786,0.9787660424544979,0.46153846153846156,0.8917817088023318,1.0,5/15,13.85%,FBXW7;TSPAN15;EGFR;BEND6;DLL1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.414751524798814,0.9786472738431266,0.42857142857142855,0.8913394154856006,1.0,4/26,12.90%,LIMD1;PUM2;MOV10;TRIM71
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3999406195279608,0.9786439214885974,0.5,0.8905775869253565,1.0,4/23,4.81%,RNF139;BAG2;FBXW7;OSBPL7
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5593097222704194,-0.9786330632894691,0.5633802816901409,1.0,1.0,2/10,12.47%,VEGFA;P2RX4
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.5613005651692041,-0.9785004751675879,0.527027027027027,1.0,1.0,1/12,8.09%,HVCN1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.421032449325441,0.9782230439406845,0.5625,0.8907009181572748,1.0,11/23,17.43%,FEM1A;FBXW7;ABL1;SMAD7;DCUN1D2;DCUN1D5;UBE2N;BAG5;DCUN1D1;ARRDC4;PINK1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.572461074876328,0.9776832893918397,0.5588235294117647,0.8910524280179681,1.0,1/6,4.91%,PPARG
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.47283237030846353,0.9776621660999045,0.47058823529411764,0.890308005488563,1.0,2/10,9.36%,AK3;CMPK1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.6070099041376187,-0.9776031967085157,0.5,1.0,1.0,2/6,17.10%,AGT;APOE
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5120964996819406,-0.9774371480260736,0.5131578947368421,1.0,1.0,6/15,22.89%,RBM3;CELF4;NCBP1;NCL;SNW1;CIRBP
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5902201805614876,-0.9774164514639443,0.5081967213114754,1.0,1.0,1/7,17.90%,ADAR
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.5976801816506674,0.9770020524130579,0.5757575757575758,0.8907960512114202,1.0,1/5,8.99%,MAPK3
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3474984568216649,0.9769194770965031,0.5454545454545454,0.8901442363654372,1.0,10/54,11.99%,IRS1;BCAR1;GAB1;FER;IGF1R;C2CD5;FOXO1;ATP6V1A;PIK3CA;SH2B2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.5058811780128705,-0.9767487243389265,0.5333333333333333,1.0,1.0,4/22,19.51%,HACD4;ELOVL2;ACOT2;ACSBG1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6472097444141264,-0.976713954263743,0.5915492957746479,1.0,1.0,2/5,14.90%,HAX1;SREBF1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.4047816039120974,0.9762477552338429,0.47619047619047616,0.8906012430369555,1.0,8/33,13.79%,GABRG1;GABRR1;SLC12A8;SLC12A1;GLRA1;GABRG3;GABRB1;GABRA1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.4437496119546137,0.975732084771975,0.5,0.8913000532794775,1.0,4/16,11.27%,LIG4;YLPM1;SMG1;HNRNPD
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5179817704788422,-0.9755827571879342,0.5833333333333334,1.0,1.0,5/16,24.51%,GAPDH;PGK1;PFKP;ADPGK;PGAM1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.46134976235358766,0.9755376126474755,0.5185185185185185,0.8908918447653145,1.0,6/15,17.29%,PPM1E;PDE4B;PPM1F;RAP2A;ACER2;FBP1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.517705981157285,-0.9754241727154731,0.47674418604651164,1.0,1.0,7/16,21.67%,RPL11;RPL23;GORASP1;FZR1;RPS7;RPL5;USP44
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.5670676816139504,0.9752742781207879,0.5526315789473685,0.8909081238217649,1.0,2/5,16.84%,SRPK2;PRIMPOL
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.45625153431729604,-0.9751985701563723,0.5384615384615384,1.0,1.0,10/49,15.38%,CRYM;LHFPL5;SLC26A5;CEMIP;NDUFB9;TIMM8B;P2RX4;ATP6V0A4;PJVK;MYO3B
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.43590044881885953,-0.9751387647240419,0.5393258426966292,1.0,1.0,20/81,25.10%,VEGFA;CLU;TGFB1;NAPA;HDAC6;CRYAB;STX1B;RACK1;APOE;WARS1;BAX;ULK1;EIF2AK2;GSN;MTLN;RHOC;PARK7;SLF1;ABCA1;HSPA8
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.5262398810416424,-0.9751381171263493,0.5211267605633803,1.0,1.0,3/16,11.33%,ZFPM1;OLFM1;EFNA1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4473091544063071,-0.9751047735004623,0.5340909090909091,1.0,1.0,23/60,29.57%,PSMB9;PSMB8;LDB1;PSMA3;LMO2;PSME1;PSMA7;EIF2AK2;PSMB6;PDCD2;DHX36;PSMC4;RUNX1;PSMB1;PSMD2;PSMB3;PSMC3;SETD1A;LMO1;SPI1;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.49503436270827744,-0.9749417498008521,0.5813953488372093,1.0,1.0,6/30,18.41%,PIGO;PIGC;PIGH;B3GNT5;PIGL;PIGG
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.6890995831809246,-0.9746635021230993,0.6176470588235294,1.0,1.0,3/5,26.44%,CCDC39;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.6890995831809246,-0.9746635021230993,0.6176470588235294,1.0,1.0,3/5,26.44%,CCDC39;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.45987591330153643,0.9743740289747107,0.45161290322580644,0.8922854194326365,1.0,4/16,16.42%,HACE1;CDH13;NCKAP1;EPS8
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3175016245094552,0.9742154357076347,0.4,0.8918320837857991,1.0,14/111,7.17%,TP63;DAPK2;HIP1;AIFM2;SEPTIN4;BCAR1;SGK1;ACER3;ABL1;TOX3;SIRT1;TP53INP1;CRADD;BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.39437367515334354,0.974100127247929,0.4444444444444444,0.8913493209555794,1.0,7/26,9.23%,NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPK3;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.4805747036279127,0.9738124400641481,0.4230769230769231,0.8912143146336063,1.0,3/10,6.17%,AIFM2;MCTP1;STOX1
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.4903527311754018,0.9734474710976035,0.4117647058823529,0.891486470170031,1.0,5/14,8.71%,RXRA;SLCO1A2;ABCC11;NCOA2;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5549824260064511,0.9734092601035227,0.42857142857142855,0.8908094554316002,1.0,3/10,14.53%,FCHSD2;WASF3;NCKAP1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.4436685851290148,-0.9733311137371895,0.5824175824175825,1.0,1.0,19/81,25.50%,SEL1L2;TRIM25;SELENOS;DERL2;TMUB1;USP19;DNAJC10;ERLEC1;CCDC47;SYVN1;WFS1;FAM8A1;FBXO6;RNF175;TMEM129;BAG6;ERLIN2;MAN1A1;TRIM13
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5154643993289978,-0.973211832276657,0.5774647887323944,1.0,1.0,4/18,13.41%,SFRP1;OVOL2;EFNA1;FUZ
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.5531665086307458,-0.9728451649349349,0.5584415584415584,1.0,1.0,2/11,4.06%,PDXDC1;ENPP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6155926545867872,-0.9727876064581005,0.6,1.0,1.0,1/7,5.88%,TGFB1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.5596289248863309,0.9727542253848032,0.5,0.8915178333777043,1.0,2/6,11.86%,NLGN1;LHFPL4
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.4902867530083499,-0.9723637192575445,0.5,1.0,1.0,2/24,1.24%,ARHGAP15;EPSTI1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5058541935936294,-0.9723632617739749,0.4875,1.0,1.0,3/15,20.76%,RPS27A;UBA52;UBC
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5058541935936294,-0.9723632617739749,0.4875,1.0,1.0,3/15,20.76%,RPS27A;UBA52;UBC
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.5250796411712995,-0.9720546998825519,0.5256410256410257,1.0,1.0,3/15,19.69%,RRAGA;TELO2;LARS1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3289448986995967,0.9719918486112291,0.625,0.8925407219098671,1.0,17/96,12.33%,HDAC9;IRS1;KAT2B;BCAR1;GAB1;PPARG;FER;IGF1R;RPS6KB1;RAB31;C2CD5;FOXO1;RAB10;CPEB2;ATP6V1A;SH2B2;MYO5A
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.48004360712075994,0.9719165956410113,0.5161290322580645,0.8919396337687467,1.0,5/8,23.43%,LANCL1;FYN;PINK1;PRKN;UBQLN1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3234403105225895,0.9716360119884961,0.5454545454545454,0.8918648452173559,1.0,13/64,12.65%,SOX11;HSPA1A;ACER3;AKR1C3;RAD18;ATG5;ADNP2;DCC;BMP7;CHRNA7;LRRK2;PRKD1;RRAS2
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.5856064027317391,-0.9716090728758788,0.5753424657534246,1.0,1.0,1/8,1.50%,ZNHIT3
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.614585062137331,-0.9715063008834182,0.6129032258064516,1.0,1.0,2/5,14.24%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.4999513983610244,0.9713351957307553,0.4634146341463415,0.8918951517788087,1.0,2/10,10.11%,STARD3;OSBPL5
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.589244188384677,0.9713348772491953,0.53125,0.8911462893507829,1.0,1/6,0.39%,SOX11
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.35438322859710436,0.9709619132522717,0.4,0.8911172659949874,1.0,13/70,11.87%,SEM1;RMI1;RPA1;RFWD3;RAD51B;RECQL5;RAD54B;SAMHD1;NSMCE2;SMC6;ERCC4;HELQ;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.576617666632049,-0.9708589337143737,0.5733333333333334,1.0,1.0,3/9,22.91%,VDAC1;SLC25A5;PARK7
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5993833850277226,-0.9705487132589661,0.5303030303030303,1.0,1.0,2/8,21.05%,GLRX;MTLN
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4992832872181309,-0.9705483994011789,0.6125,1.0,1.0,12/26,27.75%,IL20RA;OVOL2;TMC4;BTG1;CEBPD;PROM1;SLC44A3;BTC;RUNX1;CD9;UXT;SYTL2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.5806086497317839,0.9702261449367519,0.5,0.8920007245413636,1.0,1/5,7.90%,TGFBR2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.6673185583755169,-0.9701385271782142,0.6197183098591549,1.0,1.0,2/5,18.75%,SLC12A4;RHCG
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5577434080893482,-0.9699786924182483,0.52,1.0,1.0,5/11,20.10%,ALOX5;CLU;LPCAT3;USP19;WFS1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.44452068875816436,-0.9699067114719118,0.5113636363636364,1.0,1.0,20/56,29.57%,PSMB9;PSMB8;LDB1;PSMA3;LMO2;PSME1;PSMA7;EIF2AK2;PSMB6;PSMC4;RUNX1;PSMB1;PSMD2;PSMB3;PSMC3;SETD1A;LMO1;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.6479809912566106,-0.9699066052091032,0.6666666666666666,1.0,1.0,4/6,30.33%,WIZ;DBF4B;DBF4;CDC7
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.46530033200110943,-0.9697842395599633,0.5121951219512195,1.0,1.0,7/26,30.02%,GAPDH;PGK1;ENOSF1;LDHA;PGAM1;ENO4;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5948387350959807,-0.9697645625398672,0.5074626865671642,1.0,1.0,3/6,32.98%,AXL;PPT1;APPL1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.48540958151442104,-0.9695064379121981,0.5487804878048781,1.0,1.0,4/22,28.15%,HDAC6;BAG6;YME1L1;STUB1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5749848761554729,-0.969432261535651,0.5342465753424658,1.0,1.0,2/9,8.86%,TTN;OBSL1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.4975889654129962,0.9692675775394277,0.4594594594594595,0.8933460104869944,1.0,3/10,8.83%,RIPOR2;PLCB1;MAPK14
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.36344740885920845,0.9688939542111559,0.46153846153846156,0.8934048165496814,1.0,13/53,13.31%,ALG1;FAM20B;LARGE1;CSGALNACT1;COG3;GAL3ST3;GCNT2;SERP2;CHST8;FUT9;ST3GAL4;BMPR1B;COG7
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.5884521180664662,0.9682238716113746,0.5625,0.8943139871996177,1.0,1/5,4.91%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4306120482546815,0.968077641249922,0.5263157894736842,0.8939246482166786,1.0,12/32,20.02%,MAP3K5;SIRT1;GRIN2B;HMGB1;PPM1F;TTBK1;ACVR1C;FYN;BCL10;MALT1;DDX3X;GRIN1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.4931000562015089,0.968012729743312,0.6086956521739131,0.8933125268151897,1.0,1/11,0.45%,CHRM3
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.3409860838170788,0.9680051275203251,0.5454545454545454,0.8925823619062745,1.0,30/96,13.89%,ASXL3;NOVA2;CSRNP3;ADGRB3;DCX;ASTN1;NRXN1;ADGRL3;ANK2;RUNX1T1;MAGI2;LSAMP;FMN2;UNC5D;GRID2;NOVA1;GUCY1A2;GRIA1;CPT1C;CNTN1;CTNNA2;CLVS2;TMEM200C;SLC35F1;NFASC;ROBO2;KCNQ2;EFR3B;ADCYAP1R1;PCDH17
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5701312880671945,-0.9679189638701428,0.5285714285714286,1.0,1.0,4/9,23.41%,PARP9;NAXE;NUDT12;NAMPT
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.38442732252049205,0.9678755710548117,0.4117647058823529,0.8921508272893057,1.0,9/45,13.79%,GABRG1;GABRR1;XPR1;SLC12A8;SLC12A1;GLRA1;GABRG3;GABRB1;GABRA1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6196353474029274,-0.9676820735721434,0.5423728813559322,1.0,1.0,3/5,33.30%,APOE;ABCA1;ABCG1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.5315559225382951,-0.9674563460276844,0.5915492957746479,1.0,1.0,5/17,20.49%,PRPSAP1;PPAT;SHMT1;PAICS;MTHFD1
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.6579133346768826,-0.967410604108496,0.6031746031746031,1.0,1.0,4/5,33.06%,SF3A3;SF3A1;SLU7;SF3A2
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.48217293555359075,-0.967349704627624,0.5584415584415584,1.0,1.0,5/21,21.59%,TGFB1;AP2A1;CLTA;MYLIP;AP2A2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.4319862623161872,-0.9672260709920311,0.6071428571428571,1.0,1.0,9/78,12.10%,SRSF7;MBNL3;RBM8A;RBM3;DDX5;CELF4;SRRM4;SRSF10;NCBP1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.3539902806168158,0.9671264351837897,0.2727272727272727,0.8931612650026826,1.0,5/49,3.53%,PHLDB2;EPHA3;PEAK1;FAM107A;ABL1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.4604604960319598,0.9668792308749665,0.5,0.8930714230560405,1.0,4/10,18.89%,LRFN5;MFHAS1;GPR137B;CD200
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.534834714762648,0.9665061394609384,0.5333333333333333,0.8932487349766965,1.0,2/8,17.54%,PIKFYVE;ARL8B
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.5750276070999281,0.9663685296307003,0.5625,0.893010756986583,1.0,2/6,12.11%,NFATC1;NFATC3
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.49484312038951633,-0.9662870028465794,0.5,1.0,1.0,5/23,12.47%,SCN9A;CACNA1G;CACNA1B;CACNA1E;P2RX4
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.5115410636531799,-0.9661823329281021,0.5733333333333334,1.0,1.0,3/15,14.98%,GAPDH;PGK1;PFKP
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.5115410636531799,-0.9661823329281021,0.5733333333333334,1.0,1.0,3/15,14.98%,GAPDH;PGK1;PFKP
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.6133131062341871,-0.9661150487584027,0.6388888888888888,1.0,1.0,3/7,24.57%,ENPP4;USF1;ANO6
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.5272726548223874,0.9660229964461753,0.5833333333333334,0.8929656905062762,1.0,1/9,1.02%,RIPOR2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.34452164428853355,0.96598888186484,0.5,0.8923288313990415,1.0,13/35,18.84%,EPHA3;MCTP1;DYSF;NR1H2;SNX33;NDFIP2;PRKD1;PPM1F;PXK;SNCA;SNX3;PRKN;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.5963887626385609,-0.9656955097542937,0.5573770491803278,1.0,1.0,1/6,4.32%,FLOT1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.5724220559616384,-0.9656381121008721,0.5555555555555556,1.0,1.0,4/10,31.31%,NCBP1;DHX36;NCBP2;PAF1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5576180800145863,-0.9655616186908456,0.5454545454545454,1.0,1.0,4/9,31.55%,DERL2;ERLEC1;OS9;UBE2G2
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.42630378431597793,-0.9655530719918243,0.5543478260869565,1.0,1.0,15/80,16.58%,PDE5A;VEGFA;ECM2;RARRES2;ZIC1;CRYAB;ASPN;PAMR1;COL15A1;COL6A1;STEAP4;LMOD1;ACTA2;COL4A1;ADAMTS2
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.44083035699866263,-0.9654790032431252,0.5,1.0,1.0,12/45,18.85%,VEGFA;GSTK1;SPINK5;OVOL2;JAG1;KDM6B;PGK1;VIL1;VDAC1;EDF1;RHCG;CBR1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.3815605387659243,0.9652713771186812,0.2857142857142857,0.893526296273103,1.0,6/29,8.55%,SIRT1;IGF1R;FOXK1;FOXO1;UNC13B;ZBTB20
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.3059395235510657,0.9646489284136675,0.6666666666666666,0.8939979414617204,1.0,58/251,14.79%,SEMA3B;LDB2;PRR5L;GPNMB;PDGFC;PRKX;MCTP1;ERBB4;ADAM10;NAV3;SRGAP1;BCAR1;SGK1;FAM107A;PLXNA1;SEMA4D;SEMA6C;FER;PTPRK;ROBO1;SMAD7;ZNF268;IGF1R;NTNG2;MAGI2;TP53INP1;HACE1;GCNT2;TMEFF2;PLXNA3;ZMYND8;KANK1;EGFR;LMNA;CTNNA2;SEMA3A;ROR2;PPP3CA;MITF;SRCIN1;PTPRU;NF2;AMOT;CDH13;SEMA6A;RAP2B;MAP4K4;PPM1F;CHRD;ACVR1;WASHC1;ELP3;ADAM17;FOXO3;RAP2A;DOCK10;SUN2;ARID2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.43379497443089454,0.9646331907379759,0.4583333333333333,0.8932880090056329,1.0,2/13,8.59%,PPARG;ADIPOR2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.4575265181477456,0.96451410792478,0.5,0.8929774397665792,1.0,2/12,15.37%,LIG4;NIPBL
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6198692168873523,-0.9643956569172344,0.6349206349206349,1.0,1.0,2/8,8.10%,OAS3;OAS1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.509040746914418,-0.9642917288970395,0.5616438356164384,1.0,1.0,7/17,25.13%,PFN2;TMSB15B;VIL1;TMSB10;GSN;HIP1R;TMSB4X
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3027950010702511,0.9642192563897465,1.0,0.8928000037626297,1.0,62/305,13.14%,IL1RAPL2;CHRM3;ZNF358;POU6F2;LDB2;DPYSL5;SHANK2;PDGFC;MBNL1;ERBB4;NLGN1;PCDHA1;NAV3;DCX;RYK;DPF1;ADAM23;VCAN;NPAS1;SCD5;NDP;DSCAML1;LIG4;SDK2;CRIM1;DOC2A;CHD7;MERTK;ROBO1;NRXN1;FGF12;ADGRL3;LSAMP;ADAM22;VLDLR;NAV1;ZEB2;NRCAM;TRAK1;PKD2;ATXN1;OPHN1;ATXN10;HDAC4;RELN;CHST8;PROX1;DNM3;SOX8;ZBTB16;SEMA6A;FARP1;APBA1;BTBD3;UNC119B;NFASC;ROBO2;HMGCR;PRPS1;TRIM71;SOX10;KCNQ2
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.4959295114101443,-0.9642165300792386,0.6049382716049383,1.0,1.0,5/26,14.47%,IGFBPL1;SCG5;VEPH1;MTCH1;TYMP
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.5646015830294773,-0.964028657873395,0.6,1.0,1.0,2/14,8.67%,TGFB1;ASPN
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.42331782191471207,-0.9638015924502609,0.5268817204301075,1.0,1.0,8/92,5.96%,TRIM5;RPS27A;DDRGK1;RTKN2;TRIM25;FLOT1;CLU;AGT
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.48225793436946685,-0.9636185366713621,0.5802469135802469,1.0,1.0,4/30,8.10%,CLU;OAS3;RASGRP1;OAS1
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.5524418150803907,0.9634270093140035,0.475,0.8942277147750416,1.0,2/5,19.03%,MRPL18;NPM1
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6368068606931013,-0.9632025863380586,0.6,1.0,1.0,3/5,20.68%,PLEKHH2;VIL1;GSN
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4372978495473239,-0.9629618220534913,0.5294117647058824,1.0,1.0,6/62,12.10%,ELOB;POLR2I;POLR2G;GTF2F1;CDK7;NCBP1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.3358704709022115,0.9627041276749829,0.5555555555555556,0.8951675990307515,1.0,9/110,5.87%,SEMA3B;SYNDIG1;ZCCHC24;PRIMA1;EXTL1;ASTN1;FAM107A;ANK2;LAMC1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4775385109044552,-0.9626991448672229,0.5443037974683544,1.0,1.0,7/20,23.92%,RBM3;CELF4;NCBP1;NCL;SNW1;CIRBP;DHX36
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.5660475275594665,-0.9625980654264,0.5753424657534246,1.0,1.0,3/8,16.54%,ZFPM1;ATF4;THOC5
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.4777541548235118,-0.9625218267495699,0.5324675324675324,1.0,1.0,4/28,13.57%,HES5;HES1;BHLHE41;GRN
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.3582683363682891,0.9625185012784117,0.5,0.8947830089365099,1.0,22/53,21.92%,MAPK1;CDC42BPA;OXSR1;TNKS;TGFBR2;GALNT16;LRRK2;WNK1;GALNT13;LMTK2;PRKD1;ACVR1;MAPK8;TTBK1;PRKCA;NLK;GALNT11;ACVR1B;PDPK1;HIPK3;CDK10;HIPK1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.42470141023247127,-0.9619715890964002,0.5494505494505495,1.0,1.0,28/116,29.57%,PSMB9;SFRP1;EMD;PSMB8;DVL1;TLE6;SFRP4;PSMA3;FUZ;PSME1;DVL2;APOE;PSMA7;PSMB6;CAV1;DVL3;RBX1;PSMC4;SOX9;PSMB1;PSMD2;PSMB3;PSMC3;FZD6;NKD1;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.36439729463726883,0.9615563806550513,0.36363636363636365,0.896190875554488,1.0,19/106,9.30%,TCF7L1;SATB2;ESR1;KAT2B;ZBTB1;PADI2;HDAC10;HP1BP3;ARID1A;SUV39H2;SIRT1;HDAC11;BAZ2B;SMARCA2;SMARCAD1;KAT2A;RSF1;HDAC4;BAZ1B
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3489188346794075,0.9609535193038774,0.6666666666666666,0.896803976556813,1.0,18/48,24.67%,ATR;ZBTB1;SIRT1;PTPRK;ERCC4;NEDD4;N4BP1;OPN3;NPM1;EIF2S1;SDE2;MMP2;RUVBL2;STK11;ACTR5;CREBBP;POLK;INO80
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4302940359828363,-0.9607748326798504,0.5681818181818182,1.0,1.0,11/81,18.68%,B2M;APIP;ECT2;PRMT8;POLQ;BEND3;STEAP4;RNF213;SHMT1;NINJ1;RNF112
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.5368409691838227,-0.9604073083067689,0.5633802816901409,1.0,1.0,3/15,19.00%,ANKRD53;DCTN1;TACC3
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.6188612943565328,-0.9602920675500902,0.5507246376811594,1.0,1.0,3/6,18.76%,GRN;SYT11;NR1D1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.47255549113395495,-0.9598363617215321,0.575,1.0,1.0,9/48,16.27%,ESRRB;FGF1;HTR2B;RAB11A;TLE6;CDK2AP2;CALM1;RACK1;KIF18B
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.5097648251043946,-0.9595206750443701,0.6029411764705882,1.0,1.0,3/17,14.07%,PLSCR1;ABHD12B;LPCAT3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4735144555095957,-0.9592994081219561,0.5977011494252874,1.0,1.0,9/43,14.75%,PLSCR1;HVCN1;MT2A;TTN;SLC30A4;SNCB;KHK;CALM1;PPP5C
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.5868754809227694,-0.9592906238483363,0.5714285714285714,1.0,1.0,3/9,17.10%,ALOX12;CEACAM1;APOE
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.49347284419314286,-0.9591689275263668,0.5,1.0,1.0,7/22,19.36%,NOP10;GAR1;TELO2;RFC1;DKC1;HSP90AB1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.4642464746921554,-0.9590415320280136,0.5783132530120482,1.0,1.0,3/31,5.88%,HES1;JUN;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.6017785279963677,-0.9588060588595947,0.6266666666666667,1.0,1.0,1/7,5.88%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.5166258029349268,-0.9587460523505977,0.5945945945945946,1.0,1.0,3/22,4.07%,PLSCR1;POLR3D;IFI35
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.5480602214278705,-0.9587368253532663,0.5972222222222222,1.0,1.0,8/16,32.76%,DNAH17;CCDC39;CFAP100;DNAAF2;CCDC40;DNAI4;TTC12;DNAH7
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.5466244085628903,0.9583183800240812,0.5185185185185185,0.9028706846089538,1.0,6/10,21.75%,MAPK1;MAPK3;LRRK2;MAP2K2;DNAJC13;USP7
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.3645696260446416,0.9583077172687251,0.47368421052631576,0.902144062372843,1.0,12/48,16.49%,ITPR2;SMAD7;PDE4D;ANK2;SLC8A2;ATP2B4;STIM1;SLC8A1;KCNIP2;NOS1;DMPK;TMEM65
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.425272929402951,-0.9583012564020006,0.5476190476190477,1.0,1.0,21/83,24.22%,ERCC6L;RPS27;ZW10;CENPH;BUB3;ITGB3BP;DYNC1LI2;PTPA;SEC13;MIS12;NEK6;CENPC;DCTN6;STIL;TACC3;NUP107;NUP85;RMDN1;KNTC1;BCCIP;STMN1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6076053681196444,-0.9582444621141686,0.5942028985507246,1.0,1.0,3/6,26.94%,PRELID1;BAX;BNIP3
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.5822269573709183,0.9581117085156815,0.5588235294117647,0.90172604888654,1.0,2/5,36.39%,MAPK8IP2;NCK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.43540059066502956,-0.9568664602848127,0.5764705882352941,1.0,1.0,13/56,19.68%,VEGFA;FGF1;AGT;CEACAM1;PIK3CB;GLUL;EMP2;GRN;SVBP;APOE;EMC10;NRP2;PTN
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.32543277564842793,0.9565502393429911,0.5,0.9048338002151647,1.0,56/318,13.61%,VAPB;TTC29;WDR81;SMPD4;TRAPPC12;TFB1M;FMNL3;FNBP1L;PCLO;NDP;PLIN5;LIG4;PLD2;FGD4;ZRANB1;LIMD1;TMED5;SH3KBP1;COG3;YTHDF1;RAB31;SH3D19;HACE1;MTX2;ARC;BIN1;TRAPPC8;PKD2;GOLGA8N;EPS15;WASF3;CAPZB;TMED3;WASL;PPRC1;MAST3;SYNE3;SEC16A;BRWD3;PIKFYVE;VAPA;LRRK2;PALLD;AGTPBP1;FBXW8;IRAG2;SEMA6A;PRKD1;BLZF1;CLASP1;BAG5;TMCC1;PACSIN2;COG7;RHOT1;ATL2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.36070762326425776,0.9565279893526267,0.5,0.9042096598449697,1.0,29/117,16.43%,IL15;GPNMB;HDAC9;NOVA2;SPRED2;PLCL1;NR1H2;ELAPOR2;ROBO1;SMAD7;MAP2K6;NOVA1;EGFR;ATP2B4;NFIB;TWSG1;ADAMTS5;PTPRR;IP6K1;KLF7;HMGCR;PTPRG;N4BP1;ADAM17;ACVR1C;WWC2;PCTP;SPRED1;CORO1C
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.6009167348246967,-0.9564812067582519,0.5671641791044776,1.0,1.0,1/7,8.89%,JAG1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.4497813595082923,-0.9561420438393766,0.5542168674698795,1.0,1.0,10/57,20.39%,TMEM258;PMM1;DOLPP1;OST4;DAD1;MPDU1;ALG14;ALG10B;MCFD2;RPN1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.5148916378757493,0.9555678708900248,0.5,0.9057769830055635,1.0,2/6,7.89%,UNC13C;UNC13B
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.43098012752584447,-0.9554731994311717,0.5806451612903226,1.0,1.0,23/117,17.54%,HLA-F;PPIF;PARP2;POLE3;CDKN1C;TUBA4A;IRF1;RASGRP1;GGH;OLFM1;WIZ;ATP6V1F;CCK;PPAT;BTG1;H2AX;UROD;SELENOW;TAP1;HSPA13;CLTB;CYB5R1;RFC4
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6297275463802854,-0.9554129374510926,0.6086956521739131,1.0,1.0,3/7,13.14%,SFRP1;PLEKHA4;WNT5B
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.5843420937730699,-0.9552636701965275,0.6086956521739131,1.0,1.0,1/9,5.01%,CFTR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.5843420937730699,-0.9552636701965275,0.6086956521739131,1.0,1.0,1/9,5.01%,CFTR
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.5780004640362992,-0.9551639003925134,0.5694444444444444,1.0,1.0,2/9,14.47%,TK2;TYMP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.5780004640362992,-0.9551639003925134,0.5694444444444444,1.0,1.0,2/9,14.47%,TK2;TYMP
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.5909571402851026,-0.9550992934009314,0.5735294117647058,1.0,1.0,2/7,17.10%,PPIB;APOE
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.5333496614107658,-0.9550520580609887,0.52,1.0,1.0,1/11,4.14%,CHRM2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5784418110169832,-0.9547374279997513,0.5714285714285714,1.0,1.0,1/7,10.95%,CAD
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.5042011097608705,0.9547102841727156,0.6086956521739131,0.9063817645257358,1.0,2/8,10.60%,ERI1;EXOSC7
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.5042011097608705,0.9547102841727156,0.6086956521739131,0.9063817645257358,1.0,2/8,10.60%,ERI1;EXOSC7
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6312535356113944,-0.9546343508443667,0.5737704918032787,1.0,1.0,4/5,36.89%,APOE;ABCA5;ABCG1;LCAT
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.5656460922714759,-0.9545598973618988,0.6111111111111112,1.0,1.0,2/8,11.15%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5206557487556872,0.9544278069000005,0.5666666666666667,0.90554359789938,1.0,3/10,18.05%,XPR1;SLC20A2;SLC25A14
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5206557487556872,0.9544278069000005,0.5666666666666667,0.90554359789938,1.0,3/10,18.05%,XPR1;SLC20A2;SLC25A14
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.44516117346261797,-0.9541655075378656,0.5909090909090909,1.0,1.0,18/54,26.69%,RARRES2;CRYAB;ASPN;PAMR1;COL15A1;LMOD1;ACTA2;COL4A1;ADAMTS2;MYLK;RBPMS;THBS2;CALD1;COL14A1;MATN2;COL4A2;PDGFRB;C1S
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.534119071567955,-0.9533691210614486,0.5897435897435898,1.0,1.0,3/18,17.71%,VAV3;MEF2C;IL7
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.5717455351073515,-0.9533374617923562,0.5974025974025974,1.0,1.0,2/7,14.90%,HAX1;SREBF1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5036661312750685,-0.953243626663284,0.4810126582278481,1.0,1.0,2/16,11.48%,CTSL;PGK1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.6425151395547651,-0.9532325324868037,0.5737704918032787,1.0,1.0,3/6,24.14%,MTHFD1;GOT1;MTRR
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.4244663641709176,0.953112700642714,0.48,0.9080196838234402,1.0,1/19,1.26%,HSPA1A
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.5732037863161921,-0.9530999111713337,0.6176470588235294,1.0,1.0,4/9,23.78%,ANGPTL4;APOE;MTLN;IL18
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.5357112862572218,0.9529189435994803,0.5116279069767442,0.9079196443782575,1.0,2/6,16.90%,LIG4;MGMT
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.42937454613138615,0.9526454888638675,0.5,0.9079940050072824,1.0,6/19,12.66%,SEMA3B;SEMA4D;SEMA6C;SEMA3A;SEMA6A;NRP1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.5010438502758079,0.9526241380164877,0.5135135135135135,0.9072848144357738,1.0,5/7,32.85%,PIK3R4;TRAF6;IRAK1;IRAK2;PIK3C3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4719871927360011,-0.9524977083803826,0.5853658536585366,1.0,1.0,4/31,8.10%,CLU;OAS3;RASGRP1;OAS1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.48690169581817866,0.9524866351049558,0.5555555555555556,0.9068377073732895,1.0,3/7,20.02%,CPEB4;PTK2B;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.5762868689287344,-0.9524695662178928,0.582089552238806,1.0,1.0,1/8,4.62%,CREB3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.3921483736477663,0.9521901449670214,0.5,0.9068403430428895,1.0,10/55,11.33%,DAPK2;ABL1;BOK;OSBPL7;HSPB1;KEAP1;ABL2;KAT8;LRRK2;MTMR3
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.41613736484677344,0.9521618821360651,0.43478260869565216,0.9061917043268413,1.0,6/15,21.77%,PPP1R8;MFHAS1;ARPP19;URI1;ZCCHC9;CHP1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.4252444371391044,-0.9516694301723025,0.5591397849462365,1.0,1.0,16/78,23.62%,CDC37;CAMK1;TRIB1;CDKN2C;CCNI2;CDK7;CALM1;MTCP1;CNPPD1;TELO2;MAP2K1;TRIB3;CCNK;HERC5;THY1;BCCIP
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5611079829793242,-0.9515098315509877,0.6825396825396826,1.0,1.0,1/10,2.32%,SFRP1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.33450376006718324,0.9511916243664832,0.6363636363636364,0.907901250249895,1.0,19/50,19.39%,ERBB4;BCAR1;GAB1;REPS2;MAPK1;NRG2;EGFR;ERBIN;TGFA;PTPRR;PIK3CA;ADAM17;SOS1;PRKCA;KIF16B;BRAF;PDPK1;PIK3R1;PTK2B
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4898184379103704,0.9511306459024145,0.5263157894736842,0.9072961506215412,1.0,4/10,12.23%,NOVA2;NOVA1;PCBP2;PCBP4
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.6235420551309824,-0.950853840153474,0.6290322580645161,1.0,1.0,1/5,3.94%,PAH
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.42180675862150263,0.950810705782037,0.45161290322580644,0.9072695317701228,1.0,3/16,5.79%,SMAD7;ANK2;DMD
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.631116888167974,-0.9507359811037558,0.6268656716417911,1.0,1.0,2/6,20.25%,COX11;SLC7A8
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.34137390523910904,0.950653839017375,0.5263157894736842,0.9068390316001743,1.0,6/56,4.30%,ONECUT1;ESR1;DYSF;TNFRSF11B;ITGA2;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.47158441668100404,-0.9506154983449758,0.5584415584415584,1.0,1.0,4/25,12.47%,VEGFA;RARRES2;TGFB1;P2RX4
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.5051527811319052,-0.9505547638380097,0.5230769230769231,1.0,1.0,2/18,9.86%,RNASE1;LACTB2
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.4921320280281486,0.9504606994978704,0.47058823529411764,0.9064524695589958,1.0,3/12,4.04%,RIPOR2;GPNMB;FGL1
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.48769392202931994,-0.950363429180077,0.5783132530120482,1.0,1.0,8/21,28.19%,MED1;VIL1;ZFP36L2;GAREM1;PDE8A;SOX9;MARS1;SYAP1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.390777247006399,0.9501941526542776,0.45,0.9063545831793188,1.0,6/28,8.71%,RXRA;SLCO1A2;ABCC11;SLC16A2;NCOA2;AKR1C1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.5528672010213513,0.9501290022789711,0.5238095238095238,0.9057243888438364,1.0,2/5,11.45%,COLGALT1;CHADL
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.41691532239045925,0.9500587557864157,0.6296296296296297,0.9051095895040808,1.0,2/25,4.13%,DHCR7;ACAA2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5935677300914091,-0.9500149529208465,0.5588235294117647,1.0,1.0,3/8,16.94%,SPINK5;PRELID1;ZFP36L2
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.4998578604180747,-0.9499701078092305,0.5,1.0,1.0,5/20,20.74%,MX1;DNM2;MTFR1L;DNM1L;PEX11B
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.6123996229318358,-0.9498098393438,0.6212121212121212,1.0,1.0,2/5,21.48%,TAP1;TAPBP
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.3732142667459416,0.9497053146979324,0.5,0.9054296868353093,1.0,8/47,8.36%,TP63;LAMA3;ACADVL;ITGA2;HSPB1;BMP7;LMNA;NNMT
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.512762987280001,-0.9494588212957336,0.5324675324675324,1.0,1.0,4/21,14.44%,HES5;HES1;OCIAD2;CRLF3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.37357342162111284,0.9494142828645908,0.5555555555555556,0.9053903632330628,1.0,6/26,13.32%,USP51;H1-10;PPP4R2;SMARCAD1;SIRT6;SETD2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.4985845722488126,-0.9493753824310279,0.5657894736842105,1.0,1.0,3/25,8.27%,NCAPD3;H1-4;TTN
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.4396491952869068,-0.9492274649014871,0.6153846153846154,1.0,1.0,8/51,10.24%,MBNL3;FAM50A;AKAP17A;OAS3;OAS1;IGF2BP2;MED1;SRRM4
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.5737564680913739,0.9491469347005802,0.4791666666666667,0.9050642089448728,1.0,3/7,22.74%,TGFBR2;RBPJ;NOTCH1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.5138277380089096,0.948977925909925,0.5294117647058824,0.9046955790787702,1.0,3/8,5.41%,SGK1;AKR1C3;SLC15A2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.5042252308686458,-0.9489002741414515,0.625,1.0,1.0,4/25,9.68%,ISG15;ALOX5;TGFB1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.5042252308686458,-0.9489002741414515,0.625,1.0,1.0,4/25,9.68%,ISG15;ALOX5;TGFB1;MEF2C
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.44357508152796365,0.9485216988414439,0.5454545454545454,0.9050149810818289,1.0,5/19,19.84%,CNOT2;CNOT6L;CNOT9;CNOT7;PAN3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.5907370835202856,-0.9484771605754714,0.5735294117647058,1.0,1.0,1/6,7.07%,RSAD2
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.49733274451493104,-0.9484427972042103,0.5625,1.0,1.0,3/19,9.67%,PRMT8;FAM98B;SNRPB
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.37963629306428015,0.9481666748760753,0.5,0.9051478384037788,1.0,6/26,6.74%,CHRM3;NEDD4L;HOMER1;FGF12;ANK2;GPD1L
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.6287523833473505,-0.9478274302333015,0.6571428571428571,1.0,1.0,2/5,22.65%,RDH10;CYP1B1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.6293551642075252,-0.9475960455354052,0.578125,1.0,1.0,1/7,7.22%,RASGRP1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.5992840940132697,-0.9475205071988938,0.5833333333333334,1.0,1.0,4/5,34.99%,CCS;SOD2;MT3;SOD1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.43330058656582715,-0.9474479518374962,0.5714285714285714,1.0,1.0,6/63,12.10%,ELOB;POLR2I;POLR2G;GTF2F1;CDK7;NCBP1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.3852366972027885,0.9473839367301072,0.6,0.9063242892836181,1.0,6/36,9.70%,SEPTIN4;STYXL1;BOK;CRADD;BCL2L11;PML
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6347214770616356,-0.9471427824340134,0.6515151515151515,1.0,1.0,2/6,12.70%,CALM1;ATG14
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.5693861758765386,-0.9465944647988483,0.5441176470588235,1.0,1.0,2/5,16.10%,HLA-A;CD55
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5903475018586769,-0.9460962419129005,0.6164383561643836,1.0,1.0,5/7,36.68%,TPST1;TPST2;ENPP1;BPNT2;SULT1C4
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5379779754137226,-0.9460852787095654,0.5441176470588235,1.0,1.0,3/12,10.50%,ITGA4;SFRP4;CD160
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.49231543518636794,-0.945447948103539,0.5316455696202531,1.0,1.0,11/21,25.18%,RPS27A;RFC2;RPA3;UBA52;RFC1;RFC4;LIG1;UBC;RFC3;POLD2;XRCC1
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5793837327889004,-0.9450858125955591,0.6029411764705882,1.0,1.0,2/10,13.74%,STX19;STX1B
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.41805382377159334,-0.9450725140187936,0.6195652173913043,1.0,1.0,22/99,19.87%,NACA;CDC37;HAP1;RPL11;SLC25A6;ICMT;PEX1;TIMM8B;TIMM44;ZDHHC24;ZFAND2B;ZDHHC1;TOMM7;SPCS2;GIPC1;ZDHHC22;ZDHHC15;SEC61G;SRP14;TOMM20;AP4M1;GOLGA7B
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.3915086145154064,0.9448099760586945,0.5652173913043478,0.9110563867236549,1.0,2/16,7.86%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.354076964614114,0.9443790511451741,0.7333333333333333,0.9110984370185944,1.0,5/44,8.59%,ACADS;ACADVL;ACAA2;HADH;ADIPOR2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.37947245264949114,0.9442114093721579,0.5625,0.9108123382134655,1.0,4/19,11.33%,SHANK2;NLGN4X;LRRK2;GRIK3
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.5633870060493901,-0.9440643276544791,0.5625,1.0,1.0,2/8,13.77%,PLEKHH2;VIL1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.5960297794004807,-0.9439595964390757,0.578125,1.0,1.0,3/6,30.67%,SAT2;SAT1;AMD1
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.5048989284848178,-0.9434469824258449,0.547945205479452,1.0,1.0,5/19,26.78%,ATP6V1F;ATP6V0A4;ATP6V0E2;ATP6V1D;ATP6V1E1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.5327980442156549,-0.943444227376228,0.5714285714285714,1.0,1.0,1/11,3.94%,PAH
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.504084730525826,0.9431664638424546,0.52,0.9123938441463574,1.0,2/9,7.86%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.30291117103326215,0.943006448653571,1.0,0.9119932348721747,1.0,83/326,16.35%,MYRFL;SOX11;TP63;ZNF516;MAP3K5;RYBP;ERBB4;ESR1;RXRA;NR1H2;SALL1;SP3;ATF7IP;NDP;MED24;ARID1A;TCF4;MYCN;ZKSCAN3;PPARG;PPM1A;ESRRG;WNT7A;BTRC;MLLT3;TBL1XR1;TP53INP1;FOXK1;PLCB1;RFX3;FOXO1;YAF2;PICALM;SMARCA2;ARID1B;EGFR;NPAS3;BMP7;NFIB;RORA;TRERF1;PRDM11;NFATC1;KAT2A;RSF1;AFAP1L2;FBXW11;ATOH8;HDAC4;PML;KAT8;MITF;SOX8;ZBTB16;SPIN1;TRIM28;HNRNPD;CAND2;ZMIZ1;MYRF;PRDM16;ACVR1;KDM5A;SOX10;RAI1;NAA16;FOXO3;NFIL3;ARHGEF11;GLIS2;MAP3K2;KLF6;PSRC1;NOS1;MAP2K2;SP1;CEP290;ETS2;TEAD1;ZNF496;VHL;TRIP4;IKBKB
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.29300633932395026,0.9427879272421273,0.6666666666666666,0.9117924887821314,1.0,15/102,11.25%,USP51;HSPA1A;AIFM2;RPA1;BAG2;ATR;ABL1;SIRT1;MAPK1;NUP98;NUP93;MAPK3;HSPH1;SMG1;MLST8
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.537065273327477,-0.9427368563832926,0.5333333333333333,1.0,1.0,4/9,32.15%,IL7;IFIH1;AXL;WNT5A
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5647779492565181,0.9419633265593221,0.5813953488372093,0.9129002073825756,1.0,2/6,12.04%,ARFGEF2;LMTK2
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.6439261670256935,-0.9417452087208537,0.65,1.0,1.0,1/5,4.72%,CAMK1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.5368824641921298,-0.9416453601488233,0.6486486486486487,1.0,1.0,1/12,1.45%,PARP2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.5128509694953787,0.9414608662803052,0.5384615384615384,0.9136935939290624,1.0,3/6,13.97%,LIG4;PTPRC;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.5340410506484226,-0.941387153782099,0.5362318840579711,1.0,1.0,3/12,25.53%,HAX1;ID2;RUNX1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.6579359661418629,-0.9413415468109763,0.6417910447761194,1.0,1.0,4/5,33.68%,SLC6A6;ASAH1;MT3;HEBP2
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.47289643904473727,-0.9412434603905838,0.5909090909090909,1.0,1.0,3/33,6.88%,SFRP1;PFN2;S100A10
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.4749054997113943,-0.9412362483326829,0.5384615384615384,1.0,1.0,6/24,18.86%,TGFB1;ANKLE2;CALM1;PTPA;PPP2R5A;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.5444974203184579,0.9410872512261297,0.5185185185185185,0.9138184900846903,1.0,4/9,16.40%,POT1;UBE2N;TERF1;TERF2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4110073464596874,-0.9410476154664871,0.6145833333333334,1.0,1.0,24/137,19.75%,MX1;HAP1;COX7A2;TFAM;SLC25A6;HAX1;SLIRP;TIMM8B;CHCHD2;HIGD1C;TIMM44;CHCHD10;TOMM7;DNM2;TYMP;SPG7;SUPV3L1;IFIT2;MTFR1L;BAX;AIFM1;AFG3L2;DNM1L;TOMM20
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.381457322895616,0.9409674518738571,0.5,0.9133190451930604,1.0,8/30,18.42%,RAB27A;ARFGEF2;SNX33;WASHC5;TMCC1;CORO1C;SNX3;DNAJC13
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4840472535708159,-0.9409586446807292,0.6206896551724138,1.0,1.0,4/24,17.33%,HES5;B9D1;ULK3;STIL
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.33677433598655904,0.9406911188145851,0.5,0.9130896957019667,1.0,23/102,10.91%,DHCR7;BCAR1;AOX1;FKBP5;BOK;PLIN5;PC;CHST3;CDC42EP4;MPDZ;SH3D19;SLC16A2;SLC7A2;MAGI1;EGFR;UNC13B;RORA;KCTD3;ADCY6;MMP15;GPC1;CLDN12;PTPRU
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.5478604213734013,-0.9401577461794827,0.5324675324675324,1.0,1.0,1/9,1.74%,VEGFA
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.5616590460114379,-0.9396837628542422,0.5652173913043478,1.0,1.0,1/7,7.01%,KIF20B
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.5727270695618454,-0.9394588620068102,0.6285714285714286,1.0,1.0,4/9,20.52%,TLE6;ZBED3;RACK1;RBM19
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.3413798299161482,0.9391699788322244,0.45454545454545453,0.9159623066264697,1.0,19/103,6.81%,SPSB4;POU6F2;DPYSL5;ERC2;PPM1E;CSRNP3;ERBB4;DCX;BTBD17;ASTN1;PBX1;SIRT1;ADGRL3;NOL4;GAL3ST3;UNC5D;VLDLR;GRID2;SLC8A2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.44026102556034963,-0.9391532006827356,0.5824175824175825,1.0,1.0,9/51,15.38%,CRYM;LHFPL5;SLC26A5;CEMIP;NDUFB9;TIMM8B;ATP6V0A4;PJVK;MYO3B
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.5594243325129576,-0.9390096659149967,0.6470588235294118,1.0,1.0,1/8,7.01%,KIF20B
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.43268535835383226,-0.9389120768708272,0.5833333333333334,1.0,1.0,7/47,11.75%,OPRM1;GALR1;SVOP;PDE6B;SRRM4;SLC6A6;SLC7A14
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.5655207514156815,-0.938502782911012,0.5909090909090909,1.0,1.0,2/10,6.01%,VDAC2;BLOC1S2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.38482552892691424,0.9382907900148408,0.631578947368421,0.9174010792278451,1.0,12/32,22.91%,HSPA1A;TRAF1;MADD;CFLAR;ADAM17;OTULIN;IKBKB;PRKN;TRAF2;CYLD;HIPK1;RBCK1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.45963055022520816,0.9381454382618404,0.5806451612903226,0.916999359215458,1.0,3/11,11.23%,AK3;CMPK1;PNP
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5377534912497585,-0.9378632877548855,0.6338028169014085,1.0,1.0,4/9,21.59%,AP2A1;CLTA;MYLIP;AP2A2
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5377534912497585,-0.9378632877548855,0.6338028169014085,1.0,1.0,4/9,21.59%,AP2A1;CLTA;MYLIP;AP2A2
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.563390365516113,-0.9378495582023935,0.6027397260273972,1.0,1.0,1/8,12.82%,DDX11
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.42287502208709316,-0.9372803030598307,0.5909090909090909,1.0,1.0,12/59,23.56%,SPDYA;CDKN2C;BACH1;MAX;CAMK2A;CDK7;CRLF3;CDKN2A;CDK16;EIF4EBP1;DBF4;CDK4
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.41923799134014217,0.9368912057261115,0.625,0.9191132195852033,1.0,2/23,4.13%,DHCR7;ACAA2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.49104535764516477,-0.9368849060283608,0.5316455696202531,1.0,1.0,2/22,3.29%,PPIF;PPIB
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.5454228341626898,0.9367722759041454,0.5483870967741935,0.9186260743303417,1.0,3/7,15.34%,POT1;ERCC4;TERF1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2892686628813858,0.9367717143032553,1.0,0.9178998877103177,1.0,81/383,15.60%,TP63;RNF139;HDAC9;ATR;DPF1;NR1H2;NPAS1;SALL1;HDAC10;SP3;ATF7IP;PDS5A;SUV39H2;TSHZ3;ZKSCAN3;SIRT1;CREB3L1;MBD2;PPARG;PTPRK;BTRC;LIMD1;CTBP1;ZHX2;TLE1;KCTD1;RUNX1T1;FOXK1;PSPC1;PLCB1;RFX3;FOXO1;MTERF3;FOXP1;PHC2;YAF2;SMARCA2;ATXN1;BMP7;EED;TRERF1;SYNCRIP;PRDM11;RSF1;FBXW11;ATOH8;HDAC4;MECP2;PML;PROX1;KAT8;ZNF282;ZFPM2;SOX8;ZBTB16;EIF4E2;RBM15B;TRIM28;ZNF93;TOB1;PPM1F;LSM14A;NKRF;PRDM16;TRIM71;CAPRIN1;RIDA;NR3C1;NAB1;NFIL3;NACC1;ZHX3;CHMP1A;GLIS2;BCOR;ZMYND11;CNOT9;TERF1;NIPBL;MTA3;TCF7L2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.44655058770132205,-0.9365944395088283,0.575,1.0,1.0,5/40,6.96%,RBM3;RPL10;TGFB1;AGT;RBM4B
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.5591440812951104,-0.9365892409366262,0.5757575757575758,1.0,1.0,4/9,26.02%,ARG2;CYP1B1;NQO1;CYB5R3
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5591440812951104,-0.9365892409366262,0.5757575757575758,1.0,1.0,4/9,26.02%,ARG2;CYP1B1;NQO1;CYB5R3
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.4130751471771095,-0.9365601511233511,0.6703296703296703,1.0,1.0,12/84,14.77%,HES5;ELOB;RIMS1;HES1;TUBGCP2;ZW10;TUBGCP4;NDUFAF1;CHCHD10;FANCC;VIL1;SPG7
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.3297479343369245,0.9361136047479569,0.5789473684210527,0.9184575314746508,1.0,16/63,11.46%,CORO6;SORBS2;ASB5;SYNPO2;CPT1A;PDLIM5;PDE4D;DMD;VLDLR;PDE1A;STRN;PRKG1;ADIPOR2;MITF;ZFPM2;MYOM1
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.4839862117760074,0.9359196864236222,0.5862068965517241,0.9172903240279381,1.0,1/7,0.40%,CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.4839862117760074,0.9359196864236222,0.5862068965517241,0.9172903240279381,1.0,1/7,0.40%,CRB2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.5725703042078333,-0.9354284399691329,0.5737704918032787,1.0,1.0,2/8,17.10%,AGT;APOE
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.32463615635151266,0.9347902544424348,0.6,0.9188596008153235,1.0,10/35,14.29%,ZDHHC2;EPHA3;ATP2C1;SPTBN1;EGFR;ATP2B4;DPP10;ACSL3;CNST;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.5082104045788982,-0.9346625371890702,0.5694444444444444,1.0,1.0,4/16,12.64%,HAP1;GSTO1;CEMIP;CALM1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.4451084141333077,0.9346039363416738,0.55,0.9185295180026538,1.0,2/16,4.06%,SOX11;DSCAML1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.29409899642716686,0.9344479011953073,0.6666666666666666,0.9181999545964558,1.0,37/124,18.24%,RANGAP1;ARAP1;EVI5L;DOCK9;RAP1GDS1;RGS7;PKP4;SEMA4D;TBC1D14;PICALM;TBC1D12;SNX18;SGSM1;ARHGAP42;RABGAP1;TBC1D1;TBCK;RAPGEF6;MAP4K4;TIAM2;RAPGEF2;ARHGAP22;MAPRE2;TBC1D8B;DOCK11;DOCK10;RAP1A;SIPA1L1;ARHGEF7;CORO1C;CDKL5;RABGAP1L;RALGAPA2;SRGAP2;TBC1D5;RALGAPA1;NF1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.4435132129024475,-0.934368498274029,0.5308641975308642,1.0,1.0,7/32,18.42%,B2M;FLOT1;CLU;GPC3;C3;APOE;CALY
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.33937611667150214,0.9342122314921552,0.6666666666666666,0.9180392565512034,1.0,4/31,8.59%,UBE3D;OBI1;RAD18;MARCHF7
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.41348649546666705,-0.9341334213042357,0.6206896551724138,1.0,1.0,19/105,19.08%,ERCC6L;RPS27;RAB11A;ABRAXAS1;ZW10;CENPH;SMC1A;BUB3;ITGB3BP;DYNC1LI2;PTPA;SEC13;MIS12;NEK6;CENPC;DCTN6;STIL;MZT1;NUP107
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.5975086515203231,-0.9339940252379861,0.582089552238806,1.0,1.0,2/5,13.74%,NAPA;STX1B
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.48103923357793865,-0.9338803770369074,0.5975609756097561,1.0,1.0,8/23,22.91%,PPIF;ECT2;HDAC6;RNF112;MAPK13;OSER1;CYP1B1;PARK7
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.42567264342487277,-0.9336156472094621,0.5652173913043478,1.0,1.0,5/60,9.59%,POLR2I;POLR2G;TGFB1;NUP155;DND1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.3691481681799612,0.9336125575518872,0.6923076923076923,0.9186077423625393,1.0,9/26,11.27%,NAF1;MAPK1;TNKS;MAP3K4;MAPK3;MAPKAPK5;PML;SIRT6;HNRNPD
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5661331367341061,-0.9336055354683924,0.6351351351351351,1.0,1.0,5/10,25.39%,RACK1;NR4A3;TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.6216305805782543,-0.933587101578486,0.6507936507936508,1.0,1.0,3/5,32.48%,DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.6216305805782543,-0.933587101578486,0.6507936507936508,1.0,1.0,3/5,32.48%,DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.429672359337176,-0.9333985201806211,0.625,1.0,1.0,8/58,10.49%,VEGFA;FGF1;HTR2B;TRIB1;TGFB1;AGT;RASGRP1;PIK3CB
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.29361639874987083,0.9332232942230302,0.5,0.9185870455877606,1.0,30/167,13.64%,SPSB4;RNF144A;WDR81;FBXL4;NEDD4L;FEM1A;MIB1;KLHL8;RNF150;BTRC;UBE2G1;HACE1;KEAP1;UBE2D1;NDFIP2;SPSB1;UBE2H;NEDD4;RCHY1;FBXL7;PSMD13;ANAPC4;CDC16;UBE3C;ADRM1;RNF11;RNF128;RNF217;ANAPC1;FBXO11
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.4913648354115613,-0.9326716177022258,0.56,1.0,1.0,4/19,22.31%,CLU;P2RX4;HSP90AB1;CAV1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.3222701636087358,0.9325138756987187,0.6666666666666666,0.9198120183697298,1.0,16/61,14.09%,SMAD9;PARD3;SIRT1;PTPRK;SMAD7;GCNT2;TGFBRAP1;TGFBR2;LPXN;TWSG1;USP9X;MAP3K7;ZMIZ1;ACVR1;USP15;SMAD1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5226450783093898,0.9322911011309901,0.5428571428571428,0.9196785306148062,1.0,4/9,12.92%,FOXO1;ATP2B4;LMNA;GLRX3
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.4391383099969648,-0.9322098023708089,0.5365853658536586,1.0,1.0,5/46,10.24%,MBNL3;RBM8A;DDX5;CELF4;SRRM4
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.5699389433134165,-0.9321601529374053,0.6363636363636364,1.0,1.0,3/8,18.33%,HAS2;MEF2C;HDAC3
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.32426966950401914,0.9320099038565363,0.5625,0.9196989659505599,1.0,6/42,4.34%,ADAM10;SORBS2;KAT2B;DTX4;MIB1;PBX1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.3413430149261147,0.9319609835390826,0.4166666666666667,0.919035178969459,1.0,6/58,6.74%,PHLDB2;ARAP1;PPM1E;ABL1;ARHGAP28;TMEFF2
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.5705164920967701,0.9319210604659894,0.5151515151515151,0.9184700950228719,1.0,1/5,0.39%,SOX11
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5667285338376997,-0.9318728152715281,0.5857142857142857,1.0,1.0,1/7,6.63%,PARP14
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.6021135438587342,-0.9317757371530503,0.6428571428571429,1.0,1.0,2/6,13.57%,EFNA1;GRN
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.4289589082135157,-0.9315940876619436,0.5681818181818182,1.0,1.0,7/51,22.55%,POLR2I;POLR2G;NUP155;SEC13;NUP107;NUP188;NUP85
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.4289589082135157,-0.9315940876619436,0.5681818181818182,1.0,1.0,7/51,22.55%,POLR2I;POLR2G;NUP155;SEC13;NUP107;NUP188;NUP85
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3543912560087909,0.9315055163571718,0.4666666666666667,0.9187841928204444,1.0,27/79,19.04%,HSPA1A;SMAD9;SPRED2;CRIM1;SIRT1;PPARG;PPM1A;SMAD7;MAGI2;UBE2D1;TGFBR2;SPART;CHRD;PRDM16;ACVR1;BMPR1B;ADAM17;SMAD1;SPRED1;IGSF1;VWC2;GREM1;LEMD3;BMPR1A;SMAD5;FAM89B;PDPK1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5767294465969445,0.9314886392964268,0.6470588235294118,0.9180808833811046,1.0,4/7,19.39%,ANK2;ANXA6;DIAPH1;PTK2B
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.5915801579033142,-0.9313185124758369,0.640625,1.0,1.0,3/6,22.31%,LIN7B;AP4M1;CAV1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5133320552254214,-0.9312552508357796,0.5769230769230769,1.0,1.0,2/15,5.88%,SFRP1;TGFB1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.5666571294321863,-0.9309554010854003,0.6119402985074627,1.0,1.0,1/7,12.82%,DDX11
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.5219796364772469,-0.9306426067807971,0.6527777777777778,1.0,1.0,4/17,19.68%,HES5;TYMP;NSUN5;PTN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.4570078969616999,0.9305356737523399,0.5833333333333334,0.9193413208711944,1.0,3/9,8.27%,NEDD4L;PICALM;SNX33
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.4905155749658161,-0.9301252300236496,0.6266666666666667,1.0,1.0,9/19,34.49%,ALOX5;APOD;CHID1;PLD3;ADCY7;CUEDC2;PDCD4;APPL1;STAT3
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.46486989329266515,-0.9301045839319512,0.5802469135802469,1.0,1.0,4/34,9.68%,HTR2B;TGFB1;DDX5;MEF2C
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.6386589850091295,-0.9299519827207714,0.6615384615384615,1.0,1.0,2/5,25.93%,FUZ;NPHP1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.25551140838933517,0.9299074261050922,1.0,0.9198904522605044,1.0,50/235,17.37%,STK36;NINL;EHD1;DCX;FNBP1L;SEPTIN6;TUBG1;DYNC2LI1;IFT140;RFX3;HAUS2;RABL2B;CDC14A;CNTRL;BBS4;PCM1;TRAF3IP1;TTLL3;SFI1;CEP41;IFT172;TCTN2;NEDD1;CSNK1E;SSX2IP;KIF3C;UNC119B;OCRL;CLASP1;EXOC2;PCNT;CDC14B;RAB3IP;CEP20;EXOC6;CEP89;TMEM138;HAUS6;ARL3;SPAG16;CEP290;GBF1;RILPL2;EXOC4;C2CD3;TTC39C;MACIR;GALNT11;GORAB;ATAT1
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.567919131000722,-0.9298823084237786,0.5362318840579711,1.0,1.0,3/7,21.66%,RFC2;RFC4;RFC3
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.567919131000722,-0.9298823084237786,0.5362318840579711,1.0,1.0,3/7,21.66%,RFC2;RFC4;RFC3
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.29989929386287817,0.9296405794364616,0.6666666666666666,0.9198689176803125,1.0,13/104,9.88%,SHROOM2;CORO6;HIP1;BCAR1;GAS2;SHROOM3;MYO7A;RHOBTB1;ABI1;WASL;RAC3;NEBL;PROX1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.4411941613235899,0.9292895145790211,0.6,0.9200834956966972,1.0,3/12,8.93%,TNK2;BMP2K;WASL
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.5806146323651168,-0.9292104870452671,0.6142857142857143,1.0,1.0,4/7,33.12%,SLC6A6;SLC36A4;SLC7A10;SLC36A1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.44244615340075133,-0.9289137730751401,0.5930232558139535,1.0,1.0,14/48,23.37%,SFRP1;CTSL;XBP1;MEF2C;MED1;LMO2;NR4A3;PELP1;SRA1;LOC400499;CAV1;PAX8;RDX;RARA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.4877313105839196,-0.9287996787206488,0.6,1.0,1.0,3/15,17.31%,TGFB1;TMBIM1;PPP2R5A
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.49521915139323514,-0.9286966183260307,0.5897435897435898,1.0,1.0,3/19,5.88%,SFRP1;H2AZ1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.4879076287127286,0.928680710348475,0.5833333333333334,0.9209637978913165,1.0,1/13,0.35%,PHLDB2
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.43188475582735164,-0.928499441165258,0.5730337078651685,1.0,1.0,7/47,13.79%,PPIF;ROMO1;ECT2;JUN;HDAC6;PRDX5;PJVK
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.4426567436406307,0.9283041426765478,0.5,0.9210524029119929,1.0,4/13,15.16%,PPP2R2C;PPP3CA;PPM1F;PPP2R2B
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4204008587659263,0.9282290409373404,0.6,0.9205589746616063,1.0,4/15,16.53%,BBS4;PCM1;NEDD1;C2CD3
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.4762949129789179,-0.9282057977381177,0.6301369863013698,1.0,1.0,3/22,7.66%,SLC2A3;GSTO1;TBXAS1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.5472917456785479,-0.9280036007996506,0.6567164179104478,1.0,1.0,5/8,33.07%,PYGL;GBE1;PHKB;PHKG2;UGP2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3903686511264687,0.9274868233651928,0.5,0.921575298287343,1.0,6/20,7.76%,NLGN1;ATP2C1;CDH20;CDH9;CDH10;CDH18
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.43346607923112995,-0.9270058118388241,0.6129032258064516,1.0,1.0,17/61,23.31%,ERCC6L;FANCI;PRMT8;ATAD5;CENPH;BEND3;PPAT;RFC4;NCL;NUP107;PAICS;MSH6;RFC3;SET;TRIM32;PIF1;KNTC1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.36588870630592013,0.9269257882220707,0.6666666666666666,0.9222857162775593,1.0,31/115,13.85%,SOX11;SH3RF1;TAFA1;RACGAP1;NLGN4X;DCX;ASTN1;RYK;IL1RAPL1;WNT7A;ADGRL3;ADNP2;FZD3;NAV1;NRCAM;OPHN1;ATOH8;SEMA3A;RELN;USP9X;MDGA1;FUT9;AUTS2;ACSL4;ACSL3;NRP1;RAPGEF2;CEP85L;DTNB;ELP3;DLL1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6202964292155552,-0.9265992876198712,0.6376811594202898,1.0,1.0,2/6,9.38%,ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.523699599745291,-0.9262268835561572,0.6219512195121951,1.0,1.0,5/14,18.32%,VAV3;LAT2;MEF2C;BLNK;BAX
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.6431954142735012,-0.9261340310089695,0.6666666666666666,1.0,1.0,1/5,5.88%,TGFB1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.34262990804054233,0.9259761791839176,0.47058823529411764,0.9236032221137546,1.0,12/38,18.29%,EYA4;SIRT1;EYA2;EGFR;UBR5;PML;TRIM28;UBE2N;TRIP12;EYA3;WRNIP1;UBE2V2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.33781912231345784,0.9258966887841183,0.5454545454545454,0.9229988530627433,1.0,22/147,10.27%,VAPB;COL7A1;SEC24D;TRAPPC12;COG6;PREB;VTI1A;CNIH2;TMED5;ANK2;COG3;SPTBN1;GRIA1;TRAPPC8;BET1;CAPZB;COG5;TMED3;NSF;SEC16A;TGFA;VAPA
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.46081490440363915,0.9258797765977069,0.5384615384615384,0.9223402145097973,1.0,2/9,13.62%,CABYR;SPEF2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.4964054999751429,-0.9258206802217559,0.5555555555555556,1.0,1.0,1/18,1.74%,VEGFA
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.4019576593994151,-0.9257513549374542,0.6847826086956522,1.0,1.0,25/186,16.49%,EPN1;MX1;TRIP10;RIMS1;RPS27A;EMD;COX18;M6PR;CHRM2;CFTR;NAPA;NUP155;AZIN2;AP2A1;SH3GL2;CLTA;DNM2;LPCAT3;DVL2;MTCH1;BAIAP2L2;UBA52;NEMP1;CHMP4B;TMEM43
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6123018872773618,-0.9256896709281377,0.6417910447761194,1.0,1.0,2/6,20.74%,DNM1L;PEX11B
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.483391986595136,0.9254518865383006,0.5333333333333333,0.9217976560824902,1.0,4/8,17.19%,ACER3;SPTLC2;ABCA2;ACER2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.483391986595136,0.9254518865383006,0.5333333333333333,0.9217976560824902,1.0,4/8,17.19%,ACER3;SPTLC2;ABCA2;ACER2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5164138276925851,0.92500056499237,0.5333333333333333,0.9220777702937414,1.0,2/6,8.99%,MAPK1;MAPK3
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.5185094087372508,0.924915779706468,0.5294117647058824,0.9215456998566116,1.0,1/7,7.56%,RNF2
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.5363739170188153,-0.9249070934769679,0.6164383561643836,1.0,1.0,1/9,6.56%,PRELID1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.5235708094394511,0.924774285465486,0.5757575757575758,0.9211381805366677,1.0,3/6,12.66%,SEMA3A;CHRNA7;NRP1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5126866536419037,0.9246490273788553,0.5161290322580645,0.9207312886521666,1.0,3/9,10.79%,ZNF516;SPTLC2;SOX8
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.5316573101714064,-0.9244416386853478,0.6197183098591549,1.0,1.0,1/8,9.86%,LACTB2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3827911874308039,0.9242480855208938,0.42105263157894735,0.921107448646315,1.0,3/28,7.90%,CRB2;GCNT2;TGFBR2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.37747004529006634,0.9242043908979565,0.5,0.9204954626036824,1.0,4/21,12.24%,SLC25A18;SLC7A2;SLC1A2;SFXN1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.4312633374572885,0.92398994232322,0.64,0.9202544701092711,1.0,3/12,12.69%,SAXO2;PCM1;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4649025694042237,-0.923711865636129,0.5802469135802469,1.0,1.0,2/20,5.88%,JUN;TGFB1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.57843807345314,-0.9236083262269982,0.7066666666666667,1.0,1.0,1/8,1.96%,TAF7
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.4153009418370311,-0.9232325638578819,0.5913978494623656,1.0,1.0,28/94,30.16%,PSMB9;RPS27A;PSMB8;PSMA3;RPA3;CDK7;SMARCA5;H2AX;PSME1;UBA52;PSMA7;PSMB6;UBC;GMNN;XPA;RBX1;PSMC4;SOX9;PSMB1;PSMD2;PSMB3;PSMC3;DDB2;PSMC5;PSMD7;PSMA4;ASF1A;ANP32B
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.4210745744260685,0.9229402227557738,0.5555555555555556,0.9219448658954731,1.0,3/23,8.55%,NR1H2;PLIN5;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3918064175518375,-0.9226951580086572,0.6938775510204082,1.0,1.0,12/151,7.87%,BEX1;TRIM5;VEGFA;RPS27A;DDRGK1;RTKN2;TRIM25;FLOT1;CLU;AGT;COPS5;TRIM41
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.41573524832652337,-0.9224453934735585,0.5764705882352941,1.0,1.0,19/77,25.69%,VEGFA;FLOT1;CAMK1;CLU;TGFB1;GPC3;DCTN1;RACK1;APOE;WARS1;BAX;CALY;MTLN;RHOC;PARK7;FRMPD4;SLF1;RUNX1;TMED9
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.47003017570205763,0.922063641830193,0.5,0.9234684530897403,1.0,6/15,16.85%,GPSM1;CPEB2;LRRK2;WNK1;LRCH1;ARFGEF1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.42995240250859035,-0.9218748897419567,0.6309523809523809,1.0,1.0,5/37,14.87%,DENND3;SIDT2;NCBP1;RNASEH2C;SUPV3L1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.3935792103446486,-0.9218392552804185,0.6593406593406593,1.0,1.0,7/105,5.47%,TRIP10;ARHGAP15;A2M;VAV3;ECT2;RASGRF2;ARHGEF18
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.5301197294168183,-0.9214218087996415,0.576271186440678,1.0,1.0,1/9,3.39%,TFAM
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.4889006861129675,-0.9213221030135272,0.6111111111111112,1.0,1.0,4/19,16.10%,TRIM5;IRF1;ERAP1;CD55
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.38948943747634734,0.9211933775624422,0.5454545454545454,0.9245247832654108,1.0,2/22,0.95%,COL7A1;LAMA3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.44010147858615856,0.9211082135647771,0.6,0.9239945057999216,1.0,3/14,7.41%,ESR1;ABL1;ABL2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.5121756050902044,-0.9209792691456118,0.6438356164383562,1.0,1.0,1/14,1.74%,VEGFA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4715992375339072,-0.9209011788396351,0.6125,1.0,1.0,7/25,24.84%,RPS27A;RPA3;CDK7;UBA52;UBC;XPA;RBX1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.5884031954717655,-0.9208342628652374,0.7014925373134329,1.0,1.0,5/7,21.67%,RPL11;RPL23;RPS7;RPL5;USP44
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.4792094571962868,0.9207445390594841,0.5,0.9240384763818833,1.0,2/9,10.62%,RFWD3;FBXO31
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.5188069624705557,-0.9204916761489954,0.631578947368421,1.0,1.0,1/12,1.74%,VEGFA
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5972109091988808,-0.9202771061890193,0.6818181818181818,1.0,1.0,4/5,39.99%,B3GALT5;B4GAT1;B3GNT7;B3GALNT1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.38006703485425836,0.920076003361716,0.4090909090909091,0.9247508776282981,1.0,6/17,16.40%,PRELID3B;OSBPL5;OSBPL8;PITPNA;PCTP;PRELID3A
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.4007530716120745,0.9196856845591989,0.5909090909090909,0.9249714242991401,1.0,7/16,27.46%,ADCY6;PRKACB;ADCY2;ADCY9;PRKAR1B;CREB1;PRKAR2A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.45547602796526343,0.9196292785389288,0.5172413793103449,0.9244560470396465,1.0,7/10,23.85%,ERBB4;ZFPM2;RBPJ;BMPR1A;TGFBR3;NOTCH1;AKAP6
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.49175179134057506,-0.9195778456202883,0.7073170731707317,1.0,1.0,2/18,8.03%,TUBGCP2;TUBGCP4
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4581053446596396,0.9192470662896027,0.5416666666666666,0.924853432879507,1.0,6/14,16.40%,NAF1;POT1;TNKS;ERCC4;TERF1;TERF2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5008946475316076,-0.9191603477885055,0.6875,1.0,1.0,5/23,17.65%,EMD;COX18;TRAM1L1;SEC61G;CCDC47
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5365699849239798,-0.9191035556866387,0.6111111111111112,1.0,1.0,2/10,14.47%,TK2;TYMP
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.6187438079942519,-0.9190384071576898,0.6825396825396826,1.0,1.0,3/5,32.86%,BEND3;KMT5C;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.6187438079942519,-0.9190384071576898,0.6825396825396826,1.0,1.0,3/5,32.86%,BEND3;KMT5C;SMYD5
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.49512762661996135,0.9187664389183291,0.48484848484848486,0.9253590227106234,1.0,2/9,10.44%,SLC2A6;SLC2A9
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.33949547994806917,0.9187299720371392,0.4444444444444444,0.9247629826386482,1.0,16/82,9.30%,SATB2;ESR1;KAT2B;ZBTB1;ARID1A;SUV39H2;SIRT1;MBD2;BAZ2B;SMARCA2;ARID1B;SMARCAD1;KAT2A;RSF1;HDAC4;BAZ1B
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.4749799823213099,-0.9184907147429796,0.6153846153846154,1.0,1.0,3/23,5.96%,ROMO1;TGFB1;AGT
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.4880360141176374,-0.9180996958132442,0.6052631578947368,1.0,1.0,9/28,28.98%,PPIF;SPG7;MICOS13;SLC25A5;HSPA9;GHITM;RCC1L;BNIP3;DNAJC11
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.5735711894042624,-0.9180794584545862,0.640625,1.0,1.0,2/6,31.82%,FBN2;RARG
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5362529243260884,-0.9179270560160329,0.6197183098591549,1.0,1.0,3/13,19.61%,SLIRP;SUPV3L1;DNM1L
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4043733663549189,0.917689628258034,0.6,0.9261370249326529,1.0,9/24,11.21%,NEDD4L;HECW2;FGF12;DMD;GPD1L;NETO1;FGF14;NEDD4;WNK1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.616355318857617,-0.9176637716247238,0.65625,1.0,1.0,1/5,15.66%,CTDP1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.5395825108722132,-0.9174442447485174,0.6103896103896104,1.0,1.0,2/11,9.80%,TTN;OBSCN
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.45029358614674103,-0.9172570140981666,0.675,1.0,1.0,3/31,13.47%,MX1;CEACAM1;DNM2
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5278766187397728,0.9170630000565299,0.5789473684210527,0.9268847486473581,1.0,2/6,15.12%,UBR5;TRIP12
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.560662588620182,0.9170313945610218,0.6136363636363636,0.9262617882047351,1.0,2/5,18.42%,TRIM62;PRKN
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.582904268414278,-0.9168639681278338,0.6666666666666666,1.0,1.0,2/6,10.42%,VEGFA;SLC22A4
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.5801040298655329,-0.9168520088156015,0.6515151515151515,1.0,1.0,3/7,25.98%,RACK1;TNFRSF1A;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.5801040298655329,-0.9168520088156015,0.6515151515151515,1.0,1.0,3/7,25.98%,RACK1;TNFRSF1A;SPHK2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5483144755071125,-0.9167521578456255,0.6376811594202898,1.0,1.0,1/7,10.33%,APH1A
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.3305445369513661,0.9165531481284381,0.625,0.926655992528875,1.0,20/108,12.63%,HIP1;ERBB4;ESR1;IRS1;RICTOR;AKR1C2;GAB1;SIRT1;AKR1C3;IGF1R;MAGI2;GCNT2;NRG2;STRN;EGFR;TGFA;MFHAS1;PIK3CA;THEM4;FRS2
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.3939008802221411,0.9165167729242185,0.6071428571428571,0.9260341509610651,1.0,4/29,8.83%,MAPK11;HSPA1A;ABCB10;MAPK14
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5334943572466563,-0.9163411463292194,0.6119402985074627,1.0,1.0,2/9,16.24%,GABARAPL2;MAP1LC3B2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5334943572466563,-0.9163411463292194,0.6119402985074627,1.0,1.0,2/9,16.24%,GABARAPL2;MAP1LC3B2
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.5570037813935121,-0.9160376649848179,0.6153846153846154,1.0,1.0,6/7,31.48%,IGSF6;MYO1F;PSTPIP1;AOAH;SPI1;ITGAL
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.3480444697374266,0.9159219394764105,0.5,0.9266173366672805,1.0,19/87,13.80%,HSPA1A;BAG2;FBXW7;SEPTIN4;FAM107A;PRMT3;INAVA;SMAD7;HSPBP1;UBE2D1;GNL3L;NDFIP2;XIAP;LRRK2;RCHY1;UBE2N;BAG5;WASHC1;N4BP1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.4314040247011574,-0.9158909745807331,0.620253164556962,1.0,1.0,8/35,22.88%,EIF2B2;XBP1;STAT5A;KHK;ZBED3;STAT1;CAV1;STAT2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.48330115165417087,-0.9158869037732399,0.625,1.0,1.0,4/18,12.74%,RANGRF;SLC4A3;SLC30A4;WNK3
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.35947152658442794,0.9158795623886532,0.5555555555555556,0.925996466568408,1.0,15/43,13.61%,SH3RF1;DCX;ASTN1;ADGRL3;NAV1;NRCAM;SEMA3A;RELN;USP9X;MDGA1;AUTS2;NRP1;RAPGEF2;CEP85L;ELP3
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.4867036720740068,-0.9157331450407296,0.5679012345679012,1.0,1.0,1/18,1.74%,VEGFA
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4487190005618736,-0.9155697681393941,0.5764705882352941,1.0,1.0,4/34,9.67%,ICMT;PRMT8;FAM98B;SNRPB
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.48671731007917624,-0.9155536147624914,0.5857142857142857,1.0,1.0,3/17,13.47%,NOSTRIN;CALM1;DNM2
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.6254238025927922,-0.9154652084853698,0.7391304347826086,1.0,1.0,1/5,12.64%,CALM1
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.554932329418469,-0.9154043694358405,0.6025641025641025,1.0,1.0,4/8,31.93%,TRMT10C;POP4;HSD17B10;RPP30
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.5345571822562667,-0.9151945418392641,0.5694444444444444,1.0,1.0,2/8,8.63%,TRIM41;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.32402007040096314,0.9150118207226513,0.6666666666666666,0.9274163282599266,1.0,23/101,12.55%,EPHA3;FBXW7;ERBB4;RYK;MERTK;NAF1;IGF1R;MAPK1;POT1;DCUN1D2;EGFR;TNKS;DCUN1D5;MAP3K4;MAPK3;MAPKAPK5;ROR2;SERINC5;CHRNA7;HNRNPD;UBE2N;LMTK2;DSCC1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.5099300479365906,-0.9148920809968814,0.6447368421052632,1.0,1.0,2/12,10.69%,RPL23;SMARCD1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.617532949060355,-0.9148883271210695,0.6842105263157895,1.0,1.0,3/5,33.76%,ANAPC2;CPLX2;ADCY8
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.41852309512576813,-0.9147182918962671,0.5909090909090909,1.0,1.0,3/61,7.22%,DENND3;ARHGEF18;RASGRP1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.5294549219145747,-0.9146206452652749,0.6197183098591549,1.0,1.0,2/10,17.99%,CCT7;DKC1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.3391068814321992,0.9143942955613927,0.6470588235294118,0.9282401150887205,1.0,4/36,3.74%,NAV3;ABL1;MAP2;CAMSAP2
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.5674152583238408,-0.9143624861323247,0.5735294117647058,1.0,1.0,1/5,7.84%,GRIN2D
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3367045334829978,0.9139329567942384,0.36363636363636365,0.9287119651069847,1.0,26/75,20.88%,SH3RF1;MAP3K5;TRAF1;MAP3K11;WNT7A;IGF1R;MAP4K2;PLCB1;SH3RF3;EGFR;SEMA3A;MFHAS1;HMGB1;MAP4K4;TRAF5;RAP2A;ZMYND11;MTURN;PINK1;PRKN;TRAF2;PTK2B;TGFBR3;TRAF4;CYLD;RASSF2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.6335833491267046,-0.913784920709806,0.609375,1.0,1.0,1/5,2.32%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.3992581359277656,-0.9137671017766444,0.5977011494252874,1.0,1.0,9/63,13.77%,VEGFA;FGF1;ENPP2;RAB11A;AGT;HDAC6;PIK3CB;GRN;VIL1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.44321257133599556,0.9136830379642774,0.5806451612903226,0.9285226829875562,1.0,3/9,19.41%,ADCY6;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.38265170359122436,0.9136715256801912,0.6,0.927889250023135,1.0,8/26,10.40%,NLGN4X;NLGN1;WNT7A;NRXN1;SLC8A2;RELN;CHRNA7;LRRK2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.52143627062759,0.9133586261157911,0.5853658536585366,0.9277547043165469,1.0,3/6,11.06%,SIRT1;AKR1C3;DGKQ
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.3691282894888068,0.9133358677759694,0.65,0.9271631471981525,1.0,6/22,11.43%,ADRA1A;SLC8A2;JPH1;CACNA2D1;SMDT1;SLC8A1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.46694276091087994,0.9133032770250632,0.5454545454545454,0.9265993556793729,1.0,2/8,13.62%,CABYR;SPEF2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.32744270217170246,0.913291452888656,0.7333333333333333,0.9259155674516426,1.0,7/36,10.06%,AKR1C2;GRAMD1B;OSBPL7;AKR1C3;GNG2;ADCY6;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5305316392564433,0.9131384240288852,0.5862068965517241,0.9255548189239703,1.0,2/7,12.42%,ANK2;KCNIP2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.48869370213950236,-0.9130150773824555,0.6263736263736264,1.0,1.0,4/21,20.49%,SFRP1;TMBIM1;RFFL;BRCA1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.38617180712606297,-0.9126838771649103,0.6875,1.0,1.0,25/256,13.98%,ASB18;ELOB;TNC;PSMB9;SCG2;SCG3;COPS6;CP;PSMB8;FBXW12;ASB14;RAB11A;ICMT;COPS5;CKAP4;OBSL1;CHGB;FN1;GPC3;PSMA3;CST3;SERPIND1;ASB16;PSME1;FBXL13
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.5762137266150507,-0.9126489737607099,0.6610169491525424,1.0,1.0,3/6,32.52%,TNFRSF14;APP;DOCK8
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.4266649882441367,0.9125476099271406,0.5625,0.9260794786342872,1.0,7/11,20.57%,PKD2;PROX1;PRKCSH;COBL;NIPBL;NF1;TGFBR3
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.5248036610771252,-0.9123639896793595,0.59375,1.0,1.0,2/8,19.68%,IHO1;PTN
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.5551519422816991,-0.9122766974990382,0.6567164179104478,1.0,1.0,3/7,23.76%,ABHD12B;DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.4206329218250563,-0.9121901177007152,0.6363636363636364,1.0,1.0,13/95,14.15%,PSMB9;SFRP1;PSMB8;DVL1;PDE6B;SFRP4;AP2A1;PSMA3;CAMK2A;DAAM1;CALM1;PSME1;DVL2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.40662821438647884,-0.9121224200233748,0.6705882352941176,1.0,1.0,10/77,9.64%,RPS27A;COPS6;PHF1;POLE3;FAM50A;COPS5;NUP155;LDB1;CENPH;GATAD1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.3693178480166525,0.91201721493316,0.7241379310344828,0.9266703355560973,1.0,5/26,8.91%,COG6;VTI1A;COG3;COG5;NSF
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3813382006730927,0.9111592152227387,0.7058823529411765,0.9278359447136685,1.0,6/34,9.70%,AEN;ABL1;BOK;SIRT1;BCL2L11;PML
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.4544824572511007,0.910951240433577,0.5277777777777778,0.9276086074506944,1.0,3/9,20.65%,PLIN5;SNCA;PCSK6
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.4615617982986115,-0.910731471082908,0.5833333333333334,1.0,1.0,5/23,21.00%,ADAM21;COL9A3;NR0B1;MEA1;FSHR
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.49926105673537896,-0.9102316179758897,0.6129032258064516,1.0,1.0,1/12,3.39%,TFAM
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.38952142659858013,0.9101450246490177,0.5416666666666666,0.9290123716107047,1.0,5/17,7.51%,GSTM2;PDE4D;DMD;PKD2;JPH1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.4123764602163865,0.9100107937062332,0.6,0.9285841408089883,1.0,2/14,8.61%,SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.4047443232288337,-0.9096842625316445,0.6021505376344086,1.0,1.0,20/75,29.57%,TXNDC17;PSMB9;PSMB8;PSMA3;PSME1;STAT1;PSMA7;PSMB6;TNFRSF1A;PSMC4;TMSB4X;PSMB1;TNFRSF14;PSMD2;PSMB3;PSMC3;CD27;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.4064002588649165,0.9092135769761951,0.5909090909090909,0.9297181375178424,1.0,4/15,7.96%,NEDD4L;FGF12;GPD1L;ATP2B4
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.5686153732467174,-0.908237824787433,0.6119402985074627,1.0,1.0,4/5,36.70%,HOOK2;AKTIP;HOOK3;SQSTM1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5146367312920135,0.9081502112294378,0.5757575757575758,0.9311838622029517,1.0,2/5,10.06%,INSYN1;GLRA1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.5746273728304415,-0.9078748205922885,0.676923076923077,1.0,1.0,1/9,14.89%,SPCS2
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.3403226855634698,0.9074847695111753,0.75,0.9318877608179743,1.0,25/106,10.36%,ASXL3;SMAD9;NOVA2;CSRNP3;LRRC4C;ADGRB3;ASTN1;PCP4;STXBP5;CADM2;NRXN1;FGF12;NOL4;LSAMP;UNC5D;NOVA1;SLC8A2;MAPK10;CNTN1;DPP6;CLVS2;PROX1;SEZ6L;CA10;ADGRA1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.302281783441519,0.9074166549657648,0.8333333333333334,0.9313121753317165,1.0,36/302,8.10%,ONECUT1;SOX11;TCF7L1;POU6F2;ZNF280D;ZNF516;CREM;ZNF280B;RYBP;ESR1;ZNF98;ZNF536;NFYC;GPBP1L1;ABL1;HDAC10;DMTF1;SP3;HP1BP3;CHD7;ESRRG;LIMD1;ZNF2;ZNF268;APBB2;PSPC1;RFX3;ZNF678;ZNF221;NCOA2;YAF2;TGFBRAP1;SMARCA2;ATXN1;ZNF676;RORA
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.523362442325427,-0.9073638438247813,0.6417910447761194,1.0,1.0,1/11,1.96%,TAF7
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.5631252635512671,-0.9072628546461428,0.6060606060606061,1.0,1.0,1/7,3.84%,HES1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4579101534462252,0.9071563138519251,0.5483870967741935,0.9312697316888656,1.0,6/9,22.74%,ERBB4;ZFPM2;RBPJ;BMPR1A;TGFBR3;NOTCH1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.4075194002069829,-0.90692488588633,0.7032967032967034,1.0,1.0,18/86,18.65%,DDRGK1;SELENOK;FLOT1;RASGRF2;CFTR;JUN;SELENOS;SCAMP5;ATF4;USP19;DNAJC10;ERLEC1;CCDC47;TRIB3;UFC1;BAX;SYVN1;AIFM1
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.5467477241328501,-0.9065506708941938,0.5866666666666667,1.0,1.0,1/9,8.39%,XBP1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5297316041436142,-0.9062513905173648,0.7014925373134329,1.0,1.0,1/12,4.62%,CREB3
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.49753543491130436,0.9061601594609338,0.5135135135135135,0.9327432285856846,1.0,1/5,15.37%,NIPBL
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.5466985409478624,-0.9059672094882287,0.6363636363636364,1.0,1.0,2/8,24.52%,SREBF1;ERLIN2
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.5466985409478624,-0.9059672094882287,0.6363636363636364,1.0,1.0,2/8,24.52%,SREBF1;ERLIN2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.3642435484682258,0.9058057300349552,0.6818181818181818,0.9328326552662072,1.0,3/20,7.86%,SLC25A18;SLC7A2;SLC1A2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4856348360528002,-0.9057917613080158,0.64,1.0,1.0,1/17,0.33%,IFI6
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.5061771323559734,-0.9053032626183574,0.6363636363636364,1.0,1.0,2/12,8.32%,HPCA;CACNB1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.4923155289999709,-0.9051734026569023,0.6710526315789473,1.0,1.0,2/18,7.94%,SLC9B1;SLC4A3
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.5754957260622902,-0.9051257283874521,0.7142857142857143,1.0,1.0,1/7,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.44539652025003196,-0.9050500076086135,0.7142857142857143,1.0,1.0,6/30,17.11%,HAX1;ARIH2;UBL5;TOMM7;SREBF1;MICALL2
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.6017457298081251,-0.9048154663998453,0.6363636363636364,1.0,1.0,1/5,4.29%,ALOX5
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.46886930297023927,-0.904477971371295,0.6144578313253012,1.0,1.0,2/22,8.10%,IFI6;OAS1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.4255370185067951,-0.9044072125963527,0.6309523809523809,1.0,1.0,8/55,17.41%,CRYM;ACMSD;PIPOX;BCAT2;GLUL;ACAD8;ALDH4A1;SHMT1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.386109568616834,-0.9043151353067822,0.6082474226804123,1.0,1.0,18/112,19.10%,ESRRB;POLR2I;TAF7;TAF7L;POLR2G;TAF11;MED1;TEAD3;GTF2F1;CDK7;ESR2;NR5A2;TAF9B;NR4A3;NR0B1;HDAC3;NR1D1;HNF4G
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.56834708535987,-0.9042790494465648,0.6575342465753424,1.0,1.0,3/7,18.76%,GRN;SYT11;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.5043358174339192,-0.9042080819879759,0.6162790697674418,1.0,1.0,2/15,14.74%,MYRIP;AIMP1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.4869289602998089,-0.9037106013047399,0.6533333333333333,1.0,1.0,2/20,5.55%,PFN2;HAX1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.5667132292005219,-0.9036430592361131,0.6417910447761194,1.0,1.0,3/10,23.15%,GRN;PIP4K2C;ELAPOR1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.5221741264382262,-0.9032487075198312,0.6794871794871795,1.0,1.0,1/10,3.84%,HES1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.5719502968054699,0.9032475646347152,0.6,0.9377681931975393,1.0,1/6,3.78%,FERMT1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.5455527803763761,-0.9031392080174424,0.6133333333333333,1.0,1.0,3/10,24.14%,AKAP5;PHPT1;MTRR
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5342575998080278,-0.9030510219491242,0.7014925373134329,1.0,1.0,5/10,32.98%,APOD;CHID1;ADCY7;CUEDC2;PDCD4
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.4575294136110763,-0.9027678371662927,0.5733333333333334,1.0,1.0,3/26,6.96%,RBM3;RPL10;RBM4B
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.45569180974307566,0.9025937791769336,0.5652173913043478,0.93821197363994,1.0,5/12,18.16%,AKR1C3;BMP7;TRERF1;NR3C1;URI1
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.5425510889667338,-0.902518620815003,0.6065573770491803,1.0,1.0,2/6,25.69%,ARFGAP3;TMED9
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.5425510889667338,-0.902518620815003,0.6065573770491803,1.0,1.0,2/6,25.69%,ARFGAP3;TMED9
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.5425510889667338,-0.902518620815003,0.6065573770491803,1.0,1.0,2/6,25.69%,ARFGAP3;TMED9
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.3838439586382632,0.9024561366345344,0.5714285714285714,0.9378066048798581,1.0,9/26,18.14%,PHLDB2;FAM107A;AJAP1;NF2;MAP4K4;CORO1C;ACER2;ARHGAP6;CLASP2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.4285088233096219,0.9023893795246501,0.6153846153846154,0.937216368653672,1.0,2/11,11.43%,ADRA1A;SLC8A1
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.4072967910316359,0.9022866484724685,0.6956521739130435,0.9367461499955015,1.0,1/13,0.23%,YJEFN3
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.3798926847799338,0.9021345178883173,0.5833333333333334,0.9356624004574308,1.0,5/22,16.37%,PAPOLA;TENT2;SCAF8;CSTF3;MTPAP
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.3798926847799338,0.9021345178883173,0.5833333333333334,0.9356624004574308,1.0,5/22,16.37%,PAPOLA;TENT2;SCAF8;CSTF3;MTPAP
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.47663907601652944,-0.902129444479621,0.547945205479452,1.0,1.0,2/14,12.07%,VEGFA;EMP2
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.4641894855817078,-0.9017905715498152,0.631578947368421,1.0,1.0,6/25,28.63%,ATP6V1F;ATP6V0A4;ATP6V0E2;ATP6V1D;ATP6V1E1;GPR89A
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.5292346837347226,0.9017818824681749,0.5714285714285714,0.9357623454323352,1.0,2/7,10.02%,FGGY;POMK
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.5522022931248385,-0.9017086375300448,0.671875,1.0,1.0,2/8,23.30%,CD46;FBN2
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.531953967394806,-0.9013981690973545,0.6621621621621622,1.0,1.0,2/11,19.33%,CHMP4B;MITD1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.5103747378717782,-0.9003196649277708,0.6901408450704225,1.0,1.0,2/13,19.33%,CHMP4B;MITD1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.5179837713204216,-0.9002095177801805,0.6712328767123288,1.0,1.0,1/11,3.94%,ENTPD7
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.4795086060005326,0.9001434662724488,0.5384615384615384,0.9389770634487781,1.0,2/8,12.42%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.399870144827395,-0.9000457047846652,0.6511627906976745,1.0,1.0,9/57,16.49%,NACA;COX18;GORASP1;RAB11A;ICMT;ZDHHC24;ZDHHC1;ZDHHC22;ZDHHC15
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.3926408598637924,0.9000138935243837,0.6086956521739131,0.938560037401546,1.0,1/15,0.42%,GINS1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.3134278385482315,0.8997969321418118,0.5,0.9384599310564672,1.0,17/121,9.70%,MAPK11;TP63;BARD1;BANP;RMI1;RPA1;ATR;TAF3;SGK1;BOP1;RICTOR;TP53INP1;MAP2K6;CHD5;MAPK14;MAPKAPK5;PML
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.4123937487341158,-0.899054306644589,0.6774193548387096,1.0,1.0,8/53,18.86%,RANGRF;DDRGK1;TGFB1;PARP9;SYT11;RIC3;PDZK1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.4698563666157961,0.8989252752978407,0.5909090909090909,0.9398876454727858,1.0,3/10,9.16%,SIRT1;BMP7;FTO
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4361690997977122,-0.8986969106343418,0.5833333333333334,1.0,1.0,6/38,10.43%,PDXDC1;ITGA4;FAT2;HTR2B;SEMA4C;GPC3
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.3914483657739866,0.8986246920215916,0.6190476190476191,0.9397209083013718,1.0,1/27,0.38%,TAF1A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.49876495909680857,0.8985506455959977,0.5454545454545454,0.939186211694157,1.0,3/8,12.66%,DOCK5;DOCK4;NRP1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.4494456410934792,0.8980731730626976,0.5333333333333333,0.939440732653045,1.0,4/14,19.40%,PPARG;CBLB;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.5170899436957382,-0.8979163972471658,0.6470588235294118,1.0,1.0,9/14,32.28%,ACMSD;ALDH4A1;HPD;MTRR;HSD17B10;ACADSB;THNSL2;GSTZ1;ACAT1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.49080938723038336,-0.8978248264241356,0.65,1.0,1.0,1/17,1.45%,PARP2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.5321912279151668,0.8977091338333296,0.575,0.9393928698992666,1.0,1/5,5.62%,ANK2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5556288769778129,-0.8973462276786649,0.6346153846153846,1.0,1.0,3/5,23.78%,HLA-A;CD55;IL18
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.46089576649409486,-0.8972299685432704,0.6623376623376623,1.0,1.0,3/23,7.94%,SLC9B1;CFTR;SLC4A3
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.4958418931938495,-0.897131868569023,0.6666666666666666,1.0,1.0,6/12,28.77%,MEF2C;CALM1;PTPA;HSP90AB1;PDGFRB;PPP1R15B
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.5710553154782989,-0.8970773870114986,0.7096774193548387,1.0,1.0,2/7,20.69%,RPS7;PTTG1IP
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5723437635446644,-0.8968287770538901,0.6825396825396826,1.0,1.0,1/7,5.88%,TGFB1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.3163781072430372,0.896809760433696,0.7777777777777778,0.9404734987732342,1.0,35/135,14.23%,RIT2;SHANK2;PPM1E;ADGRB3;ASTN1;GPSM1;PCP4;PKP4;CADM2;CNTNAP2;LRRC3B;NRXN1;GRID2;SLC8A2;LRRTM3;PDE1A;SLC24A3;NXPH1;PRKG1;CTNNA2;CLVS2;SEZ6L;CA10;GRIA3;ADGRA1;VSTM2B;TSHZ1;GNG4;GRIK3;KCNQ2;DLGAP1;TTBK1;ADCYAP1R1;GABRA1;CACNG2
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.5966920646398004,-0.8968084815399889,0.6714285714285714,1.0,1.0,1/5,10.50%,SH3GL2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.47624703394607426,0.8967281306870462,0.5135135135135135,0.9400053783607926,1.0,2/9,12.58%,SIRT1;DNMT3B
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.5306413772192734,0.8967272379425594,0.65,0.9393152128847567,1.0,1/5,2.36%,CTBS
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.3172816478303858,0.8966891483098757,0.6363636363636364,0.9387046139069655,1.0,7/56,8.59%,ZNF516;PDGFC;LEPR;ESRRG;IGF1R;HADH;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3629232100541018,0.8965254946062311,0.65,0.9383173161134819,1.0,3/26,6.12%,STYXL1;PPP4R4;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4484893475128682,-0.8965045878145045,0.6341463414634146,1.0,1.0,3/24,7.07%,B2M;ARG2;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.5285552385112331,0.8964210558743474,0.5675675675675675,0.9378652202177695,1.0,2/6,12.01%,DOCK5;DOCK4
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4795915234575764,-0.8963762904871927,0.6486486486486487,1.0,1.0,6/17,22.91%,HAX1;HDAC6;VDAC1;SREBF1;DNM1L;PARK7
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.4248031648545043,0.8963171827791288,0.6428571428571429,0.9374268497926407,1.0,4/12,16.40%,TNKS;ERCC4;TERF1;TERF2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.5023295594277504,-0.8962658890667238,0.6081081081081081,1.0,1.0,3/13,27.67%,EIF4EBP1;PAIP2;RBM4
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.3178233607599817,0.8961613246506221,0.6666666666666666,0.9371588225673559,1.0,31/117,14.86%,NLGN1;RYK;SGK1;PARD3;MAP2;CNTNAP2;DSCAML1;WNT7A;NTNG2;ARC;DCC;NRCAM;BMP7;RAB10;WASL;SLITRK5;CTNNA2;LRRK2;ZDHHC17;KLF7;FARP1;LMTK2;BTBD3;MAP4K4;SDC2;ALCAM;FLRT3;NCKAP1;SPTBN4;DOCK10;CTNND2
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3224313140301301,0.8959168110802193,0.5555555555555556,0.9370477205370722,1.0,11/43,12.64%,SLC2A6;SLCO1A2;SLC4A7;ABCC11;CA13;SLC16A2;ABCC5;CA3;SLC4A10;SLC39A8;SLCO5A1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.5232688614972947,0.8957608003385993,0.6206896551724138,0.9366369777328403,1.0,2/5,18.14%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.32209940224041905,0.8955715944804862,0.631578947368421,0.9365264188039398,1.0,8/36,10.70%,RPA1;ATR;POT1;STN1;NSMCE2;CTC1;SMC6;ERCC4
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5129976371698229,-0.8953438372623939,0.6301369863013698,1.0,1.0,8/11,25.91%,PTGR1;GPR39;ABCC3;ATP8B1;CLDN18;SLC44A3;BTC;LIPH
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.35379479583335693,0.8952423422443543,0.5882352941176471,0.9365852278773692,1.0,7/47,7.84%,GPNMB;FAM107A;LSM11;ANKRD17;PLCB1;PKD2;EGFR
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.38767741065553446,-0.8950428756057905,0.7157894736842105,1.0,1.0,12/114,9.02%,ETV4;F13A1;SCG3;PDCD1LG2;PSMB8;LAT2;PCSK1N;TRIB1;GLRX;FUCA1;ANGPTL4;SCG5
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.4556035299334663,0.8949525809327161,0.5925925925925926,0.9366309448085445,1.0,2/10,9.60%,SRR;SERINC5
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.34205793305569115,0.894817131766356,0.7222222222222222,0.9362087052424186,1.0,11/47,13.53%,TAB3;LEPR;PLIN5;ZKSCAN3;TBC1D14;FOXK1;EIF4G3;DAPL1;TAB2;WASHC1;BCL2
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3384668079322348,0.8943956257706995,0.5625,0.9364234669349542,1.0,9/45,15.25%,RFWD3;CRADD;PML;FBXO31;ARID3A;PCBP4;CNOT2;CNOT6L;CNOT9
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.4653193132702068,-0.8941009084241357,0.6666666666666666,1.0,1.0,6/25,26.78%,ATP6V1F;ATP6V0A4;DNM2;ATP6V0E2;ATP6V1D;ATP6V1E1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.586821410462896,-0.8940837362137645,0.6825396825396826,1.0,1.0,1/5,1.74%,VEGFA
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.3964190618207893,-0.8940700988162442,0.7065217391304348,1.0,1.0,9/97,11.48%,ELOB;PSMB9;VEGFA;RPS27A;SFRP1;PSMB8;BACH1;PSMA3;PGK1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.27959806498318523,0.8940436817778435,0.7142857142857143,0.9364821798015291,1.0,44/170,19.25%,TTC29;STK36;EHD1;FNBP1L;SEPTIN6;IFT140;RFX3;RABL2B;CDC14A;PKD2;BBS4;PCM1;TRAF3IP1;TTLL3;CEP41;IFT172;TCTN2;SSX2IP;UNC119B;OCRL;EXOC2;PCNT;CDC14B;RAB3IP;CEP20;EXOC6;CEP89;TMEM138;ARL3;SPAG16;CEP290;GBF1;RILPL2;EXOC4;TTC39C;MACIR;GALNT11;ATAT1;TTC17;ABCC4;TTBK2;KIAA0586;WDR19;KIFAP3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.35506164473390106,0.8934936195333079,0.625,0.9371503317832813,1.0,11/29,12.88%,PRKX;ABL1;FERMT1;ZEB2;KANK1;LPXN;PIK3CA;CDH13;NRP1;ANLN;STARD13
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.44490278472614736,0.8934591654270561,0.4827586206896552,0.9365993497051953,1.0,5/17,8.71%,RXRA;SLCO1A2;ABCC11;NCOA2;AKR1C1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.4254151193352776,-0.893407381208218,0.6777777777777778,1.0,1.0,3/32,8.00%,PPIF;ECT2;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.48857221328002437,-0.892715448641642,0.6282051282051282,1.0,1.0,4/19,13.40%,PFN2;RAP1GAP;TCHP;ARHGAP24
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.4093935796860041,-0.8926302865967297,0.6179775280898876,1.0,1.0,11/43,22.18%,AKR1A1;OAS1;GAPDH;PGK1;GALM;APOD;ATF4;G6PC3;G6PC2;ADPGK;GOT1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5039393525744477,0.8925461837742669,0.6129032258064516,0.9379916347664703,1.0,2/5,29.99%,TEX264;SPRTN
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.41410178130841696,-0.8924088264281921,0.6352941176470588,1.0,1.0,7/37,19.48%,RBM3;RPL10;RBM4B;PARP9;ATG14;PCIF1;EIF2A
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.3351285243961498,0.8923945537962793,0.5882352941176471,0.9377384707339017,1.0,12/58,12.84%,SEMA3B;GSTM2;DHCR7;PPARG;TP53INP1;FASN;CPEB2;PLAUR;ANTXR2;ALCAM;ECH1;HMGCR
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5455553784676276,-0.8922430638089596,0.6,1.0,1.0,3/11,4.17%,OPRM1;CHRM2;AGRN
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.4495239753516614,-0.8921706241647043,0.6623376623376623,1.0,1.0,5/24,17.11%,ARIH2;UBL5;TOMM7;PDCD5;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.32476713155371256,0.8921647806394281,0.7368421052631579,0.9375503286819089,1.0,9/42,11.13%,PDGFC;SEMA4D;GAB1;SIRT1;IGF1R;UNC5B;ROR2;PIK3CA;NEDD4
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.3968132965124326,-0.8919184753064925,0.7311827956989247,1.0,1.0,22/103,23.18%,PSMB9;RPS27A;PSMB8;POLE3;RFC2;PSMA3;RPA3;PNKP;PSME1;UBA52;RFC1;RFC4;GINS3;PSMA7;PSMB6;UBC;MGME1;GMNN;RFC3;RECQL;POLD2;DBF4
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.5290444845125444,-0.891880620244851,0.640625,1.0,1.0,2/9,15.90%,DCTN1;NEK6
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.4073495245455844,0.8916924027373914,0.5769230769230769,0.9380214633398539,1.0,4/17,16.53%,BBS4;PCM1;NEDD1;C2CD3
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.577085374074302,-0.8912504626906472,0.6712328767123288,1.0,1.0,1/6,0.78%,ROMO1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5440354469519637,0.8912492923847896,0.6,0.9384015300697983,1.0,1/6,5.05%,INAVA
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.5801436356740142,-0.8912149837854526,0.7083333333333334,1.0,1.0,1/5,8.93%,ALOX12
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.4605575111787044,-0.8909352034071772,0.6470588235294118,1.0,1.0,3/25,14.49%,ENPP2;VIL1;AVIL
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.436758826051876,-0.8907832813780344,0.6438356164383562,1.0,1.0,4/32,15.40%,XBP1;RRP8;ATG14;ATF4
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5861048436879259,-0.8907090960186232,0.6891891891891891,1.0,1.0,1/5,1.96%,TAF7
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.3897170175665703,-0.8901069665887472,0.7263157894736842,1.0,1.0,24/93,22.65%,A2M;NOSTRIN;F8;PCDH12;CDKN1C;USHBP1;S100A10;PROCR;RNASE1;COL15A1;ELK3;LMOD1;COL4A1;CD55;VWF;RASGRP3;NRP2;CD46;MYLK;STAB2;CLIC4;CAV1;VWA1;CYP1B1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.5314407208427477,0.8897228163627234,0.5555555555555556,0.9409358423802657,1.0,3/5,30.13%,PIGU;PGAP1;PIGK
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.5828919602236651,-0.8893950301686725,0.6619718309859155,1.0,1.0,3/5,24.57%,EMP2;MYLK;ANO6
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.400518744467388,-0.8892872256189044,0.6875,1.0,1.0,14/122,13.93%,RSPO4;PSMB9;SFRP1;PSMB8;TGFB1;ATP6AP2;SFRP4;CDH3;GPC3;PSMA3;PLEKHA4;WNT5B;ZBED3;PSME1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5191626081099063,0.8891870305771715,0.6129032258064516,0.9412101049767511,1.0,2/5,8.99%,MAPK1;MAPK3
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.5051494267303596,0.8889616719703453,0.53125,0.9396889526523856,1.0,1/5,1.12%,SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.5051494267303596,0.8889616719703453,0.53125,0.9396889526523856,1.0,1/5,1.12%,SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.5051494267303596,0.8889616719703453,0.53125,0.9396889526523856,1.0,1/5,1.12%,SORD
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.39496837298181725,-0.8888306818455197,0.6777777777777778,1.0,1.0,32/133,29.57%,PSMB9;SFRP1;EMD;PSMB8;DVL1;TLE6;SFRP4;WIF1;PSMA3;FUZ;PSME1;DVL2;RNF213;RACK1;APOE;PSMA7;PSMB6;CAV1;DVL3;RBX1;PSMC4;SOX9;PSMB1;PSMD2;PSMB3;HMGXB4;PSMC3;FZD6;NKD1;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.39804844163838266,-0.8887653703111759,0.6947368421052632,1.0,1.0,14/84,21.01%,PDHX;NAAA;BTD;PTGR1;ALOX12;PDHB;GAMT;HYI;VDAC1;ALDH4A1;LDHA;ACOT2;MECR;SLC16A1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.5919356023275382,-0.888722533076243,0.6666666666666666,1.0,1.0,2/5,20.25%,SLC3A2;SLC7A8
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5286837306106661,-0.8887196262566631,0.6351351351351351,1.0,1.0,2/10,9.68%,TRIB1;MEF2C
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.43828641456233897,0.8886466408136637,0.5517241379310345,0.9397704759289526,1.0,2/13,5.71%,ACACB;ACACA
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.38047284537271153,0.8883624541146754,0.56,0.9396334789290666,1.0,6/19,15.01%,DMD;MYH3;PIK3CA;SLC8A1;ARHGEF11;NOS1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.5455368517215053,-0.8881238586863595,0.6666666666666666,1.0,1.0,1/8,1.74%,VEGFA
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.5786659173628972,-0.8880641062499982,0.6885245901639344,1.0,1.0,1/7,3.90%,LFNG
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.27257397856236637,0.8880491992016943,1.0,0.9397534387741574,1.0,70/348,15.01%,SOX11;RIPOR2;SERTAD2;RNF139;HSPA1A;GNRH1;GPNMB;ADRA1A;ERBB4;ADAM10;WFDC1;KAT2B;DYSF;NR1H2;NOX4;PLXNA1;SEMA4D;MYH9;SIRT1;PTPRK;RAD18;CTBP1;ZNF268;ATG5;APBB2;ADNP2;MAGI2;TP53INP1;ADAM22;PLXNA3;NMI;CHD5;PDS5B;PKD2;SMARCA2;SLIT3;ANXA6;STRN;BMP7;P3H2;LMNA;PRDM11;LPXN;ABI1;ROR2;CGRRF1;PML;PROX1;PTPRU;NF2;GNG4;ST18;CDH13;PRKD1;TOB1;PPM1D;TNFRSF21;RAPGEF2;TBRG1;BCL2;UTP20;DLL1;COL18A1;RBM5;CELF1;FRZB;CHMP1A;ARID2;PSRC1;NOS1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.39820592436119606,-0.8877545438095742,0.6590909090909091,1.0,1.0,5/58,10.35%,PPFIA4;DVL1;AGRN;TGFB1;SNCB
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.4464651514364243,0.8874791532240706,0.6666666666666666,0.9401041437657439,1.0,2/11,5.84%,FAM107A;RPS6KB1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.4012833420411104,0.8873747801413004,0.42105263157894735,0.9396082551670346,1.0,3/27,8.14%,ATR;RFWD3;SAMHD1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.333595029064647,0.887318037751366,0.5333333333333333,0.9390105958353681,1.0,5/34,8.55%,FBXW7;SIRT1;PPARG;ABHD8;ZBTB20
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.5732471011045583,-0.8871216156891768,0.671875,1.0,1.0,1/5,6.16%,CTSZ
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5191200333159284,-0.8870807872869101,0.6621621621621622,1.0,1.0,4/13,28.65%,PARP9;PNKP;DTX3L;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.46590521535536566,-0.8867291362032754,0.6538461538461539,1.0,1.0,6/20,22.57%,CFTR;GLRX;WNK3;SLC6A9;PDZK1;ACTN2
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.36119219789729357,0.8862557087919152,0.6086956521739131,0.9403467674029642,1.0,8/24,11.53%,ITPR2;SLC8A2;PKD2;CACNA2D1;ATP2B4;PTPRC;SLC8A1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3613073086404501,0.8858442081024769,0.5909090909090909,0.9405681217430425,1.0,2/23,2.35%,WDR81;IRS1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.38200869287202716,-0.885721831521106,0.7333333333333333,1.0,1.0,11/77,15.18%,GSTK1;GSS;GSTM4;PRELP;GSTO1;AKR1A1;MGST1;GSTM3;GSTM5;OMD;OGN
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.5146321777838662,-0.88561195025006,0.6323529411764706,1.0,1.0,2/11,10.40%,MED1;CDH3
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.5287625329997329,-0.8855395869168062,0.676056338028169,1.0,1.0,1/10,1.74%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.5189305936389508,-0.8854447232203346,0.7313432835820896,1.0,1.0,1/12,2.32%,SFRP1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.43994460754738174,0.8854191543902503,0.5,0.940865855809106,1.0,3/10,19.78%,DLGAP1;NPTX2;DLGAP4
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3450825216911591,0.8850452929963841,0.6,0.9410226533831028,1.0,2/40,2.02%,IL15;FEM1A
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.3898917905302539,0.8848843569603977,0.6111111111111112,0.9407197038669136,1.0,3/22,8.61%,KCNJ6;SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.32650927981959704,0.8844266648786455,0.6666666666666666,0.9411825112918152,1.0,23/70,18.16%,PTPN20;PTPN13;IL1RAPL1;RPS6KB1;NCOA2;SLIT3;TGFBR2;TIPARP;LRRK2;ROBO2;ACVR1;PTPN4;BMPR1B;MAPK8;NFAT5;ACVR1C;ZNF16;NOS1;SLIT2;PID1;BMPR1A;ACVR1B;URI1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.5419046815437012,0.8839605663648346,0.6111111111111112,0.9414789558394409,1.0,1/5,9.66%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.4849210578468951,-0.8839132813188922,0.6621621621621622,1.0,1.0,5/18,22.91%,HES1;TGFB1;EDF1;TXN;PARK7
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.5293957169412882,-0.8835975073506919,0.6956521739130435,1.0,1.0,2/10,18.54%,FN1;CD46
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.4789566343848609,-0.8835746485531082,0.6153846153846154,1.0,1.0,1/14,5.27%,MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.4789566343848609,-0.8835746485531082,0.6153846153846154,1.0,1.0,1/14,5.27%,MMACHC
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.3893591143793818,0.8835618904633108,0.52,0.941660342501036,1.0,6/18,10.79%,MBNL1;ADAM10;LIG4;CHD7;PTPRR;SOX8
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4442060781621502,-0.8835234610212337,0.6829268292682927,1.0,1.0,3/27,7.64%,JUN;TGFB1;DDX5
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.5599961172762689,-0.8834402932518332,0.6851851851851852,1.0,1.0,1/5,11.85%,DCTD
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.40977880193228616,0.8831321131503466,0.6666666666666666,0.9420578481669946,1.0,4/17,28.09%,TRIM71;DROSHA;DICER1;PARN
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.37303766385234577,-0.8831072260900769,0.7526881720430108,1.0,1.0,36/156,22.00%,SRSF7;RBM8A;RBM3;NOL3;LSM5;SNRPA1;RBMS2;PDCD7;SNRNP25;DHX16;PRPF18;SNRPD2;SNRPD1;PRPF8;SNRPB;SRRM4;PRPF6;RNPC3;SRSF5;NCBP1;LUC7L3;PRPF4;HNRNPA2B1;SF3A3;MAGOHB;SCNM1;ADAR;SRPK1;DKC1;LSM3;RP9;USP39;KIN;RBPMS;SNRPG;DDX20
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.4591641415354913,-0.8830914288187919,0.6341463414634146,1.0,1.0,3/26,9.68%,VAV3;XBP1;MEF2C
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.3612336018537323,0.8827167310062678,0.5909090909090909,0.9422640017112706,1.0,7/32,15.54%,DHCR7;OSBPL7;AKR1C3;CYP7B1;HMGCR;OSBPL6;HSD17B4
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.3847923006507689,0.8825751135922018,0.5555555555555556,0.9418597829219774,1.0,2/18,2.99%,LEPR;ACADVL
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.3188816090828962,0.8824734898653519,0.6666666666666666,0.9413545321251194,1.0,8/53,8.59%,LEPR;IRS1;SIRT1;PPARG;IGF1R;FOXK1;FOXO1;ADIPOR2
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.528006636996536,-0.8823878594290694,0.6268656716417911,1.0,1.0,5/7,41.53%,ATP1B1;ATP1A1;SLC9A1;ATP1B2;ATP1B3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.5365406826145679,-0.8822876810324615,0.6029411764705882,1.0,1.0,3/6,23.60%,QPRT;NMNAT3;NMNAT1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.4302597715395425,-0.8822809429455756,0.618421052631579,1.0,1.0,7/33,12.06%,ISG15;PARP14;OAS3;USP18;OAS1;CACTIN;NLRC5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.5165217042530692,-0.8816680745262718,0.6764705882352942,1.0,1.0,1/8,2.26%,ISG15
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.47373313805164974,-0.8815063954851067,0.6216216216216216,1.0,1.0,5/16,29.06%,AGT;S100A1;KCNMB4;KCNQ1;PER2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.43024022108051724,0.8813907987697788,0.5333333333333333,0.9428299352839032,1.0,5/10,20.27%,HOMER1;GRIK3;GRM8;GRM5;GRM7
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.34993492065619003,0.8810200972692022,0.5555555555555556,0.9428700766642627,1.0,17/38,22.99%,SMAD9;SMAD7;BMP7;MAPK3;USP9X;CHRD;ACVR1;BMPR1B;USP15;SMAD1;BMPR1A;SMAD5;MEGF8;TGFBR3;GDF6;ACVR2A;RGMA
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.5240696492578523,-0.8809205248050683,0.7272727272727273,1.0,1.0,4/8,25.48%,TGFB1;EID2B;SRA1;SOX9
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3750963795444342,-0.8801463342753534,0.8041237113402062,1.0,1.0,41/163,25.62%,UQCRQ;ENPP2;SSPN;CDKN2C;UQCR10;RMDN3;ANGPTL4;GPX4;EPHX2;COX7B;STAT5A;COL15A1;CHCHD10;ACO2;OMD;LPCAT3;CYC1;COL4A1;STOM;C3;APOE;JAGN1;NDUFB7;ACADL;SLC66A3;AIFM1;CRAT;APLP2;CD302;MYLK;COQ3;UBC;PEX14;VEGFB;CMBL;DGAT1;GHITM;ABCA1;GBE1;PTCD3;MTCH2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.49563406853434266,-0.8799703132035025,0.6666666666666666,1.0,1.0,6/16,16.05%,RPL37;RPL23;RPS15;DDX5;RPS20;RPS7
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.29883550414679133,0.8799339527205339,0.6,0.9444563724781434,1.0,33/181,11.03%,IL1RAPL2;SOX11;POU6F2;SHROOM2;PDGFC;DCX;PBX3;ADAM23;VCAN;NPAS1;CNTNAP2;DSCAML1;LIG4;PBX1;SYNJ1;CHD7;ADGRL3;ADAM22;MEIS1;NRCAM;PKD2;ATXN1;TGFBR2;NFIB;RELN;CHST8;PROX1;POMK;CA10;MDGA1;SOX8;ZBTB16;AATK
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.4837721724742481,-0.879888971108576,0.7023809523809523,1.0,1.0,8/20,24.68%,IRF1;IGSF6;FPR3;APOL6;TYMP;IFIH1;DDX60L;GPR183
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.4936048379635347,-0.8795373829278819,0.6216216216216216,1.0,1.0,2/11,14.56%,FADS2;ELOVL2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2857362945045878,0.8792913836809972,1.0,0.9451538757700653,1.0,39/334,8.10%,ONECUT1;SOX11;TCF7L1;POU6F2;ZNF280D;ZNF516;CREM;ZNF280B;RYBP;ESR1;ZNF98;TCOF1;ZNF536;NFYC;GPBP1L1;ABL1;HDAC10;DMTF1;SP3;HP1BP3;OBI1;CHD7;ESRRG;LIMD1;ZNF2;ZNF268;APBB2;PSPC1;ANKRD17;RFX3;ZNF678;ZNF221;NCOA2;YAF2;TGFBRAP1;SMARCA2;ATXN1;ZNF676;RORA
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.43964016708950826,-0.8789660410307641,0.6619718309859155,1.0,1.0,5/23,21.00%,ADAM21;COL9A3;NR0B1;MEA1;FSHR
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.3972651809133681,-0.8788852127071503,0.6931818181818182,1.0,1.0,7/59,11.01%,PDCD1LG2;TRIB1;SELENOS;TRIM41;XBP1;MEF2C;CACTIN
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4754491179325748,0.8786705933568318,0.6333333333333333,0.9459516367936348,1.0,1/8,4.98%,AKR1C3
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.6128701269992183,-0.878449870817969,0.6666666666666666,1.0,1.0,2/5,20.25%,SLC6A9;SLC7A8
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4751302585982461,-0.8780365868615633,0.6666666666666666,1.0,1.0,4/17,22.04%,CDKN1C;GIPC1;HSP90AB1;SNW1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4751302585982461,-0.8780365868615633,0.6666666666666666,1.0,1.0,4/17,22.04%,CDKN1C;GIPC1;HSP90AB1;SNW1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4846439272936198,-0.8775804626198924,0.6764705882352942,1.0,1.0,4/14,22.71%,CEMIP;P2RX4;CAV1;THY1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5440380960633961,-0.8772924938313093,0.6623376623376623,1.0,1.0,2/7,23.35%,MTIF3;EIF2D
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.463581909272221,-0.8772036142114176,0.6447368421052632,1.0,1.0,2/20,13.77%,PFN2;VIL1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.33436956251487615,0.8771328714845973,0.5555555555555556,0.9488603023170458,1.0,4/42,6.87%,ACADS;ACADVL;ACAA2;HADH
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5048165560243384,-0.8770841109819851,0.6986301369863014,1.0,1.0,2/12,20.92%,TYMP;MGME1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.3518560996441317,0.8768041562286767,0.6,0.9487696511448601,1.0,9/31,15.01%,STIM2;HOMER1;ANK2;PKD2;CACNA2D1;STIM1;BCL2;ORAI1;NOS1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.3220231344884445,0.8767311371379566,0.5,0.9481865966197619,1.0,36/108,19.79%,NLGN1;ZFYVE27;EHD1;DCX;PBX3;RYK;MAP2;CNTNAP2;PBX1;OPHN1;ATXN10;UGDH;VAPA;NEDD4;WNK1;HMGB1;RAPGEF2;TENM3;FRYL;FLRT3;ARL3;ATP8A2;GPM6B;UNK;B4GALT5;HDGFL3;PPP1R9A;UHMK1;THOC2;GPM6A;TBC1D23;EPHA5;FRY;POU3F2;VSX1;TENM1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.4504035620332552,-0.8764562190190115,0.6585365853658537,1.0,1.0,1/27,2.73%,PHF1
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.5587329030729722,-0.8760903592001235,0.6721311475409836,1.0,1.0,1/5,17.67%,GINS3
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.5587329030729722,-0.8760903592001235,0.6721311475409836,1.0,1.0,1/5,17.67%,GINS3
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.29973380591171483,0.8759646265799144,0.875,0.9490809167969828,1.0,35/149,17.19%,VAPB;SMPD4;TRAPPC12;DYSF;ARFGEF2;TMED5;COG3;SPTBN1;HACE1;TRAPPC8;GOLGA8N;SNX33;NUP93;TMED3;SEC16A;WASHC5;VAPA;LRRK2;FBXW8;PRKD1;MYOF;BLZF1;CLASP1;BAG5;TMCC1;COG7;ATL2;VMP1;SUN2;ARHGEF7;GBF1;DMPK;LEMD3;ARFGEF1;ZFP69B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4184871421245231,0.8757798732684332,0.6842105263157895,0.9488768014055771,1.0,4/18,16.76%,DIP2B;MAPK3;NOS1;TADA2A
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.5751681982182772,-0.8756977756260549,0.6911764705882353,1.0,1.0,3/5,38.63%,RTF1;PAF1;CTR9
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.5751681982182772,-0.8756977756260549,0.6911764705882353,1.0,1.0,3/5,38.63%,RTF1;PAF1;CTR9
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.3156582643515331,0.8755248199912868,0.75,0.9487485878764159,1.0,17/65,11.53%,NLGN1;HOMER1;CNIH2;FGF12;PDE4D;ANK2;DMD;NETO1;GRIA1;JPH1;FGF14;GSG1L;RELN;LRRC7;GRIA3;DLG2;GRIN2B
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.30554101357878644,0.875197632281397,0.8,0.9488472359178434,1.0,8/50,11.43%,SLC9A9;SLC8A2;PKD2;SCNN1D;SLC24A3;SLC12A1;SCN11A;SLC8A1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4312263203725035,0.8749331557709568,0.6666666666666666,0.9488954068787446,1.0,2/22,7.56%,RYBP;RNF2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.4192095108369158,0.874904927733915,0.6129032258064516,0.9482895778429805,1.0,1/12,1.70%,AIFM2
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.4717845535219719,0.8743620249705907,0.5483870967741935,0.948790477080702,1.0,2/6,16.40%,ERCC4;TERF2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.39555805641045294,-0.8741654603932951,0.75,1.0,1.0,11/81,11.97%,PLAG1;MX1;STAG3;LFNG;ENTPD7;PDE6B;RSAD2;ZC2HC1C;IL5;SNCB;GAMT
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.5697840989222455,-0.8740008794982962,0.7323943661971831,1.0,1.0,2/6,9.68%,RASGRP1;MEF2C
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.5042260635260754,0.8739151279223429,0.5294117647058824,0.9482466244157721,1.0,3/6,16.40%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.5042260635260754,0.8739151279223429,0.5294117647058824,0.9482466244157721,1.0,3/6,16.40%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.47164320132956145,0.8737433782473958,0.5333333333333333,0.9479815414982827,1.0,1/9,1.26%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3335056709884969,0.8736856150104343,0.8333333333333334,0.9474160758147918,1.0,3/40,6.76%,TP63;FBXW7;UBE2J2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.34555974610788825,0.8735521445590906,0.75,0.9470642891129197,1.0,10/47,15.68%,KCTD8;GRK5;GRK6;PLCB1;CAMKMT;DGKQ;GNG4;ZDHHC3;GIT2;MGLL
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.4715784653976849,-0.8735190562012732,0.6428571428571429,1.0,1.0,2/15,5.63%,IFI35;CLU
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.3729956750761478,-0.8734824712305892,0.7282608695652174,1.0,1.0,28/150,20.15%,MIF4GD;EIF1;RBM3;RPL10;RPL13A;EIF2B2;EIF1B;RBM4B;IGF2BP2;GAPDH;EIF5B;NCBP1;RPS4X;ZNF598;UPF3B;RACK1;UPF3A;SHMT1;NSUN5;NCL;RPS27L;PLXNB2;RPL5;SHFL;PCIF1;EIF2AK2;EIF2A;MALSU1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.3451091817033724,0.8734052348252219,0.5384615384615384,0.9466879680291066,1.0,12/59,11.43%,VAPB;STIM2;ATP2C1;CALCB;ANK2;SLC8A2;ATP2B4;SLC24A3;CHRNA7;SLC39A8;STIM1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.4074436379520557,0.8733680921286028,0.6363636363636364,0.9460370618153692,1.0,7/14,21.70%,ANK2;CACNA2D1;NOS1;FYN;DIAPH1;PTK2B;CBARP
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.47771073686658005,-0.8733065191368529,0.691358024691358,1.0,1.0,3/20,17.10%,PFN2;SVBP;APOE
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.3847482641725964,0.8732658549709362,0.6296296296296297,0.9455745126239119,1.0,3/15,9.33%,MYH9;SNX33;SNX18
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.4664717546170686,0.8732658006366609,0.6956521739130435,0.9449128089761695,1.0,1/6,5.64%,ATG5
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.5614139118332997,-0.8727356811437287,0.696969696969697,1.0,1.0,3/7,35.30%,RANBP1;KIF25;KIF11
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.48565434308519995,0.872714417593733,0.5789473684210527,0.9454250456806851,1.0,3/8,11.73%,FPGS;PRKG2;QDPR
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5194774753039746,-0.8726444747273512,0.6865671641791045,1.0,1.0,2/8,20.68%,EMP2;GSN
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.5007996037131441,-0.8726195689483095,0.7162162162162162,1.0,1.0,3/12,27.72%,PPAT;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.4366121037235762,-0.8726151642712381,0.6,1.0,1.0,3/29,10.60%,TGFB1;PARP9;GLUL
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.3788017512218202,0.8725113509080561,0.5384615384615384,0.9451883567842487,1.0,3/13,12.71%,FOXO1;KCNC2;RTF2
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.4892050877277762,0.8723914074485725,0.6285714285714286,0.9440933321540307,1.0,1/5,7.96%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.4892050877277762,0.8723914074485725,0.6285714285714286,0.9440933321540307,1.0,1/5,7.96%,ATP2B4
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.5312708076422996,-0.8722522421562333,0.6619718309859155,1.0,1.0,2/9,12.07%,CEACAM1;EMP2
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.43177782974161294,-0.872147664878476,0.7349397590361446,1.0,1.0,5/33,11.75%,SLC3A1;SLC38A4;SLC7A6;SLC6A6;SLC7A14
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.31234862882155384,0.8720001201681318,0.6842105263157895,0.9442562774368441,1.0,7/31,12.40%,INPP4B;SYNJ1;PLCB1;PLCB4;INPP1;IP6K1;OCRL
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.31233600575618287,0.871774144799609,0.7368421052631579,0.9441329813857475,1.0,7/32,12.40%,INPP4B;SYNJ1;PLCB1;PLCB4;INPP1;IP6K1;OCRL
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.500048996252725,-0.8717724400496459,0.6712328767123288,1.0,1.0,1/11,1.80%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.543428666842452,-0.8713669119991677,0.7361111111111112,1.0,1.0,3/6,24.57%,WNK3;PDZK1;ANO6
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.573715776709346,-0.8710654685440509,0.7627118644067796,1.0,1.0,1/5,10.39%,BDNF
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.5651317591081433,-0.8710313268270625,0.7213114754098361,1.0,1.0,1/5,3.84%,HES1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.5862647927363268,-0.8707743700829835,0.7419354838709677,1.0,1.0,1/5,25.63%,NUMA1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.40438162308940545,-0.8707285812719839,0.6931818181818182,1.0,1.0,7/67,9.94%,NEFM;IGFBPL1;GDAP1L1;SCG2;JPH3;INA;CACNA1B
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.5274169035309051,-0.8705831044935693,0.6615384615384615,1.0,1.0,5/7,36.24%,HMGCL;HMGCLL1;SLC27A5;ACAT1;AACS
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.40349961063955947,-0.870386999236611,0.7415730337078652,1.0,1.0,23/69,29.64%,PSMB9;PSMB8;CDKN2C;PSMA3;CDK2AP2;PSME1;ZFP36L2;PSMA7;PSMB6;CDKN2A;BRD7;CDK4;RBX1;PSMC4;PSMB1;PSMD2;CDKN2D;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4;RBL2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3894670246357369,0.8701297367254703,0.6818181818181818,0.9470544087632338,1.0,1/20,0.54%,BAIAP3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.4995345135973155,0.8700960943417996,0.6428571428571429,0.9464574495401066,1.0,2/6,8.99%,MAPK1;MAPK3
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.4728185783353718,-0.8700883413216718,0.6231884057971014,1.0,1.0,3/11,27.24%,APH1A;APEH;BACE1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.40559380322297117,0.8698574464903333,0.64,0.9463328799953035,1.0,5/15,18.42%,SYT12;SYT9;SYT17;SNCA;PRKN
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5340346329539112,0.8696943998210059,0.6153846153846154,0.9459852685607322,1.0,2/5,15.12%,UBR5;TRIP12
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3825447368391087,-0.8695999070652335,0.7333333333333333,1.0,1.0,17/103,20.49%,TXNDC17;PSMB9;SFRP1;PSMB8;YBX3;HAS2;PSMA3;CACTIN;PSME1;ADAMTS7;ZFP36L2;ASAH1;STAT1;NR1D1;PSMA7;PSMB6;BRCA1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.4202107363837687,0.868870927791101,0.5625,0.9469517155508924,1.0,2/8,13.33%,PON3;MPST
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4054076730781829,-0.8686280176688673,0.7045454545454546,1.0,1.0,23/69,29.89%,PSMB9;PSMB8;DVL1;AP2A1;PSMA3;DAAM1;PSME1;DVL2;PSMA7;PSMB6;AP2A2;DVL3;PSMC4;CELSR2;PSMB1;PSMD2;PSMB3;PSMC3;FZD6;PSMC5;PSMD7;PSMA4;AP2S1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.5690000437025392,-0.8685881299334867,0.7076923076923077,1.0,1.0,3/5,27.40%,PRUNE1;PRUNE2;ATCAY
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.36880570518518646,0.8684423765626641,0.65,0.9472233382860699,1.0,3/21,8.55%,RAB27A;CREB3L1;ZBTB20
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.3102308467858595,0.8684276367309006,0.8,0.9466035817429295,1.0,14/65,12.04%,RYK;PARD3;CAMSAP2;DSCAML1;WNT7A;NTNG2;DCC;NRCAM;RAB10;SLITRK5;CTNNA2;ZDHHC17;KLF7;LMTK2
prerank,PanglaoDB_Augmented_2021__Myocytes,0.3367610863639244,0.8683344233548321,0.7,0.9460959823185134,1.0,12/54,14.29%,PLD1;DOCK5;ASB5;SYNPO2;DMD;PRKG1;PRRX1;WASHC1;DLL1;IQSEC1;THBS4;ITGA3
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.5932247811369081,-0.868191432394877,0.7619047619047619,1.0,1.0,1/5,3.58%,POLE3
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.3111291136861011,0.8677479817334127,0.75,0.9466765807397534,1.0,25/95,14.86%,ADGRB3;RGS7BP;ASTN1;ZNF536;MAP2;CADM2;LRRC3B;HS6ST3;ANK2;SLC8A2;LRRTM3;NKAIN2;KCTD16;NXPH1;CLVS2;LRFN5;CA10;ADGRA1;VSTM2B;UBE2QL1;KCNC2;ADCYAP1R1;DUSP26;SPTBN4;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4588439774199494,-0.8677432446503476,0.7162162162162162,1.0,1.0,4/18,17.91%,HAP1;CLU;APOE;RTN2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.36034971490367734,-0.8674707055700407,0.7959183673469388,1.0,1.0,25/243,10.45%,S100A6;ROMO1;HES5;VEGFA;DDRGK1;SFRP1;SPDYA;FGF1;RPS9;RPL23;HES1;HMGN5;RTKN2;HTR2B;IL12RB2;TGFB1;AGT;FAM98B;KIF20B;DERL2;XBP1;HAS2;MEF2C;FN1;OSMR
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5508845837244868,-0.867276649667154,0.6721311475409836,1.0,1.0,1/8,4.04%,HTR2B
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.47585198206346263,0.8671699543659878,0.5882352941176471,0.947244026221292,1.0,2/7,12.66%,OPHN1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5284406294040709,-0.8669241232460101,0.6470588235294118,1.0,1.0,1/7,10.22%,CNMD
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.45832079379449997,0.8665734756866494,0.5806451612903226,0.947909413277688,1.0,3/7,28.97%,WHRN;TMC2;KIT
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.4138813599813593,0.8664884808794804,0.5789473684210527,0.9474516436875958,1.0,6/18,18.42%,SYT12;SYT9;SYT17;STX1A;SNCA;PRKN
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.5195054255782618,0.8664548189857662,0.5862068965517241,0.9462054882133062,1.0,2/7,8.61%,SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.5195054255782618,0.8664548189857662,0.5862068965517241,0.9462054882133062,1.0,2/7,8.61%,SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.4032168855574578,-0.8664416132341543,0.7176470588235294,1.0,1.0,13/50,22.48%,C2ORF49;PUS3;FAM98B;CSTF2;ELP5;TRMT10C;SARS1;TRNT1;RTRAF;QTRT1;QTRT2;TRPT1;CPSF1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.3955003746926529,-0.8663147777758269,0.6470588235294118,1.0,1.0,10/48,23.56%,SPDYA;CDKN2C;MAX;CAMK2A;CDK7;CRLF3;CDKN2A;EIF4EBP1;DBF4;CDK4
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.2762115598878735,0.8662203800013251,1.0,0.9459344422433678,1.0,77/316,15.64%,SOX11;RIT2;HIP1;PDGFC;ADRA1A;TAB3;SEPTIN4;ERBB4;ESR1;IRS1;NLGN1;STYXL1;RYK;ATP2C1;BOK;RICTOR;AKR1C2;SEMA4D;GAB1;SIRT1;PPM1A;AKR1C3;INAVA;PUM2;IGF1R;ANKRD17;SLC38A9;GCNT2;TRIM62;NMI;BCL2L11;CHD5;NRG2;STRN;EGFR;KSR1;NDFIP2;UNC5B;ROR2;RELN;PTPRC;ZCCHC3;TGFA;VAPA;MAP3K7;TNFRSF10B;MFHAS1;PELI2;LAMTOR2;LURAP1;PIK3CA;NEDD4;ZDHHC17;MLST8;CDH13;HMGB1;THEM4;TAB2;UBE2N;PRKD1;TFG;FRS2;CFLAR;RAPGEF2;BCL2;USP15;NFAT5;KITLG;TRAF5;LPAR1;MID2;IQCJ-SCHIP1;OSBPL8;FYN;TCF7L2;CXXC5;FLT1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.32298274271209226,0.865743269170027,0.7222222222222222,0.9460942095937918,1.0,5/28,9.74%,KCND2;KCNMB3;DMD;GNAQ;SCN11A
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.41338256166672616,-0.8657371283885141,0.6746987951807228,1.0,1.0,6/31,15.72%,OPRM1;CHRM2;HTR4;HTR1F;CHRM5;AKAP5
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.5537017011446743,-0.8654441504405859,0.6984126984126984,1.0,1.0,1/5,11.01%,CACTIN
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4666637185998118,-0.8653848192791879,0.6538461538461539,1.0,1.0,1/15,2.69%,SPDYA
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.41057423229535145,-0.8652745211695962,0.7209302325581395,1.0,1.0,14/63,19.68%,VEGFA;SCG2;SFRP1;FGF1;HTR2B;XBP1;STAT5A;CDH3;GRN;NR4A3;EMC10;NRP2;HRAS;PTN
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.3043597162740769,0.8648526425902034,0.7647058823529411,0.9473352599714729,1.0,6/54,7.84%,TCF7L1;CHST3;PPARG;LAMC1;SH3D19;EGFR
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.49448488288300596,-0.8647400351226129,0.6527777777777778,1.0,1.0,2/11,9.68%,TGFB1;MEF2C
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.5030366641852912,-0.8644024335805589,0.7123287671232876,1.0,1.0,3/14,21.61%,LRRC17;TCTA;FSTL3
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.36804745406125117,0.8643946110420999,0.6190476190476191,0.9477517516640269,1.0,2/15,11.19%,FER;ST18
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.40322588516350344,-0.8640472110969922,0.7058823529411765,1.0,1.0,13/66,15.32%,HLA-B;ISG15;BTN3A1;HTR2B;ALOX5;FLOT1;AGT;IGF2BP2;GAPDH;SCAMP5;BTN3A3;SYT11;BTNL2
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5009472746927917,0.8640072851382018,0.7575757575757576,0.9479590311139224,1.0,4/8,29.31%,STARD13;NOTCH1;MEOX2;RHOA
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.5388662734869707,-0.8639367909996779,0.7058823529411765,1.0,1.0,3/6,12.18%,GSTM4;GSTO1;GSTM3
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.5368085325854719,-0.8637309951414768,0.6857142857142857,1.0,1.0,1/6,8.89%,JAG1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.49718958996834456,-0.8637280173494928,0.6933333333333334,1.0,1.0,3/10,27.00%,DDX11;NCL;MARS1
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.5840284986730924,-0.8634269843841016,0.765625,1.0,1.0,2/5,13.40%,PLET1;ARHGAP24
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.5319444644415291,-0.8633932043285492,0.6891891891891891,1.0,1.0,3/9,15.40%,DDX5;MED1;ATF4
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.5128578139065969,-0.8632235370613165,0.7162162162162162,1.0,1.0,3/11,17.85%,ALOX12;CEACAM1;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.3791762682139472,0.862885069148061,0.7307692307692307,0.9496500262787546,1.0,7/21,16.62%,FBXW7;ARC;RELN;TGFA;NRP1;ADAM17;GREM1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3746621627255467,0.862834376090415,0.625,0.9491203545644552,1.0,3/17,9.70%,AEN;SIRT1;PML
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2831689631132125,0.8628247578111561,0.75,0.9485056764920553,1.0,31/174,10.12%,PKP2;SHROOM2;NLGN4X;NLGN1;ZFYVE27;DCX;QRICH2;FAM107A;PARD3;PCLO;TRAF1;CD247;REPS2;WNT7A;LAMC1;YTHDF1;SPTBN1;POT1;PICALM;LRRTM3;MAGI1;WASF3;OPHN1;LPXN;WASL;RAC3;TTLL3;PAWR;MDN1;PML;MITF
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.3506430654838417,0.8626139988325031,0.6521739130434783,0.9483814109005746,1.0,3/24,4.32%,ZNF385B;BOK;FHIT
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5615462022836115,-0.8617025118651621,0.7540983606557377,1.0,1.0,2/5,24.52%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5615462022836115,-0.8617025118651621,0.7540983606557377,1.0,1.0,2/5,24.52%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5615462022836115,-0.8617025118651621,0.7540983606557377,1.0,1.0,2/5,24.52%,APOE;ERLIN2
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.29883354142088137,0.8609513447009172,0.8333333333333334,0.9512049489954696,1.0,12/124,5.43%,GSTT2;ESR1;AHCY;BCAR1;AOX1;CDO1;AKR1C2;PDLIM5;PC;SLC35D1;AKR1C3;CAT
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.3098672837591536,0.8607196962310786,0.8888888888888888,0.950883445350746,1.0,9/51,9.33%,RACGAP1;SEPTIN4;SEPTIN6;SEPTIN11;SPTBN1;EFHC1;BBS4;SNX33;SNX18
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3699369262351697,0.8605008721470783,0.75,0.9507211651287644,1.0,8/59,10.40%,VAPB;SMPD4;UBE2J2;RAB10;SEC16A;TRAM1;VAPA;LRRK2
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5130334077890042,0.8604189615711622,0.6470588235294118,0.9502173460091896,1.0,2/7,17.17%,STARD13;RBPJ
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.5469118132048297,-0.8600824623847123,0.71875,1.0,1.0,2/6,10.95%,GLUL;CAD
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.5284224246710336,-0.8593773588283856,0.6986301369863014,1.0,1.0,4/9,28.09%,LPCAT3;SREBF1;MBTPS2;MBTPS1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.3268665221352895,0.8591184530661052,0.6875,0.9524220391698518,1.0,5/22,10.93%,MYCN;LIMD1;PUM2;EGFR;EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.5294210885705165,-0.8590817644275124,0.6,1.0,1.0,2/6,15.72%,CACNA1C;AKAP5
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5329410351818513,-0.8588516243337403,0.7746478873239436,1.0,1.0,2/9,23.07%,DKC1;FBL
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.4669471192196538,-0.8587037574707244,0.6621621621621622,1.0,1.0,3/17,18.74%,PGRMC1;UROD;NFE2L1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.35310171584377853,0.8585544004766972,0.5,0.9527831706220232,1.0,9/45,13.79%,GABRG1;GABRR1;SLC12A8;SLC12A1;SLC4A10;GLRA1;GABRG3;GABRB1;GABRA1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.31121366723152954,0.8570494628113393,0.7272727272727273,0.9553607058447116,1.0,24/92,15.69%,BCAR1;ASB5;CHST3;DMD;LAMC1;FOXK1;SH3D19;EGFR;ADCY6;PALLD;GPC1;SOX8;PTPRU;PARD3B;IRF2;SNX7;KITLG;COL5A2;NCKAP1;EPB41L1;NTN4;AMOTL2;FRMD6;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.44485253722589607,0.8570431045547195,0.6071428571428571,0.9547090273277643,1.0,3/8,17.43%,NOS1;PID1;PINK1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.5499265634966131,-0.8570314018201545,0.7833333333333333,1.0,1.0,1/6,10.39%,BDNF
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.35428721033316835,0.8568032940669543,0.68,0.9544839823438368,1.0,1/27,0.98%,DGKB
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4404484713654103,0.8567121645200623,0.6111111111111112,0.9539675033444778,1.0,4/15,9.14%,ARFIP1;FCHSD2;WASF3;CTNNA2
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.5174835463546208,-0.8566170315974239,0.6721311475409836,1.0,1.0,3/6,29.35%,APEH;PEX14;ABCE1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.5492022376891627,-0.8565927492751854,0.640625,1.0,1.0,3/6,35.83%,LGMN;MAP1A;SHANK1
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3518515995246637,0.8565245881325838,0.64,0.9537675647022813,1.0,6/29,7.95%,SPRED2;PARD3;SMAD7;MAPK1;STOX1;BMP7
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.41507928874378663,-0.8563082103845854,0.7380952380952381,1.0,1.0,8/37,18.68%,RPL10;RARRES2;TGFB1;ZFPM1;TEAD3;ATF4;STIL;RNF112
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.3570332872472787,-0.8561968262406547,0.8673469387755102,1.0,1.0,22/205,10.49%,CD63;VEGFA;RIMS1;DDRGK1;PLSCR1;RPL11;FGF1;RPL23;HMGN5;CLU;TGFB1;FAM98B;OVOL2;OLFM1;TTN;SFRP4;EPHX2;MEF2C;FN1;MED1;CDH3;PIK3CB
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.4733325108903469,-0.8558112290335591,0.684931506849315,1.0,1.0,2/15,15.13%,HAP1;KIF1A
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.4358835343396369,-0.8557376969477474,0.7,1.0,1.0,5/32,17.31%,TGFB1;ANKLE2;CALM1;PTPA;PPP2R5A
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.43628890842422086,-0.8556583606724341,0.726027397260274,1.0,1.0,3/16,8.58%,CTSL;MAFF;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.3575910197388097,0.8554707303448644,0.6666666666666666,0.9552309849837795,1.0,5/22,12.02%,PANX1;INAVA;HSPB1;HMGB1;P2RX7
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.5244035871867572,-0.8553921526977155,0.7368421052631579,1.0,1.0,5/11,23.11%,CAMK1;TERF2IP;KAT5;PARK7;FAM161A
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.4298500998356729,-0.8552583023574459,0.68,1.0,1.0,2/21,5.41%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.42145593464006403,0.8549198820644313,0.5,0.9556976679949272,1.0,2/11,19.45%,RIPOR1;YWHAZ
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.5376959680189529,0.854662894044605,0.6,0.955436347318863,1.0,1/5,19.58%,ATPAF1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.3887498955833764,-0.8545792663153715,0.6951219512195121,1.0,1.0,4/46,9.68%,PPIF;ECT2;HPCA;MEF2C
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.49331958043219837,-0.8544358718757349,0.6805555555555556,1.0,1.0,2/10,16.41%,HNRNPA2B1;SRRT
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.527471395998231,0.8543778566630056,0.6451612903225806,0.9552238398440585,1.0,3/6,18.92%,MARCHF7;LRRK2;SASH1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.36904365409132717,-0.8543208725202449,0.8241758241758241,1.0,1.0,21/145,17.49%,PSMB9;TUBB4B;NPM2;RPS27A;PSMB8;TUBA4A;ZW10;PSMA3;CEP72;BUB3;DCTN1;PSME1;TUBB4A;CDC26;UBA52;FZR1;RIOK2;ODF2;NEK6;ZFP36L2;DCTN3
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.43293228699530545,-0.8543146612347498,0.7108433734939759,1.0,1.0,8/27,28.67%,KIF20B;OBSL1;TOM1L1;USP44;BTC;CUL7;PDGFRB;LCMT1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.43317134176434857,-0.8540215773443635,0.75,1.0,1.0,2/25,8.03%,TUBGCP2;TUBGCP4
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.449412275738067,-0.8539034060528937,0.717948717948718,1.0,1.0,5/21,12.47%,OPRM1;RETREG1;SCN9A;NIPSNAP1;P2RX4
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.4978462936773046,-0.8538717331703699,0.6857142857142857,1.0,1.0,1/11,2.65%,HAP1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.5371646210510045,0.853822060561417,0.5757575757575758,0.9556895778729171,1.0,5/7,15.36%,CSGALNACT1;EXT2;HS2ST1;EXT1;NDST3
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.504064572952027,-0.853746260947508,0.7101449275362319,1.0,1.0,1/9,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.4838578234428632,-0.853592386531099,0.6956521739130435,1.0,1.0,1/12,4.62%,CREB3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.49904571487396016,-0.8533510854739758,0.7162162162162162,1.0,1.0,1/13,0.33%,IFI6
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.49904571487396016,-0.8533510854739758,0.7162162162162162,1.0,1.0,1/13,0.33%,IFI6
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.5712789905602165,0.853118930056283,0.7,0.9565055313280084,1.0,1/5,19.87%,DDX3X
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.40006327113233514,0.8530681977383786,0.6842105263157895,0.9559058522445231,1.0,9/19,15.96%,HIP1;ARAP1;FBXW7;AFAP1L2;TGFA;PLAUR;ADAM17;CNOT9;CCDC88A
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3777168578592348,-0.8529955927076149,0.7708333333333334,1.0,1.0,16/112,18.82%,PSMB9;VAV3;PSMB8;BTN3A1;LAT2;EIF2B2;HLA-A;MEF2C;PIK3CB;PSMA3;PSME1;BTN3A3;BTNL2;BLNK;PRKCQ;PSMA7
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.5188128866351557,0.8524837366526257,0.6176470588235294,0.9564789186300141,1.0,1/5,3.92%,BOK
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.5083998894169173,-0.8524610934416899,0.6962025316455697,1.0,1.0,3/10,20.54%,GLUL;SLC1A6;SLC29A2
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.41839931089313914,-0.8523070111952051,0.684931506849315,1.0,1.0,8/27,22.67%,VEGFA;AGT;HAS2;STAT1;WFS1;GREB1L;PAX8;BAG6
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.36311972302366313,0.8522145572403225,0.6875,0.9564354552556328,1.0,5/24,14.96%,HSPA1A;NAV3;MECP2;CLASP1;PSRC1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.47026552832295243,-0.8520384967771056,0.7391304347826086,1.0,1.0,4/13,18.12%,C3;NR4A3;RTN2;TRIB3
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3061969812782287,0.8520296750841833,0.7272727272727273,0.9561869379997833,1.0,19/111,12.05%,VAPB;ABHD3;GSTM2;SGMS1;ACER3;CDO1;LARGE1;SLC44A1;STARD7;DMD;SPTLC2;CERT1;SLC44A5;VAPA;PCYT1B;GSTO2;GPAT4;PPM1L;PRKD1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.3004751843182155,0.8519900945507544,0.6363636363636364,0.9556493814262923,1.0,13/51,15.15%,NLGN1;CNIH2;NETO1;GRIA1;GSG1L;RELN;LRRC7;GRIA3;DLG2;GRIN2B;DLGAP1;CACNG2;NPTX2
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.3779157076726142,-0.8519398964942159,0.7701149425287356,1.0,1.0,7/83,9.38%,TAF7;SPDYA;ECT2;DVL1;TRIB1;TTN;CEACAM1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.37792491311994947,0.8519369542342267,0.6666666666666666,0.9550884524767681,1.0,4/23,10.30%,MAP3K5;MAP3K11;MAP3K4;MAP3K7
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.36414255237752535,0.8517924848843688,0.6153846153846154,0.9547691010430449,1.0,9/32,16.62%,YJEFN3;ROBO1;CDH13;NRP1;DLL1;OTULIN;VEGFD;SLIT2;GREM1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.4490054670772268,-0.8515724375600146,0.6710526315789473,1.0,1.0,4/23,9.15%,ZFPM1;TTN;CACNA1G;KDM6B
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.4812281306437285,0.8511671126872629,0.5882352941176471,0.9546728052879755,1.0,1/6,7.96%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4812281306437285,0.8511671126872629,0.5882352941176471,0.9546728052879755,1.0,1/6,7.96%,ATP2B4
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.5563247053884306,-0.85101931949596,0.65,1.0,1.0,1/5,8.91%,BCAT2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5608914467476456,-0.8510187668801421,0.7464788732394366,1.0,1.0,4/7,26.05%,ALOX12;CEACAM1;RDX;CD9
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.3016331614981828,0.8509268550380993,0.7777777777777778,0.9544865626170635,1.0,8/46,9.23%,ATR;NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPK3;MAPKAPK5
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.4080231396161167,0.8509200283960706,0.7428571428571429,0.9538922777190061,1.0,5/10,13.85%,APOLD1;PRKX;AJAP1;KLF7;DLL1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.4107229402126185,-0.8507945783950377,0.7752808988764045,1.0,1.0,13/46,22.65%,GSTM4;ALOX5;GPX4;ALOX12;EPHX2;FADS2;ELOVL2;FAAH2;ACADL;ACOT2;ACSBG1;GSTP1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.31689306691549557,0.8507751045621381,0.782608695652174,0.953538802901859,1.0,7/36,9.13%,ATR;PDS5A;OBI1;ANKRD17;STN1;EGFR;CTC1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.29921966372692416,0.8505217699020176,1.0,0.9534256526614271,1.0,35/181,13.53%,DAPK2;TAB3;FBXW7;LEPR;ABL1;BOK;CTSA;ZKSCAN3;OSBPL7;TBC1D14;HSPB1;TP53INP1;FOXK1;SLC38A9;FOXO1;KEAP1;ABL2;CAPNS1;DHRSX;KAT8;EIF4G3;ATP6V1A;LRRK2;LAMTOR2;NEDD4;DAPL1;MLST8;MTMR3;HMGB1;TAB2;PRKD1;EEF1A2;WASHC1;MAPK8;BCL2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.37443526931817817,0.8502282834144145,0.8571428571428571,0.9535523427977571,1.0,4/31,8.99%,TAF1A;TCOF1;TAF1B;MAPK3
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.5644036830549357,-0.850128980220273,0.6774193548387096,1.0,1.0,1/5,23.82%,SUMF1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.4642431784516379,-0.8500100172061373,0.7027027027027027,1.0,1.0,3/19,18.74%,PGRMC1;UROD;NFE2L1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.45432366823244286,-0.8499930100166297,0.7,1.0,1.0,3/18,10.79%,POLE3;RRP8;BEND3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.4076216511442202,-0.8499582554638925,0.7272727272727273,1.0,1.0,3/46,3.33%,IFI6;SCG2;NOL3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.542007573131811,-0.8498937487592946,0.6944444444444444,1.0,1.0,3/5,20.30%,MEF2C;PIK3CB;CDKN2A
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.4035000129410339,0.8498805853830876,0.65,0.9537626975159049,1.0,5/14,22.96%,ADCY6;PRKACB;ADCY2;ADCY9;PRKAR1B
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.43862394546630257,-0.84967422565869,0.7088607594936709,1.0,1.0,2/26,4.72%,TAF7;CAMK1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.5856964301284081,-0.849542280075982,0.8166666666666667,1.0,1.0,1/5,2.32%,SFRP1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.3875841100302579,-0.8495295050373495,0.7586206896551724,1.0,1.0,7/52,8.09%,FMO3;CP;ANKUB1;TMEM220;FPR3;APOL6;HVCN1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.4025388665221614,0.8495140351620954,0.5238095238095238,0.9539129283476909,1.0,5/15,22.96%,ADCY6;PRKACB;ADCY2;ADCY9;PRKAR1B
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.48699700208539465,-0.8494506840616156,0.6805555555555556,1.0,1.0,1/11,13.26%,ACO2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.376992459142297,0.8493159819159815,0.75,0.9535965052239317,1.0,9/23,15.93%,ERBB4;GAB1;NRG2;EGFR;ERBIN;PTPRR;PIK3CA;SOS1;PRKCA
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.5207389926068406,0.8490921364800844,0.5833333333333334,0.9533761244675232,1.0,1/6,19.58%,ATPAF1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.4031336456051497,-0.848719250452906,0.7303370786516854,1.0,1.0,10/44,16.10%,TACR1;JPH3;HTR2C;FPR3;CACNA1C;GRM1;P2RX4;TAC4;LPAR6;CD55
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5222761471433919,-0.8485312946747094,0.704225352112676,1.0,1.0,1/7,10.49%,PIK3CB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3905556529369223,0.8482959630173101,0.6774193548387096,0.9544579686597994,1.0,3/13,5.79%,GSTM2;ANK2;DMD
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.42297498424521646,-0.8477302079815711,0.691358024691358,1.0,1.0,2/34,7.29%,RPS14;ZFPM1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.5442701924364213,-0.8473176098562513,0.6986301369863014,1.0,1.0,2/6,25.39%,ADAR;ADAT2
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.4587960829001443,-0.8470050341785815,0.7375,1.0,1.0,2/23,1.86%,CD63;RANGRF
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.38321573107404305,-0.8469502770721852,0.7444444444444445,1.0,1.0,14/85,17.11%,ISG15;PDCD1LG2;TRIM25;SELENOS;ZFPM1;CEACAM1;FN1;CACTIN;NLRC5;SYT11;UBE2L6;SARS1;APOD;CHID1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.46909405926884723,-0.8465788763949262,0.7215189873417721,1.0,1.0,1/13,3.29%,PPIB
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.4982128885412309,-0.8463868014236959,0.6567164179104478,1.0,1.0,2/10,12.47%,FGF1;P2RX4
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.4768333402100343,-0.8463122123192722,0.7432432432432432,1.0,1.0,6/15,20.25%,SLC22A4;SLC6A6;SLC1A6;SLC6A9;SLC3A2;SLC7A8
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5103829951376222,-0.8462078579941087,0.6865671641791045,1.0,1.0,2/7,10.62%,MAFF;KRT10
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3996795576786895,-0.846137978572722,0.7411764705882353,1.0,1.0,14/44,32.31%,DENND3;CEACAM1;APOE;NR1D1;FBXO6;BAG6;HSPA8;FBXO2;HTRA2;PPT1;UBE2G2;FBXO27;CUL4B;USE1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.42294099576587957,-0.8460824546348223,0.7228915662650602,1.0,1.0,4/36,10.39%,RIMS1;PPIB;AGRN;BDNF
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.5378104745960073,-0.8459119239219621,0.7727272727272727,1.0,1.0,4/7,29.43%,ZDHHC8;APOE;ABCA1;PRKACA
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.5463578584627673,-0.8455436109960621,0.7096774193548387,1.0,1.0,2/5,22.31%,EMP2;CAV1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.4725864189128363,-0.8453889697971376,0.7142857142857143,1.0,1.0,2/14,10.73%,SRSF7;SRSF10
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.5238966882522524,0.8452893766276204,0.65625,0.9588153443669724,1.0,1/5,4.40%,EDEM1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.5238966882522524,0.8452893766276204,0.65625,0.9588153443669724,1.0,1/5,4.40%,EDEM1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.5238966882522524,0.8452893766276204,0.65625,0.9588153443669724,1.0,1/5,4.40%,EDEM1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.4316304023559613,0.844916031343307,0.6153846153846154,0.9590448871777354,1.0,5/11,18.21%,IRS1;FOXO1;FOXO3;PID1;GLDC
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.5328913036009428,-0.844878111913228,0.671875,1.0,1.0,1/6,1.74%,VEGFA
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.5663465977365111,-0.8447675156499562,0.7678571428571429,1.0,1.0,1/5,7.29%,ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4260604262648946,0.8447066355987409,0.6333333333333333,0.9588217538546722,1.0,3/11,8.41%,PPARG;TAFA5;PRKG1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.5226727490474231,-0.8445030984175097,0.7121212121212122,1.0,1.0,1/5,10.10%,MED1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.36185032567921427,-0.8443391453889503,0.7894736842105263,1.0,1.0,24/136,19.78%,ESRRB;POLR2I;TAF7;TFAM;POLR2G;TAF11;POLR3H;RRN3;POLR1C;MED1;TEAD3;GTF2F1;CDK7;SMARCA5;ESR2;NR5A2;TAF9B;TAF1D;NR4A3;NR0B1;HDAC3;NR1D1;HNF4G;POLR1G
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.49364650810831584,-0.8440599050168939,0.7058823529411765,1.0,1.0,1/11,2.32%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.5043085016781819,-0.8440270851416954,0.703125,1.0,1.0,1/6,12.47%,P2RX4
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3489587367676076,0.8438737926251215,0.6,0.959633916502208,1.0,5/32,6.52%,SHROOM2;PBX3;PBX1;SMOC1;MEIS1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.3925446725175475,-0.8436581413696812,0.7530864197530864,1.0,1.0,6/44,10.39%,VEGFA;SFRP1;FLOT1;AGT;S100A10;BDNF
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.3089346375157976,0.8436397851743002,0.6,0.9595533513667747,1.0,20/90,14.75%,HID1;BCAR1;TMEM117;TSPAN15;CDC42EP4;HDAC11;PTGFRN;UNC13B;ADCY6;WASL;UNC5B;CDS1;MMP15;GPC1;PTPRU;CMTM4;COBL;RNF128;COL18A1;EPB41L1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.3811918736764922,-0.8436185385291398,0.7530864197530864,1.0,1.0,14/64,22.91%,HLA-F;RETREG1;MEF2C;BDNF;GRN;ATF4;CHMP4B;APOE;RASA1;WFS1;NRBP2;SET;VPS35;PARK7
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.31198345487902507,0.8435983654767174,0.7692307692307693,0.9576749433541266,1.0,9/54,10.26%,COL7A1;SEC24D;PREB;CNIH2;GRIA1;BET1;NSF;SEC16A;TGFA
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.31198345487902507,0.8435983654767174,0.7692307692307693,0.9576749433541266,1.0,9/54,10.26%,COL7A1;SEC24D;PREB;CNIH2;GRIA1;BET1;NSF;SEC16A;TGFA
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.31198345487902507,0.8435983654767174,0.7692307692307693,0.9576749433541266,1.0,9/54,10.26%,COL7A1;SEC24D;PREB;CNIH2;GRIA1;BET1;NSF;SEC16A;TGFA
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3708481506712349,0.8434357839119323,0.72,0.9572876117117276,1.0,2/19,4.23%,ESR1;MED24
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4124370550604099,-0.8433719353147433,0.7228915662650602,1.0,1.0,5/38,8.63%,HES5;VEGFA;DVL1;TGFB1;ZNF568
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.5027108400666546,-0.8433236621166397,0.676923076923077,1.0,1.0,1/8,14.03%,DONSON
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.5747785083857884,-0.8427312052565412,0.7313432835820896,1.0,1.0,4/5,42.47%,TIMP3;TIMP1;LRP1;TIMP2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.5386337010414022,-0.8423028198326651,0.7741935483870968,1.0,1.0,1/6,14.56%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.5386337010414022,-0.8423028198326651,0.7741935483870968,1.0,1.0,1/6,14.56%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.5386337010414022,-0.8423028198326651,0.7741935483870968,1.0,1.0,1/6,14.56%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.5386337010414022,-0.8423028198326651,0.7741935483870968,1.0,1.0,1/6,14.56%,ELOVL2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.2922426671564182,0.8419117041625956,0.7368421052631579,0.9598630788208273,1.0,16/49,22.02%,RANGAP1;NUP98;NUP93;NSMCE2;TRIM28;AAAS;NUP210;STX1A;TRPM4;PIAS1;NUP42;NUP35;ZNF451;UBE2I;NUP54;SEH1L
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.48128587187023636,0.8416416137155934,0.71875,0.959676110911181,1.0,3/6,15.53%,HOMER1;GRIN2B;FYN
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3458996773142183,0.8414201783917236,0.625,0.9596313920387561,1.0,4/26,6.94%,PANX1;INAVA;HSPB1;FOXP1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.30747430201655734,0.8413835182857955,0.6428571428571429,0.9590309301507767,1.0,8/63,9.38%,LDB2;EPHA3;ERBB4;RYK;MERTK;IGF1R;EGFR;ROR2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.28967276713990775,0.8413430438923458,0.8461538461538461,0.9584903523216748,1.0,12/55,13.05%,SOX11;LIG4;PLXNA1;IL1RAPL1;ROBO1;FZD3;PLXNA3;SOX8;FBXW8;ROBO2;CAPRIN1;TIAM2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.37068413709575126,-0.8409396697774015,0.8488372093023255,1.0,1.0,14/112,14.87%,POLR2I;RBM3;DDX24;POLR2G;LAGE3;RBMS2;SIDT2;RNASE1;GTF2F1;NCBP1;PRPF4;HNRNPA2B1;RNASEH2C;SUPV3L1
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.5227556229859676,-0.8408344626292755,0.6885245901639344,1.0,1.0,4/6,39.59%,PIK3IP1;STAMBP;TSC2;DAB2IP
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.4464278201034514,0.8407897584959868,0.5925925925925926,0.9589661438134762,1.0,3/10,11.97%,NIPAL3;NIPAL2;TUSC3
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.49281513042675784,-0.8405860100826803,0.7391304347826086,1.0,1.0,5/12,23.78%,ANGPTL4;XBP1;APOE;MTLN;IL18
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.37112076737796995,0.8403602563390061,0.7586206896551724,0.9586302594733692,1.0,2/20,1.42%,ZDHHC2;ZDHHC11
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.37112076737796995,0.8403602563390061,0.7586206896551724,0.9586302594733692,1.0,2/20,1.42%,ZDHHC2;ZDHHC11
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.5362754182901324,-0.8401409402226779,0.7352941176470589,1.0,1.0,3/7,18.76%,GRN;SYT11;NR1D1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.4727449763600088,-0.8401065878335214,0.7012987012987013,1.0,1.0,4/12,14.56%,ALOX5;ALOX12;FADS2;ELOVL2
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.29818334346930037,0.8398373130741366,0.7,0.9591403753518618,1.0,16/76,12.02%,RGS7BP;FAM107A;KCND3;CDH20;NRXN1;MAPK1;RTN1;PLXDC2;SLC1A2;SEZ6L;CA10;GRIA3;TGFA;LRRK2;SLC8A1;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.46002185802949414,-0.8397067725551003,0.7407407407407407,1.0,1.0,4/21,15.48%,HHIP;GPC3;ULK3;RACK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.4480488115578575,-0.8396858945802638,0.7532467532467533,1.0,1.0,8/17,28.81%,RPS27A;DERL2;UBA52;SYVN1;UBC;TRIM13;OS9;EDEM2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.3615134763216666,-0.8396023061472409,0.8089887640449438,1.0,1.0,10/105,10.48%,S100A6;IFIT1;HES5;ISG15;RBM3;ZIC1;INA;ARX;PLEKHH2;INAFM2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.42324515121957673,-0.8395414514455276,0.7142857142857143,1.0,1.0,8/21,23.55%,RASSF1;TOR2A;TRAPPC6A;CCS;DNAJC4;GUK1;SF3B5;RHOG
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.4491046423933197,-0.8388344487711233,0.7183098591549296,1.0,1.0,2/13,13.60%,PLS1;DCTN1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.36116931898730664,-0.8386202678195647,0.78125,1.0,1.0,25/137,18.86%,CDC37;PFN2;PPIB;RPL11;DVL1;RPL23;FLOT1;CLU;CRYAB;WIZ;GAPDH;EFNA1;CDK7;SAXO1;ZBED3;GRN;TAF9B;TELO2;RPS7;MORC3;USP19;CCT7;SYVN1;RPL5;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5116198028563446,-0.838602238404754,0.7361111111111112,1.0,1.0,1/10,1.74%,VEGFA
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.4559815329502599,-0.8385414716767262,0.7012987012987013,1.0,1.0,6/16,30.18%,ALOX5;AVIL;SOX9;AOAH;SPI1;TUBB
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.49438708795488084,-0.838138375629,0.75,1.0,1.0,1/10,1.74%,VEGFA
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3385694017225118,0.8381285730115269,0.7619047619047619,0.9621233545859186,1.0,18/27,28.85%,EFR3A;SMG1;PIK3CA;IP6K1;EFR3B;SOCS6;SOCS4;SOCS7;IP6K2;PIK3R1;PI4KB;TTC7B;PIP4K2A;PIP4K2B;ITPKB;PIK3CD;TTC7A;PI4K2B
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.395591062319425,-0.8381123563675568,0.7738095238095238,1.0,1.0,10/42,19.59%,RIMS1;HAP1;RHBDF1;SCG5;MEF2C;CAMK2A;RAB3D;SEPTIN1;RAB15;CPLX1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.4659194623421893,-0.8379081590198535,0.676056338028169,1.0,1.0,7/12,26.88%,CEACAM1;ACADL;TRIB3;BRCA1;ERLIN2;SOX9;WDTC1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.3776765782967089,-0.8377516568631574,0.7727272727272727,1.0,1.0,19/66,26.69%,ECM2;CRYAB;SFRP4;ASPN;PAMR1;COL15A1;LMOD1;ACTA2;COL4A1;ADAMTS2;MYLK;THBS2;CALD1;THY1;COL14A1;COL4A2;PDGFRB;RHOJ;C1S
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.4836858420936745,0.8376437284770093,0.6428571428571429,0.9625480964973593,1.0,1/6,4.09%,PLIN5
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.4919183658394765,0.8376243522306672,0.7435897435897436,0.9619959313758588,1.0,4/5,24.90%,PML;HABP4;ETS1;HIPK2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.3938038823614438,0.8374643232974831,0.72,0.9616913585809637,1.0,4/15,12.62%,PKD2;GRIN2B;KCNC2;CPSF6
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.2948149025923217,0.8374278593182751,0.6923076923076923,0.9610817458380214,1.0,7/34,9.33%,RACGAP1;SEPTIN6;SPTBN1;EFHC1;BBS4;SNX33;SNX18
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.35490776309662564,0.8374071837502332,0.6666666666666666,0.9604846752177845,1.0,4/27,4.98%,ONECUT1;LAMA3;TSPAN8;AKR1C3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.41678808979001625,-0.8372962596144232,0.7391304347826086,1.0,1.0,2/16,10.10%,JUN;MED1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4091639209205778,0.8372780764297224,0.631578947368421,0.9600643739312941,1.0,3/11,13.97%,ADAM10;ADAM19;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.3883097235722727,-0.8367744335021341,0.7294117647058823,1.0,1.0,12/55,22.91%,TAF7;DVL1;CDKN1C;TRIB1;CEACAM1;RTRAF;PPP2R5A;WARS1;TRIB3;GSTP1;THY1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.33437220794240496,0.8367562898393118,0.5,0.9603363747887592,1.0,4/31,8.07%,RYBP;YAF2;RNF2;EED
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4687638126285165,0.8365407867006868,0.6551724137931034,0.9600924759437598,1.0,2/9,11.52%,PPARG;CDH13
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.3707603950521883,0.8362948634941352,0.6764705882352942,0.9599308614851585,1.0,4/20,14.53%,QRICH2;RAC3;PACSIN2;NCKAP1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.5479748213067092,-0.8360003947804563,0.7619047619047619,1.0,1.0,3/7,25.98%,ALOX5;GSTP1;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.37550310540224574,-0.8359627401947238,0.7865168539325843,1.0,1.0,19/74,24.28%,RBM3;POLR2G;RPS9;YBX3;RPS4X;TRMT10C;UPF3B;RPUSD3;COA3;UPF3A;NSUN5;RPS27L;PLXNB2;RPL5;PCIF1;RMND1;CIRBP;DHX36;EIF2S3
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.43448603162016614,-0.835914136516905,0.7142857142857143,1.0,1.0,8/24,22.81%,IFI6;CLU;CAMK2A;IFIT2;BAX;DNM1L;HSPD1;VPS35
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.45497371953345367,-0.8358890098116447,0.7721518987341772,1.0,1.0,9/24,20.10%,ALOX5;CREB3;CLU;SELENOS;XBP1;LPCAT3;RACK1;SYVN1;WFS1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3727446111840026,-0.835711984643595,0.7840909090909091,1.0,1.0,22/73,29.20%,RPL13A;HDAC6;IGF2BP2;GAPDH;CST3;RACK1;APOE;SHMT1;NCL;PCIF1;EIF2AK2;MALSU1;ATRAID;BAG6;DHX36;ILF3;PAIP2;CNOT8;BTG2;RBM4;PLAT;CSTB
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.39029508171991095,-0.8355893419167076,0.7848101265822784,1.0,1.0,11/50,22.65%,VEGFA;FGF1;ANGPTL4;XBP1;BTG1;GRN;EMC10;NINJ1;BRCA1;VEGFB;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.47643198788874197,0.8355851206341659,0.5777777777777777,0.9604034491842812,1.0,2/5,4.91%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.47643198788874197,0.8355851206341659,0.5777777777777777,0.9604034491842812,1.0,2/5,4.91%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.3661361284599413,-0.8351475377890548,0.7590361445783133,1.0,1.0,10/59,18.14%,VEGFA;FGF1;TGFB1;AGT;STAT5A;PIK3CB;P2RX4;GRN;EMC10;NRP2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.4947437920167259,-0.8350993077737645,0.6865671641791045,1.0,1.0,2/12,2.63%,SFRP1;H2AZ1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.5065958472244527,-0.8350202152463202,0.6818181818181818,1.0,1.0,1/9,1.74%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5511652144342802,-0.8347165586050899,0.7966101694915254,1.0,1.0,2/5,34.49%,APPL1;STAT3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.37883899412113964,-0.8346613712321056,0.7701149425287356,1.0,1.0,3/64,3.55%,S100A6;CDHR1;DVL1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.38622721530471177,-0.8345449888949744,0.7701149425287356,1.0,1.0,7/60,11.73%,PLSCR1;CP;PAH;MRPS18C;GPC3;GLUL;CPB2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.40141440685130186,-0.8345282683554726,0.7307692307692307,1.0,1.0,2/39,5.88%,MX1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.35821351990429523,-0.8344265491474903,0.8172043010752689,1.0,1.0,15/125,13.77%,DUOX1;VEGFA;DDRGK1;FGF1;TMSB15B;PLET1;TGFB1;CEMIP;SEMA4C;XBP1;HAS2;ELP5;WNT5B;GRN;VIL1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.3985485421701082,-0.8341899817135396,0.7402597402597403,1.0,1.0,6/26,21.00%,ADAM21;COL9A3;NR0B1;MEA1;NUP107;FSHR
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.5331378136261778,-0.8340309075799012,0.7272727272727273,1.0,1.0,3/5,43.29%,IDH3B;IDH2;IDH3A
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.37407577677032294,-0.8337106602043237,0.7380952380952381,1.0,1.0,8/54,17.90%,IFIT1;POLR2I;POLR2G;GTF2F1;NR5A2;CTDP1;ADAR;SRPK1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.330882495792482,0.8334060903382845,0.7222222222222222,0.9639114099661936,1.0,6/37,7.17%,DAPK2;SEPTIN4;STYXL1;SGMS1;BOK;BCL2L11
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.509016820612041,-0.8332037988899836,0.7162162162162162,1.0,1.0,4/9,33.07%,NR1D1;GBE1;PER2;UGP2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.509016820612041,-0.8332037988899836,0.7162162162162162,1.0,1.0,4/9,33.07%,NR1D1;GBE1;PER2;UGP2
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.4775654468878274,-0.8330308952337951,0.7222222222222222,1.0,1.0,1/9,5.85%,SELENOS
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.3832277260398122,-0.8330124186698706,0.7362637362637363,1.0,1.0,9/52,18.40%,RAB11A;ABRAXAS1;ZW10;SMC1A;MIS12;CTDP1;CHMP4B;KIF18B;MZT1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.33174942760937753,0.832999138886562,0.6428571428571429,0.9641564679943189,1.0,15/63,14.21%,MMP16;TSPAN17;ADAM10;TSPAN15;PHEX;ADAM19;DNAJB11;NAA50;TSPAN5;TSPAN14;NFU1;GLRX3;NAA11;ADAM17;NAA16
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3758868066047462,-0.8327936455116716,0.75,1.0,1.0,16/66,21.59%,HLA-F;CTSL;HLA-A;AP2A1;SH3GL2;CLTA;DYNC1LI2;DNM2;DCTN1;SEC13;ACTR1B;DCTN6;DCTN3;HLA-DMA;KIF22;AP2A2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.4805248513514548,0.8327724479157076,0.6764705882352942,0.9640744203685652,1.0,2/5,22.07%,IKBKB;PPP1R12A
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.40881869638682644,-0.8327301163272658,0.7619047619047619,1.0,1.0,7/29,24.51%,GAPDH;PGK1;ATF4;G6PC3;G6PC2;GOT1;PGAM1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.4714837828251579,-0.8325344892166323,0.676056338028169,1.0,1.0,1/12,1.30%,TRPC5
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.367388444665028,0.8322900312754988,0.6818181818181818,0.9643190515166521,1.0,5/18,9.84%,NLGN1;WNT7A;NRXN1;RELN;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5309654269404946,-0.8316914332039538,0.7323943661971831,1.0,1.0,3/6,43.22%,C1QBP;NPLOC4;SEC14L1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.45870792887803746,-0.8312639698784974,0.7222222222222222,1.0,1.0,4/15,29.09%,LAS1L;WDR12;NSA2;FTSJ3
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.3654154090998807,-0.8311872712879012,0.8279569892473119,1.0,1.0,26/106,22.65%,VEGFA;SFRP1;FGF1;ALOX5;SPINK5;ANGPTL4;XBP1;CEACAM1;NAXE;CNMD;CD160;GLUL;PGK1;EMP2;BTG1;GRN;SARS1;WARS1;STAT1;EMC10;NINJ1;RNH1;BRCA1;THBS2;VEGFB;CYP1B1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.4758206383691028,0.830810487005263,0.6428571428571429,0.9665331680410154,1.0,3/7,20.64%,UGDH;LETM1;LRRC8A
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.47858008225255144,0.8306788075023069,0.625,0.9662750090754719,1.0,1/5,3.92%,NDP
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.3861079127951681,-0.8305581362226753,0.7472527472527473,1.0,1.0,6/49,12.07%,SFRP1;PLET1;LDB1;JAG1;PIK3CB;EMP2
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4275968045878827,0.8305313104135207,0.6774193548387096,0.9660171869122318,1.0,4/9,16.62%,MAPK1;MAPK3;MAP2K2;GREM1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.4257969660767744,-0.8305298455377144,0.7564102564102564,1.0,1.0,4/21,22.04%,PHF1;CHTOP;BRCA1;SNW1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.3720297299511908,0.8304027215743964,0.8125,0.9656433723331297,1.0,5/19,13.06%,FAM20B;CSGALNACT1;GAL3ST3;CHST8;BMPR1B
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.35774043076848644,-0.8303435338405883,0.8,1.0,1.0,6/101,8.86%,GOLGA8B;ARL1;GORASP1;GOLGA8A;ZW10;OBSL1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.44248284730351795,-0.8303048623358983,0.7142857142857143,1.0,1.0,3/17,15.18%,PRELP;OMD;OGN
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3279690337326706,0.8297484093352947,0.5625,0.9663279450651118,1.0,4/32,8.07%,RYBP;YAF2;RNF2;EED
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4431079820182075,-0.8294469436198216,0.7142857142857143,1.0,1.0,7/18,26.81%,SFRP1;PARP14;SH3BP5L;CAV1;THY1;SH3BP5;PTPN2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3782623625348963,0.8288297220904828,0.75,0.9673020691513796,1.0,3/16,5.79%,GSTM2;ANK2;DMD
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.40292496494947627,0.8287641416000249,0.6333333333333333,0.9667539959815876,1.0,3/10,20.02%,GLRA1;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.3925569256022903,-0.8286652791219185,0.7323943661971831,1.0,1.0,8/28,19.87%,SELENOK;ZDHHC24;GLUL;ZDHHC1;ZDHHC8;ZDHHC22;ZDHHC15;GOLGA7B
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.3666675894142951,-0.828580413666079,0.7647058823529411,1.0,1.0,13/63,17.69%,PPIB;COL5A3;COL9A3;P4HA3;OPTC;COL15A1;COL6A1;COL9A2;ADAMTS3;COL4A1;ADAMTS2;COL21A1;COL10A1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4804738781166267,0.828480233502474,0.6666666666666666,0.9665199057598053,1.0,3/6,17.19%,WNK1;JAM3;ACER2
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.44815025651244356,0.8282346661701929,0.7333333333333333,0.9662977148112325,1.0,3/14,14.53%,QRICH2;RAC3;NCKAP1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.40288965721382397,0.8281413761701555,0.75,0.9658788243590601,1.0,2/12,8.61%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.29669528329800515,0.8279226252543848,0.8571428571428571,0.965611017744812,1.0,19/47,21.92%,MAPK1;CDC42BPA;OXSR1;TNKS;TGFBR2;LRRK2;WNK1;LMTK2;PRKD1;ACVR1;MAPK8;TTBK1;PRKCA;NLK;ACVR1B;PDPK1;HIPK3;CDK10;HIPK1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.30852451108209233,0.8277501919328444,1.0,0.965482428527152,1.0,19/80,18.94%,ITPR2;ACACA;MAPK1;PLCB1;MAP2K6;MAPK10;EGFR;CAB39L;PIKFYVE;MAP3K7;THEM4;UBE2N;MAPK8;ADCY2;RPS6KA3;EIF4E;MKNK2;RALB;TRAF2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.37211655785600595,0.8277418987246984,0.6666666666666666,0.9648914058275736,1.0,4/17,11.89%,SHROOM2;AP1G1;PIKFYVE;KIF13A
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4290718320931811,-0.8276729760699378,0.7402597402597403,1.0,1.0,3/22,10.50%,HTR2B;PIK3CB;CD160
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.401865389657008,-0.8274265964247272,0.7582417582417582,1.0,1.0,9/39,25.31%,SCG2;ARFGAP3;SVBP;RAB3D;RAB15;PARK7;WLS;ABCA1;MON1A
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.4691975091845233,-0.8273173737480457,0.7692307692307693,1.0,1.0,1/12,3.29%,PPIB
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.323864545123903,0.8273098335773948,0.8181818181818182,0.965017714545744,1.0,16/78,16.45%,CALCRL;SLCO1A2;MYH9;ABCC11;ATP8A1;SLC29A4;LRP1B;ABCB9;DISP1;ABCA10;TOM1;CHMP1A;CEP290;PCTP;ABCA2;ARRDC4
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.3597891060175813,-0.8269007056669903,0.7236842105263158,1.0,1.0,14/53,20.55%,GGNBP1;TAF7L;SPATA12;BCL2L14;ZMYND19;FAM229A;SMC1B;SPATA20;MS4A5;TSACC;ODF2;MAEL;BRCA1;TMEM53
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.41651571896069944,0.8267620717905787,0.625,0.9654672606822243,1.0,4/10,22.74%,ACVR1;BMPR1A;MDM4;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.35562634823579575,0.8262324249809172,0.5384615384615384,0.9659854806310475,1.0,12/32,18.65%,GPSM1;MAP2;PLIN5;CPEB2;LRRK2;WNK1;NOS1;LRCH1;TERF2;ARFGEF1;URI1;ZCCHC9
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3275924874723459,0.8262182261703455,0.7333333333333333,0.9654071960308358,1.0,7/53,9.03%,SOX11;CRB2;ELAPOR2;ZEB2;BMP7;NUP93;TWSG1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3094186481757402,0.8262005445317826,0.7333333333333333,0.964841186217592,1.0,12/52,12.89%,DEPTOR;RICTOR;SIRT1;SLC38A9;MAPKAPK5;TNFAIP8L1;LAMTOR2;PIK3CA;DGKQ;MLST8;TBCK;TTI1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.32690039545113275,0.8260754557514393,0.7777777777777778,0.9644832709415286,1.0,12/39,20.80%,DOCK5;ABL1;IL1RAPL1;RAC3;FBXW8;NRP1;CAPRIN1;ARHGEF7;CDKL5;SS18L1;CRK;CUX1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.34889692444351844,-0.825660285316657,0.8315789473684211,1.0,1.0,29/135,20.30%,PMM1;JUN;RPS12;TGFB1;FUCA1;S100A10;PROCR;RPL36;RRP8;RPL18;HINT1;BTG1;DDIT4;RACK1;CDKN2AIP;H2AJ;TAP1;STOM;ISCU;RPS27L;TRIB3;PLXNB2;SLC3A2;BAX;HDAC3;HRAS;NINJ1;CCNK;CDKN2A
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.37422765765763166,0.8252875181715303,0.6153846153846154,0.9652540694274584,1.0,5/13,15.37%,PDS5A;PDS5B;NAA50;DSCC1;NIPBL
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.43870148989446256,-0.8252561533799216,0.7564102564102564,1.0,1.0,11/20,31.48%,PPIB;PDK1;RASGRP3;SSR4;MAN1A1;CD9;CD27;HTRA2;GUSBP11;ENPP1;ITGAL
prerank,MSigDB_Hallmark_2020__Coagulation,-0.37456932073594584,-0.8250573374064103,0.8111111111111111,1.0,1.0,11/66,17.25%,A2M;F8;CLU;MAFF;FN1;CPB2;MSRB2;S100A1;C3;VWF;ISCU
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.5152249023517173,-0.8250215859311978,0.7384615384615385,1.0,1.0,2/6,18.80%,VIL1;STMN2
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.43140419780430944,-0.8247782901502825,0.7142857142857143,1.0,1.0,7/16,22.63%,PFN2;P2RX4;ARHGAP24;HRAS;P2RY12;CAV1;RDX
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.43680056946627777,0.8247048236784648,0.6896551724137931,0.9658052722870413,1.0,2/7,3.15%,TP63;PLA2R1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.5190157996691713,-0.8243419265669859,0.7538461538461538,1.0,1.0,1/7,5.88%,TGFB1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.40320057314126034,0.8236178296497899,0.7083333333333334,0.9669881514679546,1.0,4/14,7.89%,HIP1;SGIP1;PICALM;EPS15
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.4185096277617094,-0.8235423173819749,0.7472527472527473,1.0,1.0,4/35,9.68%,ISG15;ALOX5;TGFB1;MEF2C
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.3657835134801487,-0.8234696721574264,0.8191489361702128,1.0,1.0,9/84,9.38%,DUOX1;FGF1;TMSB15B;ENPP2;TGFB1;SPINT2;LDB1;SST;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.49152986064342313,-0.8234352775514443,0.7285714285714285,1.0,1.0,4/9,22.91%,CACNA1C;AKAP5;ISCU;PARK7
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2680207728870585,0.8231742237688449,1.0,0.9672962266332019,1.0,23/174,13.71%,SPSB4;RNF139;UBE3D;NEDD4L;FBXW7;HECW2;SIRT1;BTRC;TBL1XR1;UBE2G1;HACE1;FBXW11;PML;PCBP2;SPSB1;NEDD4;PSMD13;PSMD6;FBXW5;COP1;TRIM71;KLHL42;SOCS6
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.39985158836412477,-0.8231343089955185,0.7764705882352941,1.0,1.0,6/55,7.43%,CFAP61;ENKUR;PCP4L1;RARRES2;USP18;CFAP52
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.548974526989023,-0.8231166149435603,0.7884615384615384,1.0,1.0,3/5,39.79%,PLAA;PPIA;TRIM44
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.4141077365758485,0.8231070233791847,0.75,0.9668115685802274,1.0,3/11,15.53%,IGF1R;ITGA3;FYN
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.49523650047988266,-0.8229262821876976,0.7575757575757576,1.0,1.0,1/8,5.16%,RARRES2
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4701327239881924,-0.8225712784015091,0.775,1.0,1.0,4/15,19.43%,SFRP1;EMP2;WARS1;RNH1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.30091174786133174,0.8223097108115438,1.0,0.967888236736659,1.0,15/88,11.70%,SERTAD2;HSPA1A;WFDC1;MAP2;DIP2B;SIRT1;APBB2;DCC;SMARCA2;SLIT3;PRDM11;CGRRF1;PML;GNG4;PTPRS
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.45527637039245245,-0.8222077962089808,0.7972972972972973,1.0,1.0,1/18,1.74%,VEGFA
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.4719569928161276,-0.8221151311867773,0.7066666666666667,1.0,1.0,4/11,24.73%,USP19;BAG6;UBXN1;RNFT1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.4552401137468362,0.822058926304285,0.7741935483870968,0.9677249358396789,1.0,5/9,25.69%,SESN1;ITFG2;SZT2;STK11;RNF152
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.46214797615123404,-0.8218197080804028,0.726027397260274,1.0,1.0,2/12,13.40%,PIK3CB;ARHGAP24
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.33046670888701474,0.8218095057245544,0.6190476190476191,0.9674930786136291,1.0,11/24,25.35%,BBS4;PCM1;CEP89;CEP290;C2CD3;GORAB;TOGARAM1;BBS10;TMEM216;PIBF1;DISC1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.3591781648649509,0.8217996564168226,0.782608695652174,0.9669064555869694,1.0,3/19,6.08%,SLC26A3;SLCO1A2;ABCC11
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.41782165481042255,-0.821724590109552,0.7236842105263158,1.0,1.0,8/25,34.88%,M6PR;AP4M1;LAMTOR4;SORL1;NCOA4;CD81;LAMTOR5;AP3M1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.313808666677235,0.8212876607487277,0.7272727272727273,0.9672248438028359,1.0,4/26,14.79%,RAB27A;SNF8;VTA1;CHMP1A
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.3482825728151062,-0.8211631517696953,0.8736842105263158,1.0,1.0,27/235,12.28%,NEFM;CDHR1;GDAP1L1;OPRM1;ZIC4;SURF1;PDE4A;HAP1;TACR1;PCP4L1;HPCA;ISCA1;GRIN2D;CACNB1;SST;ARX;TCEAL3;CELF4;CACNA1B;SNCB;TCEAL2;SH3GL2;CAMK2A;KCNC1;CACNA1E;CCK;GRM1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.4391394030311747,0.8209767951161803,0.6875,0.9674627510035658,1.0,3/6,20.37%,ARL3;WDR19;RAB29
prerank,MSigDB_Hallmark_2020__Complement,-0.35418049308755395,-0.8208174976529526,0.8260869565217391,1.0,1.0,11/116,7.22%,PSMB9;SCG3;F8;PLSCR1;CP;CLU;XPNPEP1;CTSL;IRF1;MAFF;RASGRP1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.5365571551295717,-0.8207421900415527,0.704225352112676,1.0,1.0,1/5,12.79%,PLS1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.3486034210745505,0.8206173638547793,0.75,0.9673574039793259,1.0,5/27,10.40%,MYO7A;ZKSCAN3;ATP10B;CLVS2;LRRK2
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.3552088884659231,-0.8205698445531455,0.7835051546391752,1.0,1.0,13/143,9.81%,PDE4A;PFN2;SEZ6L2;RETREG1;HPCA;THEM6;SCN9A;CFAP52;SLC4A3;KIFBP;B9D1;ANO2;PKIB
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.4507852552676257,-0.8203370749624911,0.7846153846153846,1.0,1.0,1/14,1.80%,RIMS1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.39716978180237966,0.8199834197745735,0.75,0.9679947731911495,1.0,5/12,14.31%,PBX1;TOX;PTPRC;SNX27;NFIL3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.3849427356135906,-0.8199786518352788,0.7411764705882353,1.0,1.0,5/46,13.60%,RAB11A;TUBGCP2;TUBGCP4;HOOK2;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3897633648150801,-0.8196194165764864,0.7560975609756098,1.0,1.0,3/30,4.89%,DDRGK1;RPL11;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.43761133229963456,-0.819279958266419,0.7613636363636364,1.0,1.0,1/21,1.04%,CD63
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.38845234862961797,-0.8192136555554682,0.7283950617283951,1.0,1.0,2/40,2.99%,VEGFA;ECM2
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.5316232757992507,-0.8186529148398776,0.7066666666666667,1.0,1.0,3/5,41.73%,TMEM167B;RAB11B;TMEM167A
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.42200704071659956,0.818370522269204,0.7058823529411765,0.9706064711547678,1.0,5/9,28.45%,IP6K1;IP6K2;PPIP5K2;ITPKB;IPMK
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.2948556417900661,0.8182740716444832,0.8333333333333334,0.9701570245717969,1.0,9/39,17.51%,ATR;LIG4;SIRT1;MAPK14;INTS7;RAD1;NIPBL;TANK;EEF1D
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.37170797310631054,-0.8181804264032829,0.8043478260869565,1.0,1.0,21/77,23.78%,B2M;RPS9;IFNGR2;RPS3A;TGFB1;HLA-A;IGSF6;GCNT1;RPL9;TAP1;WARS1;IL7;EIF3J;STAT1;CDKN2A;BRCA1;HLA-DMA;TAPBP;THY1;FYB1;IL18
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.4889897660609289,0.8174746663800031,0.6666666666666666,0.9708483952385096,1.0,3/5,17.85%,SDK2;SOX8;DSCAM
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.3034228728498824,0.8174490185732914,0.8571428571428571,0.9702626264057121,1.0,14/68,11.43%,SLC25A18;SLC26A3;PANX1;SLC9A9;SLC15A2;SLC8A2;SLC1A2;SLC24A3;SLC12A1;CHRNA7;KCNN2;GLRA1;WNK1;SLC8A1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.5173586187546717,-0.8173779622864282,0.7272727272727273,1.0,1.0,2/6,23.14%,SLC22A4;SLC25A45
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.43167200359661045,-0.817250303224228,0.8026315789473685,1.0,1.0,4/19,11.37%,CACNA1G;CACNA1C;CACNA1B;CACNA1E
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.49567086945806904,-0.8171736114880249,0.7384615384615385,1.0,1.0,1/7,22.31%,CAV1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.4896543043865437,0.8171549806000206,0.625,0.9702356111070143,1.0,1/5,2.31%,ADAM10
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3907975574432998,-0.8170966148602897,0.7948717948717948,1.0,1.0,7/35,22.55%,NUP155;NOL6;SEC13;NUP107;TOMM20;NUP188;NUP85
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.3765496933998781,-0.8170693188566587,0.7088607594936709,1.0,1.0,5/38,12.47%,VEGFA;TGFB1;MEF2C;STAT5A;P2RX4
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.4268609954986584,-0.8169241921671253,0.7397260273972602,1.0,1.0,2/15,9.46%,TGFB1;HAS2
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4422730538472375,-0.816687414345342,0.7183098591549296,1.0,1.0,1/16,4.40%,SLC35F3
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.46729127499632556,-0.8164132822684689,0.726027397260274,1.0,1.0,3/11,15.48%,PLSCR1;SYT11;RACK1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.365442766257002,-0.8163450174090534,0.7951807228915663,1.0,1.0,20/72,27.67%,HAP1;RPL13A;CLU;IGF2BP2;GAPDH;RACK1;APOE;SHMT1;NCL;RTN2;PCIF1;EIF2AK2;MALSU1;ORMDL1;DHX36;ILF3;PAIP2;CNOT8;BTG2;RBM4
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.5395776302285678,-0.8159574409999222,0.7241379310344828,1.0,1.0,1/5,5.85%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.38059776088447006,0.815577867263323,0.6818181818181818,0.9729399773624049,1.0,2/15,7.50%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.28381850540824,0.8154033897067942,1.0,0.9727634364208161,1.0,20/86,14.47%,SMAD9;PARD3;SIRT1;PTPRK;SMAD7;GCNT2;TGFBRAP1;TGFBR2;BMP7;LPXN;MAPK3;TWSG1;USP9X;MAP3K7;ZMIZ1;ACVR1;BMPR1B;USP15;SMAD1;ACVR1C
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.327215769006311,0.8152035493914761,0.6666666666666666,0.9726098526027528,1.0,3/31,3.30%,GPNMB;PDGFC;MOB1B
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.5127970027627666,-0.8151639503265449,0.7619047619047619,1.0,1.0,4/7,27.98%,POLQ;MCM3AP;MSH6;PMS2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.4430172565795599,0.8148174309072443,0.75,0.9727745129580574,1.0,2/7,7.14%,BIN1;PICALM
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.5179311471600432,-0.814703600386306,0.7761194029850746,1.0,1.0,3/6,30.58%,HDAC6;ETFBKMT;MT3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4375155787403181,-0.8146354094067991,0.7428571428571429,1.0,1.0,2/15,6.25%,RAB11A;ATAD5
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.38255262541722523,0.8145837053834343,0.6666666666666666,0.972700579075287,1.0,2/15,7.60%,RIPOR2;KANK1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.3644171417010108,0.8145142676828325,0.72,0.9721275839227302,1.0,4/18,15.52%,DMD;LAMC1;CLDN12;JAM3
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.46686759998338667,0.8144982771602478,0.7352941176470589,0.9715439796146964,1.0,4/9,28.24%,ELP3;ELP4;TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.5280689090445411,-0.8141288644077899,0.7887323943661971,1.0,1.0,2/5,19.22%,USP50;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.4723856091668407,-0.8140667277688516,0.7681159420289855,1.0,1.0,2/13,14.15%,DVL1;DVL2
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.4519488681475444,-0.8140654893732618,0.7272727272727273,1.0,1.0,1/13,1.80%,RIMS1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.545419317209275,-0.814009645030642,0.7833333333333333,1.0,1.0,3/5,17.88%,MEF2C;COL4A1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.4731622333177709,-0.8139907520011502,0.75,1.0,1.0,4/12,23.11%,CAMK1;TERF2IP;KAT5;FAM161A
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.4240230450498441,0.813900598302445,0.6551724137931034,0.9719354991776739,1.0,3/8,25.91%,B4GALT5;B4GALT6;ST3GAL2
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.4955025326572631,-0.8135886920479583,0.71875,1.0,1.0,1/7,7.29%,ZFPM1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.27808000182294074,0.8134374216328671,0.8636363636363636,0.9722246162987991,1.0,17/56,15.97%,PEAK1;FER;LAMC1;NTNG2;TMEFF2;OPHN1;RADIL;LPXN;RELN;PROX1;SRCIN1;LAMB4;NRP1;ATRNL1;NTN4;UNK;RILPL2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.4020412699894458,0.8134098530897911,0.75,0.9716646920050962,1.0,3/14,14.46%,ATG5;ATG2B;ATG3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.4435050335794296,-0.8131167750878465,0.7464788732394366,1.0,1.0,3/13,24.73%,CAV1;BAG6;RNFT1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.34900761900863264,0.8128008623936718,0.625,0.9721571671689315,1.0,2/29,2.83%,ATR;RFWD3
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.30993519486571813,0.8127269197360397,0.8571428571428571,0.9716884054502284,1.0,8/39,7.76%,CADM2;INAVA;CDH20;CDH9;SMAD7;CDH10;NECTIN3;CDH18
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.4831147276577562,-0.8125549004025583,0.8157894736842105,1.0,1.0,1/11,2.41%,PDCD1LG2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30631990944874526,0.8122326321897748,0.7647058823529411,0.9719882411955743,1.0,12/50,15.64%,MAPK11;BCAR1;HSPB1;ABI1;MAPK14;PIK3CA;PRKD1;NRP1;VEGFD;NCKAP1;FYN;FLT1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.35109182083839763,0.811957776510537,0.7222222222222222,0.9719265125485617,1.0,8/31,13.77%,ESR1;PADI2;ARID1A;TRERF1;UBR5;NEDD4;ZMIZ1;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.4671435171889404,-0.8116362281751134,0.7402597402597403,1.0,1.0,1/11,5.13%,IFITM3
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.4746385410233469,-0.8114932233075671,0.7681159420289855,1.0,1.0,1/11,3.29%,PPIB
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.4435172173099282,0.8114581384448187,0.7586206896551724,0.9721130197295286,1.0,3/9,12.42%,KCNMB3;STIM1;KCNIP2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3259487771147951,0.8113905293370474,0.8888888888888888,0.9715665609717432,1.0,15/70,12.74%,HIP1;MAP3K5;BOK;SIRT1;PPARG;ROBO1;CRADD;SENP1;EGLN3;TNFRSF10B;ST18;HMGB1;BCL2L13;PPM1F;CFLAR
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.4928378298673822,-0.8112724000565897,0.8055555555555556,1.0,1.0,2/9,16.91%,GPC3;NR4A3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.35354946927501746,-0.8106760551695115,0.8125,1.0,1.0,30/129,29.97%,PSMB9;PSMB8;CDKN1C;TGFB1;KIF20B;OBSL1;PSMA3;BUB3;BTG1;PSME1;CDC26;FZR1;NEK6;PSMA7;PSMB6;SRA1;EIF4EBP1;CUL7;PSMC4;NEK11;PSMB1;CDK11B;PSMD2;PSMB3;BTG2;PSMC3;PSMC5;PSMD7;PSMA4;APP
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.28467914311691633,0.8105880438654385,0.8888888888888888,0.9725867185397875,1.0,18/92,11.13%,CALCRL;FNBP1L;COLEC12;AP1G2;FCHSD2;RAB31;VLDLR;AP4E1;SGIP1;PICALM;EPS15;AP1S1;AP1G1;HSPH1;PIKFYVE;DNM3;LRP1B;NEDD4
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.36310163298238735,-0.8105122195055828,0.7912087912087912,1.0,1.0,10/98,12.97%,FLG;TNC;FILIP1L;RHBDF1;CRYAB;AFAP1L1;FN1;OSMR;SYNC;COL6A1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.4331579611338393,-0.8098624242150168,0.7702702702702703,1.0,1.0,3/19,11.75%,SLC35F3;MGST1;SLC6A6
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.46233618372266183,0.8097199957314675,0.6551724137931034,0.973481744797787,1.0,2/8,7.55%,PDE4B;CACNA2D1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.3997717512164414,-0.8094755600135042,0.7341772151898734,1.0,1.0,4/21,16.27%,ZW10;SMC1A;MIS12;KIF18B
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.31099387412441937,0.809377533183024,0.6666666666666666,0.9734417719778138,1.0,19/89,13.75%,SOX11;NLGN4X;PBX3;RYK;MYO7A;PBX1;IL1RAPL1;WNT7A;ADNP2;FZD3;OPHN1;UGDH;ATOH8;FUT9;ACSL4;WNK1;ACSL3;DTNB;TENM3
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.3304860951051924,0.8092906068647157,0.75,0.973019541256618,1.0,16/45,19.35%,CHRM3;MCTP1;ANK2;EGFR;PTPRC;PPP3CA;LRRK2;SLC8A1;P2RX7;MCU;DMPK;PPP1R9A;TRPM4;GRM5;PDPK1;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.515061635773286,-0.8090772664864936,0.7625,1.0,1.0,3/8,16.17%,TGFB1;DDX5;MAP2K1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.40064715601042467,-0.8090434229649491,0.7848101265822784,1.0,1.0,13/35,27.00%,NARS1;AIMP1;SARS1;WARS1;LARS1;VARS1;WARS2;CARS1;DARS2;GARS1;RARS1;QRSL1;MARS1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.3421047158848759,0.8090325176734299,0.5,0.9729574352799253,1.0,4/27,9.44%,SMPD4;SGMS1;DMD;SPTLC2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.5188273725856105,-0.8089319630846958,0.746031746031746,1.0,1.0,2/5,21.00%,TGFB1;GSTP1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.398231315624868,-0.8089316502013004,0.7529411764705882,1.0,1.0,5/28,16.99%,JAG1;WNT5B;TCF7;DVL2;SKP2
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.41931090187765047,-0.8087330016611649,0.8023255813953488,1.0,1.0,5/40,7.22%,VEGFA;FGF1;HTR2B;TGFB1;RASGRP1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.3789124843798465,0.808680539843894,0.7428571428571429,0.9730189397646788,1.0,1/11,4.78%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.32688572475416067,0.8081303286447857,0.7692307692307693,0.9734395075348784,1.0,17/47,20.79%,PRR5L;SYTL4;ATP2C1;UNC13B;PCM1;FRMD4A;MYOM1;ACSL3;PCNT;CNST;CEP290;ACHE;RIPOR1;TENM1;GOLPH3;RAB29;B3GAT3
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.3856355553380053,0.8079533347108637,0.6896551724137931,0.973130500696515,1.0,1/11,2.30%,EVI5L
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.3668822217288167,0.8079322188910737,0.7741935483870968,0.9725304468650637,1.0,4/13,19.41%,ADCY6;ADCY2;AMPD2;ADCY9
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2707941197939632,0.8077502223420484,1.0,0.9723232167270015,1.0,51/311,12.56%,RANGAP1;SPSB4;RNF144A;BARD1;RNF139;TSPAN17;NEDD4L;FBXW7;DTX4;RFWD3;MIB1;LZTR1;ASB5;HECW2;H2BC5;KLHL8;UHRF2;SIRT1;RAD18;BTRC;KLHL21;UBE2G1;HACE1;UBE2J2;TRIM62;KEAP1;NUP98;DCUN1D2;UBE2D1;DCUN1D5;NUP93;FBXW11;NSMCE2;HERC2;RNF135;USP9X;SPSB1;KLHL13;USP5;UBE2H;TRIM28;NEDD4;RCHY1;FBXW8;CAND2;FBXL7;UBE2N;UBE2E3;FBXW5;CDC16;AAAS
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.3850597226297138,0.807747697467138,0.8571428571428571,0.971713227256031,1.0,6/16,20.21%,ANKRD13D;PICALM;ANKRD13A;ABCA2;ITGAV;PSEN1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.3462563559859014,-0.807616729376024,0.9032258064516129,1.0,1.0,21/114,19.08%,COX7A2;RPL38;PFDN6;CLU;TGFB1;HIGD1C;GPX4;NDUFAF1;NSG2;CLTA;VBP1;MIS12;CENPC;CHMP4B;OTUD6B;CLTB;CCDC39;CALY;AIFM1;HSP90AB1;NUP107
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4028124769486209,-0.8075271819089628,0.8,1.0,1.0,3/37,6.88%,SFRP1;PFN2;S100A10
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.5065055694144499,-0.807442422078226,0.765625,1.0,1.0,1/5,9.68%,MEF2C
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.2945484812222575,0.8072864785511392,0.8421052631578947,0.9720661674823446,1.0,7/37,11.44%,ARID1A;MBD2;SMARCA2;ARID1B;SMARCAD1;VPS72;HNRNPC
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.4659740607545164,-0.8071621240770012,0.7727272727272727,1.0,1.0,2/12,8.89%,DDX5;JAG1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3706116346737987,-0.8070616310825536,0.8,1.0,1.0,19/58,22.41%,HES5;VEGFA;GSTK1;DVL1;TGFB1;SPINK5;PGK1;VIL1;VDAC1;STIL;STAT1;RHCG;CBR1;MTHFD1;AHI1;DNPH1;VCL;PPP2R3A;PAX8
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.5296402866730193,-0.8070187859974541,0.746268656716418,1.0,1.0,1/5,5.00%,PBLD
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.2947408361125714,0.8068066493002058,0.75,0.9723627606625543,1.0,19/130,11.87%,SEM1;BARD1;RMI1;RPA1;RFWD3;LIG4;RAD51B;RECQL5;RAD54B;SAMHD1;SMARCAD1;NSMCE2;BAZ1B;HERC2;SMC6;ERCC4;HELQ;HMGB1;UBE2N
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.4391088729643683,-0.8064748009314727,0.7837837837837838,1.0,1.0,5/15,17.98%,CFTR;SLC4A3;CA5B;CYB5R1;CA1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.4879088906748155,0.8060066054600227,0.625,0.9732735497538871,1.0,1/5,6.94%,FOXP1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.44705595047043434,-0.8059857160593463,0.8157894736842105,1.0,1.0,7/19,25.37%,RSAD2;RHBDF1;SYT11;APOE;SYT4;TNFRSF1A;ERP29
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.3537577917277709,0.8058054858576561,0.7916666666666666,0.9730330021219099,1.0,3/20,11.23%,PDE4D;NT5C1A;PNP
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3881443053384456,0.8057459060447971,0.5,0.9724691160693656,1.0,4/27,11.69%,HSPA1A;AFAP1L2;PTPRC;HMGB1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.38848220441728226,0.8056167646176061,0.7307692307692307,0.9721178418865694,1.0,3/12,6.70%,CDO1;GLYAT;SRR
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.45539844480431724,0.8055533618729447,0.72,0.9716666922129128,1.0,3/11,10.75%,LIG4;PML;SIRT6
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.4259207519299333,-0.8052560954228557,0.7727272727272727,1.0,1.0,2/17,11.29%,PMM1;MPI
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4106976730085108,-0.8051248693623566,0.7916666666666666,1.0,1.0,2/27,3.03%,SP140;STAG3
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.48102647240977514,-0.804608052836556,0.7333333333333333,1.0,1.0,1/8,12.70%,ATG14
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.34665481527745706,-0.804550647191924,0.8736842105263158,1.0,1.0,29/123,30.03%,PSMB9;RPS27A;PSMB8;APEX1;IGF2BP2;DND1;PSMA3;PSME1;UBA52;ZFP36L2;PSMA7;PSMB6;UBC;SET;CIRBP;DHX36;PSMC4;HSPA8;ANP32A;PSMB1;SERBP1;PSMD2;EXOSC8;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4;PABPC1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.4855287853206537,-0.804342215665553,0.821917808219178,1.0,1.0,1/10,5.88%,TGFB1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.37802182095287223,-0.8043099522147417,0.8444444444444444,1.0,1.0,2/49,2.57%,B2M;KCNJ13
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.4721551240136308,-0.8042434468036774,0.7941176470588235,1.0,1.0,1/9,22.31%,CAV1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.3196218562329392,0.8041753155841326,0.7142857142857143,0.9737669543584048,1.0,5/33,10.58%,SORD;NOX4;GLYAT;ALPL;FUT9
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.5286514542513522,-0.8034617253614338,0.7936507936507936,1.0,1.0,2/5,23.78%,RARA;IL18
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.44244909815973354,-0.8034510127881191,0.7323943661971831,1.0,1.0,1/12,5.16%,RARRES2
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.35979805594968695,-0.8033784511207791,0.8539325842696629,1.0,1.0,7/77,9.75%,LIPI;NAAA;ALOX5;XBP1;GPX4;ALOX12;ACSM3
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.4621039368589176,-0.8031566181886375,0.8095238095238095,1.0,1.0,3/11,21.32%,RARRES2;P2RX4;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.5340039121964193,-0.8029717773503884,0.7761194029850746,1.0,1.0,2/5,24.27%,APOE;DTX3L
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.5025318972070967,-0.8025109944248615,0.7966101694915254,1.0,1.0,3/6,20.93%,TBXAS1;CBR1;PTGES2
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.3706412184788537,-0.8024883173272267,0.7640449438202247,1.0,1.0,14/58,29.57%,PSMB9;PSMB8;PSMA3;PSME1;PSMA7;PSMB6;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.24752323635481732,0.802271854670548,1.0,0.976510259507771,1.0,40/141,19.06%,TAB3;ESR1;ZFAND6;ATP2C1;TRAF1;SIRT1;PPM1A;INAVA;TLE1;HSPB1;ANKRD17;TRIM62;RORA;NDFIP2;VAPA;MAP3K7;TNFRSF10B;PELI2;LURAP1;ZDHHC17;TAB2;UBE2N;PRKD1;TFG;CFLAR;TRAF5;LPAR1;ZMYND11;MID2;CXXC5;IKBKB;TANK;PINK1;EEF1D;BCL10;PRKN;MALT1;TRAF2;PDPK1;ZDHHC13
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.459033046064247,-0.8020055257126432,0.7808219178082192,1.0,1.0,4/12,23.92%,STAT1;IFIH1;HSPD1;DHX36
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.4559701078357233,-0.8019993982694817,0.7916666666666666,1.0,1.0,3/16,11.33%,TGFB1;JAG1;EFNA1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4011488125353069,0.8019527098054692,0.75,0.9765244730975103,1.0,4/12,17.27%,SIRT1;ATP2B4;RAPGEF2;PKIA
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.5185516410033851,0.801866705361951,0.717948717948718,0.9760383474515211,1.0,2/5,11.70%,DCC;PTPRS
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.31665248198295903,0.8016549550714864,0.8333333333333334,0.975730608522659,1.0,6/32,14.25%,YTHDF1;FTO;MOV10;TRIM71;RIDA;CELF1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4016906585600898,-0.8010584762886633,0.7640449438202247,1.0,1.0,7/29,27.12%,SLC38A4;SLC7A6;SLC7A8;SLC16A1;SLC36A4;SLC25A30;SLC7A10
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.3452510161801091,0.8010204065252648,0.8636363636363636,0.9760673088827573,1.0,3/19,8.59%,ACADVL;NR1H2;ADIPOR2
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.36545699007362864,-0.8008058200044154,0.8736842105263158,1.0,1.0,12/107,13.93%,PSMB9;SFRP1;PSMB8;TGFB1;ATP6AP2;SFRP4;CDH3;GPC3;PSMA3;PLEKHA4;ZBED3;PSME1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.3683651059584191,-0.8003538231807302,0.7674418604651163,1.0,1.0,8/56,16.71%,NPM2;PLSCR1;ECT2;KIF20B;WIZ;DDX11;GIPC1;USP19
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.44308519546152864,-0.8003384369170349,0.7183098591549296,1.0,1.0,2/12,10.10%,HSD17B14;MED1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.4019430404565896,-0.8002550049742606,0.7710843373493976,1.0,1.0,4/27,14.24%,OPRM1;MEF2C;CAMK2A;SLC6A9
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.3894348567551864,-0.8002170753508364,0.7631578947368421,1.0,1.0,2/32,2.83%,GPR155;CBR3
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.33054733843155504,-0.8001485720315501,0.91,1.0,1.0,49/270,19.22%,VEGFA;RIMS1;DDRGK1;PLSCR1;RBM3;RPL11;FGF1;BTN3A1;RPL23;HMGN5;HTR2B;FLOT1;CLU;TGFB1;AGT;POLR1C;FAM98B;OVOL2;DDX5;OLFM1;TTN;SFRP4;EPHX2;MEF2C;GAPDH;FN1;MED1;CDH3;PIK3CB;SMARCA5;PDCD5;RPS4X;TADA3;SCAMP5;UPF3B;ATF4;ACTA2;RPS7;MAP2K1;TAF1D;UPF3A;WARS1;NSUN5;RPS27L;PLXNB2;CD46;RPL5;PCIF1;EIF2AK2
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.28615174736084975,0.8000074518350356,0.8888888888888888,0.9772359039419982,1.0,21/75,20.37%,BAIAP3;VTI1A;TBC1D14;RAB9A;GGA1;PIKFYVE;ERC1;VPS50;WASHC1;ARFRP1;GBF1;SNX3;DENND5A;TBC1D5;TBC1D23;VPS54;TRAPPC10;YKT6;WASHC2C;EHD3;RAB29
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.32016028730337787,0.79991979574358,0.7272727272727273,0.9766950915754434,1.0,8/32,15.63%,PAPOLA;IWS1;QKI;SLTM;SRPK2;CPSF4;KHDRBS2;KHDRBS3
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.5552871948750961,-0.7999124977788156,0.8727272727272727,1.0,1.0,2/5,19.80%,SHMT1;PAICS
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2880188113068829,0.7994521990576221,0.7272727272727273,0.9770638166678054,1.0,10/49,12.74%,HIP1;BOK;PPARG;ROBO1;CRADD;SENP1;EGLN3;TNFRSF10B;BCL2L13;CFLAR
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.5042990451095324,-0.799282231809086,0.7794117647058824,1.0,1.0,1/5,23.58%,TNFRSF1A
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.41329545789669486,-0.7989554636206267,0.8181818181818182,1.0,1.0,5/29,17.65%,SCG2;ARFGAP3;SVBP;RAB3D;RAB15
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.331460412634994,0.7986678602391366,0.7777777777777778,0.977102485949809,1.0,11/51,16.73%,ABL1;CD247;PLD2;MAPK1;ABI1;WASL;MAPK3;PIK3CA;NCKAP1;FYN;PRKCE
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.331460412634994,0.7986678602391366,0.7777777777777778,0.977102485949809,1.0,11/51,16.73%,ABL1;CD247;PLD2;MAPK1;ABI1;WASL;MAPK3;PIK3CA;NCKAP1;FYN;PRKCE
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.28299641157041305,0.7986204462374472,0.875,0.9766405392215926,1.0,8/74,7.90%,SOX11;HSPA1A;SPRED2;SIRT1;PPM1A;SMAD7;ZEB2;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.43009837247060895,-0.7982445934475307,0.7631578947368421,1.0,1.0,3/18,13.41%,HAP1;SAXO1;FUZ
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.506237468724751,-0.7981465428529736,0.7866666666666666,1.0,1.0,1/8,6.08%,BTD
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.40617723421061713,0.7979851784978509,0.7567567567567568,0.9769973280382163,1.0,3/7,21.20%,NF2;VHL;SH2B3
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.3579114889665125,-0.7978615733624688,0.7951807228915663,1.0,1.0,13/57,22.55%,NUP155;SNRPD2;SNRPD1;SNRPB;SEC13;NUP107;RANBP6;PTTG1IP;RANBP17;SNRPG;DDX20;NUP188;NUP85
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.555675788380308,-0.7978472046267071,0.7833333333333333,1.0,1.0,4/5,42.47%,TIMP3;TIMP1;TIMP4;TIMP2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.528049237883802,-0.7978218150793683,0.7777777777777778,1.0,1.0,1/5,3.76%,RPL23
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.45948584228481815,0.7978123220084774,0.8518518518518519,0.9767238585043081,1.0,4/10,19.17%,SERAC1;RELCH;STARD4;ARV1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.5075162080385867,0.7976148905753612,0.7586206896551724,0.976472812572578,1.0,1/5,1.56%,NUTF2
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.4511609258429633,-0.7975075113693084,0.7246376811594203,1.0,1.0,2/8,19.66%,PLS1;PLS3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.32139381605573775,0.7973212116208658,0.9444444444444444,0.9763986490825781,1.0,11/35,14.93%,HDAC9;LEPR;PBX1;TOX;CHD7;HDAC4;PTPRC;ADAM17;NFIL3;TPD52;KLF6
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4104332433684608,-0.7971609919368554,0.7831325301204819,1.0,1.0,5/28,8.39%,PLSCR1;POLR3D;IFI35;RSAD2;XBP1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.3688640287423625,-0.7971481659934959,0.8395061728395061,1.0,1.0,12/59,22.65%,VEGFA;FGF1;ANGPTL4;XBP1;BTG1;GRN;S100A1;EMC10;NINJ1;BRCA1;VEGFB;CYP1B1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4350391704924756,-0.7970127952762389,0.7402597402597403,1.0,1.0,3/14,27.00%,DDX11;NCL;MARS1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4236146253867612,-0.7970108953826712,0.7857142857142857,1.0,1.0,4/17,15.30%,TRIB1;MEF2C;OGN;APOD
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.3749062964684251,0.7969730147820663,0.7619047619047619,0.9763686929665482,1.0,6/19,13.02%,TTLL1;TTLL3;CEP41;TTLL11;AGTPBP1;NAA11
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.4129238637925064,0.79695999233912,0.7037037037037037,0.975798690316833,1.0,3/11,14.08%,RMI1;ERCC4;HFM1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.3910552753953852,-0.7968314417274346,0.8024691358024691,1.0,1.0,3/35,8.61%,TRIM5;ARIH2;RNF8
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.34740593874456915,-0.7967396245662782,0.9175257731958762,1.0,1.0,36/151,23.92%,ISG15;POLR3D;BTN3A1;HTR2B;FLOT1;IL12RB2;POLR3H;TGFB1;AGT;HLA-A;POLR1C;IRF1;RASGRP1;ZFPM1;XBP1;GAPDH;SCAMP5;POLR3E;ATF4;C3;IL7;PRKCQ;CD46;EIF2AK2;CGAS;MAPK13;BRCA1;IFIH1;CD226;HSPD1;RFTN1;CYP1B1;PARK7;RARA;IL18;DHX36
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.3765298134782431,-0.79645067042239,0.7790697674418605,1.0,1.0,12/46,29.30%,COL6A1;LMOD1;ACTA2;COL4A1;ADAMTS2;CALD1;SRPX;COL4A2;PDGFRB;LIMS2;PLAT;TIMP3
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.28991184580571916,0.7963439421901367,0.7142857142857143,0.9763639682294425,1.0,33/131,18.44%,NLGN1;ZFYVE27;EHD1;RYK;SGK1;MAP2;CNTNAP2;CAMSAP2;WNT7A;ARC;BMP7;OPHN1;ATXN10;WASL;VAPA;LRRK2;NEDD4;HMGB1;MAP4K4;RAPGEF2;FRYL;FLRT3;NCKAP1;DOCK10;CTNND2;GPM6B;HDGFL3;PPP1R9A;WHRN;UHMK1;SRGAP2;GPM6A;TBC1D23
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.4204747857386757,-0.7959437992209503,0.8289473684210527,1.0,1.0,3/30,8.00%,DDRGK1;DDX5;HDAC6
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.4690880657245125,0.7954936225277078,0.6875,0.9774349403378358,1.0,3/7,28.73%,ITGAV;CBLL1;GRB2
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.39769373598292324,-0.7951961362027355,0.7848101265822784,1.0,1.0,8/25,22.65%,VEGFA;SCG2;EMP2;GIPC1;STAT1;PTP4A3;LGALS8;CYP1B1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.4761892173231823,-0.7948772182211727,0.7428571428571429,1.0,1.0,3/11,22.18%,GLUL;QPRT;GOT1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.36577881858761774,-0.7948488920430399,0.7888888888888889,1.0,1.0,16/69,22.86%,IFI6;SELENOK;PDK1;DDX5;RRP8;HINT1;ATF4;DNAJC10;TRIB3;BAX;AIFM1;BRCA1;MSH6;CYP1B1;BAG6;BCL2L2
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.442512740978387,-0.794562784604142,0.7721518987341772,1.0,1.0,2/18,3.39%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.38223746467325875,-0.7944214770337348,0.8409090909090909,1.0,1.0,13/47,29.35%,CDC37;IFNGR2;USP18;RACK1;IL7;STAT1;HSP90AB1;TNFRSF1A;RNASEL;RUNX1;PTPN2;AXL;ABCE1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3225836245378052,0.7944188975567315,0.8095238095238095,0.9786476143384115,1.0,10/37,16.40%,ATP11C;PRELID3B;ATP8A1;ATP10B;OSBPL5;OSBPL8;PITPNA;ATP8A2;PCTP;PRELID3A
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.45253208721132354,0.7944137050167169,0.6551724137931034,0.9780556224632959,1.0,5/8,24.21%,SGK1;ACSL3;MYO6;GPLD1;NRG1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.39179976232951064,0.7943523915988443,0.6842105263157895,0.9775852295999016,1.0,4/15,8.61%,GPNMB;ABL1;FGL1;KAT2A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.4200829608032032,0.7943059657315379,0.7307692307692307,0.9770824714335219,1.0,1/7,20.98%,PTPRB
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.3530281583024317,-0.7942058025077019,0.8111111111111111,1.0,1.0,6/63,5.96%,PLSCR1;POLR3D;IFI35;RARRES2;TGFB1;AGT
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.2978195601477778,0.7941517299910565,1.0,0.9768327489005545,1.0,46/292,13.64%,SPSB4;RNF144A;WDR81;FBXL4;UBE3D;NEDD4L;FEM1A;FBXW7;MIB1;HECW2;KLHL8;RNF150;SIRT1;ZRANB1;BTRC;TBL1XR1;UBE2G1;HACE1;KEAP1;UBE2D1;MVB12B;FBXW11;NDFIP2;PML;USP9X;PCBP2;SPSB1;UBE2H;NEDD4;RCHY1;FBXL7;PSMD13;ANAPC4;PSMD6;FBXW5;CDC16;UBE3C;COP1;ADRM1;TRIM71;RNF11;KLHL42;RNF128;RNF217;ANAPC1;FBXO11
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.3243462197236553,0.7941165029633339,0.75,0.976298167497515,1.0,9/35,17.49%,CDC42EP4;CDH13;PHACTR4;CDC42EP1;ARHGEF11;EPS8;ARHGAP5;ARHGAP6;RIPOR1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.37746232870581553,-0.7940669718354837,0.8354430379746836,1.0,1.0,11/46,22.74%,SFRP1;DERL2;NCBP1;SUPV3L1;TAF9B;CDKN2AIP;HDGFL2;WFS1;DNPH1;RFTN1;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.4527862513532917,0.7933554056290366,0.7096774193548387,0.9768055549275624,1.0,2/6,6.98%,NLGN1;SGIP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.3814206883174793,0.7932081180722114,0.7241379310344828,0.9764797811219883,1.0,6/12,22.74%,ERBB4;ZFPM2;RBPJ;BMPR1A;TGFBR3;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4855233835147966,-0.7931496290331249,0.835820895522388,1.0,1.0,4/9,32.98%,GSTP1;DNAJA1;AIDA;PDCD4
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.37486755552466383,-0.7928658498973816,0.8241758241758241,1.0,1.0,4/54,8.89%,CFAP61;FMO6P;WDR93;JAG1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.42195049761976744,0.7925778797257969,0.5833333333333334,0.9770849641475868,1.0,3/14,4.27%,ESR1;PADI2;ARID1A
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.3709447039398985,-0.7921146109764517,0.7710843373493976,1.0,1.0,9/41,24.84%,RPS27A;DDX11;SUPV3L1;UBA52;UBC;XPA;RECQL;PIF1;RBX1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3191548659279807,0.7920425435210324,0.7222222222222222,0.9776456409989643,1.0,10/31,18.28%,ABL1;PPA2;STOX1;SPART;LRRK2;BCO2;BCL2;PID1;PINK1;AKT2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.4913016309208988,-0.7918987827589821,0.7419354838709677,1.0,1.0,2/8,25.13%,CACTIN;TMSB4X
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3665698271918479,-0.7916808705054941,0.8131868131868132,1.0,1.0,6/68,8.86%,SFRP1;ECT2;RAB11A;IHO1;KIF20B;OBSL1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.4040998052042516,-0.7916615614878203,0.8333333333333334,1.0,1.0,3/25,23.03%,RAB11A;CHMP4B;VPS36
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.42643168140519755,-0.7913483501992811,0.7407407407407407,1.0,1.0,1/13,5.88%,TGFB1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.32561480092996165,0.7909470412098222,0.8333333333333334,0.978971032751144,1.0,10/36,18.29%,YLPM1;STOX1;SMARCAD1;SMG1;HNRNPD;UBE2N;SUB1;TERF2;WRNIP1;UBE2V2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.5084168516699512,-0.790707521081226,0.8,1.0,1.0,1/7,10.95%,CAD
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.4653071689733832,-0.7907055244896409,0.7733333333333333,1.0,1.0,5/12,24.33%,TTN;MYL6B;ACTN2;TPM4;MYL6
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.4653071689733832,-0.7907055244896409,0.7733333333333333,1.0,1.0,5/12,24.33%,TTN;MYL6B;ACTN2;TPM4;MYL6
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.44995129873324025,-0.7905023506349117,0.7945205479452054,1.0,1.0,2/9,17.61%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.3985472340773322,-0.7904618942901329,0.7105263157894737,1.0,1.0,4/24,10.28%,EIF2B2;NLRP1;CACNA1B;STAT5A
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.3549263981446399,-0.7904230717802253,0.8829787234042553,1.0,1.0,10/70,12.47%,TRPC5;TRPM3;SELENOK;CACNA1G;CACNA1C;SLC24A5;CACNA1B;CAMK2A;CACNA1E;P2RX4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3547727860318904,0.7903630243583921,0.8421052631578947,0.9795407955662201,1.0,3/22,7.50%,GPNMB;FAM107A;PKD2
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.5104051130923544,0.7900602986074012,0.8636363636363636,0.9794436842147052,1.0,1/7,4.09%,PLIN5
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.339159077309308,0.7896439784766599,0.8461538461538461,0.9795540624302819,1.0,5/26,8.36%,LAMA3;PADI2;TOX3;PYGO2;NNMT
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.48516234888731524,-0.7896410254230697,0.8292682926829268,1.0,1.0,2/10,9.68%,RASGRP1;MEF2C
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.4214668924608229,0.7895284067670009,0.7692307692307693,0.979108019124617,1.0,3/6,18.37%,ABCC11;SLCO3A1;ABCC4
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.35169958201430646,0.7895253858273492,0.7368421052631579,0.9785317097678222,1.0,6/20,10.51%,SIRT1;MAPK14;NSMCE2;MAPKAPK5;PML;SMC6
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.44135042855254003,0.7894105444108963,0.6666666666666666,0.9780650467046617,1.0,4/8,23.27%,WNT7A;COBL;CXXC4;TASOR
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.39008625505168165,-0.7888573078394493,0.8160919540229885,1.0,1.0,9/32,22.65%,ALOX5;PTGR1;GPX4;ALOX12;FADS2;ELOVL2;FAAH2;GSTP1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.4772356921158465,0.7886755485690007,0.7241379310344828,0.9786441641324173,1.0,2/6,11.15%,HOMER1;STIM1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.39269544129616507,-0.7885570828384422,0.7764705882352941,1.0,1.0,2/25,5.88%,SFRP1;TGFB1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.371408809829136,0.7885254684510499,0.6538461538461539,0.9783303352681126,1.0,3/14,7.90%,GRAMD1B;OSBPL7;TGFBR2
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.476331032443398,-0.7882331871046241,0.7671232876712328,1.0,1.0,1/9,3.15%,SLC2A3
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.40332843813228786,-0.7882100544233391,0.7307692307692307,1.0,1.0,3/24,16.49%,ARL1;OBSL1;ZDHHC15
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.46435805619640685,-0.7880338806053258,0.7162162162162162,1.0,1.0,2/10,12.74%,GLRX;WNK3
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.36620312578010583,0.7880019349353629,0.9354838709677419,0.9786910983119946,1.0,5/18,9.28%,SGCZ;DMD;RORA;MRTFA;NEBL
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.2725900349521017,0.7877609272218824,0.8333333333333334,0.9786058452973203,1.0,20/48,19.79%,FER;FCHSD2;ARHGAP28;CDC42EP4;BIN1;KANK1;SSH1;WASHC5;LATS1;CDC42EP1;NCKAP1;SSH2;SLIT2;PRKCE;CRACD;ARFGEF1;KANK4;COTL1;PTK2B;TENM1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.39277800455549505,-0.7876221775304142,0.75,1.0,1.0,6/25,12.36%,SERPINE3;AGT;SPINK5;GAPDH;CST3;SERPIND1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.4040466390219114,-0.7875031921303307,0.7710843373493976,1.0,1.0,2/36,5.41%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.3542032299954638,0.7874298178811902,0.8,0.9786618904685047,1.0,5/16,24.74%,SUV39H2;SETD2;SETD3;SETD1B;KMT2D
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3752055523277783,-0.7870977924844126,0.8045977011494253,1.0,1.0,6/61,8.17%,ELOB;DDRGK1;DVL1;CLU;TRIB1;ARIH2
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.40397626910217854,-0.7870250211493365,0.7702702702702703,1.0,1.0,1/25,1.44%,LIPI
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.5086919086829991,-0.7869813586185974,0.7647058823529411,1.0,1.0,2/5,17.10%,XBP1;APOE
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.46291781137915916,0.7865619092188252,0.7619047619047619,0.9798684446533155,1.0,3/10,17.19%,ACER3;HEXB;ACER2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.46618778489667456,-0.7864789415909361,0.7727272727272727,1.0,1.0,3/7,33.98%,DCTN1;APP;MAP1A
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.4736642026630308,0.78642950217385,0.7391304347826086,0.9795982170460957,1.0,3/7,9.06%,APOLD1;VEZF1;ATOH8
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3913610874078865,-0.786212096199146,0.7792207792207793,1.0,1.0,2/28,4.75%,POLR2G;LSM5
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.4503042903259934,-0.7857745306811724,0.7205882352941176,1.0,1.0,5/11,24.57%,AZIN2;C3;NR4A3;AZIN1;ANO6
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.34787338483128516,-0.7856830213213214,0.8695652173913043,1.0,1.0,12/118,12.28%,NEFM;GDAP1L1;SCG3;TRPM3;LRTM1;SVOP;CELF4;CACNA1B;SRRM4;RNPC3;KCNC1;GRM1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.3544513611299755,0.7855653424757181,0.6666666666666666,0.9804124490730212,1.0,3/12,16.36%,TRAPPC8;USP30;PEX5
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3044685378791935,0.7854913091062138,0.9565217391304348,0.9798713510499831,1.0,16/38,19.45%,PEAK1;FER;LAMC1;NTNG2;TMEFF2;RADIL;LPXN;SRCIN1;LAMB4;NRP1;ATRNL1;NTN4;SRGAP2;ITGAV;PIK3R1;ITGA8
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.25837711227953747,0.7853771285570991,0.8888888888888888,0.979493332038738,1.0,14/58,22.02%,SLC2A6;NUP98;NUP93;ZBTB20;HDAC4;P2RX7;AAAS;NUP210;FBP1;NUP42;NUP35;PSEN1;NUP54;SEH1L
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.3583635140180846,-0.7852542145729676,0.8571428571428571,1.0,1.0,9/64,15.52%,TRPC5;TRPM3;GRIN2D;CACNA1G;CACNA1C;SLC24A5;P2RX4;SPG7;PMPCA
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.35071523381554753,0.7851973476263627,0.75,0.9791915226364701,1.0,8/30,12.84%,TG;ZBTB1;SALL1;PKD2;MSN;PROX1;PRKCSH;COBL
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.47462534469258433,-0.7846878274271755,0.7704918032786885,1.0,1.0,2/9,24.52%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.4563471955455694,-0.7839640713123852,0.8076923076923077,1.0,1.0,3/11,23.92%,DND1;ZFP36L2;DHX36
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.33005947644508343,-0.7836689270350852,0.8631578947368421,1.0,1.0,22/166,18.32%,RSPO4;CD63;EVC;RIMS1;SFRP1;HAP1;FGF1;ATP6AP2;XBP1;JAG1;BDNF;CDH3;EMP2;STX1B;ULK3;ADAMTS3;CDKN2AIP;C3;VWF;MYORG;IL7;BAX
prerank,PanglaoDB_Augmented_2021__T Cells,0.3375865835341933,0.7835749048147007,0.75,0.9815830217640512,1.0,8/31,9.66%,CREM;TRAF1;CD247;CD96;MBD2;RORA;GPR174;PTPRC
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.4317602769708214,-0.7833900331548745,0.7123287671232876,1.0,1.0,2/14,8.53%,SCN9A;CACNA1G
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.4925612442119969,-0.7833727504493747,0.8194444444444444,1.0,1.0,1/7,2.32%,SFRP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.4441678977001138,-0.7832933018522582,0.7567567567567568,1.0,1.0,1/10,5.69%,TRIB1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.47272263657864766,-0.783261276199076,0.7878787878787878,1.0,1.0,3/8,21.41%,PDK1;PDK3;PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.47272263657864766,-0.783261276199076,0.7878787878787878,1.0,1.0,3/8,21.41%,PDK1;PDK3;PDPR
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.443651436852457,-0.7831185417164483,0.782051282051282,1.0,1.0,5/13,31.25%,SLC30A4;SLC39A6;SLC39A7;MT3;SLC39A14
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.27503538049638604,0.7829976484660242,1.0,0.9821233737240477,1.0,6/75,5.93%,PLD1;NR1H2;WNT7A;BTRC;RPS6KB1;YTHDF1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.4016720636970408,-0.7829459290064286,0.8181818181818182,1.0,1.0,5/25,15.68%,RPS27A;CFTR;HDAC6;DYNC1LI2;UBA52
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.340770525162132,0.7828964811251871,0.9285714285714286,0.9817449068032207,1.0,8/31,18.15%,TBC1D14;TBC1D12;PIKFYVE;LRRK2;MTMR3;MTM1;PINK1;RALB
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.39765108821533907,-0.7828097320440172,0.7926829268292683,1.0,1.0,3/31,7.91%,TGFB1;DDX5;OLFM1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.44275253114720414,-0.7827571117978857,0.8194444444444444,1.0,1.0,4/19,12.64%,JPH3;HPCA;CACNB1;CALM1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.35512908529612675,0.782693310395681,0.8636363636363636,0.9815396242443148,1.0,2/16,12.90%,PUM2;TRIM71
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.4098599120697985,-0.7826866407125647,0.7402597402597403,1.0,1.0,4/24,20.39%,OST4;DAD1;MCFD2;RPN1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.35694187621925166,-0.7825796670009231,0.8222222222222222,1.0,1.0,7/70,10.43%,RSPO4;SFRP1;EMD;ATP6AP2;SFRP4;WIF1;GPC3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.31427800170084746,0.7824402490918646,0.7916666666666666,0.9813345899109943,1.0,7/27,13.20%,ABL1;POT1;ABL2;MAPK14;MAPK3;PHACTR4;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.4813114975571552,-0.7822818984944074,0.7922077922077922,1.0,1.0,3/7,20.30%,MEF2C;PIK3CB;CDKN2A
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.4675393925854211,-0.782086992740339,0.7714285714285715,1.0,1.0,2/10,19.32%,ACOXL;CRAT
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.4635909119290195,-0.7820561011840114,0.8529411764705882,1.0,1.0,4/9,31.45%,USP44;DYNC1LI1;LCMT1;XRCC3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.39177618359732397,-0.7818689894035332,0.8227848101265823,1.0,1.0,11/32,24.36%,DDRGK1;RPL11;RPL23;GIPC1;RPS7;RPL5;HSP90AB1;BAG6;PARK7;CAMLG;UBXN1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.353094609815217,-0.7818229558480537,0.8352941176470589,1.0,1.0,8/54,19.44%,PUS3;OSGEP;ELP5;DUS2;WDR6;TRMT5;QTRT1;QTRT2
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5121617006336479,-0.7818122553917388,0.7777777777777778,1.0,1.0,2/5,17.88%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5121617006336479,-0.7818122553917388,0.7777777777777778,1.0,1.0,2/5,17.88%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3765750781030136,-0.781527991104552,0.7976190476190477,1.0,1.0,4/39,7.02%,SCG2;NOL3;AGT;BCL2L14
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.47562971186554626,-0.7814296719659927,0.8767123287671232,1.0,1.0,1/10,5.73%,PEX1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.3751970985397689,0.7809969507104896,0.75,0.9828218130236744,1.0,1/9,2.35%,IRS1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.3751970985397689,0.7809969507104896,0.75,0.9828218130236744,1.0,1/9,2.35%,IRS1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.4033884778009355,-0.7809585943965195,0.7402597402597403,1.0,1.0,7/20,27.54%,VIL1;KIF18B;STMN2;GSN;STMN1;DSTN;STMN4
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.41673873495125147,-0.7807394631417399,0.7974683544303798,1.0,1.0,1/20,3.84%,HES1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.4540987004228342,-0.7806827434836452,0.7794117647058824,1.0,1.0,3/10,24.79%,VIL1;GSN;DSTN
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.4406595057717856,-0.7801637706574518,0.7384615384615385,1.0,1.0,2/11,12.67%,MMP24;METRN
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.41823995169007333,-0.7798955063227304,0.7375,1.0,1.0,1/17,1.80%,RIMS1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.3587199315936456,-0.7798172822528909,0.8586956521739131,1.0,1.0,4/55,6.28%,SLC2A3;MMACHC;BTD;GSTO1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.3345663377991736,0.7796622583385359,0.8,0.9843825483237071,1.0,5/24,10.40%,RAB27A;SYT12;DOC2A;SYT9;LRRK2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.47280673036527066,-0.7795945452527127,0.746268656716418,1.0,1.0,3/7,37.03%,TSN;MRPL44;HENMT1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.4574080219694442,-0.779578794271949,0.75,1.0,1.0,4/11,27.00%,NIFK;POLR1G;GTF3A;MARS1
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.4345056541689686,0.7794246962813944,0.7142857142857143,0.9841655311268327,1.0,1/6,9.36%,CMPK1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.3515454974492383,-0.7793204137448397,0.8372093023255814,1.0,1.0,12/85,15.88%,MT1E;SFRP1;TGFB1;MT1M;CDKN2C;MT2A;TCHP;BTG1;ESR2;CRLF3;RACK1;CDKN2AIP
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.41098288264240423,0.7789941170234229,0.8064516129032258,0.9841854154712263,1.0,3/8,8.71%,AKR1C2;AKR1C3;AKR1C1
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.3395812323790093,-0.7789020436639579,0.925531914893617,1.0,1.0,22/152,18.74%,GYPE;H4C3;RAP1GAP;ISCA1;SIDT2;BACH1;CROCCP2;MOSPD1;HEBP1;GDE1;NARF;SLC22A4;DAAM1;HDGF;LMO2;UROD;SLC6A9;CAST;ANK1;C3;CA1;NFE2L1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.44704037550060644,-0.7787744668209721,0.8529411764705882,1.0,1.0,2/10,28.25%,BTBD18;ZSCAN21
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.4642091506515235,0.7787693437223867,0.6666666666666666,0.9838827794544961,1.0,1/6,4.00%,CDO1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.4343329870991147,0.7786463795987082,0.65625,0.9829135438718298,1.0,3/7,12.35%,SLC1A2;DISP1;SIGMAR1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.4343329870991147,0.7786463795987082,0.65625,0.9829135438718298,1.0,3/7,12.35%,SLC1A2;DISP1;SIGMAR1
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.37166497389261266,-0.7786375204091179,0.759493670886076,1.0,1.0,6/33,22.55%,NUP155;NOL6;SEC13;NUP107;NUP188;NUP85
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.37166497389261266,-0.7786375204091179,0.759493670886076,1.0,1.0,6/33,22.55%,NUP155;NOL6;SEC13;NUP107;NUP188;NUP85
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.4995314773031898,0.7785897837579859,0.725,0.9824512612912158,1.0,3/5,28.51%,RPS6KA3;INO80;BCLAF1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.45239871619186045,-0.7785617901196592,0.7948717948717948,1.0,1.0,3/11,27.72%,PPAT;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.33848813746657924,0.7784004806010032,0.8823529411764706,0.982096774729484,1.0,5/27,5.20%,ABL1;MAP2;CAMSAP2;FCHSD2;ARHGAP28
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.4084846946654188,-0.778335134583587,0.7631578947368421,1.0,1.0,4/25,20.39%,OST4;DAD1;MCFD2;RPN1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.4009786493548348,-0.7781043592201495,0.7763157894736842,1.0,1.0,4/20,16.80%,S100A10;MAFF;CD55;ABCC3
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.3331023292757054,0.7779718516167132,0.8823529411764706,0.982246441093482,1.0,8/38,15.88%,SMPD4;CTSA;ESYT2;GLTP;HEXB;ST3GAL4;ARSA;ABCA2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.38254038288261166,-0.7777784288802385,0.8131868131868132,1.0,1.0,3/42,5.88%,CDKN1C;IFNGR2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.4602077557729164,-0.7774343258003934,0.8,1.0,1.0,2/7,17.61%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.4602077557729164,-0.7774343258003934,0.8,1.0,1.0,2/7,17.61%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.4602077557729164,-0.7774343258003934,0.8,1.0,1.0,2/7,17.61%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.39099766570725286,-0.777293068332897,0.7564102564102564,1.0,1.0,8/39,24.36%,PPIF;CHCHD10;PDCD5;BAX;DNM1L;VPS35;PARK7;HIP1R
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.3339101765562238,-0.7772022194886185,0.9072164948453608,1.0,1.0,17/177,10.10%,ESRRB;ETV4;VEGFA;HAP1;PPIB;BTN3A1;HTR2B;FLOT1;TLE6;TGFB1;AGT;LRPAP1;OLFM1;XBP1;KDM6B;GAPDH;MED1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.3130523873571302,0.7769099722815113,0.8333333333333334,0.9832742433226631,1.0,13/38,16.90%,EYA4;HDAC10;SIRT1;FMN2;EYA2;EGFR;TRIM28;HMGB1;UBE2N;FAM168A;EYA3;SPIRE1;MGMT
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.39603639484744024,0.7769042610870402,0.8,0.9827058062253201,1.0,2/11,2.39%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.3406643267994113,0.7767681263099642,0.8695652173913043,0.9823627154683477,1.0,8/25,18.84%,ANKRD13D;PLIN5;AATF;ANKRD13A;ABCA2;PINK1;PRKN;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.44381542953669845,-0.7764472161255429,0.8028169014084507,1.0,1.0,3/11,26.81%,PARP14;CAV1;PTPN2
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.34901930102065176,-0.7763039767275882,0.8666666666666667,1.0,1.0,6/63,13.05%,SFRP1;ALOX5;MYRIP;CACNA1C;CACNA1E;CACNA2D2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.41736368163194254,0.7760959238026995,0.75,0.9830036917430685,1.0,2/7,11.70%,NLGN1;PTPRS
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.3440562721711254,-0.7758945231848048,0.8314606741573034,1.0,1.0,6/75,13.53%,VEGFA;ECT2;FGF1;TOM1L1;EMP2;STRADB
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.380990086925634,-0.7758943785768843,0.8795180722891566,1.0,1.0,13/38,27.00%,NARS1;AIMP1;SARS1;WARS1;LARS1;VARS1;WARS2;CARS1;DARS2;GARS1;RARS1;TARS3;MARS1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.4077540106951869,0.7758299747755729,0.6470588235294118,0.9829279712385773,1.0,5/5,59.24%,ABCD2;SLC27A4;ABCD3;ABCD4;ACOX1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.38735670444159237,-0.775630666421933,0.7341772151898734,1.0,1.0,8/26,24.36%,DDRGK1;RPL11;GIPC1;HSP90AB1;BAG6;PARK7;CAMLG;UBXN1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.4621868161042171,0.7755584887851502,0.8055555555555556,0.9826921546393048,1.0,1/5,4.78%,SIRT1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.4257920680744718,0.7754542493234721,0.6739130434782609,0.9822324928316919,1.0,2/6,12.07%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.4256321978214152,-0.7752985720400796,0.796875,1.0,1.0,1/14,3.33%,NOL3
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.40332337289034426,0.775234993224303,0.7142857142857143,0.981997373848442,1.0,2/8,15.52%,SMAD7;JAM3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.38786255070671194,-0.7750011314470036,0.8701298701298701,1.0,1.0,6/30,20.83%,HAP1;CLU;EFNA1;APOE;RTN2;CASP3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.38342397582886023,-0.7747862371137609,0.7654320987654321,1.0,1.0,1/19,3.99%,NAAA
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.2899728960043654,0.7747623918514073,0.8823529411764706,0.9823914743983424,1.0,13/40,18.50%,ZNF516;SIRT1;PPARG;CTBP1;FOXO1;BBS4;SOX8;PRDM16;OSBPL8;TCF7L2;PID1;AKT2;FAM120B
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.37243759562663353,-0.7745199422164359,0.8192771084337349,1.0,1.0,4/38,7.28%,ALOX5;CLU;SPINK5;HHIP
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.4094298652277877,-0.7744895487416317,0.7837837837837838,1.0,1.0,1/19,5.88%,TGFB1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.3147263360903984,0.7743453107935827,0.7727272727272727,0.9825507249042611,1.0,3/20,7.96%,FBXW7;MN1;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.3479082099998182,0.7740617002439466,0.8333333333333334,0.982560723790028,1.0,5/22,9.48%,ADRA1A;ESR1;ABL2;EGFR;GNAQ
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.30706565513617023,0.7739621468051497,0.8125,0.9820812290294251,1.0,9/37,19.31%,CRADD;PML;ARID3A;PCBP4;CNOT2;CNOT6L;CNOT9;CNOT7;MDM4
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.36720954000111117,-0.7738281361257765,0.7790697674418605,1.0,1.0,7/41,14.15%,SFRP1;DVL1;SFRP4;CDH3;WNT5B;TCF7;DVL2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.374125264440424,0.7737619715107311,0.7586206896551724,0.9818788044810953,1.0,1/13,2.34%,LEPR
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.444111173082293,0.7735813843618541,0.7714285714285715,0.9815703387408881,1.0,2/6,12.88%,FHIT;PRPS1
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.42422163198580526,-0.773529850740568,0.7916666666666666,1.0,1.0,3/19,11.33%,TGFB1;JAG1;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.45846124956972545,-0.7734836092517574,0.8133333333333334,1.0,1.0,3/9,18.76%,GRN;SYT11;NR1D1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.44873318309403887,-0.7731303709103843,0.7777777777777778,1.0,1.0,6/12,36.68%,TPST1;TPST2;ENPP1;SLC35B3;BPNT2;SULT1C4
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.34618498083204163,-0.7728219976506645,0.8901098901098901,1.0,1.0,9/91,11.79%,SEZ6;SCG3;SVOP;CELF4;SRRM4;PMP2;CACNA1E;SLC7A14;CCK
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.500740970066812,-0.7725649304192319,0.8055555555555556,1.0,1.0,4/5,41.79%,HRAS;ZSWIM8;PNPT1;RELA
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.3590369033317887,-0.7724388727975923,0.8539325842696629,1.0,1.0,5/46,9.68%,PLSCR1;POLR3D;IFI35;AGT;MEF2C
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.39175622370575813,-0.7722506873359559,0.8051948051948052,1.0,1.0,4/22,22.31%,TGFB1;MED1;CATSPERG;CAV1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.3958135368939246,-0.772010778911699,0.7948717948717948,1.0,1.0,7/23,26.44%,HES1;MEF2C;STIL;CCDC39;AHI1;NDRG4;CCDC40
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.3673419295239592,0.7716617114076642,0.85,0.9841726422938795,1.0,5/18,16.75%,ATF7IP;METTL4;DNMT3B;PPM1D;BAZ2A
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.30873917689565844,0.7714758812482574,0.8571428571428571,0.9838631789889296,1.0,5/21,23.84%,FER;ST18;PID1;IL6ST;YAP1
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.37499896576182556,0.7713270178469888,0.7692307692307693,0.9834586001770695,1.0,2/13,3.78%,LAMA3;FERMT1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.4741916990578382,-0.771216898880848,0.7681159420289855,1.0,1.0,1/6,5.93%,CTSL
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.4507117022828352,-0.7710308042344496,0.8205128205128205,1.0,1.0,2/9,15.76%,GORASP1;FZR1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.3527221571074576,0.7707970599799362,0.7575757575757576,0.9837330923237836,1.0,2/12,7.20%,MLLT3;METTL4
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.343486187710559,-0.7705289605457315,0.898876404494382,1.0,1.0,8/85,13.69%,SLC3A1;SLC38A4;SLC35F3;SLC7A6;SLC22A4;SLC6A6;SLC7A14;SCAMP5
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.37335172117484666,-0.7703051066983031,0.8372093023255814,1.0,1.0,6/54,8.39%,SFRP1;ALOX5;RARRES2;TGFB1;ZFPM1;XBP1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.4846977971288804,-0.7700311336986884,0.855072463768116,1.0,1.0,1/7,6.81%,IRF1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.4720902633258997,-0.7696484618482486,0.7666666666666667,1.0,1.0,2/8,13.63%,KHK;PPP1R3F
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.46204969537922497,0.7696132051027231,0.696969696969697,0.9852470694679655,1.0,1/6,5.55%,SH3KBP1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.4420154138846115,-0.7692898053752442,0.7733333333333333,1.0,1.0,4/10,19.32%,TMLHE;SHMT1;ACADL;CRAT
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.3787101471008987,0.7687311419926535,0.7777777777777778,0.9860708744928766,1.0,7/10,18.24%,MAPK14;MAPK3;STIM1;MAPK8;ORAI1;NOS1;NF1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.4234478166762228,-0.7686353739364447,0.8108108108108109,1.0,1.0,2/18,9.68%,FLOT1;MEF2C
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.4375760065245736,-0.7683694640414509,0.8142857142857143,1.0,1.0,3/11,22.48%,CSTF2;NCBP1;CPSF1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.32769372229967525,-0.7682831144904549,0.9583333333333334,1.0,1.0,42/231,22.95%,PARP2;FANCB;RPS27A;APEX1;ABRAXAS1;FANCI;ADPRS;BACH1;RNF8;RFC2;POLQ;PARP9;SMC1A;CENPX;NABP2;RPA3;FAN1;SMARCA5;FANCC;H2AX;ALKBH2;PNKP;PPP5C;PARP4;UBA52;RFC4;KAT5;LIG1;MMS19;BRCA1;UBC;FBXO6;MGME1;MSH6;ATRIP;RFC3;XPA;RECQL;POLD2;MBD4;PARK7;ALKBH5
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.4785873527063287,-0.7673606918147686,0.8333333333333334,1.0,1.0,3/8,33.71%,ISG20;REXO4;MUS81
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.37105785177822287,-0.7673395105345254,0.8,1.0,1.0,5/34,15.31%,POLE3;LDB1;TADA1;TADA3;BRPF3
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.5113268308522146,-0.7672954283111595,0.8166666666666667,1.0,1.0,2/6,34.83%,EZH1;DOT1L
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.46710153139163035,0.7671647575655106,0.7352941176470589,0.9882908041473059,1.0,2/5,2.39%,ADRA1A;NLGN1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.3418368711453727,-0.7671532945728058,0.9010989010989011,1.0,1.0,11/100,11.01%,SFRP1;PDCD1LG2;H2AZ1;CFTR;SELENOS;TRIM41;XBP1;MEF2C;MED1;MGST1;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.36464289688326346,-0.7668614759179383,0.8607594936708861,1.0,1.0,17/45,30.88%,RETREG1;MEF2C;BDNF;GRN;APOE;RASA1;WFS1;NRBP2;SET;PARK7;NONO;PRKCI;MAG;SOD2;PTPRZ1;MT3;PPT1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.3948881698624739,-0.7667544304980167,0.8873239436619719,1.0,1.0,1/24,1.74%,VEGFA
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.34369308026693285,0.7664677266978942,0.7391304347826086,0.988963738657047,1.0,3/15,13.53%,BOK;DCC;BCL2
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.4259586923799384,-0.7663530643664679,0.8382352941176471,1.0,1.0,4/10,26.30%,SPG7;PMPCA;AFG3L2;YME1L1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.34606186441234854,0.7663433716773356,0.8421052631578947,0.988610434085905,1.0,2/11,8.67%,KIF19;NCKAP5
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.3345974451419249,-0.7661639906899472,0.8791208791208791,1.0,1.0,32/134,26.52%,H2AZ1;TGFB1;CDKN2C;KIF20B;SNRPD1;MT2A;POLQ;SMC1A;SRSF10;BUB3;FANCC;SAP30;H2AX;CBX1;ODF2;STIL;NCL;DKC1;TACC3;HMGN2;KIF22;CTCF;DBF4;CDK4;SRSF2;STMN1;ILF3;E2F4;HSPA8;NUMA1;DR1;NOLC1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.34696438432691495,-0.7660440174152803,0.8620689655172413,1.0,1.0,20/77,26.69%,VEGFA;MEG3;CRYAB;PAMR1;FN1;COL6A1;LMOD1;ACTA2;COL4A1;ADAMTS2;VCL;THBS2;CALD1;THY1;COL14A1;SRPX;COL4A2;PDGFRB;PDZRN3;C1S
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.4428006662675291,-0.7660370193587199,0.7941176470588235,1.0,1.0,3/10,22.48%,CSTF2;NCBP1;CPSF1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.4742464367461958,-0.766026673591827,0.7692307692307693,1.0,1.0,1/7,12.74%,WNK3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3606060947635288,0.7658803509352368,0.85,0.9888280743723951,1.0,8/20,14.15%,TAB3;INAVA;MAP2K6;MAP3K7;TAB1;TAB2;UBE2N;OTULIN
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.5176656378424753,-0.7657115077634004,0.8571428571428571,1.0,1.0,1/5,8.53%,CACNA1G
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.409464908031285,0.7653449342393522,0.8125,0.989203842904338,1.0,4/10,12.09%,ABL1;PDP1;ABL2;RFK
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5216480078976906,-0.764902687475046,0.8225806451612904,1.0,1.0,1/5,11.33%,EFNA1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.3622774111203878,0.7648013434663903,0.8,0.9893786636204585,1.0,2/14,7.60%,RIPOR2;KANK1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.34625964304870255,-0.7647529078574836,0.875,1.0,1.0,18/80,24.88%,VEGFA;ISG15;CLU;TGFB1;IL5;RPA3;USP50;RACK1;WARS1;BAX;MTLN;XPA;RHOC;PARK7;SLF1;ABCA1;RBX1;PSMC4
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.5063376338414687,-0.7645578723890638,0.8387096774193549,1.0,1.0,1/6,9.68%,MEF2C
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.38475426278836516,0.7642075988760767,0.7575757575757576,0.9896692899925201,1.0,10/10,61.55%,ALMS1;ASAP3;AKAP13;ROCK1;ACTG1;ROCK2;RAC1;CDC42;SLC9A1;TSC1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.3451489041102833,0.7642030364123471,0.9,0.9890952648956703,1.0,4/14,12.07%,ESR1;KAT2B;PTBP1;PTBP2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.3567168926715996,0.7641691600506795,0.6956521739130435,0.9885429857564626,1.0,4/24,14.79%,CEP120;SIRT1;FBXW5;CHMP1A
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3488851217759724,-0.7638726300275837,0.8222222222222222,1.0,1.0,12/68,20.30%,CDKN1C;TGFB1;CDKN2C;SH3GL2;CACTIN;ANKLE2;ATG14;ZBED3;DNAJC10;WARS1;TERF2IP;CDKN2A
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.3111819896554801,0.7634974275354663,0.8181818181818182,0.9890020372702126,1.0,8/21,18.42%,LRRK2;INF2;MCU;MARCHF5;RALA;SPIRE1;PINK1;PRKN
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.36202291744821236,-0.7633810748726217,0.8588235294117647,1.0,1.0,6/56,10.39%,HES5;ECT2;HES1;MEF2C;MED1;BDNF
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.48992371531962886,0.763310088273508,0.7692307692307693,0.9887766370329545,1.0,1/6,13.13%,CDS2
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.4716876347611758,-0.7631821009807913,0.7727272727272727,1.0,1.0,3/6,42.14%,LAPTM4B;LRP1;LDLR
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.4785996529442796,-0.7631555408171746,0.7837837837837838,1.0,1.0,1/7,3.39%,FGF1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.34422584898412545,-0.7629322693880539,0.8571428571428571,1.0,1.0,6/65,10.73%,MBNL3;FAM50A;AKAP17A;RPS13;SRRM4;SRSF10
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.4603099434137732,-0.7626784332876781,0.7941176470588235,1.0,1.0,1/10,8.53%,CACNA1G
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.4516434541644102,-0.7625776993678065,0.8311688311688312,1.0,1.0,1/11,2.32%,SFRP1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.2782094048635692,0.7624328423532711,1.0,0.9895399593041866,1.0,3/40,4.58%,SORD;TCOF1;PRMT3
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.4649737279342968,0.7623783888342617,0.6666666666666666,0.9890412658111964,1.0,2/6,11.40%,CAND2;FBXL7
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4643612770867489,-0.7622184534085527,0.8115942028985508,1.0,1.0,2/10,12.74%,GLRX;WNK3
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.47244068407652917,-0.7620914620052808,0.8095238095238095,1.0,1.0,3/8,20.93%,TBXAS1;CBR1;PTGES2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.3390767265083669,-0.7619997378550609,0.8488372093023255,1.0,1.0,7/58,16.04%,HLA-F;CLU;CTSZ;MEF2C;SNCB;DDIT4;CHMP4B
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3651583348945637,-0.7617423299597662,0.927710843373494,1.0,1.0,5/47,10.50%,HTR2B;PLCH1;PLCD4;PIK3CB;CD160
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.4607423450397592,-0.7615227936462035,0.8082191780821918,1.0,1.0,2/8,19.68%,GRN;PTN
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.34286988932401397,-0.7614533979377707,0.8817204301075269,1.0,1.0,9/87,13.93%,PSMB9;VAV3;PSMB8;LAT2;JUN;PIK3CB;PSMA3;CALM1;PSME1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.46689210855461516,-0.7614508821019615,0.7878787878787878,1.0,1.0,3/8,12.58%,SFRP1;STK17A;BTG1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.42976368726706266,-0.7611160352039497,0.8117647058823529,1.0,1.0,3/14,5.88%,HES5;DVL1;TGFB1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.43291052939037394,0.760993597925888,0.7272727272727273,0.9907173052195277,1.0,4/7,20.21%,ADAM10;ADAM17;GALNT11;PSEN1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.4429832451670852,0.7609758690109015,0.825,0.9901870150430041,1.0,1/8,14.21%,NAA16
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.4305022618889927,-0.7608502504461202,0.7804878048780488,1.0,1.0,5/9,38.48%,PTN;OMG;GAP43;RTN4RL1;MAPK8IP3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.36338263665034143,0.7607787586916251,0.8285714285714286,0.990035016117089,1.0,3/9,21.58%,PID1;PRKN;ADCK1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.36233693526250516,-0.7607655043097378,0.8607594936708861,1.0,1.0,7/37,22.55%,NUP155;NOL6;SEC13;NUP107;PHAX;NUP188;NUP85
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.41912244283967426,0.7606506637583236,0.7,0.9896944728782396,1.0,2/8,9.58%,PATL1;DCP1B
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.4207698170254556,-0.7605657955506105,0.8333333333333334,1.0,1.0,3/15,21.32%,P2RX4;APOD;P2RY12
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.33921300495391327,0.7604747537411582,0.8181818181818182,0.9894172002751115,1.0,8/23,18.42%,UBE2E2;UBE2H;ANAPC4;UBE2E3;CDC16;ANAPC1;RNF4;PRKN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.3403324119910512,-0.7602838081480038,0.8829787234042553,1.0,1.0,13/87,20.18%,PSMB9;VAV3;PSMB8;LAT2;JUN;PIK3CB;PSMA3;CALM1;PSME1;NR4A3;PRKCQ;PSMA7;PSMB6
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.4377423883876329,-0.7602724896191647,0.8051948051948052,1.0,1.0,3/9,10.49%,VEGFA;RSAD2;PIK3CB
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.3409341356956975,-0.7600602226613818,0.8888888888888888,1.0,1.0,14/74,25.49%,SFRP1;CFTR;RRAGA;XBP1;MEF2C;P2RX4;TSHR;LARS1;MAPK13;BRCA1;P2RY12;KCNQ1;SOX9;LAMTOR4
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3910880600740711,-0.7598395297387022,0.8051948051948052,1.0,1.0,2/29,4.07%,RTKN2;IFI35
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.45076848563533123,-0.7597253628703059,0.7397260273972602,1.0,1.0,1/8,5.88%,TGFB1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.31031064852743817,0.7595063901126875,0.8888888888888888,0.9902607893239646,1.0,8/52,11.05%,ABL1;CD247;PLD2;MAPK1;ABI1;WASL;MAPK3;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.3556478099101543,0.7590440425924143,0.7272727272727273,0.9906847424671676,1.0,1/14,2.31%,ATR
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.3815648883802479,-0.7589891041119939,0.8148148148148148,1.0,1.0,4/28,12.00%,HAP1;CRYAB;DNAJC30;ANTKMT
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.4557392075021982,0.7589449021521862,0.7272727272727273,0.9902923167203909,1.0,4/5,36.45%,ELAVL4;TENT4B;TENT4A;METTL16
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.4618034290600038,-0.7586375653370493,0.8235294117647058,1.0,1.0,1/10,1.96%,TAF7
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.46194811674965086,-0.7586000670096994,0.8382352941176471,1.0,1.0,4/8,29.97%,MT2A;ATOX1;SLC31A1;APP
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.34781062118126205,0.7584439057326906,0.9411764705882353,0.9904125916776342,1.0,3/23,7.50%,GPNMB;FAM107A;PKD2
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4148636321209995,-0.7581883244714432,0.775,1.0,1.0,3/15,13.95%,DOLPP1;MPDU1;ALG14
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.4628708937180289,-0.7577994695227033,0.8125,1.0,1.0,4/9,25.48%,ZIC1;MYO3B;PAX8;SOX9
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3313305497180579,-0.7570303363766104,0.8936170212765957,1.0,1.0,16/85,18.94%,NPM2;RBM3;ATAD5;XBP1;LDB1;NLRC5;RPS4X;SLC6A9;UPF3B;BRPF3;UPF3A;NSUN5;RPS27L;PLXNB2;RPL5;PCIF1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.404691800653013,0.7568569159935705,0.71875,0.9925909376256183,1.0,2/9,12.93%,RELN;CAPRIN1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.32243467174039886,-0.7568216887290946,0.9230769230769231,1.0,1.0,17/141,16.10%,IGFBPL1;CD63;TRIM5;PLSCR1;LFNG;CLU;TGFB1;ZIC1;OVOL2;HHIP;ZFAND2B;VWA2;FUZ;VEPH1;MTCH1;CDKN2AIP;CD55
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.3276717998774545,-0.7566720494197848,0.8571428571428571,1.0,1.0,11/100,9.92%,NEFM;SCG2;SEZ6L2;TRPM3;GNRHR;GMPPA;CACNA1C;AGA;SST;CHGB;CELF4
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.305456453197925,0.7564340897016352,0.875,0.9926992851563866,1.0,11/37,14.97%,HPSE2;GPC4;HS3ST1;GCNT2;UGDH;EXT2;GPC1;SDC2;HS2ST1;GNS;EXT1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.43014725457061914,0.7563469438537697,0.8333333333333334,0.9916744948834607,1.0,2/7,7.50%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.43014725457061914,0.7563469438537697,0.8333333333333334,0.9916744948834607,1.0,2/7,7.50%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.4162954338140349,-0.7563256159951074,0.8524590163934426,1.0,1.0,3/18,17.73%,ZW10;DCTN1;SAPCD2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.29754907264234615,0.756185853552611,0.75,0.9913766766199185,1.0,45/178,14.43%,RIT2;CHRM3;GABRG1;GABRR1;ERC2;KCND2;NLGN4X;NLGN1;KCNQ3;HOMER1;GRIK2;CHRNB3;PDE7B;DOC2A;FCHSD2;NRXN1;UNC13C;MAPK1;GRID2;NOVA1;GRIA1;SLC1A2;UNC13B;KCNC4;CHRNA7;GLRA1;GRIA3;DLG2;GRIK3;GRIN2B;PRKACB;APBA1;ERC1;GABRG3;KCNIP2;KIF1B;GRIK4;GABRB1;NAPB;KCNQ2;DLGAP1;GABRA1;LIN7A;PTPRN2;HTR1E
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.42902813049279975,-0.7556907130811816,0.8157894736842105,1.0,1.0,2/15,15.72%,CACNA1C;AKAP5
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.4328677149417923,0.7556621128579418,0.7391304347826086,0.9916938256050944,1.0,1/7,5.76%,MMAA
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.4019031650551545,0.7555392024852925,0.7333333333333333,0.9912922315513225,1.0,4/10,22.74%,ACVR1;BMPR1A;MDM4;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.46465640462108004,-0.7549229074243856,0.8,1.0,1.0,1/9,5.88%,TGFB1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.22936234667200492,0.7549143992571332,1.0,0.991817162558432,1.0,49/266,14.25%,RNF144A;BARD1;FBXL4;UBE3D;NEDD4L;FBXW7;TRAF1;HECW2;FBXO17;UBOX5;BTRC;UBE2G1;HACE1;UBE2J2;TRIM62;UBE2D1;MARCHF1;TNKS;UBR5;FBXW11;FBXO15;CBFB;RNF135;SPSB1;PELI2;FBXO31;UBE2E2;UBE2H;FBXO28;NEDD4;FBXW8;UBE2QL1;FBXL7;PSMD13;UBE2N;ANAPC4;UBE2E3;PSMD6;FBXW5;CDC16;UBE3C;TRIM71;KLHL42;BCL2;RNF217;ANAPC1;FBXO11;TPP2;TRAF5
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3253075030714831,0.7548965571084392,0.8947368421052632,0.9912807768017567,1.0,9/25,16.30%,GNG2;FZD3;PLCB1;NFATC1;PPP3CA;MAP3K7;MOV10;TCF7L2;NLK
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.4335147200396115,0.7548408190048079,0.7857142857142857,0.9907969808975233,1.0,3/7,22.79%,EGFR;OPN3;MMP2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.3867334193422206,0.7547976242491345,0.8,0.9902929742771995,1.0,4/10,18.48%,FBXW11;SYNE3;SUN2;MTOR
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.32433924387971125,0.7544683171316865,0.68,0.9902878381993326,1.0,4/15,12.32%,MFHAS1;NFKBIL1;PTPRS;LRRC14
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.3753680239825177,-0.7539200644805496,0.8333333333333334,1.0,1.0,9/29,23.58%,SLC38A4;SLC7A6;SLC22A4;SLC6A6;SLC1A6;SLC3A2;SLC7A8;SLC36A4;SFXN3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.37897597338206057,-0.7537800851474861,0.8048780487804879,1.0,1.0,5/23,14.88%,RIMS1;MEF2C;CAMK2A;STX1B;SYT11
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.4323569175463336,-0.7536003356338226,0.8115942028985508,1.0,1.0,3/8,20.26%,STEAP4;STEAP2;ATOX1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.4852254567482558,-0.7534780760781402,0.8571428571428571,1.0,1.0,1/6,3.11%,ECT2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.44319196049663906,0.7534326837369469,0.725,0.9912475723351653,1.0,1/5,1.02%,GSTM2
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.3291432803879064,0.7533053001775604,0.8421052631578947,0.990775289033552,1.0,8/15,20.19%,CNNM2;SLC8A1;TMTC2;SNCA;PRKN;ANK3;GRIN1;TRPM7
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.28024428080971653,0.7532999091812175,1.0,0.9901999259156463,1.0,6/28,12.56%,NUTF2;GEMIN8;NUP98;ATXN1;RBM15B;AAAS
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.5018745031122344,-0.7532709585452176,0.8833333333333333,1.0,1.0,3/5,25.98%,RARA;IL18;SPHK2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.3696598377131291,-0.7530399126488286,0.7976190476190477,1.0,1.0,13/40,27.81%,ALOX5;IRF1;USP18;NLRP1;ERAP1;GRN;APOE;HERC5;PARK7;LRRC19;TMSB4X;UFL1;LRP8
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.34656387228723284,-0.7528106759655971,0.8395061728395061,1.0,1.0,9/47,25.98%,COX7A2;NUP155;BEND3;SEC13;NUP107;NUP188;NUP85;PGAM1;SPHK2
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.47447573684432315,0.7525242899056924,0.7777777777777778,0.9908576922512036,1.0,1/5,0.56%,THAP4
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.43111954349122195,-0.7524915833304969,0.8805970149253731,1.0,1.0,1/14,0.53%,HLA-B
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.27619731470416853,0.7517949953875364,0.8333333333333334,0.9912662760129254,1.0,24/101,17.12%,SYNDIG1;TLN2;BCAR1;CHST3;ANK2;MPDZ;GUCY1A2;MAGI1;CACNA2D1;EDIL3;PRICKLE2;GPC1;FBXL7;NFASC;TENM3;FIGN;EPB41L1;FRZB;NOS1;AMOTL2;TEAD1;SLIT2;GFRA1;PKDCC
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4708980310656361,-0.751632774734357,0.84375,1.0,1.0,3/8,26.81%,APOD;NDRG4;PTPN2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.41702924194651403,-0.751156933715031,0.8450704225352113,1.0,1.0,2/14,7.50%,HTR2B;HTR2C
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.4428654982097029,-0.7508741407741275,0.7971014492753623,1.0,1.0,3/11,16.94%,HTR2B;MAP2K1;ZFP36L2
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.4654155679417404,0.7507168852247738,0.7575757575757576,0.9924916262172684,1.0,3/6,18.21%,GLYAT;RIDA;GLDC
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4703938096429349,-0.7506416422220513,0.84375,1.0,1.0,3/7,12.58%,SFRP1;STK17A;BTG1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.2559515883192491,0.7504187947210057,1.0,0.9923715101216264,1.0,70/405,13.64%,SPSB4;SH3RF1;RNF144A;BARD1;RNF139;FBXL4;UBE3D;TSPAN17;NEDD4L;FBXW7;DTX4;RFWD3;MIB1;LZTR1;ASB5;HECW2;H2BC5;FBXO17;KLHL8;UBOX5;OBI1;UHRF2;SIRT1;RAD18;BTRC;KLHL21;UBE2G1;SH3RF3;HACE1;UBE2J2;TRIM62;KEAP1;UBE2D1;MARCHF1;TNKS;UBR5;MARCHF7;FBXW11;FBXO15;CBFB;HERC2;RNF135;USP9X;SPSB1;KLHL13;USP5;PELI2;FBXO31;UBE2E2;UBE2H;FBXO28;NEDD4;RCHY1;FBXW8;UBE2QL1;CAND2;FBXL7;PSMD13;UBE2N;UBE2E3;PSMD6;FBXW5;CDC16;UBE3C;TRIM71;RNF11;KLHL42;BCL2;RNF217;FBXO11
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3126146958133655,-0.7503424955489243,0.9387755102040817,1.0,1.0,24/202,15.68%,GADD45B;RPS27A;SFRP1;TFPT;VAV3;ECT2;STK17A;RASGRF2;JUN;ARHGEF18;CLU;OLFM1;HDAC6;SFRP4;OBSCN;APH1A;PDCD5;ITGB3BP;DNM2;MTCH1;PTPA;ATF4;RACK1;UBA52
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.44878314494149235,0.7501986949205725,0.7352941176470589,0.9920862078162431,1.0,4/7,16.81%,MAGI2;ACVR1;IGSF1;LEMD3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.4342823510223265,-0.7498452240210188,0.7945205479452054,1.0,1.0,1/9,1.86%,RANGRF
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.29796426079852556,0.7496635388661769,0.8666666666666667,0.9922969246392473,1.0,6/30,12.72%,RACGAP1;KIFC2;WRAP73;AAAS;CLASP1;LSM14A
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.311845880908273,0.7496506350064933,0.8333333333333334,0.9917642943786714,1.0,3/29,8.99%,TAF1A;TAF1B;MAPK3
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.3412515064553603,-0.749587191636744,0.8928571428571429,1.0,1.0,6/50,12.96%,POLE3;H1-4;RNF8;SMARCD1;SMARCA5;H2AX
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.3328475990697734,-0.7489596049404519,0.9139784946236559,1.0,1.0,23/127,20.53%,NEFM;GDAP1L1;LHFPL5;JPH3;HPCA;INA;CACNA1B;NARF;SNCB;TCEAL2;SH3GL2;KCNC1;DCTN1;TMEM179;KIF1A;ZDHHC22;RTN2;KLHDC8A;CALY;STMN2;NCAN;MAP6;SYT4
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.3992345971846297,0.7488459065626022,0.7419354838709677,0.9922534563505142,1.0,1/6,1.15%,MOXD1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.4384040438279776,0.748845851599947,0.7272727272727273,0.9916802307835872,1.0,2/5,11.71%,ACAA2;THEM4
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.42694944043395067,-0.7485725177159652,0.8169014084507042,1.0,1.0,3/15,17.10%,RSAD2;RHBDF1;APOE
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.3610664036025553,-0.7483379927972393,0.8452380952380952,1.0,1.0,8/46,22.55%,CDKN1C;TGFB1;BTG1;RNF167;NUDT6;CDKN2A;GMNN;TSPYL2
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.46833281720270925,-0.748323783704892,0.7857142857142857,1.0,1.0,2/8,18.43%,METRNL;TFE3
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.45992957653480143,-0.7481063095487006,0.8529411764705882,1.0,1.0,1/9,1.12%,ITGA4
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.3252430468150072,-0.7479416131112389,0.9278350515463918,1.0,1.0,17/189,14.15%,PSMB9;SFRP1;EMD;PSMB8;DVL1;TLE6;TGFB1;ATP6AP2;SFRP4;CDH3;GPC3;PSMA3;PLEKHA4;ZBED3;FUZ;PSME1;DVL2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.3395088583100948,-0.747742937996234,0.8409090909090909,1.0,1.0,7/50,19.20%,SFRP1;RRAGA;XBP1;ATG14;SREBF1;ZFYVE1;ULK1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.44658216225070835,-0.7477213056965081,0.8108108108108109,1.0,1.0,1/9,5.88%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.26018193680789925,0.7472884945633687,1.0,0.9936731148624918,1.0,20/79,15.55%,FEM1A;CALCRL;CD247;CALCB;MYH9;PPARG;GNG2;VIPR2;RORA;ADCY6;MAPK14;LRFN5;RXFP1;MFHAS1;PRKACB;ADCYAP1R1;ADAM17;OTULIN;FYN;ADCY2
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.3313904011532371,0.7472670593668593,0.8235294117647058,0.9931512169341981,1.0,8/30,14.09%,FNBP1L;MYO7A;TANC2;TRAK1;FBXW11;WASL;MYO5A;MYO1E
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.3169373027488681,0.7472165911377417,0.896551724137931,0.9926505032030833,1.0,4/23,12.83%,SOX11;BMP2K;ZBTB16;ACVR1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3540369099145503,-0.7472012044799181,0.9156626506024096,1.0,1.0,4/51,9.31%,ESRRB;FILIP1;KBTBD12;CTNNA3
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.36551994695986456,0.7471612539552628,0.8260869565217391,0.9921503666635895,1.0,2/16,7.56%,RYBP;RNF2
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.3463883022542952,0.7471299623905274,0.9,0.9915994100019467,1.0,5/13,16.26%,FAM107A;BCL2L11;SLIT3;NR3C1;SLIT2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.370490432810607,-0.7471019874877608,0.8441558441558441,1.0,1.0,1/29,2.65%,HAP1
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.4525672098546522,0.7469741611371264,0.7272727272727273,0.9912751013172141,1.0,2/7,9.60%,SRR;SERINC5
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.3753135425790059,-0.7468293545570079,0.8395061728395061,1.0,1.0,2/30,6.01%,HAP1;BLOC1S2
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.39311415307515274,0.7466109846272019,0.9473684210526315,0.9912181191250261,1.0,4/13,9.84%,CHRM3;PLCB1;GNAQ;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.37674513594787806,0.7464635515764506,0.7777777777777778,0.9908944026819532,1.0,3/9,12.84%,VLDLR;BMP7;COBL
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.3185586919059349,0.7460754049586098,0.8333333333333334,0.9910530730671004,1.0,6/26,12.32%,IL15;ZBTB1;PTPRC;PNP;ZMIZ1;FLOT2
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.37902500914551585,0.7459770815351554,0.76,0.9906375756186921,1.0,3/15,9.70%,TAF3;BBS4;PML
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.3398304314093257,-0.7458091670529932,0.9354838709677419,1.0,1.0,25/133,23.11%,VEGFA;FGF1;FLOT1;CAMK1;RARRES2;TGFB1;RASGRP1;ANKLE2;EFNA1;CALM1;ATG14;DVL2;PTPA;RACK1;ALG10B;C3;PPP2R5A;HDAC3;HRAS;TERF2IP;KAT5;TXN;VEGFB;DVL3;FAM161A
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.43989288211338307,-0.7457823876412555,0.84,1.0,1.0,1/8,10.58%,CLMP
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.3984272197905414,0.7457182500747348,0.8620689655172413,0.9904786516608374,1.0,4/10,16.26%,ROBO1;NFATC1;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.47501654007258365,-0.7456510843523974,0.8615384615384616,1.0,1.0,1/8,1.96%,TAF7
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.3019513901245676,0.7456426054779309,0.9090909090909091,0.9900741985138226,1.0,6/28,11.06%,IRS1;SIRT1;FOXK1;RORA;SDHAF3;DGKQ
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.4404343604193374,-0.7455988726538803,0.8656716417910447,1.0,1.0,1/11,5.16%,RARRES2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.4232238426915923,-0.7454601977253018,0.8082191780821918,1.0,1.0,1/14,5.88%,TGFB1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.40727695781348683,-0.7453275132925152,0.8082191780821918,1.0,1.0,1/19,1.74%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.33952147808511296,-0.7450445630771171,0.8837209302325582,1.0,1.0,9/57,18.80%,PFN2;PFDN6;CLU;CRYAB;PLEKHH2;TUBB4A;VBP1;APOE;STMN2
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.3358008884565676,-0.7450389566413437,0.8854166666666666,1.0,1.0,24/82,28.70%,JPH3;HPCA;INA;SNCB;KCNC1;SCAMP5;TMEM179;SLC6A9;KIF1A;STMN2;NCAN;TMEM151A;MAP6;GNG3;MPP2;LRRC4B;NDRG4;CELSR2;TMEM59L;PPFIA3;TMEM198;ACTL6B;BCAN;TUBB2B
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.4390208390416983,0.7446133874865173,0.8055555555555556,0.9910310799096619,1.0,2/5,25.91%,ST3GAL4;ST3GAL2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.47674268466976677,-0.7445267107707785,0.7941176470588235,1.0,1.0,3/5,44.65%,STAT3;TYK2;P4HB
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.33629818380469967,0.7444674492320643,0.8333333333333334,0.9906676787294946,1.0,6/24,11.06%,ACADVL;SIRT1;FMO5;FOXK1;RORA;DGKQ
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.4225268230740311,0.7444066344591451,0.8275862068965517,0.9902127103059867,1.0,2/8,15.37%,TGFBR2;NIPBL
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.407263249358699,-0.7442922958474086,0.8,1.0,1.0,5/16,17.71%,SPINK5;PRELID1;XBP1;TCF7;IL7
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.331798349282244,-0.74428764749075,0.9032258064516129,1.0,1.0,15/93,20.76%,PSMB9;RPS27A;SFRP1;PSMB8;HAS2;PSMA3;CACTIN;PSME1;ADAMTS7;UBA52;NR1D1;PSMA7;PSMB6;MAPK13;UBC
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.3281574750215516,0.7441075406206525,0.7368421052631579,0.9901770588709783,1.0,3/15,12.74%,SGCZ;BMP7;CFLAR
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4008451740215866,-0.7440801986852301,0.8493150684931506,1.0,1.0,10/14,30.52%,P2RX4;C3;HSP90AB1;TXN;PSTPIP1;IL18;ENTPD5;ANO6;APP;ENTPD1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4039898872302243,0.7439377526684854,0.7777777777777778,0.9898964395173477,1.0,5/10,29.88%,PTPRC;GRM5;DMTN;RYR2;PTPRJ
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3504724630271742,0.7437631710574345,0.7619047619047619,0.9895957353361904,1.0,4/17,12.47%,HECW2;NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.3878882019218456,-0.7437090701158606,0.8311688311688312,1.0,1.0,3/17,15.29%,TOM1L1;NABP2;PARP4
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.28665780763850646,0.7432410957405027,0.8888888888888888,0.9899683787413593,1.0,9/35,17.19%,MAP3K5;AKR1C3;PICALM;LRRK2;GRIN2B;CELF1;FYN;SNCA;ACER2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.29677980852915586,0.7429887212049113,1.0,0.9898616098478261,1.0,28/28,70.38%,AGPAT5;IP6K1;LPCAT1;IP6K2;GPHN;PPIP5K2;GNPAT;ITPKB;IPMK;NFS1;IPPK;GK;GK5;AGPAT3;TPK1;FITM2;FGF2;PIP5K1A;AGPAT4;GPAM;TKT;TPI1;FADS1;PPIP5K1;MOCS1;ITPKC;MOCS2;PCYT2
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.36755608550813174,-0.7429428546851371,0.8354430379746836,1.0,1.0,6/21,23.92%,DDX11;HNRNPA2B1;SUPV3L1;RECQL;PIF1;DHX36
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.47332051926673874,-0.7429033415518769,0.8852459016393442,1.0,1.0,1/5,10.10%,MED1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.4778956617481256,-0.7426163109525005,0.8493150684931506,1.0,1.0,2/6,23.88%,MEF2C;CAMLG
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.4063585336810296,-0.7421727634732365,0.8235294117647058,1.0,1.0,2/14,14.07%,DBI;LPCAT3
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.32645582557825975,-0.7419683253188272,0.9550561797752809,1.0,1.0,9/82,17.49%,TUBB4B;TUBA4A;RAB11A;B9D1;CEP72;DCTN1;TUBB4A;ODF2;DCTN3
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.42929437030606155,-0.7416379767747994,0.8356164383561644,1.0,1.0,3/14,8.39%,CREB3;SELENOS;XBP1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.2948685245231723,0.7412263402943292,1.0,0.9922605684600898,1.0,10/29,16.15%,FBXW7;ACADVL;PRMT3;AKR1C3;ATP2B4;PROX1;RAPGEF2;FYN;ABCA2;OPN3
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.35291216867696834,-0.7405764211112513,0.8783783783783784,1.0,1.0,2/27,9.59%,YBX3;DND1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3037471267335075,-0.7405272473767247,0.9696969696969697,1.0,1.0,48/234,24.36%,B2M;RPS27A;PPIB;COL5A3;COL9A3;TLE6;TUBGCP2;P4HA3;TUBGCP4;OPTC;APH1A;CST3;ITM2B;EMP2;COL15A1;COL6A1;ZBED3;HOOK2;DCTN1;LMOD1;AVIL;COL9A2;TMOD3;UBE2L6;UBA52;ADAMTS3;COL4A1;KIF18B;ADAMTS2;COL21A1;COL10A1;MYO1F;POF1B;STMN2;HSP90AB1;GSN;UBC;ERMN;ARHGAP12;PGM5;RHOC;CYP1B1;RHOG;COL14A1;TPM4;RND3;STMN1;HIP1R
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3329577585350069,-0.7404913290332196,0.9361702127659575,1.0,1.0,5/82,5.55%,MX1;ISG15;PLSCR1;IFITM3;HAX1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.39770421069224426,-0.7404406003004813,0.8289473684210527,1.0,1.0,1/21,2.32%,SFRP1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.3838554957644797,-0.7404097613683219,0.8860759493670886,1.0,1.0,3/28,13.74%,RIMS1;STX19;STX1B
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.38540546639322787,0.740375241866886,0.8620689655172413,0.9929568004958856,1.0,3/11,18.88%,SERAC1;RELCH;STARD4
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.44235250506864504,-0.7403739482463221,0.8157894736842105,1.0,1.0,3/8,25.18%,ANTKMT;TMSB4X;XRCC1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.31680181943875557,0.7401057165497179,0.9,0.9927671202435835,1.0,4/19,9.66%,LEPR;LIG4;CHD7;PTPRC
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.4890957675231453,-0.7399260339849167,0.8,1.0,1.0,1/5,13.46%,ABHD12B
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.4023657878115767,0.7398812218923083,0.8,0.9926183280622831,1.0,2/10,11.26%,VCAN;HEXB
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.2946516084385751,0.7398732479247018,1.0,0.992073380040637,1.0,4/30,10.53%,RNF139;BTRC;FBXW11;PLAUR
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3272443142729744,-0.7398598154472413,0.9354838709677419,1.0,1.0,6/97,9.89%,APIP;TRIM5;ATP6AP2;RASGRP1;CEACAM1;FN1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.3761476486531432,-0.7395323482805762,0.8588235294117647,1.0,1.0,7/27,22.57%,RANGRF;LEPROTL1;BDNF;RIC3;HSP90AB1;GOPC;ACTN2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.3125018236960784,-0.7388546049280216,0.9010989010989011,1.0,1.0,9/139,9.72%,IFI6;MX1;TRPC5;PLSCR1;IRF1;BCL2L14;TCHP;NLRP1;GAPDH
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.24198297651405515,0.7386566757647846,0.9,0.9932251717272247,1.0,7/48,14.40%,SLC25A18;SLC7A2;SLC1A2;ABCC5;SLC39A8;SFXN1;SLC25A1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.45028036920762865,-0.7386513555039049,0.8450704225352113,1.0,1.0,1/10,1.74%,VEGFA
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.47482725890419686,-0.7385403939710428,0.8382352941176471,1.0,1.0,2/5,27.68%,TERF2IP;DCLRE1C
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.4529714202198657,-0.7385239272900406,0.8378378378378378,1.0,1.0,1/8,5.88%,TGFB1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.33175165495258885,0.7382285234535945,0.8928571428571429,0.9932286322993081,1.0,3/22,8.59%,ASXL3;ZBTB20;ADIPOR2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.33471810199216917,-0.7367906344888902,0.8780487804878049,1.0,1.0,9/63,15.13%,VEGFA;HSD17B14;SEZ6L2;SCG5;SST;SH3GL2;GLIS3;SCAMP5;KIF1A
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.4989989112032157,-0.7363673316200021,0.9076923076923077,1.0,1.0,1/5,18.29%,LZTFL1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.3885306670307853,0.7359953544522435,0.7878787878787878,0.995930620530142,1.0,3/10,14.21%,NAA50;NAA11;NAA16
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.3821824384607144,-0.7359390321232661,0.8356164383561644,1.0,1.0,1/27,2.65%,HAP1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.3676375037874183,-0.7356930500289557,0.9058823529411765,1.0,1.0,6/35,19.20%,GABARAPL2;ATG14;MAP1LC3B2;FUNDC2;CISD2;ULK1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.322211298857098,-0.735471387735552,0.9,1.0,1.0,7/77,9.68%,RPS27A;SFRP1;JUN;ARHGEF18;TGFB1;OVOL2;MEF2C
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.27155144154090793,0.7351924510164815,1.0,0.996591580929916,1.0,29/80,22.67%,BCAR1;CHST3;LAMC1;MPDZ;SH3D19;MAGI1;CACNA2D1;EGFR;ADCY6;SNX7;PTPRG;TENM3;FIGN;KITLG;NCKAP1;AMOTL2;FRMD6;TEAD1;SLIT2;PKDCC;AADAT;ERRFI1;FAT1;ENAH;LIFR;RBFOX2;CD276;ADGRL2;TJP1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.3920878825888612,-0.7351901379992867,0.9058823529411765,1.0,1.0,2/25,4.84%,USP6;RAB11A
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3353361390684521,-0.7351658898924306,0.9302325581395349,1.0,1.0,11/57,21.04%,SLC3A1;SLC38A4;SLC7A6;CEACAM1;SLC6A6;SLC7A14;ABCC3;SLC3A2;SLC7A8;SLC16A1;ATP8B1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.38273614876529877,-0.7349815939515171,0.8809523809523809,1.0,1.0,6/27,23.58%,TRPM3;SLC6A9;SLC3A2;SLC7A8;SLC36A4;SFXN3
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.4396777136125636,-0.7348475851381504,0.8208955223880597,1.0,1.0,3/7,22.37%,RNF8;MSH6;HSPD1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.307208234182797,0.7346737235914362,0.9230769230769231,0.9967451239690462,1.0,10/27,21.73%,EHD1;IFT140;BBS4;TCTN2;ODAD4;ARL3;INVS;WDR19;RAB29;TULP3
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.3263620510524572,-0.7344519075480365,0.9113924050632911,1.0,1.0,6/33,16.49%,SELENOK;GLUL;ZDHHC1;ZDHHC8;ZDHHC22;ZDHHC15
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.280367935074829,0.7344488426126555,0.9230769230769231,0.9964933894104955,1.0,8/72,9.46%,TAF1A;KAT2B;EED;KAT2A;TAF1B;HDAC4;BAZ1B;MECP2
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.4537152407414843,-0.7342010914977238,0.8405797101449275,1.0,1.0,2/7,19.61%,CHMP4B;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3502376218461914,-0.7341098650105842,0.8205128205128205,1.0,1.0,4/33,12.47%,VEGFA;TGFB1;STAT5A;P2RX4
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.4442620705942516,-0.733996341054639,0.8378378378378378,1.0,1.0,1/9,5.88%,TGFB1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.372258655604115,-0.7335991645347256,0.8,1.0,1.0,3/19,15.86%,HES1;MEF2C;COL4A1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4049985996274607,-0.733299354789717,0.8088235294117647,1.0,1.0,4/15,26.52%,SEMA4C;EIF2AK2;TAOK3;SCIMP
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.2480231382063474,0.7331482676587302,0.9090909090909091,0.9978411908877969,1.0,15/66,18.42%,GPSM1;SIRT1;TP53INP1;FOXO1;SESN1;DHRSX;MAP3K7;LRRK2;HMGB1;PRKD1;FOXO3;MID2;TPCN1;PINK1;PRKN
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.4492216952373672,0.7324420909089606,0.7608695652173914,0.9984692211203179,1.0,1/5,14.21%,NAA16
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.4679989017009652,-0.7321459754684065,0.8356164383561644,1.0,1.0,1/5,6.45%,MMP24
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4256309578199084,-0.7319606848162832,0.8695652173913043,1.0,1.0,3/13,12.64%,HAP1;GSTO1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.3369489889548045,0.7319459504891347,0.8571428571428571,0.9986314627366032,1.0,3/20,5.78%,PANX1;INAVA;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.30317698827833933,-0.7318861312507937,0.9292929292929293,1.0,1.0,19/165,13.77%,VEGFA;DDRGK1;FGF1;TMSB15B;ENPP2;PLET1;RAB11A;TGFB1;CEMIP;SEMA4C;KIF20B;HDAC6;XBP1;HAS2;FN1;ELP5;WNT5B;GRN;VIL1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3225795691245613,-0.7315136553828829,0.956989247311828,1.0,1.0,29/104,30.03%,PSMB9;RPS27A;PSMB8;APEX1;IGF2BP2;PSMA3;PSME1;UBA52;ZFP36L2;PSMA7;PSMB6;UBC;SET;DHX36;GTPBP1;PSMC4;HSPA8;ANP32A;PSMB1;SERBP1;PSMD2;EXOSC8;CNOT8;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4;PABPC1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.23277369642271528,0.7313115768534321,1.0,0.9987935206137988,1.0,39/270,12.25%,SYNDIG1;SNX31;ARFIP1;EVI5L;EHD1;CALCRL;PREB;ARL5A;CTSA;MYH9;PPARG;TBC1D14;TMED5;TVP23B;RAB31;SPTBN1;VLDLR;RABL2B;TBC1D12;SNX33;RAB10;TMED3;NSF;GGA1;SGSM1;DNAJC27;HERC2;LRP1B;ATP6V1A;RABGAP1;ZDHHC17;TBC1D1;SNX27;TBCK;KIF13A;RAB28;LMTK2;UNC119B;BLZF1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.47528709184597917,-0.7311320059785489,0.7868852459016393,1.0,1.0,1/6,12.74%,WNK3
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.37739873827618114,-0.7309946006597917,0.8571428571428571,1.0,1.0,3/21,18.23%,RARRES2;CLMP;CCDC39
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.41244621750112587,0.730871626323587,0.7741935483870968,0.9988039111841791,1.0,1/6,1.62%,ERC2
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.43660039858906086,0.7307243664202276,0.8421052631578947,0.9984812139632725,1.0,1/6,4.22%,PPP1R3D
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.3832636991841888,0.7304844099619763,0.8181818181818182,0.9983707192386833,1.0,5/7,32.46%,TOPBP1;NAE1;STK33;SETMAR;HUS1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.31275711380449117,-0.7301113021617632,0.8409090909090909,1.0,1.0,7/75,13.47%,FTH1;FTL;NAPA;AP2A1;SH3GL2;CLTA;DNM2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.327191788251356,0.7300947370577038,0.7777777777777778,0.9983410038348038,1.0,3/10,13.77%,ESR1;BMP7;NR3C1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.41687303548270466,-0.729813286812898,0.8666666666666667,1.0,1.0,7/11,31.48%,IL5;MYO1F;NR1D1;PSTPIP1;AOAH;SPI1;ITGAL
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3660535724390491,-0.7297171927792646,0.8795180722891566,1.0,1.0,8/33,21.22%,PFDN6;CLU;CRYAB;AZIN2;VBP1;APOE;HSP90AB1;AZIN1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.3787018073472626,0.7295195097686833,0.75,0.9986539099248194,1.0,3/6,16.40%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.342583865413086,0.7293769767665264,0.8787878787878788,0.9983018145024825,1.0,5/18,20.72%,AUTS2;PIK3CA;NCKAP1;PIK3R1;ARPC2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.34938187006900234,0.7289529576686902,0.875,0.9983929652369327,1.0,7/14,26.33%,ILRUN;MFHAS1;LATS1;SUFU;CHP1;OTUD7B;UFM1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.2815767530355363,0.7287344485173518,1.0,0.998142004620566,1.0,8/36,10.70%,NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPK3;MAPKAPK5;ERCC4
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.3833847814863549,-0.7285947277324318,0.7894736842105263,1.0,1.0,1/17,1.74%,VEGFA
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.3836178601722458,0.7284377247043505,0.7741935483870968,0.996948965361369,1.0,4/9,31.19%,TERF1;ERCC1;WRN;SLX4
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.3836178601722458,0.7284377247043505,0.7741935483870968,0.996948965361369,1.0,4/9,31.19%,TERF1;ERCC1;WRN;SLX4
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.3836178601722458,0.7284377247043505,0.7741935483870968,0.996948965361369,1.0,4/9,31.19%,TERF1;ERCC1;WRN;SLX4
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3629739081661527,-0.7283298576084248,0.85,1.0,1.0,2/24,10.36%,PFN2;PLEKHH2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.38961688510780124,-0.7280801893986096,0.8513513513513513,1.0,1.0,3/18,12.64%,VEGFA;TOM1L1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.4675396813815075,-0.728039827100923,0.8307692307692308,1.0,1.0,1/5,29.47%,SOD2
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.41868239080675507,-0.727984991731301,0.8309859154929577,1.0,1.0,4/14,9.38%,OVOL2;GGH;TMC4;CEACAM1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.37658287817335157,-0.7277549170405413,0.868421052631579,1.0,1.0,5/18,22.17%,PRPSAP1;PPAT;MTHFD1;DNPH1;GUK1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.3458628443151428,0.7277048771480162,0.8214285714285714,0.9975324065039954,1.0,7/15,28.05%,HMGB1;ACVR1C;BLCAP;HMGB2;DFFA;DFFB;DICER1
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.3965279432643867,0.727455218850643,0.6666666666666666,0.9967023134796937,1.0,1/5,9.78%,MSN
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.3965279432643867,0.727455218850643,0.6666666666666666,0.9967023134796937,1.0,1/5,9.78%,MSN
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.43277625754894844,-0.727440165867514,0.8,1.0,1.0,1/9,4.07%,IFI35
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.3788527592576362,-0.7273065063231725,0.8493150684931506,1.0,1.0,3/14,25.53%,PARP9;IFIH1;RUNX1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.3849122209377992,0.7271789676529361,0.8235294117647058,0.996403190803216,1.0,3/8,28.09%,ST3GAL4;ST3GAL2;PARN
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.3176132036519164,0.727109526791976,0.9166666666666666,0.9959341672445347,1.0,3/19,8.82%,ATP11C;ATP8A1;ATP10B
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.3564219077818761,-0.7269987210099651,0.8674698795180723,1.0,1.0,4/28,15.68%,RPS27A;CTSL;S100A1;UBA52
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.2760776849882715,0.7269889385397783,1.0,0.995585769406228,1.0,16/96,12.66%,LDB2;SEC24D;WFDC1;KAT2B;NOX4;SYNPO2;PDE4DIP;SMOC1;SLIT3;PRKG1;MSRB3;ADAMTS5;NF2;FBXL7;PRRX1;ZBTB44
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2860981271445593,0.7269730453882078,0.9411764705882353,0.9950477110164553,1.0,3/21,11.13%,SNF8;MVB12B;NEDD4
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.41180502846777656,-0.7264510955166849,0.821917808219178,1.0,1.0,3/13,9.17%,JPH3;GRIN2D;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.4160062692818968,-0.7263477893556728,0.8823529411764706,1.0,1.0,1/10,6.51%,LRPAP1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.4239849499955892,-0.7262506747312608,0.8767123287671232,1.0,1.0,2/13,9.68%,GRIN2D;MEF2C
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.3271498746534809,0.725983461054414,0.9565217391304348,0.9956499234579045,1.0,1/14,2.99%,ACADVL
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.41887391526895545,0.7258785641345047,0.8666666666666667,0.9951823721061548,1.0,2/7,17.03%,STXBP6;SNCA
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.44863686191726043,-0.7258348804147198,0.8732394366197183,1.0,1.0,2/9,13.60%,RANGRF;DCTN1
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.3765856115143652,0.7258101726525072,0.8055555555555556,0.994765273528794,1.0,3/8,24.33%,TOPBP1;RAD9A;NAE1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.44076760718723706,-0.7254717521844073,0.8658536585365854,1.0,1.0,2/7,9.59%,TGFB1;DND1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.34519050224165837,0.7253125837544672,0.8214285714285714,0.9949873815861153,1.0,4/15,13.52%,GDAP1;USP30;MFN1;MIGA1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.3005630929835696,-0.7252927598539824,0.95,1.0,1.0,63/328,23.92%,ROMO1;HES5;VEGFA;DDRGK1;SFRP1;SPDYA;FGF1;RPS9;RPL23;HES1;HMGN5;RTKN2;HTR2B;FLOT1;IL12RB2;TGFB1;FAM98B;KIF20B;DERL2;XBP1;NOXA1;HAS2;FN1;CDH3;OSMR;SLC6A6;EMP2;NCBP1;P2RX4;RPS4X;GRN;DVL2;SUPV3L1;TAF9B;CDKN2AIP;ZFHX3;SLC25A5;CHTOP;TSHR;HDGFL2;IL7;SAPCD2;RPS6;TFE3;HRAS;HSP90AB1;PTN;POFUT2;GAREM1;CLEC11A;MTLN;DBF4B;DNPH1;CAV1;TRIM32;BTC;RARA;NAMPT;COPS9;RHOG;CDK4;CIAO1;DHX36
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.2977964727610295,-0.725189091888201,0.9797979797979798,1.0,1.0,36/430,10.45%,ROMO1;HES5;OPRM1;FTH1;VEGFA;DDRGK1;SFRP1;SPDYA;FGF1;RPS9;RPL23;HES1;HMGN5;RTKN2;IFIT3;HTR2B;IFI35;IL12RB2;JUN;CLU;TGFB1;AGT;CDKN2C;FAM98B;IRF1;KIF20B;TMEM115;DERL2;XBP1;SFRP4;JAG1;SST;HAS2;FN1;STAT5A;OSMR
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3031697562135758,0.7251852645757535,0.8823529411764706,0.994580833030387,1.0,12/36,22.02%,NUP98;BIN1;NUP93;IRAG2;SUN2;CHMP1A;DMPK;ATXN7;LEMD3;NUP35;NUP54;SEH1L
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.32540320347227125,-0.7249378797386038,0.9058823529411765,1.0,1.0,10/53,20.86%,MBNL3;AGRN;LAS1L;TEAD3;HDGF;GIPC1;SAPCD2;HNRNPAB;PPP1R14B;TMEM54
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.3761908702261934,0.7248335103631491,0.8,0.9944439061086311,1.0,3/9,20.53%,SMDT1;MCU;MICU3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.39017379679144404,0.7246687099074209,0.78125,0.9940381149915345,1.0,5/5,61.00%,HSF1;NUDT16L1;CYREN;TFIP11;ERCC6
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.38248941219707133,-0.7245324911880623,0.8860759493670886,1.0,1.0,3/21,8.27%,VEGFA;HES1;TTN
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.47346768271113676,-0.72388766124206,0.8333333333333334,1.0,1.0,1/5,10.10%,MED1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.4213615666640806,-0.723879268906995,0.8823529411764706,1.0,1.0,1/10,7.22%,YBX3
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.33199383555775325,0.7237747657190033,0.88,0.9946484964675597,1.0,1/12,3.21%,FARS2
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.40637447913249847,0.7235033563016158,0.7741935483870968,0.9943525211916008,1.0,3/8,21.54%,PNP;AMPD2;HPRT1
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2734522730202469,0.7233774895545343,0.9285714285714286,0.99395740652896,1.0,10/49,17.30%,ATF7IP;MED24;MECP2;CBFB;TRIM28;MOV10;PPM1D;SUB1;TCF7L2;MED13
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.4598886077860507,0.7232620767823964,0.8,0.9936223804654729,1.0,2/5,9.03%,TGFBR2;TWSG1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.37860009104334347,0.7227580721937292,0.8125,0.9937447769517174,1.0,4/15,19.03%,SIRT1;FBXW5;CHMP1A;NPM1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.3493299446489081,0.7224403336532492,0.84,0.9936684306369098,1.0,1/15,2.50%,CEP120
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3889916695994688,0.722435221018688,0.71875,0.9931157785620284,1.0,3/9,12.01%,DOCK5;PRKG1;DOCK4
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.3770228458154823,0.7216850037412148,0.8148148148148148,0.9935060733474077,1.0,3/10,13.71%,H6PD;RPE;RPIA
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.3823503286713765,0.7215468632264079,0.71875,0.9932019699875744,1.0,1/6,5.43%,CAT
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.3541583504016005,0.7210966940292473,1.0,0.9932846270090454,1.0,4/25,7.14%,FNBP1L;FCHSD2;SGIP1;PICALM
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.3641372155735904,-0.7209289366684668,0.8441558441558441,1.0,1.0,5/27,20.88%,ANKRD53;DCTN1;CHMP4B;TACC3;EML3
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.3053658785217855,-0.7208652437798293,0.9479166666666666,1.0,1.0,18/164,17.49%,TUBB4B;SPDYA;TUBA4A;CDKN2C;CCNI2;MAX;CAMK2A;CEP72;CDK7;DNM2;DCTN1;CRLF3;TUBB4A;CTDP1;ODF2;CHMP4B;SKP2;DCTN3
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.35595681930950224,-0.7206704790316153,0.9078947368421053,1.0,1.0,4/24,18.38%,ITGA4;SLC25A5;BLNK;SYVN1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.39123663204822934,0.7202211954936348,0.8064516129032258,0.9938029144029337,1.0,3/7,14.90%,MAGI2;RAPGEF2;RAP1A
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.4441176470588234,0.7201116961013052,0.7804878048780488,0.9933803850068903,1.0,5/5,55.60%,PARN;TENT4B;DIS3L2;SND1;TUT4
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.4766089326721742,-0.7201046148427043,0.85,1.0,1.0,1/5,10.49%,PIK3CB
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.4725383460305752,-0.7200375092954842,0.8676470588235294,1.0,1.0,1/5,18.63%,HRAS
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.30096013657993087,-0.7200314027635979,0.979381443298969,1.0,1.0,26/221,15.68%,GADD45B;RPS27A;SFRP1;TFPT;VAV3;ECT2;STK17A;RASGRF2;JUN;ARHGEF18;CLU;OLFM1;SFRP4;PTRH2;OBSCN;APH1A;BTG1;PDCD5;ITGB3BP;DNM2;GRN;MTCH1;PTPA;ATF4;RACK1;UBA52
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.35756784606313563,-0.7196593808747379,0.9,1.0,1.0,4/29,14.07%,ALOX5;ALOX12;EPHX2;LPCAT3
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.32684359854137957,-0.7196034368670059,0.9318181818181818,1.0,1.0,7/82,8.17%,ELOB;DDRGK1;RPL11;DVL1;CLU;TRIB1;ARIH2
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.39961936399929054,-0.7191559963369807,0.8961038961038961,1.0,1.0,4/20,17.10%,CAMK1;MEF2C;KIF1A;APOE
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.32780530198034624,-0.7191293219009491,0.8850574712643678,1.0,1.0,14/74,22.91%,TAF7;DVL1;CDKN1C;TRIB1;CEACAM1;SH3BP5L;RTRAF;WARS1;ADAR;TRIB3;GSTP1;CAV1;THY1;PARK7
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.4294629006794853,-0.7191280326884981,0.8285714285714286,1.0,1.0,5/10,42.31%,APOE;WDR45B;ATG10;WDR45;WIPI1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.43052896980543526,-0.7191119288411403,0.8607594936708861,1.0,1.0,2/11,9.17%,CACNA1G;CACNA1C
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.4177918403126492,0.718989188990757,0.7428571428571429,0.9927516090373766,1.0,1/5,10.60%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.4177918403126492,0.718989188990757,0.7428571428571429,0.9927516090373766,1.0,1/5,10.60%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.4177918403126492,0.718989188990757,0.7428571428571429,0.9927516090373766,1.0,1/5,10.60%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.4177918403126492,0.718989188990757,0.7428571428571429,0.9927516090373766,1.0,1/5,10.60%,EXOSC7
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.341456823460127,-0.7184457306195289,0.9066666666666666,1.0,1.0,6/35,18.56%,RPL11;RPL23;CLU;MAGEF1;RPS7;RPL5
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.3554837995882723,-0.7184324180901608,0.9,1.0,1.0,3/25,10.78%,KIF20B;IGSF10;CAMK2A
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.36882543596792117,-0.7182634657621157,0.8536585365853658,1.0,1.0,3/29,13.47%,MX1;SNCB;DNM2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.3674638111872093,0.718211251583504,0.8421052631578947,0.9933474305583753,1.0,2/16,4.22%,IRS1;PPP1R3D
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.36721654629250466,-0.717521218361832,0.868421052631579,1.0,1.0,8/20,34.17%,HOOK2;KIF1A;MAP6;TUBA1B;CCDC186;TUBB;TUBA1A;HOOK3
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.34924955620105563,0.7172516703504433,0.8928571428571429,0.9940905601901239,1.0,2/14,5.57%,GLS;FPGS
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.3901103949370717,-0.7170177535486735,0.9176470588235294,1.0,1.0,2/22,5.01%,MYRIP;CFTR
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.45216968225876963,-0.7168793876828166,0.8656716417910447,1.0,1.0,3/6,35.66%,MT3;PRKCB;PRKD2
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.44106843154794545,-0.7168290441573731,0.8923076923076924,1.0,1.0,2/8,10.00%,HDAC6;ECSIT
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3492242944632222,-0.7164890307591625,0.8354430379746836,1.0,1.0,1/23,1.74%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.43117765832658794,-0.7164836116908228,0.8157894736842105,1.0,1.0,6/10,35.66%,CD226;NECTIN2;TESPA1;CD81;RPS3;PRKD2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.39897546715860377,-0.7164179082985618,0.7875,1.0,1.0,1/11,5.49%,ICMT
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3241730366459524,0.7162918203367616,0.9090909090909091,0.9941455908911998,1.0,1/18,1.82%,RPA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3241730366459524,0.7162918203367616,0.9090909090909091,0.9941455908911998,1.0,1/18,1.82%,RPA1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.34722757016782574,-0.7162063528401721,0.8705882352941177,1.0,1.0,4/41,11.38%,DVL1;BDNF;GPC3;CEP72
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.4126682201821774,-0.7161583559249883,0.8717948717948718,1.0,1.0,5/14,26.10%,PTTG1IP;ATRAID;RDX;VPS35;WDR91
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.31519481323095,-0.7160672172895237,0.967391304347826,1.0,1.0,9/109,8.51%,EMD;ECT2;CAMK1;TGFB1;ZIC1;CEMIP;KIF20B;ARIH2;UBL5
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.3623445197586492,0.715840270034481,1.0,0.9942469216179204,1.0,3/14,8.10%,SIRT1;FOXK1;RORA
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.42963506387984396,-0.715814399293963,0.8387096774193549,1.0,1.0,4/8,30.82%,GNE;NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.260891160455145,0.7157036520575473,1.0,0.9938658486426429,1.0,4/41,5.78%,SPRED2;KAT2B;FER;HSPB1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.32910525399126467,-0.715543797832823,0.8554216867469879,1.0,1.0,10/42,29.72%,ABRAXAS1;DONSON;FZR1;RPS27L;BRCA1;TAOK3;BRCC3;NEK11;MDC1;CCND1
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.31871816605463366,-0.7154603026893286,0.9787234042553191,1.0,1.0,26/102,29.83%,PSMB9;PSMB8;BTN3A1;EIF2B2;HLA-A;PIK3CB;PSMA3;PSME1;BTN3A3;BTNL2;PRKCQ;PSMA7;PSMB6;RFTN1;THY1;FYB1;PSMC4;PSMB1;PSMD2;PSMB3;EIF2B5;PSMC3;PSMC5;PSMD7;PSMA4;DENND1B
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.4221651366373035,-0.715418468397321,0.8676470588235294,1.0,1.0,1/11,3.58%,POLE3
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.39458341080896564,0.7153657882695736,0.8,0.9937114529383392,1.0,1/8,1.66%,GCNA
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.4434579339433085,-0.7153038240143192,0.8378378378378378,1.0,1.0,1/11,15.40%,ATF4
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.2702342862006167,0.7151667837197965,0.9166666666666666,0.993449077057795,1.0,21/66,19.62%,RANGAP1;EVI5L;TBC1D14;TBC1D12;SGSM1;ARHGAP42;RABGAP1;TBC1D1;TBCK;TIAM2;ARHGAP22;TBC1D8B;SIPA1L1;CORO1C;RABGAP1L;RALGAPA2;TBC1D5;RALGAPA1;RALGAPB;TBC1D9;TBC1D7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.33407860538174616,-0.7151274005188422,0.8571428571428571,1.0,1.0,5/36,15.72%,RANGRF;WNK3;PLS1;ZDHHC8;AKAP5
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.41590164075526503,-0.7148724101445121,0.796875,1.0,1.0,1/12,8.61%,RNF8
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.3698224495693636,-0.7145822235205116,0.9102564102564102,1.0,1.0,3/21,15.18%,PRELP;OMD;OGN
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.40158151731544894,-0.7143301305541874,0.8641975308641975,1.0,1.0,5/18,19.73%,RPS21;KRI1;NOP14;WDR12;ERI2
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.43116955543615754,0.714328334113969,0.7380952380952381,0.9938453611004313,1.0,2/5,30.23%,CTNNBIP1;CSF1
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.4286913902630465,-0.7141658480928553,0.8666666666666667,1.0,1.0,1/8,17.28%,HADHA
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.4919321402141071,-0.7138651016671941,0.8382352941176471,1.0,1.0,1/5,11.33%,EFNA1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.2461143005580168,0.7138431450529127,0.9166666666666666,0.9941135356321036,1.0,15/99,14.07%,BAIAP3;WDR81;VTI1A;SNF8;RAB9A;EPS15;AP1G1;GGA1;PIKFYVE;ERC1;LMTK2;VPS50;WASHC1;MON2;ARFRP1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.38862348708941746,0.7138059521728918,0.9354838709677419,0.993625612238552,1.0,4/10,15.39%,ROBO1;PKD2;ROBO2;ADAMTS9
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.3330932590348793,-0.7135705509784361,0.9047619047619048,1.0,1.0,9/36,27.99%,UVSSA;RRH;USF1;MSH6;TRIM32;CIRBP;CDKN2D;SLC24A1;DDB2
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.3225510466980993,-0.7133057009513663,0.9518072289156626,1.0,1.0,9/66,19.31%,GSTK1;PIPOX;PEX1;EPHX2;PRDX5;FADS2;DIO2;IDI1;NUDT12
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.3042325533218338,-0.7129766936880226,0.9484536082474226,1.0,1.0,28/218,20.85%,PSMB9;RPS27A;COPS6;TFPT;PSMB8;USP6;CFTR;MBD6;ABRAXAS1;COPS5;USP18;PSMA3;TADA3;USP28;PSME1;USP50;UBA52;TAF9B;USP4;USP19;SKP2;OTUD6B;PSMA7;TOMM20;PSMB6;BRCA1;UBC;IFIH1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.4577191828074555,-0.7129705583598611,0.9054054054054054,1.0,1.0,2/6,20.49%,SHMT1;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.3169277382018451,0.7129611427155984,0.9230769230769231,0.9943448831127142,1.0,9/26,18.22%,FBXW7;NOX4;RELN;TGFA;SRCIN1;ADAM17;FYN;DOCK3;GRM5
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.31705139781086583,-0.7125723765077119,0.9659090909090909,1.0,1.0,9/89,12.76%,CD63;M6PR;SSPN;NAPA;ZW10;TOM1L1;SH3GL2;ARFGAP3;CLTA
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.3634905636288561,-0.7124340850911931,0.8356164383561644,1.0,1.0,9/19,41.70%,DND1;CIRBP;PABPC1;DHX34;YBX1;MEIOC;EIF4ENIF1;TENT5A;PAIP1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.4289148922266517,0.7123703114486306,0.75,0.9938701619146941,1.0,2/6,16.38%,GABRB1;DIAPH1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.4289148922266517,0.7123703114486306,0.75,0.9938701619146941,1.0,2/6,16.38%,GABRB1;DIAPH1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3425004210832583,-0.7121824072383546,0.9113924050632911,1.0,1.0,6/34,20.43%,FANCB;POLQ;MAGEF1;TERF2IP;CGAS;MMS19
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3075582132406992,0.7120401177571537,0.9545454545454546,0.9937262358335454,1.0,4/25,10.40%,MYO7A;ZKSCAN3;CLVS2;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.38034101118372643,-0.7119757688289041,0.8354430379746836,1.0,1.0,2/24,4.71%,RPS2;GORASP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.30831065674270214,0.7119337014453612,0.9444444444444444,0.9932985953379211,1.0,8/37,16.49%,PRR5L;YTHDF1;FTO;MOV10;TOB1;RIDA;CELF1;ZC3HAV1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.25011052563666075,0.7118887032870443,1.0,0.9928127237429746,1.0,11/95,9.70%,LDB2;BARD1;SLC2A6;SIRT1;FER;HSPB1;NUP98;EGFR;BMP7;NUP93;PML
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.3148396810521999,-0.7118743357626095,0.978494623655914,1.0,1.0,23/102,25.90%,NOSTRIN;FGF1;FILIP1L;CRYAB;PAMR1;MEF2C;FN1;SMARCA5;COL15A1;COL6A1;LMOD1;ACTA2;COL4A1;PTN;MYLK;RASD1;THBS2;CALD1;THY1;COL14A1;COL4A2;PDGFRB;RHOJ
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.29288343284491036,-0.7117313581643854,0.9587628865979382,1.0,1.0,16/224,9.33%,B2M;OPRM1;FTH1;SFRP1;EMD;CDKN1C;HES1;IFIT3;IFI35;TRIB1;TGFB1;CDKN2C;IRF1;TMEM115;SFRP4;SST
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.39992375464481156,0.71160209646935,0.8181818181818182,0.9925522779928417,1.0,2/6,23.14%,PIK3R1;PTK2
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.4477557686279784,-0.7116005049177385,0.7571428571428571,1.0,1.0,3/6,25.97%,FUCA1;FUCA2;GUSB
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.31124456557099084,0.711355217016666,1.0,0.9923507532162336,1.0,7/45,11.28%,RYBP;ZFYVE19;YAF2;RNF2;BMP7;EED;TOM1L2
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.26514796726623535,0.7112370569248194,1.0,0.9919541036607722,1.0,8/50,12.30%,NEDD4L;UBE2G1;HACE1;UBE2D1;UBR5;UBE2E2;UBE2H;UBE2E3
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.42061510467465096,-0.71113390164465,0.9342105263157895,1.0,1.0,4/15,23.58%,SLC22A4;SLC6A6;SLC7A8;SFXN3
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.4211472037488593,0.7110462247546516,0.8148148148148148,0.9917043169688223,1.0,3/8,23.29%,METTL4;WRNIP1;WDR18
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.3726371551101503,-0.7110258920789696,0.8875,1.0,1.0,9/22,28.81%,RPS27A;DERL2;UBA52;SYVN1;UBC;MAN1A1;TRIM13;OS9;EDEM2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.35449227062651784,-0.7107382097765661,0.8421052631578947,1.0,1.0,7/26,24.08%,SNRPB;CSTF2;NCBP1;CSTF1;SNRPG;CPSF1;SLBP
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3746996847559768,0.7104688463463903,0.88,0.9919328762712152,1.0,1/9,4.78%,SIRT1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.45785659106337206,-0.7101088707851663,0.9305555555555556,1.0,1.0,1/8,15.40%,ATF4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.40117957184288283,-0.709960115874082,0.8194444444444444,1.0,1.0,1/11,7.22%,YBX3
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.40733356257876074,-0.7098444731729687,0.918918918918919,1.0,1.0,6/16,24.98%,ZFAND2B;SPCS2;SEC61G;SRP14;SRPRA;MAN1A1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.38520421153776313,-0.7097443097171722,0.9047619047619048,1.0,1.0,4/25,12.62%,CFAP61;DNAH17;DNHD1;CFAP251
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.3771901325665244,-0.7092257363780433,0.8888888888888888,1.0,1.0,7/25,22.31%,LETM2;SLC12A4;SELENON;COX11;WFS1;SLC7A8;CAV1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.3426085477739991,-0.7083745722566143,0.891566265060241,1.0,1.0,5/36,13.05%,ALOX5;HTR2C;CACNA1C;CACNA1E;CACNA2D2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.3244861125375975,0.708034004155639,0.8095238095238095,0.9944917362985165,1.0,2/13,12.71%,ATP2B4;RTF2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.31684498178431736,0.7079095548848587,0.875,0.9940558002389788,1.0,7/17,14.90%,ZFYVE27;BCAR1;MAGI2;FRS2;RAPGEF2;SOS1;RAP1A
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.3158338973346673,-0.7078393241318225,0.9195402298850575,1.0,1.0,8/52,17.31%,RANGRF;TGFB1;WNK3;PLS1;TMBIM1;ZDHHC8;AKAP5;PPP2R5A
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.3215636039165514,-0.7077725838974692,0.9058823529411765,1.0,1.0,7/45,19.44%,NOP10;PUS3;ELP5;NSUN5;ADAR;QTRT1;QTRT2
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.3063042292800087,-0.7077271436292419,0.9693877551020408,1.0,1.0,21/116,18.94%,NPM2;RBM3;CLU;ATAD5;LDB1;CDH3;P2RX4;RPS4X;SLC6A9;SREBF1;UPF3B;BRPF3;GIPC1;UPF3A;NSUN5;RPS27L;PLXNB2;RPL5;NR1D1;HSP90AB1;PCIF1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.4350487351681004,-0.7077068989225697,0.8421052631578947,1.0,1.0,3/8,17.10%,OLFM1;DNM2;APOE
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.40063632006398014,-0.7076469402657383,0.8461538461538461,1.0,1.0,2/10,17.46%,MPDU1;B3GALT5
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.40063632006398014,-0.7076469402657383,0.8461538461538461,1.0,1.0,2/10,17.46%,MPDU1;B3GALT5
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.3578116047875567,-0.7074654539011067,0.875,1.0,1.0,6/22,26.44%,ENKUR;STIL;CCDC39;PKD1L1;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.30341860785448116,0.7071364046585982,0.7391304347826086,0.9944385514929199,1.0,3/19,12.04%,WDR81;SNF8;LMTK2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2893757885361547,-0.7069060947676427,1.0,1.0,1.0,82/576,20.49%,PLAG1;ESRRB;ETV4;BEX1;VEGFA;TAF7;RPS27A;DDRGK1;H2AZ1;PLSCR1;FGF1;DVL1;HES1;AGRN;DBP;GALR1;LAGE3;CREB3;APEX1;CAMK1;JUN;HAX1;TGFB1;COPS5;IRF1;MAFF;ZFPM1;CHCHD2;XBP1;LDB1;MOSPD1;MLX;JAG1;MAX;KDM6B;MEF2C;MED1;PRPF6;SMARCD1;CEBPZ;GTF2F1;NLRC5;CDK7;SMARCA5;LMO2;GLIS3;ELK3;ZBED3;CKAP2;DVL2;CRLF3;NR5A2;SREBF1;SS18L2;ATF4;BTBD18;UBA52;ZFHX3;RUNX2;RTRAF;USF1;ZBED4;NR4A3;ATAD2;STAT1;SSBP4;HDAC3;TFE3;ZBTB49;PELP1;HRAS;NR1D1;HNF4G;FIZ1;DRAP1;KAT5;SALL2;CCNC;CCNK;PAXBP1;NFIC;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4346939252866858,-0.7068643129431688,0.8181818181818182,1.0,1.0,3/10,18.63%,HAX1;BAIAP2L2;HRAS
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.43457138916350374,-0.7068227833210283,0.9178082191780822,1.0,1.0,1/9,3.37%,RPL11
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.3623529505273345,0.7065906863334468,0.7777777777777778,0.994665120357924,1.0,4/8,17.76%,BIN1;CACNA2D1;NOS1;SESTD1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.3048766642957491,-0.7065655073009487,0.9574468085106383,1.0,1.0,15/101,18.26%,HES5;DHX37;HAP1;ZIC1;TUBGCP2;GRIN2D;DNAJC30;B3GNT5;DDIT4;APOD;COL4A1;ZFHX3;UTP3;PLXNB2;UFC1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.38622629244592505,0.7065107955931779,0.8148148148148148,0.9942200728605962,1.0,3/7,18.28%,NRXN1;AGTPBP1;MYCBP2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.33174540832659216,-0.706309233679787,0.8837209302325582,1.0,1.0,4/52,7.01%,ECT2;ANKRD53;RAB11A;KIF20B
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.30558195482897044,0.7057414257249237,0.9047619047619048,0.9946799063389645,1.0,6/18,11.27%,MAPK1;TNKS;MAP3K4;MAPK3;MAPKAPK5;HNRNPD
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.4358199389265571,-0.7056311494526512,0.78125,1.0,1.0,2/7,29.05%,IFNAR1;AXL
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.3657791563428734,-0.7056257559347263,0.8536585365853658,1.0,1.0,2/29,5.01%,SFRP1;CFTR
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.4289170644577105,-0.7056022237016619,0.9152542372881356,1.0,1.0,3/6,29.97%,DCTN1;HSPA8;APP
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.4306733619494276,-0.7055042615323631,0.863013698630137,1.0,1.0,2/8,4.72%,FLOT1;CAMK1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.3998820178196755,-0.7054149025186647,0.8309859154929577,1.0,1.0,1/12,5.16%,RARRES2
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.27061997461832343,0.705351103455529,1.0,0.9946727081636295,1.0,6/44,13.45%,KANSL3;ZZZ3;CHD5;JADE3;KAT8;MCRS1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.3901756692029982,-0.7053001478276562,0.8441558441558441,1.0,1.0,6/14,15.29%,LDB1;NABP2;NLRC5;EMP2;PPP1R3F;PARP4
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.41850469493835063,0.7051567780154747,0.7857142857142857,0.9937942508215275,1.0,1/5,7.69%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.41850469493835063,0.7051567780154747,0.7857142857142857,0.9937942508215275,1.0,1/5,7.69%,SNF8
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.2880308703386761,0.7050664743473931,0.9375,0.9933411833709628,1.0,4/26,7.00%,HSPA1A;HNRNPLL;PRDX6;NUP98
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.23937035941833051,0.7048130105670738,1.0,0.9931504614435503,1.0,16/67,20.15%,RACGAP1;SCYL1;COG3;KIF15;TMED3;NSF;KIF3C;COG7;GBF1;KIF1C;STX18;NBAS;COPB2;KIF5A;KIFAP3;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.455713928389067,-0.7047503486042747,0.9054054054054054,1.0,1.0,1/6,5.88%,TGFB1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.33692351131505904,-0.7046769095415031,0.9213483146067416,1.0,1.0,5/49,12.10%,POLR2I;FGF1;POLR2G;GTF2F1;NCBP1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.4002170133282184,-0.7043778070395387,0.8787878787878788,1.0,1.0,2/13,7.50%,HTR2B;HTR2C
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.31064904877671695,-0.7043114751444222,0.9375,1.0,1.0,18/123,20.52%,ESRRB;VEGFA;DVL1;ENPP2;CAMK1;TLE6;XBP1;KRT10;SLC6A6;ZBED3;VIL1;DVL2;ZDHHC15;APOE;HSP90AB1;DNM1L;PTN;RBM19
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.3400776354549363,0.7042531744598269,0.8571428571428571,0.9931828855603803,1.0,3/14,14.85%,ROBO1;GPR174;LPAR1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.36791474973991833,0.7040594901551611,0.8529411764705882,0.9928858916082015,1.0,2/8,8.27%,SH3D19;SNX33
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.33374888988629414,-0.7039626219805171,0.8977272727272727,1.0,1.0,9/45,18.76%,ALOX5;SELENOS;FNDC4;CACTIN;LPCAT3;METRNL;TNFAIP6;APOE;NR1D1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.4035884178913645,-0.7038936297390381,0.8823529411764706,1.0,1.0,4/13,25.98%,DNAJC30;ANTKMT;TMSB4X;SPHK2
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.48430466808321615,-0.7035098066530006,0.8493150684931506,1.0,1.0,1/5,13.13%,ALKBH2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.309575233063051,0.7034563382124316,0.85,0.9931992158614137,1.0,2/24,3.31%,ZFAND6;GDAP1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.40201612549585547,-0.7031775967365966,0.8333333333333334,1.0,1.0,7/13,24.27%,RPL11;RPL23;RPS7;RPL5;USP44;PARK7;DTX3L
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.3972469993286778,0.7029629748340288,0.7878787878787878,0.9934154280437119,1.0,1/6,4.85%,GLS
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.2645573386807714,0.7029434184139988,0.9473684210526315,0.9928866634762225,1.0,17/47,20.17%,ABL1;SYNPO2;FER;FCHSD2;CDC42EP4;BIN1;PROX1;P2RX7;NRP1;CDC42EP1;NCKAP1;PRKCE;CRACD;SEMA5A;PTK2B;TENM1;CFL2
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.3524016103919963,0.7028505081230455,0.8378378378378378,0.9923874720031062,1.0,3/12,9.66%,CD247;GPR174;PTPRC
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.3616311948983286,0.7026447186933864,0.8285714285714286,0.992062728175584,1.0,4/14,13.03%,TOB2;FMN2;USP9X;DIAPH2
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.37911132917966034,-0.702612315736756,0.9,1.0,1.0,5/15,27.97%,GGH;SHMT1;MTHFD1;MTRR;ALDH1L2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.3455462613340346,0.702057095316961,0.7857142857142857,0.9922790873486597,1.0,3/10,10.51%,RAD18;PUM2;SMC6
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.42430946869301744,0.7017119770664269,0.8,0.9910371992756924,1.0,3/5,25.05%,NSMCE2;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.42430946869301744,0.7017119770664269,0.8,0.9910371992756924,1.0,3/5,25.05%,NSMCE2;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.42430946869301744,0.7017119770664269,0.8,0.9910371992756924,1.0,3/5,25.05%,NSMCE2;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.33938515157779614,-0.7016178766330281,0.9431818181818182,1.0,1.0,6/67,8.17%,ELOB;DDRGK1;DVL1;CLU;TRIB1;ARIH2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.4267984165479862,0.7015120849705399,0.88,0.9908007800707933,1.0,1/5,6.94%,FOXP1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.3039635064871129,-0.7006506450180672,0.9,1.0,1.0,12/69,21.07%,NACA;ICMT;ZDHHC24;ZDHHC1;CHMP4B;ZDHHC22;ZDHHC15;SRP14;ATAD1;GOLGA7B;PEX11B;PEX14
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.29215893463227505,0.7004589846305803,0.9444444444444444,0.9914217057820917,1.0,3/26,8.63%,H2BC5;UBN1;RSF1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.30415145797724974,0.7002366739673053,0.9545454545454546,0.9910698338908889,1.0,5/21,18.01%,KDM3B;KDM5A;JMJD1C;KDM4C;RIOX2
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.42076577488467454,-0.6994019469501124,0.8472222222222222,1.0,1.0,2/8,9.86%,MEF2C;SLC24A5
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.41845671387384464,-0.6988299087955252,0.8805970149253731,1.0,1.0,1/8,15.48%,BTBD18
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3478541784983884,-0.6986823835970448,0.9302325581395349,1.0,1.0,3/39,8.27%,MYRIP;TGFB1;TTN
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.29036220383693784,0.6985648453310792,0.8947368421052632,0.9925653504313587,1.0,7/33,19.02%,SYNJ1;MTMR10;MTMR3;OCRL;MTM1;PLPP2;MTMR8
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.27509381057955545,0.6984001821945692,0.875,0.992242085491778,1.0,4/38,10.17%,ATR;ABL1;MAPK14;INTS7
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.3443931407605118,0.6983518136027242,0.8846153846153846,0.9917750265373835,1.0,6/13,11.27%,MAPK1;TNKS;MAP3K4;MAPK3;MAPKAPK5;HNRNPD
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.415625816892339,0.6982284448577999,0.8181818181818182,0.9914237220126012,1.0,1/6,4.91%,PPARG
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.32324822349692284,-0.6981251676808855,0.9425287356321839,1.0,1.0,4/54,10.78%,ARHGAP15;VAV3;RAP1GAP;CAMK2A
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.4127627488402661,-0.6980352025015801,0.8395061728395061,1.0,1.0,2/8,20.49%,SHMT1;MTHFD1
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.29920324918299157,-0.6977796812304987,0.9555555555555556,1.0,1.0,35/134,24.78%,H2AZ1;CDKN2C;PNN;ZW10;RFC2;SNRPB;SMC1A;RPA3;LUC7L3;H2AX;DONSON;NOP56;CBX5;KIF18B;RFC1;SHMT1;ATAD2;GINS3;TACC3;NUP107;PAICS;CDKN2A;LIG1;BRCA1;KIF22;RFC3;POLD2;CTCF;NAA38;CDK4;SRSF2;SLBP;STMN1;ILF3;PSIP1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.24931948871054743,0.697630228926982,0.8333333333333334,0.9917063386695071,1.0,34/153,18.28%,GPNMB;EPHA3;ERBB4;LEPR;RYK;ABL1;SEMA4D;SIRT1;MERTK;IGF1R;WDFY2;EGFR;ZBTB20;MAPK3;ROR2;CHRNA7;LRRK2;PLAUR;PELI2;P2RX7;LMTK2;NRP1;ADAM17;VEGFD;RAP2A;ZNF16;FLT1;SLCO3A1;PINK1;BCL10;DSCAM;EPHA7;RALB;AKT2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.338107165159624,-0.6975520572809994,0.9523809523809523,1.0,1.0,4/34,12.96%,POLE3;H1-4;SMARCA5;H2AX
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.37314066379019717,-0.6974715598769312,0.8461538461538461,1.0,1.0,4/17,22.91%,TMBIM1;RFFL;BRCA1;PARK7
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.4141315013900375,-0.6974630606651108,0.8985507246376812,1.0,1.0,1/8,3.94%,PAH
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.35254788823436595,-0.6974197020575866,0.8674698795180723,1.0,1.0,9/26,32.15%,XBP1;MAPK13;IFIH1;HSPD1;SPHK2;SCIMP;C1QTNF4;APP;WNT5A
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.32709041168551545,-0.6970233577380381,0.9259259259259259,1.0,1.0,13/46,21.06%,ITGA4;ECT2;OVOL2;KIF20B;TMC4;CEACAM1;CDH3;CKAP2;NRP2;POF1B;CDKN2A;BRCA1;PROM1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.33304774730811904,-0.6969418830578091,0.9418604651162791,1.0,1.0,6/61,8.17%,ELOB;DDRGK1;DVL1;CLU;TRIB1;ARIH2
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.41791443850267374,0.696606807247122,0.8666666666666667,0.9923915985574738,1.0,5/5,58.22%,NFKB1;SLC30A10;ROCK1;ROCK2;RELA
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.3160730711793176,-0.6966064616603169,0.9325842696629213,1.0,1.0,4/57,6.51%,HLA-F;HTR2B;CLU;LRPAP1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.356017702055941,0.6964342968551316,0.8214285714285714,0.9920788843312718,1.0,6/12,20.21%,ADAM10;ADAM19;ADAM17;ACHE;TMCC2;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.42355897891743277,0.695893865938998,0.825,0.9921402692825467,1.0,1/5,13.30%,RNF128
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.3698165848998203,-0.6957847214089625,0.8846153846153846,1.0,1.0,2/17,10.33%,TGFB1;APH1A
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.37756789074072006,-0.6954200420239329,0.8169014084507042,1.0,1.0,3/15,19.72%,YBX3;WNK3;MYLK
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.280781024062623,0.6951215776356459,1.0,0.9926134651163824,1.0,13/38,18.53%,IGSF11;DSCAML1;SDK2;ROBO1;NECTIN3;PALLD;CDH13;ROBO2;TENM3;CDH2;CDH4;DSCAM;CADM1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.44125896490254357,-0.6951145408392868,0.9393939393939394,1.0,1.0,1/6,5.73%,PEX1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.44125896490254357,-0.6951145408392868,0.9393939393939394,1.0,1.0,1/6,5.73%,PEX1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.3636229934560158,-0.6945169397395728,0.8875,1.0,1.0,3/22,18.80%,ANKRD53;DCTN1;STMN2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.3205565619238229,-0.6944435041050266,0.896551724137931,1.0,1.0,11/47,22.74%,SFRP1;YBX3;HAS2;CACTIN;ADAMTS7;ZFP36L2;ASAH1;NR1D1;BRCA1;CASP3;TRIM32
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.3014164767371326,-0.6943952885528091,0.9659090909090909,1.0,1.0,5/114,6.14%,ESRRB;ITGA4;SFRP1;HES1;ZIC1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.39222797609800564,-0.6941433618377212,0.88,1.0,1.0,9/17,37.35%,EIF3I;EIF2D;EIF2S3;EIF4B;RBM4;DHX29;EIF2S2;EIF5;MCTS1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.3520822832703916,0.6933385027008053,0.9090909090909091,0.99419666659793,1.0,1/9,6.95%,SLC29A4
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.4267264139988589,-0.693245607820736,0.85,1.0,1.0,1/7,8.89%,JAG1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.36969047912836184,0.6932066162965199,0.88,0.993787972628353,1.0,1/10,8.39%,UBN1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),-0.4571419887957578,-0.6932037138675305,0.8235294117647058,1.0,1.0,1/5,4.54%,TMEM25
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.4101368952551371,0.693062438741776,0.8571428571428571,0.9933701535713767,1.0,4/6,19.03%,PPM1F;DUSP26;CORO1C;NPM1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.39843095936729456,-0.6927093352764568,0.855072463768116,1.0,1.0,2/11,32.09%,ADAR;MRPL44
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.3118637799759434,-0.6925777618949374,0.9325842696629213,1.0,1.0,12/70,22.74%,RIMS1;SFRP1;DERL2;BDNF;NCBP1;SUPV3L1;TAF9B;CDKN2AIP;HDGFL2;SYT4;DNPH1;TRIM32
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.283338115004604,-0.6924102975754584,0.9897959183673469,1.0,1.0,36/258,20.79%,ESRRB;ELOB;POLR2I;TAF7;POLR2G;NFE2L3;TAF11;DDX5;XBP1;SNRPB;MED1;TEAD3;NABP2;CSTF2;GTF2F1;CDK7;NCBP1;CSTF1;GLIS3;ESR2;NR5A2;ATF4;CTDP1;TAF9B;SRRT;NR4A3;NR0B1;HDAC3;CEBPD;NR1D1;HNF4G;DRAP1;CCNK;NFIC;RTF1;PHAX
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.4479785111548831,-0.6924059387223629,0.8461538461538461,1.0,1.0,1/6,9.48%,BHLHE41
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.27185216539281976,0.6923055686100276,1.0,0.9938416768462278,1.0,13/78,9.84%,BARD1;NEDD4L;NR1H2;ASB5;HECW2;WNT7A;HACE1;FOXO1;SNF8;TIPARP;ABCB10;NSF;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.4431799520712586,-0.6921790708503945,0.8767123287671232,1.0,1.0,1/8,15.72%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.4431799520712586,-0.6921790708503945,0.8767123287671232,1.0,1.0,1/8,15.72%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3000181665605386,-0.6914004208607205,0.9791666666666666,1.0,1.0,10/119,11.33%,ESRRB;HES5;SFRP1;HES1;TGFB1;OVOL2;ZFPM1;JAG1;MED1;EFNA1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.29906294014012225,-0.6913701994441793,0.945054945054945,1.0,1.0,30/117,30.33%,PSMB9;TUBB4B;PSMB8;TUBA4A;RAB11A;PSMA3;CEP72;DCTN1;PSME1;TUBB4A;ODF2;DCTN3;PSMA7;PSMB6;DBF4B;CDK4;CEP164;RBX1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PRKACA;PSMA4;CCND1;TUBB;CDC7
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.39270585895394816,-0.6913026065218284,0.9866666666666667,1.0,1.0,1/12,3.15%,SLC2A3
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.3750752156181053,0.6910874035024289,0.8620689655172413,0.9947425753885388,1.0,8/8,62.51%,MAN2C1;NEU1;NEU3;MANBA;GBA3;NEU4;MAN2B2;MAN2B1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.399157697707066,0.6910485105036762,0.8378378378378378,0.9937168502833658,1.0,6/6,60.10%,SLCO2B1;HMOX2;ABCG2;ABCC1;BLVRA;BLVRB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.399157697707066,0.6910485105036762,0.8378378378378378,0.9937168502833658,1.0,6/6,60.10%,SLCO2B1;HMOX2;ABCG2;ABCC1;BLVRA;BLVRB
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.3864855277535181,0.6908507679713964,0.8648648648648649,0.9934241742680606,1.0,1/5,5.16%,WNT7A
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3831146623939088,-0.6906968432220572,0.8589743589743589,1.0,1.0,4/17,20.10%,SELENOK;CCDC47;BAX;WFS1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.40812887571958445,-0.6906958472482956,0.855072463768116,1.0,1.0,3/7,24.68%,RNF8;MSH6;GPR183
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.39035671036758224,-0.6905693385543347,0.8732394366197183,1.0,1.0,5/13,35.66%,CNMD;MT3;CADM4;PRKCB;PRKD2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.33941160531982295,0.6904139430794757,0.9666666666666667,0.9935035776288452,1.0,3/11,12.62%,PKD2;GRIN2B;CPSF6
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.36283633637066504,-0.6903358174845339,0.8571428571428571,1.0,1.0,3/16,13.46%,ENPP2;GDE1;ABHD12B
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.4279885947047443,-0.690265804361879,0.859375,1.0,1.0,1/7,10.10%,MED1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.25088210475610395,0.6902318364430419,1.0,0.993135108883416,1.0,5/43,8.59%,LEPR;IRS1;PPARG;IGF1R;ADIPOR2
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3475328150027029,-0.6901186206886869,0.898876404494382,1.0,1.0,5/31,11.53%,AGRN;RARRES2;RBP2;GPC3;RDH10
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3841065660607569,-0.6900599261490513,0.8656716417910447,1.0,1.0,1/11,6.41%,CEMIP
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.34074705142356104,-0.6896657987688216,0.9506172839506173,1.0,1.0,9/47,23.23%,GABARAPL2;ATG14;EMC6;ATG16L2;ULK3;MAP1LC3B2;ULK1;ELAPOR1;ATG12
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.39622011261960643,-0.6895897935759112,0.9,1.0,1.0,1/12,1.74%,VEGFA
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.41390194731191077,0.6895280069671821,0.7142857142857143,0.9932621932814432,1.0,1/8,3.58%,GAS2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.34542532400043824,0.6893128294890578,0.8666666666666667,0.9929894185797993,1.0,2/10,5.16%,SLC4A7;WNT7A
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.36350083290772295,-0.6891149787854873,0.9305555555555556,1.0,1.0,3/20,16.85%,MED1;AVIL;C3
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.44913102657479076,-0.6883197492997349,0.8208955223880597,1.0,1.0,2/5,15.40%,MED1;ATF4
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.3944558853879124,-0.6882880801777169,0.85,1.0,1.0,2/12,17.49%,SLC30A4;SLC39A6
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.4353406284201933,-0.6879036775189451,0.8484848484848485,1.0,1.0,1/7,6.14%,ZIC1
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.41272592316953893,0.6876939195495493,0.7352941176470589,0.9942674157953317,1.0,1/5,4.00%,CDO1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.4520665878873576,-0.687640159510757,0.8305084745762712,1.0,1.0,1/6,15.30%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.4520665878873576,-0.687640159510757,0.8305084745762712,1.0,1.0,1/6,15.30%,APOD
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.29685906360893966,-0.6875218754560801,0.9583333333333334,1.0,1.0,19/129,18.86%,VEGFA;DDRGK1;SFRP1;TGFB1;LRPAP1;PARP14;OVOL2;OLFM1;PTRH2;MEF2C;PARP9;SH3GL2;TCEAL1;RACK1;MAP2K1;APOE;CD46;HRAS;HSP90AB1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.29329661727766815,-0.6872142698136927,0.9795918367346939,1.0,1.0,27/208,20.85%,PSMB9;RPS27A;TFPT;PSMB8;USP6;CFTR;MBD6;ABRAXAS1;COPS5;USP18;PSMA3;TADA3;USP28;PSME1;USP50;UBA52;TAF9B;USP4;USP19;SKP2;OTUD6B;PSMA7;TOMM20;PSMB6;BRCA1;UBC;IFIH1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.31246990354186666,-0.6871751371037972,0.9545454545454546,1.0,1.0,20/72,29.57%,PSMB9;PSMB8;PSMA3;BUB3;PSME1;CDC26;FZR1;PSMA7;PSMB6;DBF4B;DBF4;PSMC4;NEK11;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.38159655154514094,0.6871725644079474,0.9032258064516129,0.9945172859436149,1.0,1/9,2.23%,ERBB4
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.37570498829540694,0.6871142624804844,0.8709677419354839,0.9940732422392962,1.0,2/10,9.70%,RXRA;PML
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.36136828892558037,-0.6870121482473859,0.9358974358974359,1.0,1.0,4/26,13.30%,GCNT4;GCNT1;B3GNT5;GXYLT2
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.37379072816972125,0.6869926882416251,0.8292682926829268,0.9937246408434752,1.0,2/7,18.24%,SLC16A2;NF1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.40564208837489146,0.6868981626725017,0.8333333333333334,0.9932625073149315,1.0,6/6,59.45%,MCM4;MCM3;MCM6;MCM7;MCMDC2;ORC3
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.43678121025946115,0.6868337707068907,0.8461538461538461,0.9928008651564341,1.0,2/5,15.93%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.4502304699742077,-0.6868154428507597,0.8870967741935484,1.0,1.0,1/5,1.10%,CRYM
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.4502304699742077,-0.6868154428507597,0.8870967741935484,1.0,1.0,1/5,1.10%,CRYM
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.3246850881628363,-0.6862580065183388,0.9529411764705882,1.0,1.0,7/44,18.86%,DDRGK1;GABARAPL2;RHBDF1;PSME1;USP19;APOE;HSP90AB1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.2767136481829722,0.6861489755186343,0.9615384615384616,0.992832768660882,1.0,7/22,20.15%,ARHGEF6;CDH13;ARHGEF7;CCDC88A;ABLIM2;SRGAP2;GOLPH3
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.3097876173080577,-0.6860894616964596,0.989010989010989,1.0,1.0,18/74,29.57%,PSMB9;RPS27A;PSMB8;PSMA3;PSME1;UBA52;PSMA7;PSMB6;UBC;RBX1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.34817068951890995,-0.6860029952129568,0.881578947368421,1.0,1.0,12/28,33.46%,PRELP;OMD;OGN;NCAN;TXN2;CHAC2;IDUA;BCAN;ACAN;HYAL1;ACAT1;BGN
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.34545742413186137,0.6858618792965562,0.8620689655172413,0.9926466720428635,1.0,5/10,22.72%,ADAM17;SLIT2;PTK2B;MTUS1;CAMK1D
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.36572074802047827,-0.6857401350151374,0.8939393939393939,1.0,1.0,3/22,17.73%,ZW10;DCTN1;SAPCD2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.3727910918379954,-0.6857187304427645,0.8888888888888888,1.0,1.0,3/17,18.73%,CEMIP;HRAS;PDZK1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.4459734016103685,-0.6857130657494926,0.9142857142857143,1.0,1.0,1/5,9.38%,CEACAM1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.36645106574067937,-0.6855759763980792,0.863013698630137,1.0,1.0,4/21,18.63%,HAX1;BAIAP2L2;PHPT1;HRAS
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3824642078748445,-0.6854000246623196,0.9102564102564102,1.0,1.0,1/19,7.22%,RASGRP1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.24808041440227196,0.6849564868207415,1.0,0.993303759864622,1.0,10/100,12.00%,TMEM74;HDAC10;ATG5;MTERF3;SNF8;ILRUN;ATG16L1;VTA1;MTMR3;MFN1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.27031896248842197,0.6848778396885465,1.0,0.9928430754334903,1.0,2/32,4.52%,SORD;PC
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.2995154554567239,-0.6848426587154667,0.9775280898876404,1.0,1.0,7/70,14.88%,PPIF;ECT2;HPCA;TTN;MEF2C;CALM1;SYT11
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.42631131348805673,-0.6847796518968281,0.9027777777777778,1.0,1.0,2/9,23.15%,PIP4K2C;ELAPOR1
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.43744246694271827,0.6846600590090661,0.84375,0.9925815756208134,1.0,2/5,10.06%,PLCB1;GLRA1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.44108376407220273,0.6845546896053596,0.8611111111111112,0.992225785924388,1.0,1/5,5.12%,IMMP2L
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3539192309549518,0.6843637921108423,0.8484848484848485,0.9920121485557069,1.0,2/10,7.17%,BOK;BCL2L11
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.30728400523002725,-0.6843545703343387,0.9753086419753086,1.0,1.0,13/69,22.55%,CLU;NUP155;SEC13;APOE;NUP107;ATAD1;RANBP6;PTTG1IP;PEX11B;PEX14;RANBP17;NUP188;NUP85
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.40149742629854945,0.684319258113119,0.7555555555555555,0.9915342300043959,1.0,6/6,59.87%,LCLAT1;LPGAT1;PLAAT3;PLA2G12A;MBOAT7;PLA2G4C
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.35913892231581757,0.6841285958847333,0.7959183673469388,0.9912645344476205,1.0,7/7,64.10%,ANKRD11;HDAC2;LRP6;GLI2;BMP2;HDAC1;EDA
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.4195751635843301,0.6839736670955922,0.8387096774193549,0.9908818837236336,1.0,3/8,11.70%,SEMA4D;DCC;PTPRS
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.40264592522191095,-0.6836353519058062,0.8732394366197183,1.0,1.0,2/8,22.57%,VIL1;ACTN2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2542118715748071,0.6834681897395148,1.0,0.9908486108745969,1.0,20/141,12.02%,SHANK2;ESR1;DEPTOR;SIRT1;PPM1A;LIMD1;PDE4D;TLE1;MAGI2;GPD1L;NMI;BMP7;ATP2B4;RORA;MAPK14;MAPKAPK5;TNFAIP8L1;PLAUR;THEM4;P2RX7
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.23962621465827857,0.6834626831214895,1.0,0.9903251831879225,1.0,21/96,16.91%,INPP4B;PTPN13;SYNJ1;EFR3A;PIGQ;PIKFYVE;CDS1;SMG1;PIK3CA;IP6K1;MTMR3;OCRL;MTM1;EFR3B;SOCS6;FIG4;PIP5K1B;SOCS4;PITPNM2;SOCS7;PIGU
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.4230458458029527,-0.6832877425607338,0.8732394366197183,1.0,1.0,3/8,25.39%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.36217450281326,-0.6832655397062461,0.9078947368421053,1.0,1.0,3/15,22.31%,TGFB1;CATSPERG;CAV1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.42148818634112944,-0.6831685867182704,0.9016393442622951,1.0,1.0,1/7,14.98%,PFKP
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.24879090810209217,0.6831680248256882,0.9411764705882353,0.9900849608265649,1.0,5/37,11.13%,ATR;ZBTB1;PTPRK;ERCC4;NEDD4
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.4044847746921836,-0.6828716769952894,0.8873239436619719,1.0,1.0,2/11,17.99%,CCT7;DKC1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.34520163136265847,-0.6827830666832497,0.8888888888888888,1.0,1.0,2/24,7.50%,HTR2B;HTR2C
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.38333574818571514,-0.6827411501286074,0.935064935064935,1.0,1.0,3/15,12.30%,CNMD;GSTM3;COL15A1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.3228581764537607,0.682619460534318,0.96,0.9902404968228908,1.0,2/14,4.40%,FBXO17;EDEM1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.3695012702232919,0.6826011785045312,0.9032258064516129,0.9897652771542761,1.0,7/7,63.07%,KCNMA1;SLC12A2;ATP1A2;ATP1B3;ATP1B2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.3533741225211519,-0.6824687280231339,0.891566265060241,1.0,1.0,3/20,12.67%,HES5;MMP24;METRN
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.38724640211280065,0.6824124656706472,0.84,0.9894881024307751,1.0,1/5,9.78%,MSN
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.40248003127843296,-0.6819623761818816,0.890625,1.0,1.0,3/10,25.53%,IRF1;CD46;RUNX1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.4159994998366744,-0.6817866802334277,0.8709677419354839,1.0,1.0,1/8,8.10%,OAS1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.30940839585900615,0.6814498238556891,0.96,0.989916362073127,1.0,3/19,13.32%,SUV39H2;ATPSCKMT;SETD2
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4189201937200595,-0.6814184294344966,0.8648648648648649,1.0,1.0,3/9,25.39%,TXN;PARK7;PDE8A
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.29219899746398853,-0.6813742137430291,0.978021978021978,1.0,1.0,3/87,5.35%,B2M;HSD17B14;TMEM50A
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.34591629841275584,0.6810501767641542,0.96,0.9897897508466997,1.0,4/10,22.27%,ABCC5;ABCC4;LRRC8A;SLC19A1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3810498744263961,-0.6810001405145231,0.922077922077922,1.0,1.0,3/12,14.92%,HAP1;BDNF;DDIT4
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3132851704029569,-0.6808609652569875,0.9647058823529412,1.0,1.0,11/69,19.61%,ECT2;NOL3;PRMT8;POLQ;BEND3;KCNC1;RNF213;HGSNAT;NINJ1;RNF112;DNM1L
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.42182120636105114,-0.6807981743913547,0.7903225806451613,1.0,1.0,1/5,10.79%,BEND3
prerank,PanglaoDB_Augmented_2021__Neurons,-0.2825929505416062,-0.6804625162526606,0.9896907216494846,1.0,1.0,21/237,11.79%,NEFM;BEX2;GDAP1L1;BEX1;HAP1;NDN;IFIT3;MEG3;HPCA;ZIC1;TCEAL3;CELF4;CACNA1B;SRRM4;SNCB;TCEAL2;SH3GL2;RNPC3;KCNC1;DIPK1B;CCK
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.30182573207091407,0.6804012180641228,0.9655172413793104,0.9901516569233243,1.0,6/20,13.85%,RIPOR2;PLCB1;MAPK14;SOX8;FLOT2;DLL1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.4638009198977464,-0.6803432377556066,0.8688524590163934,1.0,1.0,2/5,28.00%,TOMM7;ATP5IF1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.41569955091899324,-0.6797816749193412,0.828125,1.0,1.0,2/8,9.30%,MAN2A2;AGA
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.37690305694253556,-0.6797555802064816,0.8904109589041096,1.0,1.0,4/19,17.71%,PARP14;PARP9;NLRC5;IL7
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.36787056819826575,-0.6797220771993454,0.8115942028985508,1.0,1.0,1/11,10.79%,BEND3
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.2993956889844525,0.6795475386920943,0.875,0.9904568598866882,1.0,8/17,20.57%,SLIT3;TGFBR2;GLRA1;GRIN2B;ABCA2;SLIT2;GRIN1;TGFBR3
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.2893818043914002,0.6793294998761785,1.0,0.9901988144444371,1.0,9/31,14.97%,GPC4;HS3ST1;GCNT2;UGDH;EXT2;GPC1;SDC2;HS2ST1;EXT1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.42571854257431385,-0.6787924162390665,0.835820895522388,1.0,1.0,2/5,22.61%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.42571854257431385,-0.6787924162390665,0.835820895522388,1.0,1.0,2/5,22.61%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.42571854257431385,-0.6787924162390665,0.835820895522388,1.0,1.0,2/5,22.61%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.3084157114133301,0.678581824497311,0.8947368421052632,0.990625575395131,1.0,5/15,20.37%,FOXP1;PTPRC;SLC39A10;BCL10;RAB29
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.4690202331300656,-0.677680038612176,0.8939393939393939,1.0,1.0,2/5,6.81%,HLA-A;IRF1
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.29286615754322753,-0.6775828452052239,0.967032967032967,1.0,1.0,30/161,24.88%,SLC2A3;M6PR;TUBA4A;GLRX;COPS5;PDK1;XBP1;GAPDH;PSMA3;PGK1;SLC6A6;FADS2;IFRD1;DDIT4;WARS1;LDHA;TRIB3;IDI1;RPN1;HSPA9;ATP6V1D;GOT1;PDAP1;HSPD1;ATP5MC1;NAMPT;SC5D;GBE1;TOMM40;PSMC4
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.3331777854726518,-0.6775658655830173,0.8292682926829268,1.0,1.0,6/33,20.33%,SFRP1;RARRES2;XBP1;METRNL;TFE3;AAMDC
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.323335964622368,-0.6775628264141305,0.9,1.0,1.0,6/33,20.21%,SFRP1;HAS2;CACTIN;ADAMTS7;NR1D1;MAPK13
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.3564359752821207,-0.676664059179782,0.9090909090909091,1.0,1.0,4/30,9.68%,ISG15;ALOX5;TGFB1;MEF2C
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.34797506829727676,0.6762870961036487,0.9117647058823529,0.9924671007539171,1.0,4/10,13.69%,SMAD7;TGFBR2;ACVR1;USP15
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.34383200509568895,0.6757290355030525,0.9310344827586207,0.9926861412685056,1.0,5/11,21.90%,SPTBN4;B4GALT5;MYCBP2;B4GALT6;ARHGAP35
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.4148740740937557,-0.6752173205781392,0.8529411764705882,1.0,1.0,2/8,14.30%,AGRN;MTCH1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2926368946520017,-0.6751143050026441,0.9565217391304348,1.0,1.0,5/106,5.03%,TRIM5;ECT2;HTR2B;TRIM25;IFIT5
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.2804173020813354,-0.6750484153332489,1.0,1.0,1.0,73/754,17.66%,ASB18;ART4;FLG;F13A1;ELOB;TNC;PARP2;PSMB9;SCG2;SCG3;ISG15;COPS6;CP;PSMB8;USP6;STK17A;FBXW12;ASB14;CAMK1;RAB11A;ICMT;TRIB1;DUSP12;GLRX;TGFB1;COPS5;PARP14;CKAP4;PDK1;UBL5;DAD1;OBSL1;MAN2A2;AGA;CHGB;PARP9;FN1;GPC3;PSMA3;KRT10;CAMK2A;PIGH;CST3;MPI;CDK7;B3GNT5;SERPIND1;WNK3;ASB16;STRADB;PSME1;FBXL13;MAK;PPP5C;UBE2L6;PARP4;FBXO32;CTDP1;UBA52;NEK6;NUCB1;ALG10B;MAP2K1;PHPT1;MORC3;MAP3K12;C3;SKP2;APOE;PPP2R5A;PPM1G;B3GALT5;GMFB
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.4297360933946348,-0.6750098786735482,0.9,1.0,1.0,1/6,9.60%,EPHX2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.3622799002453756,-0.6749788016513908,0.9154929577464789,1.0,1.0,1/18,4.84%,RAB11A
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.4490339659368068,-0.6746445007132011,0.8787878787878788,1.0,1.0,1/6,2.32%,SFRP1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.43553402256501017,-0.6745134622025809,0.9193548387096774,1.0,1.0,1/5,15.40%,ATF4
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.46450611777178463,-0.6742345795438914,0.8769230769230769,1.0,1.0,3/5,31.97%,LPCAT3;DGAT1;SOAT1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.3098566971022844,-0.673873122888835,0.978021978021978,1.0,1.0,17/73,26.69%,ADAM21;RARRES2;CRYAB;PAMR1;LMOD1;NR5A2;COL4A1;COL21A1;ACSBG1;THBS2;CALD1;COL14A1;MATN2;COL4A2;PDE8A;PDZRN3;C1S
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.2979286720585867,-0.6737593285903614,0.967741935483871,1.0,1.0,19/116,19.62%,H2AZ1;CBR3;APEX1;S100A10;ACSM3;GLUL;PDHB;HSDL2;ACO2;PSME1;UROD;UBE2L6;ACADL;LDHA;ACOT2;CBR1;IDI1;CRAT;FH
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.3771233272773591,0.673158680344302,0.8108108108108109,0.9948055262359936,1.0,3/8,18.41%,CSGALNACT1;FUT8;GFPT1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.400114068873054,-0.6729747774585303,0.8904109589041096,1.0,1.0,4/11,24.68%,DNAH17;CCDC39;DNAH2;DNAAF2
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.43154687154682747,-0.6728953722175206,0.84375,1.0,1.0,2/6,13.57%,IFI35;GRN
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.3192751379205832,-0.6728884390478025,0.9418604651162791,1.0,1.0,2/37,4.32%,STK17A;FLOT1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.33152635673324843,-0.6726516830749559,0.92,1.0,1.0,6/22,24.57%,PLSCR1;ATP8B1;ATP9B;ATP11A;ABCA1;ANO6
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.30064892389747755,-0.6725351700693575,0.967032967032967,1.0,1.0,8/118,7.22%,ARHGAP15;SFRP1;VAV3;ECT2;AGRN;RAP1GAP;S100A10;RASGRP1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.2846011626701721,-0.6724946655587094,0.9795918367346939,1.0,1.0,21/204,14.77%,HES5;ELOB;RIMS1;F8;NOL3;HES1;GORASP1;NAPA;CTSZ;TUBGCP2;ZW10;TUBGCP4;NDUFAF1;FN1;TRAPPC2L;CHCHD10;FANCC;TCF7;VIL1;SEC13;SPG7
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.3894000009585623,0.6723797795957996,0.8974358974358975,0.9951260435753192,1.0,1/9,1.87%,MAP3K5
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.3477277312876783,0.6723581128839909,0.9354838709677419,0.9946138416662262,1.0,2/8,11.64%,CAT;PXDNL
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.38540821860776947,-0.6717774729381246,0.881578947368421,1.0,1.0,2/12,7.66%,PTGR1;TBXAS1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.34456407478765294,-0.6717307449046187,0.9523809523809523,1.0,1.0,8/25,29.70%,HDAC6;HSPA14;HSPA13;BAX;HSPA9;HSPA8;STUB1;DNAJC18
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.2835739613284306,-0.6715339045423043,0.9897959183673469,1.0,1.0,35/236,20.15%,VEGFA;DXO;DDRGK1;SFRP1;PHF1;RPL13A;LSM5;TGFB1;PARP14;OVOL2;OLFM1;RPS13;IGF2BP2;PTRH2;MEF2C;GAPDH;PARP9;SH3GL2;TCEAL1;SYT11;RACK1;MAP2K1;ZFP36L2;APOE;SHMT1;NCL;CD46;HRAS;PCIF1;EIF2AK2;NUDT12;RNH1;CREBZF;RPS26;MALSU1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.36724113492260724,0.6710470034876933,0.9166666666666666,0.995392161991492,1.0,2/6,19.87%,SASH1;DDX3X
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.37272909627749257,-0.6706251950730784,0.96,1.0,1.0,4/14,23.92%,STAT1;IFIH1;HSPD1;DHX36
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.29144271953992446,-0.670391433167212,1.0,1.0,1.0,36/198,23.56%,GADD45B;GADD45GIP1;BEX2;SFRP1;RPL23;JUN;TGFB1;CDKN2C;IRF1;KIF20B;RASSF1;RRP8;CDK7;RNF167;WDR6;CRLF3;CDC26;RACK1;NEK6;MAP2K1;WDR12;SKP2;ZBTB49;NUDT6;HRAS;RNF112;HSP90AB1;CDKN2A;BRCA1;GMNN;SRA1;TSPYL2;TRIM32;ID2;RARA;CDK4
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.41482165429171913,-0.6703641917624164,0.8769230769230769,1.0,1.0,1/8,15.30%,APOD
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.30508779546521964,-0.670230572852115,0.9647058823529412,1.0,1.0,12/75,20.49%,NAAA;BTD;DBI;ACSM3;DNPEP;CPM;ATF4;SHMT1;GNE;ACOT2;AEBP1;MTHFD1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.3664496329460006,0.6702183716805002,0.8484848484848485,0.9951721505662148,1.0,1/7,8.00%,ATG2B
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.3664496329460006,0.6702183716805002,0.8484848484848485,0.9951721505662148,1.0,1/7,8.00%,ATG2B
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.3525050332651141,-0.6701771042639181,0.9156626506024096,1.0,1.0,3/20,18.73%,CEMIP;HRAS;PDZK1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.4261608921301039,-0.6701223092932269,0.8870967741935484,1.0,1.0,1/7,9.38%,CEACAM1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.3974042384908529,0.6698538256080179,0.8918918918918919,0.9949876530172429,1.0,1/6,2.45%,KAT2B
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.42440030987240285,-0.6692050937596379,0.9066666666666666,1.0,1.0,3/6,38.35%,POP4;RPP30;POP1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.35887305015093446,-0.6691900722011174,0.9230769230769231,1.0,1.0,5/18,25.49%,VAV3;LARS1;RDX;RAP1GAP2;LAMTOR4
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.2956734602575064,-0.6683294708224907,0.9574468085106383,1.0,1.0,7/66,21.59%,VAV3;AP2A1;APH1A;EFNA1;HRAS;RASA1;AP2A2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.2795312438157339,0.668146713819147,0.9166666666666666,0.9963611537779529,1.0,9/30,18.86%,SPRY4;GCNT2;KANK1;AJAP1;NF2;MAP4K4;CORO1C;ACER2;ACTN4
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.31278173881196647,-0.6681423949853977,0.9512195121951219,1.0,1.0,4/50,13.41%,SFRP1;TGFB1;CST3;FUZ
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.397172569525688,-0.668060000627813,0.922077922077922,1.0,1.0,1/9,1.74%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2958530885507254,-0.6679571371830303,0.9534883720930233,1.0,1.0,4/67,7.22%,GADD45B;VEGFA;SEMA4C;RASGRP1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.3016237996011371,0.6679019744768184,0.9655172413793104,0.9961109646849396,1.0,1/17,1.22%,PRR5L
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.3571463349792792,-0.6675321690110734,0.9402985074626866,1.0,1.0,3/21,17.73%,ZW10;DCTN1;SAPCD2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.29345142433072857,-0.6673881138082162,0.9690721649484536,1.0,1.0,29/109,29.57%,PSMB9;PSMB8;ZFP69;MED1;PSMA3;PSME1;SREBF1;APOE;HDAC3;EDF1;PMVK;NR1D1;PSMA7;IDI1;OAZ2;PSMB6;AZIN1;ID2;NQO1;SC5D;PSMC4;SIN3B;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3032980785417427,-0.6673196553547109,0.9010989010989011,1.0,1.0,7/55,14.88%,VEGFA;CLU;HDAC6;CRYAB;DNM2;SCAMP5;SYT11
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.39721455977274245,0.6671872209388398,0.9090909090909091,0.9963083217159102,1.0,1/7,1.15%,MOXD1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2728776156401484,-0.6670362594677998,1.0,1.0,1.0,77/661,16.47%,PLAG1;ESRRB;MBNL3;ZNHIT3;TRIM5;VEGFA;RIMS1;DDRGK1;SFRP1;PHF1;PLSCR1;RPL11;FGF1;DVL1;BTN3A1;FAM50A;RPL23;HMGN5;CHD3;CLU;SPIN2A;TGFB1;AKAP17A;PARP14;FAM98B;OVOL2;CGGBP1;YBX3;BACH1;OLFM1;HDAC6;TTN;SFRP4;LDB1;MLX;KDM6B;IGF2BP2;PTRH2;EPHX2;MEF2C;PARP9;HINT1;FN1;MED1;SRRM4;CDH3;PIK3CB;SH3GL2;SRSF10;CACTIN;SAP30;BTG1;HNRNPDL;PDCD5;ATG14;TADA3;ATXN7L3B;TCF7;TCEAL1;ESR2;DNM2;STX1B;DVL2;BTN3A3;ZNF90;NR5A2;ZNF100;BTNL2;ATF4;RACK1;ACTA2;ZNF460;ZFHX3;RPS7;MAP2K1;SRRT;ZNF331
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.30427629543967905,-0.6668113779351134,0.9195402298850575,1.0,1.0,9/62,18.80%,PFN2;ANKRD53;CLU;DCTN1;VIL1;LMOD1;BAIAP2L2;APOE;STMN2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3528899647234264,-0.6666801912924784,0.9324324324324325,1.0,1.0,1/18,2.69%,SPDYA
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.39255101653143515,0.6653699622484529,0.7692307692307693,0.9976417283351356,1.0,1/5,8.00%,ATG2B
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.33062706264579855,-0.6653476427146955,0.9659090909090909,1.0,1.0,3/31,8.65%,VEGFA;SCG2;LDB1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.23168231290622202,0.6651898014423626,1.0,0.9972795582199061,1.0,17/77,15.69%,BCAR1;BOK;CHST3;LAMC1;MPDZ;MAGI1;EGFR;ADCY6;GPC1;PTPRU;TENM3;FIGN;COL5A2;NCKAP1;GLIS2;AMOTL2;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.4025968205257595,0.6646614765214814,0.85,0.9974946049992728,1.0,1/5,7.17%,BCL2L11
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.35860423936191477,-0.664642724684173,0.9230769230769231,1.0,1.0,4/22,21.07%,PEX1;ATAD1;PEX11B;PEX14
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.4131652368464682,-0.6646423582426448,0.8852459016393442,1.0,1.0,2/6,28.02%,KMT2B;SETD1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.2866416421322843,-0.6645761570946852,0.9895833333333334,1.0,1.0,18/156,15.48%,SFRP1;TMEM25;TRIB1;AGT;LRPAP1;HHIP;SFRP4;WIF1;CNMD;BDNF;GPC3;PIK3CB;CACTIN;TMBIM1;ULK3;DDIT4;APOD;RACK1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.2989308468750739,-0.6644387095194055,0.9333333333333333,1.0,1.0,6/60,13.07%,ECT2;ABRAXAS1;RNF8;NABP2;H2AX;USP28
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.4227210608663083,-0.6636767542185119,0.921875,1.0,1.0,1/7,10.10%,MED1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.4070867275613682,-0.6635371484378899,0.8709677419354839,1.0,1.0,2/7,29.44%,GSN;COL4A3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.35954531674675616,-0.6635302742879771,0.9382716049382716,1.0,1.0,4/22,17.10%,TGFB1;MEF2C;SVBP;APOE
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.3770554575503509,-0.6634515371091776,0.881578947368421,1.0,1.0,5/14,26.86%,MEF2C;MYL6B;CAV1;MYL6;BASP1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.2718561269542822,0.6631786983549942,1.0,0.9986393286984051,1.0,16/69,14.97%,DSE;VCAN;CHST3;GPC4;HS3ST1;CSGALNACT1;GCNT2;B4GALT3;UGDH;EXT2;ABCC5;GPC1;SDC2;ST3GAL4;HS2ST1;EXT1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.3493194388364407,-0.6630112175703226,0.9080459770114943,1.0,1.0,4/20,12.64%,HAP1;GSTO1;ANTKMT;CALM1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.31427970142551376,-0.6629133255182796,0.9310344827586207,1.0,1.0,9/28,28.09%,TGFB1;APH1A;ERAP1;PRKCQ;AFG3L2;ADAM9;BACE1;MBTPS2;MBTPS1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.2997054397559188,0.6627714844398577,0.9473684210526315,0.9984073232312719,1.0,9/22,18.04%,FAM107A;WASF3;WASL;WASHC5;COBL;DIAPH1;SPIRE1;ARHGAP6;TTC17
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3517200422405373,-0.6627676316529237,0.9230769230769231,1.0,1.0,1/23,2.25%,DDRGK1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.29077174086891217,-0.6626684836531239,0.9777777777777777,1.0,1.0,11/99,17.49%,TUBB4B;TUBA4A;BACH1;CEP72;CDK7;DNM2;DCTN1;TUBB4A;ODF2;SKP2;DCTN3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.28454144872370263,0.6625821823487063,0.9230769230769231,0.998026930046554,1.0,3/11,20.49%,ETNK1;CEPT1;CHKA
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.3451579254671212,-0.662565522475717,0.9506172839506173,1.0,1.0,6/25,25.49%,VAV3;LARS1;PEX11B;RDX;RAP1GAP2;LAMTOR4
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.35347293526844026,-0.6624755843755594,0.9113924050632911,1.0,1.0,2/17,11.01%,TRIB1;CACTIN
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.23655352322371984,0.6622445351286769,1.0,0.9978604760969896,1.0,11/72,13.80%,ATR;ZBTB1;PTPRK;CAT;EGFR;MAP3K4;ERCC4;REV1;NEDD4;MAPK8;N4BP1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.34354602069060686,0.662181720421907,0.9354838709677419,0.996860298473242,1.0,2/8,20.98%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.34354602069060686,0.662181720421907,0.9354838709677419,0.996860298473242,1.0,2/8,20.98%,CACNG2;GPHN
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.29246741378120106,-0.6621652965559393,0.9777777777777777,1.0,1.0,26/94,26.69%,HES5;RARRES2;CLU;AGT;ANGPTL4;RHBDF1;CRYAB;OBSL1;CST3;GAMT;COL6A1;LMOD1;CD55;C3;CD46;GSN;FSHR;VWA1;MATN2;NECTIN2;SOX9;BCAR3;EPHX1;RXRB;SLC16A3;C1S
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.3528779228366564,0.6620796937428205,0.9032258064516129,0.9959085241286347,1.0,4/8,30.86%,TRIM71;TNRC6C;AGO3;AGO1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3528779228366564,0.6620796937428205,0.9032258064516129,0.9959085241286347,1.0,4/8,30.86%,TRIM71;TNRC6C;AGO3;AGO1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.2697252027438552,0.6619951862416164,0.9523809523809523,0.9954565288422064,1.0,3/32,7.95%,DUSP7;SPRY4;BMP7
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.42838988809456424,-0.6614112134981407,0.8695652173913043,1.0,1.0,2/7,10.79%,RRP8;BEND3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.2713936522897374,-0.6612647002559683,1.0,1.0,1.0,58/463,20.39%,ZBTB32;RPS14;HES5;CRYM;VEGFA;TAF7;RPS27A;RPL10;RPL23;HES1;CHD3;TLE6;JUN;ZFP69;CGGBP1;ZFPM1;DDX5;BACH1;ZNF124;ZNF568;LDB1;MOSPD1;MLX;MAX;BHLHE41;MEF2C;PARP9;MED1;BEND3;EFNA1;TCF25;HDGF;SAP30;GLIS3;ESR2;SARS1;CBX5;ATF4;UBA52;TAF9B;ZFHX3;NR4A3;ZNF248;ZNF749;STAT1;NR0B1;TRIB3;HSBP1;HDAC3;NR1D1;CBX7;DRAP1;AEBP1;KAT5;WFS1;ZNF404;NFIC;RTF1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.37641894599611797,0.6611985303016497,0.7948717948717948,0.995597360970835,1.0,2/6,11.69%,SIRT1;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.2929567671752741,-0.6608728240636368,0.9879518072289156,1.0,1.0,6/52,15.68%,RPS27A;PBLD;TGFB1;ASPN;VEPH1;UBA52
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.333597846542274,-0.6608632336687711,0.9090909090909091,1.0,1.0,6/27,22.75%,BLOC1S2;HDAC6;KXD1;NR4A3;MAP6;SPAG9
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.37729220292543447,-0.6608400336088187,0.873015873015873,1.0,1.0,1/13,8.61%,RNF8
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3698350183961607,-0.6607414020933677,0.9466666666666667,1.0,1.0,6/19,18.65%,SELENOK;ATF4;DNAJC10;TRIB3;BAX;AIFM1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.2934322105813049,-0.660372541069305,1.0,1.0,1.0,9/59,22.55%,RPL23;NUP155;SEC13;NUP107;RANBP6;PTTG1IP;RANBP17;NUP188;NUP85
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.4083322061026293,-0.6597921139851395,0.90625,1.0,1.0,1/6,25.13%,TMSB4X
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.39825217487635195,-0.6595588386904999,0.8533333333333334,1.0,1.0,4/10,28.97%,ALKBH2;ALKBH5;ASCC2;MPG
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.39825217487635195,-0.6595588386904999,0.8533333333333334,1.0,1.0,4/10,28.97%,ALKBH2;ALKBH5;ASCC2;MPG
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.35667527930047616,-0.6595445619938134,0.9428571428571428,1.0,1.0,1/16,8.61%,RNF8
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.35283086814699893,-0.6595332222325178,0.935064935064935,1.0,1.0,3/15,14.88%,RAB11A;DNM2;SYT11
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.39370103528565514,0.6595099899639377,0.8387096774193549,0.996866645178728,1.0,1/6,14.15%,PTPRN2
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.33234680483540224,-0.6592946585823247,0.963855421686747,1.0,1.0,6/32,23.23%,GABARAPL2;MAP1LC3B2;FUNDC2;CISD2;ULK1;ATG12
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.33947190039019126,0.6592686778412329,0.8888888888888888,0.9965812842359656,1.0,4/12,16.26%,ROBO1;NFATC1;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.42367914159038805,-0.6589902458142963,0.8904109589041096,1.0,1.0,1/6,9.38%,CEACAM1
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.3224744508510299,-0.6587619344992556,0.9302325581395349,1.0,1.0,7/29,24.39%,ECT2;MICALL2;POF1B;VCL;CLDN18;RHOC;CLDN10
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.25123828073288185,0.6587188717758129,0.9375,0.9966473853133322,1.0,7/55,11.87%,BARD1;LIG4;NSMCE2;HERC2;ERCC4;HMGB1;UBE2N
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.2912911289660004,-0.6586667830196614,0.9655172413793104,1.0,1.0,9/47,26.38%,JUN;MED1;RUNX2;BAX;CCNC;CDKN2A;CDK4;SOX9;MED4
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.26804815643388236,-0.6582625158494309,0.9895833333333334,1.0,1.0,17/259,9.80%,RANGRF;CDC37;HAP1;ARL1;RPL11;USP6;STX10;COX18;TGFB1;ARFIP2;NAPA;STX19;ARL4C;NUP155;HDAC6;SCG5;AP2A1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.34821234969964293,-0.6580400518234439,0.9230769230769231,1.0,1.0,2/17,5.96%,HAP1;AGT
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.41779605911153955,-0.6577773754105278,0.8676470588235294,1.0,1.0,1/5,13.57%,GRN
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.40140584322743256,0.6573358522526559,0.9375,0.9972121856936198,1.0,1/5,9.46%,MECP2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.25765307393539205,0.6569962519917594,1.0,0.9969363205311674,1.0,10/46,19.84%,PATL1;DCP1B;EXOSC7;EXOSC1;CNOT2;CNOT6L;CNOT9;CNOT7;RC3H2;PAN3
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.31908950467891917,-0.6569828694249292,0.9518072289156626,1.0,1.0,3/34,5.96%,LAT2;HTR2B;AGT
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.35359471026297373,-0.6566532099368496,0.922077922077922,1.0,1.0,1/15,3.53%,POLR2G
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.3269360725066844,-0.6562892205232137,0.9473684210526315,1.0,1.0,5/25,23.92%,DND1;DKC1;PHAX;CIRBP;DHX36
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.2953056604319746,-0.6562441121437474,0.9761904761904762,1.0,1.0,8/64,17.49%,TUBB4B;TUBA4A;ATAD5;CEP72;DCTN1;TUBB4A;ODF2;DCTN3
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.27726243990251703,-0.6562111446411286,0.9893617021276596,1.0,1.0,15/137,16.38%,HTR2B;PLCH1;DUSP12;TGFB1;PLCD4;GPX4;EPHX2;GDE1;PIK3CB;PGK1;CALM1;PNKP;PFKP;G6PC3;PGP
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.3539729824556594,-0.6561596224049951,0.8961038961038961,1.0,1.0,2/13,10.21%,ENPP2;GDE1
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.38608282854512865,0.6558667315295142,0.8275862068965517,0.9974265723363849,1.0,1/5,10.40%,LRRK2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.3542773295502877,-0.6558541517012856,0.8961038961038961,1.0,1.0,1/18,2.97%,ARL1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.2660154376019176,-0.6557647587794587,1.0,1.0,1.0,106/755,20.49%,PLAG1;ESRRB;ETV4;HES5;BEX1;VEGFA;TAF7;ZBTB48;RPS27A;DDRGK1;SFRP1;H2AZ1;PLSCR1;FGF1;TFAM;DVL1;CDKN1C;HES1;HMGN5;AGRN;DBP;GALR1;LAGE3;CREB3;APEX1;CAMK1;JUN;HAX1;TGFB1;AGT;ZIC1;COPS5;IRF1;MAFF;ZFPM1;UTP15;CHCHD2;H1-4;XBP1;LDB1;MOSPD1;MLX;JAG1;MAX;KDM6B;NIF3L1;MEF2C;PARP9;MED1;PRPF6;SMARCD1;CEBPZ;GTF2F1;NLRC5;CDK7;SMARCA5;CHCHD10;LMO2;TADA3;GLIS3;ELK3;ZBED3;CKAP2;ESR2;DNM2;DVL2;CRLF3;NR5A2;SREBF1;SS18L2;ATF4;ACTA2;UBA52;ZFHX3;RUNX2;MAP2K1;RTRAF;THOC5;USF1;MAP3K12;ZBED4;NR4A3;APOE;ATAD2;STAT1;SSBP4;HDAC3;TFE3;EDF1;DNAJC2;ZBTB49;PELP1;HRAS;NR1D1;HNRNPAB;HNF4G;FIZ1;DRAP1;KAT5;SALL2;CCNC;CCNK;PAXBP1;NFIC;MMS19;BRCA1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.24981086302733996,0.6556704750490514,0.9444444444444444,0.9970586603178205,1.0,11/58,13.20%,MAP3K5;MAPK1;SLC38A9;SESN1;MAPK3;ATP6V1A;LAMTOR2;DAPL1;MLST8;PRKD1;MAPK8
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.34352685640216374,0.6551119063853709,0.8571428571428571,0.997087474677433,1.0,1/11,4.91%,PPARG
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.36907452279556296,-0.654866840025487,0.9125,1.0,1.0,1/10,7.64%,DDX5
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.3508202845138957,-0.6546620021926891,0.9135802469135802,1.0,1.0,1/18,8.39%,XBP1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.3508806166410809,-0.6538131215645431,0.8607594936708861,1.0,1.0,5/15,19.41%,XBP1;BHLHE41;BDNF;HDAC3;FBXO22
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3781664469874805,-0.6536519856042229,0.8831168831168831,1.0,1.0,5/12,35.23%,CD226;NECTIN2;KMT5C;SHLD2;HMCES
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.43108563207185613,-0.6534273268665061,0.9154929577464789,1.0,1.0,3/6,24.94%,CDH3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.43108563207185613,-0.6534273268665061,0.9154929577464789,1.0,1.0,3/6,24.94%,CDH3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.2758142913077239,-0.6534043161707119,1.0,1.0,1.0,15/175,13.14%,ROMO1;SFRP1;PDCD1LG2;H2AZ1;CFTR;RRAGA;JUN;SELENOS;TRIM41;XBP1;MEF2C;CACTIN;PRDX5;P2RX4;WNT5B
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.43959641386324877,-0.6530853909008851,0.9014084507042254,1.0,1.0,1/5,8.89%,JAG1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.43959641386324877,-0.6530853909008851,0.9014084507042254,1.0,1.0,1/5,8.89%,JAG1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.2937615192638915,-0.6519317440266579,0.9787234042553191,1.0,1.0,18/82,26.12%,SFRP1;ZIC1;CRYAB;OBSL1;PAMR1;FNDC4;COL6A1;LMOD1;COL4A1;PTN;SCARA3;CALD1;THY1;FAM13C;COL14A1;LAMB1;COL4A2;PDZRN3
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.3524784083320368,0.6519192240046635,0.8260869565217391,0.9997234243295632,1.0,2/9,15.88%,GPC1;ABCA2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.3017196235750211,0.6514518141376657,0.8,0.9996587555090983,1.0,3/10,13.63%,HECW2;CDC16;ANAPC1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.42951679716933944,-0.6513953500597871,0.8688524590163934,1.0,1.0,3/5,29.43%,TTN;RDX;PRKACA
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.295375859183382,0.651299483241149,1.0,0.9993272636395824,1.0,5/20,13.29%,SIRT1;NNMT;SDHAF3;DGKQ;ARPP19
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.2222278163865988,0.6511700773185018,1.0,0.9989409234079963,1.0,15/101,12.05%,PRR5L;IRS1;PLIN5;TP53INP1;SH3D19;FOXO1;SNX33;ZBTB20;DHRSX;MSN;LRRK2;MOV10;HMGB1;P2RX7;PRKD1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.30775917872148806,0.6511420786291598,0.9230769230769231,0.9984630451394211,1.0,3/18,8.55%,ADAM10;MYH9;ADAM19
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.34120765321070684,0.651110884468069,0.9047619047619048,0.9980040367774314,1.0,2/16,4.91%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.38601641201647424,-0.6508176931979641,0.8493150684931506,1.0,1.0,5/10,30.67%,HDAC6;OAZ2;SAT2;SAT1;AMD1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.3160916000440133,-0.6504212959119097,0.8902439024390244,1.0,1.0,5/41,16.09%,SFRP1;TGFB1;DDX5;ADAMTS7;RUNX2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.25044670410645203,0.6502946874402965,1.0,0.9982434961944904,1.0,11/57,13.20%,MAP3K5;MAPK1;SLC38A9;SESN1;MAPK3;ATP6V1A;LAMTOR2;DAPL1;MLST8;PRKD1;MAPK8
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.23903188733669792,0.6500879936486575,1.0,0.9979044055171742,1.0,5/37,13.99%,SLC2A6;NUP98;NUP93;AAAS;NUP210
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.40488431112872275,-0.6499438632556058,0.9014084507042254,1.0,1.0,2/8,12.13%,H1-4;SMARCA5
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.3234120753163519,-0.6499403962727277,0.9135802469135802,1.0,1.0,4/28,9.38%,TGFB1;SPINT2;JAG1;CEACAM1
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.29120833116728334,0.6498270544211883,1.0,0.9975564888143201,1.0,5/24,15.47%,NUTF2;RANBP3;XPO7;CCHCR1;DUSP16
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.33669218211447516,-0.6497409830735887,0.9066666666666666,1.0,1.0,5/25,21.48%,H2AX;USP28;DONSON;FBXO6;ATRIP
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.3263045047552437,-0.6496294664808445,0.9176470588235294,1.0,1.0,5/33,11.41%,TUBB4B;ANKUB1;CFAP52;ATP5MK;CDHR3
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.4103994930112789,0.6493805073195162,0.8064516129032258,0.9974106694680822,1.0,2/5,12.28%,RFX3;ODAD4
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.4303782800698155,-0.6492594175043026,0.9384615384615385,1.0,1.0,1/5,11.08%,LRRC17
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.2620415468614006,-0.6489610838766741,1.0,1.0,1.0,181/1384,20.39%,ZBTB32;PLAG1;RPS14;ESRRB;ETV4;HES5;CRYM;BEX1;SP140;ZIC4;VEGFA;TAF7;ZBTB48;RPS27A;DDRGK1;ZNF610;H2AZ1;PLSCR1;RPL10;FGF1;ZNF883;DVL1;ZNF232;RPL23;HES1;DACH2;AGRN;NFE2L3;DBP;GALR1;LAGE3;CREB3;APEX1;CAMK1;CHD3;TLE6;JUN;ZFP69;HAX1;ZNF790;ZSCAN2;TGFB1;ZIC1;BRD9;COPS5;IRF1;OVOL2;MAFF;DUXB;ZNF829;CGGBP1;ZFPM1;ZNF574;DDX5;BACH1;CHCHD2;XBP1;ZNF124;ZNF568;LDB1;MOSPD1;ZNF546;GMEB1;MLX;JAG1;WIZ;MAX;KDM6B;ZNF850;BHLHE41;ARX;ZNF726;MEF2C;PARP9;MED1;HES4;STAT5A;PRPF6;SMARCD1;BEND3;ZBTB25;ZNF7;ZNF81;ZNF449;TEAD3;ZNF213;EFNA1;ZNF565;CEBPZ;ZSCAN31;PROX2;TCF25;GTF2F1;NLRC5;CDK7;SMARCA5;TADA1;HDGF;IFRD1;SAP30;ZNF552;LMO2;ZNF211;ZNF132;TADA3;GLIS3;ZNF394;ELK3;ZBED3;CKAP2;TCF7;ESR2;ZSCAN5A;DVL2;ZNF235;CRLF3;BUD31;MED29;NR5A2;SREBF1;ZSCAN29;SS18L2;SARS1;CBX5;ATF4;BRD3;CTDP1;UBA52;ZNF226;TAF9B;ZFHX3;RUNX2;RTRAF;USF1;ZBED4;NR4A3;ZNF248;APOE;ZSCAN30;HDGFL2;ATAD2;ZNF749;ZNF480;STAT1;NR0B1;SSBP4;TRIB3;HSBP1;BAX;HDAC3;ZNF793;TFE3;CEBPD;ZBTB49;PELP1;HRAS;NFE2L1;NR1D1;CBX7;SP110;HNF4G;FIZ1;DRAP1;AEBP1;CREBZF;ZNF426;KAT5;ZNF197;ZNF302;CCNQ;SALL2;ZNF814;CCNC;WFS1;CCNK;ZNF665;PAXBP1;ZNF404;CDKN2A;NFIC;RTF1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.43577664496966784,-0.6485695896516545,0.8548387096774194,1.0,1.0,2/5,21.00%,OSMR;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.26927422231528253,0.6482153620244111,1.0,0.9979157348221683,1.0,6/24,15.34%,ABL1;SMAD7;POT1;ERCC4;BAG5;TERF1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.33134003937184575,-0.6481928011338095,0.8831168831168831,1.0,1.0,2/22,8.93%,ALOX5;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.3888976501014883,0.6477661459336553,0.8108108108108109,0.9978614865246695,1.0,1/6,6.17%,FZD3
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.29729548935938366,-0.6477441152784761,0.967032967032967,1.0,1.0,13/61,23.64%,ALOX5;TRIB1;SELENOS;FNDC4;CACTIN;LPCAT3;METRNL;TNFAIP6;APOE;NR1D1;VPS35;TNFRSF1A;CARD8
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.42413266728128457,-0.6476856755761823,0.8823529411764706,1.0,1.0,1/6,12.64%,CALM1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.300120066494808,-0.6476510782546693,0.9545454545454546,1.0,1.0,7/57,13.62%,TRPC5;SELENOK;CACNA1C;CACNA1B;CAMK2A;CACNA1E;MMGT1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.36082887700534766,0.64729954937749,0.9411764705882353,0.9972772954868199,1.0,5/5,63.93%,PAPSS1;PAPSS2;SLC35B2;SLC26A2;SLC35B3
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.36082887700534766,0.64729954937749,0.9411764705882353,0.9972772954868199,1.0,5/5,63.93%,PAPSS1;PAPSS2;SLC35B2;SLC26A2;SLC35B3
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.28849707196133484,-0.6470544083439598,0.9789473684210527,1.0,1.0,10/90,11.75%,TAF7;KCNJ13;TRPM3;SCN9A;CNGB3;SLC7A6;PANX2;SLC22A4;KCNC1;SLC6A6
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.34212387729373184,-0.6463297923325104,0.9493670886075949,1.0,1.0,1/19,8.61%,RNF8
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.3386577668848697,-0.6460916614615704,0.9625,1.0,1.0,4/25,23.18%,POLE3;RPA3;GMNN;DBF4
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.3403591537359518,0.645989442071155,0.9583333333333334,0.9979460305133974,1.0,1/8,8.99%,MAPK3
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3003300611181642,0.6457815340616812,0.9090909090909091,0.9976176237459817,1.0,2/13,8.27%,SH3D19;SNX33
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.34507913595684125,-0.6454465903593726,0.961038961038961,1.0,1.0,3/25,9.68%,PDCD1LG2;VAV3;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.33748082346659297,-0.6453896864179516,0.8875,1.0,1.0,2/19,7.01%,ECT2;KIF20B
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.4068908132424789,-0.6453387509172686,0.9384615384615385,1.0,1.0,2/8,18.58%,TGFB1;PMVK
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.36009263197015684,-0.6453319713874995,0.8961038961038961,1.0,1.0,1/15,4.07%,IFI35
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.4195724679873506,-0.6446406698734253,0.9545454545454546,1.0,1.0,4/6,26.52%,OAS1;SCARA3;RFTN1;SCIMP
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.2810210812029531,-0.6442466140857385,0.9795918367346939,1.0,1.0,17/149,15.34%,TRPC5;TRPM3;KCNK12;SCN9A;DMAC2L;HVCN1;CACNA1G;SLC30A4;CACNA1C;SLC24A5;KCNC1;ATP6V1F;SLC6A6;P2RX4;ATP6V0A4;SLC6A9;ATP6V0E2
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.3362973858394065,0.6442045053327327,0.9032258064516129,0.9986966702153922,1.0,8/8,66.39%,CHP1;RAB11FIP5;PKD1L3;IMPACT;TRPV1;SLC9A1;RAB11B;LGMN
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.3242514981409795,0.6438655344860283,0.9375,0.9984960696855378,1.0,2/8,11.43%,PDE4D;SLC8A1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.3797679725973816,0.6438484048538881,0.8918918918918919,0.9979944577834101,1.0,1/5,6.08%,ABCC11
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.36344609150100415,-0.6438371731795014,0.95,1.0,1.0,6/14,27.36%,PARP9;ZDHHC1;STAT1;CGAS;DTX3L;PQBP1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.37662945384049756,0.643786354862346,0.8,0.9975480974303416,1.0,6/6,62.35%,DDX3X;DHX9;SSB;DDX1;DCP1A;YBX1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.2915617830260452,0.6437302414347716,0.9130434782608695,0.9970748379038589,1.0,8/16,26.44%,MAN2A1;PRKCSH;FUT8;MAN1A2;MGAT4B;MGAT4A;ST8SIA5;ST8SIA1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.2655821798401533,0.6435973881870859,0.9523809523809523,0.996674972109378,1.0,12/28,20.27%,FER;FCHSD2;CDC42EP4;BIN1;CDC42EP1;NCKAP1;PRKCE;CRACD;SPIRE1;PTK2B;TENM1;WASHC2C
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3597529000598607,-0.643384952283535,0.9027777777777778,1.0,1.0,1/12,3.94%,ENTPD7
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.37084291705256,-0.6432865781943233,0.961038961038961,1.0,1.0,2/18,12.18%,BDNF;GSTM3
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.39365312024081583,0.642599065114453,0.868421052631579,0.9969222633360444,1.0,3/5,20.07%,DLL1;NF1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3320209003118545,-0.6425350068287776,0.9078947368421053,1.0,1.0,1/23,2.25%,DDRGK1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.283315565639128,0.6424982542905725,0.9166666666666666,0.9959874130976767,1.0,4/21,11.71%,ACOT9;GLYAT;GPAT4;THEM4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.283315565639128,0.6424982542905725,0.9166666666666666,0.9959874130976767,1.0,4/21,11.71%,ACOT9;GLYAT;GPAT4;THEM4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.3460849908085136,-0.6424477402840141,0.9012345679012346,1.0,1.0,3/19,8.39%,CREB3;SELENOS;XBP1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.42080417638570483,-0.6422903739684503,0.9565217391304348,1.0,1.0,2/7,16.20%,GLUL;ALDH4A1
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.3406841245659515,0.6421460515164904,0.9666666666666667,0.99580720179484,1.0,2/7,11.99%,BCAR1;SH2B2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.35363326425563196,0.642062464930927,0.9393939393939394,0.9953635473910634,1.0,6/6,64.65%,AKT2;INPP5K;CTTNBP2NL;IRS2;AKT1;PRKCB
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.3598339380661676,-0.6417154600861495,0.9459459459459459,1.0,1.0,2/14,18.94%,TRMT10C;PCIF1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.3260550567696564,-0.6408699375075115,0.9506172839506173,1.0,1.0,2/28,8.39%,RRAGA;XBP1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.3603613209309937,0.6405486105595756,0.8888888888888888,0.9956490840078165,1.0,1/6,10.60%,EXOSC7
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.3603613209309937,0.6405486105595756,0.8888888888888888,0.9956490840078165,1.0,1/6,10.60%,EXOSC7
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.23691872237623457,0.6402047687529677,1.0,0.9954058745193846,1.0,9/62,10.36%,KAT2B;ZZZ3;CHD5;KAT2A;JADE3;NAA50;KAT8;MAP3K7;PHF20L1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.3506003756154631,-0.6401825847309555,0.9367088607594937,1.0,1.0,4/14,15.35%,SLC6A6;PRAF2;SLC1A6;GIPC1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.28037789318820966,0.6401276916360027,0.9333333333333333,0.9949542542507706,1.0,9/65,9.94%,RACGAP1;CTSV;SEC24D;KIF15;MARCHF1;CAPZB;AP1S1;AP1G1;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.29541669601811027,0.6396680951409208,0.96,0.9947025775101578,1.0,4/16,11.06%,ACADVL;FMO5;RORA;DGKQ
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.3847378590027988,-0.6391657946214931,0.881578947368421,1.0,1.0,3/7,27.69%,SLIRP;PHAX;NRDE2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.3549539079581644,0.6389095800831918,0.9090909090909091,0.9948136714117577,1.0,3/5,27.23%,LRRK2;MAPT;BAG4
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.2849406363516696,-0.6379408194321852,1.0,1.0,1.0,37/172,25.48%,VEGFA;ECT2;FGF1;FLOT1;RARRES2;TGFB1;RASGRP1;TTN;FN1;SH3GL2;CACTIN;EFNA1;ATG14;ZBED3;DVL2;ATF4;RACK1;C3;PPP2R5A;DNAJC10;WARS1;PLXNB2;HDAC3;HRAS;TERF2IP;VEGFB;TSPYL2;STAT2;PARK7;DVL3;PPIL4;AKAP8;PPP2R5D;ERP29;PDE8A;NDUFS4;SOX9
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.30958896904442174,-0.6377934768069534,0.9655172413793104,1.0,1.0,2/39,6.24%,HSD17B14;CYP3A43
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.34805873268020665,-0.6377125219652072,0.9506172839506173,1.0,1.0,5/18,17.97%,EPHX2;LPCAT3;SREBF1;APOE;ACADL
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.2998424851767715,-0.6374987504447233,0.9743589743589743,1.0,1.0,4/36,15.56%,INA;ATP5PF;CALM1;S100A1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.30016084937186394,-0.6373939863599216,0.9390243902439024,1.0,1.0,8/43,22.55%,EMD;NUP155;ANKLE2;SEC13;CHMP4B;NUP107;NUP188;NUP85
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.30016084937186394,-0.6373939863599216,0.9390243902439024,1.0,1.0,8/43,22.55%,EMD;NUP155;ANKLE2;SEC13;CHMP4B;NUP107;NUP188;NUP85
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3233029984995466,-0.6369236211746089,0.9605263157894737,1.0,1.0,3/24,16.91%,JUN;MEF2C;NR4A3
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.35458685661256006,0.6368959441715321,0.8787878787878788,0.9960931699552543,1.0,1/6,13.32%,SETD2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.30869515604978276,-0.636739690483461,0.9540229885057471,1.0,1.0,5/37,11.53%,AGRN;RARRES2;RBP2;GPC3;RDH10
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.29733766623002145,0.6364299124845314,0.875,0.9960585867403334,1.0,6/18,11.87%,TAB3;MAP2K6;MAP3K7;TAB1;TAB2;UBE2N
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.3595576822275652,-0.6364273666210749,0.9154929577464789,1.0,1.0,2/11,18.65%,H1-4;AIFM1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.34189062708918294,0.6364106955363016,0.875,0.9955534860371182,1.0,7/7,65.83%,PRMT6;PRMT7;PRDM4;COPRS;PRMT5;PRMT1;CARM1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.32328580950561014,-0.6359494042661146,0.8987341772151899,1.0,1.0,5/24,21.48%,H2AX;USP28;DONSON;FBXO6;ATRIP
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.27015439194013524,0.6358473066021622,0.9523809523809523,0.9955011224107915,1.0,9/25,21.28%,CRADD;MAPK3;MAP3K1;TNFRSF10B;MAPK8;MAP3K2;BCL10;HABP4;MAP2K4
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.295863131326085,-0.6355566706094156,0.9565217391304348,1.0,1.0,12/66,19.36%,TGFB1;DBI;SH3GL2;CACTIN;ATG14;ZBED3;PNKP;PTPA;BEX4;DNAJC10;WARS1;TERF2IP
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.2990803814655284,-0.6353348131378099,0.9506172839506173,1.0,1.0,8/46,22.55%,EMD;NUP155;ANKLE2;SEC13;CHMP4B;NUP107;NUP188;NUP85
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.2371884200002532,0.6351897948862102,1.0,0.9954397719183182,1.0,5/38,13.99%,SLC2A6;NUP98;NUP93;AAAS;NUP210
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.35700444688056937,0.635015448564515,0.8636363636363636,0.9950622465727204,1.0,2/6,20.72%,BCO2;ALDH8A1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.33786990974538544,-0.634375570457518,0.9753086419753086,1.0,1.0,4/23,18.12%,TGFB1;ZFPM1;ZFP36L2;TRIB3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.3659973701472789,0.6343192477784025,0.8108108108108109,0.9950824572067936,1.0,1/8,5.35%,CSGALNACT1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.35085185764787796,-0.6341278130176032,0.9420289855072463,1.0,1.0,1/16,3.33%,NOL3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.3416346737842774,-0.6341060126619366,0.9473684210526315,1.0,1.0,3/21,17.10%,TGFB1;MEF2C;APOE
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.3041563060844571,-0.6339078180908894,0.963855421686747,1.0,1.0,5/47,15.58%,PFN2;ANKRD53;DCTN1;LMOD1;BAIAP2L2
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3167117255342751,-0.6337524433458849,0.9240506329113924,1.0,1.0,2/25,7.01%,TGFB1;KIF20B
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.39231224544907173,-0.6337320801001071,0.92,1.0,1.0,7/9,37.35%,EIF2D;EIF2S3;EIF4B;DHX29;EIF2S2;EIF5;MCTS1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.345194420412121,-0.633660515472522,0.9090909090909091,1.0,1.0,3/14,21.02%,AP2A1;AP4M1;KLHL20
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.40038629953280425,-0.6336408617162836,0.9508196721311475,1.0,1.0,2/6,21.38%,RNF8;MSH6
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3190737940112138,0.6335785333436798,0.8636363636363636,0.9952921976336213,1.0,6/18,11.87%,TAB3;MAP2K6;MAP3K7;TAB1;TAB2;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.3466632167197544,-0.6332334386963939,0.9436619718309859,1.0,1.0,1/12,7.01%,KIF20B
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.27579577813040246,-0.6332283577786697,1.0,1.0,1.0,17/117,18.12%,TAF7;SFRP1;DVL1;TRIB1;TGFB1;CEACAM1;SH3GL2;CACTIN;CALM1;ATG14;ZBED3;DDIT4;RACK1;RTRAF;DNAJC10;WARS1;TRIB3
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.2790816940157899,-0.6329046604955235,0.9885057471264368,1.0,1.0,14/80,22.55%,RPL11;DVL1;NUP155;RPF2;CHCHD10;SEC13;MORC3;NUP107;RANBP6;PTTG1IP;RANBP17;XPA;NUP188;NUP85
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.31258644445750505,0.6327339155585335,1.0,0.9955017259872166,1.0,3/13,15.01%,ADGRB3;ADAMTS5;NOS1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.2867528777381814,-0.6327144089947483,1.0,1.0,1.0,10/57,22.55%,RAB11A;NUP155;SEC13;ZDHHC15;NUP107;RANBP6;PTTG1IP;RANBP17;NUP188;NUP85
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.26421707961409036,-0.6326865716417395,0.989247311827957,1.0,1.0,20/150,17.85%,SFRP1;NUBP1;TGFB1;AGT;CDKN2C;DERL2;TCHP;CEACAM1;OGFR;PAPPA2;NCBP1;BTG1;ESR2;CRLF3;SUPV3L1;RACK1;TAF9B;CDKN2AIP;HDGFL2;PRKCQ
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.3651216721130782,-0.6325429652971396,0.8831168831168831,1.0,1.0,2/13,18.87%,HDAC6;SHFL
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3750689944632742,-0.632449514533458,0.9069767441860465,1.0,1.0,3/11,16.17%,TGFB1;DDX5;MAP2K1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.32070440149148005,0.632045159688078,0.8484848484848485,0.9955216839121861,1.0,2/10,12.76%,PSMD13;ADRM1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.29698761445481936,0.6319336113256437,1.0,0.994624709780175,1.0,4/16,16.75%,ATF7IP;DNMT3B;PPM1D;BAZ2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.29698761445481936,0.6319336113256437,1.0,0.994624709780175,1.0,4/16,16.75%,ATF7IP;DNMT3B;PPM1D;BAZ2A
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.33608212145413396,-0.6318338018082984,0.9135802469135802,1.0,1.0,1/21,2.65%,HAP1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.3295883281277113,-0.6316839969073141,0.8974358974358975,1.0,1.0,6/19,26.44%,MEF2C;STIL;CCDC39;AHI1;NDRG4;CCDC40
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.3651849658939601,0.6315380326648962,0.875,0.9944830182217772,1.0,2/7,18.24%,PROX1;NF1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.29055718351299636,-0.6314417737806975,0.9545454545454546,1.0,1.0,7/44,15.86%,TNC;RHBDF1;CDH3;OSMR;TEAD3;ACTA2;COL4A1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.3812165775401069,0.6311190417921317,0.8780487804878049,0.994395462916164,1.0,5/5,61.89%,LNPK;TMEM33;RAB3GAP1;RAB3GAP2;ATL3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.2640714241008621,-0.630969546666498,0.9897959183673469,1.0,1.0,40/312,23.23%,GOLGA8B;RPS23;DHX37;RAB11A;GABARAPL2;GOLGA8A;TUBGCP2;CFAP52;HDAC6;TUBGCP4;B9D1;ATG14;EMC6;ATG16L2;FUZ;LMOD1;AVIL;MAK;TMOD3;MIS12;NEK6;CENPC;CHMP4B;MAP1LC3B2;TRAPPC6A;ZFYVE1;LZTFL1;HDAC3;ULK1;EIF2A;LSM3;GSN;AHI1;ATP6V1D;PGM5;CIRBP;VPS36;FAM161A;ELAPOR1;ATG12
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.2980455898101223,-0.6308836573700923,0.9782608695652174,1.0,1.0,6/57,8.89%,SFRP1;RTKN2;TGFB1;ZFPM1;ARIH2;JAG1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.3933902674841149,-0.6304086757057431,0.9324324324324325,1.0,1.0,1/8,12.08%,CDK7
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.27910946529029584,0.6303250366197706,0.9615384615384616,0.9946857587968908,1.0,6/12,20.57%,PKD2;PROX1;PRKCSH;COBL;NF1;TGFBR3
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.33907244751523896,-0.6302698485971198,0.9210526315789473,1.0,1.0,5/15,27.00%,GTF3C6;NIFK;POLR1G;GTF3A;MARS1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.41553438394367803,-0.6299480452306732,0.9264705882352942,1.0,1.0,1/5,20.92%,MGME1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.3752111328767004,-0.629936645171487,0.9014084507042254,1.0,1.0,2/9,15.92%,NEK6;RSL1D1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.3951023784818472,-0.6297571803048837,0.9130434782608695,1.0,1.0,1/6,8.93%,ALOX12
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.2638015623354308,-0.6292839701037828,1.0,1.0,1.0,39/207,23.18%,PARP2;RPS27A;POLE3;APEX1;ADPRS;BACH1;RFC2;POLQ;SMC1A;NABP2;RPA3;FAN1;FANCC;PNKP;SUPV3L1;PARP4;UBA52;RFC1;RFC4;PARG;TERF2IP;TSN;KAT5;LIG1;MMS19;BRCA1;UBC;FBXO6;GMNN;MSH6;ATRIP;RFC3;XPA;RECQL;POLD2;MBD4;GLRX2;PARK7;DBF4
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.2918803039407579,0.6291309866503474,0.9565217391304348,0.9951016197267869,1.0,2/15,8.95%,FPGS;MTHFD2L
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.41150848260805706,-0.6282992694728251,0.9242424242424242,1.0,1.0,3/5,38.63%,RNF20;RNF40;CTR9
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.33091991060134035,0.6282850756074569,0.7878787878787878,0.9952834441267068,1.0,1/8,5.05%,INAVA
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.35670833611872443,0.6280154901321586,0.813953488372093,0.9949891044082713,1.0,6/6,64.34%,CHPT1;PLA2G7;LPCAT2;PLA2G6;PLA2G4C;PAFAH1B1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.2680412586764152,-0.6279170378061033,1.0,1.0,1.0,32/213,20.92%,PSMB9;SCG2;RPS27A;FGF1;PSMB8;HTR2B;RASGRF2;ICMT;TGFB1;IL3RA;RASGRP1;MEF2C;IL5;PIK3CB;PSMA3;CAMK2A;CALM1;PSME1;PPP5C;UBA52;MAP2K1;RASA3;ZFP36L2;PRKCQ;RASGRP3;HRAS;PSMA7;RASA1;PSMB6;MAPK13;UBC;TAOK3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.39323307716995953,-0.6277832072868651,0.873015873015873,1.0,1.0,2/6,22.31%,CALM1;CAV1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.3290751307180033,0.6275685565885659,0.8928571428571429,0.9949284435158469,1.0,5/12,16.26%,TWSG1;XIAP;ZDHHC17;ITGA3;SLIT2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.2946796267418116,0.6274970005882828,0.9375,0.9944910303251305,1.0,4/11,16.16%,DMD;PIK3CA;SLC8A1;CDH2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2522180211471394,0.6274161183052713,1.0,0.9940630239823577,1.0,18/90,15.60%,ESR1;TAF3;SIRT1;BTRC;SMAD7;KEAP1;PKD2;RNF2;BMP7;HDAC4;PROX1;ERBIN;NFKBIL1;LRRC14;MDFI;OTULIN;GLIS2;TCF7L2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3353193283516209,-0.6269761122914348,0.9295774647887324,1.0,1.0,3/15,20.68%,VIL1;AVIL;GSN
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3353193283516209,-0.6269761122914348,0.9295774647887324,1.0,1.0,3/15,20.68%,VIL1;AVIL;GSN
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.3407647286342761,-0.6258693889787761,0.9397590361445783,1.0,1.0,3/21,23.07%,PRMT8;NTMT1;FBL
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.3884445066977273,-0.6255850568985395,0.9016393442622951,1.0,1.0,2/9,22.91%,CDK16;PARK7
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.2963570503866909,0.6253835614405986,0.9210526315789473,0.9951232612272207,1.0,3/11,12.02%,SSH1;DGKQ;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.31096762520415466,-0.6253199169878106,0.8947368421052632,1.0,1.0,5/22,24.36%,PFN2;TUBB4A;STMN2;STMN1;HIP1R
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.37324090556975337,0.6252608299915359,0.9333333333333333,0.9947312001584876,1.0,1/6,6.14%,GAL3ST3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3421462484303393,-0.6251816539862741,0.9333333333333333,1.0,1.0,1/13,3.94%,ENTPD7
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.33721537371428245,0.6251387965407386,1.0,0.9943663937436505,1.0,1/19,1.26%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.3543584970641911,-0.6248908080823342,0.987012987012987,1.0,1.0,6/17,27.36%,PARP9;ZDHHC1;STAT1;CGAS;DTX3L;PQBP1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.28542274812874824,-0.6248716687729812,0.9651162790697675,1.0,1.0,8/72,13.05%,ALOX5;TGFB1;RSAD2;RHBDF1;TTN;CACNA1C;CACNA1E;CACNA2D2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.3592645976753361,-0.6248499377261068,0.9459459459459459,1.0,1.0,3/13,19.67%,SLC22A4;PDZK1;SLC25A42
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.3235358819759318,-0.6246246252289428,0.9285714285714286,1.0,1.0,1/18,2.23%,RPS27A
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.4186443456044774,-0.6233956431476682,0.9814814814814815,1.0,1.0,2/5,22.31%,FUCA2;CAV1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.3244087297546986,-0.6233849563969283,0.9625,1.0,1.0,4/21,17.10%,OLFM1;STAT5A;DNM2;APOE
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.30756650193764734,0.6233413215996108,0.8333333333333334,0.9953443404715984,1.0,3/14,12.02%,CD247;PTPRC;P2RX7
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.28560727831511756,0.6223082930534778,1.0,0.9956325600955616,1.0,2/21,8.28%,HSPA1A;ABCB10
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.3292325555972324,-0.6216896605224823,0.8918918918918919,1.0,1.0,4/18,19.47%,BDNF;SH3GL2;STMN2;RAB35
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.3105275013744415,0.6215769050045887,0.9142857142857143,0.9955807602414528,1.0,4/9,22.43%,AP1G1;EHD3;CCDC91;SORT1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3056797977573982,-0.6215447154799976,0.9625,1.0,1.0,2/42,4.07%,RTKN2;IFI35
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.27259971716570536,-0.6213425793836929,0.9891304347826086,1.0,1.0,7/99,12.20%,TMEM258;GCNT4;PMM1;DOLPP1;DAD1;MPI;B3GNT5
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.36841382689147495,-0.6213378475215339,0.8695652173913043,1.0,1.0,1/8,9.81%,PKIB
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.26636497649411706,-0.6213045091716881,1.0,1.0,1.0,45/270,26.05%,SEL1L2;PSMB9;RPS27A;PSMB8;TRIM25;SELENOS;DERL2;KCTD2;ZFAND2B;PSMA3;BUB3;PSME1;FBXL13;CDC26;UBA52;FZR1;RFFL;TMUB1;USP19;SKP2;DNAJC10;SYVN1;PSMA7;KAT5;WFS1;PSMB6;FAM8A1;UBC;FBXO6;KLHL20;RMND5B;RNF175;USP44;TMEM129;BAG6;UBXN1;ERLIN2;RBX1;PSMC4;MAN1A1;RNF187;ARMC8;TRIM13;SPSB3;PSMB1
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.2606538383514922,-0.6211679799039793,1.0,1.0,1.0,41/265,22.91%,PARP2;SPDYA;PHF1;VAV3;POLE3;APEX1;ADPRS;BACH1;RNF8;RFC2;POLQ;SMC1A;NABP2;FAN1;FANCC;DDX11;H2AX;USP28;PNKP;CBX1;CBX5;PARP4;CDKN2AIP;RFC4;BAX;CGAS;CCNK;LIG1;MMS19;BRCA1;FBXO6;TAOK3;KIN;MSH6;ATRIP;RFC3;XPA;RECQL;MBD4;BCL2L2;PARK7
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.2818966691079524,-0.6211136682804774,0.9894736842105263,1.0,1.0,6/87,7.22%,SFRP1;ECT2;AGRN;RAP1GAP;S100A10;RASGRP1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.31762520412732975,0.6210971508447641,0.9615384615384616,0.9954575258312605,1.0,4/17,13.52%,GDAP1;USP30;MFN1;MIGA1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.33629738583940644,0.620973530198156,0.9375,0.9950754061553372,1.0,8/8,66.39%,RIPK2;BAD;ASPH;CYFIP2;IFI16;NLRC4;GRIN2A;LGMN
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.268669190929648,-0.6208198139735976,0.9772727272727273,1.0,1.0,4/54,10.49%,CDKN1C;AGT;PKIB;PIK3CB
prerank,PanglaoDB_Augmented_2021__Microglia,0.2767648968472106,0.6204958121987084,1.0,0.9949704015725377,1.0,4/29,5.13%,OTULINL;COLEC12;SALL1;MERTK
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3384056620286697,0.6202611735437209,0.8928571428571429,0.9947048987850879,1.0,4/8,21.77%,PLCB1;ABCA2;RAMP1;CHP1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.28438389354631016,-0.6200422543708428,0.9659090909090909,1.0,1.0,16/65,26.69%,CRYAB;PAMR1;FN1;COL6A1;LMOD1;ACTA2;COL4A1;PTN;MYLK;THBS2;CALD1;THY1;COL14A1;COL4A2;PDGFRB;C1S
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.36638810312098197,0.6199747093662967,0.8787878787878788,0.994359399893861,1.0,1/8,4.82%,CREB3L1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.358126150826887,-0.6198860834216606,0.9342105263157895,1.0,1.0,4/14,25.77%,EFNA1;P2RY12;CYP1B1;ADAM9
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.2985084087631025,-0.6196316704575912,0.9772727272727273,1.0,1.0,7/37,22.88%,HAX1;HDAC6;VDAC1;SREBF1;DNM1L;VPS35;STAT2
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.23406925858599273,0.6192929773541302,1.0,0.9943173047152529,1.0,13/36,21.48%,MAP2;FER;LRRK2;PARD6G;CSNK1E;PPM1F;KIAA1614;PINK1;PRKN;EPHA5;WWC1;GOSR1;STXBP4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.2634559565409723,-0.6187595089066038,0.9891304347826086,1.0,1.0,5/91,6.01%,CFAP61;MNS1;RAB11A;ARFIP2;BLOC1S2
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3477062794587245,-0.6178262960095808,0.9736842105263158,1.0,1.0,5/12,31.55%,DERL2;ERLEC1;OS9;EDEM2;UBE2G2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.2753978828050408,0.6174641853604241,1.0,0.9949434293405883,1.0,3/13,17.32%,PKD2;DLL1;GALNT11
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2659456374537877,0.6174518606552235,0.9375,0.9944647597660928,1.0,8/63,9.94%,RACGAP1;CTSV;SEC24D;KIF15;CAPZB;AP1S1;AP1G1;PIKFYVE
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.28944262756848876,-0.6171036424772696,0.9880952380952381,1.0,1.0,13/64,25.27%,TNC;SFRP1;HAS2;TCEAL9;ADAMTS7;COL4A1;NRP2;PLS3;PTN;CALD1;RND3;SRPX;COL4A2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.2854761137213669,-0.6163971785124222,0.9767441860465116,1.0,1.0,9/49,22.56%,RPS27A;CTSL;OAS1;S100A1;UBA52;UBC;SCARA3;HSPD1;RFTN1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.39046560781937806,-0.616157870221678,0.9523809523809523,1.0,1.0,1/6,19.61%,DNM1L
prerank,PanglaoDB_Augmented_2021__B Cells,0.288806553094244,0.6160650073309681,0.875,0.9950100849333063,1.0,8/35,12.44%,EBF1;EDEM1;EAF2;FCHSD2;GPR174;PTPRC;IRAG2;SWAP70
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.35254951129620116,0.6159942009957899,0.8974358974358975,0.9945763379354239,1.0,1/5,6.02%,RAB31
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.35022394545089913,0.6153002815452241,0.9117647058823529,0.9946142610662748,1.0,6/6,64.99%,NPM1;SDAD1;XPO1;NMD3;NUP88;RAN
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.4094919066654894,-0.6142160427696847,0.9166666666666666,1.0,1.0,1/5,17.92%,DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.4094919066654894,-0.6142160427696847,0.9166666666666666,1.0,1.0,1/5,17.92%,DPY19L1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.27059012577044605,-0.6140817138167893,1.0,1.0,1.0,15/101,19.22%,HES5;ALOX5;CAMK1;TGFB1;DDX5;BDNF;SLC6A6;EMP2;ATF4;ZFHX3;RUNX2;CEBPD;NR1D1;HSP90AB1;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.32365512826965287,0.6140260100919144,0.8666666666666667,0.9949542994305016,1.0,2/7,17.43%,PID1;PINK1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.3659072702717847,-0.6137676422688836,0.9722222222222222,1.0,1.0,2/11,16.04%,CTDP1;CHMP4B
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.2656804337639735,0.6130916962006993,1.0,0.9950186439627069,1.0,26/26,73.48%,SUV39H2;WDR82;SETD3;SETD1B;KMT2D;SETMAR;ASH2L;KDM6A;EZH2;PRDM5;SETDB2;SMYD3;SETDB1;TRMT112;KMT2A;PAXIP1;DPY30;SETD6;SMYD2;WDR5;DOT1L;MEN1;CXXC1;EHMT2;KMT2B;RBBP5
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.28290757222803803,-0.6130545029922144,1.0,1.0,1.0,4/56,9.17%,TRPC5;TACR1;FPR3;CACNA1C
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.3544718246291889,-0.6127814565597643,0.9452054794520548,1.0,1.0,2/12,10.39%,HTR2B;BDNF
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.28133499041101434,-0.6127055653534318,0.9887640449438202,1.0,1.0,2/41,8.39%,RPS27A;AZI2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.3997443776582511,-0.6126534331714969,0.9402985074626866,1.0,1.0,1/6,13.47%,DNM2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.35194268308464277,-0.6121784673073101,0.9466666666666667,1.0,1.0,3/13,14.24%,GSTO1;CALM1;SLC6A9
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.30230765056003267,-0.6121757157550864,0.9518072289156626,1.0,1.0,1/20,5.01%,CFTR
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.3611919773792739,0.6121020813289861,0.9333333333333333,0.9951717045751085,1.0,2/7,12.70%,TGFBR2;CHRD
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.2816934311238179,-0.6120231770852088,1.0,1.0,1.0,24/90,27.19%,IFI35;ALOX5;SELENOS;AGT;USP18;NLRP1;FNDC4;GRN;LPCAT3;METRNL;TNFAIP6;APOE;NINJ1;NR1D1;MAPK13;VPS35;PARK7;TNFRSF1A;IL18;LRRC19;TMSB4X;AOAH;PTPN2;UFL1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.29344492900778396,-0.6119746586466702,0.9634146341463414,1.0,1.0,6/46,17.10%,ROMO1;JUN;PRDX5;PJVK;APOD;APOE
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.2865645689828127,0.6114574258938547,0.9545454545454546,0.9951293938579256,1.0,12/12,71.37%,TP53BP1;SHLD1;KMT5B;MAD2L2;TFRC;SLC15A4;PAXIP1;SUPT6H;RIF1;HMCES;SHLD2;KMT5C
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.29555334370741027,-0.6113614461316538,0.9560439560439561,1.0,1.0,8/42,17.88%,ALOX5;SPINK5;NAXE;CNMD;CD160;PGK1;SARS1;STAT1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.27777156783746904,-0.610669414460132,0.9770114942528736,1.0,1.0,11/65,20.53%,PCSK1N;RAP1GAP;IQSEC3;CACNA2D2;SCAMP5;TMEM179;KIF1A;CALY;STMN2;CPLX1;SYT4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.27560958299826765,-0.6102857553807328,0.9880952380952381,1.0,1.0,12/57,24.08%,POLR1C;SNRPB;CSTF2;CDK7;NCBP1;CSTF1;TAF1D;POLR1G;SNRPG;CPSF1;UBTF;SLBP
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.3960983600063018,-0.609738810183364,0.9459459459459459,1.0,1.0,1/7,4.29%,ALOX5
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.26723217649462055,-0.6096965816527511,0.9659090909090909,1.0,1.0,15/117,19.69%,SFRP1;GABARAPL2;RRAGA;XBP1;RRP8;ATP6V1F;ATG14;SEC13;SREBF1;ATP6V0E2;ATF4;MAP1LC3B2;ZFYVE1;EIF2AK2;LARS1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.34569810239248877,0.6095341187722905,0.8518518518518519,0.9957434449187497,1.0,4/7,19.16%,TANC2;KIF1C;PPFIA2;KIF5A
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.30433510871796693,-0.6090924696758943,0.9230769230769231,1.0,1.0,4/28,12.64%,JPH3;GSTO1;CEMIP;CALM1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.2788889255200238,0.6089333451165059,0.9666666666666667,0.9956477035383455,1.0,1/12,4.78%,SIRT1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.27227686893848635,-0.6086135922750124,1.0,1.0,1.0,11/86,17.18%,CDKN1C;SSPN;CRYAB;JAG1;RNASE1;PAMR1;LMOD1;COL4A1;NEK6;C3;VWF
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.24968792199074086,0.6083780451167569,1.0,0.9956140798788657,1.0,5/25,17.33%,ARHGEF6;CDH13;ARHGEF7;CCDC88A;ABLIM2
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.30312516395871514,-0.6076022886029221,0.9466666666666667,1.0,1.0,6/26,24.67%,AGT;EFNA1;SH3BP5L;CAV1;THY1;SH3BP5
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.3147985117744969,0.607365167174105,1.0,0.9959701527416978,1.0,1/23,1.26%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.21828132813961404,0.6069253707037161,1.0,0.9957151127987202,1.0,6/48,11.59%,KAT2B;MEIS1;KMT2C;CBFB;ZBTB16;MOV10
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.3060482129037471,-0.6065284930456125,0.9866666666666667,1.0,1.0,5/25,26.78%,ATP6V1F;ATP6V0A4;ATP6V0E2;ATP6V1D;ATP6V1E1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.26438887761202906,0.606235842507537,0.9,0.9956284225331734,1.0,2/11,17.29%,HDAC4;FBP1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.3150785690404547,0.6060602616450708,0.9333333333333333,0.9953207478052302,1.0,10/10,68.51%,SEC16A;INSIG1;SAR1A;TM9SF4;GCC2;SAR1B;BRSK2;TMEM30A;CD81;SORL1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.31023754668658016,-0.6057511396822315,0.9605263157894737,1.0,1.0,5/27,21.63%,FN1;PIK3CB;DSC2;P2RY12;VCL
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.3813603859375964,-0.6056809334065892,0.90625,1.0,1.0,1/6,12.29%,SAXO1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.3758711382044385,-0.6056595910465884,0.9583333333333334,1.0,1.0,3/8,29.68%,MBD4;NTHL1;OGG1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.40757408537994155,-0.6052753189378798,0.9459459459459459,1.0,1.0,1/5,10.09%,TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.40757408537994155,-0.6052753189378798,0.9459459459459459,1.0,1.0,1/5,10.09%,TOM1L1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.35813611445380406,0.6052608821055383,1.0,0.995225500305656,1.0,7/7,64.20%,CHP1;RAB11FIP5;PKD1L3;IMPACT;TRPV1;SLC9A1;RAB11B
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.2666638455949258,-0.605157463446037,0.9887640449438202,1.0,1.0,11/76,21.07%,GSTK1;EPHX2;CACNA1B;PRDX5;CDK7;ESR2;HRAS;IDI1;CRAT;PEX11B;PEX14
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.2328754933563792,0.6049438498632016,1.0,0.9949359977924331,1.0,13/48,20.01%,RPS6KB1;ANKRD17;PKD2;EGFR;PROX1;SRPK2;ADAM17;PSRC1;PRKCA;EIF4E;C6ORF89;USP22;MEIS2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.3011493105437606,-0.6037528013642457,0.9866666666666667,1.0,1.0,2/25,14.25%,ABRAXAS1;USP50
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.266392128156013,-0.6036771492977132,0.9888888888888889,1.0,1.0,7/92,12.47%,SFRP1;H2AZ1;CFTR;TGFB1;MEF2C;MED1;P2RX4
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.26203826179365697,0.6033823403407804,0.9375,0.9953619865647735,1.0,14/38,20.40%,FAM107A;WASF3;ABI1;WASL;WASHC5;COBL;DIAPH1;MICAL1;SPIRE1;ARHGAP6;TTC17;MICAL2;CFL2;ENAH
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.3907355820519351,-0.6031183440594009,0.9661016949152542,1.0,1.0,3/5,30.82%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.3907355820519351,-0.6031183440594009,0.9661016949152542,1.0,1.0,3/5,30.82%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),0.34369006053259066,0.6028905146804694,0.9230769230769231,0.9951609561232747,1.0,1/9,2.21%,FBXW7
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.3438027353995774,-0.60276176508482,0.9571428571428572,1.0,1.0,1/13,3.99%,NAAA
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.34788974594170685,-0.6025024681743489,0.9295774647887324,1.0,1.0,3/10,25.53%,TYMP;ERH;OARD1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.2693348221960079,-0.6023686251899043,0.9888888888888889,1.0,1.0,16/73,24.10%,VEGFA;IL20RA;RTKN2;RHBDF1;OSMR;TEAD3;EMP2;AKAP5;THSD4;TMEM54;SCARA3;FSTL3;CLDN18;SLC44A3;BTC;RND3
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.39784425715967764,-0.6023379047371051,0.9230769230769231,1.0,1.0,2/6,15.40%,WNT5B;ATF4
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.29982611021936856,0.6019732568496594,0.9615384615384616,0.9952776789678933,1.0,13/13,70.04%,APBA1;DYNC1I1;CLIP3;SPG11;BORCS5;COPG1;ARHGAP21;BAG3;DYNC1I2;CDC42;COPG2;CAMSAP3;APP
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.296146697820594,-0.6019069037063577,0.9651162790697675,1.0,1.0,4/42,13.47%,KIF20B;ANKRD27;BDNF;DNM2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.3440042444229075,-0.6017663556224732,0.9583333333333334,1.0,1.0,6/10,26.88%,CEACAM1;ACADL;TRIB3;BRCA1;ERLIN2;WDTC1
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.3146780450752826,-0.601292747245452,0.9390243902439024,1.0,1.0,5/20,17.82%,AGRN;FUCA1;GPC3;CHIT1;HGSNAT
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3023838440625437,-0.6012374432516543,0.9625,1.0,1.0,3/27,19.69%,RRAGA;TELO2;LARS1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.31796533241554037,-0.6010188886364121,0.961038961038961,1.0,1.0,7/23,33.60%,HDAC3;TAOK3;GSTP1;DNAJA1;AIDA;PDCD4;MEN1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.27826899231195457,-0.6007571859487549,0.9770114942528736,1.0,1.0,5/52,15.04%,TTN;OBSCN;LMOD1;TMOD3;ALKBH4
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.31049349015968464,-0.6003144740026888,0.9493670886075949,1.0,1.0,6/21,26.44%,MEF2C;STIL;CCDC39;AHI1;NDRG4;CCDC40
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.28376837012816436,-0.6001537835184364,0.9736842105263158,1.0,1.0,3/36,9.46%,VEGFA;AGT;HAS2
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.2975108308537575,-0.6001030165287768,0.9873417721518988,1.0,1.0,2/31,8.39%,RRAGA;XBP1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.4078534433289246,0.6000746816493154,1.0,0.9961701473879014,1.0,2/6,12.63%,PTPRU;FRS2
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.28006494228777773,-0.5999382173070088,1.0,1.0,1.0,10/73,15.86%,RHBDF1;CRYAB;TTN;AFAP1L1;FN1;TEAD3;SYNC;COL6A1;LMOD1;COL4A1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.3682138107268722,-0.5998008100173308,0.9032258064516129,1.0,1.0,4/6,30.67%,HDAC6;SAT2;SAT1;AMD1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.30363557746776026,-0.5997479106738939,0.987012987012987,1.0,1.0,2/26,18.44%,MAEL;NIFK
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.2458881095398614,-0.5993706398929294,1.0,1.0,1.0,25/245,17.51%,CD63;ARMCX3;ARL1;USP6;STX10;COX18;RRAGA;ARFIP2;NAPA;STX19;ARL4C;HDAC6;SCG5;AP2A1;MESD;ARFGAP3;EMP2;STX1B;SEC13;RIC3;TMED1;USP4;ZDHHC15;SNX17;SEPTIN1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.28412963653031925,-0.5990075098935482,0.9885057471264368,1.0,1.0,8/61,15.68%,USP6;ICMT;DUSP12;UBL5;PIGH;UBE2L6;PARP4;UBA52
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.3570473388606579,0.5989340859240285,0.9444444444444444,0.9964272525433644,1.0,9/9,64.32%,NOS1;CBARP;INPP5K;ATP1A2;TRIM27;SLC30A1;CAV3;TMBIM6;PLN
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.29538675925006924,0.5988652153350086,1.0,0.9959706641680239,1.0,5/19,15.51%,SYT12;DOC2A;SYT9;SYT17;STX1A
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.3724259681373178,-0.5987682724363207,0.9402985074626866,1.0,1.0,3/12,25.81%,JAG1;MYLK;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.2745446008872148,-0.5987681604911346,0.9888888888888889,1.0,1.0,15/64,23.58%,RBM3;CLU;EFNA1;RPS4X;UPF3B;RACK1;UPF3A;NSUN5;RPS27L;PLXNB2;RPL5;PCIF1;CASP3;CIRBP;TNFRSF1A
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.3554301600960044,-0.5980777371205659,0.9857142857142858,1.0,1.0,3/9,25.99%,GRN;CD55;RPS19
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.2957819620873076,0.5980222060925887,1.0,0.9959811145845546,1.0,6/21,28.09%,EXOSC7;MTREX;XRN1;DIS3L;EXOSC6;PARN
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.28780953205182425,0.5976139531465329,1.0,0.9956835822906617,1.0,1/17,3.31%,GDAP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.3218242243077574,-0.5975639693561883,0.9390243902439024,1.0,1.0,8/19,25.98%,CAMK2A;P2RX4;WNK3;MYLK;WFS1;CAV1;PDGFRB;SPHK2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.25027731066976044,0.5973972418243806,1.0,0.9953951381513343,1.0,4/26,11.91%,PATL1;DCP1B;EXOSC7;EXOSC1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3174157952772267,-0.5971396146512814,0.9605263157894737,1.0,1.0,4/17,23.58%,BLOC1S2;DELE1;BAX;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3612319648538803,-0.5970839333913008,0.9545454545454546,1.0,1.0,5/10,28.77%,CALM1;PTPA;HSP90AB1;PDGFRB;PPP1R15B
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.3030321671766588,-0.597021110306878,0.9746835443037974,1.0,1.0,8/24,30.47%,FGF1;HSBP1;HSP90AB1;DHX36;STUB1;PRKACA;HTRA2;SLU7
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.3579424129509544,0.5963605494671153,0.8648648648648649,0.9955465053122892,1.0,3/7,24.74%,KMT2C;SETD1B;KMT2D
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.3039756525181667,-0.5961496218157257,0.948051948051948,1.0,1.0,6/20,24.58%,MESD;EMP2;RIC3;USP4;VCL;UNC50
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.31647383402147683,-0.5961164260169568,0.987012987012987,1.0,1.0,4/18,26.30%,SPG7;PMPCA;AFG3L2;YME1L1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.30240856520762005,-0.5957856927700003,0.975,1.0,1.0,3/25,17.90%,HNRNPA2B1;SRRT;ADAR
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.24254686999835495,-0.5954224105741449,1.0,1.0,1.0,85/640,22.31%,ZBTB32;RPS14;HES5;CRYM;VEGFA;TAF7;RPS27A;SFRP1;RPL10;RPL23;CDKN1C;HES1;CHD3;TLE6;JUN;ZFP69;TGFB1;IRF1;CGGBP1;ZFPM1;DDX5;BACH1;HDAC6;CRYAB;ZNF124;ZNF568;LDB1;MOSPD1;MLX;MAX;BHLHE41;MEF2C;SCML1;PARP9;MED1;BEND3;PRDX5;EFNA1;TCF25;HDGF;SAP30;GLIS3;ELK3;ESR2;SARS1;CBX5;ATF4;UBA52;TAF9B;ZFHX3;RUNX2;NR4A3;ZNF248;ZNF749;STAT1;NR0B1;TRIB3;HSBP1;HDAC3;MAEL;NR1D1;CBX7;DRAP1;AEBP1;CREBZF;KAT5;BCL7A;WFS1;ZNF404;CDKN2A;NFIC;RTF1;BRCA1;UBC;ATP8B1;PEX14;EID2B;ZNF875;EID1;GMNN;SET;DDX20;SNW1;EZH1;CAV1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.32153364321362754,-0.5953344148547508,0.9655172413793104,1.0,1.0,2/20,12.20%,GCNT1;B3GNT5
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.23943885959438985,0.5953055335964963,0.95,0.9956450061313056,1.0,6/25,19.37%,IRS1;ARPP19;OSBPL8;PID1;AKT2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.28340548206138416,-0.5952913711769239,0.9875,1.0,1.0,7/39,21.00%,COPS5;SEMA4C;RASGRP1;MAP2K1;EIF2AK2;TAOK3;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.37262609658423373,0.5951584193693625,0.85,0.9952428422553841,1.0,1/5,6.72%,FOXO1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.30797946068847126,0.5950354058530682,1.0,0.9948586291565427,1.0,2/11,11.73%,CDK12;ELL
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.3733642321887995,-0.5949925806661687,0.927536231884058,1.0,1.0,4/8,24.27%,PARP9;DDX11;GMNN;DTX3L
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.3887208724621858,-0.5945158121278183,0.9152542372881356,1.0,1.0,1/5,25.90%,RHOJ
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.27228840743800237,-0.5940511205978678,1.0,1.0,1.0,4/49,9.87%,ENTPD7;DBI;ACSM3;HINT1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.3074647225738465,-0.5938853604304667,0.9868421052631579,1.0,1.0,4/23,21.63%,FN1;PIK3CB;P2RY12;VCL
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.34213077713755735,-0.5936254251086254,0.9466666666666667,1.0,1.0,4/12,29.68%,MBD4;NTHL1;NT5C;OGG1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.3441778087092976,0.5935077291417932,0.9090909090909091,0.9952380670485813,1.0,3/5,24.53%,NOS1;CYP2U1;CYP2R1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.35162043471318843,-0.5919575623747362,0.8472222222222222,1.0,1.0,1/7,13.79%,PJVK
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.2949444386251383,0.5918355486971454,0.9655172413793104,0.9957749730205617,1.0,3/9,20.35%,CTBP1;NIPBL;PRMT6
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.34519888297327195,0.59170898902144,0.9459459459459459,0.9953121829567392,1.0,1/6,7.12%,PHF14
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.32876692322352774,-0.5901979445336422,0.9863013698630136,1.0,1.0,4/18,20.84%,SST;LMO2;SRP14;G6PC2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.22381611967478493,0.5901420681779455,1.0,0.9958397650559273,1.0,11/48,18.98%,NLGN1;DCC;KANK1;ADCY6;SEMA3A;PTPRS;BAG5;LPAR1;DENND5A;CBFA2T2;RTN4RL2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.22263941482656918,0.589904945301216,1.0,0.9954562016836284,1.0,13/94,11.25%,GPSM1;SIRT1;SLC38A9;SESN1;CAPNS1;MAP3K7;ATP6V1A;LRRK2;SMG1;LAMTOR2;PIK3CA;NEDD4;MLST8
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.3279557100956809,-0.5898533840144666,0.9571428571428572,1.0,1.0,5/11,32.15%,IL7;EIF2AK2;IL18;APP;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.3142552715424368,-0.5897637463216372,0.9436619718309859,1.0,1.0,3/15,18.54%,XBP1;IL7;CD46
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.3353093681609777,0.5895913960052429,0.875,0.9951080215044869,1.0,1/5,12.02%,P2RX7
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.3322567144278721,-0.5894360809069332,1.0,1.0,1.0,3/14,16.85%,SRRM4;MTCH1;C3
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.34301840231262354,0.5893177611188042,0.90625,0.9947951724843954,1.0,1/8,6.14%,GAL3ST3
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.36716800414390893,-0.589191594720294,0.90625,1.0,1.0,3/9,20.68%,ARFIP2;VIL1;GSN
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.3912100870442451,-0.5887449914947037,0.9710144927536232,1.0,1.0,1/6,9.51%,ARX
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.31093548560558204,-0.5884213196573232,0.9466666666666667,1.0,1.0,3/16,22.31%,TGFB1;CATSPERG;CAV1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.2671483023207531,0.588173461429069,1.0,0.9949809904689662,1.0,3/16,14.85%,AUTS2;DNMT3B;BCOR
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.29359105999037216,0.5880286492164246,0.9310344827586207,0.9945723823488702,1.0,6/13,26.88%,WASHC1;JMY;SPIRE1;ARPC2;ACTR3;IQGAP2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.25110344715375954,0.5875370267889074,1.0,0.9944786200697787,1.0,6/27,16.76%,CTBP1;MAPK3;UBE2N;NOS1;NIPBL;TADA2A
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.32889717044936717,-0.5873911344683049,0.971830985915493,1.0,1.0,4/13,47.64%,AXL;KPNA6;P4HB;VPS4A
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.3771353779477545,0.5869406483397449,1.0,0.9943587585350515,1.0,1/5,13.19%,RAPGEF2
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.3868505051490255,-0.5869319083317038,0.9206349206349206,1.0,1.0,1/5,10.60%,GLUL
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.3188686814656325,0.5868911049508791,0.9375,0.9938899716614656,1.0,9/9,68.13%,SETD2;SETD3;SETD4;SETD7;SETD6;EHMT1;SMYD2;CSKMT;KMT5A
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.3445763972295187,-0.5864417907793502,0.9264705882352942,1.0,1.0,4/11,24.27%,PARP9;DDX11;GMNN;DTX3L
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.32824057735443835,0.5863583055484576,0.9259259259259259,0.9937356278038518,1.0,2/7,13.13%,CDS1;CDS2
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.2886722648608817,0.5858455628316098,0.9655172413793104,0.9935814347462943,1.0,4/12,18.36%,DCX;TTLL3;SPAG16;TOGARAM1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.3478817144181694,-0.5856677064719092,0.8955223880597015,1.0,1.0,1/7,15.90%,NEK6
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.34010695187165774,0.5854778640357333,0.9318181818181818,0.9933141196051328,1.0,5/5,66.00%,PPIP5K2;IPPK;ITPK1;IMPA1;PPIP5K1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.3116236130053296,-0.5850991550468024,0.975,1.0,1.0,4/15,23.57%,RBKS;G6PC3;G6PC2;PGLS
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.2909536444285478,-0.5850695769941527,1.0,1.0,1.0,3/35,13.56%,RASGRP1;PIK3CB;LPAR6
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.29724772840003744,-0.5849398804611821,0.9642857142857143,1.0,1.0,6/22,27.32%,ECT2;MICALL2;POF1B;CLDN18;CLDN10;PRKCI
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3038409334653956,-0.5847622717136889,1.0,1.0,1.0,6/21,29.46%,BTBD18;THOC5;CCNK;HMGN1;SUPT16H;SUPT5H
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.26451223664525686,-0.5842678852664067,1.0,1.0,1.0,16/72,29.57%,PSMB9;PSMB8;PSMA3;PSME1;HRAS;PSMA7;PSMB6;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PRKACA;PSMA4
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.26451223664525686,-0.5842678852664067,1.0,1.0,1.0,16/72,29.57%,PSMB9;PSMB8;PSMA3;PSME1;HRAS;PSMA7;PSMB6;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PRKACA;PSMA4
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.26451223664525686,-0.5842678852664067,1.0,1.0,1.0,16/72,29.57%,PSMB9;PSMB8;PSMA3;PSME1;HRAS;PSMA7;PSMB6;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PRKACA;PSMA4
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.3231343996952076,0.5840200690282921,0.9333333333333333,0.993700242583651,1.0,4/7,25.63%,RAP1A;RAP1B;CBARP;STXBP3
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.362283609191701,-0.583854535930953,0.9594594594594594,1.0,1.0,2/9,15.35%,CDH3;GIPC1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.37911751835143215,-0.5837511214905127,0.971830985915493,1.0,1.0,1/7,20.92%,MGME1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.2574869942387347,-0.5836294272895752,0.9887640449438202,1.0,1.0,10/100,17.49%,TUBB4B;TUBA4A;CEP72;CDK7;DNM2;DCTN1;TUBB4A;ODF2;SKP2;DCTN3
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.3229107572022871,-0.5833345155478166,0.9594594594594594,1.0,1.0,2/15,11.33%,CLU;EFNA1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.2985276320580978,0.5832335609835266,1.0,0.9936507498074123,1.0,3/9,21.16%,MSN;PRKN;RAB21
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.31291404055848576,-0.5832187015060234,0.922077922077922,1.0,1.0,2/10,21.42%,HINT1;DNPH1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.3597384476760879,-0.5830138081074615,0.9841269841269841,1.0,1.0,2/8,24.20%,LPCAT3;OSBPL10
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.33474323983222254,-0.5823758677349425,0.9605263157894737,1.0,1.0,4/11,29.97%,MT2A;ATOX1;SLC31A1;APP
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.3654538177446185,-0.5820620585752369,0.9344262295081968,1.0,1.0,1/6,21.05%,MTLN
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.2925282874748296,-0.5819442912460671,1.0,1.0,1.0,5/29,18.32%,CLU;GRN;DDIT4;ATF4;BAX
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.35760093587927055,0.5816451538383792,0.8787878787878788,0.9940189310608154,1.0,1/5,9.16%,FTO
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.27742607111908346,-0.5815948923805723,1.0,1.0,1.0,10/28,32.52%,IL3RA;BLNK;MYO1F;PSTPIP1;ITM2C;GPR183;AOAH;SPI1;ITGAL;DOCK8
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.25178876049660104,-0.581395977173358,1.0,1.0,1.0,18/117,23.56%,TRIM5;FLOT1;CGGBP1;YBX3;KDM6B;IGF2BP2;CACTIN;HNRNPDL;ATXN7L3B;STX1B;APOE;HNRNPAB;RASA1;ATRAID;TAPBP;ZNF711;CTCF;CDK4
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.26923802213603604,-0.5813364591801953,0.9888888888888889,1.0,1.0,19/76,29.84%,PSMB9;PSMB8;PSMA3;PSME1;FBXL13;SKP2;PSMA7;PSMB6;FBXO6;RBX1;PSMC4;PSMB1;PSMD2;PSMB3;PSMC3;PSMC5;PSMD7;PSMA4;FBXO2
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.31999709108832874,-0.5811921506688977,0.9746835443037974,1.0,1.0,2/18,14.47%,HTR2C;TYMP
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.37787433155080224,0.5803137882413975,0.9285714285714286,0.9941780423399844,1.0,5/5,62.23%,EXOSC6;PARN;EXOSC10;EXOSC5;EXOSC2
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.2810466747297664,-0.5800826315875642,1.0,1.0,1.0,8/49,23.23%,GABARAPL2;ATG14;EMC6;ATG16L2;MAP1LC3B2;ULK1;ELAPOR1;ATG12
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.26958629449844473,-0.5799765211999226,0.9883720930232558,1.0,1.0,8/65,15.68%,RPS27A;SFRP1;DVL1;SFRP4;WNT5B;TCF7;DVL2;UBA52
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.3516711229946524,0.5788303480541447,0.9666666666666667,0.9945021477725551,1.0,5/5,64.84%,SLC38A6;SLC38A3;SLC38A1;SLC1A4;SLC38A2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.29971172172366356,-0.578205977764862,1.0,1.0,1.0,3/22,12.47%,RARRES2;TGFB1;P2RX4
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.336959133442303,0.5780385055810321,0.9696969696969697,0.9944871122845441,1.0,2/7,14.04%,MEGF10;THBS4
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.32627005347593574,0.577878760144111,0.9375,0.9940900129648236,1.0,5/5,67.38%,ZNF274;ATRX;SMARCB1;PIH1D1;ZNF304
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.31247014267827383,0.5771078325073791,0.9230769230769231,0.9940317956677923,1.0,1/6,11.70%,PTPRS
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.3152461748890865,-0.5769767373617926,0.9625,1.0,1.0,2/14,18.31%,ATP6V0A4;SLC12A4
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.2574190508633095,0.5765888413615314,0.9615384615384616,0.9938782082313878,1.0,5/16,19.40%,CBLB;PTPRC;SRCIN1;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.3667780748663101,0.5764531744885735,0.918918918918919,0.9934906545885567,1.0,5/5,63.33%,ACSS1;ACSS2;ALDH2;ADH5;SULT1C4
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.3368648980982347,-0.5763009827887098,0.9384615384615385,1.0,1.0,2/7,21.38%,CHTOP;MSH6
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.28981220507806704,0.5753031075242747,1.0,0.9937101486286288,1.0,6/15,18.42%,MCU;MARCHF5;RALA;SPIRE1;PINK1;PRKN
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.2881767180333966,-0.5745843029557006,0.9875,1.0,1.0,2/26,12.60%,ECT2;RRH
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.27083865549021535,-0.5740412293103043,0.9875,1.0,1.0,20/62,31.04%,RETREG1;MEF2C;BDNF;GRN;ATF4;APOE;BAX;RASA1;WFS1;NRBP2;SET;PARK7;BACE1;PRKCI;MAG;SOD2;PTPRZ1;MT3;PPT1;KCNB1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.34064559020652896,-0.5734757115619956,0.9384615384615385,1.0,1.0,3/10,25.99%,XBP1;CD46;RPS19
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.31583905119346767,-0.5731241094750789,0.9726027397260274,1.0,1.0,1/13,4.84%,RAB11A
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.32000802192659944,0.5730111872692255,0.9333333333333333,0.99456179387589,1.0,6/6,68.01%,PID1;NFKB1;PTPRT;SBNO2;RELA;ST3GAL6
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.25495960303557047,0.5729394497037206,1.0,0.9941311810725322,1.0,6/18,26.94%,ZBTB20;P2RX7;PSEN1;PFKFB3;PFKFB1;NFKB1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.23873760672209035,0.5721849168880604,1.0,0.9940038802291707,1.0,13/29,22.74%,MSN;LATS1;BAG5;RAPGEF2;RAP1A;PINK1;RAP1B;TRAF2;NCLN;BBS10;GFAP;TJP1;NOTCH1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.33555493642413603,-0.5721620022107178,0.9491525423728814,1.0,1.0,1/10,7.29%,ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.3335273799377652,-0.5721521070963442,0.9605263157894737,1.0,1.0,3/10,22.71%,PRKCQ;HSPD1;THY1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.30465249962308494,-0.5720514706486033,0.972972972972973,1.0,1.0,6/22,29.46%,LDB1;THOC5;CCNK;HMGN1;SUPT16H;SUPT5H
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.23801844512126,0.5719421694268545,1.0,0.9936777544600175,1.0,6/23,20.62%,ERI1;LSM11;TENT2;MTPAP;XRN1;CPSF2
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.27074945164466335,-0.5715587831663708,0.9764705882352941,1.0,1.0,8/39,22.20%,GPX4;VIL1;MSRB2;CHMP4B;MICALL2;WASHC3;GSN;PSTPIP1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.37477921226812005,-0.5708286099547909,0.9859154929577465,1.0,1.0,2/7,24.14%,MTHFD1;MTRR
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.311613515792878,-0.5704364316247237,0.96,1.0,1.0,2/17,11.33%,CLU;EFNA1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.32265484092034213,0.5703700894397319,0.9411764705882353,0.9940003749740426,1.0,2/6,21.90%,PIK3CA;ARHGAP35
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.3080898589906734,0.5683546731858216,0.88,0.9946164957272212,1.0,1/7,10.89%,CYP7B1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.309442271133011,-0.5679094181547196,0.9857142857142858,1.0,1.0,1/21,3.39%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.25315885001259164,0.5675612912667315,1.0,0.9944805690792582,1.0,8/23,22.50%,LRRK2;SMG1;PIK3CA;MTM1;PINK1;MTOR;QSOX1;RUBCN
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.30331595133039174,0.567090305783316,0.9411764705882353,0.9942239093103147,1.0,7/7,69.68%,MCM4;MCM3;MCM6;MCM7;MCMDC2;MUS81;CDC7
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.31999867789888214,-0.5669641551482779,0.9736842105263158,1.0,1.0,8/15,30.19%,H2AZ1;H2AX;STMN1;KLRB1;TUBA1B;HOPX;TUBB;S100B
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.3167998651286746,-0.5661373117958016,0.9864864864864865,1.0,1.0,6/17,26.02%,ARG2;ASAH1;CYP1B1;NQO1;SPHK2;CYB5R3
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.29492557050960594,-0.5659554412956698,0.9864864864864865,1.0,1.0,3/26,15.48%,RNF8;LDB1;BTBD18
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.25772180108598547,0.5651530207124685,1.0,0.9942374495216751,1.0,5/17,25.23%,ZBTB20;P2RX7;PSEN1;PFKFB3;PFKFB1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.25772180108598547,0.5651530207124685,1.0,0.9942374495216751,1.0,5/17,25.23%,ZBTB20;P2RX7;PSEN1;PFKFB3;PFKFB1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.29655351442316524,0.5650962917452246,0.9459459459459459,0.9937743829286946,1.0,2/6,21.16%,MSN;RAB21
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.3596907625905444,0.5650084806628709,1.0,0.9933376130697862,1.0,2/7,11.73%,PRKG2;QDPR
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.32655206490197614,-0.5646877695279091,0.9305555555555556,1.0,1.0,4/10,25.48%,SFRP4;BTG1;AHI1;SOX9
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.3591253273099727,-0.5644338342666699,0.9324324324324325,1.0,1.0,1/7,18.87%,SHFL
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.3553670685678477,-0.5643758410972003,0.9076923076923077,1.0,1.0,1/5,15.54%,ACTA2
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.26442987374219235,0.5632829274920139,0.9285714285714286,0.9936247026828335,1.0,3/16,13.53%,TLE1;PIK3CA;BCL2
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.33622994652406424,0.563220488860647,0.96875,0.9931712100153925,1.0,5/5,66.39%,PIAS4;CYP2R1;CUBN;LRP2;LGMN
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.35129168903422536,-0.5619215731616761,0.9285714285714286,1.0,1.0,1/7,14.88%,SYT11
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.3077077344742294,0.5606393621958923,0.926829268292683,0.9938797014963748,1.0,6/6,69.24%,ZFAND1;VCP;KIF5B;TFIP11;KLC1;DHX8
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.3151025042469023,-0.5601479966286311,0.971830985915493,1.0,1.0,2/11,19.67%,SLC25A5;SLC25A42
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.2592450715580951,0.5597329415613495,1.0,0.993839318436531,1.0,6/27,17.66%,SMAD7;BMP7;TWSG1;ACVR1;GREM1;BMPR1A
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.3308521790719113,-0.5591067563679445,0.9701492537313433,1.0,1.0,2/8,21.32%,P2RX4;P2RY12
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.29493777360928397,0.5589401063474819,1.0,0.9937989742813691,1.0,2/6,19.35%,BMPR1B;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.2945777896637027,0.5587837509450048,0.9210526315789473,0.9934150040536384,1.0,8/8,70.56%,ZC3H14;CCNT1;CDK9;NELFE;CTR9;RNF40;RNF20;SUPT5H
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.2671026290504623,0.5584611802061065,0.8461538461538461,0.9931001032910967,1.0,2/12,12.58%,AUTS2;DNMT3B
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.311660694774336,-0.5581301585555324,0.9583333333333334,1.0,1.0,4/18,21.70%,GRIN2D;MEF2C;INSYN2A;MPP2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.25498188663939386,-0.5576617239658674,1.0,1.0,1.0,6/74,10.45%,FGF1;RARRES2;CRYAB;HAS2;FN1;OSMR
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.3832594182393387,-0.55710741336259,0.9672131147540983,1.0,1.0,1/5,23.74%,WLS
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.3046769384865175,0.5569044281601276,0.9696969696969697,0.9928572755404075,1.0,2/6,13.63%,CDC16;ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.3046769384865175,0.5569044281601276,0.9696969696969697,0.9928572755404075,1.0,2/6,13.63%,CDC16;ANAPC1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.29600305009980526,0.5566574926971136,0.9615384615384616,0.9925345216446485,1.0,5/15,18.24%,FBXW7;SRPK2;FOXO3;EPHA7;NF1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.3078320359720233,-0.5565904408946173,0.95,1.0,1.0,6/16,35.60%,SPHK2;YEATS4;MSL3;BRD8;TRRAP;NAA40
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2691697548164926,-0.5553822759258787,0.9772727272727273,1.0,1.0,14/43,29.55%,ISG15;RPL11;SVBP;USP4;RPL5;CAV1;PARK7;COPS9;CAMLG;UBXN1;UFL1;DNAJA1;PER2;PIAS3
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.36024836544874606,-0.5545772169605477,0.9863013698630136,1.0,1.0,1/6,9.15%,KDM6B
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.2765407811192739,0.5543597779082675,0.9411764705882353,0.9932148836123961,1.0,3/13,16.58%,MOV10;ZNF93;PIWIL4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.333355614973262,0.5540615397512589,0.9428571428571428,0.9929179685561941,1.0,5/5,66.68%,EHD3;ATP2A2;SLC9A1;PLN;SLC8B1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.3152580903985023,0.552972332022505,0.9117647058823529,0.9929295979659443,1.0,9/9,68.49%,GABRA1;PLXNB1;FGF13;GABRB3;GABRA2;LGI2;GABRB2;WNT5A;GABRG2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.27609747182568267,0.5517295939168618,1.0,0.9929668921930845,1.0,3/11,17.03%,MAP2;ARHGEF7;SNCA
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.35494652406417104,0.5514455660744996,0.9642857142857143,0.9926020865943997,1.0,5/5,64.52%,GTF2H2;GRK3;ARRB2;GRK2;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.27376144107468336,-0.5510310418753063,0.9767441860465116,1.0,1.0,5/32,19.69%,RRAGA;SEC13;TELO2;HDAC3;LARS1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.29107276402271465,-0.5500879235783954,0.9722222222222222,1.0,1.0,1/20,5.88%,TGFB1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.2571347466149613,-0.5495748914523103,1.0,1.0,1.0,16/58,26.69%,CRYAB;PAMR1;COL15A1;LMOD1;ACTA2;COL4A1;ADAMTS2;AEBP1;PTN;MYLK;THBS2;CALD1;THY1;COL14A1;PDGFRB;C1S
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.33464911447373463,-0.5492636621265202,0.9545454545454546,1.0,1.0,2/8,22.37%,PPP2R5A;PIP4K2C
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3429275210666368,-0.5489917088226737,0.9375,1.0,1.0,1/6,10.49%,PIK3CB
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.329125455435505,-0.5485563849906465,1.0,1.0,1.0,2/8,26.81%,ID2;PTPN2
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.35136986831244255,-0.5483425792789223,0.9565217391304348,1.0,1.0,2/7,19.24%,DIO2;SEPSECS
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.35136986831244255,-0.5483425792789223,0.9565217391304348,1.0,1.0,2/7,19.24%,DIO2;SEPSECS
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.3509860838457297,-0.5483403772810157,0.9523809523809523,1.0,1.0,4/6,36.87%,MAP1S;UXT;RHOT2;LRPPRC
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.2934688147603449,0.5482474784557965,0.926829268292683,0.9936228044156437,1.0,6/6,70.66%,NPM1;XPO1;LSG1;TSC1;RAN;ABCE1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.2553333779174747,0.5473962045878945,0.9117647058823529,0.9934204149656498,1.0,12/12,74.49%,CBFB;IKBKB;TJP1;NPHP4;ROCK1;MYO1C;ROCK2;OCLN;PRKCH;PRKACA;NPHP1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.3521930249159746,-0.546770725264736,0.9841269841269841,1.0,1.0,2/7,25.48%,ADAMTS7;SOX9
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.2582895104919823,-0.5466189952632056,1.0,1.0,1.0,7/42,24.51%,NUP155;KHK;SEC13;NUP107;NUP188;NUP85;PGAM1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.34661578766881956,0.5462805656986707,0.9722222222222222,0.9933890646728688,1.0,2/5,9.56%,VLDLR;RELN
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.26631888710540397,0.545770631723757,0.9545454545454546,0.9931015989110968,1.0,13/13,73.39%,MTMR3;SMG7;PPP1R16B;MTMR9;PPP1R16A;INPP5K;SRC;MTMR2;MTMR1;IGBP1;SMG5;MTMR4;SMG6
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.33328576262707243,-0.5441551602740557,0.9508196721311475,1.0,1.0,1/7,22.47%,PGM5
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.30713816590615894,0.5440824094151316,0.9310344827586207,0.9933776586391538,1.0,2/8,11.19%,PLAUR;ST18
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.2836867752882214,-0.5435788857147881,0.9615384615384616,1.0,1.0,1/21,4.72%,CAMK1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.2770119561748426,0.5434014601416212,0.9310344827586207,0.9932269534672343,1.0,2/7,21.58%,PRKN;ADCK1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.3187966386979591,0.5426135531101436,0.9411764705882353,0.9930763923040794,1.0,2/6,23.37%,ABCA2;NECAB2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.3191166113979146,-0.5421911703615392,0.9459459459459459,1.0,1.0,1/14,4.29%,ALOX5
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.2817606059828591,-0.5420574732584788,0.9880952380952381,1.0,1.0,3/17,19.05%,XBP1;RACK1;PDK3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.3125872353192412,-0.5412656409054307,0.9859154929577465,1.0,1.0,8/14,36.20%,APOE;PTTG1IP;RDX;VPS35;ATP5IF1;CD81;VPS11;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.297648273128127,0.5409764656159497,0.9722222222222222,0.9934202435486741,1.0,3/7,21.70%,BIN1;SESTD1;CBARP
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.35639669069874425,-0.5408430256579422,0.9666666666666667,1.0,1.0,2/5,31.45%,DYNC1LI1;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.35639669069874425,-0.5408430256579422,0.9666666666666667,1.0,1.0,2/5,31.45%,DYNC1LI1;XRCC3
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.34048585725654607,-0.539599094094465,0.971830985915493,1.0,1.0,5/8,39.79%,SPINK13;TIMP1;GJA1;CALR;ZP3
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.2917406748436866,-0.5395951417354102,0.9864864864864865,1.0,1.0,3/15,17.46%,HAS2;NDST4;B3GALT5
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.33298108613446914,-0.539583036280429,0.958904109589041,1.0,1.0,1/8,11.25%,NABP2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21720841123904386,0.5394166895310417,1.0,0.9934400899524701,1.0,10/51,19.31%,CRADD;PML;ARID3A;PCBP4;CNOT2;CNOT6L;CNOT9;ACER2;CNOT7;MDM4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.27784475969625294,-0.5384723062191749,0.974025974025974,1.0,1.0,5/23,25.39%,NOL3;ATF4;TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.3011358661250838,-0.5381298519390855,0.9864864864864865,1.0,1.0,3/11,27.07%,SMARCD1;SET;SUPT16H
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.3011358661250838,-0.5381298519390855,0.9864864864864865,1.0,1.0,3/11,27.07%,SMARCD1;SET;SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.24585854099796867,-0.5374386295652783,1.0,1.0,1.0,9/69,18.73%,RANGRF;CEMIP;PDCD5;WNK3;PLS1;ZDHHC8;AKAP5;HRAS;PDZK1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.2803000159376409,-0.5369579102316744,0.9878048780487805,1.0,1.0,1/18,4.06%,ENPP2
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.279173136952027,0.5367219028893635,1.0,0.994098447989918,1.0,1/8,7.57%,OXCT1
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.37082882797103844,-0.5357968174990674,0.9558823529411765,1.0,1.0,1/5,16.06%,ALG10B
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.2699459270927288,-0.5352967290672629,0.9876543209876543,1.0,1.0,6/24,27.32%,ECT2;MICALL2;POF1B;CLDN18;CLDN10;PRKCI
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.36574753251499165,-0.5350706903827737,0.9710144927536232,1.0,1.0,3/5,32.40%,MAP3K12;NEK11;RPS6KA5
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.3173128342245991,0.5344523616056022,0.96875,0.9944753586501941,1.0,5/5,68.28%,TOPBP1;NAE1;HUS1;RAD17;ZNF830
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.2578824300108916,-0.5341158101074683,0.987012987012987,1.0,1.0,8/38,28.02%,ZFPM1;MEF2C;NR4A3;PRKCQ;RUNX1;RBBP5;KMT2B;SETD1A
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.35575228264039127,-0.5340601768047297,0.9841269841269841,1.0,1.0,2/6,25.48%,ADAMTS7;SOX9
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.24877103027779043,-0.53352266766687,1.0,1.0,1.0,19/96,26.69%,ENPP4;PROCR;AFAP1L1;EPHX2;FN1;COL6A1;GXYLT2;LMOD1;COL4A1;NR1D1;SCARA3;CAV1;CYP1B1;CALD1;COL14A1;SRPX;COL4A2;PCOLCE2;C1S
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.32596859039775977,-0.5333194661935113,0.987012987012987,1.0,1.0,3/9,26.86%,JAG1;PROM1;BASP1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.2668720203475697,-0.5326839199262273,0.9882352941176471,1.0,1.0,4/29,19.20%,SH3GL2;NRP2;HSP90AB1;ULK1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.2967284176502254,-0.5320368881303044,0.9625,1.0,1.0,3/9,25.23%,CACNA1C;KCNJ3;KCNQ1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.3516011898678873,-0.5319489510400947,1.0,1.0,1.0,1/6,13.28%,PNKP
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3104290289695745,-0.5308851481361143,0.9857142857142858,1.0,1.0,3/11,33.71%,NEK11;MDC1;MUS81
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.24157825378825645,-0.5308181039067288,1.0,1.0,1.0,16/77,27.67%,RPL13A;IGF2BP2;GAPDH;RACK1;SHMT1;NCL;PCIF1;EIF2AK2;MALSU1;EIF4EBP1;DHX36;ILF3;PAIP2;CNOT8;BTG2;RBM4
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.29188306467382297,-0.5306186519425862,0.9705882352941176,1.0,1.0,3/13,20.49%,CELF4;NR5A2;BRCA1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.32110349960328655,-0.5280869326219434,0.9850746268656716,1.0,1.0,1/7,23.92%,DHX36
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.293779658550993,0.5277568979243277,1.0,0.9969017656049978,1.0,2/9,12.70%,TGFBR2;CHRD
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.2756953348657936,0.5272272276303704,1.0,0.9967668872226396,1.0,4/11,26.56%,EXOSC7;XRN1;DIS3L;EXOSC6
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.30716754399303836,0.5270673745296912,0.96875,0.9963772115669427,1.0,2/10,8.28%,FOXP1;ABCB10
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.31524867808343304,0.5263094438854469,0.896551724137931,0.9962172308084425,1.0,1/5,11.33%,MTMR3
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.26919603986349194,-0.5262895975519715,0.9871794871794872,1.0,1.0,5/20,23.60%,DCTD;NMNAT3;GUK1;PARK7;NMNAT1
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.29919076481109547,0.5256142828376302,0.9375,0.995955528998185,1.0,2/6,19.39%,DLL1;POU3F2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.32580213903743327,0.5254643442223893,0.9459459459459459,0.9955498242331868,1.0,5/5,67.43%,WDR70;CDK9;CTR9;RNF40;RNF20
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.24322679620498192,0.5244708623845303,1.0,0.9954837598914612,1.0,1/16,3.84%,AK3
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.2549150728901965,0.5236596373120107,1.0,0.995256688855765,1.0,11/11,74.53%,RNF128;SZT2;SH3BP4;SH3GLB1;ATP13A2;LMBRD1;RTN4;MFSD1;LAMTOR5;CD81;LAMTOR4
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.28875437390154574,0.5227846641338328,1.0,0.9950976199806948,1.0,3/11,13.48%,IWS1;SLTM;SRPK2
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.30042486008569735,-0.5227281509002699,0.9866666666666667,1.0,1.0,3/13,25.98%,WNK3;PDGFRB;SPHK2
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.22064730342736968,0.5226541709466899,1.0,0.9946676847102386,1.0,4/13,18.68%,POT1;TERF1;TERF2;UNG
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.32143506546915146,-0.5220168161331352,0.967741935483871,1.0,1.0,1/7,16.85%,C3
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.32553620280405227,-0.521624246716182,1.0,1.0,1.0,4/9,23.47%,RIC3;APOE;CHRNE;NQO1
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.31497326203208564,0.5203951791287621,0.9696969696969697,0.9951016154621645,1.0,5/5,68.51%,GOLPH3;VPS13D;VPS13A;VPS13C;SORL1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3056965607204692,-0.5200246740133591,0.9846153846153847,1.0,1.0,3/11,30.03%,ZFP36L2;DHX36;PABPC1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3056965607204692,-0.5200246740133591,0.9846153846153847,1.0,1.0,3/11,30.03%,ZFP36L2;DHX36;PABPC1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.24713947177935577,0.5197714919041397,1.0,0.9948413112469844,1.0,2/10,18.48%,SESN1;MTOR
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3160356154092592,-0.5189556034135971,0.9714285714285714,1.0,1.0,2/7,29.62%,PARK7;TRAP1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.2647076527800034,-0.5188128319393409,0.9878048780487805,1.0,1.0,11/34,36.69%,DCAKD;PPCS;IMPDH2;NPR2;ADCY7;PANK2;ACAT1;ADCY8;ADCY1;SLC35B3;PPCDC
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.19346426361794944,0.5184199762143471,1.0,0.9949533728391831,1.0,9/41,22.27%,FPGS;MTHFD2L;SDHAF3;D2HGDH;AADAT;ME3;ACOT8;ME2;SLC19A1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.24633437389922144,0.5177110070450944,1.0,0.9947018387102555,1.0,3/12,23.53%,SLC1A2;SLC1A3;GPLD1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.28218431547061784,0.5173752771369885,1.0,0.9944082965619758,1.0,3/12,13.53%,TLE1;PIK3CA;BCL2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.2844202543458362,-0.5173429983799511,1.0,1.0,1.0,4/13,37.03%,TSN;NRDE2;MRPL44;HENMT1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.3235153149539049,-0.5171907922852617,0.9264705882352942,1.0,1.0,2/7,22.63%,PRKCQ;RDX
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.3459618597743141,-0.5159982605417841,0.9523809523809523,1.0,1.0,3/6,31.50%,RDX;DTX3L;SORL1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.3459618597743141,-0.5159982605417841,0.9523809523809523,1.0,1.0,3/6,31.50%,RDX;DTX3L;SORL1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.3459618597743141,-0.5159982605417841,0.9523809523809523,1.0,1.0,3/6,31.50%,RDX;DTX3L;SORL1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.23557356623870257,0.5159323535002875,1.0,0.9944021705609639,1.0,3/37,9.79%,HSPA1A;HSPB1;HSPH1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.29829552988535724,-0.5141242046460271,1.0,1.0,1.0,2/7,33.30%,MGME1;SSBP1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.28255267458744315,0.513863952624771,1.0,0.994590199089563,1.0,4/9,28.24%,ELP3;ELP4;TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.2500246031494947,-0.5134611612293438,1.0,1.0,1.0,1/27,5.30%,DOLPP1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.268294792996604,-0.5134475823267189,0.9880952380952381,1.0,1.0,4/16,27.54%,KIF18B;STMN2;STMN1;STMN4
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.2750795428929218,-0.5124654119919637,0.974025974025974,1.0,1.0,6/19,32.28%,BCAT2;ACAD8;SLC25A44;HSD17B10;ACADSB;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.2750795428929218,-0.5124654119919637,0.974025974025974,1.0,1.0,6/19,32.28%,BCAT2;ACAD8;SLC25A44;HSD17B10;ACADSB;ACAT1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.29153926768140176,-0.5124072037694953,0.9714285714285714,1.0,1.0,2/9,23.82%,APOD;NDRG4
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.33214115194906974,-0.5119307902859599,0.9710144927536232,1.0,1.0,2/6,32.99%,FH;MDH1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3048662910738117,-0.5118288043754685,0.9850746268656716,1.0,1.0,3/10,30.82%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.3048662910738117,-0.5118288043754685,0.9850746268656716,1.0,1.0,3/10,30.82%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3048662910738117,-0.5118288043754685,0.9850746268656716,1.0,1.0,3/10,30.82%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2915925783959079,-0.5116522687000455,0.9459459459459459,1.0,1.0,4/14,24.73%,XBP1;BAX;BAG6;RNFT1
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.34092822150890106,-0.5113322294970711,0.96875,1.0,1.0,2/5,25.18%,RNF112;XRCC1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.28658195917688734,-0.5108261396609676,1.0,1.0,1.0,2/17,12.70%,TGFB1;ATG14
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.2246620774377468,0.5104859694522298,0.9615384615384616,0.9950902283656328,1.0,2/11,18.39%,D2HGDH;AADAT
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.31211937172680226,0.5102274407779072,0.972972972972973,0.9947127248603962,1.0,3/5,24.29%,LRRK2;CLUH;MAPT
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.3477164061477912,-0.5096083717737472,0.9848484848484849,1.0,1.0,2/5,27.23%,PARK7;NONO
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.26638138539716505,0.5093834033888044,0.9523809523809523,0.9944788758778097,1.0,9/9,73.38%,MTMR3;PHB2;MTMR9;ABCA3;GNB3;MTMR2;DNAJC19;MTMR1;MTMR4
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.2441787275263389,0.5089744192875201,1.0,0.9941357187198826,1.0,5/21,16.40%,H1-10;ERCC4;ZNF93;SUB1;TERF2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.2727484089237999,-0.5087945629136293,0.9868421052631579,1.0,1.0,4/17,25.38%,STAT5A;STAT1;STAT2;IFNAR1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.28633129868195617,-0.5076441840742585,0.9866666666666667,1.0,1.0,2/14,22.18%,MTHFD1;GOT1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.3311468283532262,-0.5069332073483566,0.9571428571428572,1.0,1.0,2/5,30.46%,GSN;HTRA2
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.23588341118884298,0.5064702334050437,1.0,0.9942813226633324,1.0,2/18,12.62%,ZC3H3;CPSF6
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.24928420864407866,-0.505589813291748,1.0,1.0,1.0,3/26,18.12%,PIK3CB;RACK1;TRIB3
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.24999785535057134,-0.5045052460211185,1.0,1.0,1.0,5/24,26.28%,CLU;APOE;CAV1;ABCA1;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.29355501007920337,0.5044929276327239,1.0,0.9943847024496989,1.0,2/6,15.25%,CNOT2;CNOT9
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.25742554986680605,0.5044731853614741,1.0,0.9934474878385305,1.0,3/10,22.97%,SESN1;MTOR;UBR1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.25742554986680605,0.5044731853614741,1.0,0.9934474878385305,1.0,3/10,22.97%,SESN1;MTOR;UBR1
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2844249467839307,-0.5039107568340458,0.9736842105263158,1.0,1.0,4/14,26.52%,XBP1;SPHK2;TNFRSF14;SCIMP
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.24857977635210637,-0.5033575772772134,1.0,1.0,1.0,7/46,23.58%,TGFB1;BLOC1S2;DELE1;BAX;CASP3;BCL2L2;TNFRSF1A
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.3327045053967622,0.5024276752287633,0.96875,0.9936687908042792,1.0,2/5,13.36%,MSRB3;MSRA
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.25946718883285846,-0.4997494788183083,0.975609756097561,1.0,1.0,4/18,33.91%,BAG6;STUB1;DNAJC18;RNF126
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.30132386881373285,0.4987904672072896,0.9285714285714286,0.9942931577263889,1.0,2/6,16.40%,ERCC4;TERF2
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.23311077243338377,0.49844373014485255,1.0,0.9939260257050169,1.0,3/11,21.54%,PNP;AMPD2;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.24989684169172877,0.49837700105616994,1.0,0.9934585158152215,1.0,2/15,7.70%,PLIN5;AATF
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.3008020668749478,-0.4966037633812521,1.0,1.0,1.0,2/7,28.91%,IDI1;DHDDS
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.3220588235294116,0.4947544052601879,0.9230769230769231,0.9939562561077282,1.0,5/5,67.80%,MACROH2A1;MACROH2A2;MAF1;NOP53;FLNA
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.2790676977113073,0.49279624553260826,1.0,0.9939587714279078,1.0,1/6,10.66%,AUTS2
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.3021701758341734,-0.4924447882061294,1.0,1.0,1.0,3/10,24.94%,PARG;PARK7;AKAP8
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.2462578195636765,-0.49203393006011503,1.0,1.0,1.0,6/25,30.02%,BEND3;ENTPD5;TMSB4X;PRXL2C;APP;PFKFB2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.242225640339731,0.49041612318161554,1.0,0.9942127376640743,1.0,12/12,75.80%,SNCA;BICD1;MRAP;RNF157;GRK3;CRY1;YWHAB;APLP1;GRK2;MGRN1;RPGRIP1L;STMN1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.288471437669773,-0.48769863525370505,1.0,1.0,1.0,2/10,17.71%,XBP1;IL7
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.29880608881200016,-0.48722661985455307,0.9871794871794872,1.0,1.0,3/8,30.61%,VCL;PLEKHA7;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.3079534460582092,-0.48676872596473303,1.0,1.0,1.0,2/8,31.19%,CAV1;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.26425107856575814,-0.4848302682901565,0.9850746268656716,1.0,1.0,1/13,8.65%,LDB1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.2645738640728311,0.48466567492704166,1.0,0.9950194029308682,1.0,1/5,15.64%,FLT1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.28808430944768815,-0.48416372328762075,0.9868421052631579,1.0,1.0,2/12,20.89%,NDOR1;ETFRF1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.3017379679144383,0.4826165399448755,1.0,0.9949627984481548,1.0,5/5,69.84%,TANK;ITCH;OTUD4;WDR48;TNIP1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.23963284726046866,-0.48192501929996356,0.9883720930232558,1.0,1.0,4/45,11.01%,MAN2A2;AGA;CNMD;GCNT1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.229770283708113,-0.48182863442254803,1.0,1.0,1.0,6/37,25.63%,IL5;SAXO1;FUZ;PIP4K2C;ELAPOR1;NUMA1
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.2735592899964535,-0.4813415482596249,0.9615384615384616,1.0,1.0,4/12,28.09%,LPCAT3;SREBF1;MBTPS2;MBTPS1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.3157076740723046,-0.4812248121970681,0.9682539682539683,1.0,1.0,1/6,20.49%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.2561258293562888,-0.4806726735772307,1.0,1.0,1.0,2/19,12.70%,TGFB1;ATG14
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.25853464324893044,-0.4803093296555391,1.0,1.0,1.0,4/22,20.83%,TEAD3;DVL2;SAV1;CASP3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.23956478753943652,-0.4794094336636801,1.0,1.0,1.0,3/23,19.05%,XBP1;RACK1;PDK3
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.27075480710463384,-0.4792123112973427,1.0,1.0,1.0,3/15,25.23%,TTN;GSN;KCNQ1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.2508127617964323,-0.47823961693624967,0.9866666666666667,1.0,1.0,1/16,6.20%,FUCA1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.22563029278473157,0.47801155262997297,1.0,0.9955172557308518,1.0,5/12,28.05%,HMGB1;HMGB2;DFFA;DFFB;DICER1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.22618404537702194,-0.47737434450240823,1.0,1.0,1.0,7/41,24.16%,GORASP1;STX1B;MYLIP;APOE;STMN2;PRAG1;ITM2C
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.292399914076948,-0.47715811364911215,0.961038961038961,1.0,1.0,2/9,19.73%,RPS21;ERI2
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.26990997222875507,-0.4762960635035575,0.9746835443037974,1.0,1.0,3/14,22.57%,WNK3;SYT11;ACTN2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.2901447419048086,-0.475735080874231,0.9855072463768116,1.0,1.0,4/8,35.36%,PTN;RUNX1;PURB;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.3030308641536046,-0.47407660690021636,0.9701492537313433,1.0,1.0,2/6,31.91%,TNIP1;SART3
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.2701617392842503,-0.4740327219178576,1.0,1.0,1.0,2/12,27.78%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.31358564930846705,-0.4735319791376874,1.0,1.0,1.0,2/6,25.86%,CYP3A5;CYP2E1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.2932086065764552,-0.47185045126121,0.9846153846153847,1.0,1.0,3/7,32.48%,DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.27604690601708326,-0.4715840606660771,0.9861111111111112,1.0,1.0,2/10,27.78%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.23571352312134985,-0.47123530971446664,1.0,1.0,1.0,9/23,38.63%,BEND3;RBBP5;KMT2B;SETD1A;CXXC1;MEN1;ZNF335;WDR5;CTR9
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.3008248589683934,-0.469685826471636,0.9841269841269841,1.0,1.0,2/7,23.58%,VCL;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.24978109174319163,-0.46925831429189646,0.9861111111111112,1.0,1.0,5/18,27.81%,OBSL1;SS18L2;CUL7;DHX36;LRP8
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.25688609072138047,0.4672516709858277,1.0,0.9973177357225467,1.0,2/9,12.37%,PON3;NPL
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.23336412024788217,0.4655723972667287,1.0,0.9971096153364548,1.0,5/9,24.90%,PML;SRPK2;HABP4;ETS1;HIPK2
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.3013320888791581,-0.46213457642805766,0.971830985915493,1.0,1.0,2/7,24.14%,TXN2;MTRR
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.22764662609509806,0.46111209485294913,1.0,0.9975787057812151,1.0,12/12,77.25%,RHOT1;SYBU;MAPT;OPA1;SPAST;HIF1A;NEFL;UBB;LRPPRC;RHOT2;UXT;MAP1S
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.2570339843551553,-0.4551420561385993,1.0,1.0,1.0,1/10,22.67%,BAG6
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.3025131352610789,-0.4550050862625168,1.0,1.0,1.0,1/5,24.78%,PSIP1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.2884621904043454,-0.4535938118407076,0.9736842105263158,1.0,1.0,1/7,16.06%,ALG10B
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.274529407294397,-0.4527377868515433,0.9852941176470589,1.0,1.0,2/10,21.22%,CHMP4B;TMEM39A
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.2703694855416261,-0.4508618003391435,1.0,1.0,1.0,3/8,25.48%,PTN;DHX36;SOX9
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.28255347593582886,0.45083463181651445,1.0,0.9986989929952308,1.0,5/5,71.75%,GUCY1B1;GUCY1A1;PDE9A;PDE2A;NPR2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.22916945298916677,0.4500902839965775,1.0,0.998390313644036,1.0,11/11,77.10%,PTPRN2;CYB5R4;CAMK2G;RIMS2;SNX19;RAB11FIP5;RAB11FIP2;PTPRN;SELENOT;RAB11B;PARK7
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.20507159106115344,0.4475798910196007,1.0,0.9982238134210649,1.0,19/19,79.52%,MAPK3;NOS1;TADA2A;RUVBL2;PPARGC1A;TADA2B;SMARCB1;PAXIP1;KAT7;WBP2;SMAD4;RPS6KA4;GLYR1;PIH1D1;ARRB1;RPS6KA5;SPHK2;BRD7;BRCA1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.24790435069199215,-0.44498745242136195,0.9866666666666667,1.0,1.0,7/18,35.49%,ELOVL2;ACSBG1;DGAT1;HSD17B12;FAR2;ELOVL1;ACSL1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.24603183858026711,0.44484414673244105,1.0,0.9981075244213765,1.0,2/5,22.22%,NOS1;RAB6A
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.2939980637981662,-0.44033178295627634,1.0,1.0,1.0,2/6,35.73%,UBXN1;AQP11
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.21130302284775312,-0.4395991595468594,1.0,1.0,1.0,2/24,12.00%,BEND3;ANTKMT
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.288264778779305,-0.43933854399123273,1.0,1.0,1.0,1/5,21.28%,GOPC
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.2381721833732352,-0.4390049279233564,1.0,1.0,1.0,6/18,35.89%,PRDX5;DHX36;ZNF76;AR;ZNF143;ZC3H8
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.2847539572980419,-0.4385871855804252,1.0,1.0,1.0,3/6,35.17%,SFXN3;SLC7A10;SLC38A2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.27687165775401074,0.4364700895002561,1.0,0.9981503206246395,1.0,5/5,72.32%,CPSF6;DHX9;KHDRBS1;NCBP2;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.27687165775401074,0.4364700895002561,1.0,0.9981503206246395,1.0,5/5,72.32%,CPSF6;DHX9;KHDRBS1;NCBP2;NRDE2
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.20838908215145835,0.4356653633434883,1.0,0.9977926325259989,1.0,17/17,79.18%,HMGB1;HMGB2;DFFA;DFFB;DICER1;SETMAR;EXOG;H1-0;ENDOG;DNASE1;FBH1;CECR2;KPNB1;MUS81;KPNA1;REXO4;CASP3
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.2548710911079382,-0.43291814012081076,0.9701492537313433,1.0,1.0,2/9,22.81%,RAB35;VPS35
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.19436626964030182,-0.42390448308547907,1.0,1.0,1.0,9/49,28.49%,CACTIN;NLRC5;COMMD6;CDKN2A;CYP1B1;CARD8;TMSB4X;UFL1;SPI1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.28096852687486823,-0.4225748530517418,1.0,1.0,1.0,3/6,29.76%,CCDC39;CCDC40;SRP54
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.26258810651137576,-0.4213437368663097,0.9852941176470589,1.0,1.0,3/8,29.97%,WFS1;PAX8;APP
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2854539816861966,-0.4202754769382317,1.0,1.0,1.0,4/6,36.75%,P2RY12;ADAM9;PODXL;TGFB2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.231349746380751,-0.41994303540108513,0.9864864864864865,1.0,1.0,2/14,19.51%,ELOVL2;ACSBG1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.22900918725517444,0.4168466326351736,1.0,0.9988508714225046,1.0,3/7,20.38%,CD200;PTK2B;MTUS1
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.2664401170829672,-0.4162165855502279,1.0,1.0,1.0,2/5,27.84%,CCNK;PSMC3
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.24339537882351941,-0.41486006477453624,0.971830985915493,1.0,1.0,5/12,38.63%,CHTOP;PAF1;ZNF335;TTLL12;CTR9
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.29302759286295965,-0.41367897034547746,1.0,1.0,1.0,1/5,23.33%,SLC36A4
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.23678230108116738,-0.4052621590300774,1.0,1.0,1.0,2/12,21.00%,AKAP5;FSHR
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.223689676480717,-0.3990845816038421,1.0,1.0,1.0,5/18,38.46%,PTPA;PPP6R2;SH2D4A;PPP1R35;TSC1
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.25984167459697055,-0.398676443960883,1.0,0.9998818007392631,1.0,2/6,24.39%,CLDN18;CLDN10
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.2021372983590519,-0.3832075552613118,1.0,0.9999340291362915,1.0,1/20,14.25%,USP50
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.1900112627354056,-0.36243243114589035,1.0,0.9998346237276363,1.0,8/25,37.10%,HDAC3;TAOK3;GSTP1;AIDA;IGBP1;MEN1;QARS1;PPIA
